data_2lri_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lri _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.549 -0.537 . . . . 3.7 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.6 t -67.1 106.29 1.93 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.497 -0.557 . . . . 0.57 109.497 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.41 -21.76 57.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 121.344 -0.455 . . . . 0.87 112.937 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.22 -33.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.834 0.35 . . . . 1.54 111.027 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.35 -38.96 6.64 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.085 0.402 . . . . 1.63 112.085 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.11 58.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.862 -0.685 . . . . 0.77 111.421 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.01 155.05 17.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.984 0.421 . . . . 2.1 110.9 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.08 17.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.024 -0.83 . . . . 0.66 111.024 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -64.08 118.1 8.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.294 -0.453 . . . . 1.52 110.823 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.12 47.53 21.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.616 -0.72 . . . . 2.23 110.744 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.455 HG21 ' N ' ' C' ' 34' ' ' PHE . 2.9 p -89.16 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.662 -0.699 . . . . 1.76 109.735 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.43 143.7 29.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.77 0.319 . . . . 1.18 110.521 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 40.3 mmt-85 -104.74 147.04 28.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 3.64 109.948 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.36 146.55 29.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.408 -0.59 . . . . 0.37 109.408 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -92.55 -29.69 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.461 -0.336 . . . . 1.34 111.705 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -89.71 -17.23 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.32 . . . . 1.81 111.105 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 p -150.9 -173.27 4.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.973 -0.751 . . . . 0.92 108.973 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.98 115.64 30.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.008 -0.367 . . . . 1.17 110.008 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -157.29 156.9 33.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.409 -0.36 . . . . 1.13 110.459 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 111.84 9.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.841 -0.618 . . . . 1.18 109.807 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.455 ' N ' HG21 ' C' ' 24' ' ' VAL . 37.8 p90 -156.24 158.96 38.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.99 -0.55 . . . . 0.68 109.836 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.6 m170 -92.3 133.13 36.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.267 -1.012 . . . . 0.58 108.267 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.45 -52.49 28.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.375 0.422 . . . . 0.77 111.585 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -62.57 -25.8 68.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 3.8 111.86 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.14 -22.45 52.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.939 0.399 . . . . 0.54 110.852 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 0.9 OUTLIER -101.09 -40.69 7.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.324 -0.398 . . . . 0.72 111.068 178.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -117.76 79.02 12.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.402 -0.363 . . . . 0.94 110.458 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 3.8 Cg_endo -86.74 7.09 5.06 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.242 2.628 . . . . 2.64 112.411 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.58 4.54 27.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 3.71 111.789 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.7 26.64 24.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.477 -0.868 . . . . 1.86 111.76 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -75.73 140.64 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.895 -0.409 . . . . 1.52 109.895 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 11.5 p -88.7 135.35 33.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.669 0.271 . . . . 2.07 110.627 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -73.85 112.68 17.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 3.22 110.755 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.66 133.34 20.22 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.503 2.135 . . . . 1.22 112.069 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.28 -17.49 69.02 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.611 -0.804 . . . . 1.9 111.249 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 2.3 p -98.06 74.71 2.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.377 -0.412 . . . . 3.21 111.28 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.03 85.46 1.73 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.452 -0.88 . . . . 1.31 112.851 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.38 124.15 20.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.243 -0.651 . . . . 1.51 109.243 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -125.69 130.72 52.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 3.09 111.327 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -76.36 -178.37 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.55 110.067 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -60.24 -46.28 90.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 4.7 111.051 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -65.65 -48.42 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 1.89 111.056 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.76 -22.28 65.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.531 0.205 . . . . 0.72 111.514 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -86.25 -2.6 58.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.496 0.189 . . . . 1.79 111.017 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.812 -0.709 . . . . 2.19 111.855 178.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.757 -0.46 . . . . 3.7 109.757 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 4.4 t -81.83 104.8 12.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.973 -0.558 . . . . 0.57 109.753 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -2.28 60.51 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 115.759 -0.655 . . . . 0.87 113.306 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.75 -29.2 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.992 0.425 . . . . 1.54 110.384 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.99 -35.1 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.448 -0.342 . . . . 1.63 111.056 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.22 -11.86 21.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.892 -0.671 . . . . 0.77 111.992 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 24.4 t70 -97.73 147.15 24.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.733 0.302 . . . . 2.1 110.632 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.21 16.34 8.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.965 -0.636 . . . . 0.66 112.121 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.16 132.63 35.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 1.52 110.121 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t0 52.59 56.16 8.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.791 0.805 . . . . 2.23 109.488 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 6.2 p -91.44 137.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.168 -0.924 . . . . 1.76 110.63 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.97 147.9 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.18 110.225 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 10.4 mmm180 -114.47 136.05 53.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.963 -0.562 . . . . 3.64 110.16 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.8 t -67.56 136.78 55.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.349 -0.387 . . . . 0.37 110.102 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -88.26 -12.76 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 1.34 111.108 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -100.96 -23.25 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 1.81 110.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.3 p -151.28 -172.4 4.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.92 109.656 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.34 113.96 27.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.684 -0.234 . . . . 1.17 110.417 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.28 140.15 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.427 . . . . 1.13 110.653 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.71 112.17 23.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 1.18 109.354 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -150.89 166.85 29.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.293 -0.412 . . . . 0.68 110.806 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -104.4 138.17 41.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.277 -0.638 . . . . 0.58 109.277 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -63.44 -34.44 77.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.835 -0.62 . . . . 0.77 110.387 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -68.69 -36.6 78.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 3.8 110.798 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -73.61 -23.15 59.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.54 110.919 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -92.32 -54.71 3.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.136 -0.484 . . . . 0.72 110.935 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.16 144.07 30.44 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.94 110.227 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.27 165.09 25.66 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.795 2.33 . . . . 2.64 112.068 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -13.96 47.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.192 -0.913 . . . . 3.71 112.961 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.44 -6.5 77.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.49 -0.862 . . . . 1.86 112.519 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.9 m -91.48 130.46 37.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 1.52 111.123 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.3 t -89.9 150.37 22.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.816 -0.629 . . . . 2.07 109.459 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -79.41 131.69 64.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.543 -0.54 . . . . 3.22 109.543 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.6 132.15 21.43 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.176 1.917 . . . . 1.22 111.925 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.33 -2.32 67.19 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.861 -0.685 . . . . 1.9 112.323 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.2 p -89.3 -2.77 58.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.817 0.342 . . . . 3.21 111.22 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.86 5.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.519 -0.848 . . . . 1.31 112.444 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.5 123.35 25.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.047 0.451 . . . . 1.51 109.844 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.74 133.32 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 3.09 111.295 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -77.38 -174.24 3.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.176 -0.676 . . . . 0.55 109.176 172.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.23 -53.17 59.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 4.7 111.374 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -63.46 -42.47 98.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.89 111.646 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 -17.27 62.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.679 0.276 . . . . 0.72 111.297 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 70.6 m -85.39 -3.04 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 1.79 110.989 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 120.606 -0.807 . . . . 2.19 112.381 178.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.648 -0.871 . . . . 3.7 108.648 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 49.3 t -72.17 103.78 3.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 0.57 110.497 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.73 -7.65 83.92 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.856 -0.611 . . . . 0.87 111.644 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.94 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 1.54 110.255 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.2 p -102.73 -28.08 12.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.914 0.388 . . . . 1.63 110.038 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.11 24.75 10.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.77 111.693 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 27.9 t70 -142.59 147.83 36.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 2.1 110.706 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.23 16.94 8.04 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.631 -0.587 . . . . 0.66 111.631 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.5 m -80.44 120.02 23.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.155 -0.313 . . . . 1.52 110.155 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.72 50.03 17.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.56 0.695 . . . . 2.23 110.167 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.43 144.53 8.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.936 -1.029 . . . . 1.76 109.903 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.47 155.42 19.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.961 0.41 . . . . 1.18 110.376 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.0 mmm180 -123.64 151.96 42.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.014 -0.735 . . . . 3.64 109.014 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 37.9 t -69.63 138.78 53.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.618 -0.833 . . . . 0.37 109.176 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p -80.98 -10.86 59.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.101 0.477 . . . . 1.34 110.98 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -117.25 -7.81 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.031 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 14.3 m -140.92 179.32 6.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.92 110.406 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.6 113.29 26.76 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.011 -0.737 . . . . 1.17 109.011 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.91 145.34 6.22 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.058 0.224 . . . . 1.13 110.53 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.53 112.41 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.477 0.486 . . . . 1.18 110.268 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -157.06 145.15 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.913 -0.585 . . . . 0.68 110.146 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.817 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 77.2 m80 -86.75 151.35 23.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.516 -0.55 . . . . 0.58 109.516 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 67.9 t-105 -61.98 -50.5 71.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.763 0.316 . . . . 0.77 110.489 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -69.43 -14.53 62.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 3.8 111.731 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.817 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.8 m -80.79 -20.96 41.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.251 0.548 . . . . 0.54 110.029 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.06 -39.41 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.72 111.392 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -125.68 158.61 64.45 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.94 110.496 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.42 159.82 51.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.595 2.197 . . . . 2.64 110.935 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.3 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 3.71 111.458 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.21 -12.8 79.75 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.231 -0.509 . . . . 1.86 112.413 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 23.7 m -88.81 138.9 30.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 1.52 109.914 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.11 137.74 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 2.07 110.319 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . 0.466 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 14.4 ptm180 -93.12 121.74 64.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.352 -0.385 . . . . 3.22 111.221 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.02 136.57 29.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.769 2.312 . . . . 1.22 111.639 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.74 -46.99 10.32 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.075 -0.583 . . . . 1.9 112.721 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -17.65 16.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.163 0.506 . . . . 3.21 111.307 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -115.95 50.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.686 -0.769 . . . . 1.31 112.63 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.09 123.54 21.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.934 -0.765 . . . . 1.51 108.934 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 76.0 mtt180 -117.82 140.97 48.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.933 0.397 . . . . 3.09 111.832 -170.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 17.6 p -77.29 171.51 14.75 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.424 -0.954 . . . . 0.55 108.424 169.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -56.55 -38.79 72.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.194 0.452 . . . . 4.7 111.752 -171.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -68.62 -40.45 80.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 1.89 110.843 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -71.47 -26.19 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.732 0.301 . . . . 0.72 111.021 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 41.9 p -93.46 19.76 8.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.983 0.421 . . . . 1.79 110.689 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 C-N-CA 121.13 -0.557 . . . . 2.19 112.126 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.662 0.267 . . . . 3.7 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.2 t -65.4 113.56 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.57 109.699 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.61 -19.2 62.38 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.075 -0.583 . . . . 0.87 113.496 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.93 -30.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.059 0.457 . . . . 1.54 110.686 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.6 m -108.57 -24.56 11.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.56 0.578 . . . . 1.63 112.56 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.46 16.9 79.81 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.304 -0.718 . . . . 0.77 111.304 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -134.85 156.2 49.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.451 . . . . 2.1 110.137 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.89 22.09 5.19 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.721 -0.752 . . . . 0.66 112.816 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.0 m -75.66 125.83 29.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.52 110.059 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 54.36 45.73 26.57 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.334 0.588 . . . . 2.23 110.234 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.75 151.77 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.76 110.531 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.2 mt -96.02 149.49 21.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.142 -0.481 . . . . 1.18 109.898 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -107.38 155.46 19.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.114 -0.494 . . . . 3.64 110.505 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.422 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.1 t -88.92 140.43 29.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.613 -0.514 . . . . 0.37 109.613 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -90.37 -26.83 19.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.032 0.444 . . . . 1.34 111.275 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -89.96 -20.5 23.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 1.81 111.05 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.422 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.0 p -151.0 -172.32 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.961 -0.755 . . . . 0.92 108.961 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.27 114.27 28.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.949 -0.389 . . . . 1.17 109.949 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.32 151.96 10.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 1.13 110.776 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -119.35 120.58 37.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.805 -0.634 . . . . 1.18 109.679 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.84 148.17 31.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.193 -0.458 . . . . 0.68 110.873 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.473 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.6 m170 -88.82 126.61 35.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.79 -1.189 . . . . 0.58 107.79 168.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -56.57 -38.59 72.17 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.69 0.619 . . . . 0.77 111.192 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -71.71 -23.7 61.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.904 0.383 . . . . 3.8 111.222 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 84.4 m -85.14 -22.99 28.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.421 -0.354 . . . . 0.54 110.93 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . 0.419 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 7.6 m-70 -102.15 -24.72 13.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.72 111.539 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -130.87 65.1 75.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.913 0.387 . . . . 0.94 110.522 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 6.2 Cg_exo -78.97 5.42 5.72 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.159 2.572 . . . . 2.64 112.436 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.14 3.58 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.302 -0.408 . . . . 3.71 111.326 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.8 8.24 45.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 1.86 112.7 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.3 m -67.72 129.35 39.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.121 -0.325 . . . . 1.52 110.121 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 p -90.03 149.17 22.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.631 0.253 . . . . 2.07 110.575 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -78.13 121.97 84.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 3.22 111.257 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.71 155.65 58.35 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.771 2.314 . . . . 1.22 111.466 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.44 -19.43 79.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.98 -0.629 . . . . 1.9 111.814 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -147.11 142.29 27.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.917 0.389 . . . . 3.21 110.212 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 51.71 1.47 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.784 -0.722 . . . . 1.31 112.36 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.54 122.13 25.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.172 0.51 . . . . 1.51 110.372 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -127.89 137.29 52.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.171 -0.468 . . . . 3.09 110.505 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -72.89 -177.0 2.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.476 -0.564 . . . . 0.55 109.476 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -67.01 -40.43 87.31 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.631 -0.428 . . . . 4.7 110.631 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -67.68 -43.58 79.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 1.89 111.459 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.78 -17.22 62.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.72 110.791 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -87.41 19.66 3.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 1.79 110.574 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 110.498 -1.041 . . . . 2.19 110.498 172.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 110.118 -0.327 . . . . 3.7 110.118 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -64.19 103.42 0.62 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.57 109.516 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.08 -17.41 69.7 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.867 -0.682 . . . . 0.87 112.764 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.78 -38.56 80.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.824 0.345 . . . . 1.54 110.981 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.6 p -109.52 -28.96 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.979 0.419 . . . . 1.63 110.576 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.51 -14.38 56.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.044 -0.598 . . . . 0.77 111.829 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -94.94 140.27 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 2.1 110.987 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.09 20.23 16.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.925 -0.655 . . . . 0.66 112.476 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -78.36 116.37 18.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.461 0.172 . . . . 1.52 110.581 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.71 66.19 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 2.23 111.386 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.49 140.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 1.76 110.987 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -88.06 143.8 26.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 1.18 109.405 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.6 OUTLIER -108.07 135.54 49.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.069 0.462 . . . . 3.64 110.612 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -63.57 141.27 58.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.299 -0.864 . . . . 0.37 110.261 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.3 p -89.51 -26.23 21.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.324 -0.398 . . . . 1.34 111.35 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -89.64 -21.51 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.81 110.904 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.436 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.9 p -150.49 -172.29 4.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.478 -0.934 . . . . 0.92 108.478 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.03 114.4 28.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.788 0.328 . . . . 1.17 110.187 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.45 123.23 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 1.13 109.847 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.34 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.583 -0.525 . . . . 1.18 109.583 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -147.77 162.92 38.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.004 -0.544 . . . . 0.68 110.122 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.418 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -93.03 133.72 35.89 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.873 -0.788 . . . . 0.58 108.873 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -51.14 -48.05 61.91 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.632 0.582 . . . . 0.77 111.092 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 33.7 mmt180 -74.41 -5.46 42.59 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.388 0.514 . . . . 3.8 112.388 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.5 m -91.23 -22.2 20.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 0.54 110.561 175.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -102.35 -43.31 5.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.01 0.433 . . . . 0.72 110.722 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 88.3 m-85 -118.58 137.72 25.1 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.595 . . . . 0.94 109.928 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.41 177.65 6.46 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.7 2.267 . . . . 2.64 112.633 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.11 -37.89 78.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.68 0.276 . . . . 3.71 111.699 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.64 -20.93 64.43 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.105 -0.498 . . . . 1.86 113.787 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.12 132.35 34.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.125 0.463 . . . . 1.52 110.111 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.74 137.99 31.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.29 -0.414 . . . . 2.07 110.956 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -74.84 117.29 61.4 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.763 -0.653 . . . . 3.22 110.632 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.41 132.63 22.66 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.587 2.191 . . . . 1.22 111.638 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.23 -39.3 12.94 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.769 -0.729 . . . . 1.9 111.459 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.1 m -98.14 112.49 24.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.447 -0.377 . . . . 3.21 110.597 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.58 59.99 3.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.885 -0.674 . . . . 1.31 112.801 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.76 122.51 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.847 -0.797 . . . . 1.51 108.847 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.431 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 33.6 ptt180 -133.69 146.04 50.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.103 0.478 . . . . 3.09 111.032 -174.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.46 177.14 5.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.329 -0.85 . . . . 0.55 110.649 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -55.78 -49.37 73.36 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.151 0.282 . . . . 4.7 111.204 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -59.19 -43.25 92.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.999 0.428 . . . . 1.89 110.513 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.82 -27.76 62.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.404 0.52 . . . . 0.72 112.404 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -75.85 -7.14 53.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.874 0.369 . . . . 1.79 111.31 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.682 0 C-N-CA 120.937 -0.649 . . . . 2.19 111.794 -179.381 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.721 -0.474 . . . . 3.7 109.721 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 27.9 t -61.48 106.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 0.57 110.123 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.05 -25.7 64.67 Favored Glycine 0 C--O 1.229 -0.182 0 O-C-N 123.454 0.471 . . . . 0.87 112.516 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.17 -29.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.494 . . . . 1.54 110.885 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 88.5 m -108.1 -33.46 7.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 1.63 112.116 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.05 6.03 72.38 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.86 -0.896 . . . . 0.77 110.86 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.36 147.08 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.588 . . . . 2.1 109.912 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.45 30.99 4.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.864 -0.684 . . . . 0.66 112.752 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -74.72 125.73 29.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 1.52 109.723 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.13 51.91 14.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.438 0.637 . . . . 2.23 110.325 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.33 151.1 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.599 -0.728 . . . . 1.76 110.565 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' C' ' 36' ' ' TRP . 80.6 mt -102.27 148.38 25.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 1.18 110.023 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -115.57 138.73 50.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.844 -0.617 . . . . 3.64 110.447 -175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -75.49 143.69 42.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.743 -0.466 . . . . 0.37 109.743 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -91.04 -30.79 16.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.545 . . . . 1.34 111.855 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -91.58 -14.38 30.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.351 . . . . 1.81 111.507 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 p -150.47 -174.22 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.437 -0.579 . . . . 0.92 109.437 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.63 114.06 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.673 -0.492 . . . . 1.17 109.673 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 125.13 1.87 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 1.13 110.835 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.76 25.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 1.18 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -151.83 160.63 43.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.598 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.1 m170 -90.8 134.83 34.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.941 -0.763 . . . . 0.58 108.941 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.414 ' HB2' HD12 ' C' ' 25' ' ' LEU . 28.0 t-105 -50.54 -51.58 46.55 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.336 0.397 . . . . 0.77 111.476 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -62.19 -27.8 69.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 3.8 112.193 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -78.49 -22.91 46.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 0.54 111.346 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -100.22 -37.08 9.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.264 -0.425 . . . . 0.72 110.865 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.3 85.65 25.63 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 0.94 110.289 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.45 -5.19 12.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.117 2.544 . . . . 2.64 113.386 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.21 4.23 31.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.896 0.379 . . . . 3.71 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.41 33.78 27.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.713 -0.756 . . . . 1.86 112.024 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -61.66 142.21 57.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 1.52 110.733 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -88.48 135.45 33.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.422 -0.354 . . . . 2.07 110.157 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -67.4 125.78 91.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 3.22 110.342 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 137.64 38.17 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.575 2.184 . . . . 1.22 112.377 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.1 1.51 70.43 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.952 -0.642 . . . . 1.9 111.988 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -104.86 26.61 8.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.36 0.6 . . . . 3.21 110.746 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 118.08 122.38 3.19 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.546 -0.752 . . . . 1.31 111.805 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.7 123.57 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 1.51 109.548 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 54.1 mtt85 -125.68 134.29 51.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.359 -0.382 . . . . 3.09 111.119 -174.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.9 p -76.29 177.19 7.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.977 -0.749 . . . . 0.55 108.977 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -59.96 -40.33 88.66 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.318 0.508 . . . . 4.7 111.487 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m -65.09 -46.54 80.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.868 0.366 . . . . 1.89 110.965 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.91 -17.85 62.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.72 111.418 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 36.3 m -88.84 -14.33 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.38 . . . . 1.79 110.56 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 C-N-CA 120.907 -0.663 . . . . 2.19 112.623 -177.034 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 110.108 -0.33 . . . . 3.7 110.108 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -81.9 102.76 11.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.57 108.608 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.66 80.34 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.828 -0.624 . . . . 0.87 112.806 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -66.14 -28.83 44.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.085 0.469 . . . . 1.54 110.725 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.56 -41.9 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.314 -0.403 . . . . 1.63 110.326 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.49 -10.82 8.07 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.911 -0.661 . . . . 0.77 112.256 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -100.23 148.19 24.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 2.1 111.843 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.75 16.43 21.15 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.488 -0.778 . . . . 0.66 111.491 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.4 m -74.0 115.59 13.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.826 -0.187 . . . . 1.52 110.739 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.19 66.34 1.26 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.801 0.688 . . . . 2.23 111.014 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -89.97 136.53 23.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.63 -0.714 . . . . 1.76 111.008 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.03 144.09 28.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.667 -0.697 . . . . 1.18 110.014 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.1 mpt_? -103.78 146.65 28.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.953 -0.567 . . . . 3.64 110.19 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 27.0 t -72.62 141.39 48.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.515 -0.55 . . . . 0.37 109.515 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.44 -26.05 33.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.158 -0.474 . . . . 1.34 111.581 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -94.91 -28.12 15.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 1.81 111.521 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.553 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.9 p -143.93 -174.02 4.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.57 . . . . 0.92 109.46 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.58 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.781 0.324 . . . . 1.17 110.719 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -160.8 138.46 9.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.046 -0.525 . . . . 1.13 109.973 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.56 112.12 22.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.858 -0.423 . . . . 1.18 109.858 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -156.53 166.0 34.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.834 0.35 . . . . 0.68 110.976 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -97.29 135.22 39.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.58 108.795 171.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -59.62 -39.28 83.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.924 -0.58 . . . . 0.77 110.593 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.61 -15.83 60.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 3.8 111.73 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 68.7 m -84.32 -22.45 30.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.168 0.509 . . . . 0.54 110.12 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.24 -56.07 2.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 0.72 111.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.443 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 75.6 m-85 -106.99 135.24 19.6 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.833 -0.621 . . . . 0.94 110.14 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -70.78 176.3 7.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.272 . . . . 2.64 112.667 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.94 65.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.437 -0.347 . . . . 3.71 111.654 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.52 -23.08 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.86 112.88 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 13.1 m -99.0 128.88 45.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.883 -0.414 . . . . 1.52 109.883 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 63.0 p -89.21 138.0 31.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.465 -0.334 . . . . 2.07 111.216 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -75.61 116.17 52.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 3.22 110.348 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.96 133.42 21.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.237 1.958 . . . . 1.22 111.449 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.15 79.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.938 -0.649 . . . . 1.9 111.733 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.4 p -131.53 141.46 49.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.012 -0.366 . . . . 3.21 110.012 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.74 53.15 3.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 1.31 112.275 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 123.25 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.81 -0.441 . . . . 1.51 109.81 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -117.25 145.7 43.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.915 0.388 . . . . 3.09 110.779 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 13.9 p -84.65 -176.21 6.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.308 -0.627 . . . . 0.55 109.308 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -62.5 -48.31 80.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 4.7 111.348 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 19.3 t -67.1 -44.77 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.324 -0.398 . . . . 1.89 111.244 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -72.14 -29.33 63.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.816 0.302 . . . . 0.72 111.816 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 2.6 t -90.65 -12.23 37.46 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.793 -0.363 . . . . 1.79 111.679 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 C-N-CA 120.023 -1.084 . . . . 2.19 113.092 179.354 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.644 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 73.1 mtt180 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.636 -0.505 . . . . 3.7 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.87 106.62 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.227 -0.657 . . . . 0.57 109.227 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 -22.3 55.0 Favored Glycine 0 C--N 1.33 0.224 0 O-C-N 123.349 0.405 . . . . 0.87 113.109 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.4 -30.2 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.54 110.891 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 86.5 m -108.57 -46.02 3.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.774 0.657 . . . . 1.63 112.774 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . 0.644 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 102.67 -17.17 53.74 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.77 111.536 -173.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.42 150.37 20.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.864 0.364 . . . . 2.1 110.758 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.13 9.04 29.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.186 -0.766 . . . . 0.66 111.186 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 m -72.48 136.7 46.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.389 . . . . 1.52 110.539 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.92 47.09 7.0 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.967 0.889 . . . . 2.23 111.075 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.65 140.45 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.76 109.854 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.35 144.56 25.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.932 0.396 . . . . 1.18 110.381 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -109.32 149.69 29.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.588 -0.733 . . . . 3.64 109.551 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.64 137.36 33.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.022 0.439 . . . . 0.37 110.521 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 33.8 p -85.51 -3.5 58.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.591 . . . . 1.34 111.957 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -122.18 -15.44 7.71 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.002 -0.279 . . . . 1.81 111.631 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -151.9 -167.42 2.77 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.92 109.548 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.01 29.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.548 -0.296 . . . . 1.17 110.249 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.96 145.68 15.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.326 -0.397 . . . . 1.13 110.528 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.58 112.53 16.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.008 -0.542 . . . . 1.18 110.052 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.76 162.72 38.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.924 -0.398 . . . . 0.68 109.924 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -95.28 138.08 33.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.713 -0.847 . . . . 0.58 108.713 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -50.29 -53.03 31.56 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.239 0.337 . . . . 0.77 111.399 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -66.34 -18.07 65.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 3.8 111.97 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.0 m -84.17 -22.2 31.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.162 0.506 . . . . 0.54 110.852 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.94 -34.63 8.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.72 110.672 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -124.12 132.42 24.3 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.94 109.785 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.14 154.65 27.3 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.892 2.395 . . . . 2.64 111.695 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.39 -19.84 57.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.388 -0.823 . . . . 3.71 112.449 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.74 -18.8 78.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.987 -0.625 . . . . 1.86 112.067 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -85.49 125.36 32.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 1.52 110.013 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m -88.51 136.42 33.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 2.07 110.567 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -69.92 123.94 89.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 3.22 110.299 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.79 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.664 2.243 . . . . 1.22 112.581 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.84 5.42 82.08 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.827 -0.701 . . . . 1.9 111.583 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -92.7 18.46 8.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.14 0.495 . . . . 3.21 110.881 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.86 135.17 8.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.977 -0.63 . . . . 1.31 111.69 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 123.82 22.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.962 0.41 . . . . 1.51 110.008 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -117.41 138.05 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 3.09 110.69 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -81.12 -176.67 6.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.668 -0.493 . . . . 0.55 109.668 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -57.4 -52.48 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 4.7 111.1 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.9 t -63.11 -46.29 88.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.497 -0.32 . . . . 1.89 111.359 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 80.6 m -72.18 -17.77 61.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.072 0.397 . . . . 0.72 112.072 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -81.65 -13.75 57.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.423 -0.511 . . . . 1.79 110.147 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 CA-C-N 115.707 -0.679 . . . . 2.19 111.495 178.031 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.406 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.7 ttp180 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.602 0.239 . . . . 3.7 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -69.08 111.32 4.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.768 -0.456 . . . . 0.57 109.768 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.69 81.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.27 -0.49 . . . . 0.87 112.846 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.45 -37.65 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.763 0.316 . . . . 1.54 110.931 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.0 m -96.14 -43.55 7.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 1.63 111.621 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.37 1.01 55.65 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.144 -0.783 . . . . 0.77 111.144 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -117.22 143.48 45.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.338 . . . . 2.1 110.407 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -110.37 9.32 30.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.958 -0.639 . . . . 0.66 112.078 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -72.78 134.02 44.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.168 -0.308 . . . . 1.52 110.168 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.34 48.6 21.6 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.628 0.58 . . . . 2.23 110.848 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.18 145.05 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 1.76 110.518 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.26 147.43 23.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.274 -0.421 . . . . 1.18 110.407 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -112.7 150.28 31.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 3.64 110.876 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -82.79 134.28 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.37 108.883 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.464 HG22 ' O ' ' C' ' 51' ' ' LEU . 5.9 t -85.57 -11.72 53.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.732 -0.387 . . . . 1.34 111.491 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.75 -17.95 13.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.795 0.294 . . . . 1.81 111.795 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.57 -167.55 2.85 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.475 -0.565 . . . . 0.92 109.475 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 114.09 28.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.755 0.312 . . . . 1.17 110.36 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.8 146.34 19.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 1.13 110.374 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -133.26 112.18 11.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.136 -0.484 . . . . 1.18 110.256 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.6 164.82 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.104 -0.498 . . . . 0.68 109.847 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.845 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.3 m170 -96.54 137.76 35.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.104 -1.073 . . . . 0.58 108.104 171.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -47.65 -51.65 20.82 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.533 0.521 . . . . 0.77 112.006 -173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -61.65 -32.88 73.07 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.152 0.427 . . . . 3.8 112.152 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.845 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 9.1 m -71.35 -21.4 62.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.54 111.043 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.89 -42.93 5.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.72 111.174 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.99 142.94 29.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.41 -0.359 . . . . 0.94 110.714 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.16 149.02 6.49 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.602 2.868 . . . . 2.64 112.75 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -16.15 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.328 -0.851 . . . . 3.71 112.566 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.64 18.27 56.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 1.86 112.285 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.4 m -106.63 131.27 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.498 0.19 . . . . 1.52 110.542 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -88.54 133.59 34.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.975 -0.379 . . . . 2.07 109.975 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' C' ' 46' ' ' ARG . 4.1 ptm180 -80.82 130.09 65.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.714 0.292 . . . . 3.22 110.682 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.16 146.88 47.14 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.83 2.354 . . . . 1.22 112.203 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.02 -40.71 4.52 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.29 -0.724 . . . . 1.9 111.29 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.8 p -100.09 83.36 2.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.923 0.392 . . . . 3.21 110.663 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.403 ' HA2' HG23 ' C' ' 28' ' ' THR . . . 116.94 64.05 0.33 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.458 -0.877 . . . . 1.31 112.906 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.464 ' O ' HG22 ' C' ' 28' ' ' THR . 0.8 OUTLIER -77.0 121.79 24.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.782 -0.822 . . . . 1.51 108.782 176.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -126.29 132.1 51.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.436 -0.347 . . . . 3.09 110.731 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.09 179.62 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.55 109.561 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -60.17 -42.35 94.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 4.7 111.282 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -66.49 -46.26 76.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 1.89 111.057 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -71.41 -33.4 69.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.803 0.297 . . . . 0.72 111.803 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 46.1 p -83.32 -11.31 57.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 1.79 110.725 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 C-N-CA 120.971 -0.633 . . . . 2.19 111.784 179.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.604 -0.517 . . . . 3.7 109.604 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.75 103.87 1.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.52 -0.548 . . . . 0.57 109.52 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.26 86.14 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.87 113.458 -171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.94 -40.38 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.809 0.338 . . . . 1.54 110.988 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -111.67 -20.59 12.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.359 . . . . 1.63 111.147 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.95 77.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.929 -0.653 . . . . 0.77 112.036 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -109.84 146.78 34.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.259 -0.275 . . . . 2.1 110.259 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.1 17.18 9.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.66 112.753 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.76 119.43 23.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.505 -0.183 . . . . 1.52 110.505 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.72 63.1 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.413 0.445 . . . . 2.23 111.258 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -89.1 140.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 1.76 110.793 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.15 145.99 24.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.676 -0.693 . . . . 1.18 109.538 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.87 141.46 42.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 3.64 110.945 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -69.79 128.24 35.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.158 -0.682 . . . . 0.37 109.158 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 46.8 p -84.49 -8.26 59.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.495 0.664 . . . . 1.34 110.292 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -99.91 -27.97 13.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.387 -0.824 . . . . 1.81 111.056 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.1 p -151.74 -161.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.028 -0.269 . . . . 0.92 110.408 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.71 119.74 39.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.676 -0.238 . . . . 1.17 110.788 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -173.12 141.09 0.93 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.175 -0.466 . . . . 1.13 110.8 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.86 112.82 19.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.597 -0.52 . . . . 1.18 109.597 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -155.56 169.57 24.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 0.68 110.943 -173.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -102.55 134.92 45.1 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.37 -0.604 . . . . 0.58 109.37 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -63.61 -35.19 79.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.613 -0.721 . . . . 0.77 110.532 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -76.97 -17.39 58.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 3.8 111.745 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.06 -22.49 27.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.069 0.462 . . . . 0.54 110.411 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -93.3 -51.35 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.088 -0.506 . . . . 0.72 110.362 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.76 152.81 47.79 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.695 . . . . 0.94 109.963 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.29 148.48 70.59 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.244 1.963 . . . . 2.64 110.705 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.27 -11.38 31.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.022 -0.535 . . . . 3.71 111.69 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.21 7.49 80.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.11 -0.567 . . . . 1.86 112.216 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -93.02 140.54 29.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.763 -0.257 . . . . 1.52 110.308 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.3 p -87.91 143.73 26.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.973 0.416 . . . . 2.07 110.149 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -89.48 129.69 46.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.538 -0.542 . . . . 3.22 109.538 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 132.73 44.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.939 2.426 . . . . 1.22 112.761 -173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.82 -10.41 83.13 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.342 -0.703 . . . . 1.9 111.342 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -89.59 26.38 1.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.388 0.613 . . . . 3.21 110.387 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 131.99 7.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.506 -0.77 . . . . 1.31 111.758 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.76 123.13 18.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.422 -0.584 . . . . 1.51 109.422 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -110.24 147.32 34.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.32 0.581 . . . . 3.09 110.726 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.4 p -91.49 -170.05 2.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.354 -0.839 . . . . 0.55 109.526 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -61.05 -49.64 76.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.655 -0.248 . . . . 4.7 111.283 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' C' ' 58' ' ' GLY . 15.7 m -68.64 -36.97 79.31 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.196 0.522 . . . . 1.89 111.867 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -73.64 -15.73 61.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.806 0.336 . . . . 0.72 111.422 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -97.83 7.31 46.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.353 0.597 . . . . 1.79 109.772 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' C' ' 55' ' ' SER . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 110.256 -1.138 . . . . 2.19 110.256 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.423 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.6 ttt180 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.946 0.403 . . . . 3.7 110.604 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 29.5 t -90.47 103.67 16.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 0.57 109.183 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 -4.54 89.81 Favored Glycine 0 N--CA 1.453 -0.183 0 CA-C-N 115.967 -0.561 . . . . 0.87 113.253 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.11 -32.13 46.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.106 0.479 . . . . 1.54 110.21 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 p -115.89 -41.34 3.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.006 -0.543 . . . . 1.63 110.285 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.55 -15.78 7.1 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.874 -0.679 . . . . 0.77 112.381 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -91.12 140.81 29.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 2.1 111.343 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -111.28 3.48 28.22 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.989 -0.624 . . . . 0.66 112.138 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 57.6 m -80.47 134.65 36.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.52 0.2 . . . . 1.52 110.739 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 59.46 50.02 8.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.629 0.728 . . . . 2.23 110.94 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 m -89.88 144.61 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.669 -0.696 . . . . 1.76 110.869 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.6 153.26 18.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 1.18 110.023 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 25.1 mmt180 -106.86 154.44 21.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.151 -0.477 . . . . 3.64 110.411 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.4 t -89.19 144.0 26.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -23.85 22.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.766 0.317 . . . . 1.34 111.331 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -95.22 -17.58 21.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 1.81 111.232 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 9.5 p -150.84 -177.2 5.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.138 -0.69 . . . . 0.92 109.138 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.17 119.33 38.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.577 -0.283 . . . . 1.17 110.525 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.92 149.36 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.086 -0.506 . . . . 1.13 110.226 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.32 112.21 18.31 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.54 -0.541 . . . . 1.18 109.54 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -152.69 162.07 41.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.284 -0.416 . . . . 0.68 110.779 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -91.41 136.6 32.99 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.42 -0.585 . . . . 0.58 109.42 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -59.83 -36.04 76.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.77 109.975 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -72.2 -22.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 3.8 111.777 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 87.6 m -90.38 -23.44 21.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.54 111.284 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -102.07 -21.07 14.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.942 -0.303 . . . . 0.72 111.526 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -131.08 149.06 72.67 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.766 -0.457 . . . . 0.94 109.766 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.56 147.17 60.24 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.692 2.261 . . . . 2.64 111.447 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.64 61.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.203 -0.908 . . . . 3.71 112.664 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.27 -10.82 86.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.672 . . . . 1.86 112.771 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -73.44 130.04 39.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.694 0.283 . . . . 1.52 110.5 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.7 t -88.86 136.64 32.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.584 -0.525 . . . . 2.07 109.584 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -79.48 126.82 80.23 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.047 -0.524 . . . . 3.22 110.391 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.86 135.77 31.05 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.363 2.042 . . . . 1.22 111.513 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -29.36 73.85 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.737 -0.665 . . . . 1.9 112.186 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -139.38 133.24 30.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.144 -0.317 . . . . 3.21 110.144 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.07 57.19 1.61 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.524 -0.846 . . . . 1.31 112.342 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.53 123.91 22.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.498 -0.556 . . . . 1.51 109.498 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.77 140.36 49.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.482 -0.326 . . . . 3.09 110.801 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.34 169.48 12.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.409 -0.96 . . . . 0.55 108.409 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.08 -34.63 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.851 0.751 . . . . 4.7 111.158 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -64.22 -44.9 90.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 1.89 110.978 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.4 m -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.72 111.136 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.3 m -88.73 15.26 8.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 1.79 110.695 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 C-N-CA 121.051 -0.595 . . . . 2.19 111.715 179.811 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 110.303 -0.258 . . . . 3.7 110.303 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.445 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 9.4 t -82.07 104.78 12.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.705 -0.48 . . . . 0.57 109.705 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.17 -11.09 79.17 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.969 -0.559 . . . . 0.87 113.008 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 t -67.54 -28.0 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.056 0.455 . . . . 1.54 110.67 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.39 -34.7 2.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 1.63 110.866 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.27 -6.91 24.97 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.818 -0.706 . . . . 0.77 112.132 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 9.1 m-20 -102.16 145.71 29.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 2.1 111.086 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.89 3.87 30.41 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.382 -0.687 . . . . 0.66 111.382 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -63.4 121.05 12.84 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.397 0.279 . . . . 1.52 110.871 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 56.89 52.3 9.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.774 0.797 . . . . 2.23 109.806 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.91 146.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 1.76 110.566 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.84 161.89 13.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.239 -0.437 . . . . 1.18 110.324 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 11.3 tpt180 -135.01 134.51 40.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.241 -0.651 . . . . 3.64 109.241 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 29.4 t -66.43 141.13 58.03 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 119.761 -0.776 . . . . 0.37 109.919 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -81.95 -15.62 53.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 1.34 111.093 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -111.18 -9.4 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 1.81 110.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.46 173.82 11.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.123 0.487 . . . . 0.92 110.305 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.29 111.49 24.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.898 -0.779 . . . . 1.17 108.898 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -167.19 125.22 1.28 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.013 -0.539 . . . . 1.13 110.117 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.15 112.24 24.43 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.152 -0.684 . . . . 1.18 109.152 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 41.9 p90 -150.01 160.9 43.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.213 -0.448 . . . . 0.68 110.435 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -98.44 134.41 41.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.29 -0.633 . . . . 0.58 109.29 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -64.35 -31.93 73.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.575 -0.739 . . . . 0.77 109.856 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -72.26 -28.25 63.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.71 . . . . 3.8 110.915 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 58.8 m -80.46 -23.03 40.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.54 110.88 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -88.97 -44.42 10.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.18 -0.463 . . . . 0.72 110.578 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -122.59 78.65 47.22 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.928 -0.578 . . . . 0.94 110.653 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.01 -5.37 17.09 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.045 2.496 . . . . 2.64 111.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.65 -8.41 56.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 3.71 111.587 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.42 24.08 11.68 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.501 -0.857 . . . . 1.86 112.482 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -65.59 141.29 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.787 0.327 . . . . 1.52 110.624 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.0 m -89.16 131.65 35.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 2.07 110.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 142.03 85.16 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 3.22 111.183 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 149.62 55.13 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.706 2.271 . . . . 1.22 112.556 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.57 -6.04 41.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.736 -0.665 . . . . 1.9 111.651 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.6 p -89.12 46.6 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.558 0.694 . . . . 3.21 110.127 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 90.38 121.63 2.34 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.142 -0.935 . . . . 1.31 110.907 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.24 125.3 24.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.443 -0.577 . . . . 1.51 109.443 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 94.9 mtt180 -112.96 142.99 45.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 3.09 110.377 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 22.0 p -78.45 -178.26 5.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.55 109.789 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -60.87 -45.51 94.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.672 0.272 . . . . 4.7 110.581 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.6 t -63.13 -41.63 99.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 1.89 110.788 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 62.4 m -69.75 -33.48 72.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.636 0.255 . . . . 0.72 111.278 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -76.78 -14.03 59.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.155 0.503 . . . . 1.79 109.839 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 CA-C-N 115.688 -0.687 . . . . 2.19 112.585 175.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.68 -0.489 . . . . 3.7 109.68 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 33.7 t -74.73 103.49 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.852 -0.796 . . . . 0.57 108.852 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.24 -14.03 80.94 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 115.877 -0.602 . . . . 0.87 113.536 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 59.6 t -68.37 -37.03 77.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.943 0.401 . . . . 1.54 110.661 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.08 -28.28 7.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.39 . . . . 1.63 110.678 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.21 56.52 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.158 -0.544 . . . . 0.77 112.098 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 17.7 t70 -110.29 155.21 22.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 2.1 111.019 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.08 21.03 4.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.937 -0.649 . . . . 0.66 112.148 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -80.79 124.4 29.03 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.722 -0.473 . . . . 1.52 109.722 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.59 53.8 9.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 122.025 0.917 . . . . 2.23 109.352 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.44 HG21 ' N ' ' C' ' 34' ' ' PHE . 3.9 p -93.61 141.26 15.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.033 -0.985 . . . . 1.76 110.606 -172.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.447 HD13 ' HB2' ' C' ' 36' ' ' TRP . 78.2 mt -84.9 153.81 22.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.822 0.344 . . . . 1.18 110.403 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -116.47 140.17 49.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.919 -0.582 . . . . 3.64 110.957 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 13.8 t -74.41 139.24 43.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.635 -0.506 . . . . 0.37 109.635 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 26.0 p -89.54 -23.68 21.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.875 0.369 . . . . 1.34 111.328 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -94.08 -20.77 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 1.81 111.18 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.492 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.17 -172.74 4.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.942 -0.762 . . . . 0.92 108.942 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.81 114.56 28.47 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.176 -0.305 . . . . 1.17 110.176 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.12 135.34 6.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.378 . . . . 1.13 110.687 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.68 123.54 48.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 1.18 109.545 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 23.8 p90 -159.75 153.26 22.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.365 -0.38 . . . . 0.68 110.68 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -93.62 130.4 39.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.598 -0.889 . . . . 0.58 108.598 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.573 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 67.0 t-105 -60.95 -34.29 74.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.77 110.623 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.02 -38.58 82.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 3.8 111.269 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 85.4 m -70.02 -26.83 64.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.54 110.688 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -89.8 -53.5 4.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.72 111.957 -175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.77 143.65 30.44 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.305 -0.407 . . . . 0.94 111.003 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.1 169.67 14.65 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.056 2.504 . . . . 2.64 112.011 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.77 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.343 -0.844 . . . . 3.71 111.835 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.8 -30.07 72.61 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.804 -0.712 . . . . 1.86 111.833 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.0 m -79.02 135.86 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.672 0.272 . . . . 1.52 110.479 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.2 t -89.64 151.89 21.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.514 -0.312 . . . . 2.07 110.262 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . 0.573 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 22.2 mtp180 -88.76 115.73 64.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.675 -0.491 . . . . 3.22 109.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.37 132.02 34.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.499 2.132 . . . . 1.22 112.116 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.33 -26.28 59.82 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.408 -0.677 . . . . 1.9 111.408 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 13.9 p -133.24 139.85 47.18 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.308 0.243 . . . . 3.21 110.754 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.05 51.3 19.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.698 -0.763 . . . . 1.31 112.377 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 122.85 15.99 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.685 -0.487 . . . . 1.51 109.685 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -116.05 142.26 47.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.916 0.389 . . . . 3.09 110.997 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.502 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -79.6 -172.04 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.55 110.205 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -60.67 -52.06 66.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.689 0.28 . . . . 4.7 111.276 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -65.16 -43.17 92.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.357 -0.383 . . . . 1.89 111.512 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.7 m -71.37 -26.77 62.94 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.169 -0.212 . . . . 0.72 111.471 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -87.44 -13.92 41.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.113 0.482 . . . . 1.79 110.451 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 C-N-CA 120.88 -0.676 . . . . 2.19 112.063 -178.799 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 120.586 0.232 . . . . 3.7 110.529 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 35.9 t -70.28 118.59 13.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.57 109.975 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.84 76.39 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.87 113.154 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.22 -46.69 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 1.54 111.329 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.66 -34.96 16.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 1.63 111.71 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.3 -20.97 44.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.872 -0.68 . . . . 0.77 111.914 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.67 150.26 21.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.609 0.242 . . . . 2.1 110.531 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.08 11.58 11.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.878 -0.677 . . . . 0.66 112.323 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.9 m -80.26 133.22 35.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.795 -0.446 . . . . 1.52 109.795 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.27 48.94 14.14 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 122.141 0.972 . . . . 2.23 109.33 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.42 139.66 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.312 -0.858 . . . . 1.76 110.833 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.32 144.37 25.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.394 -0.821 . . . . 1.18 109.421 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -117.92 142.74 47.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.373 -0.376 . . . . 3.64 110.792 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.92 133.08 44.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.525 -0.546 . . . . 0.37 109.525 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 31.6 p -84.58 -15.58 45.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 1.34 111.318 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -101.2 -20.75 15.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 1.81 111.486 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.06 -166.58 2.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.51 -0.552 . . . . 0.92 109.51 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.67 114.92 29.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.755 0.312 . . . . 1.17 110.373 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.89 128.32 3.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 1.13 110.627 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -101.38 111.94 24.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.26 -0.644 . . . . 1.18 109.26 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -152.57 -175.05 5.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.42 -0.355 . . . . 0.68 110.083 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.768 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m80 -129.83 161.27 31.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.511 -0.922 . . . . 0.58 108.511 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -58.01 -53.31 59.71 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 121.187 -0.205 . . . . 0.77 111.287 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -56.43 -45.2 80.85 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.048 0.759 . . . . 3.8 113.048 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.768 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 0.1 OUTLIER -66.46 -21.6 66.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.164 0.431 . . . . 0.54 112.164 -173.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -109.17 -36.49 6.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.012 -0.275 . . . . 0.72 111.73 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.26 139.02 33.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.774 0.321 . . . . 0.94 110.923 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.03 156.58 63.83 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.621 2.214 . . . . 2.64 111.637 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -15.32 53.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.108 -0.951 . . . . 3.71 112.596 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.86 79.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.946 -0.645 . . . . 1.86 111.971 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -85.02 136.17 33.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.8 -0.444 . . . . 1.52 109.8 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -88.47 126.28 35.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 2.07 110.557 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -78.85 122.33 84.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 3.22 111.082 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.15 141.6 57.98 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.446 2.097 . . . . 1.22 111.547 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.4 -28.3 52.88 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.839 -0.696 . . . . 1.9 112.672 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -141.1 61.31 1.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.091 0.472 . . . . 3.21 110.851 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.23 46.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.517 -0.849 . . . . 1.31 112.352 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.81 123.84 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.295 0.569 . . . . 1.51 110.541 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -125.54 133.22 52.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.777 -0.647 . . . . 3.09 110.299 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -73.37 179.1 4.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.509 -0.552 . . . . 0.55 109.509 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -37.98 76.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.21 0.448 . . . . 4.7 112.21 -172.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -70.38 -51.62 28.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.845 0.355 . . . . 1.89 111.459 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 55.9 m -73.5 -18.01 61.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.778 0.658 . . . . 0.72 112.778 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -76.36 -14.34 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 1.79 111.438 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.106 0 C-N-CA 120.246 -0.978 . . . . 2.19 112.499 -178.557 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.958 0.408 . . . . 3.7 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -70.39 114.39 8.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.478 -0.783 . . . . 0.57 109.802 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.64 62.57 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.504 -0.379 . . . . 0.87 113.265 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.43 -30.13 29.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 1.54 110.796 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 79.6 m -108.6 -28.41 9.31 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.51 0.559 . . . . 1.63 112.51 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.06 9.91 86.13 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.202 -0.759 . . . . 0.77 111.202 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.85 145.83 50.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.226 -0.487 . . . . 2.1 110.275 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.59 24.63 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.831 -0.699 . . . . 0.66 112.749 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -77.65 122.85 25.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.874 -0.417 . . . . 1.52 109.874 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 54.86 49.14 18.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.311 0.577 . . . . 2.23 110.094 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.56 145.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.739 -0.664 . . . . 1.76 110.18 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.91 146.71 23.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.025 0.44 . . . . 1.18 110.095 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' C' ' 26' ' ' ARG . 12.2 mmt180 -110.79 148.01 33.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 3.64 110.069 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.4 t -79.12 139.82 37.96 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 0.37 108.681 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 60.1 p -89.92 -24.5 21.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.29 0.567 . . . . 1.34 110.724 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -89.88 -20.79 22.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 1.81 111.19 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.402 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.6 p -150.9 -171.77 4.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.796 -0.816 . . . . 0.92 108.796 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.7 115.43 30.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.376 -0.231 . . . . 1.17 110.376 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.84 153.69 14.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.154 -0.476 . . . . 1.13 110.514 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 118.86 23.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.525 0.516 . . . . 1.18 110.114 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -158.02 154.9 28.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.16 -0.473 . . . . 0.68 110.529 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.67 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m170 -86.65 133.12 33.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.347 -0.983 . . . . 0.58 108.347 172.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.415 ' CZ2' ' HA ' ' C' ' 46' ' ' ARG . 70.0 t-105 -49.67 -53.08 26.49 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.244 0.34 . . . . 0.77 111.338 -174.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -62.3 -23.48 66.76 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.316 0.488 . . . . 3.8 112.316 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -79.97 -22.08 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.918 0.39 . . . . 0.54 111.185 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -103.95 -44.19 5.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.72 110.665 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 71.1 m-85 -119.07 136.35 24.32 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.583 -0.735 . . . . 0.94 109.821 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 21.6 Cg_exo -65.65 157.5 58.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.442 2.094 . . . . 2.64 111.291 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -12.22 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 3.71 112.174 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.11 -25.28 74.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.751 -0.737 . . . . 1.86 111.384 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -85.29 125.84 33.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.52 110.131 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -87.57 131.84 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.474 -0.33 . . . . 2.07 110.158 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . 0.415 ' HA ' ' CZ2' ' C' ' 36' ' ' TRP . 19.3 ptp180 -70.75 132.75 86.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 3.22 110.775 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.98 132.61 30.68 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.942 2.428 . . . . 1.22 112.421 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.35 -12.22 60.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.829 -0.7 . . . . 1.9 111.718 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 9.5 p -90.07 10.72 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 3.21 111.147 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 139.08 117.29 1.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 1.31 111.94 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.36 123.28 18.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.522 -0.547 . . . . 1.51 109.522 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 81.6 mtm180 -120.9 133.59 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 3.09 111.248 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -78.48 162.8 26.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.989 -0.745 . . . . 0.55 108.989 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.23 -38.48 18.6 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.459 0.54 . . . . 4.7 112.459 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -64.64 -50.13 68.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.994 0.426 . . . . 1.89 110.758 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 82.5 m -72.67 -29.41 63.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.961 -0.563 . . . . 0.72 111.722 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.1 p -82.79 1.1 40.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 1.79 110.718 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 120.848 -0.692 . . . . 2.19 111.674 176.778 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.633 0.254 . . . . 3.7 111.024 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -69.59 107.95 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.57 110.08 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.33 66.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.448 -0.406 . . . . 0.87 113.017 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.91 -31.93 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.09 0.472 . . . . 1.54 110.576 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.0 -32.54 7.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.268 0.47 . . . . 1.63 112.268 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.29 16.46 58.98 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.156 -0.778 . . . . 0.77 111.156 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.86 144.47 41.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.412 -0.394 . . . . 2.1 110.355 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.86 9.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.66 112.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.9 m -80.72 128.46 33.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.953 -0.388 . . . . 1.52 109.953 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 56.28 47.15 19.81 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.607 0.567 . . . . 2.23 109.743 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.35 142.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.76 110.561 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.24 144.33 25.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.009 0.433 . . . . 1.18 109.951 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 25.6 tpt180 -114.16 138.06 50.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.681 -0.691 . . . . 3.64 109.559 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -70.82 139.85 51.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.325 -0.62 . . . . 0.37 109.325 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.6 p -91.57 -17.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.199 -0.455 . . . . 1.34 111.46 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -103.03 -16.82 15.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.297 -0.411 . . . . 1.81 111.052 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.3 -172.51 4.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.934 -0.765 . . . . 0.92 108.934 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.48 114.42 28.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.737 0.303 . . . . 1.17 110.271 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -158.4 146.34 18.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 1.13 110.053 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.85 112.98 16.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.458 . . . . 1.18 109.959 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.05 159.84 39.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.85 -0.614 . . . . 0.68 110.008 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.847 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.4 m80 -92.84 143.69 26.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.108 -1.071 . . . . 0.58 108.108 171.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -48.17 -53.11 17.96 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.379 0.424 . . . . 0.77 111.593 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -61.27 -20.45 62.89 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.121 -0.491 . . . . 3.8 112.259 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.847 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 13.8 m -84.2 -20.54 32.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.204 -0.453 . . . . 0.54 111.119 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . 0.48 ' HD1' ' HB2' ' C' ' 54' ' ' ARG . 1.9 m-70 -114.29 -33.23 5.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.326 -0.397 . . . . 0.72 111.655 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.46 148.3 65.93 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.31 -0.405 . . . . 0.94 110.19 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.0 146.73 72.11 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.504 2.136 . . . . 2.64 111.57 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.9 -11.76 57.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 3.71 111.653 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.32 -29.79 74.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.706 -0.759 . . . . 1.86 111.379 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -82.27 138.79 34.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.383 -0.599 . . . . 1.52 109.383 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.2 t -88.29 140.59 29.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.154 0.502 . . . . 2.07 110.397 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -72.81 110.95 9.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.326 -0.852 . . . . 3.22 110.088 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.93 145.2 44.75 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.674 2.249 . . . . 1.22 112.621 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.58 8.6 30.27 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.223 -0.751 . . . . 1.9 111.223 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -117.56 33.58 5.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.154 0.502 . . . . 3.21 110.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.53 78.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.636 -0.792 . . . . 1.31 112.355 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.25 122.29 17.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.262 -0.644 . . . . 1.51 109.262 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -120.27 140.66 50.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.529 -0.305 . . . . 3.09 110.538 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.2 p -74.61 176.63 6.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.29 -0.633 . . . . 0.55 109.29 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . 0.48 ' HB2' ' HD1' ' C' ' 39' ' ' HIS . 25.4 tpt180 -60.55 -41.98 95.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.491 0.186 . . . . 4.7 111.029 -173.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.1 m -64.75 -46.12 83.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.89 111.358 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.53 -17.35 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.41 . . . . 0.72 111.035 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -88.94 -5.21 58.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.391 -0.368 . . . . 1.79 110.318 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 C-N-CA 120.986 -0.626 . . . . 2.19 112.363 -178.547 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.454 -0.943 . . . . 3.7 108.454 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.7 t -56.96 107.74 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.146 0.279 . . . . 0.57 110.654 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.37 -16.6 62.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.271 -0.49 . . . . 0.87 112.661 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.29 -30.38 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.008 0.433 . . . . 1.54 110.679 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.6 m -108.35 -24.71 11.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.159 0.429 . . . . 1.63 112.159 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.2 15.15 80.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.788 -0.72 . . . . 0.77 111.431 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.72 136.15 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.598 -0.301 . . . . 2.1 110.422 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.09 16.55 38.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.66 112.719 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -77.61 131.84 37.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.901 -0.407 . . . . 1.52 109.901 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 39.1 t70 55.99 46.22 22.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.94 0.876 . . . . 2.23 109.577 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.81 149.25 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.194 -0.912 . . . . 1.76 110.09 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.0 157.08 17.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.306 -0.406 . . . . 1.18 110.18 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -117.2 143.78 45.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.782 -0.644 . . . . 3.64 110.109 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.88 141.18 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.712 -0.477 . . . . 0.37 109.712 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.5 p -82.29 -28.76 31.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.253 -0.431 . . . . 1.34 111.764 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -95.75 -17.11 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.883 0.327 . . . . 1.81 111.883 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.64 -172.28 4.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.92 110.053 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.36 114.01 27.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.025 -0.534 . . . . 1.17 109.678 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.96 119.86 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 1.13 110.321 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.58 112.32 24.4 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.538 -0.541 . . . . 1.18 109.538 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.65 168.43 26.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.68 110.404 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.697 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.6 m170 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.316 -0.994 . . . . 0.58 108.316 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -56.51 -38.62 72.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.77 111.438 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -66.72 -27.27 67.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 3.8 111.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 32.7 m -86.92 -22.38 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.977 -0.556 . . . . 0.54 111.48 -172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -95.96 -31.03 13.29 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.875 -0.33 . . . . 0.72 111.162 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -128.8 78.63 75.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.268 . . . . 0.94 110.339 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.84 -41.63 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.983 2.455 . . . . 2.64 112.846 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.21 -54.74 4.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.441 -0.345 . . . . 3.71 111.28 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.71 59.59 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.64 -0.791 . . . . 1.86 111.68 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -81.36 96.79 7.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.168 0.509 . . . . 1.52 111.473 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -141.28 92.74 2.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.905 -0.776 . . . . 2.07 108.905 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -57.79 118.65 27.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 3.22 111.216 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.32 133.32 22.5 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.628 2.218 . . . . 1.22 112.596 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.48 -10.37 79.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.059 -0.591 . . . . 1.9 111.88 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.9 p -94.83 35.52 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.0 0.429 . . . . 3.21 111.191 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.8 136.03 9.17 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.907 -0.663 . . . . 1.31 112.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 122.61 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.485 -0.561 . . . . 1.51 109.485 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.8 131.57 54.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 3.09 110.503 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -74.96 -179.79 4.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.46 . . . . 0.55 110.039 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -59.97 -49.42 77.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.505 0.187 . . . . 4.7 111.505 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.8 t -64.1 -41.55 97.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.577 -0.283 . . . . 1.89 111.049 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 79.2 m -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.72 110.896 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.6 m -89.19 2.4 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.48 -0.327 . . . . 1.79 110.663 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.305 0 C-N-CA 120.83 -0.7 . . . . 2.19 111.638 175.713 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.967 -0.383 . . . . 3.7 109.967 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 7.1 t -82.86 104.81 13.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.57 109.939 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.4 -8.31 75.21 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.007 -0.542 . . . . 0.87 113.405 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.456 HG12 ' O ' ' C' ' 38' ' ' CYS . 43.5 t -71.46 -29.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.051 0.453 . . . . 1.54 110.523 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.4 p -120.43 -34.03 3.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.297 -0.41 . . . . 1.63 110.529 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 -13.01 23.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.126 -0.559 . . . . 0.77 111.825 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.535 ' OD2' HG23 ' C' ' 22' ' ' THR . 15.7 t70 -95.97 152.71 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.269 . . . . 2.1 110.796 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.93 14.08 5.22 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.66 113.12 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' THR . . . . . 0.535 HG23 ' OD2' ' C' ' 20' ' ' ASP . 9.5 t -81.7 136.34 35.48 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.178 0.489 . . . . 1.52 109.904 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.71 49.84 17.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.912 0.863 . . . . 2.23 109.496 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 p -89.08 136.96 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.272 -0.876 . . . . 1.76 110.028 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.54 149.73 25.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 1.18 110.668 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' C' ' 33' ' ' ALA . 23.8 mmm180 -116.95 129.83 56.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.944 -0.571 . . . . 3.64 110.464 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.0 140.48 58.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.37 109.77 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 42.8 p -89.17 -20.13 24.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.999 0.428 . . . . 1.34 111.292 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -94.06 -22.32 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 1.81 111.134 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.59 -168.44 3.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.069 -0.715 . . . . 0.92 109.069 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.81 114.65 29.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.833 0.349 . . . . 1.17 110.103 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -156.64 131.11 8.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 1.13 110.465 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.428 ' HB3' HH11 ' C' ' 26' ' ' ARG . . . -109.73 111.83 23.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.78 -0.645 . . . . 1.18 109.623 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.513 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.9 p90 -155.63 166.51 33.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.68 110.047 -178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.443 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -102.33 133.3 47.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.775 -0.824 . . . . 0.58 108.775 171.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.68 -41.4 81.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.77 110.924 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.21 -29.06 68.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 3.8 111.352 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.456 ' O ' HG12 ' C' ' 17' ' ' VAL . 93.8 m -74.71 -22.0 59.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.086 0.47 . . . . 0.54 110.474 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -96.66 -56.03 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.12 -0.491 . . . . 0.72 111.12 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.18 147.94 38.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.928 -0.578 . . . . 0.94 110.22 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.88 163.91 29.1 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.656 2.237 . . . . 2.64 111.976 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -14.83 59.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.268 -0.878 . . . . 3.71 112.468 -171.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.88 -16.54 80.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.789 -0.72 . . . . 1.86 111.802 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.99 127.85 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.552 -0.536 . . . . 1.52 109.552 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.6 p -88.2 138.09 31.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 2.07 111.254 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -76.72 120.43 81.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.437 -0.801 . . . . 3.22 110.305 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.72 131.66 23.24 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.242 1.961 . . . . 1.22 111.476 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.6 -40.88 6.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.846 -0.692 . . . . 1.9 111.614 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -115.46 70.57 0.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.42 0.628 . . . . 3.21 110.702 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.05 51.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.66 -0.7 . . . . 1.31 111.714 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.43 122.89 19.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.665 -0.494 . . . . 1.51 109.665 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.06 137.16 53.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 3.09 110.918 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.513 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.4 p -77.22 -179.65 5.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.172 -0.677 . . . . 0.55 109.172 173.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.7 -45.13 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 4.7 110.952 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -65.24 -53.06 50.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.055 -0.521 . . . . 1.89 111.572 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.31 -16.41 62.45 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.72 111.399 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 31.8 t -83.57 6.53 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 1.79 110.448 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 120.677 -0.773 . . . . 2.19 113.045 176.372 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 . . . . . 0 CA--C 1.518 -0.282 0 N-CA-C 109.319 -0.622 . . . . 3.7 109.319 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.65 109.87 1.83 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.255 -0.429 . . . . 0.57 109.858 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.84 -29.61 58.89 Favored Glycine 0 CA--C 1.52 0.365 0 O-C-N 123.512 0.507 . . . . 0.87 113.63 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.5 -34.18 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 1.54 111.135 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -100.79 -31.77 11.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.482 0.549 . . . . 1.63 112.482 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.32 31.4 59.27 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.364 -1.095 . . . . 0.77 110.364 -170.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' C' ' 22' ' ' THR . 17.9 t70 -147.65 154.08 40.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.228 -0.486 . . . . 2.1 110.676 -172.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.98 28.84 5.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.975 -0.631 . . . . 0.66 112.68 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' THR . . . . . 0.417 ' HG1' ' CG ' ' C' ' 20' ' ' ASP . 17.5 m -79.53 128.12 32.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.786 -0.449 . . . . 1.52 109.786 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 53.71 47.73 23.1 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.53 0.681 . . . . 2.23 109.823 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.412 HG21 ' N ' ' C' ' 34' ' ' PHE . 1.1 p -89.66 149.82 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.258 -0.883 . . . . 1.76 110.506 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.0 mt -100.89 151.93 21.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.321 -0.4 . . . . 1.18 110.101 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -111.54 135.15 52.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.899 -0.592 . . . . 3.64 110.24 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.6 t -66.52 142.99 57.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.586 -0.524 . . . . 0.37 109.586 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.7 p -93.42 -24.62 17.99 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.322 0.49 . . . . 1.34 112.322 -176.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . 0.65 ' HD2' ' SG ' ' C' ' 56' ' ' CYS . 18.9 t60 -97.56 -15.67 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.206 0.527 . . . . 1.81 110.336 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.8 OUTLIER -150.31 -175.25 5.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.615 -0.883 . . . . 0.92 108.615 175.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.83 114.29 28.43 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.891 0.376 . . . . 1.17 110.666 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.36 142.88 14.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 1.13 109.807 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.33 117.23 28.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.528 0.517 . . . . 1.18 109.962 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.412 ' N ' HG21 ' C' ' 24' ' ' VAL . 33.0 p90 -156.61 167.77 29.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.827 0.346 . . . . 0.68 110.772 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.477 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.8 m170 -97.77 123.86 41.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.493 -0.929 . . . . 0.58 108.493 172.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -58.01 -32.53 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.723 -0.671 . . . . 0.77 110.74 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -76.64 -19.47 57.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 3.8 111.873 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 74.9 m -87.36 -21.94 25.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.26 0.552 . . . . 0.54 110.018 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -90.01 -53.35 4.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.72 110.353 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -115.98 143.99 31.92 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.647 -0.706 . . . . 0.94 109.993 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -173.59 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.685 2.256 . . . . 2.64 113.064 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.86 67.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 3.71 111.167 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.49 -17.73 62.5 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.164 -0.541 . . . . 1.86 112.514 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.77 130.51 45.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.859 0.361 . . . . 1.52 110.592 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 t -89.53 150.25 22.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.385 -0.371 . . . . 2.07 110.235 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -87.79 120.34 70.86 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.89 -0.595 . . . . 3.22 110.595 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.08 134.18 26.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 1.22 111.379 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 -43.41 20.0 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.771 -0.65 . . . . 1.9 113.018 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.8 p -111.42 -14.41 13.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.904 0.352 . . . . 3.21 111.865 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.41 57.03 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.577 -0.82 . . . . 1.31 112.448 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 121.82 23.38 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.288 -0.634 . . . . 1.51 109.288 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -123.47 131.82 53.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.114 0.483 . . . . 3.09 111.56 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.76 179.83 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.647 -0.706 . . . . 0.55 109.551 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -57.89 -40.1 79.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.762 0.282 . . . . 4.7 111.762 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.7 t -69.31 -47.92 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.986 0.422 . . . . 1.89 111.04 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . 0.65 ' SG ' ' HD2' ' C' ' 29' ' ' HIS . 81.7 m -72.21 -21.63 61.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.72 111.812 -177.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -102.47 16.07 27.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.489 -0.56 . . . . 1.79 109.489 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.795 0 CA-C-N 115.667 -0.697 . . . . 2.19 112.122 -179.781 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.314 -0.624 . . . . 3.7 109.314 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 46.8 t -67.69 104.62 1.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.916 -0.402 . . . . 0.57 109.916 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.19 -19.99 79.72 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.87 113.218 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.75 -43.11 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.756 0.312 . . . . 1.54 111.23 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p -108.76 -29.78 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.387 . . . . 1.63 110.896 -177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.5 56.24 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.871 -0.681 . . . . 0.77 111.998 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 10.2 m-20 -97.17 145.35 26.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 2.1 110.615 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.27 17.25 10.54 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.049 -0.596 . . . . 0.66 112.091 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -80.1 135.49 36.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.926 -0.398 . . . . 1.52 109.926 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 48.3 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.974 0.892 . . . . 2.23 109.344 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.69 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.194 -0.912 . . . . 1.76 110.315 -174.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 85.5 mt -91.87 154.27 18.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.902 0.382 . . . . 1.18 110.551 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -122.27 130.62 53.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.584 -0.735 . . . . 3.64 109.749 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -68.69 136.31 52.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.37 109.746 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.0 p -87.96 -19.49 27.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.103 0.478 . . . . 1.34 110.998 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -93.21 -24.97 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 1.81 111.116 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.9 p -151.13 -163.99 1.9 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.465 -0.569 . . . . 0.92 109.465 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 114.78 29.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 1.17 110.227 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 138.74 10.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 1.13 110.498 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.06 112.85 18.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.777 -0.647 . . . . 1.18 109.343 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 44.6 p90 -155.7 170.25 22.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.151 -0.477 . . . . 0.68 110.183 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -105.75 133.82 49.87 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.507 -0.553 . . . . 0.58 109.507 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.7 t-105 -60.25 -36.8 78.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.652 -0.703 . . . . 0.77 110.073 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -68.44 -34.17 75.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.625 -0.716 . . . . 3.8 110.93 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.74 -22.71 56.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.54 110.874 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -90.47 -42.26 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 0.72 111.582 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.8 77.3 29.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.484 -0.325 . . . . 0.94 111.284 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 4.17 4.73 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.146 2.564 . . . . 2.64 112.284 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.57 -7.27 59.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 3.71 110.873 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 28.04 11.17 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.598 -0.811 . . . . 1.86 112.109 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 15.3 m -69.42 144.05 53.45 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.979 -0.378 . . . . 1.52 109.979 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.4 t -88.24 143.93 26.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 2.07 110.536 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -92.72 117.62 67.64 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.436 -0.802 . . . . 3.22 111.453 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.99 132.89 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.714 2.276 . . . . 1.22 111.56 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.92 5.04 68.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.756 -0.735 . . . . 1.9 112.548 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -89.63 -75.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.338 0.59 . . . . 3.21 111.106 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.37 101.37 0.57 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.485 -0.78 . . . . 1.31 111.658 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.18 128.25 34.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.978 0.418 . . . . 1.51 110.354 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -114.08 135.17 54.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.198 -0.455 . . . . 3.09 110.364 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.511 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 14.3 p -74.39 176.57 6.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.432 -0.581 . . . . 0.55 109.432 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' C' ' 55' ' ' SER . 8.1 ptm85 -58.5 -43.91 89.25 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 4.7 111.527 -175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 20.2 m -65.86 -46.53 78.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.655 -0.248 . . . . 1.89 111.148 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.9 m -72.37 -22.58 61.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.72 111.569 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -81.41 -13.95 57.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.015 0.436 . . . . 1.79 110.02 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.295 -0.722 . . . . 2.19 111.295 178.063 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.701 0.286 . . . . 3.7 110.353 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 43.0 t -75.2 104.93 5.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.396 -0.594 . . . . 0.57 109.396 177.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.8 -12.42 84.2 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.87 113.631 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 87.2 t -67.19 -41.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 1.54 110.736 178.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 p -106.67 -28.44 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 1.63 110.919 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.77 1.47 55.2 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.859 -0.686 . . . . 0.77 112.092 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 19.5 m-20 -107.2 147.38 30.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.493 . . . . 2.1 111.812 -178.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 2.4 22.78 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.862 -0.895 . . . . 0.66 110.862 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.91 134.64 44.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.659 -0.271 . . . . 1.52 110.438 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.62 47.17 21.29 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.53 0.681 . . . . 2.23 109.922 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.417 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.6 p -89.59 148.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.148 -0.933 . . . . 1.76 110.668 -173.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -100.01 155.8 17.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.227 -0.442 . . . . 1.18 110.21 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.0 mmm180 -114.6 153.82 29.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.74 -0.664 . . . . 3.64 109.424 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -89.39 141.77 28.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.262 0.553 . . . . 0.37 110.433 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -81.17 -26.62 35.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 1.34 112.168 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . 0.536 ' HB2' ' SG ' ' C' ' 56' ' ' CYS . 11.8 m170 -102.61 -14.93 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.982 -0.287 . . . . 1.81 111.614 -176.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.1 p -150.95 -174.6 4.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.964 -0.384 . . . . 0.92 109.964 178.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 115.03 29.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.405 -0.362 . . . . 1.17 110.227 -178.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.56 135.1 4.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.384 -0.371 . . . . 1.13 111.043 -177.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 111.87 24.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.329 -0.619 . . . . 1.18 109.329 172.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -156.45 169.95 23.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.003 -0.544 . . . . 0.68 110.076 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 28.5 m170 -106.95 130.75 54.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.114 -0.698 . . . . 0.58 109.114 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -59.15 -36.75 75.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.68 -0.691 . . . . 0.77 110.092 178.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -70.67 -25.39 62.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.993 -0.549 . . . . 3.8 111.432 -178.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 84.2 m -83.83 -27.36 28.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 0.54 110.83 178.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -89.59 -29.06 19.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.806 0.336 . . . . 0.72 110.911 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.46 71.27 76.98 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.058 -0.519 . . . . 0.94 110.251 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.86 13.68 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.185 2.59 . . . . 2.64 112.64 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.36 4.46 35.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 3.71 111.397 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.18 17.98 38.21 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.589 -0.815 . . . . 1.86 111.518 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.7 m -74.24 130.04 38.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 1.52 110.853 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -88.95 137.91 31.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.716 -0.476 . . . . 2.07 109.716 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -72.69 136.5 80.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 3.22 111.069 -175.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.63 149.34 61.16 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.176 2.584 . . . . 1.22 112.653 -175.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.8 18.91 56.3 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.855 -0.688 . . . . 1.9 112.443 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -116.33 37.28 3.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.329 0.585 . . . . 3.21 110.471 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.62 129.77 6.45 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.786 -0.721 . . . . 1.31 111.769 -177.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 124.01 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.723 -0.473 . . . . 1.51 109.723 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.35 136.81 52.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 3.09 110.729 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.61 162.64 28.99 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.072 -1.084 . . . . 0.55 108.072 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -59.87 -31.96 70.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.838 0.745 . . . . 4.7 111.405 -170.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -64.88 -44.88 88.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.745 0.307 . . . . 1.89 110.588 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' C' ' 29' ' ' HIS . 86.7 m -72.75 -17.86 61.56 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.798 0.295 . . . . 0.72 111.798 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -89.08 -13.0 39.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.482 -0.487 . . . . 1.79 110.192 176.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 C-N-CA 120.985 -0.626 . . . . 2.19 112.025 179.131 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.116 -0.698 . . . . 3.7 109.116 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.93 104.07 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.829 -0.434 . . . . 0.57 109.829 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -3.62 90.6 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.87 112.548 -175.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.73 -41.68 54.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.044 0.45 . . . . 1.54 110.543 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.34 -29.23 8.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 1.63 110.243 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.47 45.04 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.886 -0.673 . . . . 0.77 112.252 179.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -96.13 147.85 23.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.914 0.387 . . . . 2.1 111.142 -177.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.28 15.82 13.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.107 -0.568 . . . . 0.66 112.531 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -80.79 127.9 33.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.449 -0.204 . . . . 1.52 110.449 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.3 t70 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.638 0.732 . . . . 2.23 110.492 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -89.39 135.19 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.849 -0.614 . . . . 1.76 111.124 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.15 158.96 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.361 -0.836 . . . . 1.18 109.545 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -117.24 134.77 54.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 3.64 110.713 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.57 138.87 55.46 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.16 -0.682 . . . . 0.37 109.16 177.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.1 p -91.24 -20.88 21.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.204 0.526 . . . . 1.34 110.781 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.75 -24.14 21.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.81 110.844 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.7 -169.07 3.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.434 -0.58 . . . . 0.92 109.434 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.11 114.86 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.314 -0.254 . . . . 1.17 110.314 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.54 3.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.25 -0.432 . . . . 1.13 110.479 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.64 121.75 45.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.534 0.521 . . . . 1.18 109.633 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.17 173.24 16.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.386 . . . . 0.68 111.24 -174.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -105.1 125.31 50.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.368 -0.604 . . . . 0.58 109.368 173.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -62.04 -31.69 72.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.878 -0.601 . . . . 0.77 109.746 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.92 -24.22 61.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.796 -0.638 . . . . 3.8 111.458 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -88.02 -22.79 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.54 110.617 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.85 -42.65 11.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.158 -0.474 . . . . 0.72 111.107 -178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -122.65 147.33 50.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.94 110.794 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.12 170.07 13.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.025 2.483 . . . . 2.64 112.074 177.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -18.12 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.643 . . . . 3.71 111.338 -177.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.26 -13.9 82.38 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 1.86 112.161 176.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -92.74 132.55 36.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.796 0.331 . . . . 1.52 110.548 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 m -88.66 136.24 33.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.283 -0.417 . . . . 2.07 110.674 -177.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -81.92 121.81 79.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.646 . . . . 3.22 110.369 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.81 149.16 66.22 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.419 2.079 . . . . 1.22 111.572 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -33.48 5.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.45 -0.881 . . . . 1.9 113.238 -175.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -105.75 -38.05 6.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 3.21 111.501 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.94 72.07 0.21 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.768 -0.729 . . . . 1.31 112.336 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 121.97 23.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.288 -0.634 . . . . 1.51 109.288 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -122.56 134.39 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 3.09 111.09 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -74.36 176.92 6.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.584 -0.734 . . . . 0.55 109.38 173.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -61.13 -37.32 82.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.048 0.386 . . . . 4.7 110.292 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -65.06 -51.89 58.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 1.89 110.972 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 77.5 m -71.98 -19.54 61.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.552 0.215 . . . . 0.72 111.369 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -78.74 -14.09 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.114 0.483 . . . . 1.79 109.754 178.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 110.534 -1.026 . . . . 2.19 110.534 173.035 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.843 -0.429 . . . . 3.7 109.843 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 11.2 t -79.68 103.77 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.258 -0.645 . . . . 0.57 109.258 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.66 -18.4 75.71 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.87 113.367 -171.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 48.3 t -64.39 -32.78 59.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.735 0.303 . . . . 1.54 111.104 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -118.09 -33.84 4.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.907 0.384 . . . . 1.63 110.819 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.62 -13.98 24.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.775 -0.726 . . . . 0.77 112.24 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 11.5 m-20 -87.61 131.6 34.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 2.1 110.911 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.41 -1.9 33.09 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.314 -0.714 . . . . 0.66 111.314 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -76.94 135.43 38.76 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 110.081 -0.34 . . . . 1.52 110.081 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.88 45.96 20.53 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.435 0.636 . . . . 2.23 109.784 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.61 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.151 -0.931 . . . . 1.76 110.048 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.39 146.2 25.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.897 0.379 . . . . 1.18 110.242 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -113.92 132.47 55.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.925 -0.579 . . . . 3.64 110.165 -175.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -63.52 130.72 45.56 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.658 -0.497 . . . . 0.37 109.658 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 48.4 p -85.92 -5.81 59.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 1.34 110.983 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -108.42 -21.46 12.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 1.81 111.209 -178.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.8 p -152.28 -163.51 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.726 -0.472 . . . . 0.92 109.726 176.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.56 114.93 29.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.161 -0.311 . . . . 1.17 110.161 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.48 128.47 1.81 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.429 -0.351 . . . . 1.13 110.473 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.69 112.56 25.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.744 0.653 . . . . 1.18 109.771 176.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -154.72 167.58 29.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.395 -0.366 . . . . 0.68 110.339 -176.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.41 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.8 m170 -106.06 138.56 42.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.964 -0.754 . . . . 0.58 108.964 172.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -61.79 -33.73 74.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 0.77 110.385 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -74.64 -25.29 59.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 3.8 111.452 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.7 m -83.67 -22.77 32.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.124 0.488 . . . . 0.54 110.597 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -96.88 -49.62 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.075 -0.512 . . . . 0.72 111.517 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.95 149.62 40.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.757 0.313 . . . . 0.94 111.003 -173.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 158.21 58.33 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.617 2.211 . . . . 2.64 110.881 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.19 -7.96 34.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.954 -0.566 . . . . 3.71 111.521 -177.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.18 -12.22 84.57 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.536 -0.626 . . . . 1.86 111.536 174.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 37.5 m -95.15 135.08 37.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.26 -0.274 . . . . 1.52 110.26 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 p -89.05 136.13 33.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.987 0.422 . . . . 2.07 111.257 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -80.96 127.93 72.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 3.22 110.604 -177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.03 140.47 37.99 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.874 2.383 . . . . 1.22 112.046 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.43 25.56 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.011 -0.614 . . . . 1.9 111.984 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 74.1 1.48 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.886 0.374 . . . . 3.21 110.545 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 61.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.739 -0.743 . . . . 1.31 112.212 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 122.7 18.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.938 0.399 . . . . 1.51 110.074 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -117.4 134.33 54.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.231 -0.44 . . . . 3.09 110.884 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -81.08 169.67 17.16 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.66 -0.867 . . . . 0.55 108.66 171.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -51.94 -47.17 64.86 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.415 0.447 . . . . 4.7 111.419 -174.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -63.72 -45.05 91.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.917 -0.583 . . . . 1.89 111.762 -176.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 95.6 m -71.77 -31.11 66.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.72 111.433 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 44.5 p -85.41 7.23 23.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.718 -0.219 . . . . 1.79 111.026 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 121.22 -0.514 . . . . 2.19 113.115 -176.763 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.862 0.363 . . . . 3.7 110.746 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.37 111.79 5.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.592 . . . . 0.57 109.938 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.42 -31.94 71.51 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.477 0.486 . . . . 0.87 113.128 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.34 -37.54 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.366 . . . . 1.54 110.923 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.43 -39.95 9.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.256 0.465 . . . . 1.63 112.256 -175.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.86 6.41 65.44 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.73 -0.748 . . . . 0.77 111.423 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.82 149.1 42.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.793 0.33 . . . . 2.1 110.434 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.62 12.25 38.99 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.66 112.943 -177.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 m -80.13 128.06 33.05 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.665 -0.315 . . . . 1.52 111.085 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.06 51.11 7.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.493 -0.776 . . . . 2.23 111.161 177.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -90.15 145.31 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.721 . . . . 1.76 111.227 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 78.0 mt -101.11 143.98 30.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.275 -0.875 . . . . 1.18 109.175 175.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 137.2 49.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.637 0.256 . . . . 3.64 110.465 -178.571 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -64.57 135.21 55.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.16 -19.02 29.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.181 0.515 . . . . 1.34 110.88 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -97.47 -18.08 19.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.81 111.332 -177.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.53 -168.6 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.288 -0.634 . . . . 0.92 109.288 176.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.25 114.89 29.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.663 0.268 . . . . 1.17 110.603 -178.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -172.13 136.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 1.13 109.936 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -122.05 122.83 40.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.296 0.372 . . . . 1.18 110.004 177.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -160.07 169.51 23.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.033 -0.53 . . . . 0.68 110.294 -176.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.753 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.3 m170 -95.91 130.68 42.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.002 -1.111 . . . . 0.58 108.002 171.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -56.12 -37.28 69.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.77 111.684 -177.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -72.17 -15.15 61.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 3.8 111.614 -177.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.753 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.6 m -90.89 -22.52 20.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.197 -0.456 . . . . 0.54 110.676 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -94.19 -40.78 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 0.72 110.494 175.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.72 79.55 31.29 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.94 110.178 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -83.55 11.34 3.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.814 2.342 . . . . 2.64 112.862 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.92 0.76 52.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 3.71 111.187 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.05 23.77 37.03 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 1.86 111.661 -176.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -61.88 149.52 40.15 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.606 0.362 . . . . 1.52 110.67 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -87.74 121.7 30.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.74 0.305 . . . . 2.07 110.524 -176.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.48 120.39 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 3.22 110.967 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.14 132.26 31.28 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.431 2.088 . . . . 1.22 111.703 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.53 -15.95 38.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.787 -0.721 . . . . 1.9 111.835 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.3 p -97.07 37.3 1.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 3.21 111.003 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.55 113.5 2.17 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 1.31 111.829 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.85 123.52 29.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.735 -0.468 . . . . 1.51 109.735 -177.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -112.19 148.04 34.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.046 0.45 . . . . 3.09 110.724 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 22.0 p -93.9 178.01 5.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.105 -0.702 . . . . 0.55 109.105 175.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -58.73 -33.47 70.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.886 0.312 . . . . 4.7 111.142 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -69.77 -51.56 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 1.89 111.24 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -71.98 -17.72 62.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.319 -0.4 . . . . 0.72 111.341 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -92.23 -1.23 57.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.48 . . . . 1.79 110.283 173.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-N 115.921 -0.581 . . . . 2.19 112.04 -179.949 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 110.145 -0.317 . . . . 3.7 110.145 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 t -63.15 106.12 0.81 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.57 109.515 175.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.37 -31.61 57.02 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.41 0.444 . . . . 0.87 113.492 -175.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.03 -34.44 70.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.074 0.464 . . . . 1.54 111.043 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.81 -38.14 7.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.052 0.39 . . . . 1.63 112.052 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.96 -9.2 59.81 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.585 -0.606 . . . . 0.77 111.585 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.41 146.18 37.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.954 0.407 . . . . 2.1 111.191 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.13 12.96 40.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.067 -0.813 . . . . 0.66 111.067 174.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -73.94 128.55 35.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.444 . . . . 1.52 110.375 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 55.57 47.13 21.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.669 0.747 . . . . 2.23 109.651 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.04 153.78 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.25 -0.887 . . . . 1.76 110.744 -174.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -107.48 144.26 34.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 1.18 109.834 176.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 144.64 40.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.124 -0.489 . . . . 3.64 110.166 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.1 t -68.51 140.11 55.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.393 -0.595 . . . . 0.37 109.393 177.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.5 p -90.43 -18.65 25.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.897 0.379 . . . . 1.34 110.895 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -92.83 -24.2 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 1.81 111.077 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.3 p -150.38 -173.1 4.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.036 -0.727 . . . . 0.92 109.036 178.165 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.93 118.76 37.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.582 0.229 . . . . 1.17 110.437 -178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.24 135.99 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 1.13 110.233 -177.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.33 112.76 22.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 1.18 110.11 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -153.99 166.61 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.062 -0.517 . . . . 0.68 109.873 -177.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.3 m170 -97.71 140.32 32.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.58 108.638 173.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -49.18 -53.5 20.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.413 0.446 . . . . 0.77 111.615 -175.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -72.34 -5.55 37.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 3.8 112.136 -173.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -91.45 -21.26 21.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.896 0.379 . . . . 0.54 110.63 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -108.4 -29.5 8.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.72 110.941 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.62 138.55 29.54 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.94 110.511 -177.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.5 148.6 93.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.544 2.162 . . . . 2.64 111.068 173.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -18.76 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 3.71 112.079 -174.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 -16.51 71.14 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.087 -0.578 . . . . 1.86 111.853 175.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.1 m -90.59 130.77 36.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 176.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.43 143.54 26.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 2.07 110.993 -174.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.34 125.2 86.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 3.22 110.789 -177.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.08 163.5 39.02 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.044 2.496 . . . . 1.22 112.413 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.27 7.1 8.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.853 -0.689 . . . . 1.9 111.92 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -108.92 -1.82 18.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 3.21 110.856 -178.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.74 120.87 0.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.025 -0.607 . . . . 1.31 111.673 -177.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 122.68 25.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 1.51 109.771 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -111.17 134.9 52.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.436 -0.347 . . . . 3.09 110.937 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -75.69 166.56 23.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.614 -0.884 . . . . 0.55 108.614 170.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -63.42 -30.54 71.65 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.744 . . . . 4.7 110.871 -172.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -65.12 -45.23 85.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 1.89 110.927 178.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.1 m -72.76 -31.2 64.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.72 111.9 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -83.53 -1.62 54.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 1.79 111.542 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 C-N-CA 120.875 -0.678 . . . . 2.19 111.608 -178.566 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' C' ' 19' ' ' GLY . 49.1 ttp180 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 3.7 109.88 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 31.3 t -70.91 103.0 2.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.084 -0.71 . . . . 0.57 109.084 176.021 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.12 1.8 83.6 Favored Glycine 0 CA--C 1.509 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.87 112.748 -174.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 32.0 t -77.17 -28.72 16.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.096 0.474 . . . . 1.54 110.091 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.9 p -123.6 -35.46 2.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 1.63 111.019 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' C' ' 14' ' ' ARG . . . 109.91 2.51 30.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.962 -0.637 . . . . 0.77 112.266 -178.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 8.7 m-20 -107.39 140.44 40.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 2.1 111.232 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.59 -1.99 30.8 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.66 111.522 175.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -74.86 135.19 41.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.52 110.059 178.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.34 41.05 16.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.927 0.394 . . . . 2.23 110.277 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.472 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.9 p -88.29 146.05 6.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 1.76 110.636 -174.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 77.1 mt -105.96 159.29 16.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.029 -0.532 . . . . 1.18 110.379 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 14.0 mmt180 -126.39 143.18 51.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 3.64 109.717 -178.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 35.3 t -70.63 146.53 49.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.864 -0.734 . . . . 0.37 109.066 173.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 28' ' ' THR . . . . . 0.409 HG21 ' HA2' ' C' ' 50' ' ' GLY . 28.7 p -84.79 -27.0 27.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.101 0.477 . . . . 1.34 110.812 177.276 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.4 -12.4 21.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 1.81 111.091 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 m -139.55 172.76 12.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.033 0.444 . . . . 0.92 110.279 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 113.69 27.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.659 -0.7 . . . . 1.17 109.388 174.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.12 134.74 3.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.485 -0.325 . . . . 1.13 110.601 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.72 111.98 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.759 -0.655 . . . . 1.18 109.57 175.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.06 164.71 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.0 -0.545 . . . . 0.68 110.23 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.472 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 32.5 m170 -104.63 138.57 40.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.598 -0.519 . . . . 0.58 109.598 174.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -63.93 -34.46 78.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.76 -0.655 . . . . 0.77 109.74 178.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -76.64 -15.51 59.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.586 . . . . 3.8 111.072 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.402 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 97.8 m -92.29 -22.45 19.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.54 110.507 176.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -93.96 -41.82 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.632 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -119.95 147.32 44.1 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.985 -0.552 . . . . 0.94 111.242 -171.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.76 164.33 27.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.003 2.468 . . . . 2.64 111.503 174.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.05 -15.54 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 3.71 112.184 -174.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -10.23 85.46 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.809 -0.71 . . . . 1.86 112.459 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.4 m -87.19 137.5 32.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.856 0.36 . . . . 1.52 110.72 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -89.65 131.82 35.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.328 -0.396 . . . . 2.07 110.841 -177.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -89.94 123.15 66.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 3.22 110.915 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.78 133.63 22.29 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.325 2.017 . . . . 1.22 111.266 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.42 -47.06 10.98 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.1 -0.571 . . . . 1.9 112.961 -174.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -118.96 60.08 0.82 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.133 0.492 . . . . 3.21 110.779 -177.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 164.07 57.17 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.356 -0.698 . . . . 1.31 111.356 -177.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.52 124.98 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.374 0.607 . . . . 1.51 110.587 -176.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.37 145.56 31.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.625 -0.716 . . . . 3.09 110.602 -177.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 21.4 p -89.66 -169.37 2.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.064 -0.516 . . . . 0.55 109.998 178.001 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.7 -53.0 63.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.574 0.226 . . . . 4.7 110.84 -179.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 41.4 t -61.22 -42.92 99.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.89 110.971 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.19 -16.93 62.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.105 0.409 . . . . 0.72 112.105 -176.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 43.5 m -101.1 4.73 42.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.072 0.463 . . . . 1.79 110.627 177.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.762 0 C-N-CA 120.847 -0.692 . . . . 2.19 112.115 -179.613 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.825 -0.435 . . . . 3.7 109.825 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 39.6 t -65.37 105.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.713 -0.477 . . . . 0.57 109.713 177.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.89 66.17 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.268 -0.492 . . . . 0.87 112.901 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -32.19 56.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.54 110.97 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -106.71 -37.83 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.63 111.91 -176.072 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.58 -23.63 35.4 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.317 -0.713 . . . . 0.77 111.317 -174.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -86.79 148.93 25.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 2.1 111.027 -178.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.82 12.71 35.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.66 111.888 177.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 47.8 m -73.9 124.25 25.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.373 0.13 . . . . 1.52 111.174 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 55.69 66.76 1.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.072 0.857 . . . . 2.23 111.118 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -108.48 142.3 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 1.76 111.362 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' C' ' 36' ' ' TRP . 34.4 mt -82.27 144.35 30.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.662 . . . . 1.18 110.51 178.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.43 145.81 29.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.576 -0.738 . . . . 3.64 110.307 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.14 136.75 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.666 -0.494 . . . . 0.37 109.666 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -88.56 -5.19 58.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.39 . . . . 1.34 111.648 -178.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -113.72 -20.21 11.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 1.81 110.812 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.82 -171.95 4.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.157 -0.682 . . . . 0.92 109.157 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.04 29.8 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.691 -0.485 . . . . 1.17 109.691 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 155.39 24.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.311 -0.404 . . . . 1.13 110.619 -178.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.13 124.59 17.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.872 -0.604 . . . . 1.18 109.979 178.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -163.84 161.08 22.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.471 -0.331 . . . . 0.68 110.354 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.701 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.91 127.54 36.03 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.373 -0.973 . . . . 0.58 108.373 172.606 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.42 ' HB2' HD12 ' C' ' 25' ' ' LEU . 68.1 t-105 -45.58 -53.51 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.483 0.489 . . . . 0.77 112.01 -174.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -60.37 -30.22 69.42 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.125 0.417 . . . . 3.8 112.125 -174.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.1 m -73.54 -22.46 60.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 0.54 111.004 -177.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -103.29 -44.98 5.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 0.72 110.935 178.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -116.82 122.74 31.12 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.983 -0.553 . . . . 0.94 110.217 -176.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.5 176.59 5.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 2.64 111.853 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.69 -10.79 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.65 . . . . 3.71 112.047 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.95 -26.08 74.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.872 -0.68 . . . . 1.86 111.713 174.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 41.7 m -101.73 135.45 43.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.226 -0.287 . . . . 1.52 110.226 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -89.17 154.53 20.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.767 0.318 . . . . 2.07 110.332 -178.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -88.36 112.23 48.48 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 3.22 110.757 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.62 142.78 44.99 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.838 2.358 . . . . 1.22 111.909 177.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.13 -32.4 23.33 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.463 -0.655 . . . . 1.9 111.463 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.0 p -125.64 150.91 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.93 -0.396 . . . . 3.21 109.93 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.43 39.6 80.11 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.65 -0.786 . . . . 1.31 111.971 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.79 124.77 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.557 -0.534 . . . . 1.51 109.557 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -117.31 148.17 41.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.156 -0.475 . . . . 3.09 110.81 -177.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -83.25 -176.68 6.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 0.55 109.458 173.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -63.04 -39.47 94.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.104 0.478 . . . . 4.7 110.286 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 36.3 t -66.23 -53.98 30.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.889 -0.596 . . . . 1.89 111.142 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.92 -17.1 62.12 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.453 0.538 . . . . 0.72 112.453 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -108.21 19.62 19.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.053 0.454 . . . . 1.79 110.345 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.865 0 C-N-CA 120.185 -1.007 . . . . 2.19 112.587 -178.011 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.992 -1.114 . . . . 3.7 107.992 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.7 t -58.04 106.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.51 0.195 . . . . 0.57 110.688 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.42 -28.54 73.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.244 -0.503 . . . . 0.87 112.619 -178.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.49 -39.47 85.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.453 . . . . 1.54 110.744 178.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.46 -21.44 17.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.619 -177.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.87 74.91 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.946 -0.862 . . . . 0.77 110.946 -174.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.34 144.92 30.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.342 . . . . 2.1 110.189 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.13 24.92 9.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.66 112.853 -178.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 m -80.25 129.56 34.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.736 -0.468 . . . . 1.52 109.736 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 55.24 56.01 6.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.718 0.771 . . . . 2.23 109.728 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.86 148.73 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.35 -0.841 . . . . 1.76 110.809 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 96.1 mt -94.64 150.79 19.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.18 110.544 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.2 mmt180 -117.3 152.14 35.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.793 -0.64 . . . . 3.64 110.191 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 17.9 t -81.72 138.75 35.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.654 -0.499 . . . . 0.37 109.654 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.5 p -81.7 -23.23 36.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.585 -0.28 . . . . 1.34 111.726 -177.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -103.52 -18.7 14.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.939 0.348 . . . . 1.81 111.939 -176.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.566 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.4 p -150.71 -173.89 4.61 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.626 -0.509 . . . . 0.92 109.626 177.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.32 125.36 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.566 0.222 . . . . 1.17 110.455 -178.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.83 151.46 7.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 1.13 110.22 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -137.63 112.6 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.461 0.476 . . . . 1.18 110.19 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.59 165.6 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.68 110.094 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.746 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.5 m170 -98.27 132.77 43.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 0.58 108.328 171.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -47.49 -53.49 14.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.306 0.484 . . . . 0.77 112.306 -173.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -70.47 -20.85 62.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.854 0.359 . . . . 3.8 111.783 -173.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.7 m -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.173 0.511 . . . . 0.54 110.102 177.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 1.2 m170 -93.26 -51.3 5.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.72 110.535 176.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -111.71 91.37 14.65 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.793 -0.639 . . . . 0.94 110.404 -177.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 83.1 Cg_endo -97.32 3.48 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.957 2.438 . . . . 2.64 112.358 176.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.71 55.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 3.71 112.286 -172.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.76 41.51 2.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.408 -0.901 . . . . 1.86 112.367 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.923 -0.399 . . . . 1.52 109.923 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -88.01 122.45 31.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.669 0.271 . . . . 2.07 110.567 -177.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -69.68 112.86 13.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.22 111.117 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . 0.402 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 55.2 Cg_endo -72.18 143.22 39.38 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.361 2.041 . . . . 1.22 112.141 177.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.55 -11.94 54.64 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.859 -0.686 . . . . 1.9 112.173 178.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 14.4 p -95.28 -70.63 0.7 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.374 0.607 . . . . 3.21 111.461 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.56 77.07 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 1.31 112.445 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 1.4 tm? -70.94 123.08 21.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.11 -0.7 . . . . 1.51 109.11 177.104 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -112.91 146.92 38.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 3.09 110.91 -176.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 21.1 p -83.57 -174.27 5.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.649 -0.871 . . . . 0.55 108.649 170.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' C' ' 54' ' ' ARG . 43.7 ttp180 -67.89 -43.89 78.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.495 -0.482 . . . . 4.7 110.101 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -59.32 -49.5 77.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.813 -0.63 . . . . 1.89 111.183 -178.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.2 m -70.41 -16.33 62.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.803 0.335 . . . . 0.72 111.557 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -90.2 -8.75 50.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 1.79 110.445 176.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 C-N-CA 120.981 -0.628 . . . . 2.19 112.211 -178.732 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 108.864 -0.791 . . . . 3.7 108.864 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.3 t -71.45 103.47 2.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.553 -0.536 . . . . 0.57 109.553 178.624 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.38 -4.1 77.57 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-N 115.927 -0.579 . . . . 0.87 112.28 -175.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 36.8 t -67.78 -29.11 43.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.247 0.546 . . . . 1.54 109.704 177.244 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.42 -38.42 3.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 1.63 110.163 176.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.54 -5.94 26.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.993 -0.623 . . . . 0.77 111.823 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 21.1 t70 -108.29 146.64 32.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.886 0.374 . . . . 2.1 110.704 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.15 16.57 9.99 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.17 -0.538 . . . . 0.66 112.083 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -80.26 133.39 35.98 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 122.828 -0.219 . . . . 1.52 110.512 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.41 56.12 8.43 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.448 0.642 . . . . 2.23 109.813 -175.359 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.29 146.83 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 1.76 110.798 -172.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -86.85 144.05 27.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.102 0.477 . . . . 1.18 109.864 177.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -107.99 143.79 36.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.559 -0.746 . . . . 3.64 109.945 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 t -74.89 137.81 42.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.407 -0.59 . . . . 0.37 109.407 177.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 47.9 p -91.16 -19.62 22.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.116 0.484 . . . . 1.34 110.914 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -91.7 -24.11 19.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 1.81 110.792 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.58 -165.94 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.131 -0.692 . . . . 0.92 109.131 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 114.56 28.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.75 0.31 . . . . 1.17 110.35 177.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.79 142.88 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 1.13 110.607 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.62 117.15 32.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.854 -0.612 . . . . 1.18 109.514 176.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -147.43 156.28 42.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.68 110.943 -175.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -103.25 132.21 49.69 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.999 -0.741 . . . . 0.58 108.999 173.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -57.85 -40.23 79.65 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.77 110.881 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -72.62 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.475 -0.33 . . . . 3.8 111.463 -177.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 86.3 m -72.76 -23.36 60.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.54 111.001 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -96.47 -53.71 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.72 110.747 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.07 142.8 27.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.944 -0.571 . . . . 0.94 110.649 -174.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.08 155.06 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.78 2.32 . . . . 2.64 111.348 174.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -14.67 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 3.71 112.618 -172.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.73 3.26 87.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.089 -0.577 . . . . 1.86 112.392 177.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -92.62 136.43 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.572 -0.529 . . . . 1.52 109.572 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 25.9 m -88.97 130.3 35.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.969 0.414 . . . . 2.07 111.218 -175.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -81.0 117.43 68.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.788 -0.642 . . . . 3.22 110.595 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.06 146.13 51.41 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.91 2.407 . . . . 1.22 112.595 -177.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.1 -9.85 56.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.83 -0.7 . . . . 1.9 111.503 176.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -93.24 47.84 1.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 3.21 111.781 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.91 123.25 4.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.912 -0.661 . . . . 1.31 112.928 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 127.89 34.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 1.51 110.65 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -108.66 133.31 52.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 3.09 110.953 -178.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.7 p -73.19 178.5 4.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.187 -0.671 . . . . 0.55 109.187 172.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -56.16 -43.51 78.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.677 0.275 . . . . 4.7 111.605 -175.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -68.18 -50.19 55.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.586 -0.279 . . . . 1.89 111.621 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.3 m -68.37 -17.07 64.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.831 0.308 . . . . 0.72 111.831 -177.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -98.98 9.5 43.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.388 . . . . 1.79 110.833 177.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.585 -0.817 . . . . 2.19 111.923 178.366 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.851 -0.426 . . . . 3.7 109.851 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 30.8 t -76.62 104.31 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.157 -0.683 . . . . 0.57 109.157 176.212 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.62 89.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.739 -0.664 . . . . 0.87 112.756 -173.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.426 HG13 ' O ' ' C' ' 38' ' ' CYS . 22.3 t -76.73 -29.0 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 1.54 110.287 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.06 -51.69 2.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.232 -0.44 . . . . 1.63 110.278 178.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -13.13 4.0 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.734 -0.746 . . . . 0.77 112.596 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.09 151.17 23.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.117 0.484 . . . . 2.1 111.752 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.52 21.25 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.66 111.866 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -77.15 116.18 17.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.431 0.158 . . . . 1.52 110.881 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 56.12 65.26 1.48 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.478 0.656 . . . . 2.23 110.762 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.4 134.88 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.76 111.075 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -77.9 146.49 35.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.339 -0.846 . . . . 1.18 109.672 176.118 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -113.32 140.45 48.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 3.64 110.337 -174.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' C' ' 51' ' ' LEU . 7.7 t -69.38 125.03 25.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.054 -0.721 . . . . 0.37 109.054 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 13.2 t -79.42 -5.55 54.92 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.141 0.496 . . . . 1.34 111.163 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -111.69 -22.67 11.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.81 111.758 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.7 p -150.17 -171.77 4.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.92 109.766 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.36 115.45 28.49 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.871 0.367 . . . . 1.17 110.454 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.01 143.48 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.952 -0.567 . . . . 1.13 110.523 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -122.77 116.16 23.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.616 -0.513 . . . . 1.18 109.616 177.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.96 163.85 39.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.386 -0.37 . . . . 0.68 110.498 -174.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.0 m170 -100.79 145.98 27.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.878 -0.416 . . . . 0.58 109.878 174.11 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -52.81 -53.83 42.84 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.504 0.503 . . . . 0.77 110.827 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 66.8 mtt180 -70.07 -19.54 63.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 3.8 112.09 -174.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.426 ' O ' HG13 ' C' ' 17' ' ' VAL . 89.3 m -77.09 -21.04 54.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.162 0.506 . . . . 0.54 110.484 177.142 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -103.23 -52.37 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.285 0.564 . . . . 0.72 110.647 176.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 53.7 m-85 -113.26 125.56 29.52 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.456 -0.793 . . . . 0.94 109.356 -178.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -52.28 148.73 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.619 2.213 . . . . 2.64 111.753 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -18.06 14.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.804 . . . . 3.71 112.934 -172.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.22 -2.12 61.89 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.071 -0.585 . . . . 1.86 112.488 176.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -99.3 142.28 30.99 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.024 -0.362 . . . . 1.52 110.024 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 43.3 m -88.22 124.11 33.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 2.07 111.219 -176.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -79.88 129.37 70.87 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 3.22 110.533 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.06 154.08 75.68 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.495 2.13 . . . . 1.22 111.3 176.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 -10.24 73.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 1.9 112.619 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.1 p -93.76 -160.81 0.79 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.782 -0.081 . . . . 3.21 110.782 178.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.73 143.67 48.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.128 -0.558 . . . . 1.31 112.867 -179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' C' ' 27' ' ' CYS . 0.1 OUTLIER -90.83 144.51 25.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.951 0.405 . . . . 1.51 110.562 -178.503 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -105.68 133.24 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.216 -0.447 . . . . 3.09 109.997 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -72.46 165.16 25.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.772 -0.825 . . . . 0.55 108.772 175.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -55.27 -35.89 65.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.246 0.476 . . . . 4.7 111.61 -171.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -65.6 -51.03 62.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.433 -0.348 . . . . 1.89 111.061 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.25 -17.92 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.72 111.117 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -78.86 -14.03 59.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.989 0.423 . . . . 1.79 110.868 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 C-N-CA 120.52 -0.847 . . . . 2.19 112.005 -179.313 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.454 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 28.9 ttm-85 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 120.695 0.283 . . . . 3.7 110.803 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -77.84 114.34 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.877 -0.416 . . . . 0.57 109.877 177.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.66 64.8 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.085 -0.578 . . . . 0.87 112.926 -177.622 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -81.85 -32.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.978 0.418 . . . . 1.54 110.723 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.01 -40.26 6.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -176.386 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.59 51.36 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.343 -0.703 . . . . 0.77 111.343 -173.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.78 151.97 19.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.703 0.287 . . . . 2.1 110.374 177.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.87 21.83 12.08 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.676 -0.773 . . . . 0.66 112.159 178.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.03 127.4 32.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.183 . . . . 1.52 111.263 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 t70 55.17 66.47 1.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.587 0.708 . . . . 2.23 110.872 176.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 m -108.03 145.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.29 -0.868 . . . . 1.76 111.411 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' C' ' 36' ' ' TRP . 83.4 mt -98.09 144.02 28.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 1.18 110.306 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.4 mpt_? -109.96 153.84 23.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.137 -0.483 . . . . 3.64 110.355 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 34.2 t -71.3 142.69 50.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.228 -0.656 . . . . 0.37 109.228 173.484 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -84.75 -5.61 59.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 1.34 110.704 178.186 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -118.4 -9.36 10.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.81 110.939 178.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.72 173.19 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.93 0.395 . . . . 0.92 110.072 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.55 112.82 26.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.361 -0.607 . . . . 1.17 109.361 174.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.62 131.14 1.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.624 -0.716 . . . . 1.13 109.485 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.88 122.83 48.02 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.025 0.44 . . . . 1.18 110.655 -178.318 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.3 160.85 41.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.769 -0.65 . . . . 0.68 110.141 -178.635 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.4 m170 -88.85 133.22 34.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.264 -1.013 . . . . 0.58 108.264 172.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.411 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.6 t-105 -61.16 -33.27 73.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.77 111.017 -176.189 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -76.55 -13.75 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.054 0.454 . . . . 3.8 111.184 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 59.5 m -93.05 -22.52 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.082 0.468 . . . . 0.54 110.744 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -95.27 -30.9 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.987 -0.552 . . . . 0.72 110.671 175.505 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.31 158.74 74.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.94 110.274 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.37 156.66 62.12 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.495 2.13 . . . . 2.64 111.091 173.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -10.56 55.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.926 -0.579 . . . . 3.71 112.071 -174.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.92 -11.74 78.5 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.653 -0.784 . . . . 1.86 111.946 175.478 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -88.69 120.64 30.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.037 0.446 . . . . 1.52 110.644 -179.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.0 p -89.32 138.19 31.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.048 -0.524 . . . . 2.07 110.652 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.21 126.44 91.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.486 . . . . 3.22 110.365 -179.501 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 141.09 44.67 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.987 2.458 . . . . 1.22 113.248 -173.348 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.98 0.55 89.41 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.405 -0.816 . . . . 1.9 111.675 177.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -88.95 1.53 55.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.116 0.484 . . . . 3.21 110.304 177.077 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.68 131.47 3.25 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.537 -0.756 . . . . 1.31 111.955 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.78 123.06 19.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.019 -0.734 . . . . 1.51 109.019 178.424 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -110.46 130.97 55.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.322 0.582 . . . . 3.09 111.82 -173.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 26.0 p -74.89 -176.78 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.125 -0.943 . . . . 0.55 110.032 175.06 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -64.87 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.77 -0.372 . . . . 4.7 111.287 -175.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -68.75 -41.02 79.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.823 0.344 . . . . 1.89 110.429 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 65.1 m -69.01 -23.72 64.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.508 -0.314 . . . . 0.72 111.164 177.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -93.43 1.15 56.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 1.79 110.665 177.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.465 0 CA-C-N 115.89 -0.595 . . . . 2.19 111.771 179.49 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 . . . . . 0 CA--C 1.516 -0.35 0 N-CA-C 109.439 -0.578 . . . . 3.7 109.439 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -68.82 105.51 2.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.276 -0.638 . . . . 0.57 109.276 175.561 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 -21.02 67.07 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 121.017 -0.611 . . . . 0.87 112.285 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.48 -34.56 58.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.948 0.404 . . . . 1.54 110.627 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -102.23 -33.78 9.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 1.63 111.639 -177.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.93 20.07 51.42 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -140.06 154.72 47.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 2.1 110.687 -174.228 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.59 21.81 5.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.007 -0.616 . . . . 0.66 112.09 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -80.91 127.15 32.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.028 -0.36 . . . . 1.52 110.028 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 54.36 61.14 3.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.372 0.606 . . . . 2.23 109.737 -177.122 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.28 150.62 5.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.268 -0.878 . . . . 1.76 110.393 -172.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.79 143.99 25.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.895 -0.409 . . . . 1.18 109.895 179.185 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -108.55 152.45 24.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.635 -0.711 . . . . 3.64 110.173 -177.132 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -84.75 127.27 34.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.28 -0.637 . . . . 0.37 109.28 176.447 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -80.67 -5.89 57.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.206 0.527 . . . . 1.34 110.905 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -106.31 -27.34 11.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 1.81 111.488 -178.74 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.97 -161.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.885 -0.413 . . . . 0.92 109.885 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.1 115.77 31.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.66 0.267 . . . . 1.17 110.616 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.96 151.88 10.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.216 -0.447 . . . . 1.13 110.301 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.69 112.36 9.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.334 -0.394 . . . . 1.18 110.107 179.244 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.492 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.8 p90 -156.87 177.22 11.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.18 -0.464 . . . . 0.68 109.862 -177.167 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 14.7 m170 -109.8 132.82 53.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.763 -0.829 . . . . 0.58 108.763 172.765 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -53.6 -53.23 54.68 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.106 0.41 . . . . 0.77 112.106 -171.737 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -60.81 -26.22 67.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.089 0.471 . . . . 3.8 111.359 -176.042 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.3 m -77.91 -23.66 48.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.069 -0.514 . . . . 0.54 110.809 -178.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 -34.37 11.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.72 110.779 179.316 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -126.56 75.9 74.24 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.847 -0.615 . . . . 0.94 110.365 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.43 13.11 2.85 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.985 2.457 . . . . 2.64 112.408 -177.121 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.18 4.31 31.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.931 -0.577 . . . . 3.71 111.413 -178.174 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.73 9.79 60.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.671 -0.776 . . . . 1.86 111.426 -177.113 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 25.7 m -67.64 131.79 46.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.281 . . . . 1.52 110.629 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -88.44 135.29 33.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.342 -0.39 . . . . 2.07 110.026 -178.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -72.42 134.41 82.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.298 -0.41 . . . . 3.22 111.018 -176.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.49 132.93 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.578 2.185 . . . . 1.22 112.195 178.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.86 -13.42 75.08 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.01 -0.836 . . . . 1.9 111.01 175.245 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.5 p -93.06 46.98 1.24 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.122 0.487 . . . . 3.21 111.113 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.48 106.31 3.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.72 . . . . 1.31 112.408 178.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.01 124.63 23.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.203 0.525 . . . . 1.51 109.942 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -110.56 135.33 51.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 3.09 110.749 -177.326 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -77.52 -179.04 5.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.55 109.663 174.289 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -62.19 -46.76 87.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.807 0.337 . . . . 4.7 110.575 -177.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -61.63 -45.74 92.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 1.89 111.28 -177.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.07 -23.14 61.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.617 0.228 . . . . 0.72 111.617 -179.612 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -80.81 -14.36 58.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 1.79 110.637 177.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.846 0 N-CA-C 111.346 -0.701 . . . . 2.19 111.346 177.066 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.439 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.1 ttt180 . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.249 -0.278 . . . . 3.7 110.249 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -69.14 109.06 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.857 -0.423 . . . . 0.57 109.857 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.71 -18.24 61.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.377 -0.439 . . . . 0.87 112.771 -177.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -79.43 -37.12 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.729 0.3 . . . . 1.54 111.108 178.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -97.69 -33.95 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.046 0.387 . . . . 1.63 112.046 -176.421 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.86 -1.33 65.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.603 -0.808 . . . . 0.77 111.639 -175.122 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -119.16 150.43 40.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 2.1 110.345 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -115.25 24.84 10.28 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.557 -0.83 . . . . 0.66 113.424 -175.004 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -79.0 116.4 19.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.856 0.328 . . . . 1.52 110.657 178.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 66.95 1.1 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.744 0.652 . . . . 2.23 111.923 177.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.77 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.205 -0.452 . . . . 1.76 110.542 177.218 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.95 159.46 17.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 1.18 109.855 174.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -123.89 143.51 50.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 3.64 110.554 -176.066 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -82.14 134.77 35.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.321 -0.622 . . . . 0.37 109.321 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 49.6 p -85.32 -13.5 49.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 1.34 111.43 -178.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -103.52 -21.74 13.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 1.81 111.444 -178.651 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.21 -166.14 2.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 0.92 109.426 178.602 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.97 115.3 30.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.06 -0.348 . . . . 1.17 110.06 178.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.23 134.85 12.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.431 . . . . 1.13 110.205 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.06 115.86 23.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.258 -0.428 . . . . 1.18 110.388 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -160.5 151.73 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.048 -0.524 . . . . 0.68 110.307 -176.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.849 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.7 m80 -82.44 136.59 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.985 -1.117 . . . . 0.58 107.985 171.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -44.3 -52.17 7.79 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.466 0.479 . . . . 0.77 111.979 -175.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -56.44 -34.9 67.26 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.678 0.621 . . . . 3.8 112.678 -175.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.849 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 3.4 m -71.71 -21.93 61.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.897 -0.592 . . . . 0.54 111.149 -173.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -103.94 -49.66 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.82 -0.627 . . . . 0.72 110.546 176.232 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.9 m-85 -121.43 113.61 32.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.94 110.156 -175.932 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 7.2 Cg_exo -72.54 -172.73 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.922 2.415 . . . . 2.64 113.308 -177.469 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.35 -28.17 62.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 111.935 0.346 . . . . 3.71 111.935 -177.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.53 -9.49 55.46 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.244 -0.503 . . . . 1.86 112.743 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 44' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 36.5 m -124.63 116.98 23.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 1.52 110.369 176.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -88.37 155.15 19.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.264 -0.426 . . . . 2.07 110.224 -178.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -70.25 130.95 88.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 3.22 110.679 -175.262 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.66 147.27 50.77 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.814 2.343 . . . . 1.22 111.988 178.355 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.01 -1.89 88.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.808 -0.711 . . . . 1.9 111.577 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.1 p -94.67 -168.29 1.8 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.534 -0.333 . . . . 3.21 110.86 179.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.53 127.13 43.99 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.644 -0.788 . . . . 1.31 111.439 175.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.8 122.42 17.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.221 0.534 . . . . 1.51 109.99 -176.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.6 135.52 48.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.835 -0.62 . . . . 3.09 110.433 178.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.7 p -75.7 172.54 12.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.1 -0.704 . . . . 0.55 109.1 171.777 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -53.56 -41.48 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.026 0.441 . . . . 4.7 111.4 -175.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -68.22 -45.92 71.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.072 -0.513 . . . . 1.89 111.269 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.0 m -72.58 -17.46 61.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.812 0.301 . . . . 0.72 111.812 -177.398 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -87.45 -8.45 56.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 1.79 110.608 174.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 C-N-CA 121.11 -0.567 . . . . 2.19 111.823 179.261 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.159 -0.311 . . . . 3.7 110.159 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 41.9 t -76.48 104.39 6.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.57 109.884 179.114 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.72 -6.59 88.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.011 -0.614 . . . . 0.87 112.271 -176.648 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 24.1 t -70.34 -31.65 47.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 1.54 110.664 -179.575 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -112.65 -39.33 4.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.999 0.428 . . . . 1.63 110.196 176.191 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.6 -9.63 9.92 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.612 -0.804 . . . . 0.77 112.08 179.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 2.0 m-20 -107.64 139.54 42.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.006 0.431 . . . . 2.1 111.035 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' C' ' 24' ' ' VAL . . . -107.39 2.81 34.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.03 -0.828 . . . . 0.66 111.03 174.927 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 132.35 45.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.426 -0.387 . . . . 1.52 110.409 179.316 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 56.13 49.71 14.99 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.398 0.618 . . . . 2.23 109.87 -176.612 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' C' ' 21' ' ' GLY . 4.4 p -89.38 151.28 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.343 -0.844 . . . . 1.76 110.602 -175.29 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.7 mt -100.96 160.44 14.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.435 -0.348 . . . . 1.18 110.189 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -126.82 136.03 51.81 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.594 -0.521 . . . . 3.64 109.594 -178.396 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 42.2 t -67.12 143.15 56.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.494 -0.482 . . . . 0.37 110.099 176.389 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.91 -23.35 23.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 1.34 111.049 178.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -95.03 -30.24 14.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 1.81 111.05 -178.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.426 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.0 OUTLIER -137.25 -177.59 4.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.669 -0.493 . . . . 0.92 109.669 -178.397 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.23 114.87 29.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.48 -0.327 . . . . 1.17 110.286 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -168.49 129.87 1.31 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 1.13 110.538 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -102.9 112.15 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.435 -0.58 . . . . 1.18 109.435 174.117 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -155.0 173.42 16.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.799 -0.637 . . . . 0.68 109.998 -175.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.423 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -110.13 135.96 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 173.384 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -61.59 -36.27 80.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.551 -0.75 . . . . 0.77 110.45 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -70.39 -26.46 63.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 3.8 111.276 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.428 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.8 m -84.23 -26.0 29.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.937 0.399 . . . . 0.54 110.914 178.884 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -89.81 -40.03 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.213 -0.448 . . . . 0.72 111.26 -178.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -124.32 71.38 55.64 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.315 -0.402 . . . . 0.94 110.173 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.43 6.44 3.58 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.134 2.556 . . . . 2.64 113.004 -174.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.95 3.77 28.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 3.71 111.165 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.05 32.65 20.15 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.63 -0.795 . . . . 1.86 112.036 -179.708 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 8.6 m -68.3 148.08 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.947 -0.39 . . . . 1.52 109.947 177.658 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -86.57 121.67 29.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.94 0.4 . . . . 2.07 110.504 -175.367 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -66.32 120.09 67.42 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 3.22 110.855 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.62 143.8 38.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.435 2.09 . . . . 1.22 111.859 176.277 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.98 -10.37 42.91 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.73 -0.748 . . . . 1.9 112.526 -179.209 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -96.04 9.76 39.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.803 0.335 . . . . 3.21 111.685 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 117.92 0.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.634 -0.793 . . . . 1.31 112.287 -178.669 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.29 123.24 33.9 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.44 -0.578 . . . . 1.51 109.44 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -110.46 149.07 30.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.394 0.616 . . . . 3.09 111.62 -178.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 30.3 p -102.3 -178.8 3.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.171 -0.922 . . . . 0.55 110.029 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -57.84 -39.1 76.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.507 0.558 . . . . 4.7 112.507 -172.106 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -63.7 -57.3 10.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.88 0.371 . . . . 1.89 111.443 -176.541 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 6.9 p -72.17 -24.58 61.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.233 -0.439 . . . . 0.72 111.699 -174.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.3 t -102.15 19.76 17.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.897 0.379 . . . . 1.79 110.728 -177.119 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.715 0 C-N-CA 120.366 -0.921 . . . . 2.19 112.645 -179.46 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.528 0.204 . . . . 3.7 110.748 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.45 111.22 5.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.57 109.994 178.264 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.03 -19.03 60.88 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.291 -0.48 . . . . 0.87 112.856 -178.026 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.27 -31.08 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.105 0.478 . . . . 1.54 110.682 178.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.6 m -109.04 -20.8 12.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.32 0.489 . . . . 1.63 112.32 -175.204 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.4 79.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.174 -0.77 . . . . 0.77 111.174 -174.398 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.17 147.09 37.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.281 -0.459 . . . . 2.1 109.932 -176.538 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.26 30.79 5.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.574 -0.822 . . . . 0.66 113.508 -176.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -75.28 121.08 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.237 0.519 . . . . 1.52 110.135 176.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 54.41 52.76 11.87 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.65 0.594 . . . . 2.23 110.508 -176.859 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 8.7 p -88.97 139.45 17.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.091 -0.504 . . . . 1.76 110.635 -173.902 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.09 147.8 25.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.096 -0.502 . . . . 1.18 110.688 -179.073 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 30.7 mmm180 -113.74 149.75 34.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.534 -0.757 . . . . 3.64 109.739 179.71 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 t -85.2 135.55 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.448 -0.575 . . . . 0.37 109.448 177.881 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.9 p -81.94 -18.68 42.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 1.34 111.171 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -100.5 -22.52 14.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 1.81 111.923 -176.44 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.4 p -150.55 -165.08 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.542 . . . . 0.92 109.535 178.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.65 115.58 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.958 -0.386 . . . . 1.17 109.958 179.477 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.36 146.78 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 1.13 111.273 -177.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.439 ' HB3' ' NH1' ' C' ' 26' ' ' ARG . . . -131.71 112.54 12.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.678 -0.692 . . . . 1.18 109.779 177.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.17 165.35 36.22 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.121 -0.49 . . . . 0.68 109.74 -177.212 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.773 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.9 m170 -96.71 138.37 34.38 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.297 -1.001 . . . . 0.58 108.297 171.2 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -46.09 -52.53 11.91 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.3 0.375 . . . . 0.77 111.712 -177.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.8 mtm180 -70.37 -5.93 31.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.8 112.124 -174.424 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.773 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -91.92 -20.86 20.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.096 0.474 . . . . 0.54 110.66 179.31 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . 0.428 ' HD1' ' HB2' ' C' ' 54' ' ' ARG . 4.4 m-70 -103.86 -36.17 7.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.72 110.68 174.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 92.4 m-85 -121.87 147.28 48.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.94 110.107 -179.405 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.51 159.62 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.519 2.146 . . . . 2.64 111.633 176.463 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -8.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 3.71 111.978 -175.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.69 -7.4 87.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.824 -0.703 . . . . 1.86 111.768 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.0 m -98.11 132.6 43.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.838 0.351 . . . . 1.52 110.212 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -88.87 142.21 27.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.386 -0.37 . . . . 2.07 110.2 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -80.63 127.32 75.85 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 3.22 110.796 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.03 135.65 70.01 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.752 2.301 . . . . 1.22 111.743 175.204 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -24.47 61.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.928 -0.653 . . . . 1.9 111.68 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -138.91 135.59 34.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.908 -0.404 . . . . 3.21 109.908 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.8 53.61 4.89 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.68 -0.771 . . . . 1.31 112.225 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.51 122.82 19.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.408 -0.59 . . . . 1.51 109.408 178.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -118.91 136.43 54.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.12 -0.491 . . . . 3.09 110.475 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -73.54 170.4 15.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.142 -0.481 . . . . 0.55 109.944 177.058 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . 0.428 ' HB2' ' HD1' ' C' ' 39' ' ' HIS . 37.7 ttm180 -49.4 -48.7 46.92 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.645 0.59 . . . . 4.7 111.911 -174.826 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -63.69 -45.87 88.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.57 -0.286 . . . . 1.89 111.466 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 89.1 m -72.0 -32.36 67.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.741 0.274 . . . . 0.72 111.741 -177.47 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p -80.88 -14.13 58.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 1.79 111.418 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 C-N-CA 120.792 -0.718 . . . . 2.19 112.008 -179.306 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 110.09 -0.337 . . . . 3.7 110.09 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.81 105.44 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.57 109.172 175.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.66 62.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.43 -0.414 . . . . 0.87 113.063 -176.23 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.32 -30.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.54 110.964 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -111.17 -18.1 13.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.509 0.559 . . . . 1.63 112.509 -172.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.46 26.8 71.98 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.616 -0.993 . . . . 0.77 110.616 -173.209 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -142.78 148.47 37.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.282 -0.459 . . . . 2.1 110.589 -170.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.58 25.15 5.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.069 -0.586 . . . . 0.66 111.975 177.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -80.6 129.17 34.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.233 -0.284 . . . . 1.52 110.233 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.71 52.06 11.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.177 0.989 . . . . 2.23 108.953 -179.245 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -100.69 149.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.716 -1.129 . . . . 1.76 111.235 -171.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.2 mt -91.23 144.04 26.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.073 -0.512 . . . . 1.18 109.896 176.61 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' C' ' 32' ' ' ALA . 4.3 tpp180 -110.9 130.86 55.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.084 -0.507 . . . . 3.64 109.998 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 1.8 t -68.07 134.56 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.7 -0.482 . . . . 0.37 109.7 177.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 67.6 p -92.32 -14.85 28.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 1.34 110.84 -179.543 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -98.16 -18.9 18.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.915 -0.584 . . . . 1.81 111.076 -179.344 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -151.64 -170.61 3.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.07 -0.715 . . . . 0.92 109.07 176.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.94 113.9 27.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.538 -0.542 . . . . 1.17 109.538 178.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' C' ' 26' ' ' ARG . . . -171.22 137.43 1.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.55 . . . . 1.13 110.298 -178.631 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -119.03 112.89 20.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.081 -0.711 . . . . 1.18 109.081 175.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.68 156.7 43.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.053 -0.351 . . . . 0.68 110.053 -178.371 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.775 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.29 128.82 35.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.279 -1.008 . . . . 0.58 108.279 172.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -47.83 -53.2 16.3 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.502 0.501 . . . . 0.77 111.962 -172.309 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 71.5 mtm180 -68.07 -14.16 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 3.8 112.357 -172.546 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -80.31 -21.79 42.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.54 110.631 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -105.62 -43.72 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.72 110.521 176.46 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 93.6 m-85 -110.53 139.99 22.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.94 110.384 -176.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.27 158.62 47.73 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.719 2.279 . . . . 2.64 111.197 177.201 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.4 43.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 3.71 112.293 -173.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.73 -31.65 60.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.676 -0.773 . . . . 1.86 111.545 175.298 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 38.0 m -74.59 131.12 40.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.29 -0.263 . . . . 1.52 110.29 179.361 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 9.8 p -88.73 134.83 33.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 2.07 111.189 -175.089 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.81 111.76 14.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.698 . . . . 3.22 110.088 178.257 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.17 136.3 28.98 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.66 2.24 . . . . 1.22 112.863 -174.065 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.29 0.16 71.34 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.904 -0.665 . . . . 1.9 111.652 176.772 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -122.57 83.01 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.812 0.339 . . . . 3.21 111.14 177.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.97 88.75 1.38 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.842 -0.694 . . . . 1.31 112.387 178.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.14 122.75 26.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.975 -0.75 . . . . 1.51 108.975 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.52 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 36.4 ptt180 -133.67 135.45 44.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.213 0.53 . . . . 3.09 110.734 -176.204 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.5 p -73.29 173.81 8.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.55 110.367 178.419 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . 0.56 ' HA ' ' OG ' ' C' ' 57' ' ' SER . 2.7 ptp180 -63.15 -32.5 73.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.295 0.498 . . . . 4.7 111.426 -174.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 1.89 109.838 175.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 69.4 m -74.27 -30.23 62.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.694 -0.685 . . . . 0.72 112.829 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' C' C ' 57' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' C' ' 54' ' ' ARG . 19.9 p -75.19 -14.22 60.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 1.79 111.184 -174.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 N-CA-C 110.399 -1.08 . . . . 2.19 110.399 174.158 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 107.892 -1.151 . . . . 3.7 107.892 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.09 108.65 1.59 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.631 -0.507 . . . . 0.57 109.631 177.149 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.05 -14.21 55.38 Favored Glycine 0 C--N 1.329 0.145 0 O-C-N 123.372 0.42 . . . . 0.87 113.102 -175.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.13 -31.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.082 0.468 . . . . 1.54 110.583 178.186 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.4 m -108.02 -26.35 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.471 . . . . 1.63 112.197 -174.883 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.33 25.25 59.56 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.401 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.97 142.36 32.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.663 -0.268 . . . . 2.1 110.96 -173.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.15 16.98 24.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.003 -0.618 . . . . 0.66 112.275 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -80.22 128.93 34.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.934 -0.395 . . . . 1.52 109.934 178.305 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 58.56 40.43 23.71 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.471 0.653 . . . . 2.23 110.36 -178.107 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -90.37 150.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.272 -0.877 . . . . 1.76 110.422 -175.376 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 92.8 mt -102.25 151.26 22.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.787 -0.449 . . . . 1.18 109.787 177.05 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.2 tpp180 -119.49 140.32 50.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 3.64 110.119 -175.347 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.6 t -73.47 142.88 46.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.923 -0.769 . . . . 0.37 108.923 174.319 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.6 p -96.92 -21.38 17.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 1.34 110.743 178.678 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -89.66 -21.05 22.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.81 110.567 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.4 p -151.18 -175.5 5.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.5 -0.926 . . . . 0.92 108.5 174.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 114.61 28.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.651 0.262 . . . . 1.17 110.347 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.44 135.8 6.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 1.13 110.442 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.18 118.83 36.42 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.707 0.629 . . . . 1.18 110.121 178.377 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.93 151.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.349 -0.387 . . . . 0.68 110.647 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.696 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -82.65 136.13 34.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.628 -0.878 . . . . 0.58 108.628 172.006 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 62.0 t-105 -49.04 -53.65 19.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.255 0.347 . . . . 0.77 111.618 -175.906 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.23 -15.94 64.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.361 0.504 . . . . 3.8 112.361 -173.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.4 m -85.35 -21.15 29.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.105 0.478 . . . . 0.54 110.717 -178.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -107.56 -45.12 4.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.016 -0.538 . . . . 0.72 111.052 178.048 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.39 146.17 36.8 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.94 110.355 -176.855 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . 0.416 ' HG2' ' OG1' ' C' ' 44' ' ' THR . 10.8 Cg_endo -55.82 144.11 78.39 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.01 2.473 . . . . 2.64 111.797 175.594 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -16.24 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.461 -0.791 . . . . 3.71 112.085 -175.144 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.14 -18.82 75.88 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.76 -0.733 . . . . 1.86 112.17 177.373 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 44' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' C' ' 41' ' ' PRO . 42.8 m -74.8 147.9 40.8 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.086 -0.339 . . . . 1.52 110.086 178.722 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -88.09 122.01 31.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.849 0.357 . . . . 2.07 110.738 -174.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -70.97 120.58 80.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.853 -0.612 . . . . 3.22 110.368 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.67 132.32 32.51 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.611 2.207 . . . . 1.22 111.933 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -43.3 6.71 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.146 -0.782 . . . . 1.9 111.146 176.596 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 t -115.12 135.21 54.44 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.041 -0.355 . . . . 3.21 110.041 175.293 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.2 64.14 3.55 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.773 -0.727 . . . . 1.31 112.201 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.49 131.38 37.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.088 0.47 . . . . 1.51 110.394 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -114.93 133.58 55.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.22 -0.446 . . . . 3.09 110.773 -176.669 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.5 p -77.12 178.45 7.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.205 -0.665 . . . . 0.55 109.205 173.074 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -56.99 -40.39 76.49 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.93 0.344 . . . . 4.7 111.93 -173.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -68.92 -49.18 60.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 1.89 110.919 -178.364 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.57 -17.9 62.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.72 111.348 -178.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -90.84 7.99 37.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.986 0.422 . . . . 1.79 110.429 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 C-N-CA 120.851 -0.69 . . . . 2.19 111.897 178.701 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 57.4 mtt180 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 120.74 0.305 . . . . 3.7 110.587 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' C' ' 34' ' ' PHE . 13.2 t -64.02 114.53 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.57 109.527 175.349 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.07 -22.91 50.67 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.331 0.394 . . . . 0.87 113.353 -174.546 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.52 -30.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.085 0.469 . . . . 1.54 110.889 179.003 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -107.26 -31.11 8.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.63 112.912 -173.476 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 85.04 -9.26 66.88 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.089 -0.804 . . . . 0.77 111.089 -172.704 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -106.88 147.69 29.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.171 -0.514 . . . . 2.1 110.674 -177.512 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.07 27.49 6.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.96 -0.638 . . . . 0.66 112.62 179.535 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.9 m -77.19 117.6 18.89 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.862 -0.421 . . . . 1.52 109.862 177.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 54.57 64.42 1.82 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.901 0.858 . . . . 2.23 109.511 -174.171 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -97.32 150.96 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.243 -0.89 . . . . 1.76 110.201 -176.339 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 96.5 mt -103.93 144.14 31.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.76 -0.459 . . . . 1.18 109.76 176.995 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -115.18 138.4 50.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.12 -0.491 . . . . 3.64 110.259 -179.674 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -60.14 139.92 57.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.37 109.549 174.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -90.61 -17.56 26.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.078 0.466 . . . . 1.34 111.015 179.528 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -94.83 -23.73 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 1.81 110.697 -178.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.43 -168.9 3.22 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.115 -0.698 . . . . 0.92 109.115 178.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.68 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.716 0.293 . . . . 1.17 110.741 -178.541 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.96 121.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 1.13 110.617 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.79 117.91 35.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 1.18 110.372 177.744 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' C' ' 15' ' ' CYS . 46.8 p90 -158.16 165.78 34.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.634 -0.257 . . . . 0.68 110.585 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.9 m170 -95.65 140.89 29.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.534 -0.914 . . . . 0.58 108.534 173.779 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.407 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.4 t-105 -59.39 -45.42 91.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.635 0.255 . . . . 0.77 111.0 -177.537 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' C' ' 37' ' ' ARG . 48.9 mtm180 -65.39 -14.48 60.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.286 -0.415 . . . . 3.8 111.968 -177.439 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.4 m -89.9 -20.49 23.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.957 0.408 . . . . 0.54 110.655 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -103.09 -39.75 6.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.091 -0.504 . . . . 0.72 111.403 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.68 161.02 59.9 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.257 -0.429 . . . . 0.94 110.17 -177.592 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.97 146.2 98.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.619 2.213 . . . . 2.64 112.13 178.983 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.96 66.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.5 -0.773 . . . . 3.71 111.333 -178.065 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.08 88.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.782 -0.723 . . . . 1.86 111.978 176.258 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 36.4 m -95.19 134.82 37.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.802 0.334 . . . . 1.52 110.114 179.403 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.7 p -88.95 150.08 23.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.346 -0.388 . . . . 2.07 110.571 -178.12 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -81.15 143.19 52.26 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.934 -0.575 . . . . 3.22 110.209 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 132.17 35.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.642 2.228 . . . . 1.22 112.244 178.876 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.85 -0.7 89.1 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.994 -0.548 . . . . 1.9 112.444 -178.016 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 28.7 p -90.06 -9.98 46.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.135 0.493 . . . . 3.21 110.639 176.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.96 137.12 3.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.775 -0.726 . . . . 1.31 111.922 -178.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 124.01 21.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 1.51 110.16 179.904 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -107.92 136.03 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 3.09 110.965 -177.146 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.408 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.1 p -87.0 -178.22 6.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.55 109.769 175.924 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -64.69 -39.96 94.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.839 -0.344 . . . . 4.7 111.296 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -68.98 -48.7 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.54 0.209 . . . . 1.89 111.058 -178.163 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 90.7 m -67.31 -39.85 85.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.578 0.228 . . . . 0.72 111.114 -178.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -76.43 -13.48 60.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.989 0.423 . . . . 1.79 110.372 -179.365 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 121.079 -0.582 . . . . 2.19 112.308 178.831 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-O 120.741 0.305 . . . . 3.7 110.181 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 t -69.28 108.21 3.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.57 109.584 175.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.82 -16.2 56.18 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.398 -0.429 . . . . 0.87 112.746 -177.109 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.09 -30.13 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.974 0.416 . . . . 1.54 110.495 177.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.1 m -109.64 -29.63 8.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 1.63 112.42 -175.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.82 3.94 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.904 -0.878 . . . . 0.77 110.904 -173.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.463 ' OD1' HG22 ' C' ' 22' ' ' THR . 10.6 t70 -124.43 153.76 41.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.897 -0.652 . . . . 2.1 109.419 -176.062 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 27.69 3.61 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.299 -0.953 . . . . 0.66 113.355 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 22' ' ' THR . . . . . 0.463 HG22 ' OD1' ' C' ' 20' ' ' ASP . 6.0 t -77.68 135.28 38.05 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.282 0.541 . . . . 1.52 109.711 177.003 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.76 43.35 31.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.878 -0.601 . . . . 2.23 110.183 179.375 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.93 149.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.471 -0.786 . . . . 1.76 110.504 -172.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.18 143.05 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 1.18 109.98 179.238 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 19.2 mmm180 -109.48 143.16 39.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 3.64 110.441 -178.251 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.4 t -73.47 145.43 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.473 -0.565 . . . . 0.37 109.473 177.389 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -90.92 -34.54 15.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.101 -0.499 . . . . 1.34 111.612 -178.954 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -89.2 -13.86 37.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 1.81 111.24 -176.85 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.27 -171.27 3.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.523 -0.547 . . . . 0.92 109.523 175.262 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.74 115.33 30.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.232 -0.285 . . . . 1.17 110.232 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.11 143.73 10.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.331 -0.395 . . . . 1.13 110.696 -179.334 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.17 113.51 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 1.18 109.659 177.263 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.43 154.79 39.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.416 . . . . 0.68 110.696 -178.038 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.6 m170 -92.95 134.15 35.4 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.768 -0.827 . . . . 0.58 108.768 172.845 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -49.39 -53.15 24.04 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.267 0.354 . . . . 0.77 111.217 -176.125 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.18 -30.08 69.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.933 -0.576 . . . . 3.8 111.829 -176.106 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.8 m -80.66 -22.08 40.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.54 111.487 -175.022 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -31.67 8.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.454 -0.339 . . . . 0.72 111.443 -178.568 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.12 141.78 41.77 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.405 . . . . 0.94 110.732 -176.333 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.62 153.99 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.799 2.333 . . . . 2.64 111.417 174.844 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -18.56 61.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.35 -0.841 . . . . 3.71 112.362 -172.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.9 -13.23 80.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.955 -0.64 . . . . 1.86 112.447 177.597 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -87.37 130.91 34.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.739 -0.467 . . . . 1.52 109.739 177.589 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 138.48 31.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.326 -0.397 . . . . 2.07 109.957 -175.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -68.9 115.23 29.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 3.22 110.103 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.1 138.0 46.06 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.038 2.492 . . . . 1.22 112.805 -176.431 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.47 -5.4 65.2 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.766 -0.652 . . . . 1.9 111.819 177.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -88.75 -9.71 50.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 3.21 111.023 -179.794 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.01 137.23 3.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.602 -0.808 . . . . 1.31 112.276 179.145 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.01 123.85 22.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.872 0.368 . . . . 1.51 110.676 176.893 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.373 -0.376 . . . . 3.09 110.337 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.0 p -72.79 -177.43 2.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.55 110.453 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -53.35 -49.29 67.44 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.781 0.432 . . . . 4.7 111.959 -172.774 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -68.88 -42.06 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.808 0.337 . . . . 1.89 111.392 -177.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.3 m -72.08 -28.15 63.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.202 0.445 . . . . 0.72 112.202 -175.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.6 p -107.94 11.21 28.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.974 0.416 . . . . 1.79 111.034 179.047 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 C-N-CA 120.485 -0.864 . . . . 2.19 112.746 -175.217 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 3.7 111.273 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 t -68.3 115.47 7.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.57 109.346 174.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.75 60.86 Favored Glycine 0 C--O 1.228 -0.267 0 O-C-N 123.358 0.411 . . . . 0.87 113.509 -174.852 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.9 -33.39 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.061 0.457 . . . . 1.54 110.953 179.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.87 -37.16 7.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.81 0.67 . . . . 1.63 112.81 -171.283 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.93 -7.39 76.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.856 -0.688 . . . . 0.77 111.598 -175.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -104.52 149.16 25.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.93 0.395 . . . . 2.1 110.523 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.14 6.89 32.54 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.295 -0.722 . . . . 0.66 111.295 175.66 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.9 m -66.89 133.7 50.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.56 -0.32 . . . . 1.52 110.289 178.53 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.31 41.18 4.23 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.15 0.906 . . . . 2.23 111.896 -177.458 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.16 142.6 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.564 -0.744 . . . . 1.76 110.452 -177.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 49.6 mt -87.66 148.88 24.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.027 0.442 . . . . 1.18 110.177 177.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 26.3 mmm180 -119.54 138.57 53.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.544 -0.753 . . . . 3.64 110.054 -177.069 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.91 137.51 53.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.014 -0.736 . . . . 0.37 109.014 178.05 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -92.42 -14.53 28.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 1.34 111.153 -178.891 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -98.86 -20.75 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.187 -0.46 . . . . 1.81 111.014 -179.659 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.3 p -150.82 -166.25 2.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.917 -0.771 . . . . 0.92 108.917 176.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.06 114.95 29.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.687 0.279 . . . . 1.17 110.848 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.54 139.46 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.372 -0.376 . . . . 1.13 110.92 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.38 112.86 19.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.105 -0.498 . . . . 1.18 110.195 178.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -149.91 148.61 29.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 0.68 110.197 -179.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.658 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.5 m170 -80.42 138.74 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.618 -0.882 . . . . 0.58 108.618 172.606 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -52.8 -50.59 63.31 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.173 0.296 . . . . 0.77 110.76 -177.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -67.0 -14.35 62.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.789 -0.641 . . . . 3.8 112.288 -175.688 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 85.1 m -88.56 -20.78 24.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.078 0.466 . . . . 0.54 110.876 -179.425 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -107.49 -43.86 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.72 111.212 177.03 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.0 m-85 -120.72 112.27 33.95 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.94 110.149 -176.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.52 -174.46 0.45 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.888 2.392 . . . . 2.64 113.106 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.06 51.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 3.71 112.535 -175.768 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.52 -25.04 62.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.002 -0.618 . . . . 1.86 113.086 -179.683 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 44' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 4.5 m -107.83 126.2 52.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.942 0.401 . . . . 1.52 110.778 -179.792 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -89.43 138.6 31.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.255 -0.646 . . . . 2.07 109.255 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -74.86 126.24 88.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 3.22 111.07 -177.209 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 153.52 56.5 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.771 2.314 . . . . 1.22 111.881 177.909 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.76 -24.41 55.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.955 -0.641 . . . . 1.9 111.624 178.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -141.27 159.6 41.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.822 -0.436 . . . . 3.21 109.822 177.09 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.79 56.83 6.26 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.818 -0.706 . . . . 1.31 112.024 -178.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.93 121.71 23.09 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.229 -0.656 . . . . 1.51 109.229 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -123.33 132.31 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.168 -0.469 . . . . 3.09 110.969 -175.602 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 p -74.71 -172.21 1.49 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.55 109.802 175.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -59.94 -47.45 85.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.627 0.251 . . . . 4.7 111.422 -176.229 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -68.5 -46.58 69.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.443 -0.344 . . . . 1.89 111.564 -177.211 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.8 m -71.24 -21.57 62.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.852 -0.339 . . . . 0.72 111.344 -177.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.4 t -99.75 13.32 34.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 1.79 110.498 179.188 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 120.703 -0.76 . . . . 2.19 111.461 177.555 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . 0.416 ' N ' ' HB1' ' C' ' 33' ' ' ALA . 50.8 ttt85 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.011 -0.737 . . . . 3.7 109.011 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 41.4 t -72.08 103.93 3.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.186 -0.461 . . . . 0.57 110.231 -178.621 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.48 -8.66 84.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.87 111.74 179.446 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.418 HG11 ' O ' ' C' ' 38' ' ' CYS . 25.5 t -61.68 -49.07 85.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 1.54 110.139 178.765 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.1 p -98.87 -28.12 13.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.482 -0.562 . . . . 1.63 109.482 175.12 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 3.61 55.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.895 -0.669 . . . . 0.77 111.945 178.281 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.57 145.05 48.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.767 0.318 . . . . 2.1 110.843 -176.722 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.68 17.04 13.77 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.66 111.891 179.201 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -78.31 122.77 26.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.533 0.166 . . . . 1.52 110.935 -177.947 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.35 51.65 15.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.62 0.724 . . . . 2.23 110.299 -178.0 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' C' ' 33' ' ' ALA . 6.6 p -92.39 155.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.634 -1.166 . . . . 1.76 110.416 -175.262 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 97.4 mt -86.31 146.59 26.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.678 -0.49 . . . . 1.18 109.678 176.589 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -109.45 138.45 45.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.305 -0.407 . . . . 3.64 110.272 -176.198 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.65 138.84 53.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.702 -0.481 . . . . 0.37 109.702 177.383 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -94.89 -24.51 16.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 1.34 111.339 179.744 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.48 -20.11 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.998 0.427 . . . . 1.81 110.575 -177.744 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.47 -171.09 3.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.158 -1.052 . . . . 0.92 108.158 174.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.76 112.92 26.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.961 -0.385 . . . . 1.17 109.961 178.148 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.66 146.17 8.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.123 -0.49 . . . . 1.13 110.001 -178.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.416 ' HB1' ' N ' ' C' ' 14' ' ' ARG . . . -109.66 121.41 45.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.125 -0.489 . . . . 1.18 109.694 177.403 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 31.0 p90 -149.8 143.21 25.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.226 -0.443 . . . . 0.68 110.476 -178.492 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 68.9 m80 -90.33 138.81 31.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.691 -0.855 . . . . 0.58 108.691 171.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -59.28 -43.78 92.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.354 0.409 . . . . 0.77 110.02 178.355 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.62 -26.16 66.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.027 -0.533 . . . . 3.8 111.534 -177.37 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.1 m -81.98 -23.9 35.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.041 0.448 . . . . 0.54 110.653 179.679 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -101.19 -41.46 6.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.319 -0.4 . . . . 0.72 111.701 -175.812 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.95 132.48 24.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.691 0.281 . . . . 0.94 110.706 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.6 164.7 22.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.723 2.282 . . . . 2.64 111.34 172.185 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.77 -3.48 5.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 3.71 112.12 -175.712 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.67 73.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.965 -0.636 . . . . 1.86 111.67 173.705 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -101.4 136.1 41.81 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.079 -0.341 . . . . 1.52 110.079 178.705 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -89.03 140.22 29.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 2.07 110.862 -175.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -81.91 118.15 71.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 3.22 110.641 179.854 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 158.35 49.32 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.64 2.227 . . . . 1.22 111.836 176.241 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.9 -16.45 61.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.03 -0.605 . . . . 1.9 111.677 177.351 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -142.84 146.37 34.07 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.203 -0.295 . . . . 3.21 110.203 178.602 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.19 48.47 4.58 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.719 -0.753 . . . . 1.31 112.518 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.2 122.12 27.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.159 0.504 . . . . 1.51 110.307 176.973 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.427 ' CZ ' ' HA ' ' C' ' 57' ' ' SER . 24.2 ptt180 -127.1 135.71 51.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.362 0.601 . . . . 3.09 110.051 -179.744 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.8 p -72.28 177.9 4.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.55 110.207 -178.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -58.43 -41.69 85.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.977 0.362 . . . . 4.7 111.977 -174.258 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -64.3 -42.64 96.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.109 0.481 . . . . 1.89 110.522 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' C' ' 52' ' ' ARG . 85.1 m -72.97 -19.9 61.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.72 111.472 176.839 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 57' ' ' SER . . . . . 0.427 ' HA ' ' CZ ' ' C' ' 52' ' ' ARG . 19.6 t -80.86 -14.28 58.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.104 -0.498 . . . . 1.79 110.477 -175.468 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.812 0 C-N-CA 120.648 -0.787 . . . . 2.19 111.414 176.765 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.532 -0.544 . . . . 3.7 109.532 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 42.8 t -73.65 103.9 4.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.581 -0.526 . . . . 0.57 109.581 -179.289 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.64 -21.37 77.11 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.87 113.485 -171.974 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 89.9 t -60.55 -38.09 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.887 0.375 . . . . 1.54 111.052 -179.101 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.3 p -109.24 -48.12 3.31 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.947 -0.301 . . . . 1.63 110.491 179.771 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.03 -16.54 5.25 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.914 -0.66 . . . . 0.77 112.536 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 33.7 m-20 -86.88 140.09 29.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.091 0.472 . . . . 2.1 111.799 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.15 -3.62 33.56 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.737 -0.665 . . . . 0.66 111.47 173.864 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m -80.88 136.46 36.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.329 . . . . 1.52 111.052 177.899 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 64.65 44.79 3.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.793 0.806 . . . . 2.23 110.771 174.248 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 m -93.4 155.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.381 -0.827 . . . . 1.76 111.751 -178.036 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.4 mt -97.17 145.51 25.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.355 -0.839 . . . . 1.18 108.963 172.796 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 24.7 tpt180 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.192 -0.458 . . . . 3.64 110.361 -174.278 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.33 136.85 57.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.673 -0.491 . . . . 0.37 109.673 177.676 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.58 -26.91 22.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 1.34 111.049 -179.633 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -90.02 -20.32 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.582 . . . . 1.81 111.502 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.12 -166.07 2.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.338 -0.616 . . . . 0.92 109.338 176.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.5 114.28 28.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.198 -0.297 . . . . 1.17 110.198 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -164.38 130.5 2.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.289 -0.414 . . . . 1.13 110.187 -179.786 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 112.76 24.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.09 -0.505 . . . . 1.18 109.845 176.943 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -152.11 163.79 38.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.229 -0.441 . . . . 0.68 110.565 -173.359 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -97.43 137.92 35.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.241 -0.652 . . . . 0.58 109.241 173.283 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.91 -42.68 98.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.438 0.461 . . . . 0.77 110.122 178.617 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -62.52 -34.74 77.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.907 0.384 . . . . 3.8 111.293 -179.712 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 93.5 m -73.83 -22.44 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 0.54 111.143 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -98.05 -40.86 8.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.407 . . . . 0.72 111.798 -177.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.6 140.85 31.33 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.296 -0.411 . . . . 0.94 109.971 -176.535 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.85 177.09 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.597 2.198 . . . . 2.64 112.193 178.326 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.571 -0.286 . . . . 3.71 111.682 -178.154 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.66 -35.58 89.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.019 -0.61 . . . . 1.86 112.145 176.073 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.6 m -86.03 131.25 34.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.867 -0.419 . . . . 1.52 109.867 178.918 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.6 m -88.86 150.73 22.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 2.07 111.028 -176.576 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -99.18 130.61 26.87 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.845 -0.616 . . . . 3.22 110.79 -174.012 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.13 140.41 37.54 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.325 2.016 . . . . 1.22 111.72 175.856 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.87 -20.29 63.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.911 -0.662 . . . . 1.9 112.023 -179.051 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -142.67 137.81 30.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.799 -0.445 . . . . 3.21 109.799 177.795 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.18 53.71 3.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.735 -0.745 . . . . 1.31 112.082 -179.555 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 123.32 17.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.817 -0.438 . . . . 1.51 109.817 179.065 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -112.13 141.55 45.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.39 -0.368 . . . . 3.09 110.934 -178.494 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 p -78.3 -179.58 6.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.003 -0.74 . . . . 0.55 109.003 171.872 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -60.87 -44.23 97.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 4.7 110.735 -175.764 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -63.28 -48.62 77.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.067 -0.515 . . . . 1.89 111.408 -178.355 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -71.68 -17.1 62.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.779 0.323 . . . . 0.72 111.372 -179.363 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 1.79 110.309 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 C-N-CA 120.729 -0.748 . . . . 2.19 112.189 -179.686 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.2 -0.667 . . . . 3.7 109.2 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.446 ' SG ' ' HB ' ' C' ' 17' ' ' VAL . 43.9 t -64.39 105.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.57 110.349 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.85 -12.14 67.34 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 121.296 -0.478 . . . . 0.87 112.347 -179.856 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.446 ' HB ' ' SG ' ' C' ' 15' ' ' CYS . 61.0 t -76.77 -28.71 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 1.54 110.213 176.59 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.1 m -110.38 -36.17 5.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.004 -0.544 . . . . 1.63 112.036 -177.976 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.65 7.89 74.5 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.045 -0.822 . . . . 0.77 111.045 -173.651 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -126.51 154.58 43.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.547 -0.326 . . . . 2.1 111.022 -176.871 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.91 16.36 12.18 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.402 -0.679 . . . . 0.66 111.402 175.332 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -80.05 125.57 29.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.667 -0.266 . . . . 1.52 111.166 -179.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.18 45.83 26.58 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 122.207 1.003 . . . . 2.23 110.028 -178.579 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 p -96.04 151.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.078 -0.964 . . . . 1.76 109.399 -177.159 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.34 146.75 23.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.107 0.479 . . . . 1.18 110.749 -178.108 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.6 mmm180 -107.31 149.79 27.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.64 109.876 -178.865 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -84.31 139.11 32.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 176.8 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.6 p -87.4 -13.12 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.504 0.557 . . . . 1.34 112.504 -174.857 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -111.92 -20.8 11.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.823 0.344 . . . . 1.81 110.396 -179.478 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.406 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 2.0 p -140.32 -177.12 4.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.532 -0.544 . . . . 0.92 109.532 176.379 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.32 28.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.345 -0.389 . . . . 1.17 110.224 -177.974 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.56 146.61 13.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 1.13 110.742 -176.645 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.59 111.84 15.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 1.18 109.617 176.143 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -157.8 144.03 17.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.68 109.67 -178.777 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.897 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 57.7 m80 -75.18 140.38 43.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.207 -1.035 . . . . 0.58 108.207 171.021 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -54.41 -50.76 66.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.783 0.265 . . . . 0.77 110.804 -175.922 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.6 mtp180 -64.02 -15.28 59.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 3.8 112.344 -176.295 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.897 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.3 m -83.92 -20.99 32.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.027 0.441 . . . . 0.54 110.697 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -108.59 -25.88 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.72 111.106 176.325 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 61.9 m-85 -132.86 139.03 33.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.364 . . . . 0.94 110.277 -178.565 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 148.25 90.63 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.605 2.203 . . . . 2.64 111.475 175.451 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.26 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.308 -0.86 . . . . 3.71 112.718 -172.525 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 -23.12 77.9 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.68 -0.771 . . . . 1.86 111.988 177.707 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -81.11 143.29 32.53 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.0 -0.37 . . . . 1.52 110.0 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -88.8 131.62 34.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 2.07 111.057 -174.818 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -75.9 128.81 82.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.874 -0.603 . . . . 3.22 109.932 175.976 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.21 132.23 35.49 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.383 2.055 . . . . 1.22 112.249 -178.668 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -22.07 31.14 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.144 -0.782 . . . . 1.9 111.144 176.451 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -89.84 52.4 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.176 0.512 . . . . 3.21 110.577 177.972 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 108.77 3.14 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.673 -0.775 . . . . 1.31 112.225 -178.501 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.59 123.2 19.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 1.51 109.247 177.179 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -122.76 135.14 54.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.342 -0.39 . . . . 3.09 110.732 -175.63 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.81 158.69 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.173 -0.676 . . . . 0.55 109.173 175.736 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -56.21 -31.16 63.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.737 0.699 . . . . 4.7 111.714 -170.415 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -65.91 -46.43 78.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.568 0.223 . . . . 1.89 110.741 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.6 m -72.08 -23.87 61.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.726 0.298 . . . . 0.72 111.219 -179.978 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -78.39 0.53 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.398 -0.365 . . . . 1.79 111.045 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 111.725 -0.55 . . . . 2.19 111.725 179.574 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 109.294 -0.632 . . . . 3.7 109.294 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.85 105.7 1.67 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.003 -0.369 . . . . 0.57 110.003 179.458 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.66 -30.05 75.61 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.347 -0.454 . . . . 0.87 112.597 -176.957 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 -30.6 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 1.54 110.779 -179.37 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -101.26 -36.73 8.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.173 -0.467 . . . . 1.63 111.764 -178.302 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.59 -1.66 66.51 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.258 -0.737 . . . . 0.77 111.258 -174.746 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -120.91 145.29 47.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 2.1 110.875 -177.039 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.23 14.7 56.84 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.711 -0.677 . . . . 0.66 111.481 172.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.3 m -63.95 119.63 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.397 0.279 . . . . 1.52 110.532 178.014 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 52.88 50.82 17.18 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.709 0.631 . . . . 2.23 110.753 -178.878 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -89.59 146.05 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 1.76 110.39 -176.076 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.89 144.2 25.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 1.18 110.232 179.194 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -106.77 146.54 30.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 3.64 109.767 -178.386 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.49 138.72 36.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.985 -0.746 . . . . 0.37 108.985 176.256 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -92.91 -13.54 28.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 1.34 111.873 -177.299 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.93 -18.56 14.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.435 -0.348 . . . . 1.81 111.198 178.795 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -149.72 -167.71 2.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.451 -0.574 . . . . 0.92 109.451 177.059 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 114.7 29.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.719 0.295 . . . . 1.17 110.402 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.37 153.79 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.309 -0.405 . . . . 1.13 110.858 -179.518 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.72 113.45 11.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.852 -0.613 . . . . 1.18 109.67 176.095 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.38 163.26 40.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.899 -0.591 . . . . 0.68 109.752 -178.438 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.8 m170 -94.01 139.21 31.22 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.787 -0.82 . . . . 0.58 108.787 172.208 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 60.5 t-105 -49.29 -53.24 22.84 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.412 0.445 . . . . 0.77 111.643 -176.559 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -71.07 -9.1 57.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 3.8 112.19 -174.462 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 63.3 m -91.55 -21.34 20.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.984 0.421 . . . . 0.54 110.76 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -107.63 -40.84 5.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.183 -0.462 . . . . 0.72 110.958 177.865 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.81 148.56 40.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.992 -0.549 . . . . 0.94 110.631 -175.428 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 154.17 73.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.852 2.368 . . . . 2.64 112.144 177.84 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.04 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.197 -0.911 . . . . 3.71 111.95 -175.114 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -7.22 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 1.86 111.906 176.145 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -101.29 129.81 47.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.014 -0.365 . . . . 1.52 110.014 177.709 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -87.73 130.77 34.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.796 -0.446 . . . . 2.07 109.796 -179.34 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . 0.401 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 16.3 ptm180 -71.56 118.6 67.78 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 3.22 111.11 -175.71 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.57 132.92 22.97 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.682 2.255 . . . . 1.22 112.549 -177.884 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.86 51.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.905 -0.664 . . . . 1.9 111.785 178.469 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 60.73 0.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 3.21 110.934 -176.983 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.6 82.53 0.77 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.401 -0.904 . . . . 1.31 112.458 179.356 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.25 128.28 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.074 -0.713 . . . . 1.51 109.074 177.056 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -124.41 145.87 49.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.162 0.506 . . . . 3.09 111.877 -174.774 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -83.58 -178.8 7.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 0.55 108.909 171.914 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' C' ' 55' ' ' SER . 11.5 ptp180 -63.13 -41.2 99.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.289 0.495 . . . . 4.7 111.476 -173.925 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 55' ' ' SER . . . . . 0.412 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 19.6 t -68.74 -40.68 79.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.787 0.327 . . . . 1.89 111.234 -175.153 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.43 -15.74 61.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.72 111.31 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -96.4 -13.61 23.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.078 0.466 . . . . 1.79 110.619 177.134 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 N-CA-C 111.564 -0.614 . . . . 2.19 111.564 -175.974 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 110.202 -0.296 . . . . 3.7 110.202 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.3 t -65.92 118.96 10.48 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.086 -0.339 . . . . 0.57 110.086 177.975 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.33 -17.07 77.35 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.884 -0.674 . . . . 0.87 112.265 -179.548 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -82.74 -31.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.568 0.223 . . . . 1.54 111.117 179.734 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 71.1 m -106.52 -29.13 9.85 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.571 0.582 . . . . 1.63 112.571 -177.175 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.06 81.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.894 -0.882 . . . . 0.77 110.894 -172.48 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.49 154.0 48.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.181 -0.51 . . . . 2.1 110.141 -172.877 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.09 23.97 6.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.02 -0.609 . . . . 0.66 112.63 179.209 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -81.5 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.209 -0.293 . . . . 1.52 110.209 178.474 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.23 37.47 28.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.365 0.602 . . . . 2.23 109.959 -177.5 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -90.21 158.0 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 1.76 110.565 -174.428 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 79.7 mt -95.63 146.38 24.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.74 0.305 . . . . 1.18 110.348 176.577 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -109.89 131.51 55.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 3.64 110.015 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.97 132.37 47.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.111 -0.7 . . . . 0.37 109.111 176.386 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.02 -17.52 32.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.256 0.551 . . . . 1.34 111.121 -178.926 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -97.77 -20.12 17.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.541 . . . . 1.81 111.339 -177.346 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -151.48 -164.72 2.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.104 -0.702 . . . . 0.92 109.104 176.096 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.2 114.15 28.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.203 -0.295 . . . . 1.17 110.203 178.54 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.22 131.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 1.13 110.868 -179.143 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.87 113.44 25.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.73 -0.668 . . . . 1.18 109.739 177.121 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 25.3 p90 -151.99 146.53 25.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.254 -0.43 . . . . 0.68 109.986 -179.832 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.883 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 53.7 m80 -79.55 135.2 36.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.419 -0.956 . . . . 0.58 108.419 171.338 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.43 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 73.9 t-105 -51.28 -52.04 48.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.671 0.272 . . . . 0.77 111.482 -174.042 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -68.17 -16.78 64.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 3.8 112.124 -173.456 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.883 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.93 -22.85 48.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.186 0.517 . . . . 0.54 110.52 178.804 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -104.54 -50.29 3.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.972 -0.558 . . . . 0.72 110.67 179.131 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -108.16 122.04 41.84 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.511 -0.768 . . . . 0.94 109.702 -177.089 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.21 162.73 5.31 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.972 2.448 . . . . 2.64 112.38 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -18.27 41.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.865 -1.062 . . . . 3.71 112.669 -170.75 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.66 4.73 77.64 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.987 -0.625 . . . . 1.86 112.603 178.503 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 91.1 m -112.59 133.32 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.749 0.309 . . . . 1.52 110.512 177.725 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -88.8 144.4 26.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 2.07 110.597 -175.971 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 45.9 ttp180 -87.2 122.23 71.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 3.22 110.84 -179.551 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.3 Cg_exo -69.0 132.26 24.15 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.503 2.135 . . . . 1.22 111.736 176.957 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.88 -14.73 48.33 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.971 -0.633 . . . . 1.9 112.18 -179.741 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.9 t -88.83 -10.7 47.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 3.21 111.206 -178.218 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 122.79 0.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.847 -0.692 . . . . 1.31 111.654 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.41 123.23 33.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.005 0.431 . . . . 1.51 110.155 -177.602 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -116.65 128.94 55.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.458 . . . . 3.09 110.736 -178.85 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.495 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -75.3 -169.74 1.04 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.612 . . . . 0.55 110.072 175.313 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.69 -52.83 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.373 -0.376 . . . . 4.7 111.403 -176.663 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -68.72 -42.78 77.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.539 -0.301 . . . . 1.89 111.808 -175.49 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.7 m -71.93 -17.36 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.72 111.88 -176.627 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -88.15 8.31 27.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.094 0.473 . . . . 1.79 110.532 -179.117 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.731 0 C-N-CA 120.685 -0.769 . . . . 2.19 112.159 179.532 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.452 0.168 . . . . 3.7 110.81 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.3 110.59 6.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.24 -0.652 . . . . 0.57 109.24 174.509 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.19 -24.71 65.6 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 121.304 -0.474 . . . . 0.87 112.841 -176.449 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.99 -30.75 33.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 1.54 110.781 179.168 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 95.3 m -104.63 -46.48 4.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 1.63 112.299 -175.039 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.92 -8.34 45.86 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.436 -0.666 . . . . 0.77 111.436 -174.041 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.51 154.14 22.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 2.1 110.722 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 11.15 30.38 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.112 -0.795 . . . . 0.66 111.112 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.28 134.97 53.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.35 . . . . 1.52 110.343 177.75 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 41.65 48.57 3.61 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.137 0.898 . . . . 2.23 111.757 -178.732 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . 0.405 HG23 ' N ' ' C' ' 34' ' ' PHE . 2.0 p -89.06 146.67 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.165 -0.925 . . . . 1.76 110.421 -176.319 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 84.3 mt -96.99 157.64 15.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.474 -0.33 . . . . 1.18 110.205 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 9.3 mmm180 -120.71 141.45 50.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.921 -0.581 . . . . 3.64 111.064 -174.225 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.81 139.77 47.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.823 -0.806 . . . . 0.37 108.823 173.203 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p -92.4 -21.23 20.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 1.34 111.217 179.43 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -89.54 -23.12 22.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 1.81 110.623 -178.448 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.91 -164.91 2.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.207 -0.664 . . . . 0.92 109.207 177.113 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 115.07 29.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.77 0.319 . . . . 1.17 110.48 179.449 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.14 139.1 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.96 -0.563 . . . . 1.13 110.331 178.866 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -121.24 118.93 30.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.001 -0.545 . . . . 1.18 110.171 178.765 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . 0.405 ' N ' HG23 ' C' ' 24' ' ' VAL . 52.3 p90 -160.22 162.72 33.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.68 109.901 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.66 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.7 m170 -91.34 133.35 35.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.099 -1.074 . . . . 0.58 108.099 171.616 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -59.3 -36.96 76.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.77 110.915 -177.215 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -68.82 -19.88 64.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 3.8 110.883 -179.697 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -90.57 -23.14 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.279 -0.419 . . . . 0.54 111.071 -178.123 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -92.46 -38.59 11.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.394 -0.366 . . . . 0.72 110.643 176.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.403 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 94.3 m-85 -126.66 73.47 74.76 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.488 . . . . 0.94 110.815 -178.753 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 0.06 10.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.018 2.479 . . . . 2.64 112.057 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.7 3.41 29.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 3.71 111.24 -177.828 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.43 24.8 30.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.625 -0.797 . . . . 1.86 112.35 179.747 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 44' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 7.2 m -66.18 141.93 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.869 -0.419 . . . . 1.52 109.869 176.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.8 t -88.13 133.04 34.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.004 0.431 . . . . 2.07 110.228 -175.437 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -70.72 119.0 70.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.551 -0.749 . . . . 3.22 110.548 -179.65 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.67 132.45 20.32 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.591 2.194 . . . . 1.22 112.316 -179.42 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.18 -8.62 74.81 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 1.9 111.566 177.355 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.9 p -91.96 28.52 1.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.945 0.403 . . . . 3.21 111.541 -179.963 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.72 121.76 3.06 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.941 -0.647 . . . . 1.31 112.296 179.857 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 128.33 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.668 -0.493 . . . . 1.51 109.668 -178.821 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -113.15 138.69 49.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.408 . . . . 3.09 111.395 -176.845 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 p -88.89 -176.45 5.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 0.55 109.213 173.779 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -67.29 -39.52 85.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.41 -0.516 . . . . 4.7 111.332 -175.87 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 42.3 t -67.17 -45.4 77.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.598 0.237 . . . . 1.89 110.729 -178.381 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.7 m -71.9 -17.26 62.11 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.661 0.245 . . . . 0.72 111.661 -179.512 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -96.28 -14.19 22.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.93 0.395 . . . . 1.79 110.985 178.699 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 2.19 111.899 -177.944 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.529 0.204 . . . . 3.7 111.198 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -68.22 122.91 19.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.646 -0.502 . . . . 0.57 109.646 174.872 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -24.85 64.77 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.87 113.401 -175.023 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.04 -32.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 1.54 111.177 -179.502 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.3 -40.36 7.96 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.315 0.487 . . . . 1.63 112.315 -174.439 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.63 -17.62 58.96 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.191 -0.764 . . . . 0.77 111.191 -173.076 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.5 148.8 21.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.365 . . . . 2.1 110.616 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.27 15.05 39.58 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.043 -0.599 . . . . 0.66 111.623 176.261 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.8 m -74.76 124.38 26.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.253 . . . . 1.52 110.401 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.77 42.9 28.63 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.915 -0.584 . . . . 2.23 110.823 -177.348 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.06 136.27 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.535 . . . . 1.76 110.301 -175.538 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -94.44 157.1 16.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.0 -0.546 . . . . 1.18 109.913 -178.292 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 28.6 mmm180 -121.68 149.6 42.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.901 -0.591 . . . . 3.64 110.189 -177.197 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -81.56 143.64 31.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.805 -0.443 . . . . 0.37 109.805 -179.818 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.99 -21.91 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.273 -0.421 . . . . 1.34 111.576 -179.003 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -100.94 -17.61 16.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.541 -0.299 . . . . 1.81 111.358 -177.219 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 p -151.13 -169.94 3.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.92 109.51 177.512 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.87 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.489 -0.323 . . . . 1.17 110.359 178.841 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.19 132.39 8.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.535 -0.302 . . . . 1.13 110.77 -178.66 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.85 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.515 . . . . 1.18 109.852 176.263 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -158.78 164.74 35.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.298 -0.41 . . . . 0.68 110.187 -177.63 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.65 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 28.6 m170 -98.81 138.83 35.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.439 -0.948 . . . . 0.58 108.439 171.639 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -54.99 -46.3 75.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.644 0.259 . . . . 0.77 110.54 -178.182 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 73.4 mtp180 -65.96 -18.3 65.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 3.8 112.101 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.7 m -85.35 -20.34 30.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.044 0.449 . . . . 0.54 110.809 -179.19 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . 0.406 ' HD1' ' HB2' ' C' ' 54' ' ' ARG . 5.5 m-70 -99.93 -39.27 8.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.72 110.777 174.974 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 94.9 m-85 -127.04 144.97 52.29 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.94 109.903 -179.432 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.51 154.8 34.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.593 2.196 . . . . 2.64 111.856 177.594 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -10.97 28.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 3.71 112.06 -174.68 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.54 -2.07 76.82 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.839 -0.696 . . . . 1.86 112.144 176.761 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.9 m -90.31 139.82 30.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.023 -0.362 . . . . 1.52 110.023 178.601 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.8 p -88.39 132.81 34.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.433 -0.349 . . . . 2.07 110.873 -175.631 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -88.42 134.31 34.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 3.22 110.911 -177.915 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.63 132.59 38.47 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.653 2.235 . . . . 1.22 111.328 173.745 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.08 -51.2 5.46 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.869 -0.605 . . . . 1.9 113.404 -174.023 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -95.73 -18.25 20.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 3.21 111.214 -175.451 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -131.78 67.89 0.56 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.537 -0.84 . . . . 1.31 112.521 -178.428 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.77 122.63 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.25 -0.648 . . . . 1.51 109.25 176.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 53.2 mtm180 -121.38 140.23 52.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.972 0.415 . . . . 3.09 111.122 -173.125 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.4 p -80.39 -174.72 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.55 109.784 175.703 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . 0.406 ' HB2' ' HD1' ' C' ' 39' ' ' HIS . 40.0 ttm180 -61.71 -49.56 75.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.614 0.245 . . . . 4.7 111.19 -176.036 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.6 t -64.24 -43.92 93.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.432 -0.349 . . . . 1.89 111.28 -176.151 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.5 m -71.62 -19.7 62.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.157 -0.217 . . . . 0.72 111.557 -178.064 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.0 m -83.41 -13.93 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.886 0.374 . . . . 1.79 110.732 178.811 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.241 -0.744 . . . . 2.19 111.241 178.122 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtm-85 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.219 0.533 . . . . 3.7 111.095 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 t -87.7 104.88 16.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.831 . . . . 0.57 109.698 178.873 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -16.8 69.31 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.859 -0.609 . . . . 0.87 113.846 -172.733 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.58 -29.91 48.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.54 110.86 -179.258 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.94 -42.56 2.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.347 -0.388 . . . . 1.63 110.388 178.137 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.88 -11.44 10.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.057 -0.592 . . . . 0.77 111.812 -178.508 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.96 141.94 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.116 0.484 . . . . 2.1 111.405 -177.634 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.98 16.86 27.64 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.577 -0.738 . . . . 0.66 111.273 175.826 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.9 m -76.09 115.56 15.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.461 -0.37 . . . . 1.52 110.323 179.344 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 45.77 70.99 0.31 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.921 0.763 . . . . 2.23 112.062 178.776 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.4 146.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 1.76 110.413 178.665 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.37 148.53 22.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.973 -0.558 . . . . 1.18 109.836 -179.436 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -108.58 145.51 34.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.059 -0.519 . . . . 3.64 110.054 -179.649 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 8.0 t -75.52 135.4 40.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.004 -0.739 . . . . 0.37 109.004 177.026 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 37.1 p -86.24 -7.26 58.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.939 0.4 . . . . 1.34 111.344 -179.522 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -110.75 -19.64 12.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.416 -0.356 . . . . 1.81 111.157 -179.16 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.428 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.8 p -151.56 -172.13 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.714 -0.476 . . . . 0.92 109.714 177.289 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.68 30.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.856 -0.156 . . . . 1.17 111.397 -176.153 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.74 141.87 4.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.811 -0.177 . . . . 1.13 111.127 179.241 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.25 118.11 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.791 -0.448 . . . . 1.18 109.791 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -161.87 163.36 29.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.68 111.19 -175.222 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -96.6 140.59 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.365 -0.606 . . . . 0.58 109.365 172.103 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -62.14 -42.31 99.12 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.537 -0.542 . . . . 0.77 109.537 174.678 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -63.43 -22.75 67.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.917 -0.583 . . . . 3.8 111.819 -179.442 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 63.7 m -87.17 -21.82 25.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.54 111.303 -179.055 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.42 -38.81 8.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.874 0.369 . . . . 0.72 110.813 179.924 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.95 149.88 74.09 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.5 -0.556 . . . . 0.94 109.5 -179.001 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.68 140.25 61.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.252 1.968 . . . . 2.64 111.502 178.05 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.96 -8.83 17.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 3.71 111.944 -175.611 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.81 71.81 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.778 -0.929 . . . . 1.86 110.778 172.455 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -87.45 131.57 34.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.266 -0.642 . . . . 1.52 109.266 174.603 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -87.73 115.37 25.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.141 0.496 . . . . 2.07 110.642 -176.083 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -57.96 136.3 83.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 3.22 111.179 -178.599 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.74 135.24 32.4 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.951 2.434 . . . . 1.22 112.89 -175.991 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.92 -10.66 71.75 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.042 -0.599 . . . . 1.9 111.75 179.05 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -89.31 12.08 17.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 3.21 111.057 -179.739 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.03 116.35 1.56 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.763 -0.732 . . . . 1.31 112.504 178.405 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.28 125.99 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.374 -0.602 . . . . 1.51 109.374 179.239 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -115.17 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 3.09 111.062 -175.507 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 p -73.31 174.77 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.695 -0.854 . . . . 0.55 108.695 172.056 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -58.29 -41.55 84.66 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.432 0.53 . . . . 4.7 112.432 -169.245 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -69.41 -47.84 62.9 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.22 -0.3 . . . . 1.89 111.339 -178.385 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.36 -18.74 61.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.688 0.28 . . . . 0.72 111.211 -178.781 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -84.59 -13.88 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.35 . . . . 1.79 110.429 -179.54 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 C-N-CA 120.683 -0.77 . . . . 2.19 112.04 -179.721 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.435 -0.58 . . . . 3.7 109.435 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.7 t -67.1 103.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.57 109.231 177.567 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.24 -11.54 78.09 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.834 -0.621 . . . . 0.87 112.97 -171.472 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 58.6 t -65.73 -42.45 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.833 0.349 . . . . 1.54 110.38 178.932 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -104.25 -37.2 7.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.401 -0.363 . . . . 1.63 110.684 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.01 -5.72 27.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.77 112.184 -178.883 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.533 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 5.6 m-20 -102.19 135.34 43.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.963 0.411 . . . . 2.1 111.212 -179.211 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.63 1.64 34.29 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.239 -0.744 . . . . 0.66 111.239 174.137 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 40.4 m -69.08 132.4 46.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.465 -0.368 . . . . 1.52 110.636 177.359 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 55.62 47.39 20.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.726 0.774 . . . . 2.23 109.885 178.25 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.81 149.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.274 -0.876 . . . . 1.76 110.713 -173.971 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -99.36 153.32 19.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.234 -0.439 . . . . 1.18 110.45 -179.671 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -115.57 143.01 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.624 . . . . 3.64 109.842 -177.983 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.523 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.4 t -75.62 147.02 39.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.37 110.077 177.326 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.7 p -86.35 -38.46 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.514 . . . . 1.34 112.0 -179.482 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -90.43 -12.09 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.299 . . . . 1.81 111.7 -176.571 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.8 p -150.97 -179.64 7.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.223 -0.658 . . . . 0.92 109.223 174.768 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 115.54 30.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.866 -0.42 . . . . 1.17 109.866 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.91 136.34 8.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.913 -0.585 . . . . 1.13 110.229 -179.023 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.88 112.18 25.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.103 -0.499 . . . . 1.18 109.807 175.986 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.32 158.92 40.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.68 109.98 -177.38 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -94.32 146.91 23.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.696 -0.483 . . . . 0.58 109.696 173.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -56.81 -53.52 56.87 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.584 0.553 . . . . 0.77 110.364 -179.632 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -63.9 -37.06 86.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.364 0.505 . . . . 3.8 112.364 -175.549 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 70.7 m -65.46 -24.32 67.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.957 0.408 . . . . 0.54 111.159 -177.989 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -100.89 -54.85 2.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.175 0.512 . . . . 0.72 110.698 178.366 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -107.18 129.26 24.58 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.73 -0.668 . . . . 0.94 109.66 -176.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.84 162.03 9.43 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.829 2.352 . . . . 2.64 112.224 178.693 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.19 38.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 3.71 111.903 -173.782 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.34 -15.2 81.73 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.795 -0.717 . . . . 1.86 111.73 175.019 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -90.47 125.7 35.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.07 -0.345 . . . . 1.52 110.07 179.389 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -89.27 134.58 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.803 0.335 . . . . 2.07 110.832 -177.895 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -71.46 124.35 90.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 3.22 111.097 -177.631 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.05 143.4 36.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.852 2.368 . . . . 1.22 112.81 -178.558 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.32 -10.3 48.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.915 -0.66 . . . . 1.9 112.33 178.801 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -89.14 0.09 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.347 0.594 . . . . 3.21 110.655 -179.887 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.71 119.15 1.28 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.985 -0.626 . . . . 1.31 111.986 -178.529 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.19 123.93 33.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.107 0.479 . . . . 1.51 110.318 -179.109 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -122.58 142.8 50.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.001 -0.545 . . . . 3.09 111.34 -173.998 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -73.39 165.76 24.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.55 109.489 175.176 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -53.93 -34.63 60.14 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.157 0.435 . . . . 4.7 111.899 -173.145 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 28.0 t -66.09 -50.05 65.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.924 0.392 . . . . 1.89 110.455 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.5 m -72.92 -26.54 61.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.117 0.414 . . . . 0.72 112.117 -178.571 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -89.53 0.28 57.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 1.79 111.044 -178.954 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 120.776 -0.726 . . . . 2.19 111.986 -179.312 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 109.356 -0.609 . . . . 3.7 109.356 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' C' C ' 15' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 32.0 t -62.0 112.65 2.42 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.723 -0.473 . . . . 0.57 109.723 178.22 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.59 -23.77 55.5 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 121.38 -0.438 . . . . 0.87 112.993 -175.911 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.03 -32.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.54 111.142 179.701 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.3 m -105.92 -47.42 3.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.194 0.442 . . . . 1.63 112.194 -174.689 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.0 -23.25 19.59 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.444 -0.663 . . . . 0.77 111.444 -173.902 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.78 152.21 21.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.732 0.301 . . . . 2.1 111.069 -178.165 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.83 6.79 33.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.043 -0.599 . . . . 0.66 111.804 177.307 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -70.58 127.9 34.29 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.645 -0.132 . . . . 1.52 110.645 178.563 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 58.11 39.44 26.11 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.51 0.506 . . . . 2.23 110.906 179.55 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -89.23 148.15 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.232 -0.44 . . . . 1.76 110.53 -175.093 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -114.62 148.64 37.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 1.18 110.217 -179.069 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 26' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.2 mpt_? -119.31 148.63 42.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.647 -0.501 . . . . 3.64 109.647 179.967 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 27' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 40.3 t -68.95 139.28 55.05 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.112 -0.635 . . . . 0.37 109.486 174.307 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -85.07 4.43 34.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.424 0.631 . . . . 1.34 110.596 178.932 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -127.62 -8.6 5.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 1.81 110.68 176.7 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 9.0 m -145.02 177.44 8.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.92 110.13 -177.948 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 112.96 26.2 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.802 -0.814 . . . . 1.17 108.802 173.072 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 32' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.0 111.8 0.98 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.088 -0.505 . . . . 1.13 110.531 -179.544 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -93.21 112.58 24.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.007 0.432 . . . . 1.18 109.903 176.057 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.68 158.1 40.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.878 -0.601 . . . . 0.68 109.828 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 35' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.4 m170 -87.24 138.45 31.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.166 -1.05 . . . . 0.58 108.166 172.192 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -48.94 -50.99 32.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.107 0.254 . . . . 0.77 111.443 -175.849 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -67.71 -10.46 52.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.016 -0.538 . . . . 3.8 112.099 -175.325 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 38' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.6 m -89.96 -21.63 22.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.906 0.384 . . . . 0.54 110.947 -179.083 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -101.94 -36.87 8.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.429 . . . . 0.72 110.486 174.92 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -124.5 150.0 63.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.989 -0.55 . . . . 0.94 110.219 -176.061 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.83 144.18 94.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.565 2.176 . . . . 2.64 111.089 172.786 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.85 -15.6 55.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.542 -0.754 . . . . 3.71 111.982 -175.733 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.75 -24.34 76.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.87 -0.681 . . . . 1.86 112.157 175.723 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.8 m -75.94 136.5 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.988 -0.375 . . . . 1.52 109.988 179.328 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -87.94 128.96 35.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.105 0.479 . . . . 2.07 111.266 -172.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -69.24 119.16 68.42 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 3.22 110.194 179.366 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.62 132.8 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.537 2.158 . . . . 1.22 112.405 -176.317 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.05 -11.53 67.32 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.438 -0.665 . . . . 1.9 111.438 177.126 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 21.5 p -89.7 37.44 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.368 0.604 . . . . 3.21 110.634 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.72 123.85 5.24 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.571 -0.74 . . . . 1.31 111.869 -178.12 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 123.73 22.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.105 -0.702 . . . . 1.51 109.105 178.406 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -115.52 128.48 56.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.945 0.403 . . . . 3.09 110.993 -174.876 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 53' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 15.6 p -73.24 174.13 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.724 -0.671 . . . . 0.55 109.672 177.507 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -57.66 -37.87 74.13 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.862 0.301 . . . . 4.7 111.655 -170.309 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 32.9 t -69.31 -38.84 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.977 0.418 . . . . 1.89 110.343 179.992 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.7 m -73.18 -33.24 65.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.19 -0.459 . . . . 0.72 111.984 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.1 p -83.84 -14.94 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 1.79 110.873 179.438 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 110.956 -0.857 . . . . 2.19 110.956 175.468 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.599 -0.6 . . . . 20.59 111.599 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.42 34.53 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 19.12 110.507 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 48.9 ttm -148.43 33.98 0.79 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.675 0.75 . . . . 18.25 110.232 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.91 -15.47 41.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.776 -0.647 . . . . 16.83 109.965 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.88 22.87 32.5 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.965 -0.636 . . . . 14.9 112.249 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.54 -44.02 95.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.033 0.444 . . . . 16.26 110.302 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . 0.446 ' HA ' ' OE1' ' C' ' 7' ' ' GLN . 15.3 mm-40 -94.79 66.52 3.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.476 0.655 . . . . 13.59 109.855 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.97 10.58 18.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.259 -0.882 . . . . 12.17 109.933 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.66 96.17 10.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.312 -0.858 . . . . 9.12 109.073 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -59.97 132.52 89.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.049 -0.523 . . . . 6.25 111.483 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 27.8 Cg_exo -61.14 107.39 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.859 2.373 . . . . 5.93 112.387 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.45 80.57 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.13 -0.557 . . . . 2.77 112.377 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.47 99.3 4.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 2.44 110.611 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.24 164.03 30.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.643 -0.708 . . . . 3.7 109.549 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.6 t -67.1 106.29 1.93 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.497 -0.557 . . . . 0.57 109.497 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.41 -21.76 57.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 121.344 -0.455 . . . . 0.87 112.937 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.22 -33.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.834 0.35 . . . . 1.54 111.027 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.35 -38.96 6.64 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.085 0.402 . . . . 1.63 112.085 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.11 58.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.862 -0.685 . . . . 0.77 111.421 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.01 155.05 17.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.984 0.421 . . . . 2.1 110.9 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.08 17.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.024 -0.83 . . . . 0.66 111.024 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -64.08 118.1 8.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.294 -0.453 . . . . 1.52 110.823 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.12 47.53 21.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.616 -0.72 . . . . 2.23 110.744 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.455 HG21 ' N ' ' C' ' 34' ' ' PHE . 2.9 p -89.16 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.662 -0.699 . . . . 1.76 109.735 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.43 143.7 29.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.77 0.319 . . . . 1.18 110.521 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 40.3 mmt-85 -104.74 147.04 28.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 3.64 109.948 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.36 146.55 29.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.408 -0.59 . . . . 0.37 109.408 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -92.55 -29.69 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.461 -0.336 . . . . 1.34 111.705 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -89.71 -17.23 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.32 . . . . 1.81 111.105 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 p -150.9 -173.27 4.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.973 -0.751 . . . . 0.92 108.973 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.98 115.64 30.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.008 -0.367 . . . . 1.17 110.008 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -157.29 156.9 33.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.409 -0.36 . . . . 1.13 110.459 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 111.84 9.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.841 -0.618 . . . . 1.18 109.807 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.455 ' N ' HG21 ' C' ' 24' ' ' VAL . 37.8 p90 -156.24 158.96 38.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.99 -0.55 . . . . 0.68 109.836 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.712 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.6 m170 -92.3 133.13 36.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.267 -1.012 . . . . 0.58 108.267 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.45 -52.49 28.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.375 0.422 . . . . 0.77 111.585 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -62.57 -25.8 68.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 3.8 111.86 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.14 -22.45 52.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.939 0.399 . . . . 0.54 110.852 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . 0.446 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 0.9 OUTLIER -101.09 -40.69 7.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.324 -0.398 . . . . 0.72 111.068 178.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -117.76 79.02 12.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.402 -0.363 . . . . 0.94 110.458 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 3.8 Cg_endo -86.74 7.09 5.06 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.242 2.628 . . . . 2.64 112.411 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.58 4.54 27.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 3.71 111.789 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.7 26.64 24.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.477 -0.868 . . . . 1.86 111.76 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -75.73 140.64 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.895 -0.409 . . . . 1.52 109.895 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 11.5 p -88.7 135.35 33.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.669 0.271 . . . . 2.07 110.627 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -73.85 112.68 17.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 3.22 110.755 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.66 133.34 20.22 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.503 2.135 . . . . 1.22 112.069 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.28 -17.49 69.02 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.611 -0.804 . . . . 1.9 111.249 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 2.3 p -98.06 74.71 2.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.377 -0.412 . . . . 3.21 111.28 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.03 85.46 1.73 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.452 -0.88 . . . . 1.31 112.851 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.38 124.15 20.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.243 -0.651 . . . . 1.51 109.243 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -125.69 130.72 52.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 3.09 111.327 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -76.36 -178.37 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.55 110.067 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -60.24 -46.28 90.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 4.7 111.051 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -65.65 -48.42 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 1.89 111.056 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.76 -22.28 65.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.531 0.205 . . . . 0.72 111.514 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -86.25 -2.6 58.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.496 0.189 . . . . 1.79 111.017 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.8 -69.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.812 -0.709 . . . . 2.19 111.855 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -110.92 112.6 24.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.742 0.306 . . . . 5.15 110.308 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.83 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 7.2 109.705 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 28.8 m -116.89 105.92 48.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.171 -0.468 . . . . 8.83 110.507 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.35 161.66 44.97 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.737 2.291 . . . . 11.41 112.235 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.58 116.62 66.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.203 -0.453 . . . . 13.86 110.11 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.94 99.69 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.174 2.583 . . . . 16.55 112.764 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.95 129.14 41.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.109 -0.496 . . . . 18.07 109.953 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.61 -0.709 . . . . 20.26 110.501 -176.272 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.712 -0.555 . . . . 20.59 111.712 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.77 26.73 16.28 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.95 0.405 . . . . 19.12 111.63 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 50.2 ttm -116.14 -39.32 3.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.431 . . . . 18.25 110.703 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -75.89 -34.49 59.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.565 . . . . 16.83 110.988 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.4 148.26 48.37 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.576 -0.821 . . . . 14.9 111.965 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -78.46 -30.37 47.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.219 0.533 . . . . 16.26 109.959 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -91.48 165.25 13.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 13.59 109.968 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -129.34 136.74 50.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.495 -0.558 . . . . 12.17 109.495 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.1 64.92 2.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.48 . . . . 9.12 110.657 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.75 137.54 23.15 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.953 -0.567 . . . . 6.25 110.018 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.91 41.91 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.978 2.452 . . . . 5.93 113.106 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.61 -134.33 44.48 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.173 -0.537 . . . . 2.77 112.036 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.83 73.48 9.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.127 0.489 . . . . 2.44 110.189 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -157.08 134.91 10.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.829 -0.623 . . . . 3.7 109.757 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 4.4 t -81.83 104.8 12.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.973 -0.558 . . . . 0.57 109.753 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -2.28 60.51 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 115.759 -0.655 . . . . 0.87 113.306 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.75 -29.2 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.992 0.425 . . . . 1.54 110.384 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.99 -35.1 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.448 -0.342 . . . . 1.63 111.056 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.22 -11.86 21.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.892 -0.671 . . . . 0.77 111.992 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 24.4 t70 -97.73 147.15 24.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.733 0.302 . . . . 2.1 110.632 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.21 16.34 8.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.965 -0.636 . . . . 0.66 112.121 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.16 132.63 35.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 1.52 110.121 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t0 52.59 56.16 8.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.791 0.805 . . . . 2.23 109.488 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 6.2 p -91.44 137.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.168 -0.924 . . . . 1.76 110.63 -173.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.97 147.9 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 1.18 110.225 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 10.4 mmm180 -114.47 136.05 53.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.963 -0.562 . . . . 3.64 110.16 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.8 t -67.56 136.78 55.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.349 -0.387 . . . . 0.37 110.102 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -88.26 -12.76 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 1.34 111.108 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -100.96 -23.25 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 1.81 110.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.3 p -151.28 -172.4 4.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.92 109.656 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.34 113.96 27.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.684 -0.234 . . . . 1.17 110.417 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.28 140.15 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.427 . . . . 1.13 110.653 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.71 112.17 23.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 1.18 109.354 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -150.89 166.85 29.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.293 -0.412 . . . . 0.68 110.806 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -104.4 138.17 41.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.277 -0.638 . . . . 0.58 109.277 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -63.44 -34.44 77.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.835 -0.62 . . . . 0.77 110.387 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -68.69 -36.6 78.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 3.8 110.798 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -73.61 -23.15 59.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.54 110.919 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -92.32 -54.71 3.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.136 -0.484 . . . . 0.72 110.935 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.16 144.07 30.44 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.94 110.227 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.27 165.09 25.66 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.795 2.33 . . . . 2.64 112.068 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -13.96 47.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.192 -0.913 . . . . 3.71 112.961 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.44 -6.5 77.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.49 -0.862 . . . . 1.86 112.519 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.9 m -91.48 130.46 37.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 1.52 111.123 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.3 t -89.9 150.37 22.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.816 -0.629 . . . . 2.07 109.459 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -79.41 131.69 64.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.543 -0.54 . . . . 3.22 109.543 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.6 132.15 21.43 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.176 1.917 . . . . 1.22 111.925 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.33 -2.32 67.19 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.861 -0.685 . . . . 1.9 112.323 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.2 p -89.3 -2.77 58.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.817 0.342 . . . . 3.21 111.22 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.86 5.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.519 -0.848 . . . . 1.31 112.444 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.5 123.35 25.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.047 0.451 . . . . 1.51 109.844 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.74 133.32 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 3.09 111.295 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -77.38 -174.24 3.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.176 -0.676 . . . . 0.55 109.176 172.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.23 -53.17 59.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 4.7 111.374 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -63.46 -42.47 98.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.89 111.646 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 -17.27 62.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.679 0.276 . . . . 0.72 111.297 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 70.6 m -85.39 -3.04 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 1.79 110.989 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.27 38.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.606 -0.807 . . . . 2.19 112.381 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.6 69.37 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.278 0.561 . . . . 5.15 110.491 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 31.6 t -89.51 109.45 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 7.2 109.742 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -67.82 115.01 23.45 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.385 -0.37 . . . . 8.83 111.014 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.92 146.88 16.54 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.628 2.219 . . . . 11.41 112.481 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.49 137.65 20.75 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 13.86 110.584 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.05 71.34 2.86 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.623 2.215 . . . . 16.55 111.188 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.84 138.89 52.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 18.07 110.81 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.685 -0.674 . . . . 20.26 110.091 -178.919 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 112.078 -0.409 . . . . 20.59 112.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.17 -71.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.607 0.763 . . . . 19.12 111.378 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.3 ptm -141.14 120.32 12.93 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.606 -0.516 . . . . 18.25 109.606 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.3 -33.98 32.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.296 -0.411 . . . . 16.83 110.527 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.25 112.1 0.85 Allowed Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.433 -0.889 . . . . 14.9 112.563 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.12 0.57 14.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.391 . . . . 16.26 110.513 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -79.22 66.97 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.289 0.566 . . . . 13.59 110.031 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -69.8 -43.45 72.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.659 -0.701 . . . . 12.17 109.566 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.2 120.22 39.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 9.12 109.587 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.2 123.42 85.25 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.603 -0.518 . . . . 6.25 109.603 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 89.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.888 2.392 . . . . 5.93 112.429 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.62 -17.04 37.36 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.71 -0.677 . . . . 2.77 111.506 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.94 74.8 4.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.357 0.599 . . . . 2.44 109.45 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -161.53 141.93 10.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.019 -0.991 . . . . 3.7 108.648 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 49.3 t -72.17 103.78 3.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 0.57 110.497 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.73 -7.65 83.92 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.856 -0.611 . . . . 0.87 111.644 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.94 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 1.54 110.255 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.2 p -102.73 -28.08 12.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.914 0.388 . . . . 1.63 110.038 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.11 24.75 10.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.77 111.693 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 27.9 t70 -142.59 147.83 36.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 2.1 110.706 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.23 16.94 8.04 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.631 -0.587 . . . . 0.66 111.631 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.5 m -80.44 120.02 23.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.155 -0.313 . . . . 1.52 110.155 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.72 50.03 17.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.56 0.695 . . . . 2.23 110.167 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.43 144.53 8.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.936 -1.029 . . . . 1.76 109.903 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.47 155.42 19.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.961 0.41 . . . . 1.18 110.376 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.0 mmm180 -123.64 151.96 42.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.014 -0.735 . . . . 3.64 109.014 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 37.9 t -69.63 138.78 53.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.618 -0.833 . . . . 0.37 109.176 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p -80.98 -10.86 59.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.101 0.477 . . . . 1.34 110.98 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -117.25 -7.81 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 1.81 111.031 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 14.3 m -140.92 179.32 6.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.92 110.406 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.6 113.29 26.76 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.011 -0.737 . . . . 1.17 109.011 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.91 145.34 6.22 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.058 0.224 . . . . 1.13 110.53 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.53 112.41 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.477 0.486 . . . . 1.18 110.268 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -157.06 145.15 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.913 -0.585 . . . . 0.68 110.146 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.817 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 77.2 m80 -86.75 151.35 23.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.516 -0.55 . . . . 0.58 109.516 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 67.9 t-105 -61.98 -50.5 71.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.763 0.316 . . . . 0.77 110.489 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -69.43 -14.53 62.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 3.8 111.731 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.817 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.8 m -80.79 -20.96 41.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.251 0.548 . . . . 0.54 110.029 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.06 -39.41 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.72 111.392 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -125.68 158.61 64.45 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.94 110.496 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.42 159.82 51.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.595 2.197 . . . . 2.64 110.935 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.3 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 3.71 111.458 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.21 -12.8 79.75 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.231 -0.509 . . . . 1.86 112.413 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 23.7 m -88.81 138.9 30.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 1.52 109.914 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.11 137.74 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 2.07 110.319 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . 0.466 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 14.4 ptm180 -93.12 121.74 64.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.352 -0.385 . . . . 3.22 111.221 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.02 136.57 29.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.769 2.312 . . . . 1.22 111.639 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.74 -46.99 10.32 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.075 -0.583 . . . . 1.9 112.721 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -17.65 16.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.163 0.506 . . . . 3.21 111.307 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -115.95 50.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.686 -0.769 . . . . 1.31 112.63 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.09 123.54 21.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.934 -0.765 . . . . 1.51 108.934 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 76.0 mtt180 -117.82 140.97 48.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.933 0.397 . . . . 3.09 111.832 -170.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 17.6 p -77.29 171.51 14.75 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.424 -0.954 . . . . 0.55 108.424 169.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -56.55 -38.79 72.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.194 0.452 . . . . 4.7 111.752 -171.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -68.62 -40.45 80.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 1.89 110.843 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -71.47 -26.19 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.732 0.301 . . . . 0.72 111.021 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 41.9 p -93.46 19.76 8.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.983 0.421 . . . . 1.79 110.689 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.97 60.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.13 -0.557 . . . . 2.19 112.126 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -91.12 156.8 17.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.837 0.351 . . . . 5.15 110.156 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.63 114.58 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.301 -0.408 . . . . 7.2 110.448 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 69.4 m -93.5 117.56 67.37 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.737 -0.468 . . . . 8.83 109.737 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.05 134.27 39.01 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.257 1.971 . . . . 11.41 112.219 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.56 122.72 68.0 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.951 -0.568 . . . . 13.86 110.038 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.88 86.24 0.11 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.842 2.362 . . . . 16.55 112.221 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.01 170.64 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.88 -0.6 . . . . 18.07 110.994 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.515 -0.755 . . . . 20.26 110.328 -178.455 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.853 -0.499 . . . . 20.59 111.853 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 60.15 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.405 0.622 . . . . 19.12 111.206 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.81 145.37 31.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.532 -0.758 . . . . 18.25 109.621 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -74.38 78.25 1.88 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.956 0.408 . . . . 16.83 110.908 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.4 83.96 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.583 -0.607 . . . . 14.9 111.583 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -110.69 8.65 22.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.893 0.378 . . . . 16.26 110.731 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.05 104.78 16.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 13.59 110.268 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.24 79.73 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 12.17 110.416 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 tp -143.21 133.02 23.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.968 -0.56 . . . . 9.12 110.34 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.16 139.19 52.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.063 -0.517 . . . . 6.25 110.57 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.79 57.89 2.58 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.099 2.532 . . . . 5.93 113.107 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.03 -150.38 22.58 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.791 -0.718 . . . . 2.77 112.48 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.23 83.55 3.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.805 0.336 . . . . 2.44 111.435 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -146.74 152.24 38.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.348 -0.387 . . . . 3.7 110.72 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.2 t -65.4 113.56 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.57 109.699 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.61 -19.2 62.38 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.075 -0.583 . . . . 0.87 113.496 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.93 -30.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.059 0.457 . . . . 1.54 110.686 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.6 m -108.57 -24.56 11.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.56 0.578 . . . . 1.63 112.56 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.46 16.9 79.81 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.304 -0.718 . . . . 0.77 111.304 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -134.85 156.2 49.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.451 . . . . 2.1 110.137 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.89 22.09 5.19 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.721 -0.752 . . . . 0.66 112.816 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.0 m -75.66 125.83 29.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.52 110.059 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 54.36 45.73 26.57 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.334 0.588 . . . . 2.23 110.234 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.75 151.77 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.76 110.531 -175.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.2 mt -96.02 149.49 21.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.142 -0.481 . . . . 1.18 109.898 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -107.38 155.46 19.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.114 -0.494 . . . . 3.64 110.505 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.422 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.1 t -88.92 140.43 29.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.613 -0.514 . . . . 0.37 109.613 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -90.37 -26.83 19.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.032 0.444 . . . . 1.34 111.275 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -89.96 -20.5 23.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 1.81 111.05 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.422 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.0 p -151.0 -172.32 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.961 -0.755 . . . . 0.92 108.961 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.27 114.27 28.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.949 -0.389 . . . . 1.17 109.949 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.32 151.96 10.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 1.13 110.776 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -119.35 120.58 37.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.805 -0.634 . . . . 1.18 109.679 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.84 148.17 31.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.193 -0.458 . . . . 0.68 110.873 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.473 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.6 m170 -88.82 126.61 35.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.79 -1.189 . . . . 0.58 107.79 168.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -56.57 -38.59 72.17 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.69 0.619 . . . . 0.77 111.192 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -71.71 -23.7 61.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.904 0.383 . . . . 3.8 111.222 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 84.4 m -85.14 -22.99 28.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.421 -0.354 . . . . 0.54 110.93 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . 0.419 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 7.6 m-70 -102.15 -24.72 13.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.72 111.539 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -130.87 65.1 75.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.913 0.387 . . . . 0.94 110.522 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 6.2 Cg_exo -78.97 5.42 5.72 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.159 2.572 . . . . 2.64 112.436 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.14 3.58 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.302 -0.408 . . . . 3.71 111.326 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.8 8.24 45.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 1.86 112.7 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.3 m -67.72 129.35 39.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.121 -0.325 . . . . 1.52 110.121 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 p -90.03 149.17 22.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.631 0.253 . . . . 2.07 110.575 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -78.13 121.97 84.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 3.22 111.257 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.71 155.65 58.35 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.771 2.314 . . . . 1.22 111.466 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.44 -19.43 79.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.98 -0.629 . . . . 1.9 111.814 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -147.11 142.29 27.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.917 0.389 . . . . 3.21 110.212 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 51.71 1.47 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.784 -0.722 . . . . 1.31 112.36 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.54 122.13 25.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.172 0.51 . . . . 1.51 110.372 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -127.89 137.29 52.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.171 -0.468 . . . . 3.09 110.505 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -72.89 -177.0 2.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.476 -0.564 . . . . 0.55 109.476 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -67.01 -40.43 87.31 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.631 -0.428 . . . . 4.7 110.631 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -67.68 -43.58 79.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 1.89 111.459 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.78 -17.22 62.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.72 110.791 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -87.41 19.66 3.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 1.79 110.574 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.58 94.28 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.498 -1.041 . . . . 2.19 110.498 172.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -91.94 74.63 5.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 5.15 109.485 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.53 123.22 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.722 -0.672 . . . . 7.2 110.721 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 33.6 m -97.57 115.18 65.72 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.002 -0.544 . . . . 8.83 109.827 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.72 132.91 54.4 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 11.41 111.91 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.13 141.93 33.33 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.838 -0.619 . . . . 13.86 110.812 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.87 57.63 4.55 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.804 2.336 . . . . 16.55 112.515 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.4 153.21 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 18.07 110.358 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.469 -0.777 . . . . 20.26 110.786 -179.423 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.042 -0.423 . . . . 20.59 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.58 122.54 27.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.834 0.349 . . . . 19.12 110.523 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 42.0 tpp -85.27 59.73 5.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.513 0.673 . . . . 18.25 110.094 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -93.92 69.73 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 16.83 110.177 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.6 48.22 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.205 -0.907 . . . . 14.9 111.106 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.87 -12.89 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.725 0.298 . . . . 16.26 111.296 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 58.59 56.4 4.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 13.59 110.465 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -113.9 92.26 3.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 12.17 110.322 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.03 146.67 27.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.839 -0.619 . . . . 9.12 109.917 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.84 130.88 33.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.149 -0.478 . . . . 6.25 110.134 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.12 64.52 3.43 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.947 2.431 . . . . 5.93 112.684 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.41 41.36 58.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.708 -0.758 . . . . 2.77 111.221 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.39 75.22 1.49 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 2.44 110.077 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -129.07 141.84 51.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 3.7 110.118 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -64.19 103.42 0.62 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.57 109.516 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.08 -17.41 69.7 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.867 -0.682 . . . . 0.87 112.764 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.0 t -61.78 -38.56 80.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.824 0.345 . . . . 1.54 110.981 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.6 p -109.52 -28.96 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.979 0.419 . . . . 1.63 110.576 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.51 -14.38 56.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.044 -0.598 . . . . 0.77 111.829 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -94.94 140.27 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 2.1 110.987 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.09 20.23 16.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.925 -0.655 . . . . 0.66 112.476 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -78.36 116.37 18.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.461 0.172 . . . . 1.52 110.581 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.71 66.19 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 2.23 111.386 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.49 140.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 1.76 110.987 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -88.06 143.8 26.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 1.18 109.405 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.6 OUTLIER -108.07 135.54 49.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.069 0.462 . . . . 3.64 110.612 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -63.57 141.27 58.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.299 -0.864 . . . . 0.37 110.261 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.3 p -89.51 -26.23 21.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.324 -0.398 . . . . 1.34 111.35 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -89.64 -21.51 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.81 110.904 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.436 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.9 p -150.49 -172.29 4.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.478 -0.934 . . . . 0.92 108.478 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.03 114.4 28.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.788 0.328 . . . . 1.17 110.187 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.45 123.23 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 1.13 109.847 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.34 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.583 -0.525 . . . . 1.18 109.583 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -147.77 162.92 38.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.004 -0.544 . . . . 0.68 110.122 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.418 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -93.03 133.72 35.89 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.873 -0.788 . . . . 0.58 108.873 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -51.14 -48.05 61.91 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.632 0.582 . . . . 0.77 111.092 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 33.7 mmt180 -74.41 -5.46 42.59 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.388 0.514 . . . . 3.8 112.388 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.5 m -91.23 -22.2 20.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 0.54 110.561 175.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -102.35 -43.31 5.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.01 0.433 . . . . 0.72 110.722 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 88.3 m-85 -118.58 137.72 25.1 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.595 . . . . 0.94 109.928 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.41 177.65 6.46 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.7 2.267 . . . . 2.64 112.633 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.11 -37.89 78.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.68 0.276 . . . . 3.71 111.699 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.64 -20.93 64.43 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.105 -0.498 . . . . 1.86 113.787 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.12 132.35 34.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.125 0.463 . . . . 1.52 110.111 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.74 137.99 31.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.29 -0.414 . . . . 2.07 110.956 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -74.84 117.29 61.4 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.763 -0.653 . . . . 3.22 110.632 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.41 132.63 22.66 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.587 2.191 . . . . 1.22 111.638 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.23 -39.3 12.94 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.769 -0.729 . . . . 1.9 111.459 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.1 m -98.14 112.49 24.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.447 -0.377 . . . . 3.21 110.597 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.58 59.99 3.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.885 -0.674 . . . . 1.31 112.801 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.76 122.51 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.847 -0.797 . . . . 1.51 108.847 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.431 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 33.6 ptt180 -133.69 146.04 50.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.103 0.478 . . . . 3.09 111.032 -174.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.46 177.14 5.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.329 -0.85 . . . . 0.55 110.649 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -55.78 -49.37 73.36 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.151 0.282 . . . . 4.7 111.204 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -59.19 -43.25 92.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.999 0.428 . . . . 1.89 110.513 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.82 -27.76 62.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.404 0.52 . . . . 0.72 112.404 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -75.85 -7.14 53.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.874 0.369 . . . . 1.79 111.31 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.84 -149.6 5.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.937 -0.649 . . . . 2.19 111.794 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.4 167.07 12.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.929 0.395 . . . . 5.15 110.23 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.48 40.75 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.271 0.558 . . . . 7.2 110.681 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 75.9 p -78.67 130.83 69.59 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.696 -0.683 . . . . 8.83 110.197 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.15 133.24 51.73 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.341 2.027 . . . . 11.41 111.671 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.83 126.91 29.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.338 -0.392 . . . . 13.86 110.445 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.53 98.84 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.593 2.195 . . . . 16.55 111.831 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -89.57 -39.84 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.318 0.58 . . . . 18.07 110.416 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.316 -0.856 . . . . 20.26 109.976 179.817 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 111.965 -0.454 . . . . 20.59 111.965 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.61 -20.01 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.714 0.292 . . . . 19.12 111.648 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -73.41 -12.41 60.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 18.25 111.238 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.25 84.1 7.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.919 -0.4 . . . . 16.83 109.919 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . 0.605 ' HA2' ' OD1' ' C' ' 8' ' ' ASN . . . -132.61 33.69 2.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.695 -0.764 . . . . 14.9 112.633 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -74.95 -28.42 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 16.26 111.026 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -120.22 35.3 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 13.59 110.634 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . 0.605 ' OD1' ' HA2' ' C' ' 5' ' ' GLY . 16.7 m120 -115.08 24.59 11.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.167 0.508 . . . . 12.17 110.513 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.25 76.93 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.926 -0.579 . . . . 9.12 110.285 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.62 125.91 90.61 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 6.25 109.944 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.2 95.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.952 2.435 . . . . 5.93 113.071 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.0 41.52 1.64 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.514 -0.634 . . . . 2.77 111.514 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.66 81.68 8.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.064 0.459 . . . . 2.44 111.287 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.03 154.99 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 3.7 109.721 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 27.9 t -61.48 106.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 0.57 110.123 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.05 -25.7 64.67 Favored Glycine 0 C--O 1.229 -0.182 0 O-C-N 123.454 0.471 . . . . 0.87 112.516 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.17 -29.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.494 . . . . 1.54 110.885 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 88.5 m -108.1 -33.46 7.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 1.63 112.116 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.05 6.03 72.38 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.86 -0.896 . . . . 0.77 110.86 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.36 147.08 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.588 . . . . 2.1 109.912 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.45 30.99 4.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.864 -0.684 . . . . 0.66 112.752 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -74.72 125.73 29.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 1.52 109.723 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.13 51.91 14.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.438 0.637 . . . . 2.23 110.325 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.33 151.1 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.599 -0.728 . . . . 1.76 110.565 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' C' ' 36' ' ' TRP . 80.6 mt -102.27 148.38 25.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 1.18 110.023 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -115.57 138.73 50.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.844 -0.617 . . . . 3.64 110.447 -175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -75.49 143.69 42.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.743 -0.466 . . . . 0.37 109.743 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -91.04 -30.79 16.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.545 . . . . 1.34 111.855 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -91.58 -14.38 30.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.351 . . . . 1.81 111.507 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 p -150.47 -174.22 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.437 -0.579 . . . . 0.92 109.437 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.63 114.06 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.673 -0.492 . . . . 1.17 109.673 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 125.13 1.87 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 1.13 110.835 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.76 25.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 1.18 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -151.83 160.63 43.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.374 -0.375 . . . . 0.68 110.598 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.1 m170 -90.8 134.83 34.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.941 -0.763 . . . . 0.58 108.941 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.414 ' HB2' HD12 ' C' ' 25' ' ' LEU . 28.0 t-105 -50.54 -51.58 46.55 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.336 0.397 . . . . 0.77 111.476 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -62.19 -27.8 69.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 3.8 112.193 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -78.49 -22.91 46.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 0.54 111.346 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -100.22 -37.08 9.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.264 -0.425 . . . . 0.72 110.865 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.3 85.65 25.63 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 0.94 110.289 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.45 -5.19 12.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.117 2.544 . . . . 2.64 113.386 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.21 4.23 31.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.896 0.379 . . . . 3.71 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.41 33.78 27.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.713 -0.756 . . . . 1.86 112.024 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -61.66 142.21 57.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 1.52 110.733 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -88.48 135.45 33.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.422 -0.354 . . . . 2.07 110.157 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -67.4 125.78 91.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 3.22 110.342 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 137.64 38.17 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.575 2.184 . . . . 1.22 112.377 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.1 1.51 70.43 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.952 -0.642 . . . . 1.9 111.988 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -104.86 26.61 8.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.36 0.6 . . . . 3.21 110.746 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 118.08 122.38 3.19 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.546 -0.752 . . . . 1.31 111.805 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.7 123.57 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 1.51 109.548 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 54.1 mtt85 -125.68 134.29 51.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.359 -0.382 . . . . 3.09 111.119 -174.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.9 p -76.29 177.19 7.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.977 -0.749 . . . . 0.55 108.977 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -59.96 -40.33 88.66 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.318 0.508 . . . . 4.7 111.487 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m -65.09 -46.54 80.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.868 0.366 . . . . 1.89 110.965 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.91 -17.85 62.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.72 111.418 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 36.3 m -88.84 -14.33 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.38 . . . . 1.79 110.56 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.59 100.15 1.66 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.907 -0.663 . . . . 2.19 112.623 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.54 42.26 1.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.59 0.71 . . . . 5.15 109.745 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.13 146.82 24.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.542 -0.754 . . . . 7.2 110.559 -172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.1 t -65.57 135.24 95.67 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.958 -0.565 . . . . 8.83 109.805 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.07 133.51 47.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.838 2.359 . . . . 11.41 112.425 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.59 130.5 33.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.853 -0.612 . . . . 13.86 110.896 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.09 92.78 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.567 2.178 . . . . 16.55 111.423 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -91.24 124.82 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.178 -0.465 . . . . 18.07 110.654 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.924 -0.56 . . . . 20.26 109.754 177.36 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.877 -0.489 . . . . 20.59 111.877 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.44 133.08 53.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.437 -0.208 . . . . 19.12 110.437 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 24.1 ptp -124.94 10.4 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.079 0.466 . . . . 18.25 110.748 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -89.0 72.51 8.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.509 . . . . 16.83 110.718 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.7 97.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.024 -0.608 . . . . 14.9 111.749 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 57.97 49.29 11.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.14 0.495 . . . . 16.26 110.977 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -104.48 88.93 3.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.881 -0.6 . . . . 13.59 110.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -81.09 90.78 6.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.604 -0.725 . . . . 12.17 110.727 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.01 104.8 11.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.263 -0.426 . . . . 9.12 110.349 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.81 128.64 45.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 6.25 110.383 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.0 109.03 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.782 2.322 . . . . 5.93 112.203 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.37 96.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.782 -0.723 . . . . 2.77 111.922 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.39 74.92 4.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.205 0.526 . . . . 2.44 110.809 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -147.79 130.51 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.702 -0.681 . . . . 3.7 110.108 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -81.9 102.76 11.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.57 108.608 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.66 80.34 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.828 -0.624 . . . . 0.87 112.806 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 t -66.14 -28.83 44.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.085 0.469 . . . . 1.54 110.725 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.56 -41.9 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.314 -0.403 . . . . 1.63 110.326 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.49 -10.82 8.07 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.911 -0.661 . . . . 0.77 112.256 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -100.23 148.19 24.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 2.1 111.843 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.75 16.43 21.15 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.488 -0.778 . . . . 0.66 111.491 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.4 m -74.0 115.59 13.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.826 -0.187 . . . . 1.52 110.739 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.19 66.34 1.26 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.801 0.688 . . . . 2.23 111.014 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -89.97 136.53 23.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.63 -0.714 . . . . 1.76 111.008 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.03 144.09 28.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.667 -0.697 . . . . 1.18 110.014 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.1 mpt_? -103.78 146.65 28.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.953 -0.567 . . . . 3.64 110.19 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 27.0 t -72.62 141.39 48.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.515 -0.55 . . . . 0.37 109.515 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.44 -26.05 33.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.158 -0.474 . . . . 1.34 111.581 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -94.91 -28.12 15.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 1.81 111.521 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.553 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.9 p -143.93 -174.02 4.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.57 . . . . 0.92 109.46 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.58 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.781 0.324 . . . . 1.17 110.719 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.639 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -160.8 138.46 9.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.046 -0.525 . . . . 1.13 109.973 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.56 112.12 22.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.858 -0.423 . . . . 1.18 109.858 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -156.53 166.0 34.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.834 0.35 . . . . 0.68 110.976 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -97.29 135.22 39.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.58 108.795 171.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -59.62 -39.28 83.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.924 -0.58 . . . . 0.77 110.593 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.61 -15.83 60.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 3.8 111.73 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 68.7 m -84.32 -22.45 30.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.168 0.509 . . . . 0.54 110.12 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.24 -56.07 2.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 0.72 111.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.443 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 75.6 m-85 -106.99 135.24 19.6 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.833 -0.621 . . . . 0.94 110.14 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -70.78 176.3 7.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.272 . . . . 2.64 112.667 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.94 65.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.437 -0.347 . . . . 3.71 111.654 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.52 -23.08 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.86 112.88 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 13.1 m -99.0 128.88 45.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.883 -0.414 . . . . 1.52 109.883 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 63.0 p -89.21 138.0 31.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.465 -0.334 . . . . 2.07 111.216 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -75.61 116.17 52.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 3.22 110.348 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.96 133.42 21.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.237 1.958 . . . . 1.22 111.449 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.15 79.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.938 -0.649 . . . . 1.9 111.733 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.4 p -131.53 141.46 49.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.012 -0.366 . . . . 3.21 110.012 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.74 53.15 3.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 1.31 112.275 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 123.25 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.81 -0.441 . . . . 1.51 109.81 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -117.25 145.7 43.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.915 0.388 . . . . 3.09 110.779 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 13.9 p -84.65 -176.21 6.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.308 -0.627 . . . . 0.55 109.308 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -62.5 -48.31 80.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 4.7 111.348 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 19.3 t -67.1 -44.77 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.324 -0.398 . . . . 1.89 111.244 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -72.14 -29.33 63.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.816 0.302 . . . . 0.72 111.816 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 2.6 t -90.65 -12.23 37.46 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.793 -0.363 . . . . 1.79 111.679 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.75 -111.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.023 -1.084 . . . . 2.19 113.092 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -115.54 146.98 41.22 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.062 -0.347 . . . . 5.15 110.062 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.89 122.92 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 7.2 111.11 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -109.46 105.22 56.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.695 -0.483 . . . . 8.83 109.695 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.01 137.1 51.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.531 2.154 . . . . 11.41 112.397 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' C' ' 65' ' ' VAL . . . -80.29 155.72 74.24 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.753 -0.658 . . . . 13.86 110.256 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.46 23.88 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.89 2.393 . . . . 16.55 113.184 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' C' ' 63' ' ' ALA . 27.3 m -122.95 7.78 5.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.636 -0.711 . . . . 18.07 109.445 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.22 -0.9 . . . . 20.26 109.985 -179.049 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.768 -0.533 . . . . 20.59 111.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.518 ' O ' ' HG2' ' C' ' 6' ' ' GLN . . . -81.44 -61.12 2.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.739 0.304 . . . . 19.12 111.389 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 20.3 mmt -78.85 40.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.665 0.617 . . . . 18.25 112.665 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.87 -6.43 9.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.509 -0.552 . . . . 16.83 109.509 172.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.05 -79.61 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.601 -0.727 . . . . 14.9 112.372 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' C' ' 2' ' ' ALA . 30.4 mm-40 57.79 37.22 27.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.954 0.407 . . . . 16.26 110.08 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 58.3 69.85 0.7 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.254 -0.884 . . . . 13.59 109.691 -174.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -81.06 68.93 7.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.651 0.739 . . . . 12.17 110.202 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.9 tp -149.12 100.53 3.06 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.152 -0.931 . . . . 9.12 109.454 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.41 ' HB2' ' HB1' ' C' ' 13' ' ' ALA . . . -87.42 123.43 69.7 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.026 -0.534 . . . . 6.25 110.016 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.87 -25.43 60.13 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.788 2.325 . . . . 5.93 112.704 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.66 22.99 32.53 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.829 -0.623 . . . . 2.77 112.343 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' C' ' 10' ' ' ALA . . . -135.83 107.11 6.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.015 0.436 . . . . 2.44 111.196 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.644 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 73.1 mtt180 -136.47 164.42 28.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 3.7 109.636 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.87 106.62 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.227 -0.657 . . . . 0.57 109.227 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 -22.3 55.0 Favored Glycine 0 C--N 1.33 0.224 0 O-C-N 123.349 0.405 . . . . 0.87 113.109 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.4 -30.2 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.54 110.891 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 86.5 m -108.57 -46.02 3.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.774 0.657 . . . . 1.63 112.774 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . 0.644 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 102.67 -17.17 53.74 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.77 111.536 -173.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.42 150.37 20.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.864 0.364 . . . . 2.1 110.758 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.13 9.04 29.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.186 -0.766 . . . . 0.66 111.186 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 m -72.48 136.7 46.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.389 . . . . 1.52 110.539 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.92 47.09 7.0 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.967 0.889 . . . . 2.23 111.075 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.65 140.45 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.76 109.854 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.35 144.56 25.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.932 0.396 . . . . 1.18 110.381 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -109.32 149.69 29.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.588 -0.733 . . . . 3.64 109.551 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.64 137.36 33.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.022 0.439 . . . . 0.37 110.521 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 33.8 p -85.51 -3.5 58.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.591 . . . . 1.34 111.957 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -122.18 -15.44 7.71 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.002 -0.279 . . . . 1.81 111.631 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -151.9 -167.42 2.77 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.92 109.548 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.01 29.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.548 -0.296 . . . . 1.17 110.249 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.96 145.68 15.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.326 -0.397 . . . . 1.13 110.528 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.58 112.53 16.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.008 -0.542 . . . . 1.18 110.052 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.76 162.72 38.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.924 -0.398 . . . . 0.68 109.924 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -95.28 138.08 33.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.713 -0.847 . . . . 0.58 108.713 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -50.29 -53.03 31.56 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.239 0.337 . . . . 0.77 111.399 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -66.34 -18.07 65.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 3.8 111.97 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.0 m -84.17 -22.2 31.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.162 0.506 . . . . 0.54 110.852 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.94 -34.63 8.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.72 110.672 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -124.12 132.42 24.3 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.94 109.785 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.14 154.65 27.3 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.892 2.395 . . . . 2.64 111.695 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.39 -19.84 57.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.388 -0.823 . . . . 3.71 112.449 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.74 -18.8 78.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.987 -0.625 . . . . 1.86 112.067 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -85.49 125.36 32.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 1.52 110.013 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m -88.51 136.42 33.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 2.07 110.567 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -69.92 123.94 89.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 3.22 110.299 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.79 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.664 2.243 . . . . 1.22 112.581 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.84 5.42 82.08 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.827 -0.701 . . . . 1.9 111.583 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -92.7 18.46 8.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.14 0.495 . . . . 3.21 110.881 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.86 135.17 8.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.977 -0.63 . . . . 1.31 111.69 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 123.82 22.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.962 0.41 . . . . 1.51 110.008 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -117.41 138.05 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 3.09 110.69 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -81.12 -176.67 6.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.668 -0.493 . . . . 0.55 109.668 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -57.4 -52.48 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 4.7 111.1 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.9 t -63.11 -46.29 88.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.497 -0.32 . . . . 1.89 111.359 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 80.6 m -72.18 -17.77 61.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.072 0.397 . . . . 0.72 112.072 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -81.65 -13.75 57.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.423 -0.511 . . . . 1.79 110.147 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.7 3.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.707 -0.679 . . . . 2.19 111.495 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -148.92 144.2 26.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.686 0.279 . . . . 5.15 110.635 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.447 ' O ' ' HD3' ' C' ' 62' ' ' PRO . 43.9 t -89.18 100.5 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.005 0.431 . . . . 7.2 110.101 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 19.0 p -100.48 106.16 41.15 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.772 -0.649 . . . . 8.83 111.559 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' C' ' 60' ' ' VAL . 17.2 Cg_exo -67.86 142.59 57.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.623 2.215 . . . . 11.41 111.431 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.21 120.12 77.7 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.296 -0.411 . . . . 13.86 110.802 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.41 41.65 1.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.699 2.266 . . . . 16.55 112.349 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.85 98.6 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.571 . . . . 18.07 109.989 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.576 -0.726 . . . . 20.26 110.265 -177.103 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.134 -0.387 . . . . 20.59 112.134 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.81 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.386 0.674 . . . . 19.12 111.815 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 56.2 ttm -157.68 83.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 18.25 110.363 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.42 65.39 1.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 16.83 110.174 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.38 38.67 1.85 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.513 -0.767 . . . . 14.9 111.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.81 -26.16 37.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.23 0.538 . . . . 16.26 110.09 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -81.96 108.97 15.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.607 -0.724 . . . . 13.59 109.746 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -111.35 89.19 2.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.143 -0.48 . . . . 12.17 110.576 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 118.15 23.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 9.12 110.163 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.45 139.58 78.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.964 -0.562 . . . . 6.25 110.301 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.16 69.64 2.43 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.028 2.485 . . . . 5.93 112.759 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.27 34.28 89.07 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 116.042 -0.526 . . . . 2.77 111.838 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.479 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -142.9 75.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.901 0.381 . . . . 2.44 111.002 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.406 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.7 ttp180 -147.56 128.29 14.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.334 -0.394 . . . . 3.7 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -69.08 111.32 4.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.768 -0.456 . . . . 0.57 109.768 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.69 81.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.27 -0.49 . . . . 0.87 112.846 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.45 -37.65 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.763 0.316 . . . . 1.54 110.931 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.0 m -96.14 -43.55 7.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 1.63 111.621 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.37 1.01 55.65 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.144 -0.783 . . . . 0.77 111.144 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -117.22 143.48 45.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.338 . . . . 2.1 110.407 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . 0.406 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -110.37 9.32 30.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.958 -0.639 . . . . 0.66 112.078 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -72.78 134.02 44.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.168 -0.308 . . . . 1.52 110.168 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.34 48.6 21.6 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.628 0.58 . . . . 2.23 110.848 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.18 145.05 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 1.76 110.518 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.26 147.43 23.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.274 -0.421 . . . . 1.18 110.407 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -112.7 150.28 31.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 3.64 110.876 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -82.79 134.28 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.37 108.883 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.464 HG22 ' O ' ' C' ' 51' ' ' LEU . 5.9 t -85.57 -11.72 53.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.732 -0.387 . . . . 1.34 111.491 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.75 -17.95 13.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.795 0.294 . . . . 1.81 111.795 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.57 -167.55 2.85 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.475 -0.565 . . . . 0.92 109.475 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 114.09 28.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.755 0.312 . . . . 1.17 110.36 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.8 146.34 19.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 1.13 110.374 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -133.26 112.18 11.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.136 -0.484 . . . . 1.18 110.256 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.6 164.82 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.104 -0.498 . . . . 0.68 109.847 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.845 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.3 m170 -96.54 137.76 35.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.104 -1.073 . . . . 0.58 108.104 171.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -47.65 -51.65 20.82 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.533 0.521 . . . . 0.77 112.006 -173.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -61.65 -32.88 73.07 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.152 0.427 . . . . 3.8 112.152 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.845 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 9.1 m -71.35 -21.4 62.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.54 111.043 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.89 -42.93 5.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.72 111.174 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.99 142.94 29.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.41 -0.359 . . . . 0.94 110.714 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.16 149.02 6.49 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.602 2.868 . . . . 2.64 112.75 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -16.15 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.328 -0.851 . . . . 3.71 112.566 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.64 18.27 56.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 1.86 112.285 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.4 m -106.63 131.27 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.498 0.19 . . . . 1.52 110.542 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -88.54 133.59 34.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.975 -0.379 . . . . 2.07 109.975 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' C' ' 46' ' ' ARG . 4.1 ptm180 -80.82 130.09 65.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.714 0.292 . . . . 3.22 110.682 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.16 146.88 47.14 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.83 2.354 . . . . 1.22 112.203 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.02 -40.71 4.52 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.29 -0.724 . . . . 1.9 111.29 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.8 p -100.09 83.36 2.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.923 0.392 . . . . 3.21 110.663 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.403 ' HA2' HG23 ' C' ' 28' ' ' THR . . . 116.94 64.05 0.33 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.458 -0.877 . . . . 1.31 112.906 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.464 ' O ' HG22 ' C' ' 28' ' ' THR . 0.8 OUTLIER -77.0 121.79 24.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.782 -0.822 . . . . 1.51 108.782 176.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -126.29 132.1 51.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.436 -0.347 . . . . 3.09 110.731 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.09 179.62 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.55 109.561 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -60.17 -42.35 94.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 4.7 111.282 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -66.49 -46.26 76.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 1.89 111.057 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -71.41 -33.4 69.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.803 0.297 . . . . 0.72 111.803 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 46.1 p -83.32 -11.31 57.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 1.79 110.725 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.41 75.08 0.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.971 -0.633 . . . . 2.19 111.784 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -88.85 135.61 33.44 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.727 -0.472 . . . . 5.15 109.727 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.6 144.23 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.815 -0.63 . . . . 7.2 109.837 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.2 m -93.41 104.86 13.57 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.4 -0.364 . . . . 8.83 110.039 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 141.77 32.18 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.538 2.159 . . . . 11.41 112.263 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.14 134.89 76.98 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.85 -0.613 . . . . 13.86 110.392 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.36 66.58 2.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.986 2.457 . . . . 16.55 112.131 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.25 149.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.645 -0.707 . . . . 18.07 109.794 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' C' ' 66' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 119.26 -0.4 . . . . 20.26 110.747 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.058 -0.417 . . . . 20.59 112.058 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.11 84.79 0.09 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 122.926 0.49 . . . . 19.12 111.349 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ttt -67.96 -27.09 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 18.25 109.833 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 59.75 -99.61 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.006 -0.997 . . . . 16.83 111.939 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.58 -157.88 53.37 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.724 -0.75 . . . . 14.9 112.829 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -66.57 -26.93 67.35 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.19 0.596 . . . . 16.26 112.016 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -79.01 -7.84 58.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.718 0.294 . . . . 13.59 111.541 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -79.22 90.76 4.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.189 0.518 . . . . 12.17 110.521 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -86.21 124.37 32.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.66 -0.7 . . . . 9.12 110.263 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.14 160.39 40.07 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.726 -0.67 . . . . 6.25 111.306 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.98 58.97 1.22 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.439 2.759 . . . . 5.93 112.521 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 60.26 0.22 Allowed Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 110.983 -0.847 . . . . 2.77 110.983 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.31 88.24 0.63 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.159 0.504 . . . . 2.44 110.487 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -150.2 150.5 31.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.735 -0.666 . . . . 3.7 109.604 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.75 103.87 1.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.52 -0.548 . . . . 0.57 109.52 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.26 86.14 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.87 113.458 -171.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.94 -40.38 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.809 0.338 . . . . 1.54 110.988 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -111.67 -20.59 12.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.359 . . . . 1.63 111.147 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.95 77.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.929 -0.653 . . . . 0.77 112.036 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -109.84 146.78 34.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.259 -0.275 . . . . 2.1 110.259 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.1 17.18 9.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.66 112.753 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.76 119.43 23.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.505 -0.183 . . . . 1.52 110.505 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.72 63.1 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.413 0.445 . . . . 2.23 111.258 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -89.1 140.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 1.76 110.793 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.15 145.99 24.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.676 -0.693 . . . . 1.18 109.538 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.87 141.46 42.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 3.64 110.945 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -69.79 128.24 35.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.158 -0.682 . . . . 0.37 109.158 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 46.8 p -84.49 -8.26 59.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.495 0.664 . . . . 1.34 110.292 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -99.91 -27.97 13.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.387 -0.824 . . . . 1.81 111.056 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.1 p -151.74 -161.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.028 -0.269 . . . . 0.92 110.408 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.71 119.74 39.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.676 -0.238 . . . . 1.17 110.788 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -173.12 141.09 0.93 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.175 -0.466 . . . . 1.13 110.8 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.86 112.82 19.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.597 -0.52 . . . . 1.18 109.597 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -155.56 169.57 24.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 0.68 110.943 -173.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -102.55 134.92 45.1 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.37 -0.604 . . . . 0.58 109.37 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -63.61 -35.19 79.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.613 -0.721 . . . . 0.77 110.532 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -76.97 -17.39 58.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 3.8 111.745 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.06 -22.49 27.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.069 0.462 . . . . 0.54 110.411 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -93.3 -51.35 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.088 -0.506 . . . . 0.72 110.362 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.76 152.81 47.79 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.695 . . . . 0.94 109.963 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.29 148.48 70.59 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.244 1.963 . . . . 2.64 110.705 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.27 -11.38 31.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.022 -0.535 . . . . 3.71 111.69 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.21 7.49 80.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.11 -0.567 . . . . 1.86 112.216 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -93.02 140.54 29.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.763 -0.257 . . . . 1.52 110.308 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.3 p -87.91 143.73 26.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.973 0.416 . . . . 2.07 110.149 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -89.48 129.69 46.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.538 -0.542 . . . . 3.22 109.538 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 132.73 44.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.939 2.426 . . . . 1.22 112.761 -173.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.82 -10.41 83.13 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.342 -0.703 . . . . 1.9 111.342 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -89.59 26.38 1.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.388 0.613 . . . . 3.21 110.387 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 131.99 7.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.506 -0.77 . . . . 1.31 111.758 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.76 123.13 18.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.422 -0.584 . . . . 1.51 109.422 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -110.24 147.32 34.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.32 0.581 . . . . 3.09 110.726 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.4 p -91.49 -170.05 2.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.354 -0.839 . . . . 0.55 109.526 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -61.05 -49.64 76.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.655 -0.248 . . . . 4.7 111.283 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' C' ' 58' ' ' GLY . 15.7 m -68.64 -36.97 79.31 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.196 0.522 . . . . 1.89 111.867 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -73.64 -15.73 61.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.806 0.336 . . . . 0.72 111.422 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -97.83 7.31 46.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.353 0.597 . . . . 1.79 109.772 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.498 ' O ' ' HA ' ' C' ' 55' ' ' SER . . . 144.19 147.23 4.64 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.256 -1.138 . . . . 2.19 110.256 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.92 131.59 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.194 0.997 . . . . 5.15 110.727 -169.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -89.54 78.34 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.112 -0.949 . . . . 7.2 109.643 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -77.19 117.02 62.45 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.497 -0.774 . . . . 8.83 110.107 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.18 133.81 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.463 2.109 . . . . 11.41 111.814 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.27 137.6 56.2 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 13.86 110.041 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 72.57 1.79 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.931 2.42 . . . . 16.55 112.701 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.59 33.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 122.016 0.913 . . . . 18.07 109.066 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.085 -0.961 . . . . 20.26 109.844 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.471 -0.651 . . . . 20.59 111.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.96 155.7 26.32 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.185 -0.302 . . . . 19.12 110.185 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 17.4 ptm -106.35 80.04 1.45 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.626 0.726 . . . . 18.25 110.718 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -75.83 141.87 42.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 16.83 110.289 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.52 176.13 14.33 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.794 -0.922 . . . . 14.9 110.794 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.87 44.46 1.21 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.523 0.678 . . . . 16.26 110.172 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -94.84 94.21 7.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.278 -0.874 . . . . 13.59 110.925 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.57 -8.52 59.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.255 -0.429 . . . . 12.17 110.114 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.06 60.64 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.322 0.582 . . . . 9.12 110.463 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.39 135.16 24.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.594 -0.73 . . . . 6.25 110.647 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.95 -11.67 32.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.649 2.233 . . . . 5.93 111.933 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.73 -146.4 20.63 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.64 -0.709 . . . . 2.77 112.087 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -153.87 73.53 0.95 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.934 0.397 . . . . 2.44 110.306 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.423 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.6 ttt180 -152.46 133.55 14.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 3.7 110.604 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 29.5 t -90.47 103.67 16.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 0.57 109.183 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 -4.54 89.81 Favored Glycine 0 N--CA 1.453 -0.183 0 CA-C-N 115.967 -0.561 . . . . 0.87 113.253 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.11 -32.13 46.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.106 0.479 . . . . 1.54 110.21 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 p -115.89 -41.34 3.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.006 -0.543 . . . . 1.63 110.285 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.55 -15.78 7.1 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.874 -0.679 . . . . 0.77 112.381 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -91.12 140.81 29.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 2.1 111.343 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -111.28 3.48 28.22 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.989 -0.624 . . . . 0.66 112.138 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 57.6 m -80.47 134.65 36.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.52 0.2 . . . . 1.52 110.739 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 59.46 50.02 8.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.629 0.728 . . . . 2.23 110.94 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 m -89.88 144.61 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.669 -0.696 . . . . 1.76 110.869 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.6 153.26 18.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 1.18 110.023 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 25.1 mmt180 -106.86 154.44 21.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.151 -0.477 . . . . 3.64 110.411 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.4 t -89.19 144.0 26.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -23.85 22.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.766 0.317 . . . . 1.34 111.331 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -95.22 -17.58 21.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 1.81 111.232 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 9.5 p -150.84 -177.2 5.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.138 -0.69 . . . . 0.92 109.138 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.17 119.33 38.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.577 -0.283 . . . . 1.17 110.525 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.92 149.36 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.086 -0.506 . . . . 1.13 110.226 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -121.32 112.21 18.31 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.54 -0.541 . . . . 1.18 109.54 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -152.69 162.07 41.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.284 -0.416 . . . . 0.68 110.779 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -91.41 136.6 32.99 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.42 -0.585 . . . . 0.58 109.42 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -59.83 -36.04 76.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.77 109.975 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -72.2 -22.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 3.8 111.777 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 87.6 m -90.38 -23.44 21.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.54 111.284 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -102.07 -21.07 14.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.942 -0.303 . . . . 0.72 111.526 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -131.08 149.06 72.67 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.766 -0.457 . . . . 0.94 109.766 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.56 147.17 60.24 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.692 2.261 . . . . 2.64 111.447 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.64 61.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.203 -0.908 . . . . 3.71 112.664 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.27 -10.82 86.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.672 . . . . 1.86 112.771 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -73.44 130.04 39.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.694 0.283 . . . . 1.52 110.5 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.7 t -88.86 136.64 32.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.584 -0.525 . . . . 2.07 109.584 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -79.48 126.82 80.23 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.047 -0.524 . . . . 3.22 110.391 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.86 135.77 31.05 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.363 2.042 . . . . 1.22 111.513 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -29.36 73.85 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.737 -0.665 . . . . 1.9 112.186 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -139.38 133.24 30.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.144 -0.317 . . . . 3.21 110.144 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.07 57.19 1.61 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.524 -0.846 . . . . 1.31 112.342 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.53 123.91 22.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.498 -0.556 . . . . 1.51 109.498 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.77 140.36 49.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.482 -0.326 . . . . 3.09 110.801 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.34 169.48 12.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.409 -0.96 . . . . 0.55 108.409 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.08 -34.63 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.851 0.751 . . . . 4.7 111.158 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -64.22 -44.9 90.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 1.89 110.978 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.4 m -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.72 111.136 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.3 m -88.73 15.26 8.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 1.79 110.695 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.68 -136.41 13.51 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.051 -0.595 . . . . 2.19 111.715 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -124.12 78.62 1.66 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.537 . . . . 5.15 110.238 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.06 87.83 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.814 -0.63 . . . . 7.2 110.442 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.3 p -106.71 121.05 46.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 8.83 110.848 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.81 134.68 64.23 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 11.41 111.257 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.27 120.1 51.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.202 -0.454 . . . . 13.86 110.94 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.45 91.11 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.646 2.231 . . . . 16.55 111.945 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.84 148.55 30.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 18.07 110.538 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.375 -0.821 . . . . 20.26 110.281 177.363 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.192 -0.363 . . . . 20.59 112.192 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.08 -35.75 49.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.866 0.365 . . . . 19.12 111.149 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.85 -36.3 62.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.103 -0.499 . . . . 18.25 111.01 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.73 -20.01 47.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.476 -0.329 . . . . 16.83 111.438 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.4 142.78 6.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.714 -0.755 . . . . 14.9 111.982 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -80.34 -63.22 1.46 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.587 0.232 . . . . 16.26 110.443 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -171.67 89.99 0.12 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.175 -0.466 . . . . 13.59 110.967 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -96.68 -38.91 9.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.769 -0.826 . . . . 12.17 108.769 171.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.73 106.63 17.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.232 -0.895 . . . . 9.12 109.223 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.98 134.77 90.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 6.25 110.508 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.7 69.78 2.13 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.049 2.499 . . . . 5.93 112.707 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.7 51.24 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.789 -0.641 . . . . 2.77 112.635 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.13 73.37 8.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 2.44 110.859 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -168.99 136.84 1.94 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.803 -0.635 . . . . 3.7 110.303 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.445 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 9.4 t -82.07 104.78 12.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.705 -0.48 . . . . 0.57 109.705 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.17 -11.09 79.17 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.969 -0.559 . . . . 0.87 113.008 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 t -67.54 -28.0 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.056 0.455 . . . . 1.54 110.67 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.39 -34.7 2.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 1.63 110.866 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.27 -6.91 24.97 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.818 -0.706 . . . . 0.77 112.132 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 9.1 m-20 -102.16 145.71 29.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 2.1 111.086 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.89 3.87 30.41 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.382 -0.687 . . . . 0.66 111.382 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -63.4 121.05 12.84 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.397 0.279 . . . . 1.52 110.871 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 56.89 52.3 9.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.774 0.797 . . . . 2.23 109.806 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.91 146.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 1.76 110.566 -176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.84 161.89 13.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.239 -0.437 . . . . 1.18 110.324 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.553 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 11.3 tpt180 -135.01 134.51 40.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.241 -0.651 . . . . 3.64 109.241 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 29.4 t -66.43 141.13 58.03 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 119.761 -0.776 . . . . 0.37 109.919 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -81.95 -15.62 53.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 1.34 111.093 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -111.18 -9.4 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 1.81 110.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.46 173.82 11.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.123 0.487 . . . . 0.92 110.305 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.29 111.49 24.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.898 -0.779 . . . . 1.17 108.898 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -167.19 125.22 1.28 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.013 -0.539 . . . . 1.13 110.117 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.15 112.24 24.43 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.152 -0.684 . . . . 1.18 109.152 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 41.9 p90 -150.01 160.9 43.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.213 -0.448 . . . . 0.68 110.435 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -98.44 134.41 41.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.29 -0.633 . . . . 0.58 109.29 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -64.35 -31.93 73.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.575 -0.739 . . . . 0.77 109.856 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -72.26 -28.25 63.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.71 . . . . 3.8 110.915 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 58.8 m -80.46 -23.03 40.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.54 110.88 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -88.97 -44.42 10.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.18 -0.463 . . . . 0.72 110.578 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -122.59 78.65 47.22 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.928 -0.578 . . . . 0.94 110.653 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.01 -5.37 17.09 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.045 2.496 . . . . 2.64 111.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.65 -8.41 56.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 3.71 111.587 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.42 24.08 11.68 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.501 -0.857 . . . . 1.86 112.482 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -65.59 141.29 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.787 0.327 . . . . 1.52 110.624 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.0 m -89.16 131.65 35.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 2.07 110.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 142.03 85.16 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 3.22 111.183 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 149.62 55.13 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.706 2.271 . . . . 1.22 112.556 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.57 -6.04 41.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.736 -0.665 . . . . 1.9 111.651 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.6 p -89.12 46.6 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.558 0.694 . . . . 3.21 110.127 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 90.38 121.63 2.34 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.142 -0.935 . . . . 1.31 110.907 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -64.24 125.3 24.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.443 -0.577 . . . . 1.51 109.443 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 94.9 mtt180 -112.96 142.99 45.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 3.09 110.377 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.471 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 22.0 p -78.45 -178.26 5.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.55 109.789 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -60.87 -45.51 94.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.672 0.272 . . . . 4.7 110.581 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.6 t -63.13 -41.63 99.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 1.89 110.788 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 62.4 m -69.75 -33.48 72.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.636 0.255 . . . . 0.72 111.278 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -76.78 -14.03 59.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.155 0.503 . . . . 1.79 109.839 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 -118.95 6.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.688 -0.687 . . . . 2.19 112.585 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -147.48 106.51 3.85 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.509 -0.552 . . . . 5.15 109.509 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 t -108.89 65.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.621 0.724 . . . . 7.2 109.896 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -81.42 128.01 71.44 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.304 -0.862 . . . . 8.83 109.996 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.25 142.23 72.37 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.456 2.104 . . . . 11.41 111.592 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.19 129.27 75.86 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.46 -0.336 . . . . 13.86 110.256 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.23 50.59 1.92 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.912 2.408 . . . . 16.55 112.466 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.49 125.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.679 -0.692 . . . . 18.07 109.645 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.584 -0.722 . . . . 20.26 110.443 -177.539 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 111.731 -0.547 . . . . 20.59 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.47 56.17 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.828 0.347 . . . . 19.12 111.137 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.34 35.12 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.231 0.539 . . . . 18.25 110.886 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.61 54.21 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.929 -0.578 . . . . 16.83 110.944 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.58 -150.37 17.75 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.835 -0.621 . . . . 14.9 111.993 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.47 63.02 1.62 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.112 -0.699 . . . . 16.26 109.112 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 60.49 42.52 14.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.987 -1.006 . . . . 13.59 110.965 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 57.32 63.88 1.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.674 -0.694 . . . . 12.17 110.459 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 32.2 tp 51.33 65.38 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.311 -0.859 . . . . 9.12 111.593 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.36 141.95 90.84 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 6.25 110.312 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.81 76.8 1.52 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.597 2.198 . . . . 5.93 112.438 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.35 -31.24 71.34 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.551 -0.619 . . . . 2.77 111.551 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.74 74.15 10.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.201 0.524 . . . . 2.44 110.137 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -159.57 130.6 5.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.884 -0.598 . . . . 3.7 109.68 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.516 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 33.7 t -74.73 103.49 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.852 -0.796 . . . . 0.57 108.852 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.24 -14.03 80.94 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 115.877 -0.602 . . . . 0.87 113.536 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 59.6 t -68.37 -37.03 77.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.943 0.401 . . . . 1.54 110.661 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.08 -28.28 7.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.39 . . . . 1.63 110.678 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.21 56.52 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.158 -0.544 . . . . 0.77 112.098 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 17.7 t70 -110.29 155.21 22.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 2.1 111.019 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.08 21.03 4.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.937 -0.649 . . . . 0.66 112.148 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -80.79 124.4 29.03 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.722 -0.473 . . . . 1.52 109.722 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.59 53.8 9.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 122.025 0.917 . . . . 2.23 109.352 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.44 HG21 ' N ' ' C' ' 34' ' ' PHE . 3.9 p -93.61 141.26 15.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.033 -0.985 . . . . 1.76 110.606 -172.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.447 HD13 ' HB2' ' C' ' 36' ' ' TRP . 78.2 mt -84.9 153.81 22.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.822 0.344 . . . . 1.18 110.403 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -116.47 140.17 49.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.919 -0.582 . . . . 3.64 110.957 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 13.8 t -74.41 139.24 43.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.635 -0.506 . . . . 0.37 109.635 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 26.0 p -89.54 -23.68 21.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.875 0.369 . . . . 1.34 111.328 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -94.08 -20.77 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 1.81 111.18 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.492 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.17 -172.74 4.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.942 -0.762 . . . . 0.92 108.942 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.81 114.56 28.47 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.176 -0.305 . . . . 1.17 110.176 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.12 135.34 6.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.378 . . . . 1.13 110.687 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.68 123.54 48.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 1.18 109.545 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 23.8 p90 -159.75 153.26 22.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.365 -0.38 . . . . 0.68 110.68 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -93.62 130.4 39.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.598 -0.889 . . . . 0.58 108.598 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.573 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 67.0 t-105 -60.95 -34.29 74.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.77 110.623 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.02 -38.58 82.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 3.8 111.269 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 85.4 m -70.02 -26.83 64.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.54 110.688 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -89.8 -53.5 4.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.72 111.957 -175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.77 143.65 30.44 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.305 -0.407 . . . . 0.94 111.003 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.1 169.67 14.65 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.056 2.504 . . . . 2.64 112.011 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.77 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.343 -0.844 . . . . 3.71 111.835 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.8 -30.07 72.61 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.804 -0.712 . . . . 1.86 111.833 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.0 m -79.02 135.86 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.672 0.272 . . . . 1.52 110.479 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.2 t -89.64 151.89 21.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.514 -0.312 . . . . 2.07 110.262 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . 0.573 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 22.2 mtp180 -88.76 115.73 64.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.675 -0.491 . . . . 3.22 109.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.37 132.02 34.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.499 2.132 . . . . 1.22 112.116 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.33 -26.28 59.82 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.408 -0.677 . . . . 1.9 111.408 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 13.9 p -133.24 139.85 47.18 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.308 0.243 . . . . 3.21 110.754 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.05 51.3 19.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.698 -0.763 . . . . 1.31 112.377 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 122.85 15.99 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.685 -0.487 . . . . 1.51 109.685 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -116.05 142.26 47.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.916 0.389 . . . . 3.09 110.997 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.502 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -79.6 -172.04 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.55 110.205 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -60.67 -52.06 66.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.689 0.28 . . . . 4.7 111.276 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -65.16 -43.17 92.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.357 -0.383 . . . . 1.89 111.512 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.7 m -71.37 -26.77 62.94 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.169 -0.212 . . . . 0.72 111.471 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -87.44 -13.92 41.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.113 0.482 . . . . 1.79 110.451 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.57 48.75 0.9 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.88 -0.676 . . . . 2.19 112.063 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.33 104.22 16.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 5.15 109.805 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.24 97.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.666 -0.697 . . . . 7.2 109.151 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 29.3 m -66.11 113.53 12.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.8 -0.636 . . . . 8.83 110.469 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.32 142.4 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.474 2.116 . . . . 11.41 111.842 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.54 122.5 80.7 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.98 -0.555 . . . . 13.86 109.73 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.79 106.96 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.42 2.08 . . . . 16.55 112.214 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.2 -8.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 18.07 109.985 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.3 -0.864 . . . . 20.26 109.715 177.029 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 111.682 -0.567 . . . . 20.59 111.682 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.09 56.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.379 . . . . 19.12 110.996 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tpt -68.34 -30.25 69.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.251 0.548 . . . . 18.25 110.284 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.07 148.15 52.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 16.83 110.028 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.71 176.36 35.61 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.94 -0.864 . . . . 14.9 110.94 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.97 -60.32 1.57 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.94 0.37 . . . . 16.26 110.128 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.54 56.53 1.13 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 13.59 110.458 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -87.57 107.34 18.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.173 -0.467 . . . . 12.17 110.233 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.9 tp -105.05 126.02 51.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.919 -0.582 . . . . 9.12 110.119 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.43 123.37 82.96 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.426 -0.352 . . . . 6.25 110.311 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.52 34.04 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.169 2.58 . . . . 5.93 113.535 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.17 -71.31 1.29 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.147 -0.781 . . . . 2.77 111.147 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.43 79.52 7.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.19 0.519 . . . . 2.44 109.9 175.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -140.73 126.7 19.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.794 -0.639 . . . . 3.7 110.529 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 35.9 t -70.28 118.59 13.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.57 109.975 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.84 76.39 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.87 113.154 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.22 -46.69 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 1.54 111.329 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.66 -34.96 16.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 1.63 111.71 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.3 -20.97 44.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.872 -0.68 . . . . 0.77 111.914 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.67 150.26 21.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.609 0.242 . . . . 2.1 110.531 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.08 11.58 11.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.878 -0.677 . . . . 0.66 112.323 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.9 m -80.26 133.22 35.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.795 -0.446 . . . . 1.52 109.795 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.27 48.94 14.14 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 122.141 0.972 . . . . 2.23 109.33 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -90.42 139.66 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.312 -0.858 . . . . 1.76 110.833 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.32 144.37 25.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.394 -0.821 . . . . 1.18 109.421 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -117.92 142.74 47.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.373 -0.376 . . . . 3.64 110.792 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.92 133.08 44.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.525 -0.546 . . . . 0.37 109.525 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 31.6 p -84.58 -15.58 45.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 1.34 111.318 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -101.2 -20.75 15.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 1.81 111.486 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.06 -166.58 2.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.51 -0.552 . . . . 0.92 109.51 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.67 114.92 29.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.755 0.312 . . . . 1.17 110.373 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.89 128.32 3.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 1.13 110.627 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -101.38 111.94 24.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.26 -0.644 . . . . 1.18 109.26 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -152.57 -175.05 5.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.42 -0.355 . . . . 0.68 110.083 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.768 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m80 -129.83 161.27 31.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.511 -0.922 . . . . 0.58 108.511 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -58.01 -53.31 59.71 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 121.187 -0.205 . . . . 0.77 111.287 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -56.43 -45.2 80.85 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.048 0.759 . . . . 3.8 113.048 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.768 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 0.1 OUTLIER -66.46 -21.6 66.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.164 0.431 . . . . 0.54 112.164 -173.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -109.17 -36.49 6.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.012 -0.275 . . . . 0.72 111.73 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.26 139.02 33.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.774 0.321 . . . . 0.94 110.923 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.03 156.58 63.83 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.621 2.214 . . . . 2.64 111.637 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -15.32 53.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.108 -0.951 . . . . 3.71 112.596 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.86 79.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.946 -0.645 . . . . 1.86 111.971 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -85.02 136.17 33.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.8 -0.444 . . . . 1.52 109.8 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -88.47 126.28 35.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 2.07 110.557 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -78.85 122.33 84.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 3.22 111.082 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.15 141.6 57.98 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.446 2.097 . . . . 1.22 111.547 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.4 -28.3 52.88 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.839 -0.696 . . . . 1.9 112.672 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -141.1 61.31 1.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.091 0.472 . . . . 3.21 110.851 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.23 46.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.517 -0.849 . . . . 1.31 112.352 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.81 123.84 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.295 0.569 . . . . 1.51 110.541 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -125.54 133.22 52.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.777 -0.647 . . . . 3.09 110.299 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -73.37 179.1 4.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.509 -0.552 . . . . 0.55 109.509 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -37.98 76.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.21 0.448 . . . . 4.7 112.21 -172.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -70.38 -51.62 28.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.845 0.355 . . . . 1.89 111.459 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 55.9 m -73.5 -18.01 61.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.778 0.658 . . . . 0.72 112.778 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -76.36 -14.34 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 1.79 111.438 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.36 -170.32 15.48 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.246 -0.978 . . . . 2.19 112.499 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.11 43.54 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.323 0.583 . . . . 5.15 109.864 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.0 t -88.95 93.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 7.2 110.702 -175.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.9 p -120.43 107.38 39.03 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 8.83 110.273 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.64 147.84 93.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.786 2.324 . . . . 11.41 112.632 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.33 127.53 34.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 13.86 110.576 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.4 135.64 22.68 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.457 2.105 . . . . 16.55 111.841 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.6 t -89.55 89.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.336 -0.616 . . . . 18.07 109.336 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.421 -0.8 . . . . 20.26 110.29 -176.729 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.141 -0.384 . . . . 20.59 112.141 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.98 51.55 13.36 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.825 0.45 . . . . 19.12 111.149 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -102.05 -18.44 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 18.25 110.992 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 172.76 12.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 16.83 110.325 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.7 -119.07 2.92 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.923 -0.656 . . . . 14.9 112.254 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -86.13 -6.43 59.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.161 0.505 . . . . 16.26 110.708 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -85.79 54.11 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 13.59 111.08 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -88.48 66.84 8.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.658 0.742 . . . . 12.17 110.202 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt -75.22 124.42 27.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 9.12 110.712 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 125.08 91.46 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 6.25 110.508 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.13 47.28 1.02 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.186 2.591 . . . . 5.93 112.968 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.61 136.27 4.41 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.015 -0.612 . . . . 2.77 111.725 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.36 74.33 9.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 2.44 110.184 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -136.44 151.43 49.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.529 -0.759 . . . . 3.7 110.713 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -70.39 114.39 8.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.478 -0.783 . . . . 0.57 109.802 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.64 62.57 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.504 -0.379 . . . . 0.87 113.265 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.43 -30.13 29.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 1.54 110.796 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 79.6 m -108.6 -28.41 9.31 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.51 0.559 . . . . 1.63 112.51 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.06 9.91 86.13 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.202 -0.759 . . . . 0.77 111.202 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.85 145.83 50.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.226 -0.487 . . . . 2.1 110.275 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.59 24.63 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.831 -0.699 . . . . 0.66 112.749 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -77.65 122.85 25.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.874 -0.417 . . . . 1.52 109.874 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 54.86 49.14 18.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.311 0.577 . . . . 2.23 110.094 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.56 145.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.739 -0.664 . . . . 1.76 110.18 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.91 146.71 23.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.025 0.44 . . . . 1.18 110.095 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' C' ' 26' ' ' ARG . 12.2 mmt180 -110.79 148.01 33.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 3.64 110.069 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.4 t -79.12 139.82 37.96 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 0.37 108.681 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 60.1 p -89.92 -24.5 21.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.29 0.567 . . . . 1.34 110.724 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -89.88 -20.79 22.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 1.81 111.19 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.402 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.6 p -150.9 -171.77 4.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.796 -0.816 . . . . 0.92 108.796 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.7 115.43 30.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.376 -0.231 . . . . 1.17 110.376 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.84 153.69 14.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.154 -0.476 . . . . 1.13 110.514 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 118.86 23.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.525 0.516 . . . . 1.18 110.114 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -158.02 154.9 28.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.16 -0.473 . . . . 0.68 110.529 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.67 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m170 -86.65 133.12 33.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.347 -0.983 . . . . 0.58 108.347 172.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.415 ' CZ2' ' HA ' ' C' ' 46' ' ' ARG . 70.0 t-105 -49.67 -53.08 26.49 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.244 0.34 . . . . 0.77 111.338 -174.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 64.9 mtp180 -62.3 -23.48 66.76 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.316 0.488 . . . . 3.8 112.316 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.67 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -79.97 -22.08 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.918 0.39 . . . . 0.54 111.185 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -103.95 -44.19 5.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.72 110.665 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 71.1 m-85 -119.07 136.35 24.32 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.583 -0.735 . . . . 0.94 109.821 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 21.6 Cg_exo -65.65 157.5 58.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.442 2.094 . . . . 2.64 111.291 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -12.22 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 3.71 112.174 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.11 -25.28 74.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.751 -0.737 . . . . 1.86 111.384 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -85.29 125.84 33.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.52 110.131 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -87.57 131.84 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.474 -0.33 . . . . 2.07 110.158 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . 0.415 ' HA ' ' CZ2' ' C' ' 36' ' ' TRP . 19.3 ptp180 -70.75 132.75 86.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 3.22 110.775 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.98 132.61 30.68 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.942 2.428 . . . . 1.22 112.421 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.35 -12.22 60.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.829 -0.7 . . . . 1.9 111.718 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 9.5 p -90.07 10.72 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 3.21 111.147 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 139.08 117.29 1.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 1.31 111.94 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.36 123.28 18.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.522 -0.547 . . . . 1.51 109.522 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 81.6 mtm180 -120.9 133.59 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 3.09 111.248 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -78.48 162.8 26.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.989 -0.745 . . . . 0.55 108.989 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.23 -38.48 18.6 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.459 0.54 . . . . 4.7 112.459 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -64.64 -50.13 68.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.994 0.426 . . . . 1.89 110.758 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 82.5 m -72.67 -29.41 63.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.961 -0.563 . . . . 0.72 111.722 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.1 p -82.79 1.1 40.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 1.79 110.718 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.91 79.83 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.848 -0.692 . . . . 2.19 111.674 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.45 81.09 4.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.571 -0.529 . . . . 5.15 109.571 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -89.49 116.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.77 -0.65 . . . . 7.2 109.906 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.2 m -72.69 115.57 41.13 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.292 -0.413 . . . . 8.83 110.119 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.47 152.07 33.72 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.572 2.181 . . . . 11.41 112.613 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.47 116.89 52.11 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.883 -0.599 . . . . 13.86 109.813 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.32 61.11 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.049 2.499 . . . . 16.55 112.6 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.9 158.06 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.218 -0.446 . . . . 18.07 110.087 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.579 -0.724 . . . . 20.26 110.093 -178.196 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.946 -0.462 . . . . 20.59 111.946 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.77 74.67 8.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.316 0.579 . . . . 19.12 110.517 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' MET . . . . . 0.562 ' SD ' ' HG3' ' C' ' 4' ' ' GLU . 0.0 OUTLIER -105.32 -1.1 25.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.788 -0.642 . . . . 18.25 111.068 -178.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . 0.562 ' HG3' ' SD ' ' C' ' 3' ' ' MET . 44.3 mt-10 -104.84 122.18 45.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 16.83 110.274 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.3 6.46 55.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.86 -0.686 . . . . 14.9 111.938 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -71.89 -31.81 66.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 16.26 110.645 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -82.87 2.68 33.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 13.59 110.057 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -114.54 32.69 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.403 -0.817 . . . . 12.17 109.686 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 tt 57.0 94.98 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.082 -0.963 . . . . 9.12 111.082 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.78 123.24 89.16 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 6.25 109.892 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 -17.42 31.67 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.735 2.29 . . . . 5.93 113.405 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.88 16.35 79.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.99 -0.624 . . . . 2.77 111.898 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.28 110.05 17.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.795 0.331 . . . . 2.44 110.883 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -146.89 129.48 15.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.223 -0.444 . . . . 3.7 111.024 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -69.59 107.95 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.57 110.08 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.33 66.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.448 -0.406 . . . . 0.87 113.017 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.91 -31.93 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.09 0.472 . . . . 1.54 110.576 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.0 -32.54 7.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.268 0.47 . . . . 1.63 112.268 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.29 16.46 58.98 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.156 -0.778 . . . . 0.77 111.156 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.86 144.47 41.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.412 -0.394 . . . . 2.1 110.355 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.86 9.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.66 112.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.9 m -80.72 128.46 33.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.953 -0.388 . . . . 1.52 109.953 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 56.28 47.15 19.81 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.607 0.567 . . . . 2.23 109.743 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.35 142.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.76 110.561 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.24 144.33 25.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.009 0.433 . . . . 1.18 109.951 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 25.6 tpt180 -114.16 138.06 50.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.681 -0.691 . . . . 3.64 109.559 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.442 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -70.82 139.85 51.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.325 -0.62 . . . . 0.37 109.325 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.6 p -91.57 -17.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.199 -0.455 . . . . 1.34 111.46 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -103.03 -16.82 15.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.297 -0.411 . . . . 1.81 111.052 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.3 -172.51 4.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.934 -0.765 . . . . 0.92 108.934 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.48 114.42 28.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.737 0.303 . . . . 1.17 110.271 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -158.4 146.34 18.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 1.13 110.053 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.85 112.98 16.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.458 . . . . 1.18 109.959 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.05 159.84 39.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.85 -0.614 . . . . 0.68 110.008 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.847 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.4 m80 -92.84 143.69 26.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.108 -1.071 . . . . 0.58 108.108 171.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -48.17 -53.11 17.96 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.379 0.424 . . . . 0.77 111.593 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -61.27 -20.45 62.89 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.121 -0.491 . . . . 3.8 112.259 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.847 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 13.8 m -84.2 -20.54 32.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.204 -0.453 . . . . 0.54 111.119 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . 0.48 ' HD1' ' HB2' ' C' ' 54' ' ' ARG . 1.9 m-70 -114.29 -33.23 5.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.326 -0.397 . . . . 0.72 111.655 177.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.46 148.3 65.93 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.31 -0.405 . . . . 0.94 110.19 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.0 146.73 72.11 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.504 2.136 . . . . 2.64 111.57 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.9 -11.76 57.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 3.71 111.653 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.32 -29.79 74.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.706 -0.759 . . . . 1.86 111.379 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -82.27 138.79 34.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.383 -0.599 . . . . 1.52 109.383 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.2 t -88.29 140.59 29.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.154 0.502 . . . . 2.07 110.397 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -72.81 110.95 9.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.326 -0.852 . . . . 3.22 110.088 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.93 145.2 44.75 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.674 2.249 . . . . 1.22 112.621 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.58 8.6 30.27 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.223 -0.751 . . . . 1.9 111.223 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -117.56 33.58 5.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.154 0.502 . . . . 3.21 110.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.53 78.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.636 -0.792 . . . . 1.31 112.355 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.25 122.29 17.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.262 -0.644 . . . . 1.51 109.262 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -120.27 140.66 50.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.529 -0.305 . . . . 3.09 110.538 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.2 p -74.61 176.63 6.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.29 -0.633 . . . . 0.55 109.29 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . 0.48 ' HB2' ' HD1' ' C' ' 39' ' ' HIS . 25.4 tpt180 -60.55 -41.98 95.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.491 0.186 . . . . 4.7 111.029 -173.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.1 m -64.75 -46.12 83.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.89 111.358 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.53 -17.35 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.41 . . . . 0.72 111.035 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -88.94 -5.21 58.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.391 -0.368 . . . . 1.79 110.318 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.83 128.62 9.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.986 -0.626 . . . . 2.19 112.363 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -99.27 102.32 13.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.995 0.426 . . . . 5.15 110.506 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.59 129.92 56.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 7.2 109.948 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -91.25 113.01 56.96 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.345 -0.388 . . . . 8.83 110.348 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.2 134.02 35.01 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.17 1.913 . . . . 11.41 111.436 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.91 118.65 71.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.094 -0.503 . . . . 13.86 110.768 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.78 125.72 20.05 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.927 2.418 . . . . 16.55 111.94 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.54 -21.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 18.07 110.465 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.29 -0.862 . . . . 20.26 109.736 179.909 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 112.159 -0.376 . . . . 20.59 112.159 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.02 39.26 3.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 19.12 110.18 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.9 ptm -68.34 -20.93 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 18.25 111.2 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.7 -16.96 59.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.672 0.272 . . . . 16.83 110.995 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.11 29.02 8.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.9 -0.666 . . . . 14.9 112.152 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -86.09 -39.36 16.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.467 0.651 . . . . 16.26 109.54 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.45 78.97 1.43 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.071 -0.968 . . . . 13.59 108.752 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -142.64 140.57 31.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.954 -0.566 . . . . 12.17 110.471 -175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.41 84.46 1.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 9.12 110.018 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.98 146.22 91.88 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 6.25 110.778 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.51 45.4 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.224 2.616 . . . . 5.93 112.434 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.38 44.34 0.92 Allowed Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.6 -0.6 . . . . 2.77 111.6 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.27 75.19 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 2.44 110.226 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -162.14 157.94 23.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.111 -0.95 . . . . 3.7 108.454 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.7 t -56.96 107.74 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.146 0.279 . . . . 0.57 110.654 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.37 -16.6 62.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.271 -0.49 . . . . 0.87 112.661 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.29 -30.38 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.008 0.433 . . . . 1.54 110.679 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.6 m -108.35 -24.71 11.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.159 0.429 . . . . 1.63 112.159 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.2 15.15 80.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.788 -0.72 . . . . 0.77 111.431 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.72 136.15 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.598 -0.301 . . . . 2.1 110.422 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.09 16.55 38.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.66 112.719 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -77.61 131.84 37.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.901 -0.407 . . . . 1.52 109.901 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 39.1 t70 55.99 46.22 22.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.94 0.876 . . . . 2.23 109.577 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.81 149.25 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.194 -0.912 . . . . 1.76 110.09 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.0 157.08 17.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.306 -0.406 . . . . 1.18 110.18 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -117.2 143.78 45.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.782 -0.644 . . . . 3.64 110.109 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.88 141.18 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.712 -0.477 . . . . 0.37 109.712 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.5 p -82.29 -28.76 31.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.253 -0.431 . . . . 1.34 111.764 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -95.75 -17.11 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.883 0.327 . . . . 1.81 111.883 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.64 -172.28 4.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.92 110.053 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.36 114.01 27.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.025 -0.534 . . . . 1.17 109.678 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.96 119.86 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 1.13 110.321 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.58 112.32 24.4 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.538 -0.541 . . . . 1.18 109.538 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.65 168.43 26.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.68 110.404 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.697 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.6 m170 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.316 -0.994 . . . . 0.58 108.316 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -56.51 -38.62 72.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.77 111.438 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -66.72 -27.27 67.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 3.8 111.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 32.7 m -86.92 -22.38 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.977 -0.556 . . . . 0.54 111.48 -172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -95.96 -31.03 13.29 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.875 -0.33 . . . . 0.72 111.162 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -128.8 78.63 75.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.268 . . . . 0.94 110.339 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.84 -41.63 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.983 2.455 . . . . 2.64 112.846 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.21 -54.74 4.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.441 -0.345 . . . . 3.71 111.28 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.71 59.59 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.64 -0.791 . . . . 1.86 111.68 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -81.36 96.79 7.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.168 0.509 . . . . 1.52 111.473 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -141.28 92.74 2.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.905 -0.776 . . . . 2.07 108.905 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -57.79 118.65 27.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 3.22 111.216 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.32 133.32 22.5 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.628 2.218 . . . . 1.22 112.596 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.48 -10.37 79.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.059 -0.591 . . . . 1.9 111.88 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.9 p -94.83 35.52 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.0 0.429 . . . . 3.21 111.191 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.8 136.03 9.17 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.907 -0.663 . . . . 1.31 112.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.33 122.61 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.485 -0.561 . . . . 1.51 109.485 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.8 131.57 54.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 3.09 110.503 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -74.96 -179.79 4.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.46 . . . . 0.55 110.039 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -59.97 -49.42 77.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.505 0.187 . . . . 4.7 111.505 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.8 t -64.1 -41.55 97.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.577 -0.283 . . . . 1.89 111.049 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 79.2 m -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.72 110.896 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.6 m -89.19 2.4 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.48 -0.327 . . . . 1.79 110.663 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.95 -21.44 71.5 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.83 -0.7 . . . . 2.19 111.638 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.51 -1.82 56.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.939 0.876 . . . . 5.15 109.788 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.24 105.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.27 -0.877 . . . . 7.2 110.049 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' C' ' 62' ' ' PRO . 27.0 m -90.92 112.12 51.84 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.59 -0.522 . . . . 8.83 109.59 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' C' ' 61' ' ' THR . 11.4 Cg_endo -56.79 134.16 62.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.525 2.15 . . . . 11.41 111.877 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.87 139.46 82.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.011 -0.54 . . . . 13.86 110.452 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.3 52.35 2.74 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.71 2.274 . . . . 16.55 112.271 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.01 124.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 18.07 110.518 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.247 0.959 0 CA-C-N 116.105 -0.498 . . . . 20.26 110.571 179.447 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.754 -0.538 . . . . 20.59 111.754 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.35 -159.22 0.32 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.625 0.37 . . . . 19.12 110.964 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 61.5 mtm 63.88 26.61 14.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.169 0.509 . . . . 18.25 110.762 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.08 -27.3 60.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 16.83 110.019 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.05 49.86 0.93 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.035 -0.826 . . . . 14.9 111.035 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -58.72 -45.05 90.48 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.409 0.623 . . . . 16.26 109.952 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.34 95.05 3.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.25 -0.886 . . . . 13.59 109.435 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.37 83.0 2.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.264 0.554 . . . . 12.17 110.792 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.13 132.52 37.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 9.12 110.101 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.27 122.9 79.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.448 -0.575 . . . . 6.25 109.448 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.82 -19.64 62.67 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.939 2.426 . . . . 5.93 112.806 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.13 -51.28 0.85 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.6 . . . . 2.77 111.844 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.72 74.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.379 0.609 . . . . 2.44 110.462 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -153.76 127.18 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.637 -0.71 . . . . 3.7 109.967 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.493 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 7.1 t -82.86 104.81 13.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.57 109.939 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.4 -8.31 75.21 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.007 -0.542 . . . . 0.87 113.405 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.456 HG12 ' O ' ' C' ' 38' ' ' CYS . 43.5 t -71.46 -29.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.051 0.453 . . . . 1.54 110.523 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.4 p -120.43 -34.03 3.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.297 -0.41 . . . . 1.63 110.529 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 -13.01 23.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.126 -0.559 . . . . 0.77 111.825 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.535 ' OD2' HG23 ' C' ' 22' ' ' THR . 15.7 t70 -95.97 152.71 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.269 . . . . 2.1 110.796 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.93 14.08 5.22 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.66 113.12 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' THR . . . . . 0.535 HG23 ' OD2' ' C' ' 20' ' ' ASP . 9.5 t -81.7 136.34 35.48 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.178 0.489 . . . . 1.52 109.904 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.71 49.84 17.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.912 0.863 . . . . 2.23 109.496 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 p -89.08 136.96 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.272 -0.876 . . . . 1.76 110.028 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.54 149.73 25.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 1.18 110.668 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' C' ' 33' ' ' ALA . 23.8 mmm180 -116.95 129.83 56.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.944 -0.571 . . . . 3.64 110.464 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.0 140.48 58.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.37 109.77 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 42.8 p -89.17 -20.13 24.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.999 0.428 . . . . 1.34 111.292 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -94.06 -22.32 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 1.81 111.134 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.59 -168.44 3.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.069 -0.715 . . . . 0.92 109.069 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.81 114.65 29.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.833 0.349 . . . . 1.17 110.103 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -156.64 131.11 8.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 1.13 110.465 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.428 ' HB3' HH11 ' C' ' 26' ' ' ARG . . . -109.73 111.83 23.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.78 -0.645 . . . . 1.18 109.623 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.513 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.9 p90 -155.63 166.51 33.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.68 110.047 -178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.443 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -102.33 133.3 47.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.775 -0.824 . . . . 0.58 108.775 171.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.68 -41.4 81.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.77 110.924 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.21 -29.06 68.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 3.8 111.352 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.456 ' O ' HG12 ' C' ' 17' ' ' VAL . 93.8 m -74.71 -22.0 59.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.086 0.47 . . . . 0.54 110.474 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -96.66 -56.03 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.12 -0.491 . . . . 0.72 111.12 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.18 147.94 38.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.928 -0.578 . . . . 0.94 110.22 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.88 163.91 29.1 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.656 2.237 . . . . 2.64 111.976 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -14.83 59.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.268 -0.878 . . . . 3.71 112.468 -171.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.88 -16.54 80.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.789 -0.72 . . . . 1.86 111.802 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.99 127.85 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.552 -0.536 . . . . 1.52 109.552 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.6 p -88.2 138.09 31.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 2.07 111.254 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -76.72 120.43 81.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.437 -0.801 . . . . 3.22 110.305 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -68.72 131.66 23.24 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.242 1.961 . . . . 1.22 111.476 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.6 -40.88 6.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.846 -0.692 . . . . 1.9 111.614 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -115.46 70.57 0.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.42 0.628 . . . . 3.21 110.702 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.05 51.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.66 -0.7 . . . . 1.31 111.714 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.43 122.89 19.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.665 -0.494 . . . . 1.51 109.665 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.06 137.16 53.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 3.09 110.918 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.513 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.4 p -77.22 -179.65 5.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.172 -0.677 . . . . 0.55 109.172 173.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.7 -45.13 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 4.7 110.952 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' C' ' 59' ' ' ASP . 3.6 m -65.24 -53.06 50.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.055 -0.521 . . . . 1.89 111.572 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.31 -16.41 62.45 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.72 111.399 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 31.8 t -83.57 6.53 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 1.79 110.448 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.03 48.65 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.677 -0.773 . . . . 2.19 113.045 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.559 ' HB3' ' HA ' ' C' ' 55' ' ' SER . 37.5 t70 -89.29 -19.12 25.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.986 0.898 . . . . 5.15 109.149 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -89.71 48.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.442 -1.254 . . . . 7.2 109.893 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 56.9 m -107.48 123.43 38.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.096 -0.956 . . . . 8.83 110.472 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.85 133.79 60.2 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.503 2.135 . . . . 11.41 111.445 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.18 131.52 92.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 13.86 111.172 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.93 111.55 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.562 2.175 . . . . 16.55 111.308 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.32 140.52 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.266 -0.424 . . . . 18.07 110.33 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.707 -0.663 . . . . 20.26 109.981 -179.768 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 112.076 -0.41 . . . . 20.59 112.076 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.73 4.34 33.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 19.12 111.452 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.4 ttt -118.02 28.11 8.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.774 0.797 . . . . 18.25 108.921 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.77 107.52 18.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.48 -0.782 . . . . 16.83 110.788 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.06 7.29 4.76 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.472 -0.786 . . . . 14.9 111.49 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -99.04 -49.99 4.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 16.26 109.926 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.5 -19.96 30.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.765 -0.652 . . . . 13.59 110.131 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -85.41 126.82 34.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.538 -0.755 . . . . 12.17 110.348 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.8 109.73 14.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.965 -0.562 . . . . 9.12 110.452 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.9 123.81 87.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 6.25 110.268 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.2 107.75 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.819 2.346 . . . . 5.93 112.519 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.27 70.01 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.779 -0.725 . . . . 2.77 112.246 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.01 72.5 10.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.346 0.593 . . . . 2.44 110.241 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -152.01 154.71 36.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.216 -0.902 . . . . 3.7 109.319 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.65 109.87 1.83 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.255 -0.429 . . . . 0.57 109.858 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.84 -29.61 58.89 Favored Glycine 0 CA--C 1.52 0.365 0 O-C-N 123.512 0.507 . . . . 0.87 113.63 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.5 -34.18 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 1.54 111.135 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -100.79 -31.77 11.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.482 0.549 . . . . 1.63 112.482 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.32 31.4 59.27 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.364 -1.095 . . . . 0.77 110.364 -170.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.417 ' CG ' ' HG1' ' C' ' 22' ' ' THR . 17.9 t70 -147.65 154.08 40.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.228 -0.486 . . . . 2.1 110.676 -172.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.98 28.84 5.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.975 -0.631 . . . . 0.66 112.68 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' THR . . . . . 0.417 ' HG1' ' CG ' ' C' ' 20' ' ' ASP . 17.5 m -79.53 128.12 32.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.786 -0.449 . . . . 1.52 109.786 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 53.71 47.73 23.1 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.53 0.681 . . . . 2.23 109.823 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.412 HG21 ' N ' ' C' ' 34' ' ' PHE . 1.1 p -89.66 149.82 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.258 -0.883 . . . . 1.76 110.506 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.0 mt -100.89 151.93 21.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.321 -0.4 . . . . 1.18 110.101 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -111.54 135.15 52.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.899 -0.592 . . . . 3.64 110.24 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.6 t -66.52 142.99 57.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.586 -0.524 . . . . 0.37 109.586 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.7 p -93.42 -24.62 17.99 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.322 0.49 . . . . 1.34 112.322 -176.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . 0.65 ' HD2' ' SG ' ' C' ' 56' ' ' CYS . 18.9 t60 -97.56 -15.67 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.206 0.527 . . . . 1.81 110.336 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.472 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.8 OUTLIER -150.31 -175.25 5.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.615 -0.883 . . . . 0.92 108.615 175.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.83 114.29 28.43 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.891 0.376 . . . . 1.17 110.666 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.36 142.88 14.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 1.13 109.807 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.33 117.23 28.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.528 0.517 . . . . 1.18 109.962 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.412 ' N ' HG21 ' C' ' 24' ' ' VAL . 33.0 p90 -156.61 167.77 29.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.827 0.346 . . . . 0.68 110.772 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.477 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.8 m170 -97.77 123.86 41.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.493 -0.929 . . . . 0.58 108.493 172.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -58.01 -32.53 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.723 -0.671 . . . . 0.77 110.74 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -76.64 -19.47 57.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 3.8 111.873 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 74.9 m -87.36 -21.94 25.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.26 0.552 . . . . 0.54 110.018 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -90.01 -53.35 4.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.72 110.353 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -115.98 143.99 31.92 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.647 -0.706 . . . . 0.94 109.993 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -173.59 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.685 2.256 . . . . 2.64 113.064 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.86 67.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 3.71 111.167 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.49 -17.73 62.5 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.164 -0.541 . . . . 1.86 112.514 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.77 130.51 45.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.859 0.361 . . . . 1.52 110.592 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 t -89.53 150.25 22.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.385 -0.371 . . . . 2.07 110.235 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -87.79 120.34 70.86 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.89 -0.595 . . . . 3.22 110.595 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.08 134.18 26.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 1.22 111.379 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 -43.41 20.0 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.771 -0.65 . . . . 1.9 113.018 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.8 p -111.42 -14.41 13.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.904 0.352 . . . . 3.21 111.865 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.41 57.03 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.577 -0.82 . . . . 1.31 112.448 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.1 121.82 23.38 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.288 -0.634 . . . . 1.51 109.288 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -123.47 131.82 53.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.114 0.483 . . . . 3.09 111.56 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.76 179.83 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.647 -0.706 . . . . 0.55 109.551 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -57.89 -40.1 79.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.762 0.282 . . . . 4.7 111.762 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.7 t -69.31 -47.92 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.986 0.422 . . . . 1.89 111.04 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . 0.65 ' SG ' ' HD2' ' C' ' 29' ' ' HIS . 81.7 m -72.21 -21.63 61.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.72 111.812 -177.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -102.47 16.07 27.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.489 -0.56 . . . . 1.79 109.489 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.48 113.55 3.97 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.667 -0.697 . . . . 2.19 112.122 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -89.06 125.71 35.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 5.15 110.179 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.29 145.02 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.022 -0.535 . . . . 7.2 110.41 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 27.2 m -83.17 113.09 43.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.189 -0.46 . . . . 8.83 110.601 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.41 153.15 61.08 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.716 2.277 . . . . 11.41 111.742 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.11 122.41 50.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.614 -0.266 . . . . 13.86 110.43 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.31 120.59 7.95 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.897 2.398 . . . . 16.55 112.251 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.3 22.21 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.078 0.466 . . . . 18.07 111.259 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.661 -0.685 . . . . 20.26 110.363 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.771 -0.532 . . . . 20.59 111.771 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.83 49.85 9.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.026 0.441 . . . . 19.12 111.238 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.64 -53.61 51.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 18.25 110.705 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.19 1.05 44.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 16.83 110.117 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.71 -125.58 1.9 Allowed Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.773 -0.648 . . . . 14.9 112.13 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 64.27 22.61 12.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.568 0.347 . . . . 16.26 110.84 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 63.05 21.29 12.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.729 -0.669 . . . . 13.59 110.705 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -87.56 101.08 13.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 12.17 110.123 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.53 115.84 14.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 9.12 110.496 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.85 122.56 70.14 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 6.25 110.814 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.24 60.75 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.25 2.633 . . . . 5.93 113.001 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.52 74.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 2.77 112.167 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.35 75.55 3.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.995 0.426 . . . . 2.44 110.429 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -161.58 143.47 11.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.314 -0.624 . . . . 3.7 109.314 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 46.8 t -67.69 104.62 1.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.916 -0.402 . . . . 0.57 109.916 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.19 -19.99 79.72 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.87 113.218 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.75 -43.11 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.756 0.312 . . . . 1.54 111.23 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p -108.76 -29.78 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.387 . . . . 1.63 110.896 -177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.5 56.24 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.871 -0.681 . . . . 0.77 111.998 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 10.2 m-20 -97.17 145.35 26.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 2.1 110.615 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.27 17.25 10.54 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.049 -0.596 . . . . 0.66 112.091 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -80.1 135.49 36.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.926 -0.398 . . . . 1.52 109.926 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 48.3 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.974 0.892 . . . . 2.23 109.344 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.69 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.194 -0.912 . . . . 1.76 110.315 -174.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 85.5 mt -91.87 154.27 18.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.902 0.382 . . . . 1.18 110.551 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -122.27 130.62 53.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.584 -0.735 . . . . 3.64 109.749 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -68.69 136.31 52.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.37 109.746 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.0 p -87.96 -19.49 27.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.103 0.478 . . . . 1.34 110.998 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -93.21 -24.97 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 1.81 111.116 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.9 p -151.13 -163.99 1.9 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.465 -0.569 . . . . 0.92 109.465 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 114.78 29.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 1.17 110.227 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 138.74 10.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 1.13 110.498 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.06 112.85 18.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.777 -0.647 . . . . 1.18 109.343 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 44.6 p90 -155.7 170.25 22.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.151 -0.477 . . . . 0.68 110.183 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -105.75 133.82 49.87 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.507 -0.553 . . . . 0.58 109.507 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.7 t-105 -60.25 -36.8 78.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.652 -0.703 . . . . 0.77 110.073 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -68.44 -34.17 75.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.625 -0.716 . . . . 3.8 110.93 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.74 -22.71 56.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.54 110.874 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -90.47 -42.26 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 0.72 111.582 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.8 77.3 29.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.484 -0.325 . . . . 0.94 111.284 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.54 4.17 4.73 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.146 2.564 . . . . 2.64 112.284 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.57 -7.27 59.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 3.71 110.873 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 28.04 11.17 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.598 -0.811 . . . . 1.86 112.109 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 15.3 m -69.42 144.05 53.45 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.979 -0.378 . . . . 1.52 109.979 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.4 t -88.24 143.93 26.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 2.07 110.536 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -92.72 117.62 67.64 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.436 -0.802 . . . . 3.22 111.453 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.99 132.89 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.714 2.276 . . . . 1.22 111.56 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.92 5.04 68.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.756 -0.735 . . . . 1.9 112.548 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -89.63 -75.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.338 0.59 . . . . 3.21 111.106 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.37 101.37 0.57 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.485 -0.78 . . . . 1.31 111.658 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.18 128.25 34.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.978 0.418 . . . . 1.51 110.354 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -114.08 135.17 54.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.198 -0.455 . . . . 3.09 110.364 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.511 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 14.3 p -74.39 176.57 6.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.432 -0.581 . . . . 0.55 109.432 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' C' ' 55' ' ' SER . 8.1 ptm85 -58.5 -43.91 89.25 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 4.7 111.527 -175.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 20.2 m -65.86 -46.53 78.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.655 -0.248 . . . . 1.89 111.148 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.9 m -72.37 -22.58 61.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.72 111.569 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -81.41 -13.95 57.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.015 0.436 . . . . 1.79 110.02 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.4 49.0 0.85 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.295 -0.722 . . . . 2.19 111.295 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -105.85 120.06 40.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.803 0.335 . . . . 5.15 110.762 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.61 130.04 74.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.075 -0.511 . . . . 7.2 110.236 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.0 t -83.46 134.69 44.83 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 8.83 109.737 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 134.46 59.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.842 2.361 . . . . 11.41 112.153 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.57 125.77 54.59 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 13.86 110.597 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.25 64.98 5.35 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.664 2.243 . . . . 16.55 111.828 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.58 126.39 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.059 -0.519 . . . . 18.07 110.311 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.568 -0.73 . . . . 20.26 109.583 -179.184 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.732 -0.547 . . . . 20.59 111.732 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.22 21.74 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.993 0.425 . . . . 19.12 111.463 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.3 ttm -128.52 85.01 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.197 -0.456 . . . . 18.25 109.839 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -69.36 124.27 23.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 16.83 110.169 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.49 -65.31 0.55 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.795 -0.717 . . . . 14.9 112.06 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -86.32 -52.08 5.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 16.26 110.076 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -93.28 81.94 4.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.098 -0.501 . . . . 13.59 109.932 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -83.97 41.49 0.81 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.967 -0.561 . . . . 12.17 111.051 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.55 112.5 9.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 9.12 110.149 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.22 125.35 86.65 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.844 -0.617 . . . . 6.25 110.608 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.9 -13.72 41.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.966 2.444 . . . . 5.93 112.405 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.69 -26.69 70.85 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.954 -0.641 . . . . 2.77 111.598 175.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.32 74.31 3.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.268 0.556 . . . . 2.44 109.964 177.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -144.23 144.11 31.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.839 -0.619 . . . . 3.7 110.353 -178.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 43.0 t -75.2 104.93 5.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.396 -0.594 . . . . 0.57 109.396 177.069 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.8 -12.42 84.2 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.87 113.631 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 87.2 t -67.19 -41.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 1.54 110.736 178.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 p -106.67 -28.44 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 1.63 110.919 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.77 1.47 55.2 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.859 -0.686 . . . . 0.77 112.092 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 19.5 m-20 -107.2 147.38 30.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.493 . . . . 2.1 111.812 -178.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 2.4 22.78 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.862 -0.895 . . . . 0.66 110.862 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.91 134.64 44.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.659 -0.271 . . . . 1.52 110.438 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.62 47.17 21.29 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.53 0.681 . . . . 2.23 109.922 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.417 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.6 p -89.59 148.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.148 -0.933 . . . . 1.76 110.668 -173.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.4 mt -100.01 155.8 17.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.227 -0.442 . . . . 1.18 110.21 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.0 mmm180 -114.6 153.82 29.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.74 -0.664 . . . . 3.64 109.424 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -89.39 141.77 28.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.262 0.553 . . . . 0.37 110.433 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -81.17 -26.62 35.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 1.34 112.168 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . 0.536 ' HB2' ' SG ' ' C' ' 56' ' ' CYS . 11.8 m170 -102.61 -14.93 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.982 -0.287 . . . . 1.81 111.614 -176.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.1 p -150.95 -174.6 4.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.964 -0.384 . . . . 0.92 109.964 178.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 115.03 29.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.405 -0.362 . . . . 1.17 110.227 -178.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.56 135.1 4.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.384 -0.371 . . . . 1.13 111.043 -177.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 111.87 24.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.329 -0.619 . . . . 1.18 109.329 172.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -156.45 169.95 23.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.003 -0.544 . . . . 0.68 110.076 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 28.5 m170 -106.95 130.75 54.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.114 -0.698 . . . . 0.58 109.114 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 42.3 t-105 -59.15 -36.75 75.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.68 -0.691 . . . . 0.77 110.092 178.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -70.67 -25.39 62.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.993 -0.549 . . . . 3.8 111.432 -178.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 84.2 m -83.83 -27.36 28.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 0.54 110.83 178.247 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -89.59 -29.06 19.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.806 0.336 . . . . 0.72 110.911 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.46 71.27 76.98 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.058 -0.519 . . . . 0.94 110.251 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.86 13.68 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.185 2.59 . . . . 2.64 112.64 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.36 4.46 35.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 3.71 111.397 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.18 17.98 38.21 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.589 -0.815 . . . . 1.86 111.518 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.7 m -74.24 130.04 38.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 1.52 110.853 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -88.95 137.91 31.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.716 -0.476 . . . . 2.07 109.716 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -72.69 136.5 80.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 3.22 111.069 -175.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.63 149.34 61.16 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.176 2.584 . . . . 1.22 112.653 -175.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.8 18.91 56.3 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.855 -0.688 . . . . 1.9 112.443 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -116.33 37.28 3.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.329 0.585 . . . . 3.21 110.471 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.62 129.77 6.45 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.786 -0.721 . . . . 1.31 111.769 -177.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.18 124.01 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.723 -0.473 . . . . 1.51 109.723 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.35 136.81 52.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 3.09 110.729 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.61 162.64 28.99 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.072 -1.084 . . . . 0.55 108.072 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -59.87 -31.96 70.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.838 0.745 . . . . 4.7 111.405 -170.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -64.88 -44.88 88.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.745 0.307 . . . . 1.89 110.588 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' C' ' 29' ' ' HIS . 86.7 m -72.75 -17.86 61.56 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.798 0.295 . . . . 0.72 111.798 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -89.08 -13.0 39.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.482 -0.487 . . . . 1.79 110.192 176.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.11 -125.07 5.69 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.985 -0.626 . . . . 2.19 112.025 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -131.29 157.81 42.32 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.999 -0.371 . . . . 5.15 109.999 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.4 130.99 61.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.245 -0.434 . . . . 7.2 110.081 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 12.9 p -93.48 131.37 32.68 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.425 -0.352 . . . . 8.83 111.525 -179.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.5 142.89 73.55 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.648 2.232 . . . . 11.41 111.237 175.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.25 119.03 58.8 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.427 -0.351 . . . . 13.86 110.613 -179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -56.89 135.35 70.18 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.134 2.556 . . . . 16.55 112.71 -176.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.84 -0.5 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.096 0.474 . . . . 18.07 110.94 178.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.446 -0.787 . . . . 20.26 110.128 179.603 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.898 -0.481 . . . . 20.59 111.898 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.73 28.32 17.76 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.295 0.569 . . . . 19.12 111.319 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtt -134.06 -64.32 0.7 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 18.25 110.301 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.51 62.71 7.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.951 0.405 . . . . 16.83 110.203 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.33 97.24 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.837 -0.62 . . . . 14.9 112.227 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -82.06 -55.57 4.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 16.26 109.864 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 51.42 52.18 15.28 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.814 0.816 . . . . 13.59 109.698 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -137.84 -21.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.897 -1.047 . . . . 12.17 110.572 -175.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . 0.402 HD23 ' N ' ' C' ' 9' ' ' LEU . 2.8 mm? -96.22 54.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.037 -0.529 . . . . 9.12 110.416 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.46 136.28 93.18 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.713 -0.676 . . . . 6.25 110.282 178.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.44 -17.05 30.72 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.709 2.273 . . . . 5.93 112.582 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 67.32 0.84 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.676 -0.693 . . . . 2.77 112.208 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 74.48 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.282 0.563 . . . . 2.44 110.388 178.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -169.9 146.73 3.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.284 -0.871 . . . . 3.7 109.116 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.93 104.07 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.829 -0.434 . . . . 0.57 109.829 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -3.62 90.6 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.87 112.548 -175.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.73 -41.68 54.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.044 0.45 . . . . 1.54 110.543 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.34 -29.23 8.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 1.63 110.243 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.47 45.04 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.886 -0.673 . . . . 0.77 112.252 179.529 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -96.13 147.85 23.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.914 0.387 . . . . 2.1 111.142 -177.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.28 15.82 13.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.107 -0.568 . . . . 0.66 112.531 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -80.79 127.9 33.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.449 -0.204 . . . . 1.52 110.449 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.3 t70 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.638 0.732 . . . . 2.23 110.492 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -89.39 135.19 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.849 -0.614 . . . . 1.76 111.124 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.15 158.96 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.361 -0.836 . . . . 1.18 109.545 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -117.24 134.77 54.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 3.64 110.713 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.57 138.87 55.46 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.16 -0.682 . . . . 0.37 109.16 177.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.1 p -91.24 -20.88 21.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.204 0.526 . . . . 1.34 110.781 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.75 -24.14 21.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.81 110.844 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.7 -169.07 3.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.434 -0.58 . . . . 0.92 109.434 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.11 114.86 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.314 -0.254 . . . . 1.17 110.314 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.54 3.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.25 -0.432 . . . . 1.13 110.479 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.64 121.75 45.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.534 0.521 . . . . 1.18 109.633 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.17 173.24 16.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.386 . . . . 0.68 111.24 -174.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -105.1 125.31 50.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.368 -0.604 . . . . 0.58 109.368 173.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -62.04 -31.69 72.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.878 -0.601 . . . . 0.77 109.746 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.92 -24.22 61.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.796 -0.638 . . . . 3.8 111.458 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -88.02 -22.79 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.54 110.617 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.85 -42.65 11.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.158 -0.474 . . . . 0.72 111.107 -178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -122.65 147.33 50.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.94 110.794 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.12 170.07 13.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.025 2.483 . . . . 2.64 112.074 177.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -18.12 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.643 . . . . 3.71 111.338 -177.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.26 -13.9 82.38 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 1.86 112.161 176.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -92.74 132.55 36.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.796 0.331 . . . . 1.52 110.548 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 m -88.66 136.24 33.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.283 -0.417 . . . . 2.07 110.674 -177.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -81.92 121.81 79.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.646 . . . . 3.22 110.369 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.81 149.16 66.22 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.419 2.079 . . . . 1.22 111.572 177.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -33.48 5.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.45 -0.881 . . . . 1.9 113.238 -175.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -105.75 -38.05 6.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 3.21 111.501 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.94 72.07 0.21 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.768 -0.729 . . . . 1.31 112.336 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.41 121.97 23.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.288 -0.634 . . . . 1.51 109.288 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -122.56 134.39 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 3.09 111.09 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -74.36 176.92 6.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.584 -0.734 . . . . 0.55 109.38 173.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -61.13 -37.32 82.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.048 0.386 . . . . 4.7 110.292 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -65.06 -51.89 58.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 1.89 110.972 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 77.5 m -71.98 -19.54 61.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.552 0.215 . . . . 0.72 111.369 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -78.74 -14.09 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.114 0.483 . . . . 1.79 109.754 178.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.06 69.43 1.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.534 -1.026 . . . . 2.19 110.534 173.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.43 133.92 33.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 5.15 111.176 -173.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.11 128.58 67.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 7.2 110.198 -178.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 6.8 p -102.16 141.95 23.59 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.305 -0.407 . . . . 8.83 110.256 176.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.58 145.67 42.42 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.398 2.065 . . . . 11.41 111.627 176.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.46 138.24 44.74 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.325 -0.398 . . . . 13.86 110.422 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 50.37 2.79 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.83 2.353 . . . . 16.55 112.333 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.04 85.97 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.842 -0.617 . . . . 18.07 109.609 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.702 -0.666 . . . . 20.26 110.152 -176.775 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 N-CA-C 111.888 -0.485 . . . . 20.59 111.888 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.2 102.21 6.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.652 0.263 . . . . 19.12 110.968 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 68.2 mtm 61.05 28.52 18.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.595 -0.729 . . . . 18.25 111.454 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.54 154.52 21.02 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.96 -0.385 . . . . 16.83 109.96 -178.577 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.0 8.87 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.879 -0.676 . . . . 14.9 111.562 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 59.31 34.27 22.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.29 0.567 . . . . 16.26 110.53 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -86.3 -10.29 54.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 13.59 110.734 -174.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.6 135.59 37.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 12.17 110.267 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.9 tp -91.28 87.17 6.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.091 0.472 . . . . 9.12 109.965 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.93 142.65 56.42 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 6.25 110.393 -179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.96 45.94 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.259 2.64 . . . . 5.93 112.617 177.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.81 6.31 40.76 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.457 -0.657 . . . . 2.77 111.457 178.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.54 73.48 7.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.268 0.556 . . . . 2.44 110.31 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -158.44 127.88 5.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 3.7 109.843 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 11.2 t -79.68 103.77 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.258 -0.645 . . . . 0.57 109.258 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.66 -18.4 75.71 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.87 113.367 -171.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 48.3 t -64.39 -32.78 59.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.735 0.303 . . . . 1.54 111.104 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -118.09 -33.84 4.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.907 0.384 . . . . 1.63 110.819 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.62 -13.98 24.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.775 -0.726 . . . . 0.77 112.24 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 11.5 m-20 -87.61 131.6 34.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 2.1 110.911 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.41 -1.9 33.09 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.314 -0.714 . . . . 0.66 111.314 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -76.94 135.43 38.76 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 110.081 -0.34 . . . . 1.52 110.081 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.88 45.96 20.53 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.435 0.636 . . . . 2.23 109.784 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.61 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.151 -0.931 . . . . 1.76 110.048 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.39 146.2 25.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.897 0.379 . . . . 1.18 110.242 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -113.92 132.47 55.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.925 -0.579 . . . . 3.64 110.165 -175.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -63.52 130.72 45.56 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.658 -0.497 . . . . 0.37 109.658 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 48.4 p -85.92 -5.81 59.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 1.34 110.983 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -108.42 -21.46 12.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 1.81 111.209 -178.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.8 p -152.28 -163.51 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.726 -0.472 . . . . 0.92 109.726 176.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.56 114.93 29.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.161 -0.311 . . . . 1.17 110.161 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.48 128.47 1.81 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.429 -0.351 . . . . 1.13 110.473 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.69 112.56 25.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.744 0.653 . . . . 1.18 109.771 176.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -154.72 167.58 29.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.395 -0.366 . . . . 0.68 110.339 -176.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.41 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.8 m170 -106.06 138.56 42.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.964 -0.754 . . . . 0.58 108.964 172.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -61.79 -33.73 74.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 0.77 110.385 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -74.64 -25.29 59.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 3.8 111.452 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.415 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.7 m -83.67 -22.77 32.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.124 0.488 . . . . 0.54 110.597 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -96.88 -49.62 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.075 -0.512 . . . . 0.72 111.517 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -110.95 149.62 40.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.757 0.313 . . . . 0.94 111.003 -173.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.86 158.21 58.33 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.617 2.211 . . . . 2.64 110.881 174.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.19 -7.96 34.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.954 -0.566 . . . . 3.71 111.521 -177.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.18 -12.22 84.57 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.536 -0.626 . . . . 1.86 111.536 174.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 37.5 m -95.15 135.08 37.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.26 -0.274 . . . . 1.52 110.26 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 p -89.05 136.13 33.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.987 0.422 . . . . 2.07 111.257 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -80.96 127.93 72.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 3.22 110.604 -177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.03 140.47 37.99 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.874 2.383 . . . . 1.22 112.046 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.43 25.56 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.011 -0.614 . . . . 1.9 111.984 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 74.1 1.48 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.886 0.374 . . . . 3.21 110.545 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 61.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.739 -0.743 . . . . 1.31 112.212 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 122.7 18.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.938 0.399 . . . . 1.51 110.074 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -117.4 134.33 54.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.231 -0.44 . . . . 3.09 110.884 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -81.08 169.67 17.16 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.66 -0.867 . . . . 0.55 108.66 171.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -51.94 -47.17 64.86 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.415 0.447 . . . . 4.7 111.419 -174.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -63.72 -45.05 91.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.917 -0.583 . . . . 1.89 111.762 -176.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 95.6 m -71.77 -31.11 66.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.72 111.433 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 44.5 p -85.41 7.23 23.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.718 -0.219 . . . . 1.79 111.026 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.69 91.38 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.22 -0.514 . . . . 2.19 113.115 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -105.59 121.34 43.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.33 -0.618 . . . . 5.15 109.33 176.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.57 126.4 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.086 0.469 . . . . 7.2 110.414 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.1 p -91.42 119.12 68.72 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.059 -0.519 . . . . 8.83 110.838 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.72 144.14 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.575 2.183 . . . . 11.41 111.963 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.37 132.83 51.59 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.189 -0.459 . . . . 13.86 110.446 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.85 108.13 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.65 2.233 . . . . 16.55 111.977 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.81 99.53 9.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.942 -0.572 . . . . 18.07 110.207 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.616 -0.707 . . . . 20.26 109.724 179.674 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.798 -0.521 . . . . 20.59 111.798 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.42 126.02 34.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 19.12 110.86 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 88.9 mtp -116.84 114.02 23.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 18.25 110.128 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.85 -20.68 57.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.951 0.405 . . . . 16.83 110.781 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.43 172.29 30.22 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.508 -0.637 . . . . 14.9 111.508 177.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 64.15 17.07 10.46 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.704 0.402 . . . . 16.26 111.175 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -80.81 -21.52 40.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.169 0.509 . . . . 13.59 110.7 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.23 -1.22 48.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.472 -0.785 . . . . 12.17 109.611 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -128.02 45.36 2.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.117 -0.947 . . . . 9.12 109.305 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' C' ' 12' ' ' GLY . . . -69.42 142.48 92.16 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.365 -0.834 . . . . 6.25 110.77 -177.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.46 25.11 0.23 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.296 2.664 . . . . 5.93 113.566 -178.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' C' ' 10' ' ' ALA . . . 70.11 23.8 76.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 2.77 111.969 -178.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.505 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -103.09 74.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.999 0.428 . . . . 2.44 110.496 -177.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -157.87 129.04 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 3.7 110.746 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.37 111.79 5.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.592 . . . . 0.57 109.938 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.42 -31.94 71.51 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.477 0.486 . . . . 0.87 113.128 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.34 -37.54 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.366 . . . . 1.54 110.923 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.43 -39.95 9.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.256 0.465 . . . . 1.63 112.256 -175.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.86 6.41 65.44 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.73 -0.748 . . . . 0.77 111.423 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.82 149.1 42.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.793 0.33 . . . . 2.1 110.434 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.62 12.25 38.99 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.66 112.943 -177.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 m -80.13 128.06 33.05 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.665 -0.315 . . . . 1.52 111.085 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.06 51.11 7.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.493 -0.776 . . . . 2.23 111.161 177.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -90.15 145.31 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.721 . . . . 1.76 111.227 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 78.0 mt -101.11 143.98 30.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.275 -0.875 . . . . 1.18 109.175 175.046 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 137.2 49.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.637 0.256 . . . . 3.64 110.465 -178.571 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -64.57 135.21 55.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.16 -19.02 29.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.181 0.515 . . . . 1.34 110.88 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -97.47 -18.08 19.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.81 111.332 -177.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.53 -168.6 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.288 -0.634 . . . . 0.92 109.288 176.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.25 114.89 29.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.663 0.268 . . . . 1.17 110.603 -178.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -172.13 136.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 1.13 109.936 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.505 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -122.05 122.83 40.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.296 0.372 . . . . 1.18 110.004 177.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -160.07 169.51 23.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.033 -0.53 . . . . 0.68 110.294 -176.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.753 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.3 m170 -95.91 130.68 42.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.002 -1.111 . . . . 0.58 108.002 171.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -56.12 -37.28 69.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.77 111.684 -177.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -72.17 -15.15 61.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 3.8 111.614 -177.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.753 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.6 m -90.89 -22.52 20.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.197 -0.456 . . . . 0.54 110.676 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -94.19 -40.78 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 0.72 110.494 175.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.72 79.55 31.29 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.94 110.178 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -83.55 11.34 3.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.814 2.342 . . . . 2.64 112.862 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.92 0.76 52.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 3.71 111.187 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.05 23.77 37.03 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 1.86 111.661 -176.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -61.88 149.52 40.15 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.606 0.362 . . . . 1.52 110.67 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -87.74 121.7 30.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.74 0.305 . . . . 2.07 110.524 -176.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -64.48 120.39 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 3.22 110.967 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -65.14 132.26 31.28 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.431 2.088 . . . . 1.22 111.703 179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.53 -15.95 38.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.787 -0.721 . . . . 1.9 111.835 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.3 p -97.07 37.3 1.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 3.21 111.003 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.55 113.5 2.17 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 1.31 111.829 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.85 123.52 29.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.735 -0.468 . . . . 1.51 109.735 -177.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -112.19 148.04 34.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.046 0.45 . . . . 3.09 110.724 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 22.0 p -93.9 178.01 5.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.105 -0.702 . . . . 0.55 109.105 175.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -58.73 -33.47 70.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.886 0.312 . . . . 4.7 111.142 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -69.77 -51.56 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 1.89 111.24 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -71.98 -17.72 62.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.319 -0.4 . . . . 0.72 111.341 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -92.23 -1.23 57.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.48 . . . . 1.79 110.283 173.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.12 89.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.921 -0.581 . . . . 2.19 112.04 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -88.93 -5.91 57.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.216 0.531 . . . . 5.15 110.395 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 m -88.74 72.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.532 -0.758 . . . . 7.2 110.916 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 29.8 m -67.67 122.16 82.28 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.314 -0.857 . . . . 8.83 110.155 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.99 139.87 89.93 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.766 2.311 . . . . 11.41 112.173 -177.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.16 138.99 78.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.708 -0.678 . . . . 13.86 110.478 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.1 38.02 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.873 2.382 . . . . 16.55 112.136 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.9 116.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.773 -0.649 . . . . 18.07 109.695 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.366 -0.826 . . . . 20.26 109.736 -179.993 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 112.102 -0.399 . . . . 20.59 112.102 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.35 87.54 4.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.014 0.435 . . . . 19.12 110.433 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -93.96 -37.04 11.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.927 -0.579 . . . . 18.25 110.027 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.21 137.67 48.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.537 -0.756 . . . . 16.83 109.941 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.61 -43.03 3.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.984 -0.626 . . . . 14.9 112.056 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.19 -36.26 82.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 16.26 110.345 178.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -103.8 162.33 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 13.59 110.355 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -123.26 103.82 8.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.731 -0.47 . . . . 12.17 109.731 176.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.0 107.38 8.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.245 -0.434 . . . . 9.12 111.093 -177.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -86.11 128.17 58.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.757 -0.656 . . . . 6.25 109.822 176.143 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 12.7 Cg_exo -70.2 80.95 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.733 2.288 . . . . 5.93 112.558 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.56 128.94 33.23 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.57 -0.824 . . . . 2.77 111.261 174.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 75.93 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.235 0.541 . . . . 2.44 111.104 -177.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -130.31 145.24 51.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.886 -0.597 . . . . 3.7 110.145 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 t -63.15 106.12 0.81 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.57 109.515 175.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.37 -31.61 57.02 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.41 0.444 . . . . 0.87 113.492 -175.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.03 -34.44 70.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.074 0.464 . . . . 1.54 111.043 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.81 -38.14 7.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.052 0.39 . . . . 1.63 112.052 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.96 -9.2 59.81 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.585 -0.606 . . . . 0.77 111.585 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.41 146.18 37.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.954 0.407 . . . . 2.1 111.191 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.13 12.96 40.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.067 -0.813 . . . . 0.66 111.067 174.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -73.94 128.55 35.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.444 . . . . 1.52 110.375 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 55.57 47.13 21.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.669 0.747 . . . . 2.23 109.651 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.04 153.78 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.25 -0.887 . . . . 1.76 110.744 -174.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -107.48 144.26 34.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 1.18 109.834 176.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 144.64 40.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.124 -0.489 . . . . 3.64 110.166 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.1 t -68.51 140.11 55.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.393 -0.595 . . . . 0.37 109.393 177.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.5 p -90.43 -18.65 25.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.897 0.379 . . . . 1.34 110.895 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -92.83 -24.2 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 1.81 111.077 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.3 p -150.38 -173.1 4.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.036 -0.727 . . . . 0.92 109.036 178.165 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.93 118.76 37.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.582 0.229 . . . . 1.17 110.437 -178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.665 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.24 135.99 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 1.13 110.233 -177.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.33 112.76 22.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 1.18 110.11 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -153.99 166.61 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.062 -0.517 . . . . 0.68 109.873 -177.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.3 m170 -97.71 140.32 32.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.58 108.638 173.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -49.18 -53.5 20.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.413 0.446 . . . . 0.77 111.615 -175.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -72.34 -5.55 37.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 3.8 112.136 -173.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -91.45 -21.26 21.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.896 0.379 . . . . 0.54 110.63 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -108.4 -29.5 8.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.72 110.941 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.62 138.55 29.54 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.94 110.511 -177.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.5 148.6 93.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.544 2.162 . . . . 2.64 111.068 173.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -18.76 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 3.71 112.079 -174.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 -16.51 71.14 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.087 -0.578 . . . . 1.86 111.853 175.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.1 m -90.59 130.77 36.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 176.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.43 143.54 26.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 2.07 110.993 -174.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.34 125.2 86.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 3.22 110.789 -177.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.08 163.5 39.02 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.044 2.496 . . . . 1.22 112.413 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.27 7.1 8.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.853 -0.689 . . . . 1.9 111.92 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -108.92 -1.82 18.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 3.21 110.856 -178.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.74 120.87 0.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.025 -0.607 . . . . 1.31 111.673 -177.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 122.68 25.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 1.51 109.771 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -111.17 134.9 52.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.436 -0.347 . . . . 3.09 110.937 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -75.69 166.56 23.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.614 -0.884 . . . . 0.55 108.614 170.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -63.42 -30.54 71.65 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.744 . . . . 4.7 110.871 -172.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 55' ' ' SER . . . . . 0.461 ' HA ' ' HB2' ' C' ' 59' ' ' ASP . 17.4 m -65.12 -45.23 85.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 1.89 110.927 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.1 m -72.76 -31.2 64.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.72 111.9 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -83.53 -1.62 54.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 1.79 111.542 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.4 98.74 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.875 -0.678 . . . . 2.19 111.608 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' C' ' 55' ' ' SER . 33.0 t70 -88.82 86.77 7.03 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.625 0.726 . . . . 5.15 110.344 -177.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.53 136.26 11.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.651 -1.159 . . . . 7.2 108.842 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.0 p -73.45 117.63 62.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.348 . . . . 8.83 111.055 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.4 139.77 21.09 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.393 2.062 . . . . 11.41 111.56 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.89 124.51 85.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 13.86 110.744 -178.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.07 64.8 4.21 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.861 2.374 . . . . 16.55 112.105 178.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.64 16.9 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 18.07 110.907 -178.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.446 -0.788 . . . . 20.26 110.615 -177.439 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 112.054 -0.418 . . . . 20.59 112.054 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.85 83.9 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 19.12 110.668 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 3' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' C' ' 7' ' ' GLN . 16.0 tpt -75.73 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.069 -0.514 . . . . 18.25 110.342 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -66.49 -29.49 69.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 16.83 110.575 -178.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.99 -26.85 67.84 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.979 -0.555 . . . . 14.9 112.567 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -97.48 5.47 49.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 16.26 111.094 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' C' ' 3' ' ' MET . 28.4 mt-30 -92.5 33.37 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 13.59 110.825 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -80.47 -8.49 59.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.332 0.587 . . . . 12.17 110.095 177.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -104.06 78.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 9.12 109.595 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' C' ' 12' ' ' GLY . . . -64.95 124.9 87.93 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.235 -0.439 . . . . 6.25 110.963 -177.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.05 26.35 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.92 2.414 . . . . 5.93 113.071 178.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' C' ' 10' ' ' ALA . . . -81.98 -40.88 10.0 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.68 -0.568 . . . . 2.77 111.68 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.62 75.09 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.29 0.567 . . . . 2.44 109.715 175.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' C' ' 19' ' ' GLY . 49.1 ttp180 -134.38 146.15 49.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.663 -0.699 . . . . 3.7 109.88 -177.248 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.457 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 31.3 t -70.91 103.0 2.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.084 -0.71 . . . . 0.57 109.084 176.021 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.12 1.8 83.6 Favored Glycine 0 CA--C 1.509 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.87 112.748 -174.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 32.0 t -77.17 -28.72 16.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.096 0.474 . . . . 1.54 110.091 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.9 p -123.6 -35.46 2.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 1.63 111.019 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' C' ' 14' ' ' ARG . . . 109.91 2.51 30.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.962 -0.637 . . . . 0.77 112.266 -178.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 8.7 m-20 -107.39 140.44 40.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 2.1 111.232 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.59 -1.99 30.8 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.66 111.522 175.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -74.86 135.19 41.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.52 110.059 178.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.34 41.05 16.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.927 0.394 . . . . 2.23 110.277 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.472 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.9 p -88.29 146.05 6.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 1.76 110.636 -174.162 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 77.1 mt -105.96 159.29 16.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.029 -0.532 . . . . 1.18 110.379 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 14.0 mmt180 -126.39 143.18 51.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 3.64 109.717 -178.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 35.3 t -70.63 146.53 49.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.864 -0.734 . . . . 0.37 109.066 173.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 28' ' ' THR . . . . . 0.409 HG21 ' HA2' ' C' ' 50' ' ' GLY . 28.7 p -84.79 -27.0 27.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.101 0.477 . . . . 1.34 110.812 177.276 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.4 -12.4 21.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 1.81 111.091 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 m -139.55 172.76 12.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.033 0.444 . . . . 0.92 110.279 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 113.69 27.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.659 -0.7 . . . . 1.17 109.388 174.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.12 134.74 3.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.485 -0.325 . . . . 1.13 110.601 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.72 111.98 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.759 -0.655 . . . . 1.18 109.57 175.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.06 164.71 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.0 -0.545 . . . . 0.68 110.23 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.472 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 32.5 m170 -104.63 138.57 40.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.598 -0.519 . . . . 0.58 109.598 174.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -63.93 -34.46 78.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.76 -0.655 . . . . 0.77 109.74 178.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -76.64 -15.51 59.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.586 . . . . 3.8 111.072 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.402 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 97.8 m -92.29 -22.45 19.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.54 110.507 176.35 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -93.96 -41.82 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.843 -0.617 . . . . 0.72 111.632 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -119.95 147.32 44.1 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.985 -0.552 . . . . 0.94 111.242 -171.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.76 164.33 27.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.003 2.468 . . . . 2.64 111.503 174.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.05 -15.54 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 3.71 112.184 -174.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -10.23 85.46 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.809 -0.71 . . . . 1.86 112.459 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.4 m -87.19 137.5 32.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.856 0.36 . . . . 1.52 110.72 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -89.65 131.82 35.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.328 -0.396 . . . . 2.07 110.841 -177.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -89.94 123.15 66.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 3.22 110.915 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.78 133.63 22.29 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.325 2.017 . . . . 1.22 111.266 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.42 -47.06 10.98 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.1 -0.571 . . . . 1.9 112.961 -174.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -118.96 60.08 0.82 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.133 0.492 . . . . 3.21 110.779 -177.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.409 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 164.07 57.17 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.356 -0.698 . . . . 1.31 111.356 -177.24 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.52 124.98 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.374 0.607 . . . . 1.51 110.587 -176.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.37 145.56 31.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.625 -0.716 . . . . 3.09 110.602 -177.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 21.4 p -89.66 -169.37 2.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.064 -0.516 . . . . 0.55 109.998 178.001 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.7 -53.0 63.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.574 0.226 . . . . 4.7 110.84 -179.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 41.4 t -61.22 -42.92 99.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.89 110.971 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.19 -16.93 62.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.105 0.409 . . . . 0.72 112.105 -176.582 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 43.5 m -101.1 4.73 42.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.072 0.463 . . . . 1.79 110.627 177.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.7 -134.59 7.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.847 -0.692 . . . . 2.19 112.115 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.44 84.01 5.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 5.15 110.299 -178.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -89.38 110.29 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 7.2 110.279 179.367 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 61' ' ' THR . . . . . 0.417 ' HA ' ' HD3' ' C' ' 62' ' ' PRO . 8.4 p -67.29 109.62 3.93 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 123.453 0.471 . . . . 8.83 110.74 177.053 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 61' ' ' THR . 6.4 Cg_exo -74.11 134.16 19.05 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.7 2.267 . . . . 11.41 112.509 -176.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.38 144.38 53.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.784 -0.644 . . . . 13.86 109.787 175.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.21 92.86 0.34 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.62 2.214 . . . . 16.55 112.198 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.7 2.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 18.07 111.542 -177.534 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.666 -0.683 . . . . 20.26 110.409 -178.853 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.934 -0.466 . . . . 20.59 111.934 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.61 -167.77 1.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.051 -0.351 . . . . 19.12 110.051 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -57.87 -64.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.856 -0.424 . . . . 18.25 109.856 175.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 61.89 178.96 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.543 0.687 . . . . 16.83 112.119 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.31 131.72 1.42 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.731 -0.668 . . . . 14.9 111.76 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -125.74 51.88 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.015 0.436 . . . . 16.26 110.499 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -147.56 160.78 42.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.195 0.522 . . . . 13.59 111.439 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -144.3 -54.05 0.34 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.488 -0.778 . . . . 12.17 109.048 177.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.63 151.24 23.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.795 . . . . 9.12 109.402 174.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.17 121.64 70.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 120.945 -0.302 . . . . 6.25 110.206 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.77 -14.06 38.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.536 2.157 . . . . 5.93 112.259 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.38 73.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.925 -0.655 . . . . 2.77 111.952 178.163 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.82 98.23 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.001 0.429 . . . . 2.44 110.216 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.05 164.97 31.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.012 -0.54 . . . . 3.7 109.825 -179.249 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 39.6 t -65.37 105.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.713 -0.477 . . . . 0.57 109.713 177.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.89 66.17 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.268 -0.492 . . . . 0.87 112.901 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -32.19 56.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.54 110.97 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -106.71 -37.83 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.63 111.91 -176.072 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.58 -23.63 35.4 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.317 -0.713 . . . . 0.77 111.317 -174.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -86.79 148.93 25.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 2.1 111.027 -178.753 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.82 12.71 35.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.66 111.888 177.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 47.8 m -73.9 124.25 25.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.373 0.13 . . . . 1.52 111.174 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 55.69 66.76 1.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.072 0.857 . . . . 2.23 111.118 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -108.48 142.3 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 1.76 111.362 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' C' ' 36' ' ' TRP . 34.4 mt -82.27 144.35 30.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.662 . . . . 1.18 110.51 178.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.43 145.81 29.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.576 -0.738 . . . . 3.64 110.307 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.14 136.75 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.666 -0.494 . . . . 0.37 109.666 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -88.56 -5.19 58.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.39 . . . . 1.34 111.648 -178.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -113.72 -20.21 11.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 1.81 110.812 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.82 -171.95 4.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.157 -0.682 . . . . 0.92 109.157 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.04 29.8 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.691 -0.485 . . . . 1.17 109.691 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 155.39 24.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.311 -0.404 . . . . 1.13 110.619 -178.041 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.13 124.59 17.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.872 -0.604 . . . . 1.18 109.979 178.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -163.84 161.08 22.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.471 -0.331 . . . . 0.68 110.354 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.701 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.91 127.54 36.03 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.373 -0.973 . . . . 0.58 108.373 172.606 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.42 ' HB2' HD12 ' C' ' 25' ' ' LEU . 68.1 t-105 -45.58 -53.51 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.483 0.489 . . . . 0.77 112.01 -174.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -60.37 -30.22 69.42 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.125 0.417 . . . . 3.8 112.125 -174.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.701 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.1 m -73.54 -22.46 60.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 0.54 111.004 -177.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -103.29 -44.98 5.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 0.72 110.935 178.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -116.82 122.74 31.12 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.983 -0.553 . . . . 0.94 110.217 -176.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.5 176.59 5.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 2.64 111.853 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.69 -10.79 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.65 . . . . 3.71 112.047 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.95 -26.08 74.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.872 -0.68 . . . . 1.86 111.713 174.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 41.7 m -101.73 135.45 43.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.226 -0.287 . . . . 1.52 110.226 178.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -89.17 154.53 20.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.767 0.318 . . . . 2.07 110.332 -178.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -88.36 112.23 48.48 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 3.22 110.757 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.62 142.78 44.99 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.838 2.358 . . . . 1.22 111.909 177.466 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.13 -32.4 23.33 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.463 -0.655 . . . . 1.9 111.463 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.0 p -125.64 150.91 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.93 -0.396 . . . . 3.21 109.93 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.43 39.6 80.11 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.65 -0.786 . . . . 1.31 111.971 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.79 124.77 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.557 -0.534 . . . . 1.51 109.557 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -117.31 148.17 41.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.156 -0.475 . . . . 3.09 110.81 -177.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -83.25 -176.68 6.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 0.55 109.458 173.381 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -63.04 -39.47 94.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.104 0.478 . . . . 4.7 110.286 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 36.3 t -66.23 -53.98 30.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.889 -0.596 . . . . 1.89 111.142 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.92 -17.1 62.12 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.453 0.538 . . . . 0.72 112.453 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -108.21 19.62 19.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.053 0.454 . . . . 1.79 110.345 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.69 -126.37 2.75 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.185 -1.007 . . . . 2.19 112.587 -178.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -88.95 -6.7 57.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 5.15 111.111 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.04 137.73 24.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.745 -0.662 . . . . 7.2 110.827 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 25.6 m -107.43 105.63 56.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.501 -0.555 . . . . 8.83 109.501 174.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.09 138.94 37.89 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 11.41 112.99 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 127.86 50.13 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.815 -0.63 . . . . 13.86 109.72 175.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.43 58.6 4.52 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.603 2.202 . . . . 16.55 111.848 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.09 132.15 34.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.255 0.55 . . . . 18.07 110.994 -176.458 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.395 -0.812 . . . . 20.26 109.169 176.786 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 112.197 -0.361 . . . . 20.59 112.197 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.67 -14.08 26.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.85 0.357 . . . . 19.12 111.268 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -157.53 -175.15 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.351 -0.386 . . . . 18.25 110.079 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 67.37 55.12 0.67 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.7 0.625 . . . . 16.83 110.282 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.87 156.73 33.2 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.792 -0.718 . . . . 14.9 112.019 178.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' C' ' 6' ' ' GLN . 5.7 tp60 55.06 55.15 7.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.496 0.665 . . . . 16.26 110.752 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.71 103.34 13.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.51 -0.768 . . . . 13.59 109.912 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -76.12 72.14 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.441 0.638 . . . . 12.17 110.893 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 58.3 tp -152.84 135.0 14.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 9.12 109.063 175.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.481 ' HB3' ' HB1' ' C' ' 13' ' ' ALA . . . -84.24 122.95 75.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.911 -0.403 . . . . 6.25 109.911 176.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -62.69 106.78 0.54 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.827 2.352 . . . . 5.93 112.206 179.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.38 24.67 18.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.049 -0.596 . . . . 2.77 112.626 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' C' ' 10' ' ' ALA . . . -83.63 73.18 10.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.376 0.608 . . . . 2.44 110.986 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -171.36 153.18 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.992 -1.114 . . . . 3.7 107.992 175.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.7 t -58.04 106.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.51 0.195 . . . . 0.57 110.688 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.42 -28.54 73.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.244 -0.503 . . . . 0.87 112.619 -178.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.49 -39.47 85.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.453 . . . . 1.54 110.744 178.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.46 -21.44 17.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.619 -177.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.87 74.91 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.946 -0.862 . . . . 0.77 110.946 -174.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.34 144.92 30.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.342 . . . . 2.1 110.189 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.13 24.92 9.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.66 112.853 -178.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 m -80.25 129.56 34.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.736 -0.468 . . . . 1.52 109.736 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 55.24 56.01 6.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.718 0.771 . . . . 2.23 109.728 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.86 148.73 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.35 -0.841 . . . . 1.76 110.809 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 96.1 mt -94.64 150.79 19.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 1.18 110.544 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.2 mmt180 -117.3 152.14 35.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.793 -0.64 . . . . 3.64 110.191 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.566 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 17.9 t -81.72 138.75 35.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.654 -0.499 . . . . 0.37 109.654 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.5 p -81.7 -23.23 36.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.585 -0.28 . . . . 1.34 111.726 -177.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -103.52 -18.7 14.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.939 0.348 . . . . 1.81 111.939 -176.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.566 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.4 p -150.71 -173.89 4.61 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.626 -0.509 . . . . 0.92 109.626 177.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.32 125.36 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.566 0.222 . . . . 1.17 110.455 -178.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.83 151.46 7.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 1.13 110.22 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -137.63 112.6 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.461 0.476 . . . . 1.18 110.19 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.59 165.6 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.68 110.094 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.746 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.5 m170 -98.27 132.77 43.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 0.58 108.328 171.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -47.49 -53.49 14.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.306 0.484 . . . . 0.77 112.306 -173.142 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -70.47 -20.85 62.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.854 0.359 . . . . 3.8 111.783 -173.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.7 m -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.173 0.511 . . . . 0.54 110.102 177.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . 0.435 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 1.2 m170 -93.26 -51.3 5.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.72 110.535 176.416 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -111.71 91.37 14.65 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.793 -0.639 . . . . 0.94 110.404 -177.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 83.1 Cg_endo -97.32 3.48 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.957 2.438 . . . . 2.64 112.358 176.208 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.71 55.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 3.71 112.286 -172.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.76 41.51 2.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.408 -0.901 . . . . 1.86 112.367 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.923 -0.399 . . . . 1.52 109.923 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -88.01 122.45 31.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.669 0.271 . . . . 2.07 110.567 -177.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -69.68 112.86 13.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 3.22 111.117 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . 0.402 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 55.2 Cg_endo -72.18 143.22 39.38 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.361 2.041 . . . . 1.22 112.141 177.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.55 -11.94 54.64 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.859 -0.686 . . . . 1.9 112.173 178.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 14.4 p -95.28 -70.63 0.7 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.374 0.607 . . . . 3.21 111.461 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.56 77.07 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 1.31 112.445 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 1.4 tm? -70.94 123.08 21.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.11 -0.7 . . . . 1.51 109.11 177.104 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -112.91 146.92 38.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 3.09 110.91 -176.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 21.1 p -83.57 -174.27 5.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.649 -0.871 . . . . 0.55 108.649 170.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' C' ' 54' ' ' ARG . 43.7 ttp180 -67.89 -43.89 78.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.495 -0.482 . . . . 4.7 110.101 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -59.32 -49.5 77.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.813 -0.63 . . . . 1.89 111.183 -178.091 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.2 m -70.41 -16.33 62.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.803 0.335 . . . . 0.72 111.557 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -90.2 -8.75 50.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 1.79 110.445 176.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.34 -64.98 0.45 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.981 -0.628 . . . . 2.19 112.211 -178.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -93.84 123.75 37.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.314 0.578 . . . . 5.15 110.386 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 8.7 p -150.33 137.07 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.698 -0.683 . . . . 7.2 110.118 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 46.3 m -78.99 118.04 70.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.219 -0.446 . . . . 8.83 110.575 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.72 154.41 59.24 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.405 2.07 . . . . 11.41 112.196 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.21 42.5 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.909 -0.587 . . . . 13.86 110.302 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.71 112.03 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.634 2.223 . . . . 16.55 111.81 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.93 148.64 29.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.185 -0.462 . . . . 18.07 110.299 -176.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.534 -0.746 . . . . 20.26 110.571 -178.764 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 CA-C-O 120.134 -0.259 . . . . 20.59 112.702 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.67 43.65 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.978 0.418 . . . . 19.12 111.473 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 21.5 ptm -148.57 113.28 5.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.34 0.59 . . . . 18.25 110.933 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -85.57 -60.56 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.739 -0.664 . . . . 16.83 109.898 176.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.51 60.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.589 -0.732 . . . . 14.9 111.369 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.46 62.65 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.236 0.541 . . . . 16.26 109.907 -176.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -127.85 51.34 1.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.626 . . . . 13.59 110.675 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.32 107.74 5.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.999 -0.546 . . . . 12.17 109.969 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -80.58 79.51 7.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.187 0.518 . . . . 9.12 110.784 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 123.22 88.84 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.558 -0.747 . . . . 6.25 110.127 177.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.38 -44.71 13.75 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.601 2.201 . . . . 5.93 111.8 177.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.57 -56.62 3.38 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.376 -0.829 . . . . 2.77 113.195 175.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.92 121.9 26.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.122 0.487 . . . . 2.44 111.56 -175.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -157.53 145.54 18.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.864 -0.791 . . . . 3.7 108.864 177.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.3 t -71.45 103.47 2.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.553 -0.536 . . . . 0.57 109.553 178.624 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.38 -4.1 77.57 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-N 115.927 -0.579 . . . . 0.87 112.28 -175.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 36.8 t -67.78 -29.11 43.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.247 0.546 . . . . 1.54 109.704 177.244 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.42 -38.42 3.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 1.63 110.163 176.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.54 -5.94 26.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.993 -0.623 . . . . 0.77 111.823 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 21.1 t70 -108.29 146.64 32.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.886 0.374 . . . . 2.1 110.704 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.15 16.57 9.99 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.17 -0.538 . . . . 0.66 112.083 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -80.26 133.39 35.98 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 122.828 -0.219 . . . . 1.52 110.512 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.41 56.12 8.43 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.448 0.642 . . . . 2.23 109.813 -175.359 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 5.5 p -96.29 146.83 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 1.76 110.798 -172.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -86.85 144.05 27.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.102 0.477 . . . . 1.18 109.864 177.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -107.99 143.79 36.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.559 -0.746 . . . . 3.64 109.945 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 t -74.89 137.81 42.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.407 -0.59 . . . . 0.37 109.407 177.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 47.9 p -91.16 -19.62 22.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.116 0.484 . . . . 1.34 110.914 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -91.7 -24.11 19.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 1.81 110.792 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.58 -165.94 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.131 -0.692 . . . . 0.92 109.131 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 114.56 28.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.75 0.31 . . . . 1.17 110.35 177.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.79 142.88 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 1.13 110.607 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.62 117.15 32.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.854 -0.612 . . . . 1.18 109.514 176.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -147.43 156.28 42.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.68 110.943 -175.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -103.25 132.21 49.69 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.999 -0.741 . . . . 0.58 108.999 173.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -57.85 -40.23 79.65 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.77 110.881 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 43.8 mtm105 -72.62 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.475 -0.33 . . . . 3.8 111.463 -177.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.4 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 86.3 m -72.76 -23.36 60.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.54 111.001 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -96.47 -53.71 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.72 110.747 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -113.07 142.8 27.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.944 -0.571 . . . . 0.94 110.649 -174.286 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.08 155.06 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.78 2.32 . . . . 2.64 111.348 174.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -14.67 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 3.71 112.618 -172.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.73 3.26 87.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.089 -0.577 . . . . 1.86 112.392 177.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -92.62 136.43 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.572 -0.529 . . . . 1.52 109.572 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 25.9 m -88.97 130.3 35.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.969 0.414 . . . . 2.07 111.218 -175.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -81.0 117.43 68.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.788 -0.642 . . . . 3.22 110.595 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.06 146.13 51.41 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.91 2.407 . . . . 1.22 112.595 -177.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.1 -9.85 56.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.83 -0.7 . . . . 1.9 111.503 176.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -93.24 47.84 1.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 3.21 111.781 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.91 123.25 4.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.912 -0.661 . . . . 1.31 112.928 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 127.89 34.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 1.51 110.65 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -108.66 133.31 52.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 3.09 110.953 -178.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.7 p -73.19 178.5 4.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.187 -0.671 . . . . 0.55 109.187 172.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -56.16 -43.51 78.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.677 0.275 . . . . 4.7 111.605 -175.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -68.18 -50.19 55.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.586 -0.279 . . . . 1.89 111.621 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.3 m -68.37 -17.07 64.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.831 0.308 . . . . 0.72 111.831 -177.161 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -98.98 9.5 43.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.388 . . . . 1.79 110.833 177.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.1 -27.06 26.94 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.585 -0.817 . . . . 2.19 111.923 178.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.69 29.27 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.792 0.33 . . . . 5.15 111.08 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 m -89.59 159.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.403 -0.362 . . . . 7.2 110.166 178.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 41.1 p -110.36 104.19 55.35 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.56 0.219 . . . . 8.83 110.84 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.81 135.26 21.23 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.623 2.215 . . . . 11.41 110.991 173.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.8 116.53 57.7 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.39 -0.368 . . . . 13.86 110.618 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 126.47 11.89 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.488 2.125 . . . . 16.55 112.59 -177.604 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -89.69 82.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.338 0.589 . . . . 18.07 109.714 177.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.547 -0.74 . . . . 20.26 110.02 -179.323 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.227 -0.349 . . . . 20.59 112.227 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.91 119.13 33.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.943 0.402 . . . . 19.12 110.745 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.5 mmt -90.91 27.25 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 18.25 110.757 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.04 -44.63 8.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.061 -0.518 . . . . 16.83 110.451 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.98 49.15 0.25 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.959 -0.639 . . . . 14.9 112.096 177.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -141.21 -67.47 0.41 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.848 0.356 . . . . 16.26 110.889 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' C' ' 7' ' ' GLN . 9.0 tp-100 -90.42 22.24 3.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.762 0.791 . . . . 13.59 110.41 -176.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.33 78.08 8.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 12.17 110.01 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.52 143.67 42.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 9.12 110.627 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.43 124.92 70.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.116 -0.493 . . . . 6.25 110.948 -177.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.06 114.17 2.9 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.712 2.274 . . . . 5.93 111.872 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.04 -172.8 31.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.888 -0.672 . . . . 2.77 112.245 178.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.1 76.65 4.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.338 0.59 . . . . 2.44 110.472 178.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -135.9 139.41 43.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.425 -0.807 . . . . 3.7 109.851 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 30.8 t -76.62 104.31 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.157 -0.683 . . . . 0.57 109.157 176.212 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.62 89.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.739 -0.664 . . . . 0.87 112.756 -173.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.426 HG13 ' O ' ' C' ' 38' ' ' CYS . 22.3 t -76.73 -29.0 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 1.54 110.287 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.06 -51.69 2.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.232 -0.44 . . . . 1.63 110.278 178.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -13.13 4.0 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.734 -0.746 . . . . 0.77 112.596 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.09 151.17 23.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.117 0.484 . . . . 2.1 111.752 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.52 21.25 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.66 111.866 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -77.15 116.18 17.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.431 0.158 . . . . 1.52 110.881 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 56.12 65.26 1.48 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.478 0.656 . . . . 2.23 110.762 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.4 134.88 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.76 111.075 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -77.9 146.49 35.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.339 -0.846 . . . . 1.18 109.672 176.118 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -113.32 140.45 48.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 3.64 110.337 -174.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' C' ' 51' ' ' LEU . 7.7 t -69.38 125.03 25.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.054 -0.721 . . . . 0.37 109.054 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 13.2 t -79.42 -5.55 54.92 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.141 0.496 . . . . 1.34 111.163 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -111.69 -22.67 11.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.81 111.758 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.7 p -150.17 -171.77 4.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.92 109.766 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.36 115.45 28.49 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.871 0.367 . . . . 1.17 110.454 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.01 143.48 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.952 -0.567 . . . . 1.13 110.523 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -122.77 116.16 23.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.616 -0.513 . . . . 1.18 109.616 177.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.96 163.85 39.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.386 -0.37 . . . . 0.68 110.498 -174.395 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.404 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.0 m170 -100.79 145.98 27.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.878 -0.416 . . . . 0.58 109.878 174.11 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -52.81 -53.83 42.84 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.504 0.503 . . . . 0.77 110.827 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 66.8 mtt180 -70.07 -19.54 63.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 3.8 112.09 -174.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.426 ' O ' HG13 ' C' ' 17' ' ' VAL . 89.3 m -77.09 -21.04 54.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.162 0.506 . . . . 0.54 110.484 177.142 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -103.23 -52.37 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.285 0.564 . . . . 0.72 110.647 176.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 53.7 m-85 -113.26 125.56 29.52 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.456 -0.793 . . . . 0.94 109.356 -178.092 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -52.28 148.73 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.619 2.213 . . . . 2.64 111.753 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -18.06 14.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.804 . . . . 3.71 112.934 -172.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.22 -2.12 61.89 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.071 -0.585 . . . . 1.86 112.488 176.168 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -99.3 142.28 30.99 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.024 -0.362 . . . . 1.52 110.024 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 43.3 m -88.22 124.11 33.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 2.07 111.219 -176.531 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -79.88 129.37 70.87 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 3.22 110.533 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.06 154.08 75.68 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.495 2.13 . . . . 1.22 111.3 176.159 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 -10.24 73.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 1.9 112.619 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.1 p -93.76 -160.81 0.79 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.782 -0.081 . . . . 3.21 110.782 178.392 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.73 143.67 48.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.128 -0.558 . . . . 1.31 112.867 -179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' C' ' 27' ' ' CYS . 0.1 OUTLIER -90.83 144.51 25.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.951 0.405 . . . . 1.51 110.562 -178.503 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -105.68 133.24 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.216 -0.447 . . . . 3.09 109.997 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -72.46 165.16 25.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.772 -0.825 . . . . 0.55 108.772 175.311 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -55.27 -35.89 65.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.246 0.476 . . . . 4.7 111.61 -171.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -65.6 -51.03 62.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.433 -0.348 . . . . 1.89 111.061 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.25 -17.92 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.72 111.117 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -78.86 -14.03 59.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.989 0.423 . . . . 1.79 110.868 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.39 99.8 0.19 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.52 -0.847 . . . . 2.19 112.005 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.3 114.52 25.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.96 0.41 . . . . 5.15 110.954 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.97 62.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.925 -0.768 . . . . 7.2 108.925 175.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 24.5 m -87.56 115.21 62.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.133 -0.94 . . . . 8.83 110.551 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.43 158.26 32.77 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.887 2.392 . . . . 11.41 111.975 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.56 121.05 84.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.3 -0.409 . . . . 13.86 110.146 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.8 76.87 2.37 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.75 2.3 . . . . 16.55 112.058 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.19 13.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 18.07 110.816 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.809 -0.615 . . . . 20.26 110.544 -177.272 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.05 -0.42 . . . . 20.59 112.05 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.42 121.15 21.85 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.306 -0.257 . . . . 19.12 110.306 179.466 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 68.1 mtt -64.4 119.49 10.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 18.25 110.715 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -110.67 101.16 9.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.68 -0.691 . . . . 16.83 110.389 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.14 37.99 95.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.973 -0.632 . . . . 14.9 111.92 -177.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -121.17 -16.84 7.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.031 0.443 . . . . 16.26 110.589 -178.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -132.93 140.22 47.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 13.59 109.907 179.78 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 63.74 60.37 1.07 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.721 0.638 . . . . 12.17 110.438 179.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.94 142.93 45.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 9.12 110.728 -177.695 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.5 129.01 87.78 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.069 -0.514 . . . . 6.25 110.865 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.91 62.33 3.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.038 2.492 . . . . 5.93 112.442 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.48 -146.77 19.19 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.961 -0.637 . . . . 2.77 112.221 -179.558 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.538 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -81.4 75.36 8.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 2.44 110.663 -179.59 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.454 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 28.9 ttm-85 -158.23 130.32 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.924 -0.58 . . . . 3.7 110.803 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -77.84 114.34 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.877 -0.416 . . . . 0.57 109.877 177.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.66 64.8 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.085 -0.578 . . . . 0.87 112.926 -177.622 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -81.85 -32.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.978 0.418 . . . . 1.54 110.723 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.01 -40.26 6.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.148 0.425 . . . . 1.63 112.148 -176.386 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.59 51.36 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.343 -0.703 . . . . 0.77 111.343 -173.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.78 151.97 19.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.703 0.287 . . . . 2.1 110.374 177.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.87 21.83 12.08 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.676 -0.773 . . . . 0.66 112.159 178.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.03 127.4 32.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.183 . . . . 1.52 111.263 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 t70 55.17 66.47 1.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.587 0.708 . . . . 2.23 110.872 176.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 m -108.03 145.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.29 -0.868 . . . . 1.76 111.411 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' C' ' 36' ' ' TRP . 83.4 mt -98.09 144.02 28.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 1.18 110.306 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.4 mpt_? -109.96 153.84 23.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.137 -0.483 . . . . 3.64 110.355 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 34.2 t -71.3 142.69 50.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.228 -0.656 . . . . 0.37 109.228 173.484 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -84.75 -5.61 59.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 1.34 110.704 178.186 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -118.4 -9.36 10.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.81 110.939 178.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.72 173.19 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.93 0.395 . . . . 0.92 110.072 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.55 112.82 26.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.361 -0.607 . . . . 1.17 109.361 174.204 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.62 131.14 1.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.624 -0.716 . . . . 1.13 109.485 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.538 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -108.88 122.83 48.02 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.025 0.44 . . . . 1.18 110.655 -178.318 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.3 160.85 41.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.769 -0.65 . . . . 0.68 110.141 -178.635 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.68 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.4 m170 -88.85 133.22 34.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.264 -1.013 . . . . 0.58 108.264 172.724 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.411 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.6 t-105 -61.16 -33.27 73.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.77 111.017 -176.189 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -76.55 -13.75 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.054 0.454 . . . . 3.8 111.184 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 59.5 m -93.05 -22.52 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.082 0.468 . . . . 0.54 110.744 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -95.27 -30.9 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.987 -0.552 . . . . 0.72 110.671 175.505 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.31 158.74 74.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.94 110.274 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.37 156.66 62.12 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.495 2.13 . . . . 2.64 111.091 173.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -10.56 55.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.926 -0.579 . . . . 3.71 112.071 -174.169 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.92 -11.74 78.5 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.653 -0.784 . . . . 1.86 111.946 175.478 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -88.69 120.64 30.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.037 0.446 . . . . 1.52 110.644 -179.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.0 p -89.32 138.19 31.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.048 -0.524 . . . . 2.07 110.652 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.21 126.44 91.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.486 . . . . 3.22 110.365 -179.501 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 141.09 44.67 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.987 2.458 . . . . 1.22 113.248 -173.348 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.98 0.55 89.41 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.405 -0.816 . . . . 1.9 111.675 177.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -88.95 1.53 55.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.116 0.484 . . . . 3.21 110.304 177.077 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.68 131.47 3.25 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.537 -0.756 . . . . 1.31 111.955 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.78 123.06 19.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.019 -0.734 . . . . 1.51 109.019 178.424 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -110.46 130.97 55.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.322 0.582 . . . . 3.09 111.82 -173.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 26.0 p -74.89 -176.78 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.125 -0.943 . . . . 0.55 110.032 175.06 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -64.87 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.77 -0.372 . . . . 4.7 111.287 -175.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -68.75 -41.02 79.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.823 0.344 . . . . 1.89 110.429 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 65.1 m -69.01 -23.72 64.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.508 -0.314 . . . . 0.72 111.164 177.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -93.43 1.15 56.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 1.79 110.665 177.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.07 60.22 4.47 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.89 -0.595 . . . . 2.19 111.771 179.49 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.91 132.67 35.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.789 0.328 . . . . 5.15 110.26 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 m -94.56 68.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.382 0.61 . . . . 7.2 110.388 178.896 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.1 m -56.3 119.39 27.46 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.315 -0.857 . . . . 8.83 111.025 -178.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 145.37 43.74 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.86 2.373 . . . . 11.41 112.351 -178.651 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.25 69.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 13.86 110.224 178.174 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.94 79.83 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.664 2.243 . . . . 16.55 112.394 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -91.5 107.69 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.175 -0.466 . . . . 18.07 109.964 178.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.994 -0.527 . . . . 20.26 110.209 -177.356 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.132 -0.387 . . . . 20.59 112.132 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.07 -18.68 36.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.756 0.312 . . . . 19.12 110.974 -178.506 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 70.1 mtm -69.99 -18.07 63.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.282 -0.417 . . . . 18.25 110.994 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.96 -21.48 65.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.146 0.498 . . . . 16.83 110.047 175.346 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.34 110.11 2.35 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.677 -0.692 . . . . 14.9 111.761 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -132.91 -36.99 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.702 0.251 . . . . 16.26 111.167 -178.429 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.72 -24.86 64.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 13.59 111.543 -175.477 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.37 3.33 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.908 -0.587 . . . . 12.17 110.351 178.384 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -105.86 35.39 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.704 0.764 . . . . 9.12 109.529 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.4 123.39 85.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 6.25 110.219 179.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.29 51.12 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.479 2.786 . . . . 5.93 113.629 -176.482 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.38 -63.33 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.155 -0.545 . . . . 2.77 112.408 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.26 169.91 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.763 0.316 . . . . 2.44 110.195 179.681 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -136.96 158.44 44.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.439 -0.578 . . . . 3.7 109.439 178.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -68.82 105.51 2.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.276 -0.638 . . . . 0.57 109.276 175.561 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 -21.02 67.07 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 121.017 -0.611 . . . . 0.87 112.285 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.48 -34.56 58.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.948 0.404 . . . . 1.54 110.627 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -102.23 -33.78 9.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 1.63 111.639 -177.6 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.93 20.07 51.42 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.579 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -140.06 154.72 47.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 2.1 110.687 -174.228 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.59 21.81 5.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.007 -0.616 . . . . 0.66 112.09 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -80.91 127.15 32.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.028 -0.36 . . . . 1.52 110.028 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 54.36 61.14 3.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.372 0.606 . . . . 2.23 109.737 -177.122 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.28 150.62 5.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.268 -0.878 . . . . 1.76 110.393 -172.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.79 143.99 25.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.895 -0.409 . . . . 1.18 109.895 179.185 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -108.55 152.45 24.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.635 -0.711 . . . . 3.64 110.173 -177.132 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -84.75 127.27 34.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.28 -0.637 . . . . 0.37 109.28 176.447 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -80.67 -5.89 57.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.206 0.527 . . . . 1.34 110.905 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -106.31 -27.34 11.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 1.81 111.488 -178.74 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.97 -161.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.885 -0.413 . . . . 0.92 109.885 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.1 115.77 31.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.66 0.267 . . . . 1.17 110.616 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.96 151.88 10.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.216 -0.447 . . . . 1.13 110.301 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.69 112.36 9.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.334 -0.394 . . . . 1.18 110.107 179.244 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.492 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.8 p90 -156.87 177.22 11.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.18 -0.464 . . . . 0.68 109.862 -177.167 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 14.7 m170 -109.8 132.82 53.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.763 -0.829 . . . . 0.58 108.763 172.765 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -53.6 -53.23 54.68 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.106 0.41 . . . . 0.77 112.106 -171.737 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -60.81 -26.22 67.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.089 0.471 . . . . 3.8 111.359 -176.042 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.3 m -77.91 -23.66 48.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.069 -0.514 . . . . 0.54 110.809 -178.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 -34.37 11.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.72 110.779 179.316 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -126.56 75.9 74.24 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.847 -0.615 . . . . 0.94 110.365 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.43 13.11 2.85 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.985 2.457 . . . . 2.64 112.408 -177.121 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.18 4.31 31.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.931 -0.577 . . . . 3.71 111.413 -178.174 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.73 9.79 60.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.671 -0.776 . . . . 1.86 111.426 -177.113 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 25.7 m -67.64 131.79 46.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.281 . . . . 1.52 110.629 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -88.44 135.29 33.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.342 -0.39 . . . . 2.07 110.026 -178.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -72.42 134.41 82.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.298 -0.41 . . . . 3.22 111.018 -176.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.49 132.93 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.578 2.185 . . . . 1.22 112.195 178.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.86 -13.42 75.08 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.01 -0.836 . . . . 1.9 111.01 175.245 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.5 p -93.06 46.98 1.24 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.122 0.487 . . . . 3.21 111.113 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.48 106.31 3.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.72 . . . . 1.31 112.408 178.736 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.01 124.63 23.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.203 0.525 . . . . 1.51 109.942 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -110.56 135.33 51.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 3.09 110.749 -177.326 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.492 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -77.52 -179.04 5.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.55 109.663 174.289 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -62.19 -46.76 87.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.807 0.337 . . . . 4.7 110.575 -177.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -61.63 -45.74 92.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 1.89 111.28 -177.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.07 -23.14 61.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.617 0.228 . . . . 0.72 111.617 -179.612 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -80.81 -14.36 58.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 1.79 110.637 177.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.59 25.53 9.03 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.346 -0.701 . . . . 2.19 111.346 177.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.8 106.92 18.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.038 0.446 . . . . 5.15 110.455 -178.659 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.08 103.46 14.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.856 -0.794 . . . . 7.2 108.856 173.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.3 m -77.74 113.92 36.68 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.977 -0.556 . . . . 8.83 110.825 -176.791 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 142.87 17.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.198 1.932 . . . . 11.41 111.228 176.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.89 115.79 65.78 Favored Pre-proline 0 C--N 1.318 -0.763 0 C-N-CA 120.9 -0.32 . . . . 13.86 110.264 179.642 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -73.9 120.52 6.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.539 2.159 . . . . 16.55 111.133 177.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -95.92 177.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.365 -0.379 . . . . 18.07 110.581 -179.962 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.637 -0.697 . . . . 20.26 109.908 -178.065 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 111.462 -0.655 . . . . 20.59 111.462 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.21 89.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.883 0.342 . . . . 19.12 111.018 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 87.4 mtp -122.66 113.92 19.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.955 -0.387 . . . . 18.25 109.955 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.07 108.24 18.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.061 0.458 . . . . 16.83 110.414 -178.239 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -50.8 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.039 -0.6 . . . . 14.9 111.608 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -62.2 -52.67 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.04 0.447 . . . . 16.26 110.094 178.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.9 52.56 2.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.871 -0.604 . . . . 13.59 110.4 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.81 -27.43 63.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.456 . . . . 12.17 109.965 178.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.4 104.47 13.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 9.12 110.065 173.087 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 150.51 84.63 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.437 -0.802 . . . . 6.25 110.951 -179.188 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.46 44.27 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.121 2.547 . . . . 5.93 113.359 -179.449 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.79 -52.12 5.16 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.601 -1.0 . . . . 2.77 110.601 174.656 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.53 73.39 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 2.44 109.305 171.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.439 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.1 ttt180 -156.0 123.43 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 3.7 110.249 -175.085 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -69.14 109.06 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.857 -0.423 . . . . 0.57 109.857 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.71 -18.24 61.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.377 -0.439 . . . . 0.87 112.771 -177.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -79.43 -37.12 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.729 0.3 . . . . 1.54 111.108 178.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -97.69 -33.95 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.046 0.387 . . . . 1.63 112.046 -176.421 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.86 -1.33 65.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.603 -0.808 . . . . 0.77 111.639 -175.122 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -119.16 150.43 40.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 2.1 110.345 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . 0.439 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -115.25 24.84 10.28 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.557 -0.83 . . . . 0.66 113.424 -175.004 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -79.0 116.4 19.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.856 0.328 . . . . 1.52 110.657 178.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 66.95 1.1 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.744 0.652 . . . . 2.23 111.923 177.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.77 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.205 -0.452 . . . . 1.76 110.542 177.218 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.95 159.46 17.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 1.18 109.855 174.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -123.89 143.51 50.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 3.64 110.554 -176.066 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -82.14 134.77 35.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.321 -0.622 . . . . 0.37 109.321 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 49.6 p -85.32 -13.5 49.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 1.34 111.43 -178.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -103.52 -21.74 13.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 1.81 111.444 -178.651 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.21 -166.14 2.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 0.92 109.426 178.602 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.97 115.3 30.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.06 -0.348 . . . . 1.17 110.06 178.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.23 134.85 12.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.431 . . . . 1.13 110.205 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.06 115.86 23.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.258 -0.428 . . . . 1.18 110.388 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -160.5 151.73 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.048 -0.524 . . . . 0.68 110.307 -176.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.849 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.7 m80 -82.44 136.59 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.985 -1.117 . . . . 0.58 107.985 171.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -44.3 -52.17 7.79 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.466 0.479 . . . . 0.77 111.979 -175.699 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -56.44 -34.9 67.26 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.678 0.621 . . . . 3.8 112.678 -175.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.849 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 3.4 m -71.71 -21.93 61.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.897 -0.592 . . . . 0.54 111.149 -173.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -103.94 -49.66 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.82 -0.627 . . . . 0.72 110.546 176.232 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.9 m-85 -121.43 113.61 32.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.94 110.156 -175.932 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 7.2 Cg_exo -72.54 -172.73 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.922 2.415 . . . . 2.64 113.308 -177.469 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.35 -28.17 62.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 111.935 0.346 . . . . 3.71 111.935 -177.347 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.53 -9.49 55.46 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.244 -0.503 . . . . 1.86 112.743 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 44' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 36.5 m -124.63 116.98 23.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 1.52 110.369 176.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -88.37 155.15 19.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.264 -0.426 . . . . 2.07 110.224 -178.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -70.25 130.95 88.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 3.22 110.679 -175.262 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.66 147.27 50.77 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.814 2.343 . . . . 1.22 111.988 178.355 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.01 -1.89 88.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.808 -0.711 . . . . 1.9 111.577 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.1 p -94.67 -168.29 1.8 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.534 -0.333 . . . . 3.21 110.86 179.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.53 127.13 43.99 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.644 -0.788 . . . . 1.31 111.439 175.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.8 122.42 17.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.221 0.534 . . . . 1.51 109.99 -176.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.6 135.52 48.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.835 -0.62 . . . . 3.09 110.433 178.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.7 p -75.7 172.54 12.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.1 -0.704 . . . . 0.55 109.1 171.777 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -53.56 -41.48 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.026 0.441 . . . . 4.7 111.4 -175.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 55' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' C' ' 60' ' ' VAL . 35.1 t -68.22 -45.92 71.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.072 -0.513 . . . . 1.89 111.269 -177.236 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.0 m -72.58 -17.46 61.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.812 0.301 . . . . 0.72 111.812 -177.398 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -87.45 -8.45 56.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 1.79 110.608 174.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.84 -100.13 0.85 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.11 -0.567 . . . . 2.19 111.823 179.261 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -124.92 142.79 51.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.794 -0.447 . . . . 5.15 109.794 177.795 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.471 ' HA ' ' OG ' ' C' ' 55' ' ' SER . 58.3 t -108.49 135.54 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 7.2 110.643 -178.15 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.09 122.04 32.9 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 8.83 110.466 176.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.2 142.73 81.35 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.812 2.341 . . . . 11.41 112.14 -178.538 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.28 132.89 93.3 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.153 -0.476 . . . . 13.86 110.027 177.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.44 57.4 4.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.857 2.372 . . . . 16.55 112.775 -176.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -89.19 79.75 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.32 0.581 . . . . 18.07 109.72 -179.032 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.49 -0.777 . . . . 20.26 109.948 179.385 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.859 -0.496 . . . . 20.59 111.859 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.46 95.1 3.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 19.12 110.967 -178.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 63.6 mtt -82.09 -64.84 1.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.606 . . . . 18.25 109.472 177.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -164.86 -63.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 16.83 110.436 178.683 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.41 -151.14 23.31 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.754 -0.736 . . . . 14.9 111.981 179.576 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -88.12 -10.93 48.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 16.26 110.599 179.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.11 97.93 2.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.59 . . . . 13.59 110.22 177.473 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -83.4 -2.08 54.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.901 0.382 . . . . 12.17 111.24 -178.466 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.17 131.7 35.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.08 -0.509 . . . . 9.12 109.731 177.271 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 123.12 87.63 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.504 -0.316 . . . . 6.25 110.511 -179.848 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.44 48.87 1.63 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.503 2.802 . . . . 5.93 113.404 -178.545 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.21 -84.67 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.204 -0.522 . . . . 2.77 112.694 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.84 74.53 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.465 . . . . 2.44 111.065 -178.24 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -168.33 135.44 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 3.7 110.159 179.035 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 41.9 t -76.48 104.39 6.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.57 109.884 179.114 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.72 -6.59 88.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.011 -0.614 . . . . 0.87 112.271 -176.648 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 24.1 t -70.34 -31.65 47.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 1.54 110.664 -179.575 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -112.65 -39.33 4.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.999 0.428 . . . . 1.63 110.196 176.191 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.6 -9.63 9.92 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.612 -0.804 . . . . 0.77 112.08 179.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 2.0 m-20 -107.64 139.54 42.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.006 0.431 . . . . 2.1 111.035 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' C' ' 24' ' ' VAL . . . -107.39 2.81 34.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.03 -0.828 . . . . 0.66 111.03 174.927 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 132.35 45.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.426 -0.387 . . . . 1.52 110.409 179.316 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 56.13 49.71 14.99 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.398 0.618 . . . . 2.23 109.87 -176.612 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' C' ' 21' ' ' GLY . 4.4 p -89.38 151.28 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.343 -0.844 . . . . 1.76 110.602 -175.29 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.7 mt -100.96 160.44 14.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.435 -0.348 . . . . 1.18 110.189 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -126.82 136.03 51.81 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.594 -0.521 . . . . 3.64 109.594 -178.396 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 42.2 t -67.12 143.15 56.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.494 -0.482 . . . . 0.37 110.099 176.389 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.91 -23.35 23.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 1.34 111.049 178.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -95.03 -30.24 14.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 1.81 111.05 -178.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.426 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.0 OUTLIER -137.25 -177.59 4.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.669 -0.493 . . . . 0.92 109.669 -178.397 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.23 114.87 29.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.48 -0.327 . . . . 1.17 110.286 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -168.49 129.87 1.31 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 1.13 110.538 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -102.9 112.15 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.435 -0.58 . . . . 1.18 109.435 174.117 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -155.0 173.42 16.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.799 -0.637 . . . . 0.68 109.998 -175.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.423 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -110.13 135.96 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.169 -0.678 . . . . 0.58 109.169 173.384 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -61.59 -36.27 80.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.551 -0.75 . . . . 0.77 110.45 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -70.39 -26.46 63.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 3.8 111.276 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.428 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.8 m -84.23 -26.0 29.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.937 0.399 . . . . 0.54 110.914 178.884 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -89.81 -40.03 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.213 -0.448 . . . . 0.72 111.26 -178.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -124.32 71.38 55.64 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.315 -0.402 . . . . 0.94 110.173 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.43 6.44 3.58 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.134 2.556 . . . . 2.64 113.004 -174.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.95 3.77 28.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 3.71 111.165 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.05 32.65 20.15 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.63 -0.795 . . . . 1.86 112.036 -179.708 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 8.6 m -68.3 148.08 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.947 -0.39 . . . . 1.52 109.947 177.658 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -86.57 121.67 29.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.94 0.4 . . . . 2.07 110.504 -175.367 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -66.32 120.09 67.42 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 3.22 110.855 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.62 143.8 38.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.435 2.09 . . . . 1.22 111.859 176.277 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.98 -10.37 42.91 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.73 -0.748 . . . . 1.9 112.526 -179.209 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -96.04 9.76 39.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.803 0.335 . . . . 3.21 111.685 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 117.92 0.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.634 -0.793 . . . . 1.31 112.287 -178.669 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.29 123.24 33.9 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.44 -0.578 . . . . 1.51 109.44 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -110.46 149.07 30.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.394 0.616 . . . . 3.09 111.62 -178.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 30.3 p -102.3 -178.8 3.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.171 -0.922 . . . . 0.55 110.029 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -57.84 -39.1 76.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.507 0.558 . . . . 4.7 112.507 -172.106 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -63.7 -57.3 10.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.88 0.371 . . . . 1.89 111.443 -176.541 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 6.9 p -72.17 -24.58 61.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.233 -0.439 . . . . 0.72 111.699 -174.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.3 t -102.15 19.76 17.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.897 0.379 . . . . 1.79 110.728 -177.119 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.22 58.41 0.33 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.366 -0.921 . . . . 2.19 112.645 -179.46 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.96 78.23 6.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.082 0.468 . . . . 5.15 110.117 175.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.67 117.63 35.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 7.2 109.988 179.624 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -75.48 131.95 76.54 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.077 -0.342 . . . . 8.83 110.077 179.079 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.64 135.69 54.16 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.541 2.161 . . . . 11.41 111.805 179.805 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.98 129.36 93.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.046 -0.525 . . . . 13.86 110.939 -177.695 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.76 104.78 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.749 2.299 . . . . 16.55 111.938 -179.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.24 132.92 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.889 -0.596 . . . . 18.07 110.675 -178.56 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.672 -0.68 . . . . 20.26 110.103 178.419 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.694 -0.563 . . . . 20.59 111.694 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.2 -29.96 64.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.105 0.479 . . . . 19.12 110.992 -178.133 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 22.9 mmt -104.64 74.31 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.265 0.555 . . . . 18.25 109.948 176.349 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.22 -24.7 37.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.532 -0.758 . . . . 16.83 110.503 -177.096 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.67 134.09 35.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.982 -0.628 . . . . 14.9 112.061 179.025 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -73.21 -51.49 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.57 -0.159 . . . . 16.26 110.57 -178.273 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 57.02 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.867 0.729 . . . . 13.59 112.68 176.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.41 130.76 37.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.657 -0.701 . . . . 12.17 110.209 177.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.93 76.36 8.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.202 0.525 . . . . 9.12 110.885 -176.649 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.57 146.8 42.46 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.717 -0.674 . . . . 6.25 110.553 -179.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.81 -15.6 48.05 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.033 2.488 . . . . 5.93 112.311 177.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 171.87 23.91 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.501 -0.772 . . . . 2.77 112.69 175.519 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.55 74.88 0.9 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.274 0.559 . . . . 2.44 109.654 176.746 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -137.48 130.33 30.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.662 -0.699 . . . . 3.7 110.748 -174.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.45 111.22 5.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.57 109.994 178.264 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.03 -19.03 60.88 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.291 -0.48 . . . . 0.87 112.856 -178.026 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.27 -31.08 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.105 0.478 . . . . 1.54 110.682 178.522 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.6 m -109.04 -20.8 12.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.32 0.489 . . . . 1.63 112.32 -175.204 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.4 79.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.174 -0.77 . . . . 0.77 111.174 -174.398 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.17 147.09 37.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.281 -0.459 . . . . 2.1 109.932 -176.538 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.26 30.79 5.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.574 -0.822 . . . . 0.66 113.508 -176.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -75.28 121.08 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.237 0.519 . . . . 1.52 110.135 176.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 54.41 52.76 11.87 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.65 0.594 . . . . 2.23 110.508 -176.859 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 8.7 p -88.97 139.45 17.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.091 -0.504 . . . . 1.76 110.635 -173.902 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.09 147.8 25.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.096 -0.502 . . . . 1.18 110.688 -179.073 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 30.7 mmm180 -113.74 149.75 34.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.534 -0.757 . . . . 3.64 109.739 179.71 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 17.6 t -85.2 135.55 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.448 -0.575 . . . . 0.37 109.448 177.881 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.9 p -81.94 -18.68 42.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 1.34 111.171 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -100.5 -22.52 14.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 1.81 111.923 -176.44 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.4 p -150.55 -165.08 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.542 . . . . 0.92 109.535 178.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.65 115.58 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.958 -0.386 . . . . 1.17 109.958 179.477 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.36 146.78 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 1.13 111.273 -177.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.439 ' HB3' ' NH1' ' C' ' 26' ' ' ARG . . . -131.71 112.54 12.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.678 -0.692 . . . . 1.18 109.779 177.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.17 165.35 36.22 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.121 -0.49 . . . . 0.68 109.74 -177.212 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.773 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.9 m170 -96.71 138.37 34.38 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.297 -1.001 . . . . 0.58 108.297 171.2 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -46.09 -52.53 11.91 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.3 0.375 . . . . 0.77 111.712 -177.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.8 mtm180 -70.37 -5.93 31.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.8 112.124 -174.424 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.773 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -91.92 -20.86 20.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.096 0.474 . . . . 0.54 110.66 179.31 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . 0.428 ' HD1' ' HB2' ' C' ' 54' ' ' ARG . 4.4 m-70 -103.86 -36.17 7.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.72 110.68 174.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 92.4 m-85 -121.87 147.28 48.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.94 110.107 -179.405 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.51 159.62 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.519 2.146 . . . . 2.64 111.633 176.463 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -8.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 3.71 111.978 -175.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.69 -7.4 87.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.824 -0.703 . . . . 1.86 111.768 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.0 m -98.11 132.6 43.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.838 0.351 . . . . 1.52 110.212 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -88.87 142.21 27.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.386 -0.37 . . . . 2.07 110.2 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -80.63 127.32 75.85 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 3.22 110.796 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.03 135.65 70.01 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.752 2.301 . . . . 1.22 111.743 175.204 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -24.47 61.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.928 -0.653 . . . . 1.9 111.68 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -138.91 135.59 34.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.908 -0.404 . . . . 3.21 109.908 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.8 53.61 4.89 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.68 -0.771 . . . . 1.31 112.225 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.51 122.82 19.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.408 -0.59 . . . . 1.51 109.408 178.061 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -118.91 136.43 54.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.12 -0.491 . . . . 3.09 110.475 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -73.54 170.4 15.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.142 -0.481 . . . . 0.55 109.944 177.058 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . 0.428 ' HB2' ' HD1' ' C' ' 39' ' ' HIS . 37.7 ttm180 -49.4 -48.7 46.92 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.645 0.59 . . . . 4.7 111.911 -174.826 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -63.69 -45.87 88.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.57 -0.286 . . . . 1.89 111.466 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 89.1 m -72.0 -32.36 67.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.741 0.274 . . . . 0.72 111.741 -177.47 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p -80.88 -14.13 58.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 1.79 111.418 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 -170.33 29.44 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.792 -0.718 . . . . 2.19 112.008 -179.306 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -118.82 126.03 50.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.661 0.267 . . . . 5.15 110.425 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.7 122.64 51.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.23 0.538 . . . . 7.2 109.888 176.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -110.12 105.07 56.83 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.893 -0.594 . . . . 8.83 110.281 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.44 145.75 34.23 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.471 2.114 . . . . 11.41 111.902 178.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.11 120.05 72.17 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.194 -0.457 . . . . 13.86 110.924 -177.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.28 74.11 3.71 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.826 2.351 . . . . 16.55 112.512 -178.589 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.51 63.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.642 0.734 . . . . 18.07 111.067 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.382 -0.818 . . . . 20.26 110.093 179.623 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.048 -0.421 . . . . 20.59 112.048 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.07 0.59 43.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.942 0.401 . . . . 19.12 110.951 -177.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.7 ttt -77.54 78.85 4.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.269 0.557 . . . . 18.25 109.563 177.429 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.77 -174.24 3.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 16.83 110.314 -178.082 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.65 -145.92 13.97 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.749 -0.739 . . . . 14.9 112.07 177.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -162.64 -69.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 16.26 109.774 179.616 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -110.13 67.55 0.65 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.485 -0.561 . . . . 13.59 109.485 175.159 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.98 64.72 8.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 12.17 110.985 -175.107 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.99 121.02 25.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.403 -0.592 . . . . 9.12 109.403 175.617 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.24 129.74 88.94 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.449 . . . . 6.25 110.971 -179.587 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.14 75.14 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.921 2.414 . . . . 5.93 112.096 175.244 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.45 126.42 1.69 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.326 -0.71 . . . . 2.77 111.326 177.666 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.0 92.74 7.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.911 0.386 . . . . 2.44 110.495 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 3.7 110.09 -179.578 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.81 105.44 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.57 109.172 175.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.66 62.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.43 -0.414 . . . . 0.87 113.063 -176.23 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.32 -30.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.54 110.964 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -111.17 -18.1 13.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.509 0.559 . . . . 1.63 112.509 -172.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.46 26.8 71.98 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.616 -0.993 . . . . 0.77 110.616 -173.209 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -142.78 148.47 37.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.282 -0.459 . . . . 2.1 110.589 -170.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.58 25.15 5.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.069 -0.586 . . . . 0.66 111.975 177.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -80.6 129.17 34.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.233 -0.284 . . . . 1.52 110.233 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.71 52.06 11.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.177 0.989 . . . . 2.23 108.953 -179.245 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -100.69 149.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.716 -1.129 . . . . 1.76 111.235 -171.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.2 mt -91.23 144.04 26.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.073 -0.512 . . . . 1.18 109.896 176.61 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' C' ' 32' ' ' ALA . 4.3 tpp180 -110.9 130.86 55.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.084 -0.507 . . . . 3.64 109.998 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 1.8 t -68.07 134.56 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.7 -0.482 . . . . 0.37 109.7 177.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 67.6 p -92.32 -14.85 28.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 1.34 110.84 -179.543 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -98.16 -18.9 18.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.915 -0.584 . . . . 1.81 111.076 -179.344 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -151.64 -170.61 3.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.07 -0.715 . . . . 0.92 109.07 176.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.94 113.9 27.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.538 -0.542 . . . . 1.17 109.538 178.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.474 ' O ' ' HD3' ' C' ' 26' ' ' ARG . . . -171.22 137.43 1.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.55 . . . . 1.13 110.298 -178.631 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -119.03 112.89 20.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.081 -0.711 . . . . 1.18 109.081 175.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.68 156.7 43.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.053 -0.351 . . . . 0.68 110.053 -178.371 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.775 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.29 128.82 35.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.279 -1.008 . . . . 0.58 108.279 172.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -47.83 -53.2 16.3 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.502 0.501 . . . . 0.77 111.962 -172.309 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 71.5 mtm180 -68.07 -14.16 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 3.8 112.357 -172.546 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -80.31 -21.79 42.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.54 110.631 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -105.62 -43.72 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.72 110.521 176.46 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 93.6 m-85 -110.53 139.99 22.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.94 110.384 -176.664 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.27 158.62 47.73 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.719 2.279 . . . . 2.64 111.197 177.201 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.4 43.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 3.71 112.293 -173.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.73 -31.65 60.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.676 -0.773 . . . . 1.86 111.545 175.298 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 38.0 m -74.59 131.12 40.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.29 -0.263 . . . . 1.52 110.29 179.361 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 9.8 p -88.73 134.83 33.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 2.07 111.189 -175.089 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.81 111.76 14.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.698 . . . . 3.22 110.088 178.257 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.17 136.3 28.98 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.66 2.24 . . . . 1.22 112.863 -174.065 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.29 0.16 71.34 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.904 -0.665 . . . . 1.9 111.652 176.772 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -122.57 83.01 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.812 0.339 . . . . 3.21 111.14 177.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.97 88.75 1.38 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.842 -0.694 . . . . 1.31 112.387 178.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.14 122.75 26.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.975 -0.75 . . . . 1.51 108.975 178.739 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.52 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 36.4 ptt180 -133.67 135.45 44.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.213 0.53 . . . . 3.09 110.734 -176.204 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.5 p -73.29 173.81 8.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.55 110.367 178.419 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . 0.56 ' HA ' ' OG ' ' C' ' 57' ' ' SER . 2.7 ptp180 -63.15 -32.5 73.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.295 0.498 . . . . 4.7 111.426 -174.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 1.89 109.838 175.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 69.4 m -74.27 -30.23 62.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.694 -0.685 . . . . 0.72 112.829 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 57' ' ' SER . . . . . 0.56 ' OG ' ' HA ' ' C' ' 54' ' ' ARG . 19.9 p -75.19 -14.22 60.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 1.79 111.184 -174.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.43 -158.21 9.44 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.399 -1.08 . . . . 2.19 110.399 174.158 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -120.06 131.18 55.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.181 0.49 . . . . 5.15 109.999 177.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 m -99.12 42.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 7.2 110.434 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m -72.64 116.06 46.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 8.83 111.086 -176.755 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -83.21 140.2 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.538 2.158 . . . . 11.41 111.487 175.056 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.42 122.43 86.68 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.456 -0.338 . . . . 13.86 110.146 179.448 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.41 89.91 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.64 2.227 . . . . 16.55 112.449 -177.736 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.77 147.41 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.84 -0.618 . . . . 18.07 110.719 178.459 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.527 -0.749 . . . . 20.26 110.366 -178.472 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.392 -0.283 . . . . 20.59 112.392 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.43 66.92 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.769 0.319 . . . . 19.12 111.271 -176.885 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -127.19 21.24 6.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.905 0.383 . . . . 18.25 110.767 178.647 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.56 68.07 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 16.83 110.591 -179.583 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.02 -27.9 65.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.872 -0.68 . . . . 14.9 112.04 178.38 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -92.76 -47.49 7.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.769 -0.456 . . . . 16.26 109.769 177.631 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 51.25 74.85 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.847 0.717 . . . . 13.59 111.043 177.102 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -95.29 145.62 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 12.17 110.861 -176.807 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 tp -124.34 117.26 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 9.12 110.744 -177.948 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.78 145.2 83.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.044 -0.525 . . . . 6.25 110.171 175.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.69 98.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.604 2.869 . . . . 5.93 113.849 -176.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.02 78.58 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.571 -0.74 . . . . 2.77 113.036 174.603 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.38 71.75 8.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.303 0.573 . . . . 2.44 110.646 -179.802 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -163.22 155.61 18.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.892 -1.151 . . . . 3.7 107.892 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.09 108.65 1.59 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.631 -0.507 . . . . 0.57 109.631 177.149 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.05 -14.21 55.38 Favored Glycine 0 C--N 1.329 0.145 0 O-C-N 123.372 0.42 . . . . 0.87 113.102 -175.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.13 -31.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.082 0.468 . . . . 1.54 110.583 178.186 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.4 m -108.02 -26.35 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.471 . . . . 1.63 112.197 -174.883 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.33 25.25 59.56 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.401 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.97 142.36 32.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.663 -0.268 . . . . 2.1 110.96 -173.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.15 16.98 24.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.003 -0.618 . . . . 0.66 112.275 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -80.22 128.93 34.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.934 -0.395 . . . . 1.52 109.934 178.305 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 58.56 40.43 23.71 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.471 0.653 . . . . 2.23 110.36 -178.107 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 p -90.37 150.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.272 -0.877 . . . . 1.76 110.422 -175.376 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 92.8 mt -102.25 151.26 22.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.787 -0.449 . . . . 1.18 109.787 177.05 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.2 tpp180 -119.49 140.32 50.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 3.64 110.119 -175.347 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.6 t -73.47 142.88 46.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.923 -0.769 . . . . 0.37 108.923 174.319 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.6 p -96.92 -21.38 17.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 1.34 110.743 178.678 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -89.66 -21.05 22.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.81 110.567 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.497 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.4 p -151.18 -175.5 5.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.5 -0.926 . . . . 0.92 108.5 174.806 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 114.61 28.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.651 0.262 . . . . 1.17 110.347 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.44 135.8 6.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 1.13 110.442 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.18 118.83 36.42 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.707 0.629 . . . . 1.18 110.121 178.377 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.93 151.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.349 -0.387 . . . . 0.68 110.647 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.696 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -82.65 136.13 34.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.628 -0.878 . . . . 0.58 108.628 172.006 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 62.0 t-105 -49.04 -53.65 19.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.255 0.347 . . . . 0.77 111.618 -175.906 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.23 -15.94 64.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.361 0.504 . . . . 3.8 112.361 -173.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.696 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.4 m -85.35 -21.15 29.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.105 0.478 . . . . 0.54 110.717 -178.822 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -107.56 -45.12 4.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.016 -0.538 . . . . 0.72 111.052 178.048 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.39 146.17 36.8 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.94 110.355 -176.855 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . 0.416 ' HG2' ' OG1' ' C' ' 44' ' ' THR . 10.8 Cg_endo -55.82 144.11 78.39 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.01 2.473 . . . . 2.64 111.797 175.594 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -16.24 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.461 -0.791 . . . . 3.71 112.085 -175.144 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.14 -18.82 75.88 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.76 -0.733 . . . . 1.86 112.17 177.373 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 44' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' C' ' 41' ' ' PRO . 42.8 m -74.8 147.9 40.8 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.086 -0.339 . . . . 1.52 110.086 178.722 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -88.09 122.01 31.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.849 0.357 . . . . 2.07 110.738 -174.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -70.97 120.58 80.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.853 -0.612 . . . . 3.22 110.368 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.67 132.32 32.51 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.611 2.207 . . . . 1.22 111.933 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -43.3 6.71 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.146 -0.782 . . . . 1.9 111.146 176.596 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 t -115.12 135.21 54.44 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.041 -0.355 . . . . 3.21 110.041 175.293 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.2 64.14 3.55 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.773 -0.727 . . . . 1.31 112.201 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.49 131.38 37.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.088 0.47 . . . . 1.51 110.394 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -114.93 133.58 55.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.22 -0.446 . . . . 3.09 110.773 -176.669 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.5 p -77.12 178.45 7.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.205 -0.665 . . . . 0.55 109.205 173.074 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -56.99 -40.39 76.49 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.93 0.344 . . . . 4.7 111.93 -173.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -68.92 -49.18 60.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 1.89 110.919 -178.364 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.57 -17.9 62.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.72 111.348 -178.557 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -90.84 7.99 37.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.986 0.422 . . . . 1.79 110.429 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.53 -142.01 12.87 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.851 -0.69 . . . . 2.19 111.897 178.701 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -122.65 143.62 49.66 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.014 -0.365 . . . . 5.15 110.014 179.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.49 130.18 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 7.2 110.57 179.768 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -101.06 135.66 19.89 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 8.83 110.585 -177.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.2 134.13 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.582 2.188 . . . . 11.41 111.423 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.93 123.79 87.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 13.86 110.768 -178.785 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.0 80.25 1.86 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.813 2.342 . . . . 16.55 111.857 179.723 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.24 -2.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.803 -0.635 . . . . 18.07 111.865 -175.555 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.483 -0.77 . . . . 20.26 110.425 -179.916 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 112.003 -0.439 . . . . 20.59 112.003 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 155.58 30.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.782 0.325 . . . . 19.12 111.099 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.5 ttt -147.35 121.87 9.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.082 -0.508 . . . . 18.25 110.06 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.32 53.37 1.77 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 16.83 111.232 -179.697 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.22 123.44 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.832 -0.699 . . . . 14.9 112.176 -179.015 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.48 -1.97 34.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.302 0.573 . . . . 16.26 109.741 176.102 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -89.77 -174.64 4.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.164 -0.925 . . . . 13.59 110.293 178.263 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 67.08 22.53 9.9 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.584 0.552 . . . . 12.17 110.779 178.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.69 92.12 3.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 9.12 110.2 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -74.01 126.89 88.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.901 -0.59 . . . . 6.25 110.105 178.548 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 23.4 Cg_exo -65.73 -6.05 13.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.105 2.537 . . . . 5.93 113.048 -179.167 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.84 -127.88 8.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.393 -0.683 . . . . 2.77 111.393 -178.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.11 73.85 7.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.879 0.371 . . . . 2.44 110.221 177.134 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 57.4 mtt180 -145.94 130.94 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 3.7 110.587 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' C' ' 34' ' ' PHE . 13.2 t -64.02 114.53 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.57 109.527 175.349 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.07 -22.91 50.67 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.331 0.394 . . . . 0.87 113.353 -174.546 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.52 -30.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.085 0.469 . . . . 1.54 110.889 179.003 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -107.26 -31.11 8.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 1.63 112.912 -173.476 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 85.04 -9.26 66.88 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.089 -0.804 . . . . 0.77 111.089 -172.704 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -106.88 147.69 29.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.171 -0.514 . . . . 2.1 110.674 -177.512 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.07 27.49 6.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.96 -0.638 . . . . 0.66 112.62 179.535 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.9 m -77.19 117.6 18.89 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.862 -0.421 . . . . 1.52 109.862 177.822 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 54.57 64.42 1.82 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.901 0.858 . . . . 2.23 109.511 -174.171 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -97.32 150.96 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.243 -0.89 . . . . 1.76 110.201 -176.339 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.407 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 96.5 mt -103.93 144.14 31.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.76 -0.459 . . . . 1.18 109.76 176.995 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -115.18 138.4 50.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.12 -0.491 . . . . 3.64 110.259 -179.674 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -60.14 139.92 57.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.37 109.549 174.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -90.61 -17.56 26.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.078 0.466 . . . . 1.34 111.015 179.528 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -94.83 -23.73 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 1.81 110.697 -178.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.43 -168.9 3.22 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.115 -0.698 . . . . 0.92 109.115 178.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.68 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.716 0.293 . . . . 1.17 110.741 -178.541 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.96 121.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 1.13 110.617 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.79 117.91 35.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 1.18 110.372 177.744 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' C' ' 15' ' ' CYS . 46.8 p90 -158.16 165.78 34.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.634 -0.257 . . . . 0.68 110.585 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.9 m170 -95.65 140.89 29.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.534 -0.914 . . . . 0.58 108.534 173.779 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.407 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.4 t-105 -59.39 -45.42 91.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.635 0.255 . . . . 0.77 111.0 -177.537 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' C' ' 37' ' ' ARG . 48.9 mtm180 -65.39 -14.48 60.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.286 -0.415 . . . . 3.8 111.968 -177.439 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.4 m -89.9 -20.49 23.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.957 0.408 . . . . 0.54 110.655 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -103.09 -39.75 6.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.091 -0.504 . . . . 0.72 111.403 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.68 161.02 59.9 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.257 -0.429 . . . . 0.94 110.17 -177.592 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.97 146.2 98.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.619 2.213 . . . . 2.64 112.13 178.983 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.96 66.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.5 -0.773 . . . . 3.71 111.333 -178.065 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.08 88.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.782 -0.723 . . . . 1.86 111.978 176.258 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 36.4 m -95.19 134.82 37.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.802 0.334 . . . . 1.52 110.114 179.403 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.7 p -88.95 150.08 23.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.346 -0.388 . . . . 2.07 110.571 -178.12 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -81.15 143.19 52.26 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.934 -0.575 . . . . 3.22 110.209 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 132.17 35.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.642 2.228 . . . . 1.22 112.244 178.876 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.85 -0.7 89.1 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.994 -0.548 . . . . 1.9 112.444 -178.016 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 28.7 p -90.06 -9.98 46.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.135 0.493 . . . . 3.21 110.639 176.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.96 137.12 3.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.775 -0.726 . . . . 1.31 111.922 -178.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 124.01 21.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 1.51 110.16 179.904 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -107.92 136.03 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 3.09 110.965 -177.146 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.408 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.1 p -87.0 -178.22 6.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.55 109.769 175.924 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -64.69 -39.96 94.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.839 -0.344 . . . . 4.7 111.296 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -68.98 -48.7 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.54 0.209 . . . . 1.89 111.058 -178.163 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 90.7 m -67.31 -39.85 85.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.578 0.228 . . . . 0.72 111.114 -178.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -76.43 -13.48 60.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.989 0.423 . . . . 1.79 110.372 -179.365 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.6 -8.96 61.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.079 -0.582 . . . . 2.19 112.308 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -88.27 -9.99 51.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.57 0.7 . . . . 5.15 109.488 179.558 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -92.9 70.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.141 -0.936 . . . . 7.2 109.562 178.609 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 5.7 t -122.4 132.45 24.26 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 8.83 109.995 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.23 134.31 54.99 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.95 2.433 . . . . 11.41 112.493 -178.558 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.28 124.71 91.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 13.86 111.418 -176.624 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.21 106.47 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.621 2.214 . . . . 16.55 112.209 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.56 12.81 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 18.07 110.418 178.138 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.452 -0.794 . . . . 20.26 110.366 -176.939 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.935 -0.466 . . . . 20.59 111.935 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.15 36.18 27.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.095 0.474 . . . . 19.12 111.322 179.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 24.3 ttt -89.07 127.29 35.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.018 -0.537 . . . . 18.25 110.329 -177.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.87 160.43 19.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.746 -0.464 . . . . 16.83 109.746 176.812 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.8 121.1 4.81 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.803 -0.713 . . . . 14.9 112.213 -179.151 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -115.47 23.03 12.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.039 0.447 . . . . 16.26 110.395 -179.559 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 61.53 65.98 0.9 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.146 -0.934 . . . . 13.59 110.435 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -73.08 -26.47 61.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 12.17 110.872 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.42 93.91 7.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.806 -0.442 . . . . 9.12 109.806 177.001 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.24 137.46 97.13 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.929 -0.578 . . . . 6.25 111.075 -177.746 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -70.7 74.03 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.938 2.426 . . . . 5.93 112.171 176.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.29 81.31 1.59 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.82 -0.705 . . . . 2.77 112.32 178.559 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.27 73.41 8.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.317 0.58 . . . . 2.44 109.541 175.258 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -149.0 163.67 36.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.262 -0.881 . . . . 3.7 110.181 -177.721 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 t -69.28 108.21 3.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.57 109.584 175.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.82 -16.2 56.18 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.398 -0.429 . . . . 0.87 112.746 -177.109 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.09 -30.13 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.974 0.416 . . . . 1.54 110.495 177.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.1 m -109.64 -29.63 8.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 1.63 112.42 -175.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.82 3.94 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.904 -0.878 . . . . 0.77 110.904 -173.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.463 ' OD1' HG22 ' C' ' 22' ' ' THR . 10.6 t70 -124.43 153.76 41.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.897 -0.652 . . . . 2.1 109.419 -176.062 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 27.69 3.61 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.299 -0.953 . . . . 0.66 113.355 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 22' ' ' THR . . . . . 0.463 HG22 ' OD1' ' C' ' 20' ' ' ASP . 6.0 t -77.68 135.28 38.05 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.282 0.541 . . . . 1.52 109.711 177.003 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.76 43.35 31.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.878 -0.601 . . . . 2.23 110.183 179.375 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.93 149.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.471 -0.786 . . . . 1.76 110.504 -172.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.18 143.05 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 1.18 109.98 179.238 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 19.2 mmm180 -109.48 143.16 39.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 3.64 110.441 -178.251 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.4 t -73.47 145.43 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.473 -0.565 . . . . 0.37 109.473 177.389 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -90.92 -34.54 15.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.101 -0.499 . . . . 1.34 111.612 -178.954 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -89.2 -13.86 37.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 1.81 111.24 -176.85 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.27 -171.27 3.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.523 -0.547 . . . . 0.92 109.523 175.262 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.74 115.33 30.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.232 -0.285 . . . . 1.17 110.232 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.11 143.73 10.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.331 -0.395 . . . . 1.13 110.696 -179.334 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.17 113.51 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 1.18 109.659 177.263 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.43 154.79 39.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.416 . . . . 0.68 110.696 -178.038 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.6 m170 -92.95 134.15 35.4 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.768 -0.827 . . . . 0.58 108.768 172.845 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -49.39 -53.15 24.04 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.267 0.354 . . . . 0.77 111.217 -176.125 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.18 -30.08 69.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.933 -0.576 . . . . 3.8 111.829 -176.106 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.8 m -80.66 -22.08 40.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.54 111.487 -175.022 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -31.67 8.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.454 -0.339 . . . . 0.72 111.443 -178.568 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.12 141.78 41.77 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.405 . . . . 0.94 110.732 -176.333 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.62 153.99 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.799 2.333 . . . . 2.64 111.417 174.844 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -18.56 61.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.35 -0.841 . . . . 3.71 112.362 -172.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.9 -13.23 80.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.955 -0.64 . . . . 1.86 112.447 177.597 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -87.37 130.91 34.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.739 -0.467 . . . . 1.52 109.739 177.589 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 138.48 31.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.326 -0.397 . . . . 2.07 109.957 -175.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -68.9 115.23 29.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 3.22 110.103 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.1 138.0 46.06 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.038 2.492 . . . . 1.22 112.805 -176.431 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.47 -5.4 65.2 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.766 -0.652 . . . . 1.9 111.819 177.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -88.75 -9.71 50.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 3.21 111.023 -179.794 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.01 137.23 3.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.602 -0.808 . . . . 1.31 112.276 179.145 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.01 123.85 22.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.872 0.368 . . . . 1.51 110.676 176.893 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.373 -0.376 . . . . 3.09 110.337 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.0 p -72.79 -177.43 2.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.55 110.453 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -53.35 -49.29 67.44 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.781 0.432 . . . . 4.7 111.959 -172.774 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -68.88 -42.06 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.808 0.337 . . . . 1.89 111.392 -177.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.3 m -72.08 -28.15 63.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.202 0.445 . . . . 0.72 112.202 -175.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.6 p -107.94 11.21 28.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.974 0.416 . . . . 1.79 111.034 179.047 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.26 -172.15 16.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.485 -0.864 . . . . 2.19 112.746 -175.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -100.73 97.86 8.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.927 -0.398 . . . . 5.15 109.927 179.65 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.87 140.96 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.105 0.478 . . . . 7.2 110.873 -177.639 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 9.1 p -108.16 103.48 50.46 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.053 -0.521 . . . . 8.83 109.881 173.82 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 144.87 24.29 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.871 2.38 . . . . 11.41 111.992 -179.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.22 128.02 26.07 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.218 -0.446 . . . . 13.86 110.017 176.644 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.81 35.14 0.43 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.909 2.406 . . . . 16.55 112.883 -178.184 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 t -93.38 88.41 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.142 0.496 . . . . 18.07 109.914 -179.146 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.222 -0.894 . . . . 20.26 110.273 -176.869 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 111.717 -0.553 . . . . 20.59 111.717 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.96 65.78 1.37 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.107 0.479 . . . . 19.12 110.908 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 91.5 mtp -61.21 118.56 7.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.821 -0.627 . . . . 18.25 110.677 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 70.54 -3.43 1.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.497 0.719 . . . . 16.83 111.392 -179.354 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.07 -12.34 63.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.083 -0.58 . . . . 14.9 111.749 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -88.65 -4.87 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.049 0.452 . . . . 16.26 110.232 177.835 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -82.48 68.64 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 13.59 110.89 -178.257 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.36 -42.38 99.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 12.17 109.759 176.692 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.06 109.43 17.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 9.12 109.505 175.738 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.98 123.28 83.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.396 -0.365 . . . . 6.25 110.521 -178.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.96 77.82 1.12 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.781 2.32 . . . . 5.93 111.908 177.262 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.06 135.49 20.14 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.917 -0.658 . . . . 2.77 112.393 179.594 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.29 88.49 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.972 0.415 . . . . 2.44 110.16 177.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -131.94 143.29 50.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 3.7 111.273 -176.774 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 t -68.3 115.47 7.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.57 109.346 174.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.75 60.86 Favored Glycine 0 C--O 1.228 -0.267 0 O-C-N 123.358 0.411 . . . . 0.87 113.509 -174.852 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.9 -33.39 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.061 0.457 . . . . 1.54 110.953 179.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.87 -37.16 7.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.81 0.67 . . . . 1.63 112.81 -171.283 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.93 -7.39 76.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.856 -0.688 . . . . 0.77 111.598 -175.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -104.52 149.16 25.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.93 0.395 . . . . 2.1 110.523 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.14 6.89 32.54 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.295 -0.722 . . . . 0.66 111.295 175.66 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.9 m -66.89 133.7 50.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.56 -0.32 . . . . 1.52 110.289 178.53 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.31 41.18 4.23 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.15 0.906 . . . . 2.23 111.896 -177.458 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.16 142.6 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.564 -0.744 . . . . 1.76 110.452 -177.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 49.6 mt -87.66 148.88 24.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.027 0.442 . . . . 1.18 110.177 177.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 26.3 mmm180 -119.54 138.57 53.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.544 -0.753 . . . . 3.64 110.054 -177.069 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.91 137.51 53.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.014 -0.736 . . . . 0.37 109.014 178.05 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -92.42 -14.53 28.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 1.34 111.153 -178.891 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -98.86 -20.75 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.187 -0.46 . . . . 1.81 111.014 -179.659 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.3 p -150.82 -166.25 2.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.917 -0.771 . . . . 0.92 108.917 176.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.06 114.95 29.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.687 0.279 . . . . 1.17 110.848 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.54 139.46 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.372 -0.376 . . . . 1.13 110.92 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.38 112.86 19.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.105 -0.498 . . . . 1.18 110.195 178.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -149.91 148.61 29.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 0.68 110.197 -179.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.658 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.5 m170 -80.42 138.74 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.618 -0.882 . . . . 0.58 108.618 172.606 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -52.8 -50.59 63.31 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.173 0.296 . . . . 0.77 110.76 -177.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -67.0 -14.35 62.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.789 -0.641 . . . . 3.8 112.288 -175.688 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 85.1 m -88.56 -20.78 24.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.078 0.466 . . . . 0.54 110.876 -179.425 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -107.49 -43.86 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.72 111.212 177.03 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.0 m-85 -120.72 112.27 33.95 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.94 110.149 -176.669 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.52 -174.46 0.45 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.888 2.392 . . . . 2.64 113.106 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.06 51.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 3.71 112.535 -175.768 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.52 -25.04 62.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.002 -0.618 . . . . 1.86 113.086 -179.683 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 44' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 4.5 m -107.83 126.2 52.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.942 0.401 . . . . 1.52 110.778 -179.792 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -89.43 138.6 31.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.255 -0.646 . . . . 2.07 109.255 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -74.86 126.24 88.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 3.22 111.07 -177.209 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 153.52 56.5 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.771 2.314 . . . . 1.22 111.881 177.909 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.76 -24.41 55.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.955 -0.641 . . . . 1.9 111.624 178.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -141.27 159.6 41.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.822 -0.436 . . . . 3.21 109.822 177.09 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.79 56.83 6.26 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.818 -0.706 . . . . 1.31 112.024 -178.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.93 121.71 23.09 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.229 -0.656 . . . . 1.51 109.229 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -123.33 132.31 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.168 -0.469 . . . . 3.09 110.969 -175.602 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 p -74.71 -172.21 1.49 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.55 109.802 175.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -59.94 -47.45 85.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.627 0.251 . . . . 4.7 111.422 -176.229 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -68.5 -46.58 69.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.443 -0.344 . . . . 1.89 111.564 -177.211 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.8 m -71.24 -21.57 62.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.852 -0.339 . . . . 0.72 111.344 -177.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.4 t -99.75 13.32 34.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 1.79 110.498 179.188 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.98 -41.51 10.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.703 -0.76 . . . . 2.19 111.461 177.555 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.47 152.97 17.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.073 0.463 . . . . 5.15 110.174 178.276 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.92 115.59 36.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.952 -0.567 . . . . 7.2 110.135 179.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.4 114.24 20.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.33 -0.395 . . . . 8.83 111.014 177.835 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.78 147.1 19.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.511 2.141 . . . . 11.41 112.319 -178.387 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.67 140.41 22.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.048 -0.523 . . . . 13.86 110.306 178.795 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.39 32.96 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.122 2.548 . . . . 16.55 113.018 -179.266 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.19 98.23 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 18.07 109.478 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.563 -0.732 . . . . 20.26 109.954 -177.307 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.599 -0.6 . . . . 20.59 111.599 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.09 -71.71 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.818 0.309 . . . . 19.12 110.997 179.416 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.5 ptm -106.46 -33.33 7.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.895 0.379 . . . . 18.25 110.795 179.67 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.88 83.03 6.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 16.83 110.588 -179.712 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.14 -178.3 46.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.816 -0.707 . . . . 14.9 112.039 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -124.48 14.19 8.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 16.26 110.393 -179.497 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.1 47.4 11.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.679 -0.691 . . . . 13.59 110.97 -176.513 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -152.32 -57.28 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 12.17 110.422 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 66.4 tp -104.67 123.9 48.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.968 -0.56 . . . . 9.12 110.66 -178.789 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.13 123.77 89.9 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 6.25 109.815 175.144 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.85 -19.1 60.39 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.921 2.414 . . . . 5.93 113.01 -177.447 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.58 -46.38 3.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.038 -0.601 . . . . 2.77 112.298 178.337 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.95 73.42 10.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.34 0.591 . . . . 2.44 110.839 179.704 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . 0.416 ' N ' ' HB1' ' C' ' 33' ' ' ALA . 50.8 ttt85 -169.95 132.75 1.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.214 -0.903 . . . . 3.7 109.011 175.024 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 41.4 t -72.08 103.93 3.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.186 -0.461 . . . . 0.57 110.231 -178.621 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.48 -8.66 84.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.87 111.74 179.446 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.418 HG11 ' O ' ' C' ' 38' ' ' CYS . 25.5 t -61.68 -49.07 85.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 1.54 110.139 178.765 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.1 p -98.87 -28.12 13.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.482 -0.562 . . . . 1.63 109.482 175.12 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 3.61 55.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.895 -0.669 . . . . 0.77 111.945 178.281 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.57 145.05 48.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.767 0.318 . . . . 2.1 110.843 -176.722 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.68 17.04 13.77 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.66 111.891 179.201 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -78.31 122.77 26.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.533 0.166 . . . . 1.52 110.935 -177.947 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.35 51.65 15.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.62 0.724 . . . . 2.23 110.299 -178.0 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' C' ' 33' ' ' ALA . 6.6 p -92.39 155.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.634 -1.166 . . . . 1.76 110.416 -175.262 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 97.4 mt -86.31 146.59 26.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.678 -0.49 . . . . 1.18 109.678 176.589 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -109.45 138.45 45.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.305 -0.407 . . . . 3.64 110.272 -176.198 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.65 138.84 53.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.702 -0.481 . . . . 0.37 109.702 177.383 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -94.89 -24.51 16.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 1.34 111.339 179.744 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.48 -20.11 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.998 0.427 . . . . 1.81 110.575 -177.744 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.47 -171.09 3.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.158 -1.052 . . . . 0.92 108.158 174.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.76 112.92 26.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.961 -0.385 . . . . 1.17 109.961 178.148 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.66 146.17 8.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.123 -0.49 . . . . 1.13 110.001 -178.502 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.416 ' HB1' ' N ' ' C' ' 14' ' ' ARG . . . -109.66 121.41 45.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.125 -0.489 . . . . 1.18 109.694 177.403 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 31.0 p90 -149.8 143.21 25.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.226 -0.443 . . . . 0.68 110.476 -178.492 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 68.9 m80 -90.33 138.81 31.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.691 -0.855 . . . . 0.58 108.691 171.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -59.28 -43.78 92.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.354 0.409 . . . . 0.77 110.02 178.355 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.62 -26.16 66.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.027 -0.533 . . . . 3.8 111.534 -177.37 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.1 m -81.98 -23.9 35.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.041 0.448 . . . . 0.54 110.653 179.679 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -101.19 -41.46 6.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.319 -0.4 . . . . 0.72 111.701 -175.812 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.95 132.48 24.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.691 0.281 . . . . 0.94 110.706 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.6 164.7 22.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.723 2.282 . . . . 2.64 111.34 172.185 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.77 -3.48 5.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 3.71 112.12 -175.712 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.67 73.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.965 -0.636 . . . . 1.86 111.67 173.705 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -101.4 136.1 41.81 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.079 -0.341 . . . . 1.52 110.079 178.705 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -89.03 140.22 29.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 2.07 110.862 -175.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -81.91 118.15 71.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 3.22 110.641 179.854 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 158.35 49.32 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.64 2.227 . . . . 1.22 111.836 176.241 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.9 -16.45 61.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.03 -0.605 . . . . 1.9 111.677 177.351 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -142.84 146.37 34.07 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.203 -0.295 . . . . 3.21 110.203 178.602 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.19 48.47 4.58 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.719 -0.753 . . . . 1.31 112.518 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.2 122.12 27.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.159 0.504 . . . . 1.51 110.307 176.973 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.427 ' CZ ' ' HA ' ' C' ' 57' ' ' SER . 24.2 ptt180 -127.1 135.71 51.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.362 0.601 . . . . 3.09 110.051 -179.744 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.8 p -72.28 177.9 4.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.55 110.207 -178.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -58.43 -41.69 85.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.977 0.362 . . . . 4.7 111.977 -174.258 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -64.3 -42.64 96.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.109 0.481 . . . . 1.89 110.522 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' C' ' 52' ' ' ARG . 85.1 m -72.97 -19.9 61.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.72 111.472 176.839 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 57' ' ' SER . . . . . 0.427 ' HA ' ' CZ ' ' C' ' 52' ' ' ARG . 19.6 t -80.86 -14.28 58.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.104 -0.498 . . . . 1.79 110.477 -175.468 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.15 143.23 16.5 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.648 -0.787 . . . . 2.19 111.414 176.765 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.27 152.87 21.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.809 -0.441 . . . . 5.15 109.809 -179.847 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.49 124.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.26 0.553 . . . . 7.2 110.841 -179.66 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 5.4 p -82.18 115.14 55.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.669 -0.696 . . . . 8.83 110.321 175.279 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.26 134.05 59.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.84 2.36 . . . . 11.41 112.069 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.32 141.81 23.59 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 13.86 110.284 -178.206 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -75.38 63.19 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.6 2.2 . . . . 16.55 111.881 178.886 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.96 129.12 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 18.07 110.538 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.538 -0.744 . . . . 20.26 110.402 177.809 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 111.887 -0.485 . . . . 20.59 111.887 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.45 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.478 0.18 . . . . 19.12 111.324 -177.763 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.74 37.43 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 18.25 110.818 -178.048 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.72 131.55 46.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.955 -0.566 . . . . 16.83 110.954 178.371 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.66 -28.61 15.1 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.974 -0.85 . . . . 14.9 110.974 -175.213 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -98.82 -61.01 1.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.381 -0.6 . . . . 16.26 109.381 175.635 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 52.66 58.78 5.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.397 -0.819 . . . . 13.59 110.181 -179.301 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -75.71 119.19 19.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.615 -0.72 . . . . 12.17 110.696 -178.023 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.35 107.38 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 9.12 110.702 179.915 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.34 141.9 29.35 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.591 . . . . 6.25 110.453 -179.591 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.95 -1.23 6.59 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.903 2.402 . . . . 5.93 112.582 -178.912 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.94 -31.6 81.46 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.792 -0.523 . . . . 2.77 111.792 176.532 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.19 73.11 10.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.068 0.461 . . . . 2.44 109.957 175.785 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -169.47 128.35 0.98 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.538 -0.755 . . . . 3.7 109.532 -177.95 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.414 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 42.8 t -73.65 103.9 4.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.581 -0.526 . . . . 0.57 109.581 -179.289 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.64 -21.37 77.11 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.87 113.485 -171.974 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 89.9 t -60.55 -38.09 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.887 0.375 . . . . 1.54 111.052 -179.101 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.3 p -109.24 -48.12 3.31 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.947 -0.301 . . . . 1.63 110.491 179.771 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.03 -16.54 5.25 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.914 -0.66 . . . . 0.77 112.536 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 33.7 m-20 -86.88 140.09 29.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.091 0.472 . . . . 2.1 111.799 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.15 -3.62 33.56 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.737 -0.665 . . . . 0.66 111.47 173.864 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m -80.88 136.46 36.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.329 . . . . 1.52 111.052 177.899 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 64.65 44.79 3.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.793 0.806 . . . . 2.23 110.771 174.248 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.7 m -93.4 155.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.381 -0.827 . . . . 1.76 111.751 -178.036 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.4 mt -97.17 145.51 25.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.355 -0.839 . . . . 1.18 108.963 172.796 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 24.7 tpt180 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.192 -0.458 . . . . 3.64 110.361 -174.278 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.33 136.85 57.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.673 -0.491 . . . . 0.37 109.673 177.676 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.58 -26.91 22.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 1.34 111.049 -179.633 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -90.02 -20.32 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.582 . . . . 1.81 111.502 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.12 -166.07 2.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.338 -0.616 . . . . 0.92 109.338 176.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.5 114.28 28.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.198 -0.297 . . . . 1.17 110.198 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -164.38 130.5 2.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.289 -0.414 . . . . 1.13 110.187 -179.786 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.5 112.76 24.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.09 -0.505 . . . . 1.18 109.845 176.943 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -152.11 163.79 38.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.229 -0.441 . . . . 0.68 110.565 -173.359 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -97.43 137.92 35.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.241 -0.652 . . . . 0.58 109.241 173.283 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 71.4 t-105 -60.91 -42.68 98.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.438 0.461 . . . . 0.77 110.122 178.617 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -62.52 -34.74 77.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.907 0.384 . . . . 3.8 111.293 -179.712 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 93.5 m -73.83 -22.44 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 0.54 111.143 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -98.05 -40.86 8.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.407 . . . . 0.72 111.798 -177.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.6 140.85 31.33 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.296 -0.411 . . . . 0.94 109.971 -176.535 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.85 177.09 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.597 2.198 . . . . 2.64 112.193 178.326 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.571 -0.286 . . . . 3.71 111.682 -178.154 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.66 -35.58 89.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.019 -0.61 . . . . 1.86 112.145 176.073 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.6 m -86.03 131.25 34.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.867 -0.419 . . . . 1.52 109.867 178.918 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.6 m -88.86 150.73 22.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 2.07 111.028 -176.576 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -99.18 130.61 26.87 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.845 -0.616 . . . . 3.22 110.79 -174.012 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.13 140.41 37.54 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.325 2.016 . . . . 1.22 111.72 175.856 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.87 -20.29 63.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.911 -0.662 . . . . 1.9 112.023 -179.051 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -142.67 137.81 30.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.799 -0.445 . . . . 3.21 109.799 177.795 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.18 53.71 3.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.735 -0.745 . . . . 1.31 112.082 -179.555 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 123.32 17.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.817 -0.438 . . . . 1.51 109.817 179.065 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -112.13 141.55 45.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.39 -0.368 . . . . 3.09 110.934 -178.494 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 p -78.3 -179.58 6.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.003 -0.74 . . . . 0.55 109.003 171.872 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -60.87 -44.23 97.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 4.7 110.735 -175.764 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -63.28 -48.62 77.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.067 -0.515 . . . . 1.89 111.408 -178.355 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -71.68 -17.1 62.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.779 0.323 . . . . 0.72 111.372 -179.363 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 1.79 110.309 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.61 -171.37 12.63 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.729 -0.748 . . . . 2.19 112.189 -179.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -147.29 142.09 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.022 -0.362 . . . . 5.15 110.022 178.414 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.64 87.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.175 -0.466 . . . . 7.2 109.79 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -79.45 121.65 83.0 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.158 -0.474 . . . . 8.83 110.754 -179.533 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.4 133.65 19.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.421 2.081 . . . . 11.41 112.244 -177.829 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.35 129.96 23.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 13.86 110.266 179.796 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.6 91.45 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.569 2.179 . . . . 16.55 111.616 174.907 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.24 78.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.294 0.568 . . . . 18.07 109.481 179.458 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.276 -0.869 . . . . 20.26 109.634 -179.313 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.784 -0.526 . . . . 20.59 111.784 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.0 -28.03 61.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.693 0.282 . . . . 19.12 111.095 -179.084 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.6 tpp -79.57 80.77 5.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 18.25 109.763 178.256 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -138.14 139.62 39.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.813 -0.631 . . . . 16.83 109.83 -179.302 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.48 106.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.636 -0.792 . . . . 14.9 112.233 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . 0.412 ' HG2' ' HG3' ' C' ' 7' ' ' GLN . 5.6 pm0 -70.26 -17.44 63.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 16.26 110.804 -179.801 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . 0.412 ' HG3' ' HG2' ' C' ' 6' ' ' GLN . 45.7 mt-30 -117.09 22.48 12.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.207 0.527 . . . . 13.59 110.28 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.02 -41.61 97.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.042 -0.725 . . . . 12.17 109.042 175.338 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -111.04 80.48 1.31 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.427 -0.806 . . . . 9.12 109.162 172.206 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -64.64 134.86 96.15 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 6.25 110.727 -178.091 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 13.5 Cg_exo -70.51 54.57 1.48 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.148 2.565 . . . . 5.93 113.207 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.24 -25.28 75.83 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.178 -0.769 . . . . 2.77 111.178 174.515 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.08 116.79 32.2 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 2.44 109.631 173.481 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -150.57 143.52 24.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.2 -0.667 . . . . 3.7 109.2 -176.867 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.446 ' SG ' ' HB ' ' C' ' 17' ' ' VAL . 43.9 t -64.39 105.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.57 110.349 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.85 -12.14 67.34 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 121.296 -0.478 . . . . 0.87 112.347 -179.856 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.446 ' HB ' ' SG ' ' C' ' 15' ' ' CYS . 61.0 t -76.77 -28.71 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 1.54 110.213 176.59 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.1 m -110.38 -36.17 5.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.004 -0.544 . . . . 1.63 112.036 -177.976 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.65 7.89 74.5 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.045 -0.822 . . . . 0.77 111.045 -173.651 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -126.51 154.58 43.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.547 -0.326 . . . . 2.1 111.022 -176.871 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.91 16.36 12.18 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.402 -0.679 . . . . 0.66 111.402 175.332 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -80.05 125.57 29.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.667 -0.266 . . . . 1.52 111.166 -179.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.18 45.83 26.58 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 122.207 1.003 . . . . 2.23 110.028 -178.579 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.7 p -96.04 151.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.078 -0.964 . . . . 1.76 109.399 -177.159 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.34 146.75 23.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.107 0.479 . . . . 1.18 110.749 -178.108 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.6 mmm180 -107.31 149.79 27.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.64 109.876 -178.865 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.406 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -84.31 139.11 32.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 176.8 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.6 p -87.4 -13.12 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.504 0.557 . . . . 1.34 112.504 -174.857 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -111.92 -20.8 11.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.823 0.344 . . . . 1.81 110.396 -179.478 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.406 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 2.0 p -140.32 -177.12 4.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.532 -0.544 . . . . 0.92 109.532 176.379 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.32 28.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.345 -0.389 . . . . 1.17 110.224 -177.974 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.56 146.61 13.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 1.13 110.742 -176.645 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.59 111.84 15.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 1.18 109.617 176.143 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -157.8 144.03 17.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.68 109.67 -178.777 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.897 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 57.7 m80 -75.18 140.38 43.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.207 -1.035 . . . . 0.58 108.207 171.021 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -54.41 -50.76 66.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.783 0.265 . . . . 0.77 110.804 -175.922 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.6 mtp180 -64.02 -15.28 59.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 3.8 112.344 -176.295 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.897 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.3 m -83.92 -20.99 32.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.027 0.441 . . . . 0.54 110.697 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -108.59 -25.88 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.72 111.106 176.325 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 61.9 m-85 -132.86 139.03 33.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.364 . . . . 0.94 110.277 -178.565 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 148.25 90.63 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.605 2.203 . . . . 2.64 111.475 175.451 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.26 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.308 -0.86 . . . . 3.71 112.718 -172.525 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 -23.12 77.9 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.68 -0.771 . . . . 1.86 111.988 177.707 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -81.11 143.29 32.53 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.0 -0.37 . . . . 1.52 110.0 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -88.8 131.62 34.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 2.07 111.057 -174.818 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -75.9 128.81 82.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.874 -0.603 . . . . 3.22 109.932 175.976 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.21 132.23 35.49 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.383 2.055 . . . . 1.22 112.249 -178.668 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -22.07 31.14 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.144 -0.782 . . . . 1.9 111.144 176.451 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -89.84 52.4 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.176 0.512 . . . . 3.21 110.577 177.972 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 108.77 3.14 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.673 -0.775 . . . . 1.31 112.225 -178.501 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.59 123.2 19.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 1.51 109.247 177.179 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -122.76 135.14 54.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.342 -0.39 . . . . 3.09 110.732 -175.63 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.81 158.69 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.173 -0.676 . . . . 0.55 109.173 175.736 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -56.21 -31.16 63.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.737 0.699 . . . . 4.7 111.714 -170.415 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -65.91 -46.43 78.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.568 0.223 . . . . 1.89 110.741 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.6 m -72.08 -23.87 61.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.726 0.298 . . . . 0.72 111.219 -179.978 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -78.39 0.53 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.398 -0.365 . . . . 1.79 111.045 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.88 -126.59 9.76 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.725 -0.55 . . . . 2.19 111.725 179.574 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.94 135.72 33.47 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.66 -0.496 . . . . 5.15 109.66 175.675 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 52.8 t -93.11 131.26 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.171 -0.468 . . . . 7.2 110.288 -179.652 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 39.9 p -90.22 117.79 68.32 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.432 -0.349 . . . . 8.83 110.123 178.217 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 134.87 64.0 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.804 2.336 . . . . 11.41 112.271 179.594 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.21 130.68 85.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.072 -0.513 . . . . 13.86 110.557 179.678 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.01 88.24 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.546 2.164 . . . . 16.55 112.548 -179.564 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -98.66 12.07 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 18.07 111.001 178.229 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.649 -0.691 . . . . 20.26 109.668 179.863 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.931 -0.468 . . . . 20.59 111.931 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.75 54.28 10.8 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.831 0.452 . . . . 19.12 111.822 177.652 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ptp -119.94 157.58 28.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.175 -0.466 . . . . 18.25 110.197 179.06 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -159.35 -39.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.037 0.446 . . . . 16.83 110.31 -177.633 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.18 178.43 38.39 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.973 -0.632 . . . . 14.9 111.568 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 57.94 46.28 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.402 0.62 . . . . 16.26 110.71 -179.987 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.33 19.82 11.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.537 -0.756 . . . . 13.59 110.271 -177.882 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -61.03 -52.78 63.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.58 -0.736 . . . . 12.17 110.336 -178.185 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 tp -70.58 104.72 2.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.119 -0.491 . . . . 9.12 110.023 176.891 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.81 123.02 87.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.397 -0.365 . . . . 6.25 110.434 179.514 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.77 105.44 0.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.605 2.204 . . . . 5.93 111.748 177.536 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.72 -58.73 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.677 -0.773 . . . . 2.77 112.024 -179.689 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.15 158.19 38.59 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.242 -0.281 . . . . 2.44 110.242 179.695 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.68 167.0 31.81 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.294 -0.632 . . . . 3.7 109.294 -179.755 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.85 105.7 1.67 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.003 -0.369 . . . . 0.57 110.003 179.458 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.66 -30.05 75.61 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.347 -0.454 . . . . 0.87 112.597 -176.957 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 -30.6 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 1.54 110.779 -179.37 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -101.26 -36.73 8.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.173 -0.467 . . . . 1.63 111.764 -178.302 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.59 -1.66 66.51 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.258 -0.737 . . . . 0.77 111.258 -174.746 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -120.91 145.29 47.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 2.1 110.875 -177.039 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.23 14.7 56.84 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.711 -0.677 . . . . 0.66 111.481 172.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.3 m -63.95 119.63 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.397 0.279 . . . . 1.52 110.532 178.014 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 52.88 50.82 17.18 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.709 0.631 . . . . 2.23 110.753 -178.878 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 p -89.59 146.05 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 1.76 110.39 -176.076 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.89 144.2 25.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 1.18 110.232 179.194 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -106.77 146.54 30.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 3.64 109.767 -178.386 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.3 t -80.49 138.72 36.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.985 -0.746 . . . . 0.37 108.985 176.256 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -92.91 -13.54 28.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 1.34 111.873 -177.299 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.93 -18.56 14.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.435 -0.348 . . . . 1.81 111.198 178.795 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -149.72 -167.71 2.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.451 -0.574 . . . . 0.92 109.451 177.059 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 114.7 29.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.719 0.295 . . . . 1.17 110.402 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.37 153.79 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.309 -0.405 . . . . 1.13 110.858 -179.518 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -134.72 113.45 11.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.852 -0.613 . . . . 1.18 109.67 176.095 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.38 163.26 40.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.899 -0.591 . . . . 0.68 109.752 -178.438 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.705 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.8 m170 -94.01 139.21 31.22 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.787 -0.82 . . . . 0.58 108.787 172.208 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 60.5 t-105 -49.29 -53.24 22.84 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.412 0.445 . . . . 0.77 111.643 -176.559 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -71.07 -9.1 57.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 3.8 112.19 -174.462 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 63.3 m -91.55 -21.34 20.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.984 0.421 . . . . 0.54 110.76 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -107.63 -40.84 5.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.183 -0.462 . . . . 0.72 110.958 177.865 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.81 148.56 40.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.992 -0.549 . . . . 0.94 110.631 -175.428 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 154.17 73.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.852 2.368 . . . . 2.64 112.144 177.84 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.04 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.197 -0.911 . . . . 3.71 111.95 -175.114 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -7.22 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 1.86 111.906 176.145 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -101.29 129.81 47.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.014 -0.365 . . . . 1.52 110.014 177.709 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -87.73 130.77 34.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.796 -0.446 . . . . 2.07 109.796 -179.34 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . 0.401 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 16.3 ptm180 -71.56 118.6 67.78 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 3.22 111.11 -175.71 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.57 132.92 22.97 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.682 2.255 . . . . 1.22 112.549 -177.884 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.86 51.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.905 -0.664 . . . . 1.9 111.785 178.469 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 60.73 0.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 3.21 110.934 -176.983 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.6 82.53 0.77 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.401 -0.904 . . . . 1.31 112.458 179.356 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.25 128.28 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.074 -0.713 . . . . 1.51 109.074 177.056 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -124.41 145.87 49.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.162 0.506 . . . . 3.09 111.877 -174.774 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -83.58 -178.8 7.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 0.55 108.909 171.914 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' C' ' 55' ' ' SER . 11.5 ptp180 -63.13 -41.2 99.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.289 0.495 . . . . 4.7 111.476 -173.925 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 55' ' ' SER . . . . . 0.424 ' HA ' ' HB3' ' C' ' 59' ' ' ASP . 19.6 t -68.74 -40.68 79.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.787 0.327 . . . . 1.89 111.234 -175.153 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.43 -15.74 61.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.72 111.31 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -96.4 -13.61 23.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.078 0.466 . . . . 1.79 110.619 177.134 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.62 88.91 1.78 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.564 -0.614 . . . . 2.19 111.564 -175.974 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.424 ' HB3' ' HA ' ' C' ' 55' ' ' SER . 5.6 p-10 -88.96 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.19 0.519 . . . . 5.15 110.744 -177.883 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.86 78.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.088 -0.708 . . . . 7.2 109.088 175.934 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -59.98 117.44 23.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.335 -0.848 . . . . 8.83 110.895 -177.371 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 136.33 38.0 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.509 2.139 . . . . 11.41 111.985 -178.827 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.71 131.04 68.81 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 13.86 110.153 177.789 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.83 106.57 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.717 2.278 . . . . 16.55 111.889 178.136 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.89 151.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.146 -0.479 . . . . 18.07 110.055 -178.859 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.398 -0.81 . . . . 20.26 109.531 178.844 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.841 -0.504 . . . . 20.59 111.841 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.74 48.92 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.479 . . . . 19.12 111.315 178.555 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 51.3 ttp -89.61 64.12 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.504 0.668 . . . . 18.25 109.972 179.545 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -88.86 138.1 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 16.83 110.893 -177.462 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.71 -66.24 0.24 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.961 -0.638 . . . . 14.9 112.743 177.195 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 57.93 38.61 26.99 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.096 0.474 . . . . 16.26 110.873 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -81.25 -1.26 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 13.59 111.101 -177.618 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -102.54 3.07 37.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.316 0.579 . . . . 12.17 109.857 175.178 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.1 tp -90.08 133.75 34.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.726 -0.67 . . . . 9.12 110.119 -179.644 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -80.4 144.52 57.66 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 6.25 110.348 179.577 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 11.3 Cg_exo -71.48 53.32 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.03 2.487 . . . . 5.93 112.429 177.648 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.11 -86.05 1.29 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.74 -0.544 . . . . 2.77 111.74 -177.843 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.21 108.13 3.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.717 0.294 . . . . 2.44 110.217 179.136 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -162.12 142.68 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 3.7 110.202 -176.409 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.3 t -65.92 118.96 10.48 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.086 -0.339 . . . . 0.57 110.086 177.975 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.33 -17.07 77.35 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.884 -0.674 . . . . 0.87 112.265 -179.548 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -82.74 -31.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.568 0.223 . . . . 1.54 111.117 179.734 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 71.1 m -106.52 -29.13 9.85 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.571 0.582 . . . . 1.63 112.571 -177.175 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.06 81.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.894 -0.882 . . . . 0.77 110.894 -172.48 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.49 154.0 48.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.181 -0.51 . . . . 2.1 110.141 -172.877 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.09 23.97 6.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.02 -0.609 . . . . 0.66 112.63 179.209 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -81.5 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.209 -0.293 . . . . 1.52 110.209 178.474 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.23 37.47 28.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.365 0.602 . . . . 2.23 109.959 -177.5 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.8 p -90.21 158.0 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 1.76 110.565 -174.428 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 79.7 mt -95.63 146.38 24.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.74 0.305 . . . . 1.18 110.348 176.577 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -109.89 131.51 55.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 3.64 110.015 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.97 132.37 47.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.111 -0.7 . . . . 0.37 109.111 176.386 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.02 -17.52 32.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.256 0.551 . . . . 1.34 111.121 -178.926 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -97.77 -20.12 17.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.541 . . . . 1.81 111.339 -177.346 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -151.48 -164.72 2.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.104 -0.702 . . . . 0.92 109.104 176.096 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.2 114.15 28.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.203 -0.295 . . . . 1.17 110.203 178.54 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.22 131.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 1.13 110.868 -179.143 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.87 113.44 25.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.73 -0.668 . . . . 1.18 109.739 177.121 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.512 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 25.3 p90 -151.99 146.53 25.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.254 -0.43 . . . . 0.68 109.986 -179.832 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.883 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 53.7 m80 -79.55 135.2 36.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.419 -0.956 . . . . 0.58 108.419 171.338 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.43 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 73.9 t-105 -51.28 -52.04 48.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.671 0.272 . . . . 0.77 111.482 -174.042 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -68.17 -16.78 64.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 3.8 112.124 -173.456 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.883 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.93 -22.85 48.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.186 0.517 . . . . 0.54 110.52 178.804 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -104.54 -50.29 3.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.972 -0.558 . . . . 0.72 110.67 179.131 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -108.16 122.04 41.84 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.511 -0.768 . . . . 0.94 109.702 -177.089 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.21 162.73 5.31 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.972 2.448 . . . . 2.64 112.38 -179.338 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -18.27 41.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.865 -1.062 . . . . 3.71 112.669 -170.75 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.66 4.73 77.64 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.987 -0.625 . . . . 1.86 112.603 178.503 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 91.1 m -112.59 133.32 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.749 0.309 . . . . 1.52 110.512 177.725 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -88.8 144.4 26.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 2.07 110.597 -175.971 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 45.9 ttp180 -87.2 122.23 71.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 3.22 110.84 -179.551 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.3 Cg_exo -69.0 132.26 24.15 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.503 2.135 . . . . 1.22 111.736 176.957 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.88 -14.73 48.33 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.971 -0.633 . . . . 1.9 112.18 -179.741 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.9 t -88.83 -10.7 47.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 3.21 111.206 -178.218 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 122.79 0.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.847 -0.692 . . . . 1.31 111.654 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.41 123.23 33.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.005 0.431 . . . . 1.51 110.155 -177.602 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -116.65 128.94 55.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.458 . . . . 3.09 110.736 -178.85 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.495 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -75.3 -169.74 1.04 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.612 . . . . 0.55 110.072 175.313 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.69 -52.83 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.373 -0.376 . . . . 4.7 111.403 -176.663 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -68.72 -42.78 77.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.539 -0.301 . . . . 1.89 111.808 -175.49 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.7 m -71.93 -17.36 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.72 111.88 -176.627 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -88.15 8.31 27.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.094 0.473 . . . . 1.79 110.532 -179.117 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.22 174.47 29.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.685 -0.769 . . . . 2.19 112.159 179.532 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.43 92.86 3.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.644 -0.502 . . . . 5.15 109.644 176.794 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -89.36 102.59 13.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.869 -0.605 . . . . 7.2 110.774 -176.528 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 87.4 m -67.98 130.17 92.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 8.83 110.392 177.014 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.34 135.21 52.64 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.636 2.224 . . . . 11.41 112.145 179.123 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.8 120.88 83.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.894 -0.594 . . . . 13.86 111.046 -178.883 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.49 131.49 15.0 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.305 2.004 . . . . 16.55 111.354 176.572 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.9 -9.24 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.955 0.407 . . . . 18.07 111.168 -179.4 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.704 -0.665 . . . . 20.26 110.324 177.93 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.015 -0.434 . . . . 20.59 112.015 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.17 111.82 17.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.756 0.312 . . . . 19.12 110.292 178.675 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.3 ttp -83.53 121.61 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 18.25 110.577 -178.864 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -125.34 150.33 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.837 -0.619 . . . . 16.83 109.746 179.83 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.41 -59.99 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.212 -0.755 . . . . 14.9 111.212 -177.662 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -69.24 -30.89 69.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.518 . . . . 16.26 109.662 174.485 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -110.26 148.5 31.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.499 -0.773 . . . . 13.59 109.375 175.827 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -128.84 117.91 21.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.828 0.347 . . . . 12.17 110.393 -179.742 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.13 113.58 22.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.19 -0.459 . . . . 9.12 110.245 -179.696 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.3 145.42 93.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.107 -0.497 . . . . 6.25 110.568 178.516 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 23.6 Cg_exo -63.66 -11.48 26.59 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.977 2.452 . . . . 5.93 113.325 -177.454 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.37 77.72 1.11 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.967 -0.635 . . . . 2.77 112.854 176.774 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -105.21 74.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.877 0.37 . . . . 2.44 110.269 177.575 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -160.64 129.62 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.509 . . . . 3.7 110.81 -177.929 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.3 110.59 6.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.24 -0.652 . . . . 0.57 109.24 174.509 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.19 -24.71 65.6 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 121.304 -0.474 . . . . 0.87 112.841 -176.449 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.99 -30.75 33.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 1.54 110.781 179.168 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 95.3 m -104.63 -46.48 4.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 1.63 112.299 -175.039 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.92 -8.34 45.86 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.436 -0.666 . . . . 0.77 111.436 -174.041 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.51 154.14 22.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 2.1 110.722 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 11.15 30.38 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.112 -0.795 . . . . 0.66 111.112 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.28 134.97 53.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.35 . . . . 1.52 110.343 177.75 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 41.65 48.57 3.61 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.137 0.898 . . . . 2.23 111.757 -178.732 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . 0.405 HG23 ' N ' ' C' ' 34' ' ' PHE . 2.0 p -89.06 146.67 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.165 -0.925 . . . . 1.76 110.421 -176.319 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 84.3 mt -96.99 157.64 15.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.474 -0.33 . . . . 1.18 110.205 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 9.3 mmm180 -120.71 141.45 50.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.921 -0.581 . . . . 3.64 111.064 -174.225 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.81 139.77 47.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.823 -0.806 . . . . 0.37 108.823 173.203 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p -92.4 -21.23 20.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 1.34 111.217 179.43 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -89.54 -23.12 22.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 1.81 110.623 -178.448 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.91 -164.91 2.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.207 -0.664 . . . . 0.92 109.207 177.113 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 115.07 29.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.77 0.319 . . . . 1.17 110.48 179.449 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.14 139.1 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.96 -0.563 . . . . 1.13 110.331 178.866 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -121.24 118.93 30.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.001 -0.545 . . . . 1.18 110.171 178.765 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . 0.405 ' N ' HG23 ' C' ' 24' ' ' VAL . 52.3 p90 -160.22 162.72 33.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.68 109.901 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.66 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.7 m170 -91.34 133.35 35.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.099 -1.074 . . . . 0.58 108.099 171.616 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -59.3 -36.96 76.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.77 110.915 -177.215 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -68.82 -19.88 64.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 3.8 110.883 -179.697 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -90.57 -23.14 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.279 -0.419 . . . . 0.54 111.071 -178.123 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -92.46 -38.59 11.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.394 -0.366 . . . . 0.72 110.643 176.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.403 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 94.3 m-85 -126.66 73.47 74.76 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.488 . . . . 0.94 110.815 -178.753 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 0.06 10.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.018 2.479 . . . . 2.64 112.057 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.7 3.41 29.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 3.71 111.24 -177.828 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.43 24.8 30.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.625 -0.797 . . . . 1.86 112.35 179.747 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 44' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 7.2 m -66.18 141.93 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.869 -0.419 . . . . 1.52 109.869 176.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.8 t -88.13 133.04 34.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.004 0.431 . . . . 2.07 110.228 -175.437 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -70.72 119.0 70.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.551 -0.749 . . . . 3.22 110.548 -179.65 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.67 132.45 20.32 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.591 2.194 . . . . 1.22 112.316 -179.42 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.18 -8.62 74.81 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 1.9 111.566 177.355 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.9 p -91.96 28.52 1.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.945 0.403 . . . . 3.21 111.541 -179.963 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.72 121.76 3.06 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.941 -0.647 . . . . 1.31 112.296 179.857 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 128.33 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.668 -0.493 . . . . 1.51 109.668 -178.821 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -113.15 138.69 49.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.408 . . . . 3.09 111.395 -176.845 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 p -88.89 -176.45 5.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 0.55 109.213 173.779 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -67.29 -39.52 85.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.41 -0.516 . . . . 4.7 111.332 -175.87 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 42.3 t -67.17 -45.4 77.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.598 0.237 . . . . 1.89 110.729 -178.381 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.7 m -71.9 -17.26 62.11 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.661 0.245 . . . . 0.72 111.661 -179.512 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -96.28 -14.19 22.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.93 0.395 . . . . 1.79 110.985 178.699 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.53 85.71 0.5 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 2.19 111.899 -177.944 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.58 146.09 24.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.947 0.403 . . . . 5.15 110.316 -178.874 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.04 131.39 50.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.094 -0.503 . . . . 7.2 110.134 179.737 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 p -80.25 123.52 83.15 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.559 -0.291 . . . . 8.83 110.392 176.223 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.25 133.94 37.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.398 2.065 . . . . 11.41 111.676 -178.097 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.25 135.56 47.33 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 13.86 110.173 -179.673 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.56 42.88 1.38 Allowed 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.674 2.249 . . . . 16.55 112.308 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.84 108.88 19.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.117 -0.492 . . . . 18.07 110.629 -177.077 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.612 -0.709 . . . . 20.26 110.077 -179.855 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.851 -0.499 . . . . 20.59 111.851 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.48 -24.29 25.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 19.12 110.825 179.748 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 123.48 23.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 18.25 110.54 -179.072 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -103.92 -52.38 2.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.752 -0.658 . . . . 16.83 110.0 -179.801 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.87 76.63 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.612 -0.722 . . . . 14.9 111.786 -179.164 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -71.0 -27.13 63.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.015 0.436 . . . . 16.26 109.929 -179.809 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -82.45 13.67 3.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.592 . . . . 13.59 111.277 178.517 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -93.91 14.81 18.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 12.17 110.24 176.72 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.49 101.63 0.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.787 . . . . 9.12 109.44 179.352 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.53 128.21 91.33 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.967 -0.56 . . . . 6.25 110.864 -178.01 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 13.7 Cg_exo -71.18 52.51 1.48 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.134 2.556 . . . . 5.93 112.916 176.565 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.21 -29.83 65.95 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.331 -0.708 . . . . 2.77 111.331 177.008 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.24 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 2.44 109.353 174.898 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -166.34 112.81 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.954 -0.566 . . . . 3.7 111.198 -176.513 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -68.22 122.91 19.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.646 -0.502 . . . . 0.57 109.646 174.872 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -24.85 64.77 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.87 113.401 -175.023 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.04 -32.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 1.54 111.177 -179.502 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.3 -40.36 7.96 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.315 0.487 . . . . 1.63 112.315 -174.439 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.63 -17.62 58.96 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.191 -0.764 . . . . 0.77 111.191 -173.076 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.5 148.8 21.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.365 . . . . 2.1 110.616 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.27 15.05 39.58 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.043 -0.599 . . . . 0.66 111.623 176.261 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.8 m -74.76 124.38 26.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.253 . . . . 1.52 110.401 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.77 42.9 28.63 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.915 -0.584 . . . . 2.23 110.823 -177.348 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.06 136.27 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.535 . . . . 1.76 110.301 -175.538 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -94.44 157.1 16.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.0 -0.546 . . . . 1.18 109.913 -178.292 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 28.6 mmm180 -121.68 149.6 42.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.901 -0.591 . . . . 3.64 110.189 -177.197 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -81.56 143.64 31.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.805 -0.443 . . . . 0.37 109.805 -179.818 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.99 -21.91 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.273 -0.421 . . . . 1.34 111.576 -179.003 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -100.94 -17.61 16.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.541 -0.299 . . . . 1.81 111.358 -177.219 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 p -151.13 -169.94 3.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.92 109.51 177.512 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.87 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.489 -0.323 . . . . 1.17 110.359 178.841 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.19 132.39 8.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.535 -0.302 . . . . 1.13 110.77 -178.66 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.93 112.85 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.515 . . . . 1.18 109.852 176.263 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -158.78 164.74 35.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.298 -0.41 . . . . 0.68 110.187 -177.63 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.65 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 28.6 m170 -98.81 138.83 35.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.439 -0.948 . . . . 0.58 108.439 171.639 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -54.99 -46.3 75.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.644 0.259 . . . . 0.77 110.54 -178.182 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 73.4 mtp180 -65.96 -18.3 65.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 3.8 112.101 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.65 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.7 m -85.35 -20.34 30.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.044 0.449 . . . . 0.54 110.809 -179.19 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . 0.406 ' HD1' ' HB2' ' C' ' 54' ' ' ARG . 5.5 m-70 -99.93 -39.27 8.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.72 110.777 174.974 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 94.9 m-85 -127.04 144.97 52.29 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.94 109.903 -179.432 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.51 154.8 34.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.593 2.196 . . . . 2.64 111.856 177.594 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -10.97 28.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 3.71 112.06 -174.68 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.54 -2.07 76.82 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.839 -0.696 . . . . 1.86 112.144 176.761 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.9 m -90.31 139.82 30.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.023 -0.362 . . . . 1.52 110.023 178.601 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.8 p -88.39 132.81 34.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.433 -0.349 . . . . 2.07 110.873 -175.631 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -88.42 134.31 34.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 3.22 110.911 -177.915 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.63 132.59 38.47 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.653 2.235 . . . . 1.22 111.328 173.745 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.08 -51.2 5.46 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.869 -0.605 . . . . 1.9 113.404 -174.023 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -95.73 -18.25 20.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 3.21 111.214 -175.451 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -131.78 67.89 0.56 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.537 -0.84 . . . . 1.31 112.521 -178.428 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.77 122.63 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.25 -0.648 . . . . 1.51 109.25 176.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 53.2 mtm180 -121.38 140.23 52.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.972 0.415 . . . . 3.09 111.122 -173.125 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.4 p -80.39 -174.72 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.55 109.784 175.703 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . 0.406 ' HB2' ' HD1' ' C' ' 39' ' ' HIS . 40.0 ttm180 -61.71 -49.56 75.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.614 0.245 . . . . 4.7 111.19 -176.036 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.6 t -64.24 -43.92 93.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.432 -0.349 . . . . 1.89 111.28 -176.151 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.5 m -71.62 -19.7 62.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.157 -0.217 . . . . 0.72 111.557 -178.064 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.0 m -83.41 -13.93 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.886 0.374 . . . . 1.79 110.732 178.811 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.8 170.6 13.37 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.241 -0.744 . . . . 2.19 111.241 178.122 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.54 114.97 29.55 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.446 0.641 . . . . 5.15 110.497 179.399 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . 0.492 ' O ' ' HD3' ' C' ' 62' ' ' PRO . 25.1 t -90.4 75.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.854 -0.795 . . . . 7.2 108.854 176.583 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.5 p -99.52 105.57 34.36 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.525 -0.761 . . . . 8.83 111.669 -175.09 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' C' ' 60' ' ' VAL . 13.1 Cg_exo -70.25 135.75 30.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.58 2.187 . . . . 11.41 111.453 176.319 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.23 120.69 60.63 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 13.86 110.346 179.4 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -62.49 92.82 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.026 2.484 . . . . 16.55 112.803 -178.223 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -105.29 156.74 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 18.07 110.585 178.622 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.701 -0.666 . . . . 20.26 109.329 177.755 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.764 -0.534 . . . . 20.59 111.764 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.5 44.3 18.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.232 0.539 . . . . 19.12 110.808 -179.207 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.59 -30.69 41.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.805 -0.634 . . . . 18.25 110.917 -177.087 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 47.46 66.87 0.91 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.164 0.506 . . . . 16.83 111.168 -179.282 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.84 65.08 4.18 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.782 -0.645 . . . . 14.9 111.7 179.61 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.31 52.56 1.01 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.618 . . . . 16.26 109.973 -179.594 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -80.37 92.83 5.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.977 -0.556 . . . . 13.59 109.541 177.619 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 57.43 43.45 23.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.641 0.734 . . . . 12.17 110.14 -176.316 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 tp -102.21 134.0 46.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 9.12 110.59 -176.044 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.73 146.07 34.74 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.132 -0.486 . . . . 6.25 109.888 176.561 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.74 46.04 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.014 2.476 . . . . 5.93 112.476 178.295 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.78 169.68 36.32 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.305 -0.718 . . . . 2.77 111.305 -177.445 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.82 80.93 7.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.423 . . . . 2.44 111.144 -177.625 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.9 mtm-85 -124.39 141.55 51.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.219 0.533 . . . . 3.7 111.095 178.875 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 t -87.7 104.88 16.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.831 . . . . 0.57 109.698 178.873 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -16.8 69.31 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.859 -0.609 . . . . 0.87 113.846 -172.733 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.58 -29.91 48.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.54 110.86 -179.258 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.94 -42.56 2.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.347 -0.388 . . . . 1.63 110.388 178.137 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.88 -11.44 10.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.057 -0.592 . . . . 0.77 111.812 -178.508 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.96 141.94 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.116 0.484 . . . . 2.1 111.405 -177.634 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.98 16.86 27.64 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.577 -0.738 . . . . 0.66 111.273 175.826 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.9 m -76.09 115.56 15.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.461 -0.37 . . . . 1.52 110.323 179.344 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 45.77 70.99 0.31 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.921 0.763 . . . . 2.23 112.062 178.776 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.4 146.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 1.76 110.413 178.665 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.37 148.53 22.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.973 -0.558 . . . . 1.18 109.836 -179.436 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -108.58 145.51 34.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.059 -0.519 . . . . 3.64 110.054 -179.649 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.428 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 8.0 t -75.52 135.4 40.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.004 -0.739 . . . . 0.37 109.004 177.026 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 37.1 p -86.24 -7.26 58.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.939 0.4 . . . . 1.34 111.344 -179.522 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -110.75 -19.64 12.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.416 -0.356 . . . . 1.81 111.157 -179.16 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.428 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.8 p -151.56 -172.13 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.714 -0.476 . . . . 0.92 109.714 177.289 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.68 30.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.856 -0.156 . . . . 1.17 111.397 -176.153 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.74 141.87 4.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.811 -0.177 . . . . 1.13 111.127 179.241 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.25 118.11 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.791 -0.448 . . . . 1.18 109.791 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -161.87 163.36 29.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.68 111.19 -175.222 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -96.6 140.59 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.365 -0.606 . . . . 0.58 109.365 172.103 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -62.14 -42.31 99.12 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.537 -0.542 . . . . 0.77 109.537 174.678 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -63.43 -22.75 67.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.917 -0.583 . . . . 3.8 111.819 -179.442 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 63.7 m -87.17 -21.82 25.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.54 111.303 -179.055 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.42 -38.81 8.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.874 0.369 . . . . 0.72 110.813 179.924 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.95 149.88 74.09 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.5 -0.556 . . . . 0.94 109.5 -179.001 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.68 140.25 61.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.252 1.968 . . . . 2.64 111.502 178.05 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.96 -8.83 17.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 3.71 111.944 -175.611 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.81 71.81 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.778 -0.929 . . . . 1.86 110.778 172.455 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -87.45 131.57 34.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.266 -0.642 . . . . 1.52 109.266 174.603 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -87.73 115.37 25.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.141 0.496 . . . . 2.07 110.642 -176.083 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -57.96 136.3 83.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 3.22 111.179 -178.599 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.74 135.24 32.4 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.951 2.434 . . . . 1.22 112.89 -175.991 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.92 -10.66 71.75 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.042 -0.599 . . . . 1.9 111.75 179.05 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -89.31 12.08 17.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 3.21 111.057 -179.739 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.03 116.35 1.56 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.763 -0.732 . . . . 1.31 112.504 178.405 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.28 125.99 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.374 -0.602 . . . . 1.51 109.374 179.239 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -115.17 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 3.09 111.062 -175.507 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 p -73.31 174.77 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.695 -0.854 . . . . 0.55 108.695 172.056 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -58.29 -41.55 84.66 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.432 0.53 . . . . 4.7 112.432 -169.245 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -69.41 -47.84 62.9 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.22 -0.3 . . . . 1.89 111.339 -178.385 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.36 -18.74 61.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.688 0.28 . . . . 0.72 111.211 -178.781 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -84.59 -13.88 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.35 . . . . 1.79 110.429 -179.54 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.94 119.67 4.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.683 -0.77 . . . . 2.19 112.04 -179.721 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -89.62 179.19 6.09 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.279 -0.637 . . . . 5.15 109.279 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -110.99 102.68 14.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.436 0.636 . . . . 7.2 111.033 -178.985 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -93.06 120.56 66.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.684 -0.689 . . . . 8.83 110.163 178.448 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.56 142.64 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.456 2.104 . . . . 11.41 111.895 -178.938 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.67 69.39 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.155 -0.475 . . . . 13.86 110.099 179.034 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.61 57.79 3.72 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.878 2.385 . . . . 16.55 112.459 -179.404 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.44 139.59 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 18.07 110.026 178.073 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.381 -0.819 . . . . 20.26 110.084 179.412 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.96 -0.456 . . . . 20.59 111.96 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.0 107.07 4.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.922 0.391 . . . . 19.12 110.433 -179.503 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 62.8 mtt -95.76 -60.95 1.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.08 -0.509 . . . . 18.25 110.09 -179.721 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -103.87 -20.15 14.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.533 . . . . 16.83 110.958 178.758 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.11 72.29 2.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.125 -0.559 . . . . 14.9 112.977 -176.812 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -103.7 2.0 32.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 16.26 110.238 177.666 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 64.62 24.29 12.97 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.293 -0.867 . . . . 13.59 111.416 177.934 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.16 119.74 36.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.93 -0.577 . . . . 12.17 109.558 176.935 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -79.77 73.37 6.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.064 0.459 . . . . 9.12 110.598 -179.211 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.1 122.82 87.61 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.552 -0.536 . . . . 6.25 109.552 175.846 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.57 -11.84 28.59 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.282 . . . . 5.93 113.169 -175.657 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.85 -46.61 3.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.849 -0.691 . . . . 2.77 111.626 -176.419 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.83 76.86 2.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 2.44 110.609 176.953 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -144.39 145.13 31.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.478 -0.783 . . . . 3.7 109.435 179.87 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.7 t -67.1 103.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.57 109.231 177.567 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.24 -11.54 78.09 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.834 -0.621 . . . . 0.87 112.97 -171.472 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 58.6 t -65.73 -42.45 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.833 0.349 . . . . 1.54 110.38 178.932 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -104.25 -37.2 7.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.401 -0.363 . . . . 1.63 110.684 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.01 -5.72 27.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.77 112.184 -178.883 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.533 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 5.6 m-20 -102.19 135.34 43.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.963 0.411 . . . . 2.1 111.212 -179.211 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.63 1.64 34.29 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.239 -0.744 . . . . 0.66 111.239 174.137 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 40.4 m -69.08 132.4 46.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.465 -0.368 . . . . 1.52 110.636 177.359 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 55.62 47.39 20.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.726 0.774 . . . . 2.23 109.885 178.25 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.81 149.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.274 -0.876 . . . . 1.76 110.713 -173.971 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -99.36 153.32 19.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.234 -0.439 . . . . 1.18 110.45 -179.671 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -115.57 143.01 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.624 . . . . 3.64 109.842 -177.983 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.523 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.4 t -75.62 147.02 39.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.37 110.077 177.326 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.7 p -86.35 -38.46 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.514 . . . . 1.34 112.0 -179.482 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -90.43 -12.09 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.299 . . . . 1.81 111.7 -176.571 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . 0.523 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.8 p -150.97 -179.64 7.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.223 -0.658 . . . . 0.92 109.223 174.768 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 115.54 30.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.866 -0.42 . . . . 1.17 109.866 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.91 136.34 8.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.913 -0.585 . . . . 1.13 110.229 -179.023 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.88 112.18 25.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.103 -0.499 . . . . 1.18 109.807 175.986 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.32 158.92 40.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.68 109.98 -177.38 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -94.32 146.91 23.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.696 -0.483 . . . . 0.58 109.696 173.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -56.81 -53.52 56.87 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.584 0.553 . . . . 0.77 110.364 -179.632 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -63.9 -37.06 86.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.364 0.505 . . . . 3.8 112.364 -175.549 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 70.7 m -65.46 -24.32 67.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.957 0.408 . . . . 0.54 111.159 -177.989 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -100.89 -54.85 2.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.175 0.512 . . . . 0.72 110.698 178.366 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -107.18 129.26 24.58 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.73 -0.668 . . . . 0.94 109.66 -176.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.84 162.03 9.43 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.829 2.352 . . . . 2.64 112.224 178.693 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.19 38.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 3.71 111.903 -173.782 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.34 -15.2 81.73 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.795 -0.717 . . . . 1.86 111.73 175.019 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -90.47 125.7 35.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.07 -0.345 . . . . 1.52 110.07 179.389 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -89.27 134.58 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.803 0.335 . . . . 2.07 110.832 -177.895 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -71.46 124.35 90.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 3.22 111.097 -177.631 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.05 143.4 36.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.852 2.368 . . . . 1.22 112.81 -178.558 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.32 -10.3 48.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.915 -0.66 . . . . 1.9 112.33 178.801 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -89.14 0.09 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.347 0.594 . . . . 3.21 110.655 -179.887 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.71 119.15 1.28 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.985 -0.626 . . . . 1.31 111.986 -178.529 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.19 123.93 33.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.107 0.479 . . . . 1.51 110.318 -179.109 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -122.58 142.8 50.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.001 -0.545 . . . . 3.09 111.34 -173.998 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -73.39 165.76 24.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.55 109.489 175.176 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -53.93 -34.63 60.14 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.157 0.435 . . . . 4.7 111.899 -173.145 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 28.0 t -66.09 -50.05 65.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.924 0.392 . . . . 1.89 110.455 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.5 m -72.92 -26.54 61.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.117 0.414 . . . . 0.72 112.117 -178.571 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -89.53 0.28 57.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 1.79 111.044 -178.954 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.13 46.68 2.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.776 -0.726 . . . . 2.19 111.986 -179.312 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -110.24 20.75 17.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.16 0.505 . . . . 5.15 110.31 -179.148 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 t -88.72 70.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.574 0.702 . . . . 7.2 109.84 -177.836 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 p -106.35 125.33 33.19 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.405 -0.816 . . . . 8.83 110.633 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.8 133.99 22.96 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.305 2.003 . . . . 11.41 111.804 179.182 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.91 127.04 90.09 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.988 -0.551 . . . . 13.86 110.995 179.888 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.8 86.36 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.54 2.16 . . . . 16.55 111.593 178.157 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.55 113.27 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 18.07 110.414 -177.932 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.681 -0.676 . . . . 20.26 109.921 -178.668 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.477 -0.249 . . . . 20.59 112.477 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.68 89.48 5.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.963 0.411 . . . . 19.12 111.383 -176.114 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -88.34 -55.69 3.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.089 -0.708 . . . . 18.25 109.089 174.774 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 57.06 58.71 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 16.83 111.409 177.68 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.81 12.48 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.181 -0.918 . . . . 14.9 111.077 173.92 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -125.46 20.29 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 16.26 110.829 179.998 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.35 78.54 0.23 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.223 -0.898 . . . . 13.59 111.273 -179.365 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -94.47 -51.02 4.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.818 -0.438 . . . . 12.17 109.818 179.47 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.57 113.8 7.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 9.12 109.552 176.77 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.48 133.31 56.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 6.25 110.745 -177.151 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.52 57.86 2.41 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.032 2.488 . . . . 5.93 111.878 176.939 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.67 19.09 56.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.755 -0.657 . . . . 2.77 112.551 -177.385 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.08 71.9 1.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.297 0.57 . . . . 2.44 109.928 177.756 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -150.65 129.71 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.327 -0.852 . . . . 3.7 109.356 -179.596 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 15' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 32.0 t -62.0 112.65 2.42 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.723 -0.473 . . . . 0.57 109.723 178.22 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.59 -23.77 55.5 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 121.38 -0.438 . . . . 0.87 112.993 -175.911 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.03 -32.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.54 111.142 179.701 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.3 m -105.92 -47.42 3.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.194 0.442 . . . . 1.63 112.194 -174.689 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.0 -23.25 19.59 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.444 -0.663 . . . . 0.77 111.444 -173.902 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.78 152.21 21.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.732 0.301 . . . . 2.1 111.069 -178.165 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.83 6.79 33.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.043 -0.599 . . . . 0.66 111.804 177.307 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -70.58 127.9 34.29 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.645 -0.132 . . . . 1.52 110.645 178.563 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 58.11 39.44 26.11 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.51 0.506 . . . . 2.23 110.906 179.55 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -89.23 148.15 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.232 -0.44 . . . . 1.76 110.53 -175.093 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -114.62 148.64 37.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 1.18 110.217 -179.069 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 26' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.2 mpt_? -119.31 148.63 42.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.647 -0.501 . . . . 3.64 109.647 179.967 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 27' ' ' CYS . . . . . 0.43 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 40.3 t -68.95 139.28 55.05 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.112 -0.635 . . . . 0.37 109.486 174.307 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 12.4 t -85.07 4.43 34.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.424 0.631 . . . . 1.34 110.596 178.932 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -127.62 -8.6 5.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 1.81 110.68 176.7 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 9.0 m -145.02 177.44 8.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.92 110.13 -177.948 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 112.96 26.2 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.802 -0.814 . . . . 1.17 108.802 173.072 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 32' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.0 111.8 0.98 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.088 -0.505 . . . . 1.13 110.531 -179.544 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -93.21 112.58 24.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.007 0.432 . . . . 1.18 109.903 176.057 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.68 158.1 40.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.878 -0.601 . . . . 0.68 109.828 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 35' ' ' HIS . . . . . 0.75 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.4 m170 -87.24 138.45 31.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.166 -1.05 . . . . 0.58 108.166 172.192 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -48.94 -50.99 32.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.107 0.254 . . . . 0.77 111.443 -175.849 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -67.71 -10.46 52.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.016 -0.538 . . . . 3.8 112.099 -175.325 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 38' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.6 m -89.96 -21.63 22.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.906 0.384 . . . . 0.54 110.947 -179.083 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -101.94 -36.87 8.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.429 . . . . 0.72 110.486 174.92 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -124.5 150.0 63.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.989 -0.55 . . . . 0.94 110.219 -176.061 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.83 144.18 94.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.565 2.176 . . . . 2.64 111.089 172.786 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.85 -15.6 55.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.542 -0.754 . . . . 3.71 111.982 -175.733 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.75 -24.34 76.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.87 -0.681 . . . . 1.86 112.157 175.723 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.8 m -75.94 136.5 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.988 -0.375 . . . . 1.52 109.988 179.328 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -87.94 128.96 35.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.105 0.479 . . . . 2.07 111.266 -172.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -69.24 119.16 68.42 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 3.22 110.194 179.366 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.62 132.8 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.537 2.158 . . . . 1.22 112.405 -176.317 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.05 -11.53 67.32 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.438 -0.665 . . . . 1.9 111.438 177.126 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 21.5 p -89.7 37.44 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.368 0.604 . . . . 3.21 110.634 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.72 123.85 5.24 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.571 -0.74 . . . . 1.31 111.869 -178.12 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 123.73 22.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.105 -0.702 . . . . 1.51 109.105 178.406 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -115.52 128.48 56.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.945 0.403 . . . . 3.09 110.993 -174.876 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 53' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 15.6 p -73.24 174.13 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.724 -0.671 . . . . 0.55 109.672 177.507 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -57.66 -37.87 74.13 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.862 0.301 . . . . 4.7 111.655 -170.309 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 32.9 t -69.31 -38.84 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.977 0.418 . . . . 1.89 110.343 179.992 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.7 m -73.18 -33.24 65.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.19 -0.459 . . . . 0.72 111.984 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.1 p -83.84 -14.94 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 1.79 110.873 179.438 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.79 -58.89 1.66 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.956 -0.857 . . . . 2.19 110.956 175.468 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.01 89.74 7.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.402 -0.592 . . . . 5.15 109.402 174.753 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -88.87 104.28 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.951 -0.568 . . . . 7.2 110.479 -175.899 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.6 p -105.73 108.39 61.45 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.773 -0.649 . . . . 8.83 110.608 179.533 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.79 140.61 95.79 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.645 2.23 . . . . 11.41 111.807 178.715 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.39 136.43 91.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.991 -0.55 . . . . 13.86 110.861 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.71 69.71 5.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 16.55 112.128 -178.999 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.46 121.17 39.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.808 -0.633 . . . . 18.07 110.063 179.052 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.541 -0.742 . . . . 20.26 109.2 179.968 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.549 -0.537 . . . . 3.18 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.6 t -67.1 106.29 1.93 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.497 -0.557 . . . . 0.53 109.497 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.41 -21.76 57.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 121.344 -0.455 . . . . 0.65 112.937 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.22 -33.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.834 0.35 . . . . 1.04 111.027 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.35 -38.96 6.64 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.085 0.402 . . . . 0.84 112.085 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.11 58.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.862 -0.685 . . . . 0.77 111.421 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.01 155.05 17.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.984 0.421 . . . . 2.1 110.9 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.08 17.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.024 -0.83 . . . . 0.55 111.024 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -64.08 118.1 8.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.294 -0.453 . . . . 1.06 110.823 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.12 47.53 21.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.616 -0.72 . . . . 2.23 110.744 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.451 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.9 p -89.16 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.662 -0.699 . . . . 1.16 109.735 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.43 143.7 29.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.77 0.319 . . . . 0.48 110.521 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 40.3 mmt-85 -104.74 147.04 28.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 3.18 109.948 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.36 146.55 29.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.408 -0.59 . . . . 0.37 109.408 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -92.55 -29.69 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.461 -0.336 . . . . 0.75 111.705 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -89.71 -17.23 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.32 . . . . 1.43 111.105 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 p -150.9 -173.27 4.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.973 -0.751 . . . . 0.79 108.973 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.98 115.64 30.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.008 -0.367 . . . . 0.47 110.008 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -157.29 156.9 33.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.409 -0.36 . . . . 0.4 110.459 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 111.84 9.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.841 -0.618 . . . . 0.45 109.807 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.451 ' N ' HG22 ' C' ' 24' ' ' VAL . 37.8 p90 -156.24 158.96 38.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.99 -0.55 . . . . 0.61 109.836 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.6 m170 -92.3 133.13 36.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.267 -1.012 . . . . 0.42 108.267 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.45 -52.49 28.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.375 0.422 . . . . 0.68 111.585 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -62.57 -25.8 68.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 3.33 111.86 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.14 -22.45 52.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.939 0.399 . . . . 0.54 110.852 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 0.9 OUTLIER -101.09 -40.69 7.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.324 -0.398 . . . . 0.61 111.068 178.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -117.76 79.02 12.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.402 -0.363 . . . . 0.8 110.458 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 3.8 Cg_endo -86.74 7.09 5.06 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.242 2.628 . . . . 2.12 112.411 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.58 4.54 27.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 3.3 111.789 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.7 26.64 24.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.477 -0.868 . . . . 1.46 111.76 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -75.73 140.64 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.895 -0.409 . . . . 1.03 109.895 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 11.5 p -88.7 135.35 33.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.669 0.271 . . . . 1.6 110.627 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -73.85 112.68 17.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 2.68 110.755 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.66 133.34 20.22 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.503 2.135 . . . . 1.14 112.069 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.28 -17.49 69.02 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.611 -0.804 . . . . 1.9 111.249 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 2.3 p -98.06 74.71 2.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.377 -0.412 . . . . 2.75 111.28 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.03 85.46 1.73 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.452 -0.88 . . . . 0.82 112.851 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.38 124.15 20.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.243 -0.651 . . . . 0.87 109.243 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -125.69 130.72 52.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 2.65 111.327 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -76.36 -178.37 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.49 110.067 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -60.24 -46.28 90.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 4.09 111.051 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -65.65 -48.42 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 1.54 111.056 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.76 -22.28 65.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.531 0.205 . . . . 0.72 111.514 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -86.25 -2.6 58.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.496 0.189 . . . . 1.25 111.017 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.812 -0.709 . . . . 2.19 111.855 178.736 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.757 -0.46 . . . . 3.18 109.757 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 4.4 t -81.83 104.8 12.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.973 -0.558 . . . . 0.53 109.753 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -2.28 60.51 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 115.759 -0.655 . . . . 0.65 113.306 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.75 -29.2 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.992 0.425 . . . . 1.04 110.384 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.99 -35.1 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.448 -0.342 . . . . 0.84 111.056 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.22 -11.86 21.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.892 -0.671 . . . . 0.77 111.992 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 24.4 t70 -97.73 147.15 24.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.733 0.302 . . . . 2.1 110.632 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.21 16.34 8.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.965 -0.636 . . . . 0.55 112.121 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.16 132.63 35.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 1.06 110.121 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t0 52.59 56.16 8.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.791 0.805 . . . . 2.23 109.488 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' C' ' 33' ' ' ALA . 6.2 p -91.44 137.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.168 -0.924 . . . . 1.16 110.63 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.97 147.9 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 0.48 110.225 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 10.4 mmm180 -114.47 136.05 53.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.963 -0.562 . . . . 3.18 110.16 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.8 t -67.56 136.78 55.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.349 -0.387 . . . . 0.37 110.102 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -88.26 -12.76 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.75 111.108 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -100.96 -23.25 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 1.43 110.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.3 p -151.28 -172.4 4.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.79 109.656 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.34 113.96 27.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.684 -0.234 . . . . 0.47 110.417 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.28 140.15 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.427 . . . . 0.4 110.653 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.71 112.17 23.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.45 109.354 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' C' ' 15' ' ' CYS . 34.8 p90 -150.89 166.85 29.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.293 -0.412 . . . . 0.61 110.806 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -104.4 138.17 41.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.277 -0.638 . . . . 0.42 109.277 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 69.2 t-105 -63.44 -34.44 77.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.835 -0.62 . . . . 0.68 110.387 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' C' ' 37' ' ' ARG . 19.4 mtm180 -68.69 -36.6 78.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 3.33 110.798 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -73.61 -23.15 59.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.54 110.919 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -92.32 -54.71 3.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.136 -0.484 . . . . 0.61 110.935 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.16 144.07 30.44 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.8 110.227 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.27 165.09 25.66 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.795 2.33 . . . . 2.12 112.068 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -13.96 47.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.192 -0.913 . . . . 3.3 112.961 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.44 -6.5 77.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.49 -0.862 . . . . 1.46 112.519 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.9 m -91.48 130.46 37.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 1.03 111.123 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.3 t -89.9 150.37 22.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.816 -0.629 . . . . 1.6 109.459 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 93.5 mtt180 -79.41 131.69 64.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.543 -0.54 . . . . 2.68 109.543 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.6 132.15 21.43 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.176 1.917 . . . . 1.14 111.925 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.33 -2.32 67.19 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.861 -0.685 . . . . 1.9 112.323 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.2 p -89.3 -2.77 58.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.817 0.342 . . . . 2.75 111.22 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.86 5.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.519 -0.848 . . . . 0.82 112.444 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.5 123.35 25.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.047 0.451 . . . . 0.87 109.844 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.74 133.32 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 2.65 111.295 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -77.38 -174.24 3.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.176 -0.676 . . . . 0.49 109.176 172.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.23 -53.17 59.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 4.09 111.374 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -63.46 -42.47 98.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.54 111.646 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 -17.27 62.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.679 0.276 . . . . 0.72 111.297 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 70.6 m -85.39 -3.04 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 1.25 110.989 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 120.606 -0.807 . . . . 2.19 112.381 178.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.648 -0.871 . . . . 3.18 108.648 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 49.3 t -72.17 103.78 3.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 0.53 110.497 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.73 -7.65 83.92 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.856 -0.611 . . . . 0.65 111.644 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.94 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 1.04 110.255 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.2 p -102.73 -28.08 12.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.914 0.388 . . . . 0.84 110.038 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.11 24.75 10.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.77 111.693 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 27.9 t70 -142.59 147.83 36.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 2.1 110.706 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.23 16.94 8.04 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.631 -0.587 . . . . 0.55 111.631 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.5 m -80.44 120.02 23.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.155 -0.313 . . . . 1.06 110.155 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.72 50.03 17.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.56 0.695 . . . . 2.23 110.167 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.43 144.53 8.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.936 -1.029 . . . . 1.16 109.903 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.47 155.42 19.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.961 0.41 . . . . 0.48 110.376 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.0 mmm180 -123.64 151.96 42.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.014 -0.735 . . . . 3.18 109.014 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 37.9 t -69.63 138.78 53.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.618 -0.833 . . . . 0.37 109.176 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p -80.98 -10.86 59.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.101 0.477 . . . . 0.75 110.98 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -117.25 -7.81 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 1.43 111.031 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 14.3 m -140.92 179.32 6.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.79 110.406 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.6 113.29 26.76 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.011 -0.737 . . . . 0.47 109.011 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.91 145.34 6.22 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.058 0.224 . . . . 0.4 110.53 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.53 112.41 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.477 0.486 . . . . 0.45 110.268 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -157.06 145.15 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.913 -0.585 . . . . 0.61 110.146 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.821 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 77.2 m80 -86.75 151.35 23.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.516 -0.55 . . . . 0.42 109.516 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 67.9 t-105 -61.98 -50.5 71.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.763 0.316 . . . . 0.68 110.489 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 79.9 mtp180 -69.43 -14.53 62.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 3.33 111.731 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.821 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.8 m -80.79 -20.96 41.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.251 0.548 . . . . 0.54 110.029 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.06 -39.41 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.61 111.392 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 99.0 m-85 -125.68 158.61 64.45 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.8 110.496 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.42 159.82 51.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.595 2.197 . . . . 2.12 110.935 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.3 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 3.3 111.458 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.21 -12.8 79.75 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.231 -0.509 . . . . 1.46 112.413 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 23.7 m -88.81 138.9 30.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 1.03 109.914 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.11 137.74 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 1.6 110.319 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 14.4 ptm180 -93.12 121.74 64.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.352 -0.385 . . . . 2.68 111.221 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.02 136.57 29.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.769 2.312 . . . . 1.14 111.639 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.74 -46.99 10.32 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.075 -0.583 . . . . 1.9 112.721 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -17.65 16.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.163 0.506 . . . . 2.75 111.307 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -115.95 50.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.686 -0.769 . . . . 0.82 112.63 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -70.09 123.54 21.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.934 -0.765 . . . . 0.87 108.934 178.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 76.0 mtt180 -117.82 140.97 48.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.933 0.397 . . . . 2.65 111.832 -170.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 17.6 p -77.29 171.51 14.75 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.424 -0.954 . . . . 0.49 108.424 169.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -56.55 -38.79 72.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.194 0.452 . . . . 4.09 111.752 -171.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -68.62 -40.45 80.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 1.54 110.843 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -71.47 -26.19 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.732 0.301 . . . . 0.72 111.021 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 41.9 p -93.46 19.76 8.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.983 0.421 . . . . 1.25 110.689 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 C-N-CA 121.13 -0.557 . . . . 2.19 112.126 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.662 0.267 . . . . 3.18 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.2 t -65.4 113.56 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.53 109.699 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.61 -19.2 62.38 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.075 -0.583 . . . . 0.65 113.496 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.93 -30.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.059 0.457 . . . . 1.04 110.686 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.6 m -108.57 -24.56 11.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.56 0.578 . . . . 0.84 112.56 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.46 16.9 79.81 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.304 -0.718 . . . . 0.77 111.304 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -134.85 156.2 49.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.451 . . . . 2.1 110.137 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.89 22.09 5.19 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.721 -0.752 . . . . 0.55 112.816 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.0 m -75.66 125.83 29.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.06 110.059 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 54.36 45.73 26.57 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.334 0.588 . . . . 2.23 110.234 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -91.75 151.77 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.16 110.531 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' C' ' 36' ' ' TRP . 74.2 mt -96.02 149.49 21.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.142 -0.481 . . . . 0.48 109.898 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -107.38 155.46 19.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.114 -0.494 . . . . 3.18 110.505 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.1 t -88.92 140.43 29.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.613 -0.514 . . . . 0.37 109.613 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -90.37 -26.83 19.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.032 0.444 . . . . 0.75 111.275 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -89.96 -20.5 23.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 1.43 111.05 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.0 p -151.0 -172.32 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.961 -0.755 . . . . 0.79 108.961 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.27 114.27 28.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.949 -0.389 . . . . 0.47 109.949 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.32 151.96 10.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.4 110.776 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -119.35 120.58 37.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.805 -0.634 . . . . 0.45 109.679 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.84 148.17 31.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.193 -0.458 . . . . 0.61 110.873 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.6 m170 -88.82 126.61 35.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.79 -1.189 . . . . 0.42 107.79 168.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.409 ' HB2' HD12 ' C' ' 25' ' ' LEU . 56.4 t-105 -56.57 -38.59 72.17 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.69 0.619 . . . . 0.68 111.192 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -71.71 -23.7 61.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.904 0.383 . . . . 3.33 111.222 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 84.4 m -85.14 -22.99 28.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.421 -0.354 . . . . 0.54 110.93 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' HIS . . . . . 0.426 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 7.6 m-70 -102.15 -24.72 13.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.61 111.539 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -130.87 65.1 75.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.913 0.387 . . . . 0.8 110.522 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 6.2 Cg_exo -78.97 5.42 5.72 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.159 2.572 . . . . 2.12 112.436 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.14 3.58 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.302 -0.408 . . . . 3.3 111.326 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.8 8.24 45.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 1.46 112.7 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.3 m -67.72 129.35 39.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.121 -0.325 . . . . 1.03 110.121 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 p -90.03 149.17 22.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.631 0.253 . . . . 1.6 110.575 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -78.13 121.97 84.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 2.68 111.257 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.71 155.65 58.35 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.771 2.314 . . . . 1.14 111.466 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.44 -19.43 79.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.98 -0.629 . . . . 1.9 111.814 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -147.11 142.29 27.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.917 0.389 . . . . 2.75 110.212 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 51.71 1.47 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.784 -0.722 . . . . 0.82 112.36 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.54 122.13 25.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.172 0.51 . . . . 0.87 110.372 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -127.89 137.29 52.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.171 -0.468 . . . . 2.65 110.505 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -72.89 -177.0 2.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.476 -0.564 . . . . 0.49 109.476 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -67.01 -40.43 87.31 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.631 -0.428 . . . . 4.09 110.631 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -67.68 -43.58 79.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 1.54 111.459 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.78 -17.22 62.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.72 110.791 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -87.41 19.66 3.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 1.25 110.574 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 110.498 -1.041 . . . . 2.19 110.498 172.689 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 110.118 -0.327 . . . . 3.18 110.118 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -64.19 103.42 0.62 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.53 109.516 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.08 -17.41 69.7 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.867 -0.682 . . . . 0.65 112.764 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 42.0 t -61.78 -38.56 80.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.824 0.345 . . . . 1.04 110.981 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.6 p -109.52 -28.96 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.979 0.419 . . . . 0.84 110.576 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.51 -14.38 56.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.044 -0.598 . . . . 0.77 111.829 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -94.94 140.27 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 2.1 110.987 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.09 20.23 16.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.925 -0.655 . . . . 0.55 112.476 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -78.36 116.37 18.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.461 0.172 . . . . 1.06 110.581 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.71 66.19 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 2.23 111.386 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.49 140.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 1.16 110.987 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -88.06 143.8 26.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 0.48 109.405 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.6 OUTLIER -108.07 135.54 49.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.069 0.462 . . . . 3.18 110.612 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 6.7 t -63.57 141.27 58.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.299 -0.864 . . . . 0.37 110.261 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.3 p -89.51 -26.23 21.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.324 -0.398 . . . . 0.75 111.35 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -89.64 -21.51 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.43 110.904 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.9 p -150.49 -172.29 4.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.478 -0.934 . . . . 0.79 108.478 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.03 114.4 28.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.788 0.328 . . . . 0.47 110.187 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.45 123.23 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.4 109.847 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.34 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.583 -0.525 . . . . 0.45 109.583 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -147.77 162.92 38.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.004 -0.544 . . . . 0.61 110.122 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.427 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -93.03 133.72 35.89 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.873 -0.788 . . . . 0.42 108.873 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -51.14 -48.05 61.91 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.632 0.582 . . . . 0.68 111.092 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 33.7 mmt180 -74.41 -5.46 42.59 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.388 0.514 . . . . 3.33 112.388 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.5 m -91.23 -22.2 20.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 0.54 110.561 175.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -102.35 -43.31 5.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.01 0.433 . . . . 0.61 110.722 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 88.3 m-85 -118.58 137.72 25.1 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.595 . . . . 0.8 109.928 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.41 177.65 6.46 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.7 2.267 . . . . 2.12 112.633 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.11 -37.89 78.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.68 0.276 . . . . 3.3 111.699 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.64 -20.93 64.43 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.105 -0.498 . . . . 1.46 113.787 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.12 132.35 34.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.125 0.463 . . . . 1.03 110.111 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.74 137.99 31.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.29 -0.414 . . . . 1.6 110.956 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -74.84 117.29 61.4 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.763 -0.653 . . . . 2.68 110.632 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.41 132.63 22.66 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.587 2.191 . . . . 1.14 111.638 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.23 -39.3 12.94 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.769 -0.729 . . . . 1.9 111.459 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.1 m -98.14 112.49 24.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.447 -0.377 . . . . 2.75 110.597 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.58 59.99 3.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.885 -0.674 . . . . 0.82 112.801 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.76 122.51 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.847 -0.797 . . . . 0.87 108.847 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 33.6 ptt180 -133.69 146.04 50.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.103 0.478 . . . . 2.65 111.032 -174.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.46 177.14 5.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.329 -0.85 . . . . 0.49 110.649 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -55.78 -49.37 73.36 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.151 0.282 . . . . 4.09 111.204 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -59.19 -43.25 92.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.999 0.428 . . . . 1.54 110.513 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.82 -27.76 62.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.404 0.52 . . . . 0.72 112.404 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -75.85 -7.14 53.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.874 0.369 . . . . 1.25 111.31 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.682 0 C-N-CA 120.937 -0.649 . . . . 2.19 111.794 -179.381 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.721 -0.474 . . . . 3.18 109.721 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 27.9 t -61.48 106.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 0.53 110.123 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.05 -25.7 64.67 Favored Glycine 0 C--O 1.229 -0.182 0 O-C-N 123.454 0.471 . . . . 0.65 112.516 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.17 -29.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.494 . . . . 1.04 110.885 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 88.5 m -108.1 -33.46 7.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.84 112.116 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.05 6.03 72.38 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.86 -0.896 . . . . 0.77 110.86 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.36 147.08 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.588 . . . . 2.1 109.912 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.45 30.99 4.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.864 -0.684 . . . . 0.55 112.752 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -74.72 125.73 29.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 1.06 109.723 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.13 51.91 14.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.438 0.637 . . . . 2.23 110.325 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.33 151.1 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.599 -0.728 . . . . 1.16 110.565 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' C' ' 36' ' ' TRP . 80.6 mt -102.27 148.38 25.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.48 110.023 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.3 tpt180 -115.57 138.73 50.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.844 -0.617 . . . . 3.18 110.447 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -75.49 143.69 42.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.743 -0.466 . . . . 0.37 109.743 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -91.04 -30.79 16.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.545 . . . . 0.75 111.855 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -91.58 -14.38 30.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.351 . . . . 1.43 111.507 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 p -150.47 -174.22 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.437 -0.579 . . . . 0.79 109.437 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.63 114.06 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.673 -0.492 . . . . 0.47 109.673 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.14 125.13 1.87 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.4 110.835 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.76 25.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.45 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -151.83 160.63 43.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.374 -0.375 . . . . 0.61 110.598 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.1 m170 -90.8 134.83 34.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.941 -0.763 . . . . 0.42 108.941 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.445 ' HB2' HD12 ' C' ' 25' ' ' LEU . 28.0 t-105 -50.54 -51.58 46.55 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.336 0.397 . . . . 0.68 111.476 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -62.19 -27.8 69.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 3.33 112.193 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -78.49 -22.91 46.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 0.54 111.346 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -100.22 -37.08 9.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.264 -0.425 . . . . 0.61 110.865 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.3 85.65 25.63 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 0.8 110.289 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.45 -5.19 12.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.117 2.544 . . . . 2.12 113.386 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.21 4.23 31.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.896 0.379 . . . . 3.3 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.41 33.78 27.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.713 -0.756 . . . . 1.46 112.024 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -61.66 142.21 57.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 1.03 110.733 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -88.48 135.45 33.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.422 -0.354 . . . . 1.6 110.157 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -67.4 125.78 91.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 2.68 110.342 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 137.64 38.17 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.575 2.184 . . . . 1.14 112.377 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.1 1.51 70.43 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.952 -0.642 . . . . 1.9 111.988 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -104.86 26.61 8.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.36 0.6 . . . . 2.75 110.746 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 118.08 122.38 3.19 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.546 -0.752 . . . . 0.82 111.805 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.7 123.57 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 54.1 mtt85 -125.68 134.29 51.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.359 -0.382 . . . . 2.65 111.119 -174.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.9 p -76.29 177.19 7.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.977 -0.749 . . . . 0.49 108.977 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -59.96 -40.33 88.66 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.318 0.508 . . . . 4.09 111.487 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m -65.09 -46.54 80.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.868 0.366 . . . . 1.54 110.965 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.91 -17.85 62.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.72 111.418 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 36.3 m -88.84 -14.33 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.38 . . . . 1.25 110.56 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 C-N-CA 120.907 -0.663 . . . . 2.19 112.623 -177.034 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 110.108 -0.33 . . . . 3.18 110.108 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -81.9 102.76 11.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.53 108.608 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.66 80.34 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.828 -0.624 . . . . 0.65 112.806 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.4 HG11 ' O ' ' C' ' 38' ' ' CYS . 33.4 t -66.14 -28.83 44.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.085 0.469 . . . . 1.04 110.725 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.56 -41.9 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.314 -0.403 . . . . 0.84 110.326 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.49 -10.82 8.07 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.911 -0.661 . . . . 0.77 112.256 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -100.23 148.19 24.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 2.1 111.843 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.75 16.43 21.15 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.488 -0.778 . . . . 0.55 111.491 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.4 m -74.0 115.59 13.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.826 -0.187 . . . . 1.06 110.739 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.19 66.34 1.26 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.801 0.688 . . . . 2.23 111.014 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -89.97 136.53 23.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.63 -0.714 . . . . 1.16 111.008 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.03 144.09 28.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.667 -0.697 . . . . 0.48 110.014 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.1 mpt_? -103.78 146.65 28.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.953 -0.567 . . . . 3.18 110.19 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 27.0 t -72.62 141.39 48.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.515 -0.55 . . . . 0.37 109.515 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.44 -26.05 33.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.581 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -94.91 -28.12 15.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 1.43 111.521 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.9 p -143.93 -174.02 4.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.57 . . . . 0.79 109.46 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.58 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.781 0.324 . . . . 0.47 110.719 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -160.8 138.46 9.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.046 -0.525 . . . . 0.4 109.973 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.56 112.12 22.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.858 -0.423 . . . . 0.45 109.858 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -156.53 166.0 34.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.834 0.35 . . . . 0.61 110.976 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -97.29 135.22 39.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.42 108.795 171.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -59.62 -39.28 83.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.924 -0.58 . . . . 0.68 110.593 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.61 -15.83 60.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 3.33 111.73 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.4 ' O ' HG11 ' C' ' 17' ' ' VAL . 68.7 m -84.32 -22.45 30.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.168 0.509 . . . . 0.54 110.12 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.24 -56.07 2.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 0.61 111.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 75.6 m-85 -106.99 135.24 19.6 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.833 -0.621 . . . . 0.8 110.14 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 9.1 Cg_exo -70.78 176.3 7.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.272 . . . . 2.12 112.667 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.94 65.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.437 -0.347 . . . . 3.3 111.654 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.52 -23.08 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.46 112.88 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 13.1 m -99.0 128.88 45.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.883 -0.414 . . . . 1.03 109.883 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 63.0 p -89.21 138.0 31.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.465 -0.334 . . . . 1.6 111.216 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -75.61 116.17 52.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 2.68 110.348 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.96 133.42 21.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.237 1.958 . . . . 1.14 111.449 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.15 79.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.938 -0.649 . . . . 1.9 111.733 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.4 p -131.53 141.46 49.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.012 -0.366 . . . . 2.75 110.012 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.74 53.15 3.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.82 112.275 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 123.25 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.81 -0.441 . . . . 0.87 109.81 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -117.25 145.7 43.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.915 0.388 . . . . 2.65 110.779 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 13.9 p -84.65 -176.21 6.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.308 -0.627 . . . . 0.49 109.308 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -62.5 -48.31 80.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 4.09 111.348 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 19.3 t -67.1 -44.77 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.324 -0.398 . . . . 1.54 111.244 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -72.14 -29.33 63.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.816 0.302 . . . . 0.72 111.816 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 2.6 t -90.65 -12.23 37.46 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.793 -0.363 . . . . 1.25 111.679 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 C-N-CA 120.023 -1.084 . . . . 2.19 113.092 179.354 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 73.1 mtt180 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.636 -0.505 . . . . 3.18 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.87 106.62 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.227 -0.657 . . . . 0.53 109.227 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 -22.3 55.0 Favored Glycine 0 C--N 1.33 0.224 0 O-C-N 123.349 0.405 . . . . 0.65 113.109 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.4 -30.2 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.04 110.891 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 86.5 m -108.57 -46.02 3.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.774 0.657 . . . . 0.84 112.774 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' GLY . . . . . 0.658 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 102.67 -17.17 53.74 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.77 111.536 -173.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.42 150.37 20.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.864 0.364 . . . . 2.1 110.758 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.13 9.04 29.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.186 -0.766 . . . . 0.55 111.186 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 m -72.48 136.7 46.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.389 . . . . 1.06 110.539 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.92 47.09 7.0 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.967 0.889 . . . . 2.23 111.075 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.65 140.45 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.16 109.854 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.35 144.56 25.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.932 0.396 . . . . 0.48 110.381 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -109.32 149.69 29.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.588 -0.733 . . . . 3.18 109.551 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.64 137.36 33.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.022 0.439 . . . . 0.37 110.521 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 33.8 p -85.51 -3.5 58.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.591 . . . . 0.75 111.957 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -122.18 -15.44 7.71 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.002 -0.279 . . . . 1.43 111.631 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -151.9 -167.42 2.77 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.79 109.548 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.01 29.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.548 -0.296 . . . . 0.47 110.249 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.96 145.68 15.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.326 -0.397 . . . . 0.4 110.528 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.58 112.53 16.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.008 -0.542 . . . . 0.45 110.052 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.76 162.72 38.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.924 -0.398 . . . . 0.61 109.924 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.757 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -95.28 138.08 33.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.713 -0.847 . . . . 0.42 108.713 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -50.29 -53.03 31.56 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.239 0.337 . . . . 0.68 111.399 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -66.34 -18.07 65.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 3.33 111.97 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.0 m -84.17 -22.2 31.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.162 0.506 . . . . 0.54 110.852 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.94 -34.63 8.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.61 110.672 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -124.12 132.42 24.3 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.8 109.785 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.14 154.65 27.3 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.892 2.395 . . . . 2.12 111.695 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.39 -19.84 57.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.388 -0.823 . . . . 3.3 112.449 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.74 -18.8 78.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.067 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -85.49 125.36 32.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 1.03 110.013 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m -88.51 136.42 33.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 1.6 110.567 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -69.92 123.94 89.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 2.68 110.299 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.79 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.664 2.243 . . . . 1.14 112.581 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.84 5.42 82.08 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.827 -0.701 . . . . 1.9 111.583 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -92.7 18.46 8.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.14 0.495 . . . . 2.75 110.881 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.86 135.17 8.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.977 -0.63 . . . . 0.82 111.69 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 123.82 22.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.962 0.41 . . . . 0.87 110.008 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -117.41 138.05 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 2.65 110.69 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -81.12 -176.67 6.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.668 -0.493 . . . . 0.49 109.668 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -57.4 -52.48 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 4.09 111.1 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.9 t -63.11 -46.29 88.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.497 -0.32 . . . . 1.54 111.359 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 80.6 m -72.18 -17.77 61.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.072 0.397 . . . . 0.72 112.072 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -81.65 -13.75 57.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.423 -0.511 . . . . 1.25 110.147 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 CA-C-N 115.707 -0.679 . . . . 2.19 111.495 178.031 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.417 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.7 ttp180 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.602 0.239 . . . . 3.18 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -69.08 111.32 4.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.768 -0.456 . . . . 0.53 109.768 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.69 81.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.27 -0.49 . . . . 0.65 112.846 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.45 -37.65 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.763 0.316 . . . . 1.04 110.931 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.0 m -96.14 -43.55 7.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 0.84 111.621 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.37 1.01 55.65 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.144 -0.783 . . . . 0.77 111.144 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -117.22 143.48 45.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.338 . . . . 2.1 110.407 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -110.37 9.32 30.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.958 -0.639 . . . . 0.55 112.078 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -72.78 134.02 44.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.168 -0.308 . . . . 1.06 110.168 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.34 48.6 21.6 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.628 0.58 . . . . 2.23 110.848 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.9 p -91.18 145.05 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 1.16 110.518 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.26 147.43 23.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.274 -0.421 . . . . 0.48 110.407 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -112.7 150.28 31.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 3.18 110.876 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 11.7 t -82.79 134.28 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.37 108.883 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.459 HG22 ' O ' ' C' ' 51' ' ' LEU . 5.9 t -85.57 -11.72 53.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.732 -0.387 . . . . 0.75 111.491 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.75 -17.95 13.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.795 0.294 . . . . 1.43 111.795 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.57 -167.55 2.85 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.475 -0.565 . . . . 0.79 109.475 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 114.09 28.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.755 0.312 . . . . 0.47 110.36 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -157.8 146.34 19.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.4 110.374 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -133.26 112.18 11.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.136 -0.484 . . . . 0.45 110.256 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.6 164.82 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.104 -0.498 . . . . 0.61 109.847 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.3 m170 -96.54 137.76 35.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.104 -1.073 . . . . 0.42 108.104 171.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -47.65 -51.65 20.82 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.533 0.521 . . . . 0.68 112.006 -173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -61.65 -32.88 73.07 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.152 0.427 . . . . 3.33 112.152 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 9.1 m -71.35 -21.4 62.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.54 111.043 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.89 -42.93 5.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.61 111.174 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.99 142.94 29.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.41 -0.359 . . . . 0.8 110.714 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.16 149.02 6.49 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.602 2.868 . . . . 2.12 112.75 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -16.15 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.328 -0.851 . . . . 3.3 112.566 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.64 18.27 56.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 1.46 112.285 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.4 m -106.63 131.27 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.498 0.19 . . . . 1.03 110.542 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -88.54 133.59 34.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.975 -0.379 . . . . 1.6 109.975 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 46' ' ' ARG . 4.1 ptm180 -80.82 130.09 65.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.714 0.292 . . . . 2.68 110.682 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.16 146.88 47.14 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.83 2.354 . . . . 1.14 112.203 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.02 -40.71 4.52 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.29 -0.724 . . . . 1.9 111.29 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.8 p -100.09 83.36 2.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.923 0.392 . . . . 2.75 110.663 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 116.94 64.05 0.33 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.458 -0.877 . . . . 0.82 112.906 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.459 ' O ' HG22 ' C' ' 28' ' ' THR . 0.8 OUTLIER -77.0 121.79 24.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.782 -0.822 . . . . 0.87 108.782 176.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -126.29 132.1 51.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.436 -0.347 . . . . 2.65 110.731 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.09 179.62 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.49 109.561 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -60.17 -42.35 94.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 4.09 111.282 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -66.49 -46.26 76.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 1.54 111.057 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -71.41 -33.4 69.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.803 0.297 . . . . 0.72 111.803 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 46.1 p -83.32 -11.31 57.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 1.25 110.725 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 C-N-CA 120.971 -0.633 . . . . 2.19 111.784 179.729 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.604 -0.517 . . . . 3.18 109.604 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.75 103.87 1.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.52 -0.548 . . . . 0.53 109.52 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.26 86.14 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.65 113.458 -171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.94 -40.38 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.809 0.338 . . . . 1.04 110.988 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -111.67 -20.59 12.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.359 . . . . 0.84 111.147 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.95 77.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.929 -0.653 . . . . 0.77 112.036 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -109.84 146.78 34.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.259 -0.275 . . . . 2.1 110.259 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.1 17.18 9.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.55 112.753 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.76 119.43 23.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.505 -0.183 . . . . 1.06 110.505 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.72 63.1 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.413 0.445 . . . . 2.23 111.258 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -89.1 140.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 1.16 110.793 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.15 145.99 24.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.676 -0.693 . . . . 0.48 109.538 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.87 141.46 42.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 3.18 110.945 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -69.79 128.24 35.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.158 -0.682 . . . . 0.37 109.158 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 46.8 p -84.49 -8.26 59.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.495 0.664 . . . . 0.75 110.292 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -99.91 -27.97 13.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.387 -0.824 . . . . 1.43 111.056 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.1 p -151.74 -161.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.028 -0.269 . . . . 0.79 110.408 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.71 119.74 39.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.676 -0.238 . . . . 0.47 110.788 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -173.12 141.09 0.93 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.175 -0.466 . . . . 0.4 110.8 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.86 112.82 19.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.597 -0.52 . . . . 0.45 109.597 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -155.56 169.57 24.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 0.61 110.943 -173.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -102.55 134.92 45.1 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.37 -0.604 . . . . 0.42 109.37 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -63.61 -35.19 79.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.613 -0.721 . . . . 0.68 110.532 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -76.97 -17.39 58.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 3.33 111.745 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.06 -22.49 27.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.069 0.462 . . . . 0.54 110.411 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -93.3 -51.35 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.088 -0.506 . . . . 0.61 110.362 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.76 152.81 47.79 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.695 . . . . 0.8 109.963 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.29 148.48 70.59 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.244 1.963 . . . . 2.12 110.705 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.27 -11.38 31.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.022 -0.535 . . . . 3.3 111.69 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.21 7.49 80.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.11 -0.567 . . . . 1.46 112.216 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -93.02 140.54 29.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.763 -0.257 . . . . 1.03 110.308 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.3 p -87.91 143.73 26.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.973 0.416 . . . . 1.6 110.149 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -89.48 129.69 46.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.538 -0.542 . . . . 2.68 109.538 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 132.73 44.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.939 2.426 . . . . 1.14 112.761 -173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.82 -10.41 83.13 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.342 -0.703 . . . . 1.9 111.342 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -89.59 26.38 1.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.388 0.613 . . . . 2.75 110.387 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 131.99 7.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.506 -0.77 . . . . 0.82 111.758 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.76 123.13 18.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.422 -0.584 . . . . 0.87 109.422 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -110.24 147.32 34.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.32 0.581 . . . . 2.65 110.726 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.4 p -91.49 -170.05 2.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.354 -0.839 . . . . 0.49 109.526 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -61.05 -49.64 76.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.655 -0.248 . . . . 4.09 111.283 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' C' ' 58' ' ' GLY . 15.7 m -68.64 -36.97 79.31 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.196 0.522 . . . . 1.54 111.867 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -73.64 -15.73 61.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.806 0.336 . . . . 0.72 111.422 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -97.83 7.31 46.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.353 0.597 . . . . 1.25 109.772 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' C' ' 55' ' ' SER . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 110.256 -1.138 . . . . 2.19 110.256 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.462 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.6 ttt180 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.946 0.403 . . . . 3.18 110.604 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 29.5 t -90.47 103.67 16.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 0.53 109.183 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 -4.54 89.81 Favored Glycine 0 N--CA 1.453 -0.183 0 CA-C-N 115.967 -0.561 . . . . 0.65 113.253 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.11 -32.13 46.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.106 0.479 . . . . 1.04 110.21 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 p -115.89 -41.34 3.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.006 -0.543 . . . . 0.84 110.285 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.55 -15.78 7.1 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.874 -0.679 . . . . 0.77 112.381 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -91.12 140.81 29.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 2.1 111.343 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -111.28 3.48 28.22 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.989 -0.624 . . . . 0.55 112.138 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 57.6 m -80.47 134.65 36.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.52 0.2 . . . . 1.06 110.739 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 59.46 50.02 8.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.629 0.728 . . . . 2.23 110.94 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 m -89.88 144.61 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.669 -0.696 . . . . 1.16 110.869 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.6 153.26 18.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.48 110.023 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 25.1 mmt180 -106.86 154.44 21.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.151 -0.477 . . . . 3.18 110.411 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.4 t -89.19 144.0 26.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -23.85 22.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.766 0.317 . . . . 0.75 111.331 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -95.22 -17.58 21.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 1.43 111.232 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 9.5 p -150.84 -177.2 5.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.138 -0.69 . . . . 0.79 109.138 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.17 119.33 38.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.577 -0.283 . . . . 0.47 110.525 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.92 149.36 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.086 -0.506 . . . . 0.4 110.226 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.32 112.21 18.31 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.54 -0.541 . . . . 0.45 109.54 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -152.69 162.07 41.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.284 -0.416 . . . . 0.61 110.779 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -91.41 136.6 32.99 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.42 -0.585 . . . . 0.42 109.42 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -59.83 -36.04 76.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.68 109.975 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -72.2 -22.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 3.33 111.777 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 87.6 m -90.38 -23.44 21.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.54 111.284 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -102.07 -21.07 14.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.942 -0.303 . . . . 0.61 111.526 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -131.08 149.06 72.67 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.766 -0.457 . . . . 0.8 109.766 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.56 147.17 60.24 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.692 2.261 . . . . 2.12 111.447 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.64 61.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.203 -0.908 . . . . 3.3 112.664 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.27 -10.82 86.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.672 . . . . 1.46 112.771 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -73.44 130.04 39.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.694 0.283 . . . . 1.03 110.5 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.7 t -88.86 136.64 32.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.584 -0.525 . . . . 1.6 109.584 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -79.48 126.82 80.23 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.047 -0.524 . . . . 2.68 110.391 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.86 135.77 31.05 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.363 2.042 . . . . 1.14 111.513 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -29.36 73.85 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.737 -0.665 . . . . 1.9 112.186 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -139.38 133.24 30.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.144 -0.317 . . . . 2.75 110.144 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.07 57.19 1.61 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.524 -0.846 . . . . 0.82 112.342 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.53 123.91 22.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.498 -0.556 . . . . 0.87 109.498 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.77 140.36 49.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.482 -0.326 . . . . 2.65 110.801 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.34 169.48 12.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.409 -0.96 . . . . 0.49 108.409 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.08 -34.63 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.851 0.751 . . . . 4.09 111.158 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -64.22 -44.9 90.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 1.54 110.978 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.4 m -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.72 111.136 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.3 m -88.73 15.26 8.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 1.25 110.695 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 C-N-CA 121.051 -0.595 . . . . 2.19 111.715 179.811 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 110.303 -0.258 . . . . 3.18 110.303 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 9.4 t -82.07 104.78 12.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.705 -0.48 . . . . 0.53 109.705 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.17 -11.09 79.17 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.969 -0.559 . . . . 0.65 113.008 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 t -67.54 -28.0 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.056 0.455 . . . . 1.04 110.67 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.39 -34.7 2.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.84 110.866 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.27 -6.91 24.97 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.818 -0.706 . . . . 0.77 112.132 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 9.1 m-20 -102.16 145.71 29.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 2.1 111.086 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.89 3.87 30.41 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.382 -0.687 . . . . 0.55 111.382 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -63.4 121.05 12.84 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.397 0.279 . . . . 1.06 110.871 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 56.89 52.3 9.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.774 0.797 . . . . 2.23 109.806 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.447 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.0 p -89.91 146.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 1.16 110.566 -176.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.84 161.89 13.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.239 -0.437 . . . . 0.48 110.324 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 11.3 tpt180 -135.01 134.51 40.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.241 -0.651 . . . . 3.18 109.241 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 29.4 t -66.43 141.13 58.03 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 119.761 -0.776 . . . . 0.37 109.919 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -81.95 -15.62 53.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 0.75 111.093 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -111.18 -9.4 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 1.43 110.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.46 173.82 11.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.123 0.487 . . . . 0.79 110.305 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.29 111.49 24.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.898 -0.779 . . . . 0.47 108.898 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -167.19 125.22 1.28 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.013 -0.539 . . . . 0.4 110.117 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.447 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.15 112.24 24.43 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.152 -0.684 . . . . 0.45 109.152 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 41.9 p90 -150.01 160.9 43.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.213 -0.448 . . . . 0.61 110.435 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -98.44 134.41 41.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.29 -0.633 . . . . 0.42 109.29 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -64.35 -31.93 73.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.575 -0.739 . . . . 0.68 109.856 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -72.26 -28.25 63.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.71 . . . . 3.33 110.915 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 58.8 m -80.46 -23.03 40.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.54 110.88 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -88.97 -44.42 10.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.18 -0.463 . . . . 0.61 110.578 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -122.59 78.65 47.22 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.928 -0.578 . . . . 0.8 110.653 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.01 -5.37 17.09 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.045 2.496 . . . . 2.12 111.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.65 -8.41 56.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 3.3 111.587 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.42 24.08 11.68 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.501 -0.857 . . . . 1.46 112.482 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -65.59 141.29 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.787 0.327 . . . . 1.03 110.624 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.0 m -89.16 131.65 35.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 1.6 110.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 142.03 85.16 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 2.68 111.183 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 149.62 55.13 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.706 2.271 . . . . 1.14 112.556 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.57 -6.04 41.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.736 -0.665 . . . . 1.9 111.651 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.6 p -89.12 46.6 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.558 0.694 . . . . 2.75 110.127 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 90.38 121.63 2.34 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.142 -0.935 . . . . 0.82 110.907 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' C' ' 51' ' ' LEU . 2.0 tm? -64.24 125.3 24.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.443 -0.577 . . . . 0.87 109.443 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 94.9 mtt180 -112.96 142.99 45.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 2.65 110.377 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 22.0 p -78.45 -178.26 5.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.49 109.789 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -60.87 -45.51 94.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.672 0.272 . . . . 4.09 110.581 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.6 t -63.13 -41.63 99.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 1.54 110.788 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 62.4 m -69.75 -33.48 72.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.636 0.255 . . . . 0.72 111.278 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -76.78 -14.03 59.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.155 0.503 . . . . 1.25 109.839 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 CA-C-N 115.688 -0.687 . . . . 2.19 112.585 175.952 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.68 -0.489 . . . . 3.18 109.68 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 33.7 t -74.73 103.49 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.852 -0.796 . . . . 0.53 108.852 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.24 -14.03 80.94 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 115.877 -0.602 . . . . 0.65 113.536 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 59.6 t -68.37 -37.03 77.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.943 0.401 . . . . 1.04 110.661 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.08 -28.28 7.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.39 . . . . 0.84 110.678 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.21 56.52 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.158 -0.544 . . . . 0.77 112.098 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 17.7 t70 -110.29 155.21 22.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 2.1 111.019 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.08 21.03 4.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.937 -0.649 . . . . 0.55 112.148 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -80.79 124.4 29.03 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.722 -0.473 . . . . 1.06 109.722 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.59 53.8 9.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 122.025 0.917 . . . . 2.23 109.352 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.438 HG22 ' N ' ' C' ' 34' ' ' PHE . 3.9 p -93.61 141.26 15.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.033 -0.985 . . . . 1.16 110.606 -172.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' C' ' 36' ' ' TRP . 78.2 mt -84.9 153.81 22.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.822 0.344 . . . . 0.48 110.403 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -116.47 140.17 49.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.919 -0.582 . . . . 3.18 110.957 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 13.8 t -74.41 139.24 43.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.635 -0.506 . . . . 0.37 109.635 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 26.0 p -89.54 -23.68 21.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.875 0.369 . . . . 0.75 111.328 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -94.08 -20.77 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 1.43 111.18 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.17 -172.74 4.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.942 -0.762 . . . . 0.79 108.942 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.81 114.56 28.47 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.176 -0.305 . . . . 0.47 110.176 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.12 135.34 6.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.378 . . . . 0.4 110.687 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.68 123.54 48.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.45 109.545 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 23.8 p90 -159.75 153.26 22.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.365 -0.38 . . . . 0.61 110.68 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -93.62 130.4 39.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.598 -0.889 . . . . 0.42 108.598 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 67.0 t-105 -60.95 -34.29 74.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.68 110.623 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.02 -38.58 82.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 3.33 111.269 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 85.4 m -70.02 -26.83 64.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.54 110.688 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 39' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' C' ' 54' ' ' ARG . 4.3 m-70 -89.8 -53.5 4.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.61 111.957 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.77 143.65 30.44 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.305 -0.407 . . . . 0.8 111.003 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.1 169.67 14.65 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.056 2.504 . . . . 2.12 112.011 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.77 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.343 -0.844 . . . . 3.3 111.835 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.8 -30.07 72.61 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.804 -0.712 . . . . 1.46 111.833 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.0 m -79.02 135.86 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.672 0.272 . . . . 1.03 110.479 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.2 t -89.64 151.89 21.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.514 -0.312 . . . . 1.6 110.262 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.589 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 22.2 mtp180 -88.76 115.73 64.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.675 -0.491 . . . . 2.68 109.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.37 132.02 34.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.499 2.132 . . . . 1.14 112.116 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.33 -26.28 59.82 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.408 -0.677 . . . . 1.9 111.408 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 13.9 p -133.24 139.85 47.18 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.308 0.243 . . . . 2.75 110.754 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.05 51.3 19.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.698 -0.763 . . . . 0.82 112.377 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 122.85 15.99 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.685 -0.487 . . . . 0.87 109.685 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -116.05 142.26 47.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.916 0.389 . . . . 2.65 110.997 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.511 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -79.6 -172.04 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.49 110.205 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' C' ' 39' ' ' HIS . 42.9 ttp180 -60.67 -52.06 66.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.689 0.28 . . . . 4.09 111.276 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -65.16 -43.17 92.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.357 -0.383 . . . . 1.54 111.512 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.7 m -71.37 -26.77 62.94 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.169 -0.212 . . . . 0.72 111.471 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -87.44 -13.92 41.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.113 0.482 . . . . 1.25 110.451 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 C-N-CA 120.88 -0.676 . . . . 2.19 112.063 -178.799 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 120.586 0.232 . . . . 3.18 110.529 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 35.9 t -70.28 118.59 13.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.53 109.975 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.84 76.39 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.65 113.154 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.22 -46.69 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 1.04 111.329 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.66 -34.96 16.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 0.84 111.71 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.3 -20.97 44.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.872 -0.68 . . . . 0.77 111.914 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.67 150.26 21.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.609 0.242 . . . . 2.1 110.531 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.08 11.58 11.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.878 -0.677 . . . . 0.55 112.323 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.9 m -80.26 133.22 35.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.795 -0.446 . . . . 1.06 109.795 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.27 48.94 14.14 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 122.141 0.972 . . . . 2.23 109.33 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -90.42 139.66 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.312 -0.858 . . . . 1.16 110.833 -174.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.32 144.37 25.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.394 -0.821 . . . . 0.48 109.421 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -117.92 142.74 47.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.373 -0.376 . . . . 3.18 110.792 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.92 133.08 44.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.525 -0.546 . . . . 0.37 109.525 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 31.6 p -84.58 -15.58 45.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 0.75 111.318 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -101.2 -20.75 15.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 1.43 111.486 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.06 -166.58 2.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.51 -0.552 . . . . 0.79 109.51 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.67 114.92 29.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.755 0.312 . . . . 0.47 110.373 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.89 128.32 3.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.4 110.627 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -101.38 111.94 24.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.26 -0.644 . . . . 0.45 109.26 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -152.57 -175.05 5.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.42 -0.355 . . . . 0.61 110.083 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m80 -129.83 161.27 31.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.511 -0.922 . . . . 0.42 108.511 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -58.01 -53.31 59.71 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 121.187 -0.205 . . . . 0.68 111.287 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -56.43 -45.2 80.85 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.048 0.759 . . . . 3.33 113.048 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 0.1 OUTLIER -66.46 -21.6 66.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.164 0.431 . . . . 0.54 112.164 -173.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -109.17 -36.49 6.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.012 -0.275 . . . . 0.61 111.73 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.26 139.02 33.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.774 0.321 . . . . 0.8 110.923 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.03 156.58 63.83 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.621 2.214 . . . . 2.12 111.637 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -15.32 53.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.108 -0.951 . . . . 3.3 112.596 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.86 79.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.946 -0.645 . . . . 1.46 111.971 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -85.02 136.17 33.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.8 -0.444 . . . . 1.03 109.8 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -88.47 126.28 35.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 1.6 110.557 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -78.85 122.33 84.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 2.68 111.082 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.15 141.6 57.98 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.446 2.097 . . . . 1.14 111.547 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.4 -28.3 52.88 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.839 -0.696 . . . . 1.9 112.672 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -141.1 61.31 1.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.091 0.472 . . . . 2.75 110.851 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.23 46.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.517 -0.849 . . . . 0.82 112.352 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.81 123.84 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.295 0.569 . . . . 0.87 110.541 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -125.54 133.22 52.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.777 -0.647 . . . . 2.65 110.299 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -73.37 179.1 4.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.509 -0.552 . . . . 0.49 109.509 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -37.98 76.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.21 0.448 . . . . 4.09 112.21 -172.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -70.38 -51.62 28.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.845 0.355 . . . . 1.54 111.459 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 55.9 m -73.5 -18.01 61.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.778 0.658 . . . . 0.72 112.778 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -76.36 -14.34 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 1.25 111.438 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.106 0 C-N-CA 120.246 -0.978 . . . . 2.19 112.499 -178.557 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.958 0.408 . . . . 3.18 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -70.39 114.39 8.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.478 -0.783 . . . . 0.53 109.802 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.64 62.57 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.504 -0.379 . . . . 0.65 113.265 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.43 -30.13 29.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 1.04 110.796 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 79.6 m -108.6 -28.41 9.31 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.51 0.559 . . . . 0.84 112.51 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.06 9.91 86.13 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.202 -0.759 . . . . 0.77 111.202 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.85 145.83 50.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.226 -0.487 . . . . 2.1 110.275 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.59 24.63 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.831 -0.699 . . . . 0.55 112.749 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -77.65 122.85 25.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.874 -0.417 . . . . 1.06 109.874 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 54.86 49.14 18.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.311 0.577 . . . . 2.23 110.094 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.56 145.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.739 -0.664 . . . . 1.16 110.18 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.91 146.71 23.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.025 0.44 . . . . 0.48 110.095 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 26' ' ' ARG . 12.2 mmt180 -110.79 148.01 33.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 3.18 110.069 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.4 t -79.12 139.82 37.96 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 0.37 108.681 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 60.1 p -89.92 -24.5 21.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.29 0.567 . . . . 0.75 110.724 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -89.88 -20.79 22.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 1.43 111.19 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.6 p -150.9 -171.77 4.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.796 -0.816 . . . . 0.79 108.796 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.7 115.43 30.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.376 -0.231 . . . . 0.47 110.376 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.84 153.69 14.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.4 110.514 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 118.86 23.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.525 0.516 . . . . 0.45 110.114 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -158.02 154.9 28.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.16 -0.473 . . . . 0.61 110.529 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m170 -86.65 133.12 33.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.347 -0.983 . . . . 0.42 108.347 172.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' C' ' 46' ' ' ARG . 70.0 t-105 -49.67 -53.08 26.49 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.244 0.34 . . . . 0.68 111.338 -174.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 64.9 mtp180 -62.3 -23.48 66.76 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.316 0.488 . . . . 3.33 112.316 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -79.97 -22.08 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.918 0.39 . . . . 0.54 111.185 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -103.95 -44.19 5.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.61 110.665 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 71.1 m-85 -119.07 136.35 24.32 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.583 -0.735 . . . . 0.8 109.821 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 21.6 Cg_exo -65.65 157.5 58.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.442 2.094 . . . . 2.12 111.291 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -12.22 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 3.3 112.174 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.11 -25.28 74.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.751 -0.737 . . . . 1.46 111.384 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -85.29 125.84 33.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.03 110.131 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -87.57 131.84 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.474 -0.33 . . . . 1.6 110.158 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' CZ2' ' C' ' 36' ' ' TRP . 19.3 ptp180 -70.75 132.75 86.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 2.68 110.775 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.98 132.61 30.68 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.942 2.428 . . . . 1.14 112.421 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.35 -12.22 60.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.829 -0.7 . . . . 1.9 111.718 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 9.5 p -90.07 10.72 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 2.75 111.147 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 139.08 117.29 1.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 0.82 111.94 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -63.36 123.28 18.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.522 -0.547 . . . . 0.87 109.522 178.211 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 81.6 mtm180 -120.9 133.59 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 2.65 111.248 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -78.48 162.8 26.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.989 -0.745 . . . . 0.49 108.989 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.23 -38.48 18.6 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.459 0.54 . . . . 4.09 112.459 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -64.64 -50.13 68.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.994 0.426 . . . . 1.54 110.758 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 82.5 m -72.67 -29.41 63.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.961 -0.563 . . . . 0.72 111.722 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.1 p -82.79 1.1 40.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 1.25 110.718 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 120.848 -0.692 . . . . 2.19 111.674 176.778 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.633 0.254 . . . . 3.18 111.024 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -69.59 107.95 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.53 110.08 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.33 66.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.448 -0.406 . . . . 0.65 113.017 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.91 -31.93 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.09 0.472 . . . . 1.04 110.576 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.0 -32.54 7.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.268 0.47 . . . . 0.84 112.268 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.29 16.46 58.98 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.156 -0.778 . . . . 0.77 111.156 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.86 144.47 41.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.412 -0.394 . . . . 2.1 110.355 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.86 9.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.55 112.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.9 m -80.72 128.46 33.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.953 -0.388 . . . . 1.06 109.953 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 56.28 47.15 19.81 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.607 0.567 . . . . 2.23 109.743 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.459 HG21 ' HB1' ' C' ' 33' ' ' ALA . 7.7 p -89.35 142.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.16 110.561 -175.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.24 144.33 25.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.009 0.433 . . . . 0.48 109.951 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 25.6 tpt180 -114.16 138.06 50.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.681 -0.691 . . . . 3.18 109.559 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -70.82 139.85 51.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.325 -0.62 . . . . 0.37 109.325 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.6 p -91.57 -17.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.199 -0.455 . . . . 0.75 111.46 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -103.03 -16.82 15.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.297 -0.411 . . . . 1.43 111.052 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.3 -172.51 4.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.934 -0.765 . . . . 0.79 108.934 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.48 114.42 28.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.737 0.303 . . . . 0.47 110.271 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.573 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -158.4 146.34 18.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.4 110.053 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -125.85 112.98 16.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.458 . . . . 0.45 109.959 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.05 159.84 39.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.85 -0.614 . . . . 0.61 110.008 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.85 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.4 m80 -92.84 143.69 26.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.108 -1.071 . . . . 0.42 108.108 171.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -48.17 -53.11 17.96 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.379 0.424 . . . . 0.68 111.593 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -61.27 -20.45 62.89 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.121 -0.491 . . . . 3.33 112.259 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.85 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 13.8 m -84.2 -20.54 32.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.204 -0.453 . . . . 0.54 111.119 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -114.29 -33.23 5.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.326 -0.397 . . . . 0.61 111.655 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.46 148.3 65.93 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.31 -0.405 . . . . 0.8 110.19 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.0 146.73 72.11 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.504 2.136 . . . . 2.12 111.57 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.9 -11.76 57.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 3.3 111.653 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.32 -29.79 74.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.706 -0.759 . . . . 1.46 111.379 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -82.27 138.79 34.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.383 -0.599 . . . . 1.03 109.383 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.2 t -88.29 140.59 29.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.154 0.502 . . . . 1.6 110.397 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -72.81 110.95 9.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.326 -0.852 . . . . 2.68 110.088 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.93 145.2 44.75 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.674 2.249 . . . . 1.14 112.621 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.58 8.6 30.27 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.223 -0.751 . . . . 1.9 111.223 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -117.56 33.58 5.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.154 0.502 . . . . 2.75 110.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.53 78.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.636 -0.792 . . . . 0.82 112.355 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.25 122.29 17.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.262 -0.644 . . . . 0.87 109.262 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -120.27 140.66 50.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.529 -0.305 . . . . 2.65 110.538 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.2 p -74.61 176.63 6.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.29 -0.633 . . . . 0.49 109.29 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.55 -41.98 95.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.491 0.186 . . . . 4.09 111.029 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.1 m -64.75 -46.12 83.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.54 111.358 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.53 -17.35 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.41 . . . . 0.72 111.035 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -88.94 -5.21 58.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.391 -0.368 . . . . 1.25 110.318 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 C-N-CA 120.986 -0.626 . . . . 2.19 112.363 -178.547 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.454 -0.943 . . . . 3.18 108.454 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.7 t -56.96 107.74 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.146 0.279 . . . . 0.53 110.654 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.37 -16.6 62.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.271 -0.49 . . . . 0.65 112.661 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.29 -30.38 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.008 0.433 . . . . 1.04 110.679 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.6 m -108.35 -24.71 11.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.159 0.429 . . . . 0.84 112.159 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.2 15.15 80.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.788 -0.72 . . . . 0.77 111.431 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.72 136.15 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.598 -0.301 . . . . 2.1 110.422 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.09 16.55 38.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.55 112.719 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -77.61 131.84 37.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.901 -0.407 . . . . 1.06 109.901 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 39.1 t70 55.99 46.22 22.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.94 0.876 . . . . 2.23 109.577 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.81 149.25 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.194 -0.912 . . . . 1.16 110.09 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.0 157.08 17.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.306 -0.406 . . . . 0.48 110.18 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -117.2 143.78 45.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.782 -0.644 . . . . 3.18 110.109 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.88 141.18 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.712 -0.477 . . . . 0.37 109.712 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.5 p -82.29 -28.76 31.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.253 -0.431 . . . . 0.75 111.764 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -95.75 -17.11 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.883 0.327 . . . . 1.43 111.883 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.64 -172.28 4.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.79 110.053 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.36 114.01 27.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.025 -0.534 . . . . 0.47 109.678 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.96 119.86 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.4 110.321 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.58 112.32 24.4 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.538 -0.541 . . . . 0.45 109.538 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.65 168.43 26.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.404 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.6 m170 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.316 -0.994 . . . . 0.42 108.316 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -56.51 -38.62 72.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.68 111.438 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -66.72 -27.27 67.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 3.33 111.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 32.7 m -86.92 -22.38 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.977 -0.556 . . . . 0.54 111.48 -172.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -95.96 -31.03 13.29 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.875 -0.33 . . . . 0.61 111.162 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -128.8 78.63 75.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.268 . . . . 0.8 110.339 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.84 -41.63 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.983 2.455 . . . . 2.12 112.846 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.21 -54.74 4.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.441 -0.345 . . . . 3.3 111.28 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.71 59.59 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.64 -0.791 . . . . 1.46 111.68 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -81.36 96.79 7.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.168 0.509 . . . . 1.03 111.473 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -141.28 92.74 2.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.905 -0.776 . . . . 1.6 108.905 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -57.79 118.65 27.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 2.68 111.216 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.32 133.32 22.5 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.628 2.218 . . . . 1.14 112.596 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.48 -10.37 79.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.059 -0.591 . . . . 1.9 111.88 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.9 p -94.83 35.52 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.0 0.429 . . . . 2.75 111.191 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.8 136.03 9.17 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.907 -0.663 . . . . 0.82 112.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -72.33 122.61 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.485 -0.561 . . . . 0.87 109.485 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.8 131.57 54.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 2.65 110.503 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -74.96 -179.79 4.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.46 . . . . 0.49 110.039 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -59.97 -49.42 77.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.505 0.187 . . . . 4.09 111.505 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.8 t -64.1 -41.55 97.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.577 -0.283 . . . . 1.54 111.049 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 79.2 m -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.72 110.896 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.6 m -89.19 2.4 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.48 -0.327 . . . . 1.25 110.663 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.305 0 C-N-CA 120.83 -0.7 . . . . 2.19 111.638 175.713 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.967 -0.383 . . . . 3.18 109.967 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 7.1 t -82.86 104.81 13.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.53 109.939 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.4 -8.31 75.21 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.007 -0.542 . . . . 0.65 113.405 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.466 HG11 ' O ' ' C' ' 38' ' ' CYS . 43.5 t -71.46 -29.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.051 0.453 . . . . 1.04 110.523 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.4 p -120.43 -34.03 3.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.297 -0.41 . . . . 0.84 110.529 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 -13.01 23.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.126 -0.559 . . . . 0.77 111.825 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' C' ' 22' ' ' THR . 15.7 t70 -95.97 152.71 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.269 . . . . 2.1 110.796 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.93 14.08 5.22 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.55 113.12 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' THR . . . . . 0.546 HG22 ' OD2' ' C' ' 20' ' ' ASP . 9.5 t -81.7 136.34 35.48 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.178 0.489 . . . . 1.06 109.904 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.71 49.84 17.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.912 0.863 . . . . 2.23 109.496 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 p -89.08 136.96 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.272 -0.876 . . . . 1.16 110.028 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.54 149.73 25.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 0.48 110.668 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.468 HH11 ' HB2' ' C' ' 33' ' ' ALA . 23.8 mmm180 -116.95 129.83 56.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.944 -0.571 . . . . 3.18 110.464 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.0 140.48 58.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.37 109.77 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 42.8 p -89.17 -20.13 24.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.999 0.428 . . . . 0.75 111.292 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -94.06 -22.32 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 1.43 111.134 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.59 -168.44 3.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.069 -0.715 . . . . 0.79 109.069 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.81 114.65 29.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.833 0.349 . . . . 0.47 110.103 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -156.64 131.11 8.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.4 110.465 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.468 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -109.73 111.83 23.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.78 -0.645 . . . . 0.45 109.623 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.9 p90 -155.63 166.51 33.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.61 110.047 -178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.451 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -102.33 133.3 47.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.775 -0.824 . . . . 0.42 108.775 171.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.68 -41.4 81.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.68 110.924 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.21 -29.06 68.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 3.33 111.352 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.466 ' O ' HG11 ' C' ' 17' ' ' VAL . 93.8 m -74.71 -22.0 59.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.086 0.47 . . . . 0.54 110.474 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -96.66 -56.03 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.12 -0.491 . . . . 0.61 111.12 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.18 147.94 38.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.928 -0.578 . . . . 0.8 110.22 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.88 163.91 29.1 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.656 2.237 . . . . 2.12 111.976 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -14.83 59.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.268 -0.878 . . . . 3.3 112.468 -171.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.88 -16.54 80.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.789 -0.72 . . . . 1.46 111.802 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.99 127.85 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.552 -0.536 . . . . 1.03 109.552 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.6 p -88.2 138.09 31.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 1.6 111.254 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 55.8 ttp180 -76.72 120.43 81.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.437 -0.801 . . . . 2.68 110.305 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 47' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.2 Cg_exo -68.72 131.66 23.24 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.242 1.961 . . . . 1.14 111.476 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.6 -40.88 6.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.846 -0.692 . . . . 1.9 111.614 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -115.46 70.57 0.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.42 0.628 . . . . 2.75 110.702 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.05 51.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.66 -0.7 . . . . 0.82 111.714 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.43 122.89 19.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.665 -0.494 . . . . 0.87 109.665 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.06 137.16 53.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 2.65 110.918 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.522 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.4 p -77.22 -179.65 5.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.172 -0.677 . . . . 0.49 109.172 173.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.7 -45.13 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 4.09 110.952 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -65.24 -53.06 50.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.055 -0.521 . . . . 1.54 111.572 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.31 -16.41 62.45 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.72 111.399 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 31.8 t -83.57 6.53 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 1.25 110.448 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 120.677 -0.773 . . . . 2.19 113.045 176.372 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 . . . . . 0 CA--C 1.518 -0.282 0 N-CA-C 109.319 -0.622 . . . . 3.18 109.319 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.65 109.87 1.83 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.255 -0.429 . . . . 0.53 109.858 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.84 -29.61 58.89 Favored Glycine 0 CA--C 1.52 0.365 0 O-C-N 123.512 0.507 . . . . 0.65 113.63 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.5 -34.18 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 1.04 111.135 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -100.79 -31.77 11.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.482 0.549 . . . . 0.84 112.482 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.32 31.4 59.27 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.364 -1.095 . . . . 0.77 110.364 -170.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.65 154.08 40.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.228 -0.486 . . . . 2.1 110.676 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.98 28.84 5.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.975 -0.631 . . . . 0.55 112.68 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -79.53 128.12 32.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.786 -0.449 . . . . 1.06 109.786 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 53.71 47.73 23.1 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.53 0.681 . . . . 2.23 109.823 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.416 HG22 ' N ' ' C' ' 34' ' ' PHE . 1.1 p -89.66 149.82 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.258 -0.883 . . . . 1.16 110.506 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.0 mt -100.89 151.93 21.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.321 -0.4 . . . . 0.48 110.101 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -111.54 135.15 52.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.899 -0.592 . . . . 3.18 110.24 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.6 t -66.52 142.99 57.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.586 -0.524 . . . . 0.37 109.586 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.7 p -93.42 -24.62 17.99 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.322 0.49 . . . . 0.75 112.322 -176.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -97.56 -15.67 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.206 0.527 . . . . 1.43 110.336 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.8 OUTLIER -150.31 -175.25 5.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.615 -0.883 . . . . 0.79 108.615 175.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.83 114.29 28.43 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.891 0.376 . . . . 0.47 110.666 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.36 142.88 14.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.4 109.807 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.33 117.23 28.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.528 0.517 . . . . 0.45 109.962 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.416 ' N ' HG22 ' C' ' 24' ' ' VAL . 33.0 p90 -156.61 167.77 29.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.827 0.346 . . . . 0.61 110.772 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.493 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.8 m170 -97.77 123.86 41.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.493 -0.929 . . . . 0.42 108.493 172.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -58.01 -32.53 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.723 -0.671 . . . . 0.68 110.74 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -76.64 -19.47 57.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 3.33 111.873 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 74.9 m -87.36 -21.94 25.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.26 0.552 . . . . 0.54 110.018 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -90.01 -53.35 4.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.61 110.353 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -115.98 143.99 31.92 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.647 -0.706 . . . . 0.8 109.993 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -173.59 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.685 2.256 . . . . 2.12 113.064 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.86 67.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 3.3 111.167 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.49 -17.73 62.5 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.164 -0.541 . . . . 1.46 112.514 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.77 130.51 45.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.859 0.361 . . . . 1.03 110.592 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 t -89.53 150.25 22.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.385 -0.371 . . . . 1.6 110.235 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -87.79 120.34 70.86 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.89 -0.595 . . . . 2.68 110.595 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.08 134.18 26.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 1.14 111.379 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 -43.41 20.0 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.771 -0.65 . . . . 1.9 113.018 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.8 p -111.42 -14.41 13.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.904 0.352 . . . . 2.75 111.865 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.41 57.03 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.577 -0.82 . . . . 0.82 112.448 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.9 OUTLIER -76.1 121.82 23.38 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -123.47 131.82 53.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.114 0.483 . . . . 2.65 111.56 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.401 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -73.76 179.83 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.647 -0.706 . . . . 0.49 109.551 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -57.89 -40.1 79.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.762 0.282 . . . . 4.09 111.762 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.7 t -69.31 -47.92 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.986 0.422 . . . . 1.54 111.04 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.21 -21.63 61.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.72 111.812 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -102.47 16.07 27.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.489 -0.56 . . . . 1.25 109.489 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.795 0 CA-C-N 115.667 -0.697 . . . . 2.19 112.122 -179.781 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.314 -0.624 . . . . 3.18 109.314 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 46.8 t -67.69 104.62 1.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.916 -0.402 . . . . 0.53 109.916 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.19 -19.99 79.72 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.65 113.218 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.75 -43.11 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.756 0.312 . . . . 1.04 111.23 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p -108.76 -29.78 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.387 . . . . 0.84 110.896 -177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.5 56.24 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.871 -0.681 . . . . 0.77 111.998 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 10.2 m-20 -97.17 145.35 26.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 2.1 110.615 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.27 17.25 10.54 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.049 -0.596 . . . . 0.55 112.091 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -80.1 135.49 36.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.926 -0.398 . . . . 1.06 109.926 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 48.3 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.974 0.892 . . . . 2.23 109.344 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.69 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.194 -0.912 . . . . 1.16 110.315 -174.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 85.5 mt -91.87 154.27 18.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.902 0.382 . . . . 0.48 110.551 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -122.27 130.62 53.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.584 -0.735 . . . . 3.18 109.749 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -68.69 136.31 52.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.37 109.746 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.0 p -87.96 -19.49 27.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.103 0.478 . . . . 0.75 110.998 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -93.21 -24.97 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 1.43 111.116 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.9 p -151.13 -163.99 1.9 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.465 -0.569 . . . . 0.79 109.465 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 114.78 29.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.47 110.227 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 138.74 10.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.4 110.498 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -122.06 112.85 18.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.777 -0.647 . . . . 0.45 109.343 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 44.6 p90 -155.7 170.25 22.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.151 -0.477 . . . . 0.61 110.183 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -105.75 133.82 49.87 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.507 -0.553 . . . . 0.42 109.507 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.7 t-105 -60.25 -36.8 78.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.652 -0.703 . . . . 0.68 110.073 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -68.44 -34.17 75.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.625 -0.716 . . . . 3.33 110.93 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.74 -22.71 56.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.54 110.874 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 2.8 m170 -90.47 -42.26 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 0.61 111.582 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.8 77.3 29.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.484 -0.325 . . . . 0.8 111.284 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 7.1 Cg_exo -74.54 4.17 4.73 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.146 2.564 . . . . 2.12 112.284 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.57 -7.27 59.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 3.3 110.873 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 28.04 11.17 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.598 -0.811 . . . . 1.46 112.109 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 15.3 m -69.42 144.05 53.45 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.979 -0.378 . . . . 1.03 109.979 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.4 t -88.24 143.93 26.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 1.6 110.536 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -92.72 117.62 67.64 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.436 -0.802 . . . . 2.68 111.453 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.99 132.89 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.714 2.276 . . . . 1.14 111.56 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.92 5.04 68.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.756 -0.735 . . . . 1.9 112.548 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -89.63 -75.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.338 0.59 . . . . 2.75 111.106 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.37 101.37 0.57 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.485 -0.78 . . . . 0.82 111.658 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.18 128.25 34.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.978 0.418 . . . . 0.87 110.354 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -114.08 135.17 54.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.198 -0.455 . . . . 2.65 110.364 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.523 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 14.3 p -74.39 176.57 6.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.432 -0.581 . . . . 0.49 109.432 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' C' ' 55' ' ' SER . 8.1 ptm85 -58.5 -43.91 89.25 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 4.09 111.527 -175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' SER . . . . . 0.457 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 20.2 m -65.86 -46.53 78.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.655 -0.248 . . . . 1.54 111.148 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.9 m -72.37 -22.58 61.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.72 111.569 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -81.41 -13.95 57.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.015 0.436 . . . . 1.25 110.02 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.295 -0.722 . . . . 2.19 111.295 178.063 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.701 0.286 . . . . 3.18 110.353 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 43.0 t -75.2 104.93 5.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.396 -0.594 . . . . 0.53 109.396 177.069 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.8 -12.42 84.2 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.65 113.631 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 87.2 t -67.19 -41.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 1.04 110.736 178.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 p -106.67 -28.44 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 0.84 110.919 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.77 1.47 55.2 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.859 -0.686 . . . . 0.77 112.092 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 19.5 m-20 -107.2 147.38 30.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.493 . . . . 2.1 111.812 -178.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 2.4 22.78 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.862 -0.895 . . . . 0.55 110.862 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 22' ' ' THR . . . . . 0.416 HG22 ' HB3' ' C' ' 20' ' ' ASP . 13.4 t -72.91 134.64 44.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.659 -0.271 . . . . 1.06 110.438 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.62 47.17 21.29 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.53 0.681 . . . . 2.23 109.922 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.6 p -89.59 148.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.148 -0.933 . . . . 1.16 110.668 -173.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.438 HD12 ' H ' ' C' ' 36' ' ' TRP . 90.4 mt -100.01 155.8 17.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.227 -0.442 . . . . 0.48 110.21 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.0 mmm180 -114.6 153.82 29.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.74 -0.664 . . . . 3.18 109.424 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -89.39 141.77 28.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.262 0.553 . . . . 0.37 110.433 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -81.17 -26.62 35.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 0.75 112.168 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 29' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' C' ' 56' ' ' CYS . 11.8 m170 -102.61 -14.93 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.982 -0.287 . . . . 1.43 111.614 -176.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.1 p -150.95 -174.6 4.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.964 -0.384 . . . . 0.79 109.964 178.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 115.03 29.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.405 -0.362 . . . . 0.47 110.227 -178.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.56 135.1 4.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.384 -0.371 . . . . 0.4 111.043 -177.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 111.87 24.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.329 -0.619 . . . . 0.45 109.329 172.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -156.45 169.95 23.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.003 -0.544 . . . . 0.61 110.076 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 28.5 m170 -106.95 130.75 54.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.114 -0.698 . . . . 0.42 109.114 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.438 ' H ' HD12 ' C' ' 25' ' ' LEU . 42.3 t-105 -59.15 -36.75 75.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.68 -0.691 . . . . 0.68 110.092 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -70.67 -25.39 62.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.993 -0.549 . . . . 3.33 111.432 -178.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 84.2 m -83.83 -27.36 28.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 0.54 110.83 178.247 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -89.59 -29.06 19.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.806 0.336 . . . . 0.61 110.911 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.46 71.27 76.98 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.058 -0.519 . . . . 0.8 110.251 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.86 13.68 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.185 2.59 . . . . 2.12 112.64 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.36 4.46 35.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 3.3 111.397 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.18 17.98 38.21 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.589 -0.815 . . . . 1.46 111.518 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.7 m -74.24 130.04 38.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 1.03 110.853 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -88.95 137.91 31.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.716 -0.476 . . . . 1.6 109.716 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -72.69 136.5 80.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 2.68 111.069 -175.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.63 149.34 61.16 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.176 2.584 . . . . 1.14 112.653 -175.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.8 18.91 56.3 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.855 -0.688 . . . . 1.9 112.443 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -116.33 37.28 3.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.329 0.585 . . . . 2.75 110.471 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.62 129.77 6.45 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.786 -0.721 . . . . 0.82 111.769 -177.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -71.18 124.01 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.723 -0.473 . . . . 0.87 109.723 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.35 136.81 52.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.729 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.61 162.64 28.99 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.072 -1.084 . . . . 0.49 108.072 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -59.87 -31.96 70.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.838 0.745 . . . . 4.09 111.405 -170.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -64.88 -44.88 88.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.745 0.307 . . . . 1.54 110.588 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 56' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' C' ' 29' ' ' HIS . 86.7 m -72.75 -17.86 61.56 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.798 0.295 . . . . 0.72 111.798 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -89.08 -13.0 39.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.482 -0.487 . . . . 1.25 110.192 176.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 C-N-CA 120.985 -0.626 . . . . 2.19 112.025 179.131 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.116 -0.698 . . . . 3.18 109.116 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.93 104.07 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.829 -0.434 . . . . 0.53 109.829 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -3.62 90.6 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.65 112.548 -175.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.73 -41.68 54.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.044 0.45 . . . . 1.04 110.543 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.34 -29.23 8.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.84 110.243 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.47 45.04 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.886 -0.673 . . . . 0.77 112.252 179.529 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -96.13 147.85 23.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.914 0.387 . . . . 2.1 111.142 -177.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.28 15.82 13.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.107 -0.568 . . . . 0.55 112.531 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -80.79 127.9 33.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.449 -0.204 . . . . 1.06 110.449 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.3 t70 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.638 0.732 . . . . 2.23 110.492 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -89.39 135.19 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.849 -0.614 . . . . 1.16 111.124 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.15 158.96 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.361 -0.836 . . . . 0.48 109.545 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -117.24 134.77 54.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 3.18 110.713 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.57 138.87 55.46 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.16 -0.682 . . . . 0.37 109.16 177.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.1 p -91.24 -20.88 21.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.204 0.526 . . . . 0.75 110.781 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.75 -24.14 21.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.43 110.844 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.7 -169.07 3.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.434 -0.58 . . . . 0.79 109.434 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.11 114.86 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.314 -0.254 . . . . 0.47 110.314 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.54 3.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.25 -0.432 . . . . 0.4 110.479 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.64 121.75 45.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.534 0.521 . . . . 0.45 109.633 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.17 173.24 16.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.386 . . . . 0.61 111.24 -174.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -105.1 125.31 50.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.368 -0.604 . . . . 0.42 109.368 173.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -62.04 -31.69 72.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.878 -0.601 . . . . 0.68 109.746 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.92 -24.22 61.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.796 -0.638 . . . . 3.33 111.458 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -88.02 -22.79 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.54 110.617 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.85 -42.65 11.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.158 -0.474 . . . . 0.61 111.107 -178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -122.65 147.33 50.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.8 110.794 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.12 170.07 13.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.025 2.483 . . . . 2.12 112.074 177.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -18.12 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.643 . . . . 3.3 111.338 -177.177 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.26 -13.9 82.38 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 1.46 112.161 176.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -92.74 132.55 36.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.796 0.331 . . . . 1.03 110.548 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 m -88.66 136.24 33.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.283 -0.417 . . . . 1.6 110.674 -177.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -81.92 121.81 79.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.646 . . . . 2.68 110.369 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 47' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 42.3 Cg_endo -69.81 149.16 66.22 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.419 2.079 . . . . 1.14 111.572 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -33.48 5.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.45 -0.881 . . . . 1.9 113.238 -175.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -105.75 -38.05 6.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 2.75 111.501 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.94 72.07 0.21 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.768 -0.729 . . . . 0.82 112.336 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 0.4 OUTLIER -75.41 121.97 23.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -122.56 134.39 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 2.65 111.09 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -74.36 176.92 6.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.584 -0.734 . . . . 0.49 109.38 173.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -61.13 -37.32 82.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.048 0.386 . . . . 4.09 110.292 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -65.06 -51.89 58.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 1.54 110.972 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 77.5 m -71.98 -19.54 61.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.552 0.215 . . . . 0.72 111.369 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -78.74 -14.09 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.114 0.483 . . . . 1.25 109.754 178.584 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 110.534 -1.026 . . . . 2.19 110.534 173.035 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.843 -0.429 . . . . 3.18 109.843 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 11.2 t -79.68 103.77 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.258 -0.645 . . . . 0.53 109.258 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.66 -18.4 75.71 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.65 113.367 -171.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 48.3 t -64.39 -32.78 59.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.735 0.303 . . . . 1.04 111.104 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -118.09 -33.84 4.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.907 0.384 . . . . 0.84 110.819 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.62 -13.98 24.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.775 -0.726 . . . . 0.77 112.24 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 11.5 m-20 -87.61 131.6 34.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 2.1 110.911 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.41 -1.9 33.09 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.314 -0.714 . . . . 0.55 111.314 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -76.94 135.43 38.76 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 110.081 -0.34 . . . . 1.06 110.081 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.88 45.96 20.53 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.435 0.636 . . . . 2.23 109.784 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.61 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.151 -0.931 . . . . 1.16 110.048 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.39 146.2 25.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.897 0.379 . . . . 0.48 110.242 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -113.92 132.47 55.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.925 -0.579 . . . . 3.18 110.165 -175.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -63.52 130.72 45.56 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.658 -0.497 . . . . 0.37 109.658 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 48.4 p -85.92 -5.81 59.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.75 110.983 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -108.42 -21.46 12.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 1.43 111.209 -178.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.8 p -152.28 -163.51 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.726 -0.472 . . . . 0.79 109.726 176.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.56 114.93 29.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.161 -0.311 . . . . 0.47 110.161 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.48 128.47 1.81 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.429 -0.351 . . . . 0.4 110.473 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.69 112.56 25.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.744 0.653 . . . . 0.45 109.771 176.34 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -154.72 167.58 29.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.395 -0.366 . . . . 0.61 110.339 -176.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.8 m170 -106.06 138.56 42.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.964 -0.754 . . . . 0.42 108.964 172.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -61.79 -33.73 74.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 0.68 110.385 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -74.64 -25.29 59.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 3.33 111.452 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.7 m -83.67 -22.77 32.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.124 0.488 . . . . 0.54 110.597 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -96.88 -49.62 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.075 -0.512 . . . . 0.61 111.517 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 96.3 m-85 -110.95 149.62 40.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.757 0.313 . . . . 0.8 111.003 -173.197 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 16.6 Cg_exo -67.86 158.21 58.33 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.617 2.211 . . . . 2.12 110.881 174.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.19 -7.96 34.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.954 -0.566 . . . . 3.3 111.521 -177.351 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.18 -12.22 84.57 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.536 -0.626 . . . . 1.46 111.536 174.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 37.5 m -95.15 135.08 37.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.26 -0.274 . . . . 1.03 110.26 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 p -89.05 136.13 33.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.987 0.422 . . . . 1.6 111.257 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -80.96 127.93 72.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 2.68 110.604 -177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.03 140.47 37.99 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.874 2.383 . . . . 1.14 112.046 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.43 25.56 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.011 -0.614 . . . . 1.9 111.984 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 74.1 1.48 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.886 0.374 . . . . 2.75 110.545 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 61.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.739 -0.743 . . . . 0.82 112.212 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 122.7 18.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.938 0.399 . . . . 0.87 110.074 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -117.4 134.33 54.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.231 -0.44 . . . . 2.65 110.884 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -81.08 169.67 17.16 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.66 -0.867 . . . . 0.49 108.66 171.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -51.94 -47.17 64.86 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.415 0.447 . . . . 4.09 111.419 -174.19 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -63.72 -45.05 91.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.917 -0.583 . . . . 1.54 111.762 -176.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 95.6 m -71.77 -31.11 66.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.72 111.433 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 44.5 p -85.41 7.23 23.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.718 -0.219 . . . . 1.25 111.026 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 121.22 -0.514 . . . . 2.19 113.115 -176.763 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.4 ttp180 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.862 0.363 . . . . 3.18 110.746 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.37 111.79 5.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.592 . . . . 0.53 109.938 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.42 -31.94 71.51 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.477 0.486 . . . . 0.65 113.128 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.34 -37.54 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.366 . . . . 1.04 110.923 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.43 -39.95 9.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.256 0.465 . . . . 0.84 112.256 -175.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.86 6.41 65.44 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.73 -0.748 . . . . 0.77 111.423 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.82 149.1 42.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.793 0.33 . . . . 2.1 110.434 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -107.62 12.25 38.99 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.55 112.943 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 m -80.13 128.06 33.05 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.665 -0.315 . . . . 1.06 111.085 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.06 51.11 7.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.493 -0.776 . . . . 2.23 111.161 177.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -90.15 145.31 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.721 . . . . 1.16 111.227 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 78.0 mt -101.11 143.98 30.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.275 -0.875 . . . . 0.48 109.175 175.046 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 137.2 49.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.637 0.256 . . . . 3.18 110.465 -178.571 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -64.57 135.21 55.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.16 -19.02 29.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.181 0.515 . . . . 0.75 110.88 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -97.47 -18.08 19.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.43 111.332 -177.111 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.53 -168.6 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.288 -0.634 . . . . 0.79 109.288 176.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.25 114.89 29.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.663 0.268 . . . . 0.47 110.603 -178.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -172.13 136.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.4 109.936 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -122.05 122.83 40.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.296 0.372 . . . . 0.45 110.004 177.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -160.07 169.51 23.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.033 -0.53 . . . . 0.61 110.294 -176.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.3 m170 -95.91 130.68 42.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.002 -1.111 . . . . 0.42 108.002 171.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -56.12 -37.28 69.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.68 111.684 -177.33 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -72.17 -15.15 61.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 3.33 111.614 -177.669 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.6 m -90.89 -22.52 20.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.197 -0.456 . . . . 0.54 110.676 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -94.19 -40.78 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 0.61 110.494 175.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.72 79.55 31.29 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.8 110.178 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -83.55 11.34 3.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.814 2.342 . . . . 2.12 112.862 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.92 0.76 52.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 3.3 111.187 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.05 23.77 37.03 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 1.46 111.661 -176.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -61.88 149.52 40.15 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.606 0.362 . . . . 1.03 110.67 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -87.74 121.7 30.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.74 0.305 . . . . 1.6 110.524 -176.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 11.5 ttp180 -64.48 120.39 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 2.68 110.967 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 17.4 Cg_exo -65.14 132.26 31.28 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.431 2.088 . . . . 1.14 111.703 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.53 -15.95 38.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.787 -0.721 . . . . 1.9 111.835 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.3 p -97.07 37.3 1.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 2.75 111.003 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.55 113.5 2.17 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.82 111.829 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.85 123.52 29.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.735 -0.468 . . . . 0.87 109.735 -177.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -112.19 148.04 34.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.046 0.45 . . . . 2.65 110.724 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 22.0 p -93.9 178.01 5.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.105 -0.702 . . . . 0.49 109.105 175.098 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -58.73 -33.47 70.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.886 0.312 . . . . 4.09 111.142 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -69.77 -51.56 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 1.54 111.24 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -71.98 -17.72 62.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.319 -0.4 . . . . 0.72 111.341 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -92.23 -1.23 57.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.48 . . . . 1.25 110.283 173.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-N 115.921 -0.581 . . . . 2.19 112.04 -179.949 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 110.145 -0.317 . . . . 3.18 110.145 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 t -63.15 106.12 0.81 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.53 109.515 175.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.37 -31.61 57.02 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.41 0.444 . . . . 0.65 113.492 -175.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.03 -34.44 70.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.074 0.464 . . . . 1.04 111.043 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.81 -38.14 7.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.052 0.39 . . . . 0.84 112.052 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.96 -9.2 59.81 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.585 -0.606 . . . . 0.77 111.585 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.41 146.18 37.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.954 0.407 . . . . 2.1 111.191 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.13 12.96 40.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.067 -0.813 . . . . 0.55 111.067 174.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -73.94 128.55 35.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.444 . . . . 1.06 110.375 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 55.57 47.13 21.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.669 0.747 . . . . 2.23 109.651 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.04 153.78 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.25 -0.887 . . . . 1.16 110.744 -174.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -107.48 144.26 34.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.48 109.834 176.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 144.64 40.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.124 -0.489 . . . . 3.18 110.166 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.1 t -68.51 140.11 55.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.393 -0.595 . . . . 0.37 109.393 177.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.5 p -90.43 -18.65 25.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.897 0.379 . . . . 0.75 110.895 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -92.83 -24.2 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 1.43 111.077 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.3 p -150.38 -173.1 4.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.036 -0.727 . . . . 0.79 109.036 178.165 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.93 118.76 37.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.582 0.229 . . . . 0.47 110.437 -178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.24 135.99 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.4 110.233 -177.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.33 112.76 22.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 0.45 110.11 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -153.99 166.61 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.062 -0.517 . . . . 0.61 109.873 -177.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.763 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.3 m170 -97.71 140.32 32.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.42 108.638 173.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -49.18 -53.5 20.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.413 0.446 . . . . 0.68 111.615 -175.333 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -72.34 -5.55 37.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 3.33 112.136 -173.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -91.45 -21.26 21.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.896 0.379 . . . . 0.54 110.63 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -108.4 -29.5 8.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.61 110.941 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.62 138.55 29.54 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.8 110.511 -177.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.5 148.6 93.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.544 2.162 . . . . 2.12 111.068 173.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -18.76 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 3.3 112.079 -174.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 -16.51 71.14 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.087 -0.578 . . . . 1.46 111.853 175.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.1 m -90.59 130.77 36.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.498 -0.556 . . . . 1.03 109.498 176.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.43 143.54 26.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 1.6 110.993 -174.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.34 125.2 86.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 2.68 110.789 -177.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.08 163.5 39.02 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.044 2.496 . . . . 1.14 112.413 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.27 7.1 8.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.853 -0.689 . . . . 1.9 111.92 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -108.92 -1.82 18.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 2.75 110.856 -178.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.74 120.87 0.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.025 -0.607 . . . . 0.82 111.673 -177.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 122.68 25.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 0.87 109.771 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -111.17 134.9 52.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.436 -0.347 . . . . 2.65 110.937 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -75.69 166.56 23.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.614 -0.884 . . . . 0.49 108.614 170.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -63.42 -30.54 71.65 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.744 . . . . 4.09 110.871 -172.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -65.12 -45.23 85.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.927 178.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.1 m -72.76 -31.2 64.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.72 111.9 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -83.53 -1.62 54.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 1.25 111.542 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 C-N-CA 120.875 -0.678 . . . . 2.19 111.608 -178.566 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' C' ' 19' ' ' GLY . 49.1 ttp180 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 3.18 109.88 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 31.3 t -70.91 103.0 2.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.084 -0.71 . . . . 0.53 109.084 176.021 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.12 1.8 83.6 Favored Glycine 0 CA--C 1.509 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.65 112.748 -174.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 32.0 t -77.17 -28.72 16.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.096 0.474 . . . . 1.04 110.091 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.9 p -123.6 -35.46 2.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.84 111.019 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' C' ' 14' ' ' ARG . . . 109.91 2.51 30.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.962 -0.637 . . . . 0.77 112.266 -178.352 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 8.7 m-20 -107.39 140.44 40.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 2.1 111.232 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.59 -1.99 30.8 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.55 111.522 175.365 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -74.86 135.19 41.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.06 110.059 178.106 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.34 41.05 16.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.927 0.394 . . . . 2.23 110.277 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.483 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.9 p -88.29 146.05 6.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 1.16 110.636 -174.162 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 77.1 mt -105.96 159.29 16.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.029 -0.532 . . . . 0.48 110.379 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 14.0 mmt180 -126.39 143.18 51.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 3.18 109.717 -178.16 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 35.3 t -70.63 146.53 49.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.864 -0.734 . . . . 0.37 109.066 173.338 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.464 HG21 ' HA2' ' C' ' 50' ' ' GLY . 28.7 p -84.79 -27.0 27.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.101 0.477 . . . . 0.75 110.812 177.276 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -98.4 -12.4 21.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 1.43 111.091 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 m -139.55 172.76 12.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.033 0.444 . . . . 0.79 110.279 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 113.69 27.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.659 -0.7 . . . . 0.47 109.388 174.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.12 134.74 3.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.485 -0.325 . . . . 0.4 110.601 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -100.72 111.98 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.759 -0.655 . . . . 0.45 109.57 175.049 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.06 164.71 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.0 -0.545 . . . . 0.61 110.23 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 32.5 m170 -104.63 138.57 40.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.598 -0.519 . . . . 0.42 109.598 174.787 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -63.93 -34.46 78.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.76 -0.655 . . . . 0.68 109.74 178.016 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -76.64 -15.51 59.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.586 . . . . 3.33 111.072 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 97.8 m -92.29 -22.45 19.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.54 110.507 176.35 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -93.96 -41.82 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.843 -0.617 . . . . 0.61 111.632 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -119.95 147.32 44.1 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.985 -0.552 . . . . 0.8 111.242 -171.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.76 164.33 27.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.003 2.468 . . . . 2.12 111.503 174.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.05 -15.54 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 3.3 112.184 -174.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -10.23 85.46 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.809 -0.71 . . . . 1.46 112.459 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.4 m -87.19 137.5 32.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.856 0.36 . . . . 1.03 110.72 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -89.65 131.82 35.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.328 -0.396 . . . . 1.6 110.841 -177.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -89.94 123.15 66.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 2.68 110.915 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.78 133.63 22.29 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.325 2.017 . . . . 1.14 111.266 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.42 -47.06 10.98 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.1 -0.571 . . . . 1.9 112.961 -174.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -118.96 60.08 0.82 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.133 0.492 . . . . 2.75 110.779 -177.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 164.07 57.17 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.356 -0.698 . . . . 0.82 111.356 -177.24 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.52 124.98 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.374 0.607 . . . . 0.87 110.587 -176.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.37 145.56 31.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.625 -0.716 . . . . 2.65 110.602 -177.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 21.4 p -89.66 -169.37 2.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.064 -0.516 . . . . 0.49 109.998 178.001 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.7 -53.0 63.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.574 0.226 . . . . 4.09 110.84 -179.154 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 41.4 t -61.22 -42.92 99.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.54 110.971 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.19 -16.93 62.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.105 0.409 . . . . 0.72 112.105 -176.582 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 43.5 m -101.1 4.73 42.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.072 0.463 . . . . 1.25 110.627 177.112 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.762 0 C-N-CA 120.847 -0.692 . . . . 2.19 112.115 -179.613 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.825 -0.435 . . . . 3.18 109.825 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 39.6 t -65.37 105.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.713 -0.477 . . . . 0.53 109.713 177.762 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.89 66.17 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.268 -0.492 . . . . 0.65 112.901 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -32.19 56.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.04 110.97 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -106.71 -37.83 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.84 111.91 -176.072 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.58 -23.63 35.4 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.317 -0.713 . . . . 0.77 111.317 -174.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -86.79 148.93 25.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 2.1 111.027 -178.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.82 12.71 35.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.55 111.888 177.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 47.8 m -73.9 124.25 25.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.373 0.13 . . . . 1.06 111.174 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 55.69 66.76 1.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.072 0.857 . . . . 2.23 111.118 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -108.48 142.3 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 1.16 111.362 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' C' ' 36' ' ' TRP . 34.4 mt -82.27 144.35 30.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.662 . . . . 0.48 110.51 178.322 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.43 145.81 29.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.576 -0.738 . . . . 3.18 110.307 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.14 136.75 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.666 -0.494 . . . . 0.37 109.666 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -88.56 -5.19 58.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.75 111.648 -178.119 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -113.72 -20.21 11.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 1.43 110.812 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.82 -171.95 4.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.157 -0.682 . . . . 0.79 109.157 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.04 29.8 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.691 -0.485 . . . . 0.47 109.691 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 155.39 24.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.311 -0.404 . . . . 0.4 110.619 -178.041 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.13 124.59 17.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.872 -0.604 . . . . 0.45 109.979 178.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -163.84 161.08 22.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.471 -0.331 . . . . 0.61 110.354 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.71 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.91 127.54 36.03 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.373 -0.973 . . . . 0.42 108.373 172.606 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.475 ' HB2' HD12 ' C' ' 25' ' ' LEU . 68.1 t-105 -45.58 -53.51 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.483 0.489 . . . . 0.68 112.01 -174.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -60.37 -30.22 69.42 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.125 0.417 . . . . 3.33 112.125 -174.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.1 m -73.54 -22.46 60.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 0.54 111.004 -177.608 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -103.29 -44.98 5.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 0.61 110.935 178.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 88.3 m-85 -116.82 122.74 31.12 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.983 -0.553 . . . . 0.8 110.217 -176.354 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.5 176.59 5.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 2.12 111.853 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.69 -10.79 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.65 . . . . 3.3 112.047 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.95 -26.08 74.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.872 -0.68 . . . . 1.46 111.713 174.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 41.7 m -101.73 135.45 43.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.226 -0.287 . . . . 1.03 110.226 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -89.17 154.53 20.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.767 0.318 . . . . 1.6 110.332 -178.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -88.36 112.23 48.48 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 2.68 110.757 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.62 142.78 44.99 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.838 2.358 . . . . 1.14 111.909 177.466 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.13 -32.4 23.33 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.463 -0.655 . . . . 1.9 111.463 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.0 p -125.64 150.91 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.93 -0.396 . . . . 2.75 109.93 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.43 39.6 80.11 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.65 -0.786 . . . . 0.82 111.971 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.79 124.77 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.557 -0.534 . . . . 0.87 109.557 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -117.31 148.17 41.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.156 -0.475 . . . . 2.65 110.81 -177.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -83.25 -176.68 6.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 0.49 109.458 173.381 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -63.04 -39.47 94.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.104 0.478 . . . . 4.09 110.286 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 36.3 t -66.23 -53.98 30.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.889 -0.596 . . . . 1.54 111.142 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.92 -17.1 62.12 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.453 0.538 . . . . 0.72 112.453 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -108.21 19.62 19.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.053 0.454 . . . . 1.25 110.345 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.865 0 C-N-CA 120.185 -1.007 . . . . 2.19 112.587 -178.011 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.992 -1.114 . . . . 3.18 107.992 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.7 t -58.04 106.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.51 0.195 . . . . 0.53 110.688 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.42 -28.54 73.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.244 -0.503 . . . . 0.65 112.619 -178.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.49 -39.47 85.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.453 . . . . 1.04 110.744 178.663 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.46 -21.44 17.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.197 -0.456 . . . . 0.84 111.619 -177.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.87 74.91 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.946 -0.862 . . . . 0.77 110.946 -174.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.34 144.92 30.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.342 . . . . 2.1 110.189 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.13 24.92 9.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.55 112.853 -178.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 m -80.25 129.56 34.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.736 -0.468 . . . . 1.06 109.736 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 55.24 56.01 6.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.718 0.771 . . . . 2.23 109.728 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.86 148.73 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.35 -0.841 . . . . 1.16 110.809 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 96.1 mt -94.64 150.79 19.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 0.48 110.544 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.2 mmt180 -117.3 152.14 35.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.793 -0.64 . . . . 3.18 110.191 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.564 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 17.9 t -81.72 138.75 35.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.654 -0.499 . . . . 0.37 109.654 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.5 p -81.7 -23.23 36.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.585 -0.28 . . . . 0.75 111.726 -177.584 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.52 -18.7 14.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.939 0.348 . . . . 1.43 111.939 -176.358 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.564 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.4 p -150.71 -173.89 4.61 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.626 -0.509 . . . . 0.79 109.626 177.739 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.32 125.36 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.566 0.222 . . . . 0.47 110.455 -178.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.83 151.46 7.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.4 110.22 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -137.63 112.6 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.461 0.476 . . . . 0.45 110.19 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.59 165.6 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.61 110.094 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.5 m170 -98.27 132.77 43.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 0.42 108.328 171.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -47.49 -53.49 14.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.306 0.484 . . . . 0.68 112.306 -173.142 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -70.47 -20.85 62.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.854 0.359 . . . . 3.33 111.783 -173.33 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.7 m -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.173 0.511 . . . . 0.54 110.102 177.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 39' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 1.2 m170 -93.26 -51.3 5.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.61 110.535 176.416 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -111.71 91.37 14.65 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.793 -0.639 . . . . 0.8 110.404 -177.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 83.1 Cg_endo -97.32 3.48 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.957 2.438 . . . . 2.12 112.358 176.208 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.71 55.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 3.3 112.286 -172.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.76 41.51 2.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.408 -0.901 . . . . 1.46 112.367 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.923 -0.399 . . . . 1.03 109.923 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -88.01 122.45 31.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.669 0.271 . . . . 1.6 110.567 -177.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -69.68 112.86 13.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 2.68 111.117 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 47' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 55.2 Cg_endo -72.18 143.22 39.38 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.361 2.041 . . . . 1.14 112.141 177.674 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.55 -11.94 54.64 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.859 -0.686 . . . . 1.9 112.173 178.013 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 14.4 p -95.28 -70.63 0.7 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.374 0.607 . . . . 2.75 111.461 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.56 77.07 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.82 112.445 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 1.4 tm? -70.94 123.08 21.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.11 -0.7 . . . . 0.87 109.11 177.104 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -112.91 146.92 38.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 2.65 110.91 -176.442 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 21.1 p -83.57 -174.27 5.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.649 -0.871 . . . . 0.49 108.649 170.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 54' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' C' ' 54' ' ' ARG . 43.7 ttp180 -67.89 -43.89 78.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.495 -0.482 . . . . 4.09 110.101 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -59.32 -49.5 77.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.813 -0.63 . . . . 1.54 111.183 -178.091 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.2 m -70.41 -16.33 62.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.803 0.335 . . . . 0.72 111.557 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -90.2 -8.75 50.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 1.25 110.445 176.346 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 C-N-CA 120.981 -0.628 . . . . 2.19 112.211 -178.732 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 108.864 -0.791 . . . . 3.18 108.864 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.3 t -71.45 103.47 2.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.553 -0.536 . . . . 0.53 109.553 178.624 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.38 -4.1 77.57 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-N 115.927 -0.579 . . . . 0.65 112.28 -175.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 36.8 t -67.78 -29.11 43.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.247 0.546 . . . . 1.04 109.704 177.244 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.42 -38.42 3.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.84 110.163 176.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.54 -5.94 26.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.993 -0.623 . . . . 0.77 111.823 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 21.1 t70 -108.29 146.64 32.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.886 0.374 . . . . 2.1 110.704 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.15 16.57 9.99 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.17 -0.538 . . . . 0.55 112.083 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -80.26 133.39 35.98 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 122.828 -0.219 . . . . 1.06 110.512 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.41 56.12 8.43 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.448 0.642 . . . . 2.23 109.813 -175.359 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' C' ' 33' ' ' ALA . 5.5 p -96.29 146.83 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 1.16 110.798 -172.218 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -86.85 144.05 27.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.102 0.477 . . . . 0.48 109.864 177.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -107.99 143.79 36.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.559 -0.746 . . . . 3.18 109.945 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 t -74.89 137.81 42.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.407 -0.59 . . . . 0.37 109.407 177.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 47.9 p -91.16 -19.62 22.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.116 0.484 . . . . 0.75 110.914 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -91.7 -24.11 19.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 1.43 110.792 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.58 -165.94 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.131 -0.692 . . . . 0.79 109.131 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 114.56 28.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.75 0.31 . . . . 0.47 110.35 177.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.79 142.88 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.4 110.607 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.62 117.15 32.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.854 -0.612 . . . . 0.45 109.514 176.577 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.409 ' HB2' ' NE2' ' C' ' 39' ' ' HIS . 37.7 p90 -147.43 156.28 42.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.61 110.943 -175.759 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -103.25 132.21 49.69 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.999 -0.741 . . . . 0.42 108.999 173.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -57.85 -40.23 79.65 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.68 110.881 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' C' ' 37' ' ' ARG . 43.8 mtm105 -72.62 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.475 -0.33 . . . . 3.33 111.463 -177.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 86.3 m -72.76 -23.36 60.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.54 111.001 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 39' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' C' ' 34' ' ' PHE . 10.7 m170 -96.47 -53.71 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.61 110.747 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 87.5 m-85 -113.07 142.8 27.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.944 -0.571 . . . . 0.8 110.649 -174.286 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 32.0 Cg_exo -60.08 155.06 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.78 2.32 . . . . 2.12 111.348 174.302 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -14.67 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 3.3 112.618 -172.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.73 3.26 87.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.089 -0.577 . . . . 1.46 112.392 177.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -92.62 136.43 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.572 -0.529 . . . . 1.03 109.572 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 25.9 m -88.97 130.3 35.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.969 0.414 . . . . 1.6 111.218 -175.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -81.0 117.43 68.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.788 -0.642 . . . . 2.68 110.595 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.06 146.13 51.41 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.91 2.407 . . . . 1.14 112.595 -177.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.1 -9.85 56.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.83 -0.7 . . . . 1.9 111.503 176.205 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -93.24 47.84 1.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 2.75 111.781 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.91 123.25 4.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.912 -0.661 . . . . 0.82 112.928 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 127.89 34.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.87 110.65 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -108.66 133.31 52.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 2.65 110.953 -178.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.7 p -73.19 178.5 4.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.187 -0.671 . . . . 0.49 109.187 172.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -56.16 -43.51 78.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.677 0.275 . . . . 4.09 111.605 -175.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -68.18 -50.19 55.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.586 -0.279 . . . . 1.54 111.621 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.3 m -68.37 -17.07 64.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.831 0.308 . . . . 0.72 111.831 -177.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -98.98 9.5 43.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.388 . . . . 1.25 110.833 177.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.585 -0.817 . . . . 2.19 111.923 178.366 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.851 -0.426 . . . . 3.18 109.851 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 t -76.62 104.31 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.157 -0.683 . . . . 0.53 109.157 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.62 89.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.739 -0.664 . . . . 0.65 112.756 -173.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 22.3 t -76.73 -29.0 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 1.04 110.287 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.06 -51.69 2.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.232 -0.44 . . . . 0.84 110.278 178.147 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -13.13 4.0 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.734 -0.746 . . . . 0.77 112.596 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.09 151.17 23.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.117 0.484 . . . . 2.1 111.752 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.52 21.25 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.55 111.866 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -77.15 116.18 17.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.431 0.158 . . . . 1.06 110.881 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 56.12 65.26 1.48 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.478 0.656 . . . . 2.23 110.762 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.4 134.88 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.16 111.075 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -77.9 146.49 35.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.339 -0.846 . . . . 0.48 109.672 176.118 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -113.32 140.45 48.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 3.18 110.337 -174.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' C' ' 51' ' ' LEU . 7.7 t -69.38 125.03 25.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.054 -0.721 . . . . 0.37 109.054 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 13.2 t -79.42 -5.55 54.92 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.141 0.496 . . . . 0.75 111.163 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -111.69 -22.67 11.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.43 111.758 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.7 p -150.17 -171.77 4.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.79 109.766 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.36 115.45 28.49 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.871 0.367 . . . . 0.47 110.454 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.01 143.48 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.952 -0.567 . . . . 0.4 110.523 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.77 116.16 23.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.616 -0.513 . . . . 0.45 109.616 177.231 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.96 163.85 39.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.386 -0.37 . . . . 0.61 110.498 -174.395 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.0 m170 -100.79 145.98 27.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.878 -0.416 . . . . 0.42 109.878 174.11 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -52.81 -53.83 42.84 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.504 0.503 . . . . 0.68 110.827 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 66.8 mtt180 -70.07 -19.54 63.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 3.33 112.09 -174.082 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 89.3 m -77.09 -21.04 54.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.162 0.506 . . . . 0.54 110.484 177.142 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -103.23 -52.37 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.285 0.564 . . . . 0.61 110.647 176.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 53.7 m-85 -113.26 125.56 29.52 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.456 -0.793 . . . . 0.8 109.356 -178.092 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -52.28 148.73 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.619 2.213 . . . . 2.12 111.753 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -18.06 14.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.804 . . . . 3.3 112.934 -172.618 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.22 -2.12 61.89 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.071 -0.585 . . . . 1.46 112.488 176.168 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -99.3 142.28 30.99 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.024 -0.362 . . . . 1.03 110.024 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 43.3 m -88.22 124.11 33.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 1.6 111.219 -176.531 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -79.88 129.37 70.87 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 2.68 110.533 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.06 154.08 75.68 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.495 2.13 . . . . 1.14 111.3 176.159 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 -10.24 73.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 1.9 112.619 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 49' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' C' ' 50' ' ' GLY . 17.1 p -93.76 -160.81 0.79 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.782 -0.081 . . . . 2.75 110.782 178.392 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' C' ' 49' ' ' THR . . . -62.73 143.67 48.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.128 -0.558 . . . . 0.82 112.867 -179.021 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 27' ' ' CYS . 0.1 OUTLIER -90.83 144.51 25.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.951 0.405 . . . . 0.87 110.562 -178.503 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -105.68 133.24 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.216 -0.447 . . . . 2.65 109.997 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -72.46 165.16 25.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.772 -0.825 . . . . 0.49 108.772 175.311 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -55.27 -35.89 65.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.246 0.476 . . . . 4.09 111.61 -171.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -65.6 -51.03 62.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.433 -0.348 . . . . 1.54 111.061 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.25 -17.92 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.72 111.117 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -78.86 -14.03 59.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.989 0.423 . . . . 1.25 110.868 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 C-N-CA 120.52 -0.847 . . . . 2.19 112.005 -179.313 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.49 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 28.9 ttm-85 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 120.695 0.283 . . . . 3.18 110.803 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -77.84 114.34 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.877 -0.416 . . . . 0.53 109.877 177.609 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.66 64.8 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.085 -0.578 . . . . 0.65 112.926 -177.622 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -81.85 -32.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.978 0.418 . . . . 1.04 110.723 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.01 -40.26 6.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.148 0.425 . . . . 0.84 112.148 -176.386 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.59 51.36 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.343 -0.703 . . . . 0.77 111.343 -173.757 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.78 151.97 19.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.703 0.287 . . . . 2.1 110.374 177.913 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 21' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.87 21.83 12.08 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.676 -0.773 . . . . 0.55 112.159 178.746 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.03 127.4 32.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.183 . . . . 1.06 111.263 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 t70 55.17 66.47 1.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.587 0.708 . . . . 2.23 110.872 176.895 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 m -108.03 145.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.29 -0.868 . . . . 1.16 111.411 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' C' ' 36' ' ' TRP . 83.4 mt -98.09 144.02 28.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 0.48 110.306 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.4 mpt_? -109.96 153.84 23.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.137 -0.483 . . . . 3.18 110.355 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 34.2 t -71.3 142.69 50.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.228 -0.656 . . . . 0.37 109.228 173.484 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -84.75 -5.61 59.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 0.75 110.704 178.186 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -118.4 -9.36 10.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.43 110.939 178.491 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.72 173.19 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.93 0.395 . . . . 0.79 110.072 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.55 112.82 26.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.361 -0.607 . . . . 0.47 109.361 174.204 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.62 131.14 1.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.624 -0.716 . . . . 0.4 109.485 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.88 122.83 48.02 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.025 0.44 . . . . 0.45 110.655 -178.318 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.3 160.85 41.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.769 -0.65 . . . . 0.61 110.141 -178.635 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.69 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.4 m170 -88.85 133.22 34.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.264 -1.013 . . . . 0.42 108.264 172.724 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.463 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.6 t-105 -61.16 -33.27 73.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.68 111.017 -176.189 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -76.55 -13.75 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.054 0.454 . . . . 3.33 111.184 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 59.5 m -93.05 -22.52 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.082 0.468 . . . . 0.54 110.744 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -95.27 -30.9 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.987 -0.552 . . . . 0.61 110.671 175.505 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.31 158.74 74.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.8 110.274 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.37 156.66 62.12 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.495 2.13 . . . . 2.12 111.091 173.821 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -10.56 55.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.926 -0.579 . . . . 3.3 112.071 -174.169 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.92 -11.74 78.5 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.653 -0.784 . . . . 1.46 111.946 175.478 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -88.69 120.64 30.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.037 0.446 . . . . 1.03 110.644 -179.378 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.0 p -89.32 138.19 31.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.048 -0.524 . . . . 1.6 110.652 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.21 126.44 91.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.486 . . . . 2.68 110.365 -179.501 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 141.09 44.67 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.987 2.458 . . . . 1.14 113.248 -173.348 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.98 0.55 89.41 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.405 -0.816 . . . . 1.9 111.675 177.545 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -88.95 1.53 55.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.116 0.484 . . . . 2.75 110.304 177.077 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.68 131.47 3.25 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.537 -0.756 . . . . 0.82 111.955 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.78 123.06 19.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.019 -0.734 . . . . 0.87 109.019 178.424 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -110.46 130.97 55.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.322 0.582 . . . . 2.65 111.82 -173.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 26.0 p -74.89 -176.78 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.125 -0.943 . . . . 0.49 110.032 175.06 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -64.87 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.77 -0.372 . . . . 4.09 111.287 -175.492 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -68.75 -41.02 79.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.823 0.344 . . . . 1.54 110.429 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 65.1 m -69.01 -23.72 64.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.508 -0.314 . . . . 0.72 111.164 177.659 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -93.43 1.15 56.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 1.25 110.665 177.268 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.465 0 CA-C-N 115.89 -0.595 . . . . 2.19 111.771 179.49 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 . . . . . 0 CA--C 1.516 -0.35 0 N-CA-C 109.439 -0.578 . . . . 3.18 109.439 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -68.82 105.51 2.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.276 -0.638 . . . . 0.53 109.276 175.561 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 -21.02 67.07 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 121.017 -0.611 . . . . 0.65 112.285 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.48 -34.56 58.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.948 0.404 . . . . 1.04 110.627 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -102.23 -33.78 9.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.84 111.639 -177.6 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.93 20.07 51.42 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.579 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -140.06 154.72 47.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 2.1 110.687 -174.228 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.59 21.81 5.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.007 -0.616 . . . . 0.55 112.09 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -80.91 127.15 32.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.028 -0.36 . . . . 1.06 110.028 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 54.36 61.14 3.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.372 0.606 . . . . 2.23 109.737 -177.122 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.28 150.62 5.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.268 -0.878 . . . . 1.16 110.393 -172.719 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.403 HD12 ' H ' ' C' ' 36' ' ' TRP . 81.2 mt -91.79 143.99 25.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.895 -0.409 . . . . 0.48 109.895 179.185 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -108.55 152.45 24.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.635 -0.711 . . . . 3.18 110.173 -177.132 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -84.75 127.27 34.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.28 -0.637 . . . . 0.37 109.28 176.447 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -80.67 -5.89 57.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.206 0.527 . . . . 0.75 110.905 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -106.31 -27.34 11.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 1.43 111.488 -178.74 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.97 -161.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.885 -0.413 . . . . 0.79 109.885 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.1 115.77 31.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.66 0.267 . . . . 0.47 110.616 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.96 151.88 10.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.216 -0.447 . . . . 0.4 110.301 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.69 112.36 9.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.334 -0.394 . . . . 0.45 110.107 179.244 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.8 p90 -156.87 177.22 11.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.18 -0.464 . . . . 0.61 109.862 -177.167 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.695 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 14.7 m170 -109.8 132.82 53.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.763 -0.829 . . . . 0.42 108.763 172.765 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.403 ' H ' HD12 ' C' ' 25' ' ' LEU . 75.9 t-105 -53.6 -53.23 54.68 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.106 0.41 . . . . 0.68 112.106 -171.737 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -60.81 -26.22 67.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.089 0.471 . . . . 3.33 111.359 -176.042 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.695 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.3 m -77.91 -23.66 48.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.069 -0.514 . . . . 0.54 110.809 -178.993 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 -34.37 11.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.61 110.779 179.316 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -126.56 75.9 74.24 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.847 -0.615 . . . . 0.8 110.365 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.43 13.11 2.85 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.985 2.457 . . . . 2.12 112.408 -177.121 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.18 4.31 31.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.931 -0.577 . . . . 3.3 111.413 -178.174 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.73 9.79 60.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.671 -0.776 . . . . 1.46 111.426 -177.113 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 25.7 m -67.64 131.79 46.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.281 . . . . 1.03 110.629 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -88.44 135.29 33.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.342 -0.39 . . . . 1.6 110.026 -178.884 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -72.42 134.41 82.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.298 -0.41 . . . . 2.68 111.018 -176.523 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.49 132.93 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.578 2.185 . . . . 1.14 112.195 178.992 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.86 -13.42 75.08 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.01 -0.836 . . . . 1.9 111.01 175.245 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.5 p -93.06 46.98 1.24 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.122 0.487 . . . . 2.75 111.113 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.48 106.31 3.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.72 . . . . 0.82 112.408 178.736 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.01 124.63 23.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.203 0.525 . . . . 0.87 109.942 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -110.56 135.33 51.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.749 -177.326 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.504 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -77.52 -179.04 5.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.49 109.663 174.289 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -62.19 -46.76 87.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.807 0.337 . . . . 4.09 110.575 -177.955 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -61.63 -45.74 92.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 1.54 111.28 -177.615 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.07 -23.14 61.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.617 0.228 . . . . 0.72 111.617 -179.612 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -80.81 -14.36 58.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 1.25 110.637 177.858 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.846 0 N-CA-C 111.346 -0.701 . . . . 2.19 111.346 177.066 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.1 ttt180 . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.249 -0.278 . . . . 3.18 110.249 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -69.14 109.06 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.857 -0.423 . . . . 0.53 109.857 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.71 -18.24 61.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.377 -0.439 . . . . 0.65 112.771 -177.692 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -79.43 -37.12 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.729 0.3 . . . . 1.04 111.108 178.628 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -97.69 -33.95 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.046 0.387 . . . . 0.84 112.046 -176.421 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.86 -1.33 65.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.603 -0.808 . . . . 0.77 111.639 -175.122 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -119.16 150.43 40.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 2.1 110.345 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.25 24.84 10.28 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.557 -0.83 . . . . 0.55 113.424 -175.004 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -79.0 116.4 19.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.856 0.328 . . . . 1.06 110.657 178.124 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 66.95 1.1 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.744 0.652 . . . . 2.23 111.923 177.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.77 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.205 -0.452 . . . . 1.16 110.542 177.218 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.95 159.46 17.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.48 109.855 174.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -123.89 143.51 50.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 3.18 110.554 -176.066 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -82.14 134.77 35.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.321 -0.622 . . . . 0.37 109.321 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 49.6 p -85.32 -13.5 49.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.75 111.43 -178.64 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -103.52 -21.74 13.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 1.43 111.444 -178.651 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.21 -166.14 2.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 0.79 109.426 178.602 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.97 115.3 30.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.06 -0.348 . . . . 0.47 110.06 178.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.23 134.85 12.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.431 . . . . 0.4 110.205 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.06 115.86 23.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.258 -0.428 . . . . 0.45 110.388 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -160.5 151.73 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.048 -0.524 . . . . 0.61 110.307 -176.994 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.853 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.7 m80 -82.44 136.59 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.985 -1.117 . . . . 0.42 107.985 171.176 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -44.3 -52.17 7.79 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.466 0.479 . . . . 0.68 111.979 -175.699 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -56.44 -34.9 67.26 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.678 0.621 . . . . 3.33 112.678 -175.16 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.853 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 3.4 m -71.71 -21.93 61.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.897 -0.592 . . . . 0.54 111.149 -173.836 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -103.94 -49.66 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.82 -0.627 . . . . 0.61 110.546 176.232 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.9 m-85 -121.43 113.61 32.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.8 110.156 -175.932 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 7.2 Cg_exo -72.54 -172.73 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.922 2.415 . . . . 2.12 113.308 -177.469 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.35 -28.17 62.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 111.935 0.346 . . . . 3.3 111.935 -177.347 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.53 -9.49 55.46 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.244 -0.503 . . . . 1.46 112.743 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 44' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 36.5 m -124.63 116.98 23.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 1.03 110.369 176.997 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -88.37 155.15 19.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.264 -0.426 . . . . 1.6 110.224 -178.896 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -70.25 130.95 88.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 2.68 110.679 -175.262 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.66 147.27 50.77 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.814 2.343 . . . . 1.14 111.988 178.355 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.01 -1.89 88.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.808 -0.711 . . . . 1.9 111.577 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.1 p -94.67 -168.29 1.8 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.534 -0.333 . . . . 2.75 110.86 179.252 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.53 127.13 43.99 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.644 -0.788 . . . . 0.82 111.439 175.568 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.8 122.42 17.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.221 0.534 . . . . 0.87 109.99 -176.928 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.6 135.52 48.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.433 178.902 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.7 p -75.7 172.54 12.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.1 -0.704 . . . . 0.49 109.1 171.777 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -53.56 -41.48 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.026 0.441 . . . . 4.09 111.4 -175.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -68.22 -45.92 71.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.072 -0.513 . . . . 1.54 111.269 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.0 m -72.58 -17.46 61.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.812 0.301 . . . . 0.72 111.812 -177.398 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -87.45 -8.45 56.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 1.25 110.608 174.858 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 C-N-CA 121.11 -0.567 . . . . 2.19 111.823 179.261 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.159 -0.311 . . . . 3.18 110.159 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 41.9 t -76.48 104.39 6.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.53 109.884 179.114 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.72 -6.59 88.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.011 -0.614 . . . . 0.65 112.271 -176.648 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 24.1 t -70.34 -31.65 47.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 1.04 110.664 -179.575 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -112.65 -39.33 4.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.999 0.428 . . . . 0.84 110.196 176.191 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.6 -9.63 9.92 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.612 -0.804 . . . . 0.77 112.08 179.479 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 2.0 m-20 -107.64 139.54 42.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.006 0.431 . . . . 2.1 111.035 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 21' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' C' ' 24' ' ' VAL . . . -107.39 2.81 34.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.03 -0.828 . . . . 0.55 111.03 174.927 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 132.35 45.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.426 -0.387 . . . . 1.06 110.409 179.316 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 56.13 49.71 14.99 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.398 0.618 . . . . 2.23 109.87 -176.612 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' C' ' 21' ' ' GLY . 4.4 p -89.38 151.28 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.343 -0.844 . . . . 1.16 110.602 -175.29 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.7 mt -100.96 160.44 14.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.435 -0.348 . . . . 0.48 110.189 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -126.82 136.03 51.81 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.594 -0.521 . . . . 3.18 109.594 -178.396 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 42.2 t -67.12 143.15 56.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.494 -0.482 . . . . 0.37 110.099 176.389 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.91 -23.35 23.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.049 178.6 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -95.03 -30.24 14.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 1.43 111.05 -178.572 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.0 OUTLIER -137.25 -177.59 4.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.669 -0.493 . . . . 0.79 109.669 -178.397 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.23 114.87 29.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.48 -0.327 . . . . 0.47 110.286 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -168.49 129.87 1.31 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.4 110.538 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -102.9 112.15 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.435 -0.58 . . . . 0.45 109.435 174.117 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -155.0 173.42 16.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.799 -0.637 . . . . 0.61 109.998 -175.392 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.431 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -110.13 135.96 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.169 -0.678 . . . . 0.42 109.169 173.384 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -61.59 -36.27 80.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.551 -0.75 . . . . 0.68 110.45 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -70.39 -26.46 63.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 3.33 111.276 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.8 m -84.23 -26.0 29.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.937 0.399 . . . . 0.54 110.914 178.884 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 39' ' ' HIS . . . . . 0.402 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 1.5 m-70 -89.81 -40.03 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.213 -0.448 . . . . 0.61 111.26 -178.965 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -124.32 71.38 55.64 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.315 -0.402 . . . . 0.8 110.173 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 3.0 Cg_exo -75.43 6.44 3.58 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.134 2.556 . . . . 2.12 113.004 -174.918 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.95 3.77 28.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 3.3 111.165 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.05 32.65 20.15 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.63 -0.795 . . . . 1.46 112.036 -179.708 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 8.6 m -68.3 148.08 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.947 -0.39 . . . . 1.03 109.947 177.658 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -86.57 121.67 29.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.94 0.4 . . . . 1.6 110.504 -175.367 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -66.32 120.09 67.42 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 2.68 110.855 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.62 143.8 38.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.435 2.09 . . . . 1.14 111.859 176.277 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.98 -10.37 42.91 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.73 -0.748 . . . . 1.9 112.526 -179.209 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -96.04 9.76 39.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.803 0.335 . . . . 2.75 111.685 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 117.92 0.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.634 -0.793 . . . . 0.82 112.287 -178.669 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -90.29 123.24 33.9 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.44 -0.578 . . . . 0.87 109.44 179.924 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' C' ' 57' ' ' SER . 28.6 mtm180 -110.46 149.07 30.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.394 0.616 . . . . 2.65 111.62 -178.851 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 30.3 p -102.3 -178.8 3.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.171 -0.922 . . . . 0.49 110.029 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -57.84 -39.1 76.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.507 0.558 . . . . 4.09 112.507 -172.106 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -63.7 -57.3 10.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.88 0.371 . . . . 1.54 111.443 -176.541 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 6.9 p -72.17 -24.58 61.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.233 -0.439 . . . . 0.72 111.699 -174.786 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' C' C ' 57' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' C' ' 52' ' ' ARG . 25.3 t -102.15 19.76 17.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.897 0.379 . . . . 1.25 110.728 -177.119 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.715 0 C-N-CA 120.366 -0.921 . . . . 2.19 112.645 -179.46 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.528 0.204 . . . . 3.18 110.748 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.45 111.22 5.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.53 109.994 178.264 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.03 -19.03 60.88 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.291 -0.48 . . . . 0.65 112.856 -178.026 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.27 -31.08 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.105 0.478 . . . . 1.04 110.682 178.522 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.6 m -109.04 -20.8 12.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.32 0.489 . . . . 0.84 112.32 -175.204 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.4 79.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.174 -0.77 . . . . 0.77 111.174 -174.398 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.17 147.09 37.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.281 -0.459 . . . . 2.1 109.932 -176.538 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.26 30.79 5.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.574 -0.822 . . . . 0.55 113.508 -176.826 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -75.28 121.08 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.237 0.519 . . . . 1.06 110.135 176.276 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 54.41 52.76 11.87 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.65 0.594 . . . . 2.23 110.508 -176.859 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' C' ' 33' ' ' ALA . 8.7 p -88.97 139.45 17.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.091 -0.504 . . . . 1.16 110.635 -173.902 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.09 147.8 25.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.096 -0.502 . . . . 0.48 110.688 -179.073 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.529 HH11 ' HB2' ' C' ' 33' ' ' ALA . 30.7 mmm180 -113.74 149.75 34.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.534 -0.757 . . . . 3.18 109.739 179.71 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 17.6 t -85.2 135.55 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.448 -0.575 . . . . 0.37 109.448 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.9 p -81.94 -18.68 42.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.75 111.171 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -100.5 -22.52 14.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 1.43 111.923 -176.44 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.4 p -150.55 -165.08 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.542 . . . . 0.79 109.535 178.438 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.65 115.58 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.958 -0.386 . . . . 0.47 109.958 179.477 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.36 146.78 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.4 111.273 -177.955 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.529 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -131.71 112.54 12.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.678 -0.692 . . . . 0.45 109.779 177.535 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.17 165.35 36.22 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.121 -0.49 . . . . 0.61 109.74 -177.212 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.786 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.9 m170 -96.71 138.37 34.38 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.297 -1.001 . . . . 0.42 108.297 171.2 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -46.09 -52.53 11.91 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.3 0.375 . . . . 0.68 111.712 -177.903 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.8 mtm180 -70.37 -5.93 31.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.33 112.124 -174.424 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.786 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -91.92 -20.86 20.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.096 0.474 . . . . 0.54 110.66 179.31 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -103.86 -36.17 7.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.61 110.68 174.891 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 92.4 m-85 -121.87 147.28 48.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.8 110.107 -179.405 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.51 159.62 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.519 2.146 . . . . 2.12 111.633 176.463 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -8.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 3.3 111.978 -175.093 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.69 -7.4 87.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.824 -0.703 . . . . 1.46 111.768 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.0 m -98.11 132.6 43.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.838 0.351 . . . . 1.03 110.212 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -88.87 142.21 27.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.386 -0.37 . . . . 1.6 110.2 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -80.63 127.32 75.85 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 2.68 110.796 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.03 135.65 70.01 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.752 2.301 . . . . 1.14 111.743 175.204 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -24.47 61.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.928 -0.653 . . . . 1.9 111.68 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -138.91 135.59 34.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.908 -0.404 . . . . 2.75 109.908 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.8 53.61 4.89 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.68 -0.771 . . . . 0.82 112.225 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.51 122.82 19.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.408 -0.59 . . . . 0.87 109.408 178.061 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -118.91 136.43 54.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.12 -0.491 . . . . 2.65 110.475 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -73.54 170.4 15.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.142 -0.481 . . . . 0.49 109.944 177.058 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -49.4 -48.7 46.92 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.645 0.59 . . . . 4.09 111.911 -174.826 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -63.69 -45.87 88.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.57 -0.286 . . . . 1.54 111.466 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 89.1 m -72.0 -32.36 67.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.741 0.274 . . . . 0.72 111.741 -177.47 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p -80.88 -14.13 58.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 1.25 111.418 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 C-N-CA 120.792 -0.718 . . . . 2.19 112.008 -179.306 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 110.09 -0.337 . . . . 3.18 110.09 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.81 105.44 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.53 109.172 175.469 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.66 62.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.43 -0.414 . . . . 0.65 113.063 -176.23 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.32 -30.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.04 110.964 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -111.17 -18.1 13.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.509 0.559 . . . . 0.84 112.509 -172.934 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.46 26.8 71.98 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.616 -0.993 . . . . 0.77 110.616 -173.209 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -142.78 148.47 37.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.282 -0.459 . . . . 2.1 110.589 -170.897 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.58 25.15 5.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.069 -0.586 . . . . 0.55 111.975 177.805 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -80.6 129.17 34.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.233 -0.284 . . . . 1.06 110.233 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.71 52.06 11.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.177 0.989 . . . . 2.23 108.953 -179.245 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -100.69 149.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.716 -1.129 . . . . 1.16 111.235 -171.507 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.2 mt -91.23 144.04 26.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.073 -0.512 . . . . 0.48 109.896 176.61 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' C' ' 32' ' ' ALA . 4.3 tpp180 -110.9 130.86 55.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.084 -0.507 . . . . 3.18 109.998 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 1.8 t -68.07 134.56 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.7 -0.482 . . . . 0.37 109.7 177.943 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 67.6 p -92.32 -14.85 28.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.75 110.84 -179.543 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -98.16 -18.9 18.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.915 -0.584 . . . . 1.43 111.076 -179.344 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -151.64 -170.61 3.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.07 -0.715 . . . . 0.79 109.07 176.782 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.94 113.9 27.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.538 -0.542 . . . . 0.47 109.538 178.331 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' C' ' 26' ' ' ARG . . . -171.22 137.43 1.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.55 . . . . 0.4 110.298 -178.631 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -119.03 112.89 20.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.081 -0.711 . . . . 0.45 109.081 175.99 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.68 156.7 43.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.053 -0.351 . . . . 0.61 110.053 -178.371 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.29 128.82 35.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.279 -1.008 . . . . 0.42 108.279 172.987 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -47.83 -53.2 16.3 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.502 0.501 . . . . 0.68 111.962 -172.309 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 71.5 mtm180 -68.07 -14.16 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 3.33 112.357 -172.546 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -80.31 -21.79 42.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.54 110.631 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -105.62 -43.72 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.61 110.521 176.46 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 93.6 m-85 -110.53 139.99 22.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.8 110.384 -176.664 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.27 158.62 47.73 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.719 2.279 . . . . 2.12 111.197 177.201 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.4 43.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 3.3 112.293 -173.788 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.73 -31.65 60.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.676 -0.773 . . . . 1.46 111.545 175.298 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 38.0 m -74.59 131.12 40.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.29 -0.263 . . . . 1.03 110.29 179.361 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 9.8 p -88.73 134.83 33.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 1.6 111.189 -175.089 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.81 111.76 14.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.698 . . . . 2.68 110.088 178.257 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.17 136.3 28.98 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.66 2.24 . . . . 1.14 112.863 -174.065 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.29 0.16 71.34 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.904 -0.665 . . . . 1.9 111.652 176.772 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -122.57 83.01 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.812 0.339 . . . . 2.75 111.14 177.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.97 88.75 1.38 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.842 -0.694 . . . . 0.82 112.387 178.932 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -78.14 122.75 26.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.975 -0.75 . . . . 0.87 108.975 178.739 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.541 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 36.4 ptt180 -133.67 135.45 44.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.213 0.53 . . . . 2.65 110.734 -176.204 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.5 p -73.29 173.81 8.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.49 110.367 178.419 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 54' ' ' ARG . . . . . 0.562 ' HA ' ' OG ' ' C' ' 57' ' ' SER . 2.7 ptp180 -63.15 -32.5 73.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.295 0.498 . . . . 4.09 111.426 -174.68 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 1.54 109.838 175.91 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 69.4 m -74.27 -30.23 62.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.694 -0.685 . . . . 0.72 112.829 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' C' C ' 57' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' C' ' 54' ' ' ARG . 19.9 p -75.19 -14.22 60.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 1.25 111.184 -174.815 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 N-CA-C 110.399 -1.08 . . . . 2.19 110.399 174.158 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 107.892 -1.151 . . . . 3.18 107.892 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.09 108.65 1.59 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.631 -0.507 . . . . 0.53 109.631 177.149 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.05 -14.21 55.38 Favored Glycine 0 C--N 1.329 0.145 0 O-C-N 123.372 0.42 . . . . 0.65 113.102 -175.936 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.13 -31.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.082 0.468 . . . . 1.04 110.583 178.186 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.4 m -108.02 -26.35 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.471 . . . . 0.84 112.197 -174.883 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.33 25.25 59.56 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.401 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.97 142.36 32.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.663 -0.268 . . . . 2.1 110.96 -173.56 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.15 16.98 24.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.003 -0.618 . . . . 0.55 112.275 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -80.22 128.93 34.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.934 -0.395 . . . . 1.06 109.934 178.305 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 58.56 40.43 23.71 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.471 0.653 . . . . 2.23 110.36 -178.107 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' C' ' 33' ' ' ALA . 1.5 p -90.37 150.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.272 -0.877 . . . . 1.16 110.422 -175.376 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 92.8 mt -102.25 151.26 22.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.787 -0.449 . . . . 0.48 109.787 177.05 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.2 tpp180 -119.49 140.32 50.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 3.18 110.119 -175.347 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.6 t -73.47 142.88 46.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.923 -0.769 . . . . 0.37 108.923 174.319 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.6 p -96.92 -21.38 17.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 0.75 110.743 178.678 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -89.66 -21.05 22.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.43 110.567 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.4 p -151.18 -175.5 5.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.5 -0.926 . . . . 0.79 108.5 174.806 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 114.61 28.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.651 0.262 . . . . 0.47 110.347 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.44 135.8 6.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.4 110.442 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.18 118.83 36.42 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.707 0.629 . . . . 0.45 110.121 178.377 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.93 151.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.349 -0.387 . . . . 0.61 110.647 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.702 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -82.65 136.13 34.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.628 -0.878 . . . . 0.42 108.628 172.006 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 62.0 t-105 -49.04 -53.65 19.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.255 0.347 . . . . 0.68 111.618 -175.906 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.23 -15.94 64.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.361 0.504 . . . . 3.33 112.361 -173.921 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.4 m -85.35 -21.15 29.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.105 0.478 . . . . 0.54 110.717 -178.822 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -107.56 -45.12 4.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.016 -0.538 . . . . 0.61 111.052 178.048 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.39 146.17 36.8 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.8 110.355 -176.855 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' C' ' 44' ' ' THR . 10.8 Cg_endo -55.82 144.11 78.39 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.01 2.473 . . . . 2.12 111.797 175.594 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -16.24 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.461 -0.791 . . . . 3.3 112.085 -175.144 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.14 -18.82 75.88 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.17 177.373 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' C' ' 41' ' ' PRO . 42.8 m -74.8 147.9 40.8 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.086 -0.339 . . . . 1.03 110.086 178.722 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -88.09 122.01 31.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.849 0.357 . . . . 1.6 110.738 -174.89 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -70.97 120.58 80.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.853 -0.612 . . . . 2.68 110.368 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.67 132.32 32.51 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.611 2.207 . . . . 1.14 111.933 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -43.3 6.71 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.146 -0.782 . . . . 1.9 111.146 176.596 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 t -115.12 135.21 54.44 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.041 -0.355 . . . . 2.75 110.041 175.293 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.2 64.14 3.55 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.773 -0.727 . . . . 0.82 112.201 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.49 131.38 37.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.088 0.47 . . . . 0.87 110.394 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -114.93 133.58 55.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.22 -0.446 . . . . 2.65 110.773 -176.669 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.5 p -77.12 178.45 7.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.205 -0.665 . . . . 0.49 109.205 173.074 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -56.99 -40.39 76.49 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.93 0.344 . . . . 4.09 111.93 -173.88 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -68.92 -49.18 60.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 1.54 110.919 -178.364 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.57 -17.9 62.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.72 111.348 -178.557 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -90.84 7.99 37.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.986 0.422 . . . . 1.25 110.429 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 C-N-CA 120.851 -0.69 . . . . 2.19 111.897 178.701 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 57.4 mtt180 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 120.74 0.305 . . . . 3.18 110.587 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' C' ' 34' ' ' PHE . 13.2 t -64.02 114.53 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.53 109.527 175.349 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.07 -22.91 50.67 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.331 0.394 . . . . 0.65 113.353 -174.546 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.52 -30.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.085 0.469 . . . . 1.04 110.889 179.003 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -107.26 -31.11 8.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 0.84 112.912 -173.476 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 85.04 -9.26 66.88 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.089 -0.804 . . . . 0.77 111.089 -172.704 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -106.88 147.69 29.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.171 -0.514 . . . . 2.1 110.674 -177.512 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.07 27.49 6.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.96 -0.638 . . . . 0.55 112.62 179.535 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.9 m -77.19 117.6 18.89 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.862 -0.421 . . . . 1.06 109.862 177.822 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 54.57 64.42 1.82 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.901 0.858 . . . . 2.23 109.511 -174.171 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.483 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.7 p -97.32 150.96 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.243 -0.89 . . . . 1.16 110.201 -176.339 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 96.5 mt -103.93 144.14 31.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.76 -0.459 . . . . 0.48 109.76 176.995 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -115.18 138.4 50.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.12 -0.491 . . . . 3.18 110.259 -179.674 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -60.14 139.92 57.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.37 109.549 174.952 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -90.61 -17.56 26.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.078 0.466 . . . . 0.75 111.015 179.528 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -94.83 -23.73 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 1.43 110.697 -178.828 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.43 -168.9 3.22 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.115 -0.698 . . . . 0.79 109.115 178.532 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.68 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.716 0.293 . . . . 0.47 110.741 -178.541 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.96 121.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.4 110.617 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.483 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.79 117.91 35.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.372 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 15' ' ' CYS . 46.8 p90 -158.16 165.78 34.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.634 -0.257 . . . . 0.61 110.585 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.709 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.9 m170 -95.65 140.89 29.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.534 -0.914 . . . . 0.42 108.534 173.779 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.4 t-105 -59.39 -45.42 91.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.635 0.255 . . . . 0.68 111.0 -177.537 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 37' ' ' ARG . 48.9 mtm180 -65.39 -14.48 60.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.286 -0.415 . . . . 3.33 111.968 -177.439 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.4 m -89.9 -20.49 23.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.957 0.408 . . . . 0.54 110.655 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -103.09 -39.75 6.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.091 -0.504 . . . . 0.61 111.403 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.68 161.02 59.9 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.257 -0.429 . . . . 0.8 110.17 -177.592 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.97 146.2 98.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.619 2.213 . . . . 2.12 112.13 178.983 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.96 66.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.5 -0.773 . . . . 3.3 111.333 -178.065 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.08 88.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.782 -0.723 . . . . 1.46 111.978 176.258 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 36.4 m -95.19 134.82 37.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.802 0.334 . . . . 1.03 110.114 179.403 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.7 p -88.95 150.08 23.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.346 -0.388 . . . . 1.6 110.571 -178.12 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -81.15 143.19 52.26 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.934 -0.575 . . . . 2.68 110.209 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 132.17 35.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.642 2.228 . . . . 1.14 112.244 178.876 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.85 -0.7 89.1 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.994 -0.548 . . . . 1.9 112.444 -178.016 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 28.7 p -90.06 -9.98 46.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.135 0.493 . . . . 2.75 110.639 176.687 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.96 137.12 3.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.775 -0.726 . . . . 0.82 111.922 -178.782 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 124.01 21.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.87 110.16 179.904 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -107.92 136.03 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 2.65 110.965 -177.146 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.42 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.1 p -87.0 -178.22 6.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.49 109.769 175.924 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -64.69 -39.96 94.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.839 -0.344 . . . . 4.09 111.296 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -68.98 -48.7 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.54 0.209 . . . . 1.54 111.058 -178.163 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 90.7 m -67.31 -39.85 85.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.578 0.228 . . . . 0.72 111.114 -178.997 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -76.43 -13.48 60.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.989 0.423 . . . . 1.25 110.372 -179.365 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 121.079 -0.582 . . . . 2.19 112.308 178.831 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-O 120.741 0.305 . . . . 3.18 110.181 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 t -69.28 108.21 3.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.53 109.584 175.298 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.82 -16.2 56.18 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.398 -0.429 . . . . 0.65 112.746 -177.109 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.09 -30.13 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.974 0.416 . . . . 1.04 110.495 177.882 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.1 m -109.64 -29.63 8.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.84 112.42 -175.235 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.82 3.94 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.904 -0.878 . . . . 0.77 110.904 -173.425 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' C' ' 22' ' ' THR . 10.6 t70 -124.43 153.76 41.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.897 -0.652 . . . . 2.1 109.419 -176.062 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 27.69 3.61 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.299 -0.953 . . . . 0.55 113.355 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 22' ' ' THR . . . . . 0.469 HG22 ' OD1' ' C' ' 20' ' ' ASP . 6.0 t -77.68 135.28 38.05 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.282 0.541 . . . . 1.06 109.711 177.003 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.76 43.35 31.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.878 -0.601 . . . . 2.23 110.183 179.375 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.93 149.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.471 -0.786 . . . . 1.16 110.504 -172.307 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.18 143.05 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 0.48 109.98 179.238 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 19.2 mmm180 -109.48 143.16 39.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 3.18 110.441 -178.251 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.4 t -73.47 145.43 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.473 -0.565 . . . . 0.37 109.473 177.389 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -90.92 -34.54 15.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.101 -0.499 . . . . 0.75 111.612 -178.954 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -89.2 -13.86 37.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 1.43 111.24 -176.85 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.27 -171.27 3.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.523 -0.547 . . . . 0.79 109.523 175.262 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.74 115.33 30.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.232 -0.285 . . . . 0.47 110.232 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.11 143.73 10.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.331 -0.395 . . . . 0.4 110.696 -179.334 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.17 113.51 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.45 109.659 177.263 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.43 154.79 39.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.416 . . . . 0.61 110.696 -178.038 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.6 m170 -92.95 134.15 35.4 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.768 -0.827 . . . . 0.42 108.768 172.845 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -49.39 -53.15 24.04 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.267 0.354 . . . . 0.68 111.217 -176.125 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.18 -30.08 69.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.933 -0.576 . . . . 3.33 111.829 -176.106 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.8 m -80.66 -22.08 40.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.54 111.487 -175.022 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -31.67 8.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.454 -0.339 . . . . 0.61 111.443 -178.568 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.12 141.78 41.77 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.405 . . . . 0.8 110.732 -176.333 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.62 153.99 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.799 2.333 . . . . 2.12 111.417 174.844 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -18.56 61.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.35 -0.841 . . . . 3.3 112.362 -172.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.9 -13.23 80.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.955 -0.64 . . . . 1.46 112.447 177.597 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -87.37 130.91 34.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.739 -0.467 . . . . 1.03 109.739 177.589 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 138.48 31.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.326 -0.397 . . . . 1.6 109.957 -175.81 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -68.9 115.23 29.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 2.68 110.103 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.1 138.0 46.06 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.038 2.492 . . . . 1.14 112.805 -176.431 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.47 -5.4 65.2 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.766 -0.652 . . . . 1.9 111.819 177.702 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -88.75 -9.71 50.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 2.75 111.023 -179.794 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.01 137.23 3.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.602 -0.808 . . . . 0.82 112.276 179.145 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.01 123.85 22.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.872 0.368 . . . . 0.87 110.676 176.893 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.373 -0.376 . . . . 2.65 110.337 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.0 p -72.79 -177.43 2.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.49 110.453 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -53.35 -49.29 67.44 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.781 0.432 . . . . 4.09 111.959 -172.774 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -68.88 -42.06 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.808 0.337 . . . . 1.54 111.392 -177.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.3 m -72.08 -28.15 63.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.202 0.445 . . . . 0.72 112.202 -175.077 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.6 p -107.94 11.21 28.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.974 0.416 . . . . 1.25 111.034 179.047 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 C-N-CA 120.485 -0.864 . . . . 2.19 112.746 -175.217 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 3.18 111.273 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 t -68.3 115.47 7.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.53 109.346 174.191 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.75 60.86 Favored Glycine 0 C--O 1.228 -0.267 0 O-C-N 123.358 0.411 . . . . 0.65 113.509 -174.852 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.9 -33.39 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.061 0.457 . . . . 1.04 110.953 179.223 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.87 -37.16 7.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.81 0.67 . . . . 0.84 112.81 -171.283 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.93 -7.39 76.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.856 -0.688 . . . . 0.77 111.598 -175.489 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -104.52 149.16 25.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.93 0.395 . . . . 2.1 110.523 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.14 6.89 32.54 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.295 -0.722 . . . . 0.55 111.295 175.66 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.9 m -66.89 133.7 50.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.56 -0.32 . . . . 1.06 110.289 178.53 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.31 41.18 4.23 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.15 0.906 . . . . 2.23 111.896 -177.458 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.16 142.6 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.564 -0.744 . . . . 1.16 110.452 -177.715 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' C' ' 36' ' ' TRP . 49.6 mt -87.66 148.88 24.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.027 0.442 . . . . 0.48 110.177 177.665 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 26.3 mmm180 -119.54 138.57 53.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.544 -0.753 . . . . 3.18 110.054 -177.069 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.91 137.51 53.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.014 -0.736 . . . . 0.37 109.014 178.05 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -92.42 -14.53 28.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.75 111.153 -178.891 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -98.86 -20.75 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.187 -0.46 . . . . 1.43 111.014 -179.659 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.3 p -150.82 -166.25 2.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.917 -0.771 . . . . 0.79 108.917 176.994 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.06 114.95 29.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.687 0.279 . . . . 0.47 110.848 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.54 139.46 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.372 -0.376 . . . . 0.4 110.92 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.38 112.86 19.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.105 -0.498 . . . . 0.45 110.195 178.191 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -149.91 148.61 29.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 0.61 110.197 -179.201 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.5 m170 -80.42 138.74 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.618 -0.882 . . . . 0.42 108.618 172.606 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.0 t-105 -52.8 -50.59 63.31 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.173 0.296 . . . . 0.68 110.76 -177.651 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -67.0 -14.35 62.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.789 -0.641 . . . . 3.33 112.288 -175.688 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 85.1 m -88.56 -20.78 24.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.078 0.466 . . . . 0.54 110.876 -179.425 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -107.49 -43.86 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.61 111.212 177.03 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.0 m-85 -120.72 112.27 33.95 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.8 110.149 -176.669 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.52 -174.46 0.45 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.888 2.392 . . . . 2.12 113.106 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.06 51.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 3.3 112.535 -175.768 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.52 -25.04 62.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.002 -0.618 . . . . 1.46 113.086 -179.683 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 44' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 4.5 m -107.83 126.2 52.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.942 0.401 . . . . 1.03 110.778 -179.792 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -89.43 138.6 31.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.255 -0.646 . . . . 1.6 109.255 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -74.86 126.24 88.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 2.68 111.07 -177.209 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 153.52 56.5 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.771 2.314 . . . . 1.14 111.881 177.909 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.76 -24.41 55.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.955 -0.641 . . . . 1.9 111.624 178.713 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -141.27 159.6 41.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.822 -0.436 . . . . 2.75 109.822 177.09 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.79 56.83 6.26 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.818 -0.706 . . . . 0.82 112.024 -178.853 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.93 121.71 23.09 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.229 -0.656 . . . . 0.87 109.229 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -123.33 132.31 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.168 -0.469 . . . . 2.65 110.969 -175.602 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 p -74.71 -172.21 1.49 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.49 109.802 175.58 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -59.94 -47.45 85.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.627 0.251 . . . . 4.09 111.422 -176.229 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -68.5 -46.58 69.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.443 -0.344 . . . . 1.54 111.564 -177.211 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.8 m -71.24 -21.57 62.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.852 -0.339 . . . . 0.72 111.344 -177.944 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.4 t -99.75 13.32 34.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 1.25 110.498 179.188 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 120.703 -0.76 . . . . 2.19 111.461 177.555 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.411 ' N ' ' HB3' ' C' ' 33' ' ' ALA . 50.8 ttt85 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.011 -0.737 . . . . 3.18 109.011 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 41.4 t -72.08 103.93 3.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.186 -0.461 . . . . 0.53 110.231 -178.621 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.48 -8.66 84.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.65 111.74 179.446 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.427 HG11 ' O ' ' C' ' 38' ' ' CYS . 25.5 t -61.68 -49.07 85.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 1.04 110.139 178.765 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.1 p -98.87 -28.12 13.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.482 -0.562 . . . . 0.84 109.482 175.12 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 3.61 55.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.895 -0.669 . . . . 0.77 111.945 178.281 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.57 145.05 48.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.767 0.318 . . . . 2.1 110.843 -176.722 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.68 17.04 13.77 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.55 111.891 179.201 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -78.31 122.77 26.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.533 0.166 . . . . 1.06 110.935 -177.947 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.35 51.65 15.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.62 0.724 . . . . 2.23 110.299 -178.0 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.557 HG11 ' HB1' ' C' ' 33' ' ' ALA . 6.6 p -92.39 155.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.634 -1.166 . . . . 1.16 110.416 -175.262 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 97.4 mt -86.31 146.59 26.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.678 -0.49 . . . . 0.48 109.678 176.589 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -109.45 138.45 45.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.305 -0.407 . . . . 3.18 110.272 -176.198 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.65 138.84 53.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.702 -0.481 . . . . 0.37 109.702 177.383 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -94.89 -24.51 16.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 0.75 111.339 179.744 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.48 -20.11 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.998 0.427 . . . . 1.43 110.575 -177.744 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.47 -171.09 3.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.158 -1.052 . . . . 0.79 108.158 174.491 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.76 112.92 26.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.961 -0.385 . . . . 0.47 109.961 178.148 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.66 146.17 8.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.123 -0.49 . . . . 0.4 110.001 -178.502 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.557 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -109.66 121.41 45.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.125 -0.489 . . . . 0.45 109.694 177.403 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 31.0 p90 -149.8 143.21 25.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.226 -0.443 . . . . 0.61 110.476 -178.492 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 68.9 m80 -90.33 138.81 31.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.691 -0.855 . . . . 0.42 108.691 171.618 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -59.28 -43.78 92.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.354 0.409 . . . . 0.68 110.02 178.355 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.62 -26.16 66.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.027 -0.533 . . . . 3.33 111.534 -177.37 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.1 m -81.98 -23.9 35.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.041 0.448 . . . . 0.54 110.653 179.679 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -101.19 -41.46 6.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.319 -0.4 . . . . 0.61 111.701 -175.812 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.95 132.48 24.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.691 0.281 . . . . 0.8 110.706 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.6 164.7 22.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.723 2.282 . . . . 2.12 111.34 172.185 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.77 -3.48 5.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 3.3 112.12 -175.712 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.67 73.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.965 -0.636 . . . . 1.46 111.67 173.705 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -101.4 136.1 41.81 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.079 -0.341 . . . . 1.03 110.079 178.705 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -89.03 140.22 29.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 1.6 110.862 -175.604 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -81.91 118.15 71.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.68 110.641 179.854 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 158.35 49.32 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.64 2.227 . . . . 1.14 111.836 176.241 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.9 -16.45 61.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.03 -0.605 . . . . 1.9 111.677 177.351 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -142.84 146.37 34.07 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.203 -0.295 . . . . 2.75 110.203 178.602 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.19 48.47 4.58 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.719 -0.753 . . . . 0.82 112.518 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.2 122.12 27.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.159 0.504 . . . . 0.87 110.307 176.973 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.448 ' CZ ' ' HA ' ' C' ' 57' ' ' SER . 24.2 ptt180 -127.1 135.71 51.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.362 0.601 . . . . 2.65 110.051 -179.744 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.8 p -72.28 177.9 4.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.49 110.207 -178.424 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -58.43 -41.69 85.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.977 0.362 . . . . 4.09 111.977 -174.258 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -64.3 -42.64 96.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.109 0.481 . . . . 1.54 110.522 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' C' C ' 56' ' ' CYS . . . . . 0.424 ' CB ' ' HB2' ' C' ' 52' ' ' ARG . 85.1 m -72.97 -19.9 61.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.72 111.472 176.839 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 57' ' ' SER . . . . . 0.448 ' HA ' ' CZ ' ' C' ' 52' ' ' ARG . 19.6 t -80.86 -14.28 58.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.104 -0.498 . . . . 1.25 110.477 -175.468 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.812 0 C-N-CA 120.648 -0.787 . . . . 2.19 111.414 176.765 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.532 -0.544 . . . . 3.18 109.532 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 42.8 t -73.65 103.9 4.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.581 -0.526 . . . . 0.53 109.581 -179.289 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.64 -21.37 77.11 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.65 113.485 -171.974 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 89.9 t -60.55 -38.09 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.887 0.375 . . . . 1.04 111.052 -179.101 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.3 p -109.24 -48.12 3.31 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.947 -0.301 . . . . 0.84 110.491 179.771 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.03 -16.54 5.25 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.914 -0.66 . . . . 0.77 112.536 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 33.7 m-20 -86.88 140.09 29.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.091 0.472 . . . . 2.1 111.799 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.15 -3.62 33.56 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.737 -0.665 . . . . 0.55 111.47 173.864 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m -80.88 136.46 36.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.329 . . . . 1.06 111.052 177.899 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 64.65 44.79 3.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.793 0.806 . . . . 2.23 110.771 174.248 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' C' ' 33' ' ' ALA . 11.7 m -93.4 155.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.381 -0.827 . . . . 1.16 111.751 -178.036 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' C' ' 36' ' ' TRP . 96.4 mt -97.17 145.51 25.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.355 -0.839 . . . . 0.48 108.963 172.796 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 24.7 tpt180 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.192 -0.458 . . . . 3.18 110.361 -174.278 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.33 136.85 57.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.673 -0.491 . . . . 0.37 109.673 177.676 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.58 -26.91 22.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.75 111.049 -179.633 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -90.02 -20.32 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.582 . . . . 1.43 111.502 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.12 -166.07 2.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.338 -0.616 . . . . 0.79 109.338 176.728 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.5 114.28 28.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.198 -0.297 . . . . 0.47 110.198 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -164.38 130.5 2.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.289 -0.414 . . . . 0.4 110.187 -179.786 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.5 112.76 24.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.09 -0.505 . . . . 0.45 109.845 176.943 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -152.11 163.79 38.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.229 -0.441 . . . . 0.61 110.565 -173.359 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -97.43 137.92 35.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.241 -0.652 . . . . 0.42 109.241 173.283 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.424 ' HB2' HD12 ' C' ' 25' ' ' LEU . 71.4 t-105 -60.91 -42.68 98.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.438 0.461 . . . . 0.68 110.122 178.617 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -62.52 -34.74 77.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.907 0.384 . . . . 3.33 111.293 -179.712 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.435 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 93.5 m -73.83 -22.44 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 0.54 111.143 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -98.05 -40.86 8.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.407 . . . . 0.61 111.798 -177.935 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 83.6 m-85 -137.6 140.85 31.33 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.296 -0.411 . . . . 0.8 109.971 -176.535 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.85 177.09 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.597 2.198 . . . . 2.12 112.193 178.326 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.571 -0.286 . . . . 3.3 111.682 -178.154 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.66 -35.58 89.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.019 -0.61 . . . . 1.46 112.145 176.073 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 44' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 22.6 m -86.03 131.25 34.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.867 -0.419 . . . . 1.03 109.867 178.918 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.6 m -88.86 150.73 22.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 1.6 111.028 -176.576 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -99.18 130.61 26.87 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.845 -0.616 . . . . 2.68 110.79 -174.012 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.13 140.41 37.54 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.325 2.016 . . . . 1.14 111.72 175.856 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.87 -20.29 63.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.911 -0.662 . . . . 1.9 112.023 -179.051 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -142.67 137.81 30.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.799 -0.445 . . . . 2.75 109.799 177.795 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.18 53.71 3.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.735 -0.745 . . . . 0.82 112.082 -179.555 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 123.32 17.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.817 -0.438 . . . . 0.87 109.817 179.065 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -112.13 141.55 45.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.39 -0.368 . . . . 2.65 110.934 -178.494 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 p -78.3 -179.58 6.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.003 -0.74 . . . . 0.49 109.003 171.872 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -60.87 -44.23 97.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 4.09 110.735 -175.764 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -63.28 -48.62 77.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.067 -0.515 . . . . 1.54 111.408 -178.355 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -71.68 -17.1 62.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.779 0.323 . . . . 0.72 111.372 -179.363 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 1.25 110.309 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 C-N-CA 120.729 -0.748 . . . . 2.19 112.189 -179.686 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.2 -0.667 . . . . 3.18 109.2 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' C' ' 17' ' ' VAL . 43.9 t -64.39 105.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.53 110.349 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.85 -12.14 67.34 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 121.296 -0.478 . . . . 0.65 112.347 -179.856 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.454 ' HB ' ' SG ' ' C' ' 15' ' ' CYS . 61.0 t -76.77 -28.71 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 1.04 110.213 176.59 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.1 m -110.38 -36.17 5.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.004 -0.544 . . . . 0.84 112.036 -177.976 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.65 7.89 74.5 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.045 -0.822 . . . . 0.77 111.045 -173.651 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -126.51 154.58 43.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.547 -0.326 . . . . 2.1 111.022 -176.871 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.91 16.36 12.18 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.402 -0.679 . . . . 0.55 111.402 175.332 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -80.05 125.57 29.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.667 -0.266 . . . . 1.06 111.166 -179.682 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.18 45.83 26.58 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 122.207 1.003 . . . . 2.23 110.028 -178.579 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.7 p -96.04 151.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.078 -0.964 . . . . 1.16 109.399 -177.159 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.34 146.75 23.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.107 0.479 . . . . 0.48 110.749 -178.108 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.6 mmm180 -107.31 149.79 27.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.18 109.876 -178.865 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -84.31 139.11 32.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 176.8 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.6 p -87.4 -13.12 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.504 0.557 . . . . 0.75 112.504 -174.857 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -111.92 -20.8 11.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.823 0.344 . . . . 1.43 110.396 -179.478 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.408 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 2.0 p -140.32 -177.12 4.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.532 -0.544 . . . . 0.79 109.532 176.379 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.32 28.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.345 -0.389 . . . . 0.47 110.224 -177.974 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.56 146.61 13.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.4 110.742 -176.645 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -125.59 111.84 15.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.45 109.617 176.143 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -157.8 144.03 17.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.61 109.67 -178.777 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.906 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 57.7 m80 -75.18 140.38 43.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.207 -1.035 . . . . 0.42 108.207 171.021 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -54.41 -50.76 66.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.783 0.265 . . . . 0.68 110.804 -175.922 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.6 mtp180 -64.02 -15.28 59.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 3.33 112.344 -176.295 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.3 m -83.92 -20.99 32.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.027 0.441 . . . . 0.54 110.697 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -108.59 -25.88 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.61 111.106 176.325 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 61.9 m-85 -132.86 139.03 33.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.364 . . . . 0.8 110.277 -178.565 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 148.25 90.63 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.605 2.203 . . . . 2.12 111.475 175.451 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.26 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.308 -0.86 . . . . 3.3 112.718 -172.525 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 -23.12 77.9 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.68 -0.771 . . . . 1.46 111.988 177.707 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -81.11 143.29 32.53 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.0 -0.37 . . . . 1.03 110.0 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -88.8 131.62 34.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 1.6 111.057 -174.818 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 22.8 ptt180 -75.9 128.81 82.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.874 -0.603 . . . . 2.68 109.932 175.976 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 24.0 Cg_exo -63.21 132.23 35.49 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.383 2.055 . . . . 1.14 112.249 -178.668 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -22.07 31.14 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.144 -0.782 . . . . 1.9 111.144 176.451 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -89.84 52.4 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.176 0.512 . . . . 2.75 110.577 177.972 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 108.77 3.14 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.673 -0.775 . . . . 0.82 112.225 -178.501 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.59 123.2 19.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.87 109.247 177.179 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -122.76 135.14 54.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.342 -0.39 . . . . 2.65 110.732 -175.63 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.81 158.69 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.173 -0.676 . . . . 0.49 109.173 175.736 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -56.21 -31.16 63.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.737 0.699 . . . . 4.09 111.714 -170.415 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -65.91 -46.43 78.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.568 0.223 . . . . 1.54 110.741 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.6 m -72.08 -23.87 61.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.726 0.298 . . . . 0.72 111.219 -179.978 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -78.39 0.53 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.398 -0.365 . . . . 1.25 111.045 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 111.725 -0.55 . . . . 2.19 111.725 179.574 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 109.294 -0.632 . . . . 3.18 109.294 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.85 105.7 1.67 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.003 -0.369 . . . . 0.53 110.003 179.458 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.66 -30.05 75.61 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.347 -0.454 . . . . 0.65 112.597 -176.957 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 -30.6 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 1.04 110.779 -179.37 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -101.26 -36.73 8.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.173 -0.467 . . . . 0.84 111.764 -178.302 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.59 -1.66 66.51 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.258 -0.737 . . . . 0.77 111.258 -174.746 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -120.91 145.29 47.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 2.1 110.875 -177.039 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.23 14.7 56.84 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.711 -0.677 . . . . 0.55 111.481 172.977 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.3 m -63.95 119.63 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.397 0.279 . . . . 1.06 110.532 178.014 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 52.88 50.82 17.18 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.709 0.631 . . . . 2.23 110.753 -178.878 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.414 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.2 p -89.59 146.05 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 1.16 110.39 -176.076 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.89 144.2 25.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.48 110.232 179.194 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -106.77 146.54 30.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 3.18 109.767 -178.386 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 5.3 t -80.49 138.72 36.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.985 -0.746 . . . . 0.37 108.985 176.256 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -92.91 -13.54 28.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 0.75 111.873 -177.299 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.93 -18.56 14.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.435 -0.348 . . . . 1.43 111.198 178.795 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -149.72 -167.71 2.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.451 -0.574 . . . . 0.79 109.451 177.059 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 114.7 29.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.719 0.295 . . . . 0.47 110.402 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -160.37 153.79 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.309 -0.405 . . . . 0.4 110.858 -179.518 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -134.72 113.45 11.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.852 -0.613 . . . . 0.45 109.67 176.095 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.38 163.26 40.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.899 -0.591 . . . . 0.61 109.752 -178.438 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.714 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.8 m170 -94.01 139.21 31.22 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.787 -0.82 . . . . 0.42 108.787 172.208 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 60.5 t-105 -49.29 -53.24 22.84 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.412 0.445 . . . . 0.68 111.643 -176.559 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -71.07 -9.1 57.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 3.33 112.19 -174.462 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 63.3 m -91.55 -21.34 20.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.984 0.421 . . . . 0.54 110.76 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -107.63 -40.84 5.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.183 -0.462 . . . . 0.61 110.958 177.865 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.81 148.56 40.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.992 -0.549 . . . . 0.8 110.631 -175.428 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 154.17 73.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.852 2.368 . . . . 2.12 112.144 177.84 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.04 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.197 -0.911 . . . . 3.3 111.95 -175.114 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -7.22 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 1.46 111.906 176.145 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -101.29 129.81 47.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.014 -0.365 . . . . 1.03 110.014 177.709 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -87.73 130.77 34.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.796 -0.446 . . . . 1.6 109.796 -179.34 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 16.3 ptm180 -71.56 118.6 67.78 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 2.68 111.11 -175.71 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.57 132.92 22.97 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.682 2.255 . . . . 1.14 112.549 -177.884 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.86 51.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.905 -0.664 . . . . 1.9 111.785 178.469 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 60.73 0.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 2.75 110.934 -176.983 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.6 82.53 0.77 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.401 -0.904 . . . . 0.82 112.458 179.356 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -76.25 128.28 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.074 -0.713 . . . . 0.87 109.074 177.056 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -124.41 145.87 49.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.162 0.506 . . . . 2.65 111.877 -174.774 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -83.58 -178.8 7.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 0.49 108.909 171.914 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' C' ' 55' ' ' SER . 11.5 ptp180 -63.13 -41.2 99.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.289 0.495 . . . . 4.09 111.476 -173.925 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 55' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 19.6 t -68.74 -40.68 79.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.787 0.327 . . . . 1.54 111.234 -175.153 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.43 -15.74 61.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.72 111.31 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -96.4 -13.61 23.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.078 0.466 . . . . 1.25 110.619 177.134 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 N-CA-C 111.564 -0.614 . . . . 2.19 111.564 -175.974 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 110.202 -0.296 . . . . 3.18 110.202 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.3 t -65.92 118.96 10.48 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.086 -0.339 . . . . 0.53 110.086 177.975 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.33 -17.07 77.35 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.884 -0.674 . . . . 0.65 112.265 -179.548 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -82.74 -31.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.568 0.223 . . . . 1.04 111.117 179.734 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 71.1 m -106.52 -29.13 9.85 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.571 0.582 . . . . 0.84 112.571 -177.175 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.06 81.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.894 -0.882 . . . . 0.77 110.894 -172.48 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.49 154.0 48.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.181 -0.51 . . . . 2.1 110.141 -172.877 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.09 23.97 6.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.02 -0.609 . . . . 0.55 112.63 179.209 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -81.5 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.209 -0.293 . . . . 1.06 110.209 178.474 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.23 37.47 28.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.365 0.602 . . . . 2.23 109.959 -177.5 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.8 p -90.21 158.0 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 1.16 110.565 -174.428 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 79.7 mt -95.63 146.38 24.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.74 0.305 . . . . 0.48 110.348 176.577 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -109.89 131.51 55.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 3.18 110.015 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.97 132.37 47.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.111 -0.7 . . . . 0.37 109.111 176.386 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.02 -17.52 32.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.256 0.551 . . . . 0.75 111.121 -178.926 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -97.77 -20.12 17.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.541 . . . . 1.43 111.339 -177.346 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -151.48 -164.72 2.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.104 -0.702 . . . . 0.79 109.104 176.096 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.2 114.15 28.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.203 -0.295 . . . . 0.47 110.203 178.54 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.22 131.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.4 110.868 -179.143 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -111.87 113.44 25.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.73 -0.668 . . . . 0.45 109.739 177.121 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 25.3 p90 -151.99 146.53 25.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.254 -0.43 . . . . 0.61 109.986 -179.832 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.892 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 53.7 m80 -79.55 135.2 36.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.419 -0.956 . . . . 0.42 108.419 171.338 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 73.9 t-105 -51.28 -52.04 48.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.671 0.272 . . . . 0.68 111.482 -174.042 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -68.17 -16.78 64.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 3.33 112.124 -173.456 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.93 -22.85 48.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.186 0.517 . . . . 0.54 110.52 178.804 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -104.54 -50.29 3.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.972 -0.558 . . . . 0.61 110.67 179.131 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 78.2 m-85 -108.16 122.04 41.84 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.511 -0.768 . . . . 0.8 109.702 -177.089 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 50.8 Cg_exo -55.21 162.73 5.31 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.972 2.448 . . . . 2.12 112.38 -179.338 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -18.27 41.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.865 -1.062 . . . . 3.3 112.669 -170.75 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.66 4.73 77.64 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.603 178.503 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 91.1 m -112.59 133.32 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.749 0.309 . . . . 1.03 110.512 177.725 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -88.8 144.4 26.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 1.6 110.597 -175.971 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 46' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 45.9 ttp180 -87.2 122.23 71.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 2.68 110.84 -179.551 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 47' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.3 Cg_exo -69.0 132.26 24.15 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.503 2.135 . . . . 1.14 111.736 176.957 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.88 -14.73 48.33 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.971 -0.633 . . . . 1.9 112.18 -179.741 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.9 t -88.83 -10.7 47.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 2.75 111.206 -178.218 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 122.79 0.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.847 -0.692 . . . . 0.82 111.654 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.41 123.23 33.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.005 0.431 . . . . 0.87 110.155 -177.602 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -116.65 128.94 55.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.736 -178.85 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -75.3 -169.74 1.04 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.612 . . . . 0.49 110.072 175.313 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.69 -52.83 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.373 -0.376 . . . . 4.09 111.403 -176.663 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -68.72 -42.78 77.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.539 -0.301 . . . . 1.54 111.808 -175.49 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.7 m -71.93 -17.36 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.72 111.88 -176.627 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -88.15 8.31 27.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.094 0.473 . . . . 1.25 110.532 -179.117 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.731 0 C-N-CA 120.685 -0.769 . . . . 2.19 112.159 179.532 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.452 0.168 . . . . 3.18 110.81 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.3 110.59 6.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.24 -0.652 . . . . 0.53 109.24 174.509 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.19 -24.71 65.6 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 121.304 -0.474 . . . . 0.65 112.841 -176.449 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.99 -30.75 33.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 1.04 110.781 179.168 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 95.3 m -104.63 -46.48 4.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.84 112.299 -175.039 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.92 -8.34 45.86 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.436 -0.666 . . . . 0.77 111.436 -174.041 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.51 154.14 22.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 2.1 110.722 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 11.15 30.38 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.112 -0.795 . . . . 0.55 111.112 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.28 134.97 53.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.35 . . . . 1.06 110.343 177.75 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 41.65 48.57 3.61 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.137 0.898 . . . . 2.23 111.757 -178.732 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.404 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.0 p -89.06 146.67 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.165 -0.925 . . . . 1.16 110.421 -176.319 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 25' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 84.3 mt -96.99 157.64 15.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.474 -0.33 . . . . 0.48 110.205 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 9.3 mmm180 -120.71 141.45 50.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.921 -0.581 . . . . 3.18 111.064 -174.225 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.81 139.77 47.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.823 -0.806 . . . . 0.37 108.823 173.203 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p -92.4 -21.23 20.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 0.75 111.217 179.43 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -89.54 -23.12 22.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 1.43 110.623 -178.448 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.91 -164.91 2.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.207 -0.664 . . . . 0.79 109.207 177.113 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 115.07 29.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.77 0.319 . . . . 0.47 110.48 179.449 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.14 139.1 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.96 -0.563 . . . . 0.4 110.331 178.866 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -121.24 118.93 30.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.001 -0.545 . . . . 0.45 110.171 178.765 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 34' ' ' PHE . . . . . 0.404 ' N ' HG22 ' C' ' 24' ' ' VAL . 52.3 p90 -160.22 162.72 33.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.61 109.901 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.7 m170 -91.34 133.35 35.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.099 -1.074 . . . . 0.42 108.099 171.616 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.401 ' HB2' HD12 ' C' ' 25' ' ' LEU . 74.3 t-105 -59.3 -36.96 76.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.68 110.915 -177.215 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -68.82 -19.88 64.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 3.33 110.883 -179.697 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -90.57 -23.14 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.279 -0.419 . . . . 0.54 111.071 -178.123 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -92.46 -38.59 11.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.394 -0.366 . . . . 0.61 110.643 176.838 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 94.3 m-85 -126.66 73.47 74.76 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.488 . . . . 0.8 110.815 -178.753 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 0.06 10.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.018 2.479 . . . . 2.12 112.057 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.7 3.41 29.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 3.3 111.24 -177.828 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.43 24.8 30.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.625 -0.797 . . . . 1.46 112.35 179.747 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 7.2 m -66.18 141.93 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.869 -0.419 . . . . 1.03 109.869 176.849 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.8 t -88.13 133.04 34.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.004 0.431 . . . . 1.6 110.228 -175.437 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -70.72 119.0 70.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.551 -0.749 . . . . 2.68 110.548 -179.65 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.67 132.45 20.32 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.591 2.194 . . . . 1.14 112.316 -179.42 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.18 -8.62 74.81 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 1.9 111.566 177.355 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.9 p -91.96 28.52 1.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.945 0.403 . . . . 2.75 111.541 -179.963 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.72 121.76 3.06 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.941 -0.647 . . . . 0.82 112.296 179.857 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 52' ' ' ARG . 0.5 OUTLIER -75.91 128.33 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.668 -0.493 . . . . 0.87 109.668 -178.821 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.413 ' N ' HD13 ' C' ' 51' ' ' LEU . 86.3 mtt180 -113.15 138.69 49.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.408 . . . . 2.65 111.395 -176.845 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 p -88.89 -176.45 5.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 0.49 109.213 173.779 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -67.29 -39.52 85.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.41 -0.516 . . . . 4.09 111.332 -175.87 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 42.3 t -67.17 -45.4 77.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.598 0.237 . . . . 1.54 110.729 -178.381 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.7 m -71.9 -17.26 62.11 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.661 0.245 . . . . 0.72 111.661 -179.512 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -96.28 -14.19 22.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.93 0.395 . . . . 1.25 110.985 178.699 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 2.19 111.899 -177.944 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.529 0.204 . . . . 3.18 111.198 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -68.22 122.91 19.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.646 -0.502 . . . . 0.53 109.646 174.872 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -24.85 64.77 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.65 113.401 -175.023 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.04 -32.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 1.04 111.177 -179.502 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.3 -40.36 7.96 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.315 0.487 . . . . 0.84 112.315 -174.439 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.63 -17.62 58.96 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.191 -0.764 . . . . 0.77 111.191 -173.076 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.5 148.8 21.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.365 . . . . 2.1 110.616 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.27 15.05 39.58 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.043 -0.599 . . . . 0.55 111.623 176.261 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.8 m -74.76 124.38 26.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.253 . . . . 1.06 110.401 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.77 42.9 28.63 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.915 -0.584 . . . . 2.23 110.823 -177.348 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 9.9 p -88.06 136.27 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.535 . . . . 1.16 110.301 -175.538 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -94.44 157.1 16.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.0 -0.546 . . . . 0.48 109.913 -178.292 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 28.6 mmm180 -121.68 149.6 42.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.901 -0.591 . . . . 3.18 110.189 -177.197 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -81.56 143.64 31.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.805 -0.443 . . . . 0.37 109.805 -179.818 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.99 -21.91 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.273 -0.421 . . . . 0.75 111.576 -179.003 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -100.94 -17.61 16.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.541 -0.299 . . . . 1.43 111.358 -177.219 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 p -151.13 -169.94 3.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.79 109.51 177.512 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.87 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.489 -0.323 . . . . 0.47 110.359 178.841 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.19 132.39 8.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.535 -0.302 . . . . 0.4 110.77 -178.66 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -106.93 112.85 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.515 . . . . 0.45 109.852 176.263 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -158.78 164.74 35.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.298 -0.41 . . . . 0.61 110.187 -177.63 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.66 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 28.6 m170 -98.81 138.83 35.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.439 -0.948 . . . . 0.42 108.439 171.639 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -54.99 -46.3 75.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.644 0.259 . . . . 0.68 110.54 -178.182 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 73.4 mtp180 -65.96 -18.3 65.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 3.33 112.101 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.7 m -85.35 -20.34 30.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.044 0.449 . . . . 0.54 110.809 -179.19 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -99.93 -39.27 8.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.61 110.777 174.974 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 94.9 m-85 -127.04 144.97 52.29 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.8 109.903 -179.432 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.51 154.8 34.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.593 2.196 . . . . 2.12 111.856 177.594 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -10.97 28.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 3.3 112.06 -174.68 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.54 -2.07 76.82 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.839 -0.696 . . . . 1.46 112.144 176.761 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.9 m -90.31 139.82 30.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.023 -0.362 . . . . 1.03 110.023 178.601 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.8 p -88.39 132.81 34.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.433 -0.349 . . . . 1.6 110.873 -175.631 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -88.42 134.31 34.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 2.68 110.911 -177.915 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.63 132.59 38.47 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.653 2.235 . . . . 1.14 111.328 173.745 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.08 -51.2 5.46 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.869 -0.605 . . . . 1.9 113.404 -174.023 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -95.73 -18.25 20.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 2.75 111.214 -175.451 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -131.78 67.89 0.56 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.537 -0.84 . . . . 0.82 112.521 -178.428 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.77 122.63 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.25 -0.648 . . . . 0.87 109.25 176.89 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 52' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 53.2 mtm180 -121.38 140.23 52.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.972 0.415 . . . . 2.65 111.122 -173.125 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.4 p -80.39 -174.72 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.49 109.784 175.703 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -61.71 -49.56 75.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.614 0.245 . . . . 4.09 111.19 -176.036 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.6 t -64.24 -43.92 93.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.432 -0.349 . . . . 1.54 111.28 -176.151 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.5 m -71.62 -19.7 62.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.157 -0.217 . . . . 0.72 111.557 -178.064 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.0 m -83.41 -13.93 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.886 0.374 . . . . 1.25 110.732 178.811 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.241 -0.744 . . . . 2.19 111.241 178.122 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' C' C ' 14' ' ' ARG . . . . . 0.426 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.9 mtm-85 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.219 0.533 . . . . 3.18 111.095 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 t -87.7 104.88 16.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.831 . . . . 0.53 109.698 178.873 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -16.8 69.31 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.859 -0.609 . . . . 0.65 113.846 -172.733 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.58 -29.91 48.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.04 110.86 -179.258 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.94 -42.56 2.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.347 -0.388 . . . . 0.84 110.388 178.137 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.88 -11.44 10.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.057 -0.592 . . . . 0.77 111.812 -178.508 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.96 141.94 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.116 0.484 . . . . 2.1 111.405 -177.634 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -110.98 16.86 27.64 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.577 -0.738 . . . . 0.55 111.273 175.826 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.9 m -76.09 115.56 15.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.461 -0.37 . . . . 1.06 110.323 179.344 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 45.77 70.99 0.31 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.921 0.763 . . . . 2.23 112.062 178.776 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.4 146.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 1.16 110.413 178.665 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.37 148.53 22.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.973 -0.558 . . . . 0.48 109.836 -179.436 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -108.58 145.51 34.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.059 -0.519 . . . . 3.18 110.054 -179.649 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 8.0 t -75.52 135.4 40.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.004 -0.739 . . . . 0.37 109.004 177.026 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 37.1 p -86.24 -7.26 58.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.939 0.4 . . . . 0.75 111.344 -179.522 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -110.75 -19.64 12.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.416 -0.356 . . . . 1.43 111.157 -179.16 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.8 p -151.56 -172.13 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.714 -0.476 . . . . 0.79 109.714 177.289 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.68 30.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.856 -0.156 . . . . 0.47 111.397 -176.153 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.74 141.87 4.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.811 -0.177 . . . . 0.4 111.127 179.241 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.25 118.11 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.791 -0.448 . . . . 0.45 109.791 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -161.87 163.36 29.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.61 111.19 -175.222 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -96.6 140.59 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.365 -0.606 . . . . 0.42 109.365 172.103 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -62.14 -42.31 99.12 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.537 -0.542 . . . . 0.68 109.537 174.678 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -63.43 -22.75 67.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.917 -0.583 . . . . 3.33 111.819 -179.442 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 63.7 m -87.17 -21.82 25.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.54 111.303 -179.055 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.42 -38.81 8.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.874 0.369 . . . . 0.61 110.813 179.924 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.95 149.88 74.09 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.5 -0.556 . . . . 0.8 109.5 -179.001 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.68 140.25 61.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.252 1.968 . . . . 2.12 111.502 178.05 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.96 -8.83 17.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 3.3 111.944 -175.611 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.81 71.81 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.778 -0.929 . . . . 1.46 110.778 172.455 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -87.45 131.57 34.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.266 -0.642 . . . . 1.03 109.266 174.603 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -87.73 115.37 25.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.141 0.496 . . . . 1.6 110.642 -176.083 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -57.96 136.3 83.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 2.68 111.179 -178.599 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.74 135.24 32.4 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.951 2.434 . . . . 1.14 112.89 -175.991 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.92 -10.66 71.75 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.042 -0.599 . . . . 1.9 111.75 179.05 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -89.31 12.08 17.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 2.75 111.057 -179.739 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.03 116.35 1.56 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.763 -0.732 . . . . 0.82 112.504 178.405 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.3 OUTLIER -71.28 125.99 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.374 -0.602 . . . . 0.87 109.374 179.239 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -115.17 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 2.65 111.062 -175.507 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 p -73.31 174.77 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.695 -0.854 . . . . 0.49 108.695 172.056 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -58.29 -41.55 84.66 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.432 0.53 . . . . 4.09 112.432 -169.245 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -69.41 -47.84 62.9 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.22 -0.3 . . . . 1.54 111.339 -178.385 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.36 -18.74 61.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.688 0.28 . . . . 0.72 111.211 -178.781 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -84.59 -13.88 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.35 . . . . 1.25 110.429 -179.54 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 C-N-CA 120.683 -0.77 . . . . 2.19 112.04 -179.721 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.435 -0.58 . . . . 3.18 109.435 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.7 t -67.1 103.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.53 109.231 177.567 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.24 -11.54 78.09 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.834 -0.621 . . . . 0.65 112.97 -171.472 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 58.6 t -65.73 -42.45 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.833 0.349 . . . . 1.04 110.38 178.932 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -104.25 -37.2 7.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.401 -0.363 . . . . 0.84 110.684 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.01 -5.72 27.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.77 112.184 -178.883 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 5.6 m-20 -102.19 135.34 43.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.963 0.411 . . . . 2.1 111.212 -179.211 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.63 1.64 34.29 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.239 -0.744 . . . . 0.55 111.239 174.137 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 40.4 m -69.08 132.4 46.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.465 -0.368 . . . . 1.06 110.636 177.359 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 55.62 47.39 20.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.726 0.774 . . . . 2.23 109.885 178.25 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.81 149.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.274 -0.876 . . . . 1.16 110.713 -173.971 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -99.36 153.32 19.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.234 -0.439 . . . . 0.48 110.45 -179.671 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 16.7 tpp180 -115.57 143.01 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.624 . . . . 3.18 109.842 -177.983 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.4 t -75.62 147.02 39.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.37 110.077 177.326 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.7 p -86.35 -38.46 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.514 . . . . 0.75 112.0 -179.482 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -90.43 -12.09 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.299 . . . . 1.43 111.7 -176.571 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 30' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.8 p -150.97 -179.64 7.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.223 -0.658 . . . . 0.79 109.223 174.768 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 115.54 30.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.866 -0.42 . . . . 0.47 109.866 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -159.91 136.34 8.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.913 -0.585 . . . . 0.4 110.229 -179.023 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.88 112.18 25.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.45 109.807 175.986 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.32 158.92 40.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.61 109.98 -177.38 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -94.32 146.91 23.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.696 -0.483 . . . . 0.42 109.696 173.342 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -56.81 -53.52 56.87 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.584 0.553 . . . . 0.68 110.364 -179.632 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -63.9 -37.06 86.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.364 0.505 . . . . 3.33 112.364 -175.549 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.422 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 70.7 m -65.46 -24.32 67.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.957 0.408 . . . . 0.54 111.159 -177.989 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -100.89 -54.85 2.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.175 0.512 . . . . 0.61 110.698 178.366 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -107.18 129.26 24.58 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.73 -0.668 . . . . 0.8 109.66 -176.829 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.84 162.03 9.43 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.829 2.352 . . . . 2.12 112.224 178.693 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.19 38.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 3.3 111.903 -173.782 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.34 -15.2 81.73 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.795 -0.717 . . . . 1.46 111.73 175.019 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -90.47 125.7 35.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.07 -0.345 . . . . 1.03 110.07 179.389 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -89.27 134.58 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.803 0.335 . . . . 1.6 110.832 -177.895 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -71.46 124.35 90.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 2.68 111.097 -177.631 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.05 143.4 36.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.852 2.368 . . . . 1.14 112.81 -178.558 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.32 -10.3 48.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.915 -0.66 . . . . 1.9 112.33 178.801 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -89.14 0.09 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.347 0.594 . . . . 2.75 110.655 -179.887 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.71 119.15 1.28 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.985 -0.626 . . . . 0.82 111.986 -178.529 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.19 123.93 33.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.107 0.479 . . . . 0.87 110.318 -179.109 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -122.58 142.8 50.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.001 -0.545 . . . . 2.65 111.34 -173.998 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -73.39 165.76 24.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.49 109.489 175.176 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -53.93 -34.63 60.14 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.157 0.435 . . . . 4.09 111.899 -173.145 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 28.0 t -66.09 -50.05 65.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.924 0.392 . . . . 1.54 110.455 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.5 m -72.92 -26.54 61.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.117 0.414 . . . . 0.72 112.117 -178.571 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -89.53 0.28 57.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 1.25 111.044 -178.954 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 120.776 -0.726 . . . . 2.19 111.986 -179.312 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 109.356 -0.609 . . . . 3.18 109.356 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' C' C ' 15' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 32.0 t -62.0 112.65 2.42 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.723 -0.473 . . . . 0.53 109.723 178.22 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.59 -23.77 55.5 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 121.38 -0.438 . . . . 0.65 112.993 -175.911 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.03 -32.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.04 111.142 179.701 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.3 m -105.92 -47.42 3.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.194 0.442 . . . . 0.84 112.194 -174.689 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.0 -23.25 19.59 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.444 -0.663 . . . . 0.77 111.444 -173.902 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.78 152.21 21.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.732 0.301 . . . . 2.1 111.069 -178.165 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.83 6.79 33.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.043 -0.599 . . . . 0.55 111.804 177.307 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -70.58 127.9 34.29 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.645 -0.132 . . . . 1.06 110.645 178.563 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 58.11 39.44 26.11 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.51 0.506 . . . . 2.23 110.906 179.55 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -89.23 148.15 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.232 -0.44 . . . . 1.16 110.53 -175.093 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -114.62 148.64 37.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.48 110.217 -179.069 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 26' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.2 mpt_? -119.31 148.63 42.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.647 -0.501 . . . . 3.18 109.647 179.967 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 27' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 40.3 t -68.95 139.28 55.05 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.112 -0.635 . . . . 0.37 109.486 174.307 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 28' ' ' THR . . . . . 0.408 HG21 ' HA3' ' C' ' 50' ' ' GLY . 12.4 t -85.07 4.43 34.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.424 0.631 . . . . 0.75 110.596 178.932 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -127.62 -8.6 5.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 1.43 110.68 176.7 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 9.0 m -145.02 177.44 8.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.79 110.13 -177.948 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 112.96 26.2 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.802 -0.814 . . . . 0.47 108.802 173.072 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 32' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.0 111.8 0.98 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.088 -0.505 . . . . 0.4 110.531 -179.544 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -93.21 112.58 24.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.007 0.432 . . . . 0.45 109.903 176.057 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.68 158.1 40.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.878 -0.601 . . . . 0.61 109.828 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 35' ' ' HIS . . . . . 0.76 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.4 m170 -87.24 138.45 31.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.166 -1.05 . . . . 0.42 108.166 172.192 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -48.94 -50.99 32.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.107 0.254 . . . . 0.68 111.443 -175.849 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 37' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 90.8 mtt180 -67.71 -10.46 52.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.016 -0.538 . . . . 3.33 112.099 -175.325 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 38' ' ' CYS . . . . . 0.76 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.6 m -89.96 -21.63 22.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.906 0.384 . . . . 0.54 110.947 -179.083 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -101.94 -36.87 8.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.429 . . . . 0.61 110.486 174.92 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 40' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 57.3 m-85 -124.5 150.0 63.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.989 -0.55 . . . . 0.8 110.219 -176.061 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.83 144.18 94.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.565 2.176 . . . . 2.12 111.089 172.786 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.85 -15.6 55.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.542 -0.754 . . . . 3.3 111.982 -175.733 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.75 -24.34 76.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.87 -0.681 . . . . 1.46 112.157 175.723 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.8 m -75.94 136.5 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.988 -0.375 . . . . 1.03 109.988 179.328 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -87.94 128.96 35.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.105 0.479 . . . . 1.6 111.266 -172.959 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -69.24 119.16 68.42 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 2.68 110.194 179.366 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.62 132.8 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.537 2.158 . . . . 1.14 112.405 -176.317 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.05 -11.53 67.32 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.438 -0.665 . . . . 1.9 111.438 177.126 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 21.5 p -89.7 37.44 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.368 0.604 . . . . 2.75 110.634 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 50' ' ' GLY . . . . . 0.408 ' HA3' HG21 ' C' ' 28' ' ' THR . . . 105.72 123.85 5.24 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.571 -0.74 . . . . 0.82 111.869 -178.12 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 123.73 22.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.105 -0.702 . . . . 0.87 109.105 178.406 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -115.52 128.48 56.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.945 0.403 . . . . 2.65 110.993 -174.876 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 53' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 15.6 p -73.24 174.13 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.724 -0.671 . . . . 0.49 109.672 177.507 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -57.66 -37.87 74.13 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.862 0.301 . . . . 4.09 111.655 -170.309 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 32.9 t -69.31 -38.84 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.977 0.418 . . . . 1.54 110.343 179.992 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.7 m -73.18 -33.24 65.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.19 -0.459 . . . . 0.72 111.984 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.1 p -83.84 -14.94 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 1.25 110.873 179.438 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 110.956 -0.857 . . . . 2.19 110.956 175.468 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.599 -0.6 . . . . 20.38 111.599 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.42 34.53 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 18.81 110.507 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 48.9 ttm -148.43 33.98 0.79 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.675 0.75 . . . . 18.06 110.232 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.91 -15.47 41.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.776 -0.647 . . . . 16.83 109.965 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.88 22.87 32.5 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.965 -0.636 . . . . 14.66 112.249 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -63.54 -44.02 95.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.033 0.444 . . . . 15.8 110.302 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' C' ' 7' ' ' GLN . 15.3 mm-40 -94.79 66.52 3.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.476 0.655 . . . . 13.13 109.855 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.97 10.58 18.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.259 -0.882 . . . . 11.74 109.933 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.66 96.17 10.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.312 -0.858 . . . . 8.72 109.073 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -59.97 132.52 89.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.049 -0.523 . . . . 5.93 111.483 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 27.8 Cg_exo -61.14 107.39 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.859 2.373 . . . . 5.25 112.387 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.45 80.57 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.13 -0.557 . . . . 2.28 112.377 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.47 99.3 4.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 2.07 110.611 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.24 164.03 30.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.643 -0.708 . . . . 3.18 109.549 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.6 t -67.1 106.29 1.93 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.497 -0.557 . . . . 0.53 109.497 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.41 -21.76 57.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 121.344 -0.455 . . . . 0.65 112.937 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.22 -33.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.834 0.35 . . . . 1.04 111.027 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.35 -38.96 6.64 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.085 0.402 . . . . 0.84 112.085 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.11 58.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.862 -0.685 . . . . 0.77 111.421 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.01 155.05 17.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.984 0.421 . . . . 2.1 110.9 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.08 17.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.024 -0.83 . . . . 0.55 111.024 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -64.08 118.1 8.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.294 -0.453 . . . . 1.06 110.823 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.12 47.53 21.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.616 -0.72 . . . . 2.23 110.744 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.451 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.9 p -89.16 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.662 -0.699 . . . . 1.16 109.735 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.43 143.7 29.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.77 0.319 . . . . 0.48 110.521 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 40.3 mmt-85 -104.74 147.04 28.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 3.18 109.948 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.36 146.55 29.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.408 -0.59 . . . . 0.37 109.408 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -92.55 -29.69 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.461 -0.336 . . . . 0.75 111.705 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -89.71 -17.23 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.32 . . . . 1.43 111.105 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 p -150.9 -173.27 4.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.973 -0.751 . . . . 0.79 108.973 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.98 115.64 30.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.008 -0.367 . . . . 0.47 110.008 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -157.29 156.9 33.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.409 -0.36 . . . . 0.4 110.459 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 111.84 9.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.841 -0.618 . . . . 0.45 109.807 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.451 ' N ' HG22 ' C' ' 24' ' ' VAL . 37.8 p90 -156.24 158.96 38.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.99 -0.55 . . . . 0.61 109.836 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.6 m170 -92.3 133.13 36.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.267 -1.012 . . . . 0.42 108.267 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.45 -52.49 28.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.375 0.422 . . . . 0.68 111.585 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -62.57 -25.8 68.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 3.33 111.86 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.14 -22.45 52.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.939 0.399 . . . . 0.54 110.852 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 0.9 OUTLIER -101.09 -40.69 7.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.324 -0.398 . . . . 0.61 111.068 178.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -117.76 79.02 12.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.402 -0.363 . . . . 0.8 110.458 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 3.8 Cg_endo -86.74 7.09 5.06 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.242 2.628 . . . . 2.12 112.411 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.58 4.54 27.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 3.3 111.789 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.7 26.64 24.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.477 -0.868 . . . . 1.46 111.76 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -75.73 140.64 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.895 -0.409 . . . . 1.03 109.895 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 11.5 p -88.7 135.35 33.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.669 0.271 . . . . 1.6 110.627 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -73.85 112.68 17.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 2.68 110.755 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.66 133.34 20.22 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.503 2.135 . . . . 1.14 112.069 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.28 -17.49 69.02 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.611 -0.804 . . . . 1.9 111.249 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 2.3 p -98.06 74.71 2.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.377 -0.412 . . . . 2.75 111.28 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.03 85.46 1.73 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.452 -0.88 . . . . 0.82 112.851 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.38 124.15 20.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.243 -0.651 . . . . 0.87 109.243 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -125.69 130.72 52.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 2.65 111.327 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -76.36 -178.37 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.49 110.067 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -60.24 -46.28 90.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 4.09 111.051 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -65.65 -48.42 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 1.54 111.056 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.76 -22.28 65.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.531 0.205 . . . . 0.72 111.514 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -86.25 -2.6 58.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.496 0.189 . . . . 1.25 111.017 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.8 -69.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.812 -0.709 . . . . 2.19 111.855 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -110.92 112.6 24.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.742 0.306 . . . . 5.15 110.308 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.83 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 6.76 109.705 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 28.8 m -116.89 105.92 48.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.171 -0.468 . . . . 8.83 110.507 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.35 161.66 44.97 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.737 2.291 . . . . 11.04 112.235 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.58 116.62 66.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.203 -0.453 . . . . 13.86 110.11 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.94 99.69 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.174 2.583 . . . . 16.55 112.764 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.95 129.14 41.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.109 -0.496 . . . . 18.07 109.953 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.61 -0.709 . . . . 20.26 110.501 -176.272 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.712 -0.555 . . . . 20.38 111.712 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.77 26.73 16.28 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.95 0.405 . . . . 18.81 111.63 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 50.2 ttm -116.14 -39.32 3.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.431 . . . . 18.06 110.703 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -75.89 -34.49 59.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.565 . . . . 16.83 110.988 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.4 148.26 48.37 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.576 -0.821 . . . . 14.66 111.965 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -78.46 -30.37 47.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.219 0.533 . . . . 15.8 109.959 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -91.48 165.25 13.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 13.13 109.968 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -129.34 136.74 50.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.495 -0.558 . . . . 11.74 109.495 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.1 64.92 2.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.48 . . . . 8.72 110.657 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.75 137.54 23.15 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.953 -0.567 . . . . 5.93 110.018 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.91 41.91 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.978 2.452 . . . . 5.25 113.106 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.61 -134.33 44.48 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.173 -0.537 . . . . 2.28 112.036 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.83 73.48 9.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.127 0.489 . . . . 2.07 110.189 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -157.08 134.91 10.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.829 -0.623 . . . . 3.18 109.757 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 4.4 t -81.83 104.8 12.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.973 -0.558 . . . . 0.53 109.753 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -2.28 60.51 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 115.759 -0.655 . . . . 0.65 113.306 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.75 -29.2 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.992 0.425 . . . . 1.04 110.384 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.99 -35.1 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.448 -0.342 . . . . 0.84 111.056 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.22 -11.86 21.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.892 -0.671 . . . . 0.77 111.992 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 24.4 t70 -97.73 147.15 24.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.733 0.302 . . . . 2.1 110.632 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.21 16.34 8.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.965 -0.636 . . . . 0.55 112.121 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.16 132.63 35.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 1.06 110.121 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t0 52.59 56.16 8.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.791 0.805 . . . . 2.23 109.488 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' C' ' 33' ' ' ALA . 6.2 p -91.44 137.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.168 -0.924 . . . . 1.16 110.63 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.97 147.9 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 0.48 110.225 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 10.4 mmm180 -114.47 136.05 53.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.963 -0.562 . . . . 3.18 110.16 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.8 t -67.56 136.78 55.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.349 -0.387 . . . . 0.37 110.102 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -88.26 -12.76 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.75 111.108 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -100.96 -23.25 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 1.43 110.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.3 p -151.28 -172.4 4.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.79 109.656 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.34 113.96 27.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.684 -0.234 . . . . 0.47 110.417 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.28 140.15 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.427 . . . . 0.4 110.653 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.71 112.17 23.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.45 109.354 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' C' ' 15' ' ' CYS . 34.8 p90 -150.89 166.85 29.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.293 -0.412 . . . . 0.61 110.806 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -104.4 138.17 41.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.277 -0.638 . . . . 0.42 109.277 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 69.2 t-105 -63.44 -34.44 77.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.835 -0.62 . . . . 0.68 110.387 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' C' ' 37' ' ' ARG . 19.4 mtm180 -68.69 -36.6 78.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 3.33 110.798 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -73.61 -23.15 59.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.54 110.919 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -92.32 -54.71 3.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.136 -0.484 . . . . 0.61 110.935 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.16 144.07 30.44 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.8 110.227 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.27 165.09 25.66 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.795 2.33 . . . . 2.12 112.068 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -13.96 47.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.192 -0.913 . . . . 3.3 112.961 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.44 -6.5 77.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.49 -0.862 . . . . 1.46 112.519 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.9 m -91.48 130.46 37.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 1.03 111.123 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.3 t -89.9 150.37 22.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.816 -0.629 . . . . 1.6 109.459 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 93.5 mtt180 -79.41 131.69 64.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.543 -0.54 . . . . 2.68 109.543 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.6 132.15 21.43 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.176 1.917 . . . . 1.14 111.925 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.33 -2.32 67.19 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.861 -0.685 . . . . 1.9 112.323 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.2 p -89.3 -2.77 58.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.817 0.342 . . . . 2.75 111.22 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.86 5.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.519 -0.848 . . . . 0.82 112.444 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.5 123.35 25.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.047 0.451 . . . . 0.87 109.844 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.74 133.32 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 2.65 111.295 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -77.38 -174.24 3.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.176 -0.676 . . . . 0.49 109.176 172.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.23 -53.17 59.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 4.09 111.374 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -63.46 -42.47 98.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.54 111.646 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 -17.27 62.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.679 0.276 . . . . 0.72 111.297 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 70.6 m -85.39 -3.04 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 1.25 110.989 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.27 38.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.606 -0.807 . . . . 2.19 112.381 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.6 69.37 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.278 0.561 . . . . 5.15 110.491 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 31.6 t -89.51 109.45 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 6.76 109.742 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -67.82 115.01 23.45 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.385 -0.37 . . . . 8.83 111.014 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.92 146.88 16.54 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.628 2.219 . . . . 11.04 112.481 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.49 137.65 20.75 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 13.86 110.584 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.05 71.34 2.86 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.623 2.215 . . . . 16.55 111.188 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.84 138.89 52.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 18.07 110.81 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.685 -0.674 . . . . 20.26 110.091 -178.919 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 112.078 -0.409 . . . . 20.38 112.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.17 -71.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.607 0.763 . . . . 18.81 111.378 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.3 ptm -141.14 120.32 12.93 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.606 -0.516 . . . . 18.06 109.606 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' C' ' 4' ' ' GLU . 0.0 OUTLIER -81.3 -33.98 32.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.296 -0.411 . . . . 16.83 110.527 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.25 112.1 0.85 Allowed Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.433 -0.889 . . . . 14.66 112.563 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -114.12 0.57 14.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.391 . . . . 15.8 110.513 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -79.22 66.97 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.289 0.566 . . . . 13.13 110.031 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -69.8 -43.45 72.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.659 -0.701 . . . . 11.74 109.566 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.2 120.22 39.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 8.72 109.587 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.2 123.42 85.25 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.603 -0.518 . . . . 5.93 109.603 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 89.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.888 2.392 . . . . 5.25 112.429 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.62 -17.04 37.36 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.71 -0.677 . . . . 2.28 111.506 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.94 74.8 4.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.357 0.599 . . . . 2.07 109.45 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -161.53 141.93 10.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.019 -0.991 . . . . 3.18 108.648 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 49.3 t -72.17 103.78 3.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 0.53 110.497 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.73 -7.65 83.92 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.856 -0.611 . . . . 0.65 111.644 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.94 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 1.04 110.255 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.2 p -102.73 -28.08 12.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.914 0.388 . . . . 0.84 110.038 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.11 24.75 10.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.77 111.693 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 27.9 t70 -142.59 147.83 36.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 2.1 110.706 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.23 16.94 8.04 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.631 -0.587 . . . . 0.55 111.631 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.5 m -80.44 120.02 23.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.155 -0.313 . . . . 1.06 110.155 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.72 50.03 17.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.56 0.695 . . . . 2.23 110.167 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.43 144.53 8.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.936 -1.029 . . . . 1.16 109.903 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.47 155.42 19.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.961 0.41 . . . . 0.48 110.376 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.0 mmm180 -123.64 151.96 42.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.014 -0.735 . . . . 3.18 109.014 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 37.9 t -69.63 138.78 53.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.618 -0.833 . . . . 0.37 109.176 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p -80.98 -10.86 59.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.101 0.477 . . . . 0.75 110.98 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -117.25 -7.81 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 1.43 111.031 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 14.3 m -140.92 179.32 6.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.79 110.406 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.6 113.29 26.76 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.011 -0.737 . . . . 0.47 109.011 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.91 145.34 6.22 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.058 0.224 . . . . 0.4 110.53 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.53 112.41 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.477 0.486 . . . . 0.45 110.268 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -157.06 145.15 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.913 -0.585 . . . . 0.61 110.146 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.821 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 77.2 m80 -86.75 151.35 23.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.516 -0.55 . . . . 0.42 109.516 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 67.9 t-105 -61.98 -50.5 71.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.763 0.316 . . . . 0.68 110.489 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 79.9 mtp180 -69.43 -14.53 62.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 3.33 111.731 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.821 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.8 m -80.79 -20.96 41.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.251 0.548 . . . . 0.54 110.029 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.06 -39.41 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.61 111.392 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 99.0 m-85 -125.68 158.61 64.45 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.8 110.496 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.42 159.82 51.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.595 2.197 . . . . 2.12 110.935 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.3 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 3.3 111.458 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.21 -12.8 79.75 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.231 -0.509 . . . . 1.46 112.413 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 23.7 m -88.81 138.9 30.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 1.03 109.914 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.11 137.74 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 1.6 110.319 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 14.4 ptm180 -93.12 121.74 64.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.352 -0.385 . . . . 2.68 111.221 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.02 136.57 29.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.769 2.312 . . . . 1.14 111.639 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.74 -46.99 10.32 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.075 -0.583 . . . . 1.9 112.721 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -17.65 16.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.163 0.506 . . . . 2.75 111.307 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -115.95 50.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.686 -0.769 . . . . 0.82 112.63 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -70.09 123.54 21.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.934 -0.765 . . . . 0.87 108.934 178.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 76.0 mtt180 -117.82 140.97 48.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.933 0.397 . . . . 2.65 111.832 -170.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 17.6 p -77.29 171.51 14.75 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.424 -0.954 . . . . 0.49 108.424 169.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -56.55 -38.79 72.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.194 0.452 . . . . 4.09 111.752 -171.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -68.62 -40.45 80.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 1.54 110.843 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -71.47 -26.19 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.732 0.301 . . . . 0.72 111.021 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 41.9 p -93.46 19.76 8.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.983 0.421 . . . . 1.25 110.689 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.97 60.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.13 -0.557 . . . . 2.19 112.126 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -91.12 156.8 17.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.837 0.351 . . . . 5.15 110.156 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.63 114.58 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.301 -0.408 . . . . 6.76 110.448 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 69.4 m -93.5 117.56 67.37 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.737 -0.468 . . . . 8.83 109.737 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.05 134.27 39.01 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.257 1.971 . . . . 11.04 112.219 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.56 122.72 68.0 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.951 -0.568 . . . . 13.86 110.038 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.88 86.24 0.11 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.842 2.362 . . . . 16.55 112.221 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.01 170.64 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.88 -0.6 . . . . 18.07 110.994 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.515 -0.755 . . . . 20.26 110.328 -178.455 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.853 -0.499 . . . . 20.38 111.853 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 60.15 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.405 0.622 . . . . 18.81 111.206 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.81 145.37 31.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.532 -0.758 . . . . 18.06 109.621 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -74.38 78.25 1.88 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.956 0.408 . . . . 16.83 110.908 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.4 83.96 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.583 -0.607 . . . . 14.66 111.583 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -110.69 8.65 22.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.893 0.378 . . . . 15.8 110.731 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.05 104.78 16.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 13.13 110.268 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.24 79.73 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 11.74 110.416 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 tp -143.21 133.02 23.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.968 -0.56 . . . . 8.72 110.34 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.16 139.19 52.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.063 -0.517 . . . . 5.93 110.57 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.79 57.89 2.58 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.099 2.532 . . . . 5.25 113.107 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.03 -150.38 22.58 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.791 -0.718 . . . . 2.28 112.48 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.23 83.55 3.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.805 0.336 . . . . 2.07 111.435 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -146.74 152.24 38.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.348 -0.387 . . . . 3.18 110.72 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.2 t -65.4 113.56 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.53 109.699 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.61 -19.2 62.38 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.075 -0.583 . . . . 0.65 113.496 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.93 -30.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.059 0.457 . . . . 1.04 110.686 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.6 m -108.57 -24.56 11.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.56 0.578 . . . . 0.84 112.56 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.46 16.9 79.81 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.304 -0.718 . . . . 0.77 111.304 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -134.85 156.2 49.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.451 . . . . 2.1 110.137 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.89 22.09 5.19 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.721 -0.752 . . . . 0.55 112.816 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.0 m -75.66 125.83 29.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.06 110.059 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 54.36 45.73 26.57 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.334 0.588 . . . . 2.23 110.234 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -91.75 151.77 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.16 110.531 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' C' ' 36' ' ' TRP . 74.2 mt -96.02 149.49 21.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.142 -0.481 . . . . 0.48 109.898 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -107.38 155.46 19.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.114 -0.494 . . . . 3.18 110.505 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.1 t -88.92 140.43 29.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.613 -0.514 . . . . 0.37 109.613 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -90.37 -26.83 19.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.032 0.444 . . . . 0.75 111.275 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -89.96 -20.5 23.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 1.43 111.05 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.0 p -151.0 -172.32 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.961 -0.755 . . . . 0.79 108.961 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.27 114.27 28.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.949 -0.389 . . . . 0.47 109.949 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.32 151.96 10.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.4 110.776 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -119.35 120.58 37.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.805 -0.634 . . . . 0.45 109.679 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.84 148.17 31.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.193 -0.458 . . . . 0.61 110.873 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.6 m170 -88.82 126.61 35.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.79 -1.189 . . . . 0.42 107.79 168.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.409 ' HB2' HD12 ' C' ' 25' ' ' LEU . 56.4 t-105 -56.57 -38.59 72.17 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.69 0.619 . . . . 0.68 111.192 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -71.71 -23.7 61.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.904 0.383 . . . . 3.33 111.222 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 84.4 m -85.14 -22.99 28.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.421 -0.354 . . . . 0.54 110.93 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' HIS . . . . . 0.426 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 7.6 m-70 -102.15 -24.72 13.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.61 111.539 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -130.87 65.1 75.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.913 0.387 . . . . 0.8 110.522 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 6.2 Cg_exo -78.97 5.42 5.72 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.159 2.572 . . . . 2.12 112.436 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.14 3.58 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.302 -0.408 . . . . 3.3 111.326 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.8 8.24 45.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 1.46 112.7 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.3 m -67.72 129.35 39.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.121 -0.325 . . . . 1.03 110.121 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 p -90.03 149.17 22.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.631 0.253 . . . . 1.6 110.575 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -78.13 121.97 84.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 2.68 111.257 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.71 155.65 58.35 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.771 2.314 . . . . 1.14 111.466 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.44 -19.43 79.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.98 -0.629 . . . . 1.9 111.814 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -147.11 142.29 27.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.917 0.389 . . . . 2.75 110.212 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 51.71 1.47 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.784 -0.722 . . . . 0.82 112.36 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.54 122.13 25.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.172 0.51 . . . . 0.87 110.372 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -127.89 137.29 52.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.171 -0.468 . . . . 2.65 110.505 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -72.89 -177.0 2.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.476 -0.564 . . . . 0.49 109.476 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -67.01 -40.43 87.31 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.631 -0.428 . . . . 4.09 110.631 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -67.68 -43.58 79.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 1.54 111.459 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.78 -17.22 62.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.72 110.791 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -87.41 19.66 3.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 1.25 110.574 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.58 94.28 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.498 -1.041 . . . . 2.19 110.498 172.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -91.94 74.63 5.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 5.15 109.485 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.53 123.22 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.722 -0.672 . . . . 6.76 110.721 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 33.6 m -97.57 115.18 65.72 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.002 -0.544 . . . . 8.83 109.827 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.72 132.91 54.4 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 11.04 111.91 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.13 141.93 33.33 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.838 -0.619 . . . . 13.86 110.812 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.87 57.63 4.55 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.804 2.336 . . . . 16.55 112.515 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.4 153.21 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 18.07 110.358 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.469 -0.777 . . . . 20.26 110.786 -179.423 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.042 -0.423 . . . . 20.38 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.58 122.54 27.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.834 0.349 . . . . 18.81 110.523 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 42.0 tpp -85.27 59.73 5.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.513 0.673 . . . . 18.06 110.094 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -93.92 69.73 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 16.83 110.177 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.6 48.22 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.205 -0.907 . . . . 14.66 111.106 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.87 -12.89 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.725 0.298 . . . . 15.8 111.296 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 58.59 56.4 4.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 13.13 110.465 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -113.9 92.26 3.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 11.74 110.322 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.03 146.67 27.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.839 -0.619 . . . . 8.72 109.917 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.84 130.88 33.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.149 -0.478 . . . . 5.93 110.134 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.12 64.52 3.43 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.947 2.431 . . . . 5.25 112.684 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.41 41.36 58.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.708 -0.758 . . . . 2.28 111.221 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.39 75.22 1.49 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 2.07 110.077 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -129.07 141.84 51.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 3.18 110.118 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -64.19 103.42 0.62 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.53 109.516 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.08 -17.41 69.7 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.867 -0.682 . . . . 0.65 112.764 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 42.0 t -61.78 -38.56 80.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.824 0.345 . . . . 1.04 110.981 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.6 p -109.52 -28.96 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.979 0.419 . . . . 0.84 110.576 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.51 -14.38 56.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.044 -0.598 . . . . 0.77 111.829 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -94.94 140.27 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 2.1 110.987 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.09 20.23 16.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.925 -0.655 . . . . 0.55 112.476 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -78.36 116.37 18.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.461 0.172 . . . . 1.06 110.581 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.71 66.19 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 2.23 111.386 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.49 140.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 1.16 110.987 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -88.06 143.8 26.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 0.48 109.405 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.6 OUTLIER -108.07 135.54 49.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.069 0.462 . . . . 3.18 110.612 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 6.7 t -63.57 141.27 58.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.299 -0.864 . . . . 0.37 110.261 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.3 p -89.51 -26.23 21.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.324 -0.398 . . . . 0.75 111.35 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -89.64 -21.51 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.43 110.904 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.9 p -150.49 -172.29 4.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.478 -0.934 . . . . 0.79 108.478 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.03 114.4 28.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.788 0.328 . . . . 0.47 110.187 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.45 123.23 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.4 109.847 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.34 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.583 -0.525 . . . . 0.45 109.583 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -147.77 162.92 38.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.004 -0.544 . . . . 0.61 110.122 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.427 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -93.03 133.72 35.89 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.873 -0.788 . . . . 0.42 108.873 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -51.14 -48.05 61.91 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.632 0.582 . . . . 0.68 111.092 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 33.7 mmt180 -74.41 -5.46 42.59 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.388 0.514 . . . . 3.33 112.388 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.5 m -91.23 -22.2 20.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 0.54 110.561 175.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -102.35 -43.31 5.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.01 0.433 . . . . 0.61 110.722 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 88.3 m-85 -118.58 137.72 25.1 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.595 . . . . 0.8 109.928 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.41 177.65 6.46 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.7 2.267 . . . . 2.12 112.633 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.11 -37.89 78.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.68 0.276 . . . . 3.3 111.699 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.64 -20.93 64.43 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.105 -0.498 . . . . 1.46 113.787 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.12 132.35 34.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.125 0.463 . . . . 1.03 110.111 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.74 137.99 31.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.29 -0.414 . . . . 1.6 110.956 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -74.84 117.29 61.4 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.763 -0.653 . . . . 2.68 110.632 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.41 132.63 22.66 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.587 2.191 . . . . 1.14 111.638 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.23 -39.3 12.94 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.769 -0.729 . . . . 1.9 111.459 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.1 m -98.14 112.49 24.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.447 -0.377 . . . . 2.75 110.597 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.58 59.99 3.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.885 -0.674 . . . . 0.82 112.801 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.76 122.51 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.847 -0.797 . . . . 0.87 108.847 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 33.6 ptt180 -133.69 146.04 50.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.103 0.478 . . . . 2.65 111.032 -174.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.46 177.14 5.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.329 -0.85 . . . . 0.49 110.649 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -55.78 -49.37 73.36 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.151 0.282 . . . . 4.09 111.204 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -59.19 -43.25 92.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.999 0.428 . . . . 1.54 110.513 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.82 -27.76 62.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.404 0.52 . . . . 0.72 112.404 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -75.85 -7.14 53.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.874 0.369 . . . . 1.25 111.31 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.84 -149.6 5.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.937 -0.649 . . . . 2.19 111.794 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.4 167.07 12.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.929 0.395 . . . . 5.15 110.23 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.48 40.75 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.271 0.558 . . . . 6.76 110.681 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 75.9 p -78.67 130.83 69.59 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.696 -0.683 . . . . 8.83 110.197 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.15 133.24 51.73 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.341 2.027 . . . . 11.04 111.671 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.83 126.91 29.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.338 -0.392 . . . . 13.86 110.445 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.53 98.84 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.593 2.195 . . . . 16.55 111.831 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -89.57 -39.84 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.318 0.58 . . . . 18.07 110.416 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.316 -0.856 . . . . 20.26 109.976 179.817 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 111.965 -0.454 . . . . 20.38 111.965 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.61 -20.01 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.714 0.292 . . . . 18.81 111.648 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -73.41 -12.41 60.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 18.06 111.238 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.25 84.1 7.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.919 -0.4 . . . . 16.83 109.919 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' GLY . . . . . 0.616 ' HA2' ' OD1' ' C' ' 8' ' ' ASN . . . -132.61 33.69 2.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.695 -0.764 . . . . 14.66 112.633 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -74.95 -28.42 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 15.8 111.026 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -120.22 35.3 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 13.13 110.634 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' ASN . . . . . 0.616 ' OD1' ' HA2' ' C' ' 5' ' ' GLY . 16.7 m120 -115.08 24.59 11.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.167 0.508 . . . . 11.74 110.513 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.25 76.93 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.926 -0.579 . . . . 8.72 110.285 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.62 125.91 90.61 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 5.93 109.944 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.2 95.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.952 2.435 . . . . 5.25 113.071 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.0 41.52 1.64 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.514 -0.634 . . . . 2.28 111.514 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.66 81.68 8.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.064 0.459 . . . . 2.07 111.287 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.03 154.99 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 3.18 109.721 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 27.9 t -61.48 106.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 0.53 110.123 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.05 -25.7 64.67 Favored Glycine 0 C--O 1.229 -0.182 0 O-C-N 123.454 0.471 . . . . 0.65 112.516 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.17 -29.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.494 . . . . 1.04 110.885 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 88.5 m -108.1 -33.46 7.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.84 112.116 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.05 6.03 72.38 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.86 -0.896 . . . . 0.77 110.86 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.36 147.08 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.588 . . . . 2.1 109.912 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.45 30.99 4.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.864 -0.684 . . . . 0.55 112.752 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -74.72 125.73 29.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 1.06 109.723 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.13 51.91 14.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.438 0.637 . . . . 2.23 110.325 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.33 151.1 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.599 -0.728 . . . . 1.16 110.565 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' C' ' 36' ' ' TRP . 80.6 mt -102.27 148.38 25.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.48 110.023 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.3 tpt180 -115.57 138.73 50.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.844 -0.617 . . . . 3.18 110.447 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -75.49 143.69 42.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.743 -0.466 . . . . 0.37 109.743 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -91.04 -30.79 16.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.545 . . . . 0.75 111.855 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -91.58 -14.38 30.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.351 . . . . 1.43 111.507 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 p -150.47 -174.22 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.437 -0.579 . . . . 0.79 109.437 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.63 114.06 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.673 -0.492 . . . . 0.47 109.673 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.14 125.13 1.87 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.4 110.835 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.76 25.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.45 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -151.83 160.63 43.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.374 -0.375 . . . . 0.61 110.598 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.1 m170 -90.8 134.83 34.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.941 -0.763 . . . . 0.42 108.941 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.445 ' HB2' HD12 ' C' ' 25' ' ' LEU . 28.0 t-105 -50.54 -51.58 46.55 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.336 0.397 . . . . 0.68 111.476 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -62.19 -27.8 69.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 3.33 112.193 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -78.49 -22.91 46.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 0.54 111.346 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -100.22 -37.08 9.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.264 -0.425 . . . . 0.61 110.865 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.3 85.65 25.63 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 0.8 110.289 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.45 -5.19 12.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.117 2.544 . . . . 2.12 113.386 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.21 4.23 31.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.896 0.379 . . . . 3.3 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.41 33.78 27.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.713 -0.756 . . . . 1.46 112.024 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -61.66 142.21 57.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 1.03 110.733 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -88.48 135.45 33.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.422 -0.354 . . . . 1.6 110.157 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -67.4 125.78 91.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 2.68 110.342 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 137.64 38.17 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.575 2.184 . . . . 1.14 112.377 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.1 1.51 70.43 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.952 -0.642 . . . . 1.9 111.988 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -104.86 26.61 8.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.36 0.6 . . . . 2.75 110.746 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 118.08 122.38 3.19 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.546 -0.752 . . . . 0.82 111.805 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.7 123.57 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 54.1 mtt85 -125.68 134.29 51.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.359 -0.382 . . . . 2.65 111.119 -174.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.9 p -76.29 177.19 7.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.977 -0.749 . . . . 0.49 108.977 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -59.96 -40.33 88.66 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.318 0.508 . . . . 4.09 111.487 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m -65.09 -46.54 80.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.868 0.366 . . . . 1.54 110.965 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.91 -17.85 62.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.72 111.418 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 36.3 m -88.84 -14.33 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.38 . . . . 1.25 110.56 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.59 100.15 1.66 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.907 -0.663 . . . . 2.19 112.623 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.54 42.26 1.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.59 0.71 . . . . 5.15 109.745 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.13 146.82 24.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.542 -0.754 . . . . 6.76 110.559 -172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.1 t -65.57 135.24 95.67 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.958 -0.565 . . . . 8.83 109.805 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.07 133.51 47.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.838 2.359 . . . . 11.04 112.425 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.59 130.5 33.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.853 -0.612 . . . . 13.86 110.896 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.09 92.78 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.567 2.178 . . . . 16.55 111.423 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -91.24 124.82 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.178 -0.465 . . . . 18.07 110.654 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.924 -0.56 . . . . 20.26 109.754 177.36 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.877 -0.489 . . . . 20.38 111.877 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.44 133.08 53.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.437 -0.208 . . . . 18.81 110.437 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 24.1 ptp -124.94 10.4 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.079 0.466 . . . . 18.06 110.748 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -89.0 72.51 8.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.509 . . . . 16.83 110.718 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.7 97.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.024 -0.608 . . . . 14.66 111.749 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 57.97 49.29 11.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.14 0.495 . . . . 15.8 110.977 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -104.48 88.93 3.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.881 -0.6 . . . . 13.13 110.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -81.09 90.78 6.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.604 -0.725 . . . . 11.74 110.727 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.01 104.8 11.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.263 -0.426 . . . . 8.72 110.349 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.81 128.64 45.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 5.93 110.383 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.0 109.03 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.782 2.322 . . . . 5.25 112.203 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.37 96.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.782 -0.723 . . . . 2.28 111.922 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.39 74.92 4.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.205 0.526 . . . . 2.07 110.809 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -147.79 130.51 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.702 -0.681 . . . . 3.18 110.108 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -81.9 102.76 11.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.53 108.608 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.66 80.34 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.828 -0.624 . . . . 0.65 112.806 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.4 HG11 ' O ' ' C' ' 38' ' ' CYS . 33.4 t -66.14 -28.83 44.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.085 0.469 . . . . 1.04 110.725 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.56 -41.9 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.314 -0.403 . . . . 0.84 110.326 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.49 -10.82 8.07 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.911 -0.661 . . . . 0.77 112.256 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -100.23 148.19 24.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 2.1 111.843 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.75 16.43 21.15 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.488 -0.778 . . . . 0.55 111.491 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.4 m -74.0 115.59 13.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.826 -0.187 . . . . 1.06 110.739 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.19 66.34 1.26 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.801 0.688 . . . . 2.23 111.014 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -89.97 136.53 23.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.63 -0.714 . . . . 1.16 111.008 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.03 144.09 28.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.667 -0.697 . . . . 0.48 110.014 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.1 mpt_? -103.78 146.65 28.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.953 -0.567 . . . . 3.18 110.19 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 27.0 t -72.62 141.39 48.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.515 -0.55 . . . . 0.37 109.515 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.44 -26.05 33.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.581 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -94.91 -28.12 15.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 1.43 111.521 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.9 p -143.93 -174.02 4.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.57 . . . . 0.79 109.46 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.58 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.781 0.324 . . . . 0.47 110.719 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -160.8 138.46 9.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.046 -0.525 . . . . 0.4 109.973 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.56 112.12 22.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.858 -0.423 . . . . 0.45 109.858 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -156.53 166.0 34.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.834 0.35 . . . . 0.61 110.976 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -97.29 135.22 39.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.42 108.795 171.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -59.62 -39.28 83.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.924 -0.58 . . . . 0.68 110.593 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.61 -15.83 60.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 3.33 111.73 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.4 ' O ' HG11 ' C' ' 17' ' ' VAL . 68.7 m -84.32 -22.45 30.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.168 0.509 . . . . 0.54 110.12 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.24 -56.07 2.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 0.61 111.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 75.6 m-85 -106.99 135.24 19.6 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.833 -0.621 . . . . 0.8 110.14 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 9.1 Cg_exo -70.78 176.3 7.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.272 . . . . 2.12 112.667 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.94 65.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.437 -0.347 . . . . 3.3 111.654 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.52 -23.08 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.46 112.88 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 13.1 m -99.0 128.88 45.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.883 -0.414 . . . . 1.03 109.883 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 63.0 p -89.21 138.0 31.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.465 -0.334 . . . . 1.6 111.216 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -75.61 116.17 52.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 2.68 110.348 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.96 133.42 21.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.237 1.958 . . . . 1.14 111.449 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.15 79.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.938 -0.649 . . . . 1.9 111.733 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.4 p -131.53 141.46 49.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.012 -0.366 . . . . 2.75 110.012 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.74 53.15 3.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.82 112.275 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 123.25 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.81 -0.441 . . . . 0.87 109.81 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -117.25 145.7 43.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.915 0.388 . . . . 2.65 110.779 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 13.9 p -84.65 -176.21 6.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.308 -0.627 . . . . 0.49 109.308 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -62.5 -48.31 80.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 4.09 111.348 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 19.3 t -67.1 -44.77 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.324 -0.398 . . . . 1.54 111.244 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -72.14 -29.33 63.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.816 0.302 . . . . 0.72 111.816 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 2.6 t -90.65 -12.23 37.46 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.793 -0.363 . . . . 1.25 111.679 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.75 -111.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.023 -1.084 . . . . 2.19 113.092 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -115.54 146.98 41.22 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.062 -0.347 . . . . 5.15 110.062 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.89 122.92 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 6.76 111.11 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -109.46 105.22 56.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.695 -0.483 . . . . 8.83 109.695 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.01 137.1 51.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.531 2.154 . . . . 11.04 112.397 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' C' ' 65' ' ' VAL . . . -80.29 155.72 74.24 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.753 -0.658 . . . . 13.86 110.256 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.46 23.88 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.89 2.393 . . . . 16.55 113.184 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' C' ' 63' ' ' ALA . 27.3 m -122.95 7.78 5.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.636 -0.711 . . . . 18.07 109.445 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.22 -0.9 . . . . 20.26 109.985 -179.049 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.768 -0.533 . . . . 20.38 111.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' C' ' 6' ' ' GLN . . . -81.44 -61.12 2.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.739 0.304 . . . . 18.81 111.389 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 20.3 mmt -78.85 40.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.665 0.617 . . . . 18.06 112.665 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.87 -6.43 9.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.509 -0.552 . . . . 16.83 109.509 172.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.05 -79.61 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.601 -0.727 . . . . 14.66 112.372 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' C' ' 2' ' ' ALA . 30.4 mm-40 57.79 37.22 27.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.954 0.407 . . . . 15.8 110.08 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 58.3 69.85 0.7 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.254 -0.884 . . . . 13.13 109.691 -174.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -81.06 68.93 7.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.651 0.739 . . . . 11.74 110.202 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.9 tp -149.12 100.53 3.06 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.152 -0.931 . . . . 8.72 109.454 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' C' ' 13' ' ' ALA . . . -87.42 123.43 69.7 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.026 -0.534 . . . . 5.93 110.016 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.87 -25.43 60.13 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.788 2.325 . . . . 5.25 112.704 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.66 22.99 32.53 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.829 -0.623 . . . . 2.28 112.343 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' C' ' 10' ' ' ALA . . . -135.83 107.11 6.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.015 0.436 . . . . 2.07 111.196 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 73.1 mtt180 -136.47 164.42 28.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 3.18 109.636 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.87 106.62 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.227 -0.657 . . . . 0.53 109.227 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 -22.3 55.0 Favored Glycine 0 C--N 1.33 0.224 0 O-C-N 123.349 0.405 . . . . 0.65 113.109 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.4 -30.2 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.04 110.891 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 86.5 m -108.57 -46.02 3.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.774 0.657 . . . . 0.84 112.774 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' GLY . . . . . 0.658 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 102.67 -17.17 53.74 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.77 111.536 -173.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.42 150.37 20.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.864 0.364 . . . . 2.1 110.758 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.13 9.04 29.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.186 -0.766 . . . . 0.55 111.186 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 m -72.48 136.7 46.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.389 . . . . 1.06 110.539 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.92 47.09 7.0 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.967 0.889 . . . . 2.23 111.075 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.65 140.45 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.16 109.854 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.35 144.56 25.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.932 0.396 . . . . 0.48 110.381 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -109.32 149.69 29.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.588 -0.733 . . . . 3.18 109.551 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.64 137.36 33.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.022 0.439 . . . . 0.37 110.521 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 33.8 p -85.51 -3.5 58.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.591 . . . . 0.75 111.957 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -122.18 -15.44 7.71 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.002 -0.279 . . . . 1.43 111.631 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -151.9 -167.42 2.77 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.79 109.548 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.01 29.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.548 -0.296 . . . . 0.47 110.249 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.96 145.68 15.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.326 -0.397 . . . . 0.4 110.528 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.58 112.53 16.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.008 -0.542 . . . . 0.45 110.052 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.76 162.72 38.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.924 -0.398 . . . . 0.61 109.924 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.757 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -95.28 138.08 33.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.713 -0.847 . . . . 0.42 108.713 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -50.29 -53.03 31.56 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.239 0.337 . . . . 0.68 111.399 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -66.34 -18.07 65.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 3.33 111.97 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.0 m -84.17 -22.2 31.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.162 0.506 . . . . 0.54 110.852 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.94 -34.63 8.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.61 110.672 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -124.12 132.42 24.3 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.8 109.785 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.14 154.65 27.3 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.892 2.395 . . . . 2.12 111.695 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.39 -19.84 57.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.388 -0.823 . . . . 3.3 112.449 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.74 -18.8 78.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.067 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -85.49 125.36 32.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 1.03 110.013 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m -88.51 136.42 33.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 1.6 110.567 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -69.92 123.94 89.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 2.68 110.299 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.79 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.664 2.243 . . . . 1.14 112.581 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.84 5.42 82.08 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.827 -0.701 . . . . 1.9 111.583 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -92.7 18.46 8.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.14 0.495 . . . . 2.75 110.881 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.86 135.17 8.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.977 -0.63 . . . . 0.82 111.69 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 123.82 22.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.962 0.41 . . . . 0.87 110.008 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -117.41 138.05 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 2.65 110.69 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -81.12 -176.67 6.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.668 -0.493 . . . . 0.49 109.668 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -57.4 -52.48 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 4.09 111.1 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.9 t -63.11 -46.29 88.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.497 -0.32 . . . . 1.54 111.359 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 80.6 m -72.18 -17.77 61.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.072 0.397 . . . . 0.72 112.072 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -81.65 -13.75 57.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.423 -0.511 . . . . 1.25 110.147 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.7 3.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.707 -0.679 . . . . 2.19 111.495 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -148.92 144.2 26.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.686 0.279 . . . . 5.15 110.635 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.454 ' O ' ' HD3' ' C' ' 62' ' ' PRO . 43.9 t -89.18 100.5 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.005 0.431 . . . . 6.76 110.101 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 19.0 p -100.48 106.16 41.15 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.772 -0.649 . . . . 8.83 111.559 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' C' ' 60' ' ' VAL . 17.2 Cg_exo -67.86 142.59 57.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.623 2.215 . . . . 11.04 111.431 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.21 120.12 77.7 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.296 -0.411 . . . . 13.86 110.802 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.41 41.65 1.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.699 2.266 . . . . 16.55 112.349 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.85 98.6 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.571 . . . . 18.07 109.989 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.576 -0.726 . . . . 20.26 110.265 -177.103 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.134 -0.387 . . . . 20.38 112.134 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.81 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.386 0.674 . . . . 18.81 111.815 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 56.2 ttm -157.68 83.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 18.06 110.363 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.42 65.39 1.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 16.83 110.174 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.38 38.67 1.85 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.513 -0.767 . . . . 14.66 111.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.81 -26.16 37.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.23 0.538 . . . . 15.8 110.09 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -81.96 108.97 15.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.607 -0.724 . . . . 13.13 109.746 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -111.35 89.19 2.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.143 -0.48 . . . . 11.74 110.576 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 118.15 23.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 8.72 110.163 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.45 139.58 78.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.964 -0.562 . . . . 5.93 110.301 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.16 69.64 2.43 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.028 2.485 . . . . 5.25 112.759 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.27 34.28 89.07 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 116.042 -0.526 . . . . 2.28 111.838 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -142.9 75.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.901 0.381 . . . . 2.07 111.002 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.417 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.7 ttp180 -147.56 128.29 14.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.334 -0.394 . . . . 3.18 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -69.08 111.32 4.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.768 -0.456 . . . . 0.53 109.768 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.69 81.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.27 -0.49 . . . . 0.65 112.846 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.45 -37.65 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.763 0.316 . . . . 1.04 110.931 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.0 m -96.14 -43.55 7.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 0.84 111.621 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.37 1.01 55.65 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.144 -0.783 . . . . 0.77 111.144 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -117.22 143.48 45.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.338 . . . . 2.1 110.407 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -110.37 9.32 30.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.958 -0.639 . . . . 0.55 112.078 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -72.78 134.02 44.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.168 -0.308 . . . . 1.06 110.168 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.34 48.6 21.6 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.628 0.58 . . . . 2.23 110.848 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.9 p -91.18 145.05 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 1.16 110.518 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.26 147.43 23.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.274 -0.421 . . . . 0.48 110.407 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -112.7 150.28 31.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 3.18 110.876 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 11.7 t -82.79 134.28 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.37 108.883 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.459 HG22 ' O ' ' C' ' 51' ' ' LEU . 5.9 t -85.57 -11.72 53.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.732 -0.387 . . . . 0.75 111.491 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.75 -17.95 13.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.795 0.294 . . . . 1.43 111.795 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.57 -167.55 2.85 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.475 -0.565 . . . . 0.79 109.475 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 114.09 28.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.755 0.312 . . . . 0.47 110.36 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -157.8 146.34 19.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.4 110.374 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -133.26 112.18 11.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.136 -0.484 . . . . 0.45 110.256 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.6 164.82 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.104 -0.498 . . . . 0.61 109.847 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.3 m170 -96.54 137.76 35.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.104 -1.073 . . . . 0.42 108.104 171.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -47.65 -51.65 20.82 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.533 0.521 . . . . 0.68 112.006 -173.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -61.65 -32.88 73.07 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.152 0.427 . . . . 3.33 112.152 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 9.1 m -71.35 -21.4 62.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.54 111.043 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.89 -42.93 5.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.61 111.174 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.99 142.94 29.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.41 -0.359 . . . . 0.8 110.714 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.16 149.02 6.49 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.602 2.868 . . . . 2.12 112.75 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -16.15 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.328 -0.851 . . . . 3.3 112.566 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.64 18.27 56.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 1.46 112.285 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.4 m -106.63 131.27 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.498 0.19 . . . . 1.03 110.542 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -88.54 133.59 34.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.975 -0.379 . . . . 1.6 109.975 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 46' ' ' ARG . 4.1 ptm180 -80.82 130.09 65.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.714 0.292 . . . . 2.68 110.682 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.16 146.88 47.14 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.83 2.354 . . . . 1.14 112.203 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.02 -40.71 4.52 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.29 -0.724 . . . . 1.9 111.29 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.8 p -100.09 83.36 2.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.923 0.392 . . . . 2.75 110.663 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 116.94 64.05 0.33 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.458 -0.877 . . . . 0.82 112.906 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.459 ' O ' HG22 ' C' ' 28' ' ' THR . 0.8 OUTLIER -77.0 121.79 24.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.782 -0.822 . . . . 0.87 108.782 176.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -126.29 132.1 51.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.436 -0.347 . . . . 2.65 110.731 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.09 179.62 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.49 109.561 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -60.17 -42.35 94.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 4.09 111.282 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -66.49 -46.26 76.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 1.54 111.057 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -71.41 -33.4 69.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.803 0.297 . . . . 0.72 111.803 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 46.1 p -83.32 -11.31 57.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 1.25 110.725 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.41 75.08 0.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.971 -0.633 . . . . 2.19 111.784 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -88.85 135.61 33.44 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.727 -0.472 . . . . 5.15 109.727 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.6 144.23 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.815 -0.63 . . . . 6.76 109.837 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.2 m -93.41 104.86 13.57 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.4 -0.364 . . . . 8.83 110.039 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 141.77 32.18 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.538 2.159 . . . . 11.04 112.263 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.14 134.89 76.98 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.85 -0.613 . . . . 13.86 110.392 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.36 66.58 2.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.986 2.457 . . . . 16.55 112.131 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.25 149.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.645 -0.707 . . . . 18.07 109.794 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' C' ' 66' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 119.26 -0.4 . . . . 20.26 110.747 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.058 -0.417 . . . . 20.38 112.058 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.11 84.79 0.09 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 122.926 0.49 . . . . 18.81 111.349 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ttt -67.96 -27.09 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 18.06 109.833 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 59.75 -99.61 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.006 -0.997 . . . . 16.83 111.939 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.58 -157.88 53.37 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.724 -0.75 . . . . 14.66 112.829 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -66.57 -26.93 67.35 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.19 0.596 . . . . 15.8 112.016 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -79.01 -7.84 58.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.718 0.294 . . . . 13.13 111.541 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -79.22 90.76 4.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.189 0.518 . . . . 11.74 110.521 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -86.21 124.37 32.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.66 -0.7 . . . . 8.72 110.263 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.14 160.39 40.07 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.726 -0.67 . . . . 5.93 111.306 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.98 58.97 1.22 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.439 2.759 . . . . 5.25 112.521 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 60.26 0.22 Allowed Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 110.983 -0.847 . . . . 2.28 110.983 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.31 88.24 0.63 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.159 0.504 . . . . 2.07 110.487 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -150.2 150.5 31.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.735 -0.666 . . . . 3.18 109.604 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.75 103.87 1.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.52 -0.548 . . . . 0.53 109.52 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.26 86.14 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.65 113.458 -171.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.94 -40.38 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.809 0.338 . . . . 1.04 110.988 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -111.67 -20.59 12.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.359 . . . . 0.84 111.147 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.95 77.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.929 -0.653 . . . . 0.77 112.036 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -109.84 146.78 34.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.259 -0.275 . . . . 2.1 110.259 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.1 17.18 9.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.55 112.753 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.76 119.43 23.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.505 -0.183 . . . . 1.06 110.505 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.72 63.1 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.413 0.445 . . . . 2.23 111.258 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -89.1 140.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 1.16 110.793 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.15 145.99 24.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.676 -0.693 . . . . 0.48 109.538 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.87 141.46 42.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 3.18 110.945 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -69.79 128.24 35.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.158 -0.682 . . . . 0.37 109.158 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 46.8 p -84.49 -8.26 59.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.495 0.664 . . . . 0.75 110.292 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -99.91 -27.97 13.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.387 -0.824 . . . . 1.43 111.056 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.1 p -151.74 -161.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.028 -0.269 . . . . 0.79 110.408 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.71 119.74 39.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.676 -0.238 . . . . 0.47 110.788 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -173.12 141.09 0.93 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.175 -0.466 . . . . 0.4 110.8 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.86 112.82 19.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.597 -0.52 . . . . 0.45 109.597 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -155.56 169.57 24.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 0.61 110.943 -173.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -102.55 134.92 45.1 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.37 -0.604 . . . . 0.42 109.37 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -63.61 -35.19 79.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.613 -0.721 . . . . 0.68 110.532 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -76.97 -17.39 58.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 3.33 111.745 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.06 -22.49 27.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.069 0.462 . . . . 0.54 110.411 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -93.3 -51.35 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.088 -0.506 . . . . 0.61 110.362 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.76 152.81 47.79 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.695 . . . . 0.8 109.963 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.29 148.48 70.59 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.244 1.963 . . . . 2.12 110.705 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.27 -11.38 31.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.022 -0.535 . . . . 3.3 111.69 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.21 7.49 80.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.11 -0.567 . . . . 1.46 112.216 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -93.02 140.54 29.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.763 -0.257 . . . . 1.03 110.308 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.3 p -87.91 143.73 26.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.973 0.416 . . . . 1.6 110.149 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -89.48 129.69 46.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.538 -0.542 . . . . 2.68 109.538 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 132.73 44.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.939 2.426 . . . . 1.14 112.761 -173.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.82 -10.41 83.13 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.342 -0.703 . . . . 1.9 111.342 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -89.59 26.38 1.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.388 0.613 . . . . 2.75 110.387 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 131.99 7.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.506 -0.77 . . . . 0.82 111.758 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.76 123.13 18.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.422 -0.584 . . . . 0.87 109.422 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -110.24 147.32 34.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.32 0.581 . . . . 2.65 110.726 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.4 p -91.49 -170.05 2.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.354 -0.839 . . . . 0.49 109.526 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -61.05 -49.64 76.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.655 -0.248 . . . . 4.09 111.283 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' C' ' 58' ' ' GLY . 15.7 m -68.64 -36.97 79.31 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.196 0.522 . . . . 1.54 111.867 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -73.64 -15.73 61.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.806 0.336 . . . . 0.72 111.422 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -97.83 7.31 46.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.353 0.597 . . . . 1.25 109.772 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' C' ' 55' ' ' SER . . . 144.19 147.23 4.64 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.256 -1.138 . . . . 2.19 110.256 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.92 131.59 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.194 0.997 . . . . 5.15 110.727 -169.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -89.54 78.34 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.112 -0.949 . . . . 6.76 109.643 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -77.19 117.02 62.45 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.497 -0.774 . . . . 8.83 110.107 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.18 133.81 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.463 2.109 . . . . 11.04 111.814 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.27 137.6 56.2 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 13.86 110.041 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 72.57 1.79 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.931 2.42 . . . . 16.55 112.701 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.59 33.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 122.016 0.913 . . . . 18.07 109.066 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.085 -0.961 . . . . 20.26 109.844 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.471 -0.651 . . . . 20.38 111.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.96 155.7 26.32 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.185 -0.302 . . . . 18.81 110.185 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 17.4 ptm -106.35 80.04 1.45 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.626 0.726 . . . . 18.06 110.718 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -75.83 141.87 42.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 16.83 110.289 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.52 176.13 14.33 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.794 -0.922 . . . . 14.66 110.794 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.87 44.46 1.21 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.523 0.678 . . . . 15.8 110.172 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -94.84 94.21 7.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.278 -0.874 . . . . 13.13 110.925 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.57 -8.52 59.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.255 -0.429 . . . . 11.74 110.114 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.06 60.64 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.322 0.582 . . . . 8.72 110.463 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -94.39 135.16 24.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.594 -0.73 . . . . 5.93 110.647 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 16.8 Cg_exo -67.95 -11.67 32.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.649 2.233 . . . . 5.25 111.933 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.73 -146.4 20.63 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.64 -0.709 . . . . 2.28 112.087 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.429 ' HB2' HH22 ' C' ' 26' ' ' ARG . . . -153.87 73.53 0.95 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.934 0.397 . . . . 2.07 110.306 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.462 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.6 ttt180 -152.46 133.55 14.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 3.18 110.604 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 29.5 t -90.47 103.67 16.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 0.53 109.183 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 -4.54 89.81 Favored Glycine 0 N--CA 1.453 -0.183 0 CA-C-N 115.967 -0.561 . . . . 0.65 113.253 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.11 -32.13 46.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.106 0.479 . . . . 1.04 110.21 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 p -115.89 -41.34 3.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.006 -0.543 . . . . 0.84 110.285 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.55 -15.78 7.1 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.874 -0.679 . . . . 0.77 112.381 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -91.12 140.81 29.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 2.1 111.343 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -111.28 3.48 28.22 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.989 -0.624 . . . . 0.55 112.138 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 57.6 m -80.47 134.65 36.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.52 0.2 . . . . 1.06 110.739 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 59.46 50.02 8.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.629 0.728 . . . . 2.23 110.94 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 m -89.88 144.61 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.669 -0.696 . . . . 1.16 110.869 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.6 153.26 18.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.48 110.023 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 25.1 mmt180 -106.86 154.44 21.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.151 -0.477 . . . . 3.18 110.411 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.4 t -89.19 144.0 26.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -23.85 22.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.766 0.317 . . . . 0.75 111.331 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -95.22 -17.58 21.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 1.43 111.232 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 9.5 p -150.84 -177.2 5.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.138 -0.69 . . . . 0.79 109.138 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.17 119.33 38.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.577 -0.283 . . . . 0.47 110.525 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.92 149.36 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.086 -0.506 . . . . 0.4 110.226 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -121.32 112.21 18.31 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.54 -0.541 . . . . 0.45 109.54 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -152.69 162.07 41.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.284 -0.416 . . . . 0.61 110.779 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -91.41 136.6 32.99 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.42 -0.585 . . . . 0.42 109.42 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -59.83 -36.04 76.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.68 109.975 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -72.2 -22.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 3.33 111.777 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 87.6 m -90.38 -23.44 21.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.54 111.284 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -102.07 -21.07 14.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.942 -0.303 . . . . 0.61 111.526 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -131.08 149.06 72.67 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.766 -0.457 . . . . 0.8 109.766 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.56 147.17 60.24 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.692 2.261 . . . . 2.12 111.447 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.64 61.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.203 -0.908 . . . . 3.3 112.664 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.27 -10.82 86.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.672 . . . . 1.46 112.771 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -73.44 130.04 39.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.694 0.283 . . . . 1.03 110.5 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.7 t -88.86 136.64 32.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.584 -0.525 . . . . 1.6 109.584 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -79.48 126.82 80.23 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.047 -0.524 . . . . 2.68 110.391 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.86 135.77 31.05 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.363 2.042 . . . . 1.14 111.513 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -29.36 73.85 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.737 -0.665 . . . . 1.9 112.186 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -139.38 133.24 30.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.144 -0.317 . . . . 2.75 110.144 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.07 57.19 1.61 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.524 -0.846 . . . . 0.82 112.342 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.53 123.91 22.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.498 -0.556 . . . . 0.87 109.498 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.77 140.36 49.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.482 -0.326 . . . . 2.65 110.801 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.34 169.48 12.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.409 -0.96 . . . . 0.49 108.409 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.08 -34.63 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.851 0.751 . . . . 4.09 111.158 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -64.22 -44.9 90.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 1.54 110.978 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.4 m -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.72 111.136 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.3 m -88.73 15.26 8.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 1.25 110.695 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.68 -136.41 13.51 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.051 -0.595 . . . . 2.19 111.715 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -124.12 78.62 1.66 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.537 . . . . 5.15 110.238 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.06 87.83 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.814 -0.63 . . . . 6.76 110.442 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.3 p -106.71 121.05 46.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 8.83 110.848 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.81 134.68 64.23 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 11.04 111.257 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.27 120.1 51.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.202 -0.454 . . . . 13.86 110.94 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.45 91.11 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.646 2.231 . . . . 16.55 111.945 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.84 148.55 30.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 18.07 110.538 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.375 -0.821 . . . . 20.26 110.281 177.363 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.192 -0.363 . . . . 20.38 112.192 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.08 -35.75 49.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.866 0.365 . . . . 18.81 111.149 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.85 -36.3 62.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.103 -0.499 . . . . 18.06 111.01 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.73 -20.01 47.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.476 -0.329 . . . . 16.83 111.438 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.4 142.78 6.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.714 -0.755 . . . . 14.66 111.982 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -80.34 -63.22 1.46 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.587 0.232 . . . . 15.8 110.443 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -171.67 89.99 0.12 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.175 -0.466 . . . . 13.13 110.967 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -96.68 -38.91 9.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.769 -0.826 . . . . 11.74 108.769 171.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.73 106.63 17.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.232 -0.895 . . . . 8.72 109.223 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.98 134.77 90.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 5.93 110.508 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.7 69.78 2.13 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.049 2.499 . . . . 5.25 112.707 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.7 51.24 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.789 -0.641 . . . . 2.28 112.635 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.13 73.37 8.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 2.07 110.859 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -168.99 136.84 1.94 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.803 -0.635 . . . . 3.18 110.303 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 9.4 t -82.07 104.78 12.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.705 -0.48 . . . . 0.53 109.705 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.17 -11.09 79.17 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.969 -0.559 . . . . 0.65 113.008 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 t -67.54 -28.0 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.056 0.455 . . . . 1.04 110.67 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.39 -34.7 2.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.84 110.866 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.27 -6.91 24.97 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.818 -0.706 . . . . 0.77 112.132 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 9.1 m-20 -102.16 145.71 29.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 2.1 111.086 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.89 3.87 30.41 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.382 -0.687 . . . . 0.55 111.382 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -63.4 121.05 12.84 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.397 0.279 . . . . 1.06 110.871 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 56.89 52.3 9.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.774 0.797 . . . . 2.23 109.806 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.447 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.0 p -89.91 146.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 1.16 110.566 -176.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.84 161.89 13.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.239 -0.437 . . . . 0.48 110.324 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 11.3 tpt180 -135.01 134.51 40.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.241 -0.651 . . . . 3.18 109.241 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 29.4 t -66.43 141.13 58.03 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 119.761 -0.776 . . . . 0.37 109.919 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -81.95 -15.62 53.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 0.75 111.093 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -111.18 -9.4 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 1.43 110.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.46 173.82 11.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.123 0.487 . . . . 0.79 110.305 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.29 111.49 24.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.898 -0.779 . . . . 0.47 108.898 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -167.19 125.22 1.28 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.013 -0.539 . . . . 0.4 110.117 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.447 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.15 112.24 24.43 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.152 -0.684 . . . . 0.45 109.152 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 41.9 p90 -150.01 160.9 43.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.213 -0.448 . . . . 0.61 110.435 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -98.44 134.41 41.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.29 -0.633 . . . . 0.42 109.29 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -64.35 -31.93 73.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.575 -0.739 . . . . 0.68 109.856 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -72.26 -28.25 63.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.71 . . . . 3.33 110.915 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 58.8 m -80.46 -23.03 40.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.54 110.88 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -88.97 -44.42 10.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.18 -0.463 . . . . 0.61 110.578 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -122.59 78.65 47.22 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.928 -0.578 . . . . 0.8 110.653 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.01 -5.37 17.09 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.045 2.496 . . . . 2.12 111.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.65 -8.41 56.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 3.3 111.587 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.42 24.08 11.68 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.501 -0.857 . . . . 1.46 112.482 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -65.59 141.29 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.787 0.327 . . . . 1.03 110.624 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.0 m -89.16 131.65 35.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 1.6 110.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 142.03 85.16 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 2.68 111.183 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 149.62 55.13 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.706 2.271 . . . . 1.14 112.556 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.57 -6.04 41.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.736 -0.665 . . . . 1.9 111.651 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.6 p -89.12 46.6 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.558 0.694 . . . . 2.75 110.127 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 90.38 121.63 2.34 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.142 -0.935 . . . . 0.82 110.907 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' C' ' 51' ' ' LEU . 2.0 tm? -64.24 125.3 24.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.443 -0.577 . . . . 0.87 109.443 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 94.9 mtt180 -112.96 142.99 45.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 2.65 110.377 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 22.0 p -78.45 -178.26 5.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.49 109.789 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -60.87 -45.51 94.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.672 0.272 . . . . 4.09 110.581 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.6 t -63.13 -41.63 99.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 1.54 110.788 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 62.4 m -69.75 -33.48 72.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.636 0.255 . . . . 0.72 111.278 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -76.78 -14.03 59.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.155 0.503 . . . . 1.25 109.839 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 -118.95 6.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.688 -0.687 . . . . 2.19 112.585 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -147.48 106.51 3.85 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.509 -0.552 . . . . 5.15 109.509 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 t -108.89 65.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.621 0.724 . . . . 6.76 109.896 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -81.42 128.01 71.44 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.304 -0.862 . . . . 8.83 109.996 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.25 142.23 72.37 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.456 2.104 . . . . 11.04 111.592 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.19 129.27 75.86 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.46 -0.336 . . . . 13.86 110.256 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.23 50.59 1.92 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.912 2.408 . . . . 16.55 112.466 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.49 125.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.679 -0.692 . . . . 18.07 109.645 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.584 -0.722 . . . . 20.26 110.443 -177.539 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 111.731 -0.547 . . . . 20.38 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.47 56.17 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.828 0.347 . . . . 18.81 111.137 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.34 35.12 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.231 0.539 . . . . 18.06 110.886 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.61 54.21 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.929 -0.578 . . . . 16.83 110.944 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.58 -150.37 17.75 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.835 -0.621 . . . . 14.66 111.993 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -135.47 63.02 1.62 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.112 -0.699 . . . . 15.8 109.112 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' C' ' 10' ' ' ALA . 81.9 mm-40 60.49 42.52 14.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.987 -1.006 . . . . 13.13 110.965 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 57.32 63.88 1.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.674 -0.694 . . . . 11.74 110.459 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 32.2 tp 51.33 65.38 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.311 -0.859 . . . . 8.72 111.593 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' C' ' 7' ' ' GLN . . . -60.36 141.95 90.84 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 5.93 110.312 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.81 76.8 1.52 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.597 2.198 . . . . 5.25 112.438 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.35 -31.24 71.34 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.551 -0.619 . . . . 2.28 111.551 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.74 74.15 10.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.201 0.524 . . . . 2.07 110.137 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -159.57 130.6 5.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.884 -0.598 . . . . 3.18 109.68 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 33.7 t -74.73 103.49 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.852 -0.796 . . . . 0.53 108.852 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.24 -14.03 80.94 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 115.877 -0.602 . . . . 0.65 113.536 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 59.6 t -68.37 -37.03 77.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.943 0.401 . . . . 1.04 110.661 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.08 -28.28 7.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.39 . . . . 0.84 110.678 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.21 56.52 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.158 -0.544 . . . . 0.77 112.098 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 17.7 t70 -110.29 155.21 22.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 2.1 111.019 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.08 21.03 4.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.937 -0.649 . . . . 0.55 112.148 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -80.79 124.4 29.03 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.722 -0.473 . . . . 1.06 109.722 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.59 53.8 9.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 122.025 0.917 . . . . 2.23 109.352 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.438 HG22 ' N ' ' C' ' 34' ' ' PHE . 3.9 p -93.61 141.26 15.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.033 -0.985 . . . . 1.16 110.606 -172.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' C' ' 36' ' ' TRP . 78.2 mt -84.9 153.81 22.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.822 0.344 . . . . 0.48 110.403 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -116.47 140.17 49.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.919 -0.582 . . . . 3.18 110.957 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 13.8 t -74.41 139.24 43.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.635 -0.506 . . . . 0.37 109.635 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 26.0 p -89.54 -23.68 21.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.875 0.369 . . . . 0.75 111.328 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -94.08 -20.77 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 1.43 111.18 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.17 -172.74 4.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.942 -0.762 . . . . 0.79 108.942 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.81 114.56 28.47 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.176 -0.305 . . . . 0.47 110.176 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.12 135.34 6.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.378 . . . . 0.4 110.687 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.68 123.54 48.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.45 109.545 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 23.8 p90 -159.75 153.26 22.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.365 -0.38 . . . . 0.61 110.68 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -93.62 130.4 39.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.598 -0.889 . . . . 0.42 108.598 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 67.0 t-105 -60.95 -34.29 74.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.68 110.623 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.02 -38.58 82.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 3.33 111.269 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 85.4 m -70.02 -26.83 64.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.54 110.688 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 39' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' C' ' 54' ' ' ARG . 4.3 m-70 -89.8 -53.5 4.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.61 111.957 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.77 143.65 30.44 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.305 -0.407 . . . . 0.8 111.003 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.1 169.67 14.65 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.056 2.504 . . . . 2.12 112.011 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.77 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.343 -0.844 . . . . 3.3 111.835 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.8 -30.07 72.61 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.804 -0.712 . . . . 1.46 111.833 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.0 m -79.02 135.86 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.672 0.272 . . . . 1.03 110.479 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.2 t -89.64 151.89 21.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.514 -0.312 . . . . 1.6 110.262 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.589 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 22.2 mtp180 -88.76 115.73 64.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.675 -0.491 . . . . 2.68 109.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.37 132.02 34.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.499 2.132 . . . . 1.14 112.116 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.33 -26.28 59.82 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.408 -0.677 . . . . 1.9 111.408 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 13.9 p -133.24 139.85 47.18 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.308 0.243 . . . . 2.75 110.754 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.05 51.3 19.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.698 -0.763 . . . . 0.82 112.377 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 122.85 15.99 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.685 -0.487 . . . . 0.87 109.685 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -116.05 142.26 47.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.916 0.389 . . . . 2.65 110.997 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.511 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -79.6 -172.04 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.49 110.205 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' C' ' 39' ' ' HIS . 42.9 ttp180 -60.67 -52.06 66.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.689 0.28 . . . . 4.09 111.276 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -65.16 -43.17 92.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.357 -0.383 . . . . 1.54 111.512 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.7 m -71.37 -26.77 62.94 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.169 -0.212 . . . . 0.72 111.471 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -87.44 -13.92 41.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.113 0.482 . . . . 1.25 110.451 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.57 48.75 0.9 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.88 -0.676 . . . . 2.19 112.063 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.33 104.22 16.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 5.15 109.805 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.24 97.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.666 -0.697 . . . . 6.76 109.151 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' C' ' 62' ' ' PRO . 29.3 m -66.11 113.53 12.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.8 -0.636 . . . . 8.83 110.469 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' C' ' 61' ' ' THR . 6.3 Cg_exo -76.32 142.4 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.474 2.116 . . . . 11.04 111.842 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.54 122.5 80.7 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.98 -0.555 . . . . 13.86 109.73 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.79 106.96 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.42 2.08 . . . . 16.55 112.214 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.2 -8.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 18.07 109.985 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.3 -0.864 . . . . 20.26 109.715 177.029 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 111.682 -0.567 . . . . 20.38 111.682 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.09 56.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.379 . . . . 18.81 110.996 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tpt -68.34 -30.25 69.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.251 0.548 . . . . 18.06 110.284 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.07 148.15 52.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 16.83 110.028 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.71 176.36 35.61 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.94 -0.864 . . . . 14.66 110.94 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.97 -60.32 1.57 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.94 0.37 . . . . 15.8 110.128 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -98.54 56.53 1.13 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 13.13 110.458 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -87.57 107.34 18.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.173 -0.467 . . . . 11.74 110.233 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.9 tp -105.05 126.02 51.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.919 -0.582 . . . . 8.72 110.119 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.43 123.37 82.96 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.426 -0.352 . . . . 5.93 110.311 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.52 34.04 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.169 2.58 . . . . 5.25 113.535 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.17 -71.31 1.29 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.147 -0.781 . . . . 2.28 111.147 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' C' ' 21' ' ' GLY . . . -80.43 79.52 7.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.19 0.519 . . . . 2.07 109.9 175.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -140.73 126.7 19.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.794 -0.639 . . . . 3.18 110.529 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 35.9 t -70.28 118.59 13.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.53 109.975 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.84 76.39 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.65 113.154 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.22 -46.69 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 1.04 111.329 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.66 -34.96 16.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 0.84 111.71 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.3 -20.97 44.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.872 -0.68 . . . . 0.77 111.914 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.67 150.26 21.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.609 0.242 . . . . 2.1 110.531 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' C' ' 13' ' ' ALA . . . -119.08 11.58 11.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.878 -0.677 . . . . 0.55 112.323 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.9 m -80.26 133.22 35.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.795 -0.446 . . . . 1.06 109.795 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.27 48.94 14.14 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 122.141 0.972 . . . . 2.23 109.33 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -90.42 139.66 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.312 -0.858 . . . . 1.16 110.833 -174.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.32 144.37 25.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.394 -0.821 . . . . 0.48 109.421 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -117.92 142.74 47.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.373 -0.376 . . . . 3.18 110.792 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.92 133.08 44.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.525 -0.546 . . . . 0.37 109.525 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 31.6 p -84.58 -15.58 45.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 0.75 111.318 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -101.2 -20.75 15.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 1.43 111.486 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.06 -166.58 2.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.51 -0.552 . . . . 0.79 109.51 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.67 114.92 29.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.755 0.312 . . . . 0.47 110.373 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.89 128.32 3.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.4 110.627 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -101.38 111.94 24.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.26 -0.644 . . . . 0.45 109.26 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -152.57 -175.05 5.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.42 -0.355 . . . . 0.61 110.083 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m80 -129.83 161.27 31.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.511 -0.922 . . . . 0.42 108.511 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -58.01 -53.31 59.71 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 121.187 -0.205 . . . . 0.68 111.287 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -56.43 -45.2 80.85 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.048 0.759 . . . . 3.33 113.048 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 0.1 OUTLIER -66.46 -21.6 66.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.164 0.431 . . . . 0.54 112.164 -173.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -109.17 -36.49 6.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.012 -0.275 . . . . 0.61 111.73 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.26 139.02 33.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.774 0.321 . . . . 0.8 110.923 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.03 156.58 63.83 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.621 2.214 . . . . 2.12 111.637 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -15.32 53.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.108 -0.951 . . . . 3.3 112.596 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.86 79.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.946 -0.645 . . . . 1.46 111.971 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -85.02 136.17 33.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.8 -0.444 . . . . 1.03 109.8 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -88.47 126.28 35.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 1.6 110.557 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -78.85 122.33 84.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 2.68 111.082 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.15 141.6 57.98 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.446 2.097 . . . . 1.14 111.547 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.4 -28.3 52.88 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.839 -0.696 . . . . 1.9 112.672 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -141.1 61.31 1.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.091 0.472 . . . . 2.75 110.851 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.23 46.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.517 -0.849 . . . . 0.82 112.352 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.81 123.84 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.295 0.569 . . . . 0.87 110.541 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -125.54 133.22 52.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.777 -0.647 . . . . 2.65 110.299 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -73.37 179.1 4.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.509 -0.552 . . . . 0.49 109.509 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -37.98 76.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.21 0.448 . . . . 4.09 112.21 -172.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -70.38 -51.62 28.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.845 0.355 . . . . 1.54 111.459 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 55.9 m -73.5 -18.01 61.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.778 0.658 . . . . 0.72 112.778 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -76.36 -14.34 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 1.25 111.438 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.36 -170.32 15.48 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.246 -0.978 . . . . 2.19 112.499 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.11 43.54 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.323 0.583 . . . . 5.15 109.864 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.0 t -88.95 93.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 6.76 110.702 -175.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.9 p -120.43 107.38 39.03 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 8.83 110.273 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.64 147.84 93.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.786 2.324 . . . . 11.04 112.632 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.33 127.53 34.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 13.86 110.576 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.4 135.64 22.68 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.457 2.105 . . . . 16.55 111.841 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.6 t -89.55 89.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.336 -0.616 . . . . 18.07 109.336 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.421 -0.8 . . . . 20.26 110.29 -176.729 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.141 -0.384 . . . . 20.38 112.141 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.98 51.55 13.36 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.825 0.45 . . . . 18.81 111.149 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -102.05 -18.44 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 18.06 110.992 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 172.76 12.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 16.83 110.325 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.7 -119.07 2.92 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.923 -0.656 . . . . 14.66 112.254 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -86.13 -6.43 59.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.161 0.505 . . . . 15.8 110.708 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -85.79 54.11 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 13.13 111.08 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -88.48 66.84 8.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.658 0.742 . . . . 11.74 110.202 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt -75.22 124.42 27.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 8.72 110.712 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 125.08 91.46 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 5.93 110.508 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.13 47.28 1.02 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.186 2.591 . . . . 5.25 112.968 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.61 136.27 4.41 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.015 -0.612 . . . . 2.28 111.725 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.36 74.33 9.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 2.07 110.184 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -136.44 151.43 49.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.529 -0.759 . . . . 3.18 110.713 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -70.39 114.39 8.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.478 -0.783 . . . . 0.53 109.802 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.64 62.57 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.504 -0.379 . . . . 0.65 113.265 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.43 -30.13 29.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 1.04 110.796 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 79.6 m -108.6 -28.41 9.31 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.51 0.559 . . . . 0.84 112.51 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.06 9.91 86.13 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.202 -0.759 . . . . 0.77 111.202 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.85 145.83 50.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.226 -0.487 . . . . 2.1 110.275 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.59 24.63 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.831 -0.699 . . . . 0.55 112.749 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -77.65 122.85 25.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.874 -0.417 . . . . 1.06 109.874 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 54.86 49.14 18.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.311 0.577 . . . . 2.23 110.094 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.56 145.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.739 -0.664 . . . . 1.16 110.18 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.91 146.71 23.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.025 0.44 . . . . 0.48 110.095 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 26' ' ' ARG . 12.2 mmt180 -110.79 148.01 33.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 3.18 110.069 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.4 t -79.12 139.82 37.96 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 0.37 108.681 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 60.1 p -89.92 -24.5 21.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.29 0.567 . . . . 0.75 110.724 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -89.88 -20.79 22.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 1.43 111.19 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.6 p -150.9 -171.77 4.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.796 -0.816 . . . . 0.79 108.796 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.7 115.43 30.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.376 -0.231 . . . . 0.47 110.376 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.84 153.69 14.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.4 110.514 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 118.86 23.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.525 0.516 . . . . 0.45 110.114 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -158.02 154.9 28.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.16 -0.473 . . . . 0.61 110.529 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m170 -86.65 133.12 33.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.347 -0.983 . . . . 0.42 108.347 172.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' C' ' 46' ' ' ARG . 70.0 t-105 -49.67 -53.08 26.49 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.244 0.34 . . . . 0.68 111.338 -174.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 64.9 mtp180 -62.3 -23.48 66.76 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.316 0.488 . . . . 3.33 112.316 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -79.97 -22.08 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.918 0.39 . . . . 0.54 111.185 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -103.95 -44.19 5.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.61 110.665 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 71.1 m-85 -119.07 136.35 24.32 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.583 -0.735 . . . . 0.8 109.821 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 21.6 Cg_exo -65.65 157.5 58.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.442 2.094 . . . . 2.12 111.291 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -12.22 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 3.3 112.174 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.11 -25.28 74.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.751 -0.737 . . . . 1.46 111.384 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -85.29 125.84 33.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.03 110.131 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -87.57 131.84 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.474 -0.33 . . . . 1.6 110.158 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' CZ2' ' C' ' 36' ' ' TRP . 19.3 ptp180 -70.75 132.75 86.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 2.68 110.775 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.98 132.61 30.68 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.942 2.428 . . . . 1.14 112.421 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.35 -12.22 60.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.829 -0.7 . . . . 1.9 111.718 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 9.5 p -90.07 10.72 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 2.75 111.147 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 139.08 117.29 1.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 0.82 111.94 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -63.36 123.28 18.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.522 -0.547 . . . . 0.87 109.522 178.211 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 81.6 mtm180 -120.9 133.59 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 2.65 111.248 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -78.48 162.8 26.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.989 -0.745 . . . . 0.49 108.989 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.23 -38.48 18.6 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.459 0.54 . . . . 4.09 112.459 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -64.64 -50.13 68.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.994 0.426 . . . . 1.54 110.758 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 82.5 m -72.67 -29.41 63.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.961 -0.563 . . . . 0.72 111.722 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.1 p -82.79 1.1 40.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 1.25 110.718 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.91 79.83 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.848 -0.692 . . . . 2.19 111.674 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.45 81.09 4.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.571 -0.529 . . . . 5.15 109.571 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -89.49 116.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.77 -0.65 . . . . 6.76 109.906 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.2 m -72.69 115.57 41.13 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.292 -0.413 . . . . 8.83 110.119 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.47 152.07 33.72 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.572 2.181 . . . . 11.04 112.613 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -110.47 116.89 52.11 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.883 -0.599 . . . . 13.86 109.813 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 15.8 Cg_exo -69.32 61.11 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.049 2.499 . . . . 16.55 112.6 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.9 158.06 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.218 -0.446 . . . . 18.07 110.087 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.579 -0.724 . . . . 20.26 110.093 -178.196 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.946 -0.462 . . . . 20.38 111.946 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.77 74.67 8.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.316 0.579 . . . . 18.81 110.517 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' MET . . . . . 0.583 ' SD ' ' HG3' ' C' ' 4' ' ' GLU . 0.0 OUTLIER -105.32 -1.1 25.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.788 -0.642 . . . . 18.06 111.068 -178.209 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.583 ' HG3' ' SD ' ' C' ' 3' ' ' MET . 44.3 mt-10 -104.84 122.18 45.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 16.83 110.274 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.3 6.46 55.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.86 -0.686 . . . . 14.66 111.938 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -71.89 -31.81 66.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 15.8 110.645 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -82.87 2.68 33.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 13.13 110.057 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -114.54 32.69 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.403 -0.817 . . . . 11.74 109.686 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 tt 57.0 94.98 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.082 -0.963 . . . . 8.72 111.082 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.78 123.24 89.16 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 5.93 109.892 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 -17.42 31.67 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.735 2.29 . . . . 5.25 113.405 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.88 16.35 79.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.99 -0.624 . . . . 2.28 111.898 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.28 110.05 17.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.795 0.331 . . . . 2.07 110.883 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -146.89 129.48 15.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.223 -0.444 . . . . 3.18 111.024 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -69.59 107.95 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.53 110.08 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.33 66.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.448 -0.406 . . . . 0.65 113.017 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.91 -31.93 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.09 0.472 . . . . 1.04 110.576 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.0 -32.54 7.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.268 0.47 . . . . 0.84 112.268 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.29 16.46 58.98 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.156 -0.778 . . . . 0.77 111.156 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.86 144.47 41.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.412 -0.394 . . . . 2.1 110.355 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.86 9.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.55 112.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.9 m -80.72 128.46 33.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.953 -0.388 . . . . 1.06 109.953 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 56.28 47.15 19.81 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.607 0.567 . . . . 2.23 109.743 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.459 HG21 ' HB1' ' C' ' 33' ' ' ALA . 7.7 p -89.35 142.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.16 110.561 -175.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.24 144.33 25.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.009 0.433 . . . . 0.48 109.951 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 25.6 tpt180 -114.16 138.06 50.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.681 -0.691 . . . . 3.18 109.559 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -70.82 139.85 51.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.325 -0.62 . . . . 0.37 109.325 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.6 p -91.57 -17.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.199 -0.455 . . . . 0.75 111.46 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -103.03 -16.82 15.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.297 -0.411 . . . . 1.43 111.052 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.3 -172.51 4.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.934 -0.765 . . . . 0.79 108.934 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.48 114.42 28.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.737 0.303 . . . . 0.47 110.271 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.573 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -158.4 146.34 18.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.4 110.053 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -125.85 112.98 16.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.458 . . . . 0.45 109.959 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.05 159.84 39.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.85 -0.614 . . . . 0.61 110.008 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.85 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.4 m80 -92.84 143.69 26.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.108 -1.071 . . . . 0.42 108.108 171.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -48.17 -53.11 17.96 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.379 0.424 . . . . 0.68 111.593 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -61.27 -20.45 62.89 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.121 -0.491 . . . . 3.33 112.259 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.85 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 13.8 m -84.2 -20.54 32.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.204 -0.453 . . . . 0.54 111.119 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -114.29 -33.23 5.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.326 -0.397 . . . . 0.61 111.655 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.46 148.3 65.93 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.31 -0.405 . . . . 0.8 110.19 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.0 146.73 72.11 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.504 2.136 . . . . 2.12 111.57 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.9 -11.76 57.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 3.3 111.653 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.32 -29.79 74.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.706 -0.759 . . . . 1.46 111.379 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -82.27 138.79 34.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.383 -0.599 . . . . 1.03 109.383 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.2 t -88.29 140.59 29.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.154 0.502 . . . . 1.6 110.397 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -72.81 110.95 9.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.326 -0.852 . . . . 2.68 110.088 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.93 145.2 44.75 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.674 2.249 . . . . 1.14 112.621 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.58 8.6 30.27 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.223 -0.751 . . . . 1.9 111.223 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -117.56 33.58 5.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.154 0.502 . . . . 2.75 110.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.53 78.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.636 -0.792 . . . . 0.82 112.355 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.25 122.29 17.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.262 -0.644 . . . . 0.87 109.262 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -120.27 140.66 50.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.529 -0.305 . . . . 2.65 110.538 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.2 p -74.61 176.63 6.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.29 -0.633 . . . . 0.49 109.29 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.55 -41.98 95.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.491 0.186 . . . . 4.09 111.029 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.1 m -64.75 -46.12 83.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.54 111.358 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.53 -17.35 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.41 . . . . 0.72 111.035 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -88.94 -5.21 58.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.391 -0.368 . . . . 1.25 110.318 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.83 128.62 9.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.986 -0.626 . . . . 2.19 112.363 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -99.27 102.32 13.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.995 0.426 . . . . 5.15 110.506 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.59 129.92 56.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 6.76 109.948 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -91.25 113.01 56.96 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.345 -0.388 . . . . 8.83 110.348 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.2 134.02 35.01 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.17 1.913 . . . . 11.04 111.436 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.91 118.65 71.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.094 -0.503 . . . . 13.86 110.768 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.78 125.72 20.05 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.927 2.418 . . . . 16.55 111.94 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.54 -21.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 18.07 110.465 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.29 -0.862 . . . . 20.26 109.736 179.909 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 112.159 -0.376 . . . . 20.38 112.159 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.02 39.26 3.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 18.81 110.18 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.9 ptm -68.34 -20.93 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 18.06 111.2 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.7 -16.96 59.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.672 0.272 . . . . 16.83 110.995 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.11 29.02 8.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.9 -0.666 . . . . 14.66 112.152 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -86.09 -39.36 16.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.467 0.651 . . . . 15.8 109.54 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -148.45 78.97 1.43 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.071 -0.968 . . . . 13.13 108.752 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -142.64 140.57 31.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.954 -0.566 . . . . 11.74 110.471 -175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.41 84.46 1.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 8.72 110.018 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -61.98 146.22 91.88 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 5.93 110.778 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 12.0 Cg_exo -71.51 45.4 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.224 2.616 . . . . 5.25 112.434 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.38 44.34 0.92 Allowed Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.6 -0.6 . . . . 2.28 111.6 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.27 75.19 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 2.07 110.226 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -162.14 157.94 23.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.111 -0.95 . . . . 3.18 108.454 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.7 t -56.96 107.74 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.146 0.279 . . . . 0.53 110.654 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.37 -16.6 62.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.271 -0.49 . . . . 0.65 112.661 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.29 -30.38 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.008 0.433 . . . . 1.04 110.679 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.6 m -108.35 -24.71 11.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.159 0.429 . . . . 0.84 112.159 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.2 15.15 80.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.788 -0.72 . . . . 0.77 111.431 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.72 136.15 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.598 -0.301 . . . . 2.1 110.422 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.09 16.55 38.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.55 112.719 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -77.61 131.84 37.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.901 -0.407 . . . . 1.06 109.901 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 39.1 t70 55.99 46.22 22.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.94 0.876 . . . . 2.23 109.577 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.81 149.25 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.194 -0.912 . . . . 1.16 110.09 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.0 157.08 17.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.306 -0.406 . . . . 0.48 110.18 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -117.2 143.78 45.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.782 -0.644 . . . . 3.18 110.109 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.88 141.18 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.712 -0.477 . . . . 0.37 109.712 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.5 p -82.29 -28.76 31.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.253 -0.431 . . . . 0.75 111.764 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -95.75 -17.11 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.883 0.327 . . . . 1.43 111.883 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.64 -172.28 4.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.79 110.053 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.36 114.01 27.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.025 -0.534 . . . . 0.47 109.678 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.96 119.86 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.4 110.321 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.58 112.32 24.4 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.538 -0.541 . . . . 0.45 109.538 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.65 168.43 26.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.404 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.6 m170 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.316 -0.994 . . . . 0.42 108.316 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -56.51 -38.62 72.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.68 111.438 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -66.72 -27.27 67.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 3.33 111.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 32.7 m -86.92 -22.38 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.977 -0.556 . . . . 0.54 111.48 -172.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -95.96 -31.03 13.29 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.875 -0.33 . . . . 0.61 111.162 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -128.8 78.63 75.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.268 . . . . 0.8 110.339 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.84 -41.63 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.983 2.455 . . . . 2.12 112.846 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.21 -54.74 4.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.441 -0.345 . . . . 3.3 111.28 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.71 59.59 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.64 -0.791 . . . . 1.46 111.68 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -81.36 96.79 7.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.168 0.509 . . . . 1.03 111.473 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -141.28 92.74 2.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.905 -0.776 . . . . 1.6 108.905 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -57.79 118.65 27.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 2.68 111.216 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.32 133.32 22.5 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.628 2.218 . . . . 1.14 112.596 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.48 -10.37 79.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.059 -0.591 . . . . 1.9 111.88 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.9 p -94.83 35.52 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.0 0.429 . . . . 2.75 111.191 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.8 136.03 9.17 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.907 -0.663 . . . . 0.82 112.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -72.33 122.61 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.485 -0.561 . . . . 0.87 109.485 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.8 131.57 54.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 2.65 110.503 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -74.96 -179.79 4.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.46 . . . . 0.49 110.039 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -59.97 -49.42 77.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.505 0.187 . . . . 4.09 111.505 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.8 t -64.1 -41.55 97.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.577 -0.283 . . . . 1.54 111.049 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 79.2 m -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.72 110.896 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.6 m -89.19 2.4 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.48 -0.327 . . . . 1.25 110.663 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.95 -21.44 71.5 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.83 -0.7 . . . . 2.19 111.638 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.51 -1.82 56.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.939 0.876 . . . . 5.15 109.788 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.24 105.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.27 -0.877 . . . . 6.76 110.049 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' THR . . . . . 0.422 ' HA ' ' HD2' ' C' ' 62' ' ' PRO . 27.0 m -90.92 112.12 51.84 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.59 -0.522 . . . . 8.83 109.59 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' C' ' 61' ' ' THR . 11.4 Cg_endo -56.79 134.16 62.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.525 2.15 . . . . 11.04 111.877 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.87 139.46 82.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.011 -0.54 . . . . 13.86 110.452 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.3 52.35 2.74 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.71 2.274 . . . . 16.55 112.271 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.01 124.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 18.07 110.518 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.247 0.959 0 CA-C-N 116.105 -0.498 . . . . 20.26 110.571 179.447 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.754 -0.538 . . . . 20.38 111.754 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.35 -159.22 0.32 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.625 0.37 . . . . 18.81 110.964 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 61.5 mtm 63.88 26.61 14.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.169 0.509 . . . . 18.06 110.762 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.08 -27.3 60.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 16.83 110.019 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.05 49.86 0.93 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.035 -0.826 . . . . 14.66 111.035 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -58.72 -45.05 90.48 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.409 0.623 . . . . 15.8 109.952 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.34 95.05 3.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.25 -0.886 . . . . 13.13 109.435 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.37 83.0 2.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.264 0.554 . . . . 11.74 110.792 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.13 132.52 37.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 8.72 110.101 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.27 122.9 79.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.448 -0.575 . . . . 5.93 109.448 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.82 -19.64 62.67 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.939 2.426 . . . . 5.25 112.806 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.13 -51.28 0.85 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.6 . . . . 2.28 111.844 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.72 74.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.379 0.609 . . . . 2.07 110.462 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -153.76 127.18 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.637 -0.71 . . . . 3.18 109.967 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 7.1 t -82.86 104.81 13.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.53 109.939 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.4 -8.31 75.21 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.007 -0.542 . . . . 0.65 113.405 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.466 HG11 ' O ' ' C' ' 38' ' ' CYS . 43.5 t -71.46 -29.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.051 0.453 . . . . 1.04 110.523 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.4 p -120.43 -34.03 3.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.297 -0.41 . . . . 0.84 110.529 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 -13.01 23.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.126 -0.559 . . . . 0.77 111.825 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' C' ' 22' ' ' THR . 15.7 t70 -95.97 152.71 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.269 . . . . 2.1 110.796 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.93 14.08 5.22 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.55 113.12 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' THR . . . . . 0.546 HG22 ' OD2' ' C' ' 20' ' ' ASP . 9.5 t -81.7 136.34 35.48 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.178 0.489 . . . . 1.06 109.904 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.71 49.84 17.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.912 0.863 . . . . 2.23 109.496 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 p -89.08 136.96 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.272 -0.876 . . . . 1.16 110.028 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.54 149.73 25.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 0.48 110.668 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.468 HH11 ' HB2' ' C' ' 33' ' ' ALA . 23.8 mmm180 -116.95 129.83 56.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.944 -0.571 . . . . 3.18 110.464 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.0 140.48 58.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.37 109.77 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 42.8 p -89.17 -20.13 24.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.999 0.428 . . . . 0.75 111.292 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.1 m80 -94.06 -22.32 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 1.43 111.134 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.59 -168.44 3.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.069 -0.715 . . . . 0.79 109.069 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.81 114.65 29.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.833 0.349 . . . . 0.47 110.103 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -156.64 131.11 8.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.4 110.465 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.468 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -109.73 111.83 23.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.78 -0.645 . . . . 0.45 109.623 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.9 p90 -155.63 166.51 33.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.61 110.047 -178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.451 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -102.33 133.3 47.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.775 -0.824 . . . . 0.42 108.775 171.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.68 -41.4 81.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.68 110.924 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.21 -29.06 68.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 3.33 111.352 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.466 ' O ' HG11 ' C' ' 17' ' ' VAL . 93.8 m -74.71 -22.0 59.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.086 0.47 . . . . 0.54 110.474 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -96.66 -56.03 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.12 -0.491 . . . . 0.61 111.12 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.18 147.94 38.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.928 -0.578 . . . . 0.8 110.22 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.88 163.91 29.1 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.656 2.237 . . . . 2.12 111.976 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -14.83 59.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.268 -0.878 . . . . 3.3 112.468 -171.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.88 -16.54 80.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.789 -0.72 . . . . 1.46 111.802 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.99 127.85 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.552 -0.536 . . . . 1.03 109.552 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.6 p -88.2 138.09 31.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 1.6 111.254 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 55.8 ttp180 -76.72 120.43 81.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.437 -0.801 . . . . 2.68 110.305 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.2 Cg_exo -68.72 131.66 23.24 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.242 1.961 . . . . 1.14 111.476 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.6 -40.88 6.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.846 -0.692 . . . . 1.9 111.614 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -115.46 70.57 0.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.42 0.628 . . . . 2.75 110.702 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.05 51.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.66 -0.7 . . . . 0.82 111.714 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.43 122.89 19.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.665 -0.494 . . . . 0.87 109.665 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.06 137.16 53.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 2.65 110.918 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.522 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.4 p -77.22 -179.65 5.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.172 -0.677 . . . . 0.49 109.172 173.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.7 -45.13 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 4.09 110.952 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' SER . . . . . 0.61 ' HA ' ' HB3' ' C' ' 59' ' ' ASP . 3.6 m -65.24 -53.06 50.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.055 -0.521 . . . . 1.54 111.572 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.31 -16.41 62.45 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.72 111.399 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 31.8 t -83.57 6.53 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 1.25 110.448 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.03 48.65 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.677 -0.773 . . . . 2.19 113.045 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.61 ' HB3' ' HA ' ' C' ' 55' ' ' SER . 37.5 t70 -89.29 -19.12 25.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.986 0.898 . . . . 5.15 109.149 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -89.71 48.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.442 -1.254 . . . . 6.76 109.893 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 56.9 m -107.48 123.43 38.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.096 -0.956 . . . . 8.83 110.472 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.85 133.79 60.2 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.503 2.135 . . . . 11.04 111.445 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.18 131.52 92.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 13.86 111.172 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.93 111.55 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.562 2.175 . . . . 16.55 111.308 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.32 140.52 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.266 -0.424 . . . . 18.07 110.33 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.707 -0.663 . . . . 20.26 109.981 -179.768 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 112.076 -0.41 . . . . 20.38 112.076 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.73 4.34 33.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 18.81 111.452 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.4 ttt -118.02 28.11 8.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.774 0.797 . . . . 18.06 108.921 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.77 107.52 18.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.48 -0.782 . . . . 16.83 110.788 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.06 7.29 4.76 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.472 -0.786 . . . . 14.66 111.49 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -99.04 -49.99 4.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 15.8 109.926 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -85.5 -19.96 30.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.765 -0.652 . . . . 13.13 110.131 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -85.41 126.82 34.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.538 -0.755 . . . . 11.74 110.348 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.8 109.73 14.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.965 -0.562 . . . . 8.72 110.452 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -67.9 123.81 87.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 5.93 110.268 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 33.7 Cg_exo -58.2 107.75 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.819 2.346 . . . . 5.25 112.519 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.27 70.01 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.779 -0.725 . . . . 2.28 112.246 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.01 72.5 10.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.346 0.593 . . . . 2.07 110.241 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -152.01 154.71 36.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.216 -0.902 . . . . 3.18 109.319 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.65 109.87 1.83 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.255 -0.429 . . . . 0.53 109.858 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.84 -29.61 58.89 Favored Glycine 0 CA--C 1.52 0.365 0 O-C-N 123.512 0.507 . . . . 0.65 113.63 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.5 -34.18 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 1.04 111.135 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -100.79 -31.77 11.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.482 0.549 . . . . 0.84 112.482 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.32 31.4 59.27 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.364 -1.095 . . . . 0.77 110.364 -170.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.65 154.08 40.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.228 -0.486 . . . . 2.1 110.676 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.98 28.84 5.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.975 -0.631 . . . . 0.55 112.68 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -79.53 128.12 32.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.786 -0.449 . . . . 1.06 109.786 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 53.71 47.73 23.1 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.53 0.681 . . . . 2.23 109.823 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.416 HG22 ' N ' ' C' ' 34' ' ' PHE . 1.1 p -89.66 149.82 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.258 -0.883 . . . . 1.16 110.506 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.0 mt -100.89 151.93 21.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.321 -0.4 . . . . 0.48 110.101 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -111.54 135.15 52.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.899 -0.592 . . . . 3.18 110.24 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.6 t -66.52 142.99 57.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.586 -0.524 . . . . 0.37 109.586 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.7 p -93.42 -24.62 17.99 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.322 0.49 . . . . 0.75 112.322 -176.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -97.56 -15.67 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.206 0.527 . . . . 1.43 110.336 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.8 OUTLIER -150.31 -175.25 5.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.615 -0.883 . . . . 0.79 108.615 175.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.83 114.29 28.43 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.891 0.376 . . . . 0.47 110.666 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.36 142.88 14.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.4 109.807 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.33 117.23 28.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.528 0.517 . . . . 0.45 109.962 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.416 ' N ' HG22 ' C' ' 24' ' ' VAL . 33.0 p90 -156.61 167.77 29.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.827 0.346 . . . . 0.61 110.772 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.493 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.8 m170 -97.77 123.86 41.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.493 -0.929 . . . . 0.42 108.493 172.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -58.01 -32.53 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.723 -0.671 . . . . 0.68 110.74 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -76.64 -19.47 57.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 3.33 111.873 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 74.9 m -87.36 -21.94 25.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.26 0.552 . . . . 0.54 110.018 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -90.01 -53.35 4.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.61 110.353 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -115.98 143.99 31.92 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.647 -0.706 . . . . 0.8 109.993 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -173.59 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.685 2.256 . . . . 2.12 113.064 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.86 67.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 3.3 111.167 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.49 -17.73 62.5 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.164 -0.541 . . . . 1.46 112.514 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.77 130.51 45.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.859 0.361 . . . . 1.03 110.592 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 t -89.53 150.25 22.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.385 -0.371 . . . . 1.6 110.235 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -87.79 120.34 70.86 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.89 -0.595 . . . . 2.68 110.595 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.08 134.18 26.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 1.14 111.379 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 -43.41 20.0 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.771 -0.65 . . . . 1.9 113.018 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.8 p -111.42 -14.41 13.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.904 0.352 . . . . 2.75 111.865 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.41 57.03 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.577 -0.82 . . . . 0.82 112.448 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.9 OUTLIER -76.1 121.82 23.38 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -123.47 131.82 53.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.114 0.483 . . . . 2.65 111.56 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.401 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -73.76 179.83 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.647 -0.706 . . . . 0.49 109.551 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -57.89 -40.1 79.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.762 0.282 . . . . 4.09 111.762 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.7 t -69.31 -47.92 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.986 0.422 . . . . 1.54 111.04 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.7 m -72.21 -21.63 61.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.72 111.812 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -102.47 16.07 27.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.489 -0.56 . . . . 1.25 109.489 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.48 113.55 3.97 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.667 -0.697 . . . . 2.19 112.122 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -89.06 125.71 35.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 5.15 110.179 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.29 145.02 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.022 -0.535 . . . . 6.76 110.41 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 27.2 m -83.17 113.09 43.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.189 -0.46 . . . . 8.83 110.601 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.41 153.15 61.08 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.716 2.277 . . . . 11.04 111.742 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.11 122.41 50.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.614 -0.266 . . . . 13.86 110.43 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.31 120.59 7.95 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.897 2.398 . . . . 16.55 112.251 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.3 22.21 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.078 0.466 . . . . 18.07 111.259 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.661 -0.685 . . . . 20.26 110.363 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.771 -0.532 . . . . 20.38 111.771 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.83 49.85 9.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.026 0.441 . . . . 18.81 111.238 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.64 -53.61 51.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 18.06 110.705 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.19 1.05 44.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 16.83 110.117 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.71 -125.58 1.9 Allowed Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.773 -0.648 . . . . 14.66 112.13 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 64.27 22.61 12.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.568 0.347 . . . . 15.8 110.84 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 63.05 21.29 12.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.729 -0.669 . . . . 13.13 110.705 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -87.56 101.08 13.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 11.74 110.123 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.53 115.84 14.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 8.72 110.496 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.85 122.56 70.14 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 5.93 110.814 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.24 60.75 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.25 2.633 . . . . 5.25 113.001 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.52 74.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 2.28 112.167 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.35 75.55 3.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.995 0.426 . . . . 2.07 110.429 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -161.58 143.47 11.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.314 -0.624 . . . . 3.18 109.314 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 46.8 t -67.69 104.62 1.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.916 -0.402 . . . . 0.53 109.916 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.19 -19.99 79.72 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.65 113.218 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.75 -43.11 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.756 0.312 . . . . 1.04 111.23 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p -108.76 -29.78 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.387 . . . . 0.84 110.896 -177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.5 56.24 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.871 -0.681 . . . . 0.77 111.998 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 10.2 m-20 -97.17 145.35 26.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 2.1 110.615 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.27 17.25 10.54 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.049 -0.596 . . . . 0.55 112.091 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -80.1 135.49 36.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.926 -0.398 . . . . 1.06 109.926 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 48.3 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.974 0.892 . . . . 2.23 109.344 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.69 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.194 -0.912 . . . . 1.16 110.315 -174.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 85.5 mt -91.87 154.27 18.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.902 0.382 . . . . 0.48 110.551 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -122.27 130.62 53.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.584 -0.735 . . . . 3.18 109.749 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -68.69 136.31 52.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.37 109.746 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.0 p -87.96 -19.49 27.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.103 0.478 . . . . 0.75 110.998 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -93.21 -24.97 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 1.43 111.116 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.9 p -151.13 -163.99 1.9 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.465 -0.569 . . . . 0.79 109.465 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 114.78 29.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.47 110.227 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 138.74 10.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.4 110.498 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -122.06 112.85 18.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.777 -0.647 . . . . 0.45 109.343 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 44.6 p90 -155.7 170.25 22.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.151 -0.477 . . . . 0.61 110.183 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -105.75 133.82 49.87 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.507 -0.553 . . . . 0.42 109.507 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.7 t-105 -60.25 -36.8 78.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.652 -0.703 . . . . 0.68 110.073 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -68.44 -34.17 75.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.625 -0.716 . . . . 3.33 110.93 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.74 -22.71 56.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.54 110.874 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 2.8 m170 -90.47 -42.26 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 0.61 111.582 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.8 77.3 29.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.484 -0.325 . . . . 0.8 111.284 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 7.1 Cg_exo -74.54 4.17 4.73 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.146 2.564 . . . . 2.12 112.284 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.57 -7.27 59.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 3.3 110.873 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 28.04 11.17 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.598 -0.811 . . . . 1.46 112.109 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 15.3 m -69.42 144.05 53.45 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.979 -0.378 . . . . 1.03 109.979 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.4 t -88.24 143.93 26.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 1.6 110.536 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -92.72 117.62 67.64 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.436 -0.802 . . . . 2.68 111.453 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.99 132.89 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.714 2.276 . . . . 1.14 111.56 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.92 5.04 68.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.756 -0.735 . . . . 1.9 112.548 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -89.63 -75.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.338 0.59 . . . . 2.75 111.106 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.37 101.37 0.57 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.485 -0.78 . . . . 0.82 111.658 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.18 128.25 34.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.978 0.418 . . . . 0.87 110.354 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -114.08 135.17 54.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.198 -0.455 . . . . 2.65 110.364 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.523 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 14.3 p -74.39 176.57 6.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.432 -0.581 . . . . 0.49 109.432 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' C' ' 55' ' ' SER . 8.1 ptm85 -58.5 -43.91 89.25 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 4.09 111.527 -175.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' SER . . . . . 0.457 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 20.2 m -65.86 -46.53 78.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.655 -0.248 . . . . 1.54 111.148 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.9 m -72.37 -22.58 61.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.72 111.569 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -81.41 -13.95 57.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.015 0.436 . . . . 1.25 110.02 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.4 49.0 0.85 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.295 -0.722 . . . . 2.19 111.295 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -105.85 120.06 40.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.803 0.335 . . . . 5.15 110.762 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.61 130.04 74.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.075 -0.511 . . . . 6.76 110.236 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.0 t -83.46 134.69 44.83 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 8.83 109.737 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 134.46 59.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.842 2.361 . . . . 11.04 112.153 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.57 125.77 54.59 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 13.86 110.597 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.25 64.98 5.35 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.664 2.243 . . . . 16.55 111.828 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.58 126.39 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.059 -0.519 . . . . 18.07 110.311 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.568 -0.73 . . . . 20.26 109.583 -179.184 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.732 -0.547 . . . . 20.38 111.732 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.22 21.74 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.993 0.425 . . . . 18.81 111.463 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.3 ttm -128.52 85.01 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.197 -0.456 . . . . 18.06 109.839 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -69.36 124.27 23.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 16.83 110.169 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.49 -65.31 0.55 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.795 -0.717 . . . . 14.66 112.06 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -86.32 -52.08 5.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 15.8 110.076 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -93.28 81.94 4.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.098 -0.501 . . . . 13.13 109.932 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -83.97 41.49 0.81 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.967 -0.561 . . . . 11.74 111.051 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.55 112.5 9.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 8.72 110.149 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.22 125.35 86.65 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.844 -0.617 . . . . 5.93 110.608 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.9 -13.72 41.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.966 2.444 . . . . 5.25 112.405 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.69 -26.69 70.85 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.954 -0.641 . . . . 2.28 111.598 175.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.32 74.31 3.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.268 0.556 . . . . 2.07 109.964 177.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -144.23 144.11 31.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.839 -0.619 . . . . 3.18 110.353 -178.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 43.0 t -75.2 104.93 5.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.396 -0.594 . . . . 0.53 109.396 177.069 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.8 -12.42 84.2 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.65 113.631 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 87.2 t -67.19 -41.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 1.04 110.736 178.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 p -106.67 -28.44 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 0.84 110.919 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.77 1.47 55.2 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.859 -0.686 . . . . 0.77 112.092 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 19.5 m-20 -107.2 147.38 30.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.493 . . . . 2.1 111.812 -178.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 2.4 22.78 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.862 -0.895 . . . . 0.55 110.862 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 22' ' ' THR . . . . . 0.416 HG22 ' HB3' ' C' ' 20' ' ' ASP . 13.4 t -72.91 134.64 44.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.659 -0.271 . . . . 1.06 110.438 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.62 47.17 21.29 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.53 0.681 . . . . 2.23 109.922 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.6 p -89.59 148.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.148 -0.933 . . . . 1.16 110.668 -173.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.438 HD12 ' H ' ' C' ' 36' ' ' TRP . 90.4 mt -100.01 155.8 17.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.227 -0.442 . . . . 0.48 110.21 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.0 mmm180 -114.6 153.82 29.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.74 -0.664 . . . . 3.18 109.424 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -89.39 141.77 28.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.262 0.553 . . . . 0.37 110.433 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -81.17 -26.62 35.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 0.75 112.168 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 29' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' C' ' 56' ' ' CYS . 11.8 m170 -102.61 -14.93 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.982 -0.287 . . . . 1.43 111.614 -176.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.1 p -150.95 -174.6 4.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.964 -0.384 . . . . 0.79 109.964 178.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 115.03 29.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.405 -0.362 . . . . 0.47 110.227 -178.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.56 135.1 4.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.384 -0.371 . . . . 0.4 111.043 -177.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 111.87 24.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.329 -0.619 . . . . 0.45 109.329 172.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -156.45 169.95 23.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.003 -0.544 . . . . 0.61 110.076 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 28.5 m170 -106.95 130.75 54.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.114 -0.698 . . . . 0.42 109.114 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.438 ' H ' HD12 ' C' ' 25' ' ' LEU . 42.3 t-105 -59.15 -36.75 75.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.68 -0.691 . . . . 0.68 110.092 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -70.67 -25.39 62.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.993 -0.549 . . . . 3.33 111.432 -178.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 84.2 m -83.83 -27.36 28.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 0.54 110.83 178.247 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -89.59 -29.06 19.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.806 0.336 . . . . 0.61 110.911 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.46 71.27 76.98 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.058 -0.519 . . . . 0.8 110.251 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.86 13.68 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.185 2.59 . . . . 2.12 112.64 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.36 4.46 35.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 3.3 111.397 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.18 17.98 38.21 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.589 -0.815 . . . . 1.46 111.518 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.7 m -74.24 130.04 38.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 1.03 110.853 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -88.95 137.91 31.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.716 -0.476 . . . . 1.6 109.716 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -72.69 136.5 80.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 2.68 111.069 -175.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.63 149.34 61.16 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.176 2.584 . . . . 1.14 112.653 -175.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.8 18.91 56.3 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.855 -0.688 . . . . 1.9 112.443 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -116.33 37.28 3.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.329 0.585 . . . . 2.75 110.471 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.62 129.77 6.45 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.786 -0.721 . . . . 0.82 111.769 -177.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -71.18 124.01 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.723 -0.473 . . . . 0.87 109.723 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.35 136.81 52.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.729 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.61 162.64 28.99 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.072 -1.084 . . . . 0.49 108.072 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -59.87 -31.96 70.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.838 0.745 . . . . 4.09 111.405 -170.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -64.88 -44.88 88.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.745 0.307 . . . . 1.54 110.588 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 56' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' C' ' 29' ' ' HIS . 86.7 m -72.75 -17.86 61.56 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.798 0.295 . . . . 0.72 111.798 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -89.08 -13.0 39.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.482 -0.487 . . . . 1.25 110.192 176.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.11 -125.07 5.69 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.985 -0.626 . . . . 2.19 112.025 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -131.29 157.81 42.32 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.999 -0.371 . . . . 5.15 109.999 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.4 130.99 61.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.245 -0.434 . . . . 6.76 110.081 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' C' ' 62' ' ' PRO . 12.9 p -93.48 131.37 32.68 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.425 -0.352 . . . . 8.83 111.525 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 61' ' ' THR . 19.7 Cg_exo -65.5 142.89 73.55 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.648 2.232 . . . . 11.04 111.237 175.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -66.25 119.03 58.8 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.427 -0.351 . . . . 13.86 110.613 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 64' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 40.5 Cg_exo -56.89 135.35 70.18 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.134 2.556 . . . . 16.55 112.71 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.84 -0.5 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.096 0.474 . . . . 18.07 110.94 178.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.446 -0.787 . . . . 20.26 110.128 179.603 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.898 -0.481 . . . . 20.38 111.898 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.73 28.32 17.76 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.295 0.569 . . . . 18.81 111.319 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtt -134.06 -64.32 0.7 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 18.06 110.301 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.51 62.71 7.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.951 0.405 . . . . 16.83 110.203 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.33 97.24 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.837 -0.62 . . . . 14.66 112.227 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -82.06 -55.57 4.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 15.8 109.864 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 51.42 52.18 15.28 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.814 0.816 . . . . 13.13 109.698 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -137.84 -21.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.897 -1.047 . . . . 11.74 110.572 -175.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 9' ' ' LEU . . . . . 0.404 HD22 ' N ' ' C' ' 9' ' ' LEU . 2.8 mm? -96.22 54.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.037 -0.529 . . . . 8.72 110.416 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.46 136.28 93.18 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.713 -0.676 . . . . 5.93 110.282 178.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.44 -17.05 30.72 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.709 2.273 . . . . 5.25 112.582 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 67.32 0.84 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.676 -0.693 . . . . 2.28 112.208 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 74.48 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.282 0.563 . . . . 2.07 110.388 178.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -169.9 146.73 3.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.284 -0.871 . . . . 3.18 109.116 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.93 104.07 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.829 -0.434 . . . . 0.53 109.829 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -3.62 90.6 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.65 112.548 -175.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.73 -41.68 54.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.044 0.45 . . . . 1.04 110.543 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.34 -29.23 8.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.84 110.243 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.47 45.04 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.886 -0.673 . . . . 0.77 112.252 179.529 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -96.13 147.85 23.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.914 0.387 . . . . 2.1 111.142 -177.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.28 15.82 13.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.107 -0.568 . . . . 0.55 112.531 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -80.79 127.9 33.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.449 -0.204 . . . . 1.06 110.449 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.3 t70 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.638 0.732 . . . . 2.23 110.492 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -89.39 135.19 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.849 -0.614 . . . . 1.16 111.124 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.15 158.96 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.361 -0.836 . . . . 0.48 109.545 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -117.24 134.77 54.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 3.18 110.713 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.57 138.87 55.46 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.16 -0.682 . . . . 0.37 109.16 177.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.1 p -91.24 -20.88 21.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.204 0.526 . . . . 0.75 110.781 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.75 -24.14 21.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.43 110.844 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.7 -169.07 3.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.434 -0.58 . . . . 0.79 109.434 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.11 114.86 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.314 -0.254 . . . . 0.47 110.314 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.54 3.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.25 -0.432 . . . . 0.4 110.479 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.64 121.75 45.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.534 0.521 . . . . 0.45 109.633 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.17 173.24 16.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.386 . . . . 0.61 111.24 -174.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -105.1 125.31 50.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.368 -0.604 . . . . 0.42 109.368 173.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -62.04 -31.69 72.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.878 -0.601 . . . . 0.68 109.746 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.92 -24.22 61.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.796 -0.638 . . . . 3.33 111.458 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -88.02 -22.79 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.54 110.617 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.85 -42.65 11.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.158 -0.474 . . . . 0.61 111.107 -178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -122.65 147.33 50.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.8 110.794 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.12 170.07 13.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.025 2.483 . . . . 2.12 112.074 177.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -18.12 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.643 . . . . 3.3 111.338 -177.177 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.26 -13.9 82.38 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 1.46 112.161 176.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -92.74 132.55 36.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.796 0.331 . . . . 1.03 110.548 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 m -88.66 136.24 33.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.283 -0.417 . . . . 1.6 110.674 -177.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -81.92 121.81 79.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.646 . . . . 2.68 110.369 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 47' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 42.3 Cg_endo -69.81 149.16 66.22 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.419 2.079 . . . . 1.14 111.572 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -33.48 5.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.45 -0.881 . . . . 1.9 113.238 -175.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -105.75 -38.05 6.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 2.75 111.501 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.94 72.07 0.21 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.768 -0.729 . . . . 0.82 112.336 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 0.4 OUTLIER -75.41 121.97 23.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -122.56 134.39 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 2.65 111.09 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -74.36 176.92 6.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.584 -0.734 . . . . 0.49 109.38 173.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -61.13 -37.32 82.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.048 0.386 . . . . 4.09 110.292 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -65.06 -51.89 58.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 1.54 110.972 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 77.5 m -71.98 -19.54 61.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.552 0.215 . . . . 0.72 111.369 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -78.74 -14.09 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.114 0.483 . . . . 1.25 109.754 178.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.06 69.43 1.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.534 -1.026 . . . . 2.19 110.534 173.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.43 133.92 33.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 5.15 111.176 -173.308 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.11 128.58 67.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 6.76 110.198 -178.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 6.8 p -102.16 141.95 23.59 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.305 -0.407 . . . . 8.83 110.256 176.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.58 145.67 42.42 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.398 2.065 . . . . 11.04 111.627 176.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.46 138.24 44.74 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.325 -0.398 . . . . 13.86 110.422 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 50.37 2.79 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.83 2.353 . . . . 16.55 112.333 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.04 85.97 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.842 -0.617 . . . . 18.07 109.609 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.702 -0.666 . . . . 20.26 110.152 -176.775 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 N-CA-C 111.888 -0.485 . . . . 20.38 111.888 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.2 102.21 6.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.652 0.263 . . . . 18.81 110.968 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 68.2 mtm 61.05 28.52 18.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.595 -0.729 . . . . 18.06 111.454 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.54 154.52 21.02 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.96 -0.385 . . . . 16.83 109.96 -178.577 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.0 8.87 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.879 -0.676 . . . . 14.66 111.562 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 59.31 34.27 22.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.29 0.567 . . . . 15.8 110.53 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -86.3 -10.29 54.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 13.13 110.734 -174.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.6 135.59 37.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 11.74 110.267 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.9 tp -91.28 87.17 6.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.091 0.472 . . . . 8.72 109.965 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -79.93 142.65 56.42 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 5.93 110.393 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 12.8 Cg_exo -70.96 45.94 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.259 2.64 . . . . 5.25 112.617 177.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.81 6.31 40.76 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.457 -0.657 . . . . 2.28 111.457 178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.54 73.48 7.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.268 0.556 . . . . 2.07 110.31 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -158.44 127.88 5.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 3.18 109.843 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 11.2 t -79.68 103.77 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.258 -0.645 . . . . 0.53 109.258 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.66 -18.4 75.71 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.65 113.367 -171.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 48.3 t -64.39 -32.78 59.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.735 0.303 . . . . 1.04 111.104 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -118.09 -33.84 4.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.907 0.384 . . . . 0.84 110.819 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.62 -13.98 24.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.775 -0.726 . . . . 0.77 112.24 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 11.5 m-20 -87.61 131.6 34.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 2.1 110.911 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.41 -1.9 33.09 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.314 -0.714 . . . . 0.55 111.314 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -76.94 135.43 38.76 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 110.081 -0.34 . . . . 1.06 110.081 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.88 45.96 20.53 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.435 0.636 . . . . 2.23 109.784 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.61 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.151 -0.931 . . . . 1.16 110.048 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.39 146.2 25.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.897 0.379 . . . . 0.48 110.242 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -113.92 132.47 55.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.925 -0.579 . . . . 3.18 110.165 -175.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -63.52 130.72 45.56 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.658 -0.497 . . . . 0.37 109.658 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 48.4 p -85.92 -5.81 59.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.75 110.983 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -108.42 -21.46 12.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 1.43 111.209 -178.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.8 p -152.28 -163.51 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.726 -0.472 . . . . 0.79 109.726 176.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.56 114.93 29.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.161 -0.311 . . . . 0.47 110.161 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.48 128.47 1.81 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.429 -0.351 . . . . 0.4 110.473 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.69 112.56 25.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.744 0.653 . . . . 0.45 109.771 176.34 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -154.72 167.58 29.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.395 -0.366 . . . . 0.61 110.339 -176.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.8 m170 -106.06 138.56 42.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.964 -0.754 . . . . 0.42 108.964 172.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -61.79 -33.73 74.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 0.68 110.385 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -74.64 -25.29 59.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 3.33 111.452 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.7 m -83.67 -22.77 32.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.124 0.488 . . . . 0.54 110.597 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -96.88 -49.62 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.075 -0.512 . . . . 0.61 111.517 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 96.3 m-85 -110.95 149.62 40.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.757 0.313 . . . . 0.8 111.003 -173.197 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 16.6 Cg_exo -67.86 158.21 58.33 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.617 2.211 . . . . 2.12 110.881 174.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.19 -7.96 34.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.954 -0.566 . . . . 3.3 111.521 -177.351 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.18 -12.22 84.57 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.536 -0.626 . . . . 1.46 111.536 174.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 37.5 m -95.15 135.08 37.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.26 -0.274 . . . . 1.03 110.26 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 p -89.05 136.13 33.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.987 0.422 . . . . 1.6 111.257 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -80.96 127.93 72.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 2.68 110.604 -177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.03 140.47 37.99 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.874 2.383 . . . . 1.14 112.046 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.43 25.56 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.011 -0.614 . . . . 1.9 111.984 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 74.1 1.48 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.886 0.374 . . . . 2.75 110.545 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 61.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.739 -0.743 . . . . 0.82 112.212 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 122.7 18.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.938 0.399 . . . . 0.87 110.074 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -117.4 134.33 54.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.231 -0.44 . . . . 2.65 110.884 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -81.08 169.67 17.16 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.66 -0.867 . . . . 0.49 108.66 171.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -51.94 -47.17 64.86 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.415 0.447 . . . . 4.09 111.419 -174.19 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -63.72 -45.05 91.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.917 -0.583 . . . . 1.54 111.762 -176.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 95.6 m -71.77 -31.11 66.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.72 111.433 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 44.5 p -85.41 7.23 23.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.718 -0.219 . . . . 1.25 111.026 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.69 91.38 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.22 -0.514 . . . . 2.19 113.115 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -105.59 121.34 43.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.33 -0.618 . . . . 5.15 109.33 176.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.57 126.4 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.086 0.469 . . . . 6.76 110.414 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.1 p -91.42 119.12 68.72 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.059 -0.519 . . . . 8.83 110.838 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.72 144.14 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.575 2.183 . . . . 11.04 111.963 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.37 132.83 51.59 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.189 -0.459 . . . . 13.86 110.446 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.85 108.13 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.65 2.233 . . . . 16.55 111.977 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.81 99.53 9.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.942 -0.572 . . . . 18.07 110.207 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.616 -0.707 . . . . 20.26 109.724 179.674 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.798 -0.521 . . . . 20.38 111.798 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.42 126.02 34.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 18.81 110.86 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 88.9 mtp -116.84 114.02 23.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 18.06 110.128 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.85 -20.68 57.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.951 0.405 . . . . 16.83 110.781 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.43 172.29 30.22 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.508 -0.637 . . . . 14.66 111.508 177.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 64.15 17.07 10.46 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.704 0.402 . . . . 15.8 111.175 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -80.81 -21.52 40.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.169 0.509 . . . . 13.13 110.7 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.23 -1.22 48.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.472 -0.785 . . . . 11.74 109.611 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -128.02 45.36 2.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.117 -0.947 . . . . 8.72 109.305 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.42 142.48 92.16 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.365 -0.834 . . . . 5.93 110.77 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.46 25.11 0.23 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.296 2.664 . . . . 5.25 113.566 -178.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.8 76.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 2.28 111.969 -178.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -103.09 74.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.999 0.428 . . . . 2.07 110.496 -177.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.4 ttp180 -157.87 129.04 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 3.18 110.746 -178.013 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.37 111.79 5.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.592 . . . . 0.53 109.938 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.42 -31.94 71.51 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.477 0.486 . . . . 0.65 113.128 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.34 -37.54 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.366 . . . . 1.04 110.923 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.43 -39.95 9.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.256 0.465 . . . . 0.84 112.256 -175.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.86 6.41 65.44 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.73 -0.748 . . . . 0.77 111.423 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.82 149.1 42.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.793 0.33 . . . . 2.1 110.434 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -107.62 12.25 38.99 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.55 112.943 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 m -80.13 128.06 33.05 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.665 -0.315 . . . . 1.06 111.085 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.06 51.11 7.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.493 -0.776 . . . . 2.23 111.161 177.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -90.15 145.31 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.721 . . . . 1.16 111.227 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 78.0 mt -101.11 143.98 30.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.275 -0.875 . . . . 0.48 109.175 175.046 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 137.2 49.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.637 0.256 . . . . 3.18 110.465 -178.571 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -64.57 135.21 55.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.16 -19.02 29.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.181 0.515 . . . . 0.75 110.88 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -97.47 -18.08 19.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.43 111.332 -177.111 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.53 -168.6 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.288 -0.634 . . . . 0.79 109.288 176.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.25 114.89 29.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.663 0.268 . . . . 0.47 110.603 -178.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -172.13 136.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.4 109.936 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -122.05 122.83 40.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.296 0.372 . . . . 0.45 110.004 177.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -160.07 169.51 23.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.033 -0.53 . . . . 0.61 110.294 -176.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.3 m170 -95.91 130.68 42.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.002 -1.111 . . . . 0.42 108.002 171.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -56.12 -37.28 69.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.68 111.684 -177.33 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -72.17 -15.15 61.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 3.33 111.614 -177.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.6 m -90.89 -22.52 20.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.197 -0.456 . . . . 0.54 110.676 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -94.19 -40.78 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 0.61 110.494 175.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.72 79.55 31.29 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.8 110.178 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -83.55 11.34 3.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.814 2.342 . . . . 2.12 112.862 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.92 0.76 52.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 3.3 111.187 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.05 23.77 37.03 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 1.46 111.661 -176.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -61.88 149.52 40.15 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.606 0.362 . . . . 1.03 110.67 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -87.74 121.7 30.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.74 0.305 . . . . 1.6 110.524 -176.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 11.5 ttp180 -64.48 120.39 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 2.68 110.967 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 17.4 Cg_exo -65.14 132.26 31.28 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.431 2.088 . . . . 1.14 111.703 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.53 -15.95 38.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.787 -0.721 . . . . 1.9 111.835 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.3 p -97.07 37.3 1.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 2.75 111.003 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.55 113.5 2.17 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.82 111.829 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.85 123.52 29.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.735 -0.468 . . . . 0.87 109.735 -177.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -112.19 148.04 34.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.046 0.45 . . . . 2.65 110.724 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 22.0 p -93.9 178.01 5.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.105 -0.702 . . . . 0.49 109.105 175.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -58.73 -33.47 70.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.886 0.312 . . . . 4.09 111.142 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -69.77 -51.56 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 1.54 111.24 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -71.98 -17.72 62.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.319 -0.4 . . . . 0.72 111.341 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -92.23 -1.23 57.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.48 . . . . 1.25 110.283 173.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.12 89.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.921 -0.581 . . . . 2.19 112.04 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -88.93 -5.91 57.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.216 0.531 . . . . 5.15 110.395 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 m -88.74 72.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.532 -0.758 . . . . 6.76 110.916 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 29.8 m -67.67 122.16 82.28 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.314 -0.857 . . . . 8.83 110.155 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.99 139.87 89.93 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.766 2.311 . . . . 11.04 112.173 -177.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.16 138.99 78.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.708 -0.678 . . . . 13.86 110.478 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.1 38.02 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.873 2.382 . . . . 16.55 112.136 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.9 116.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.773 -0.649 . . . . 18.07 109.695 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.366 -0.826 . . . . 20.26 109.736 -179.993 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 112.102 -0.399 . . . . 20.38 112.102 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.35 87.54 4.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.014 0.435 . . . . 18.81 110.433 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -93.96 -37.04 11.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.927 -0.579 . . . . 18.06 110.027 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.21 137.67 48.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.537 -0.756 . . . . 16.83 109.941 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.61 -43.03 3.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.984 -0.626 . . . . 14.66 112.056 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.19 -36.26 82.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.8 110.345 178.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -103.8 162.33 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 13.13 110.355 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -123.26 103.82 8.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.731 -0.47 . . . . 11.74 109.731 176.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.0 107.38 8.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.245 -0.434 . . . . 8.72 111.093 -177.051 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -86.11 128.17 58.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.757 -0.656 . . . . 5.93 109.822 176.143 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 12.7 Cg_exo -70.2 80.95 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.733 2.288 . . . . 5.25 112.558 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.56 128.94 33.23 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.57 -0.824 . . . . 2.28 111.261 174.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 75.93 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.235 0.541 . . . . 2.07 111.104 -177.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -130.31 145.24 51.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.886 -0.597 . . . . 3.18 110.145 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 t -63.15 106.12 0.81 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.53 109.515 175.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.37 -31.61 57.02 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.41 0.444 . . . . 0.65 113.492 -175.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.03 -34.44 70.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.074 0.464 . . . . 1.04 111.043 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.81 -38.14 7.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.052 0.39 . . . . 0.84 112.052 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.96 -9.2 59.81 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.585 -0.606 . . . . 0.77 111.585 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.41 146.18 37.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.954 0.407 . . . . 2.1 111.191 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.13 12.96 40.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.067 -0.813 . . . . 0.55 111.067 174.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -73.94 128.55 35.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.444 . . . . 1.06 110.375 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 55.57 47.13 21.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.669 0.747 . . . . 2.23 109.651 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.04 153.78 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.25 -0.887 . . . . 1.16 110.744 -174.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -107.48 144.26 34.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.48 109.834 176.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 144.64 40.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.124 -0.489 . . . . 3.18 110.166 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.1 t -68.51 140.11 55.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.393 -0.595 . . . . 0.37 109.393 177.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.5 p -90.43 -18.65 25.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.897 0.379 . . . . 0.75 110.895 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -92.83 -24.2 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 1.43 111.077 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.3 p -150.38 -173.1 4.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.036 -0.727 . . . . 0.79 109.036 178.165 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.93 118.76 37.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.582 0.229 . . . . 0.47 110.437 -178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.24 135.99 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.4 110.233 -177.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.33 112.76 22.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 0.45 110.11 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -153.99 166.61 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.062 -0.517 . . . . 0.61 109.873 -177.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.763 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.3 m170 -97.71 140.32 32.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.42 108.638 173.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -49.18 -53.5 20.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.413 0.446 . . . . 0.68 111.615 -175.333 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -72.34 -5.55 37.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 3.33 112.136 -173.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -91.45 -21.26 21.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.896 0.379 . . . . 0.54 110.63 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -108.4 -29.5 8.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.61 110.941 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.62 138.55 29.54 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.8 110.511 -177.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.5 148.6 93.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.544 2.162 . . . . 2.12 111.068 173.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -18.76 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 3.3 112.079 -174.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 -16.51 71.14 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.087 -0.578 . . . . 1.46 111.853 175.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.1 m -90.59 130.77 36.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.498 -0.556 . . . . 1.03 109.498 176.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.43 143.54 26.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 1.6 110.993 -174.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.34 125.2 86.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 2.68 110.789 -177.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.08 163.5 39.02 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.044 2.496 . . . . 1.14 112.413 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.27 7.1 8.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.853 -0.689 . . . . 1.9 111.92 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -108.92 -1.82 18.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 2.75 110.856 -178.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.74 120.87 0.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.025 -0.607 . . . . 0.82 111.673 -177.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 122.68 25.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 0.87 109.771 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -111.17 134.9 52.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.436 -0.347 . . . . 2.65 110.937 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -75.69 166.56 23.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.614 -0.884 . . . . 0.49 108.614 170.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -63.42 -30.54 71.65 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.744 . . . . 4.09 110.871 -172.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 55' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' C' ' 59' ' ' ASP . 17.4 m -65.12 -45.23 85.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.927 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.1 m -72.76 -31.2 64.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.72 111.9 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -83.53 -1.62 54.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 1.25 111.542 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.4 98.74 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.875 -0.678 . . . . 2.19 111.608 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' C' ' 55' ' ' SER . 33.0 t70 -88.82 86.77 7.03 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.625 0.726 . . . . 5.15 110.344 -177.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.53 136.26 11.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.651 -1.159 . . . . 6.76 108.842 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.0 p -73.45 117.63 62.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.348 . . . . 8.83 111.055 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.4 139.77 21.09 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.393 2.062 . . . . 11.04 111.56 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.89 124.51 85.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 13.86 110.744 -178.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.07 64.8 4.21 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.861 2.374 . . . . 16.55 112.105 178.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.64 16.9 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 18.07 110.907 -178.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.446 -0.788 . . . . 20.26 110.615 -177.439 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 112.054 -0.418 . . . . 20.38 112.054 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.85 83.9 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 18.81 110.668 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 3' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' C' ' 7' ' ' GLN . 16.0 tpt -75.73 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.069 -0.514 . . . . 18.06 110.342 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -66.49 -29.49 69.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 16.83 110.575 -178.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.99 -26.85 67.84 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.979 -0.555 . . . . 14.66 112.567 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -97.48 5.47 49.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 15.8 111.094 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 7' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' C' ' 3' ' ' MET . 28.4 mt-30 -92.5 33.37 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 13.13 110.825 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -80.47 -8.49 59.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.332 0.587 . . . . 11.74 110.095 177.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -104.06 78.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 8.72 109.595 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' C' ' 12' ' ' GLY . . . -64.95 124.9 87.93 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.235 -0.439 . . . . 5.93 110.963 -177.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.05 26.35 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.92 2.414 . . . . 5.25 113.071 178.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 12' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' C' ' 10' ' ' ALA . . . -81.98 -40.88 10.0 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.68 -0.568 . . . . 2.28 111.68 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.62 75.09 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.29 0.567 . . . . 2.07 109.715 175.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' C' ' 19' ' ' GLY . 49.1 ttp180 -134.38 146.15 49.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.663 -0.699 . . . . 3.18 109.88 -177.248 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 31.3 t -70.91 103.0 2.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.084 -0.71 . . . . 0.53 109.084 176.021 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.12 1.8 83.6 Favored Glycine 0 CA--C 1.509 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.65 112.748 -174.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 32.0 t -77.17 -28.72 16.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.096 0.474 . . . . 1.04 110.091 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.9 p -123.6 -35.46 2.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.84 111.019 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' C' ' 14' ' ' ARG . . . 109.91 2.51 30.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.962 -0.637 . . . . 0.77 112.266 -178.352 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 8.7 m-20 -107.39 140.44 40.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 2.1 111.232 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.59 -1.99 30.8 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.55 111.522 175.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -74.86 135.19 41.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.06 110.059 178.106 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.34 41.05 16.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.927 0.394 . . . . 2.23 110.277 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.483 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.9 p -88.29 146.05 6.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 1.16 110.636 -174.162 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 77.1 mt -105.96 159.29 16.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.029 -0.532 . . . . 0.48 110.379 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 14.0 mmt180 -126.39 143.18 51.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 3.18 109.717 -178.16 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 35.3 t -70.63 146.53 49.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.864 -0.734 . . . . 0.37 109.066 173.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.464 HG21 ' HA2' ' C' ' 50' ' ' GLY . 28.7 p -84.79 -27.0 27.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.101 0.477 . . . . 0.75 110.812 177.276 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -98.4 -12.4 21.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 1.43 111.091 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 m -139.55 172.76 12.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.033 0.444 . . . . 0.79 110.279 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 113.69 27.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.659 -0.7 . . . . 0.47 109.388 174.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.12 134.74 3.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.485 -0.325 . . . . 0.4 110.601 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -100.72 111.98 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.759 -0.655 . . . . 0.45 109.57 175.049 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.06 164.71 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.0 -0.545 . . . . 0.61 110.23 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 32.5 m170 -104.63 138.57 40.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.598 -0.519 . . . . 0.42 109.598 174.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -63.93 -34.46 78.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.76 -0.655 . . . . 0.68 109.74 178.016 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -76.64 -15.51 59.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.586 . . . . 3.33 111.072 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 97.8 m -92.29 -22.45 19.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.54 110.507 176.35 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -93.96 -41.82 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.843 -0.617 . . . . 0.61 111.632 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -119.95 147.32 44.1 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.985 -0.552 . . . . 0.8 111.242 -171.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.76 164.33 27.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.003 2.468 . . . . 2.12 111.503 174.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.05 -15.54 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 3.3 112.184 -174.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -10.23 85.46 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.809 -0.71 . . . . 1.46 112.459 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.4 m -87.19 137.5 32.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.856 0.36 . . . . 1.03 110.72 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -89.65 131.82 35.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.328 -0.396 . . . . 1.6 110.841 -177.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -89.94 123.15 66.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 2.68 110.915 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.78 133.63 22.29 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.325 2.017 . . . . 1.14 111.266 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.42 -47.06 10.98 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.1 -0.571 . . . . 1.9 112.961 -174.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -118.96 60.08 0.82 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.133 0.492 . . . . 2.75 110.779 -177.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 164.07 57.17 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.356 -0.698 . . . . 0.82 111.356 -177.24 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.52 124.98 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.374 0.607 . . . . 0.87 110.587 -176.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.37 145.56 31.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.625 -0.716 . . . . 2.65 110.602 -177.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 21.4 p -89.66 -169.37 2.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.064 -0.516 . . . . 0.49 109.998 178.001 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.7 -53.0 63.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.574 0.226 . . . . 4.09 110.84 -179.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 41.4 t -61.22 -42.92 99.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.54 110.971 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.19 -16.93 62.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.105 0.409 . . . . 0.72 112.105 -176.582 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 43.5 m -101.1 4.73 42.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.072 0.463 . . . . 1.25 110.627 177.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.7 -134.59 7.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.847 -0.692 . . . . 2.19 112.115 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.44 84.01 5.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 5.15 110.299 -178.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -89.38 110.29 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 6.76 110.279 179.367 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 61' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' C' ' 62' ' ' PRO . 8.4 p -67.29 109.62 3.93 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 123.453 0.471 . . . . 8.83 110.74 177.053 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' C' ' 61' ' ' THR . 6.4 Cg_exo -74.11 134.16 19.05 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.7 2.267 . . . . 11.04 112.509 -176.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.38 144.38 53.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.784 -0.644 . . . . 13.86 109.787 175.326 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.21 92.86 0.34 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.62 2.214 . . . . 16.55 112.198 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.7 2.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 18.07 111.542 -177.534 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.666 -0.683 . . . . 20.26 110.409 -178.853 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.934 -0.466 . . . . 20.38 111.934 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.61 -167.77 1.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.051 -0.351 . . . . 18.81 110.051 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -57.87 -64.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.856 -0.424 . . . . 18.06 109.856 175.381 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 61.89 178.96 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.543 0.687 . . . . 16.83 112.119 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.31 131.72 1.42 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.731 -0.668 . . . . 14.66 111.76 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -125.74 51.88 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.015 0.436 . . . . 15.8 110.499 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -147.56 160.78 42.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.195 0.522 . . . . 13.13 111.439 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -144.3 -54.05 0.34 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.488 -0.778 . . . . 11.74 109.048 177.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.63 151.24 23.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.795 . . . . 8.72 109.402 174.573 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.17 121.64 70.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 120.945 -0.302 . . . . 5.93 110.206 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.77 -14.06 38.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.536 2.157 . . . . 5.25 112.259 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.38 73.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.925 -0.655 . . . . 2.28 111.952 178.163 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.82 98.23 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.001 0.429 . . . . 2.07 110.216 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.05 164.97 31.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.012 -0.54 . . . . 3.18 109.825 -179.249 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 39.6 t -65.37 105.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.713 -0.477 . . . . 0.53 109.713 177.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.89 66.17 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.268 -0.492 . . . . 0.65 112.901 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -32.19 56.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.04 110.97 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -106.71 -37.83 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.84 111.91 -176.072 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.58 -23.63 35.4 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.317 -0.713 . . . . 0.77 111.317 -174.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -86.79 148.93 25.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 2.1 111.027 -178.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.82 12.71 35.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.55 111.888 177.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 47.8 m -73.9 124.25 25.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.373 0.13 . . . . 1.06 111.174 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 55.69 66.76 1.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.072 0.857 . . . . 2.23 111.118 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -108.48 142.3 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 1.16 111.362 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' C' ' 36' ' ' TRP . 34.4 mt -82.27 144.35 30.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.662 . . . . 0.48 110.51 178.322 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.43 145.81 29.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.576 -0.738 . . . . 3.18 110.307 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.14 136.75 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.666 -0.494 . . . . 0.37 109.666 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -88.56 -5.19 58.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.75 111.648 -178.119 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -113.72 -20.21 11.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 1.43 110.812 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.82 -171.95 4.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.157 -0.682 . . . . 0.79 109.157 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.04 29.8 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.691 -0.485 . . . . 0.47 109.691 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 155.39 24.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.311 -0.404 . . . . 0.4 110.619 -178.041 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.13 124.59 17.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.872 -0.604 . . . . 0.45 109.979 178.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -163.84 161.08 22.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.471 -0.331 . . . . 0.61 110.354 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.71 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.91 127.54 36.03 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.373 -0.973 . . . . 0.42 108.373 172.606 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.475 ' HB2' HD12 ' C' ' 25' ' ' LEU . 68.1 t-105 -45.58 -53.51 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.483 0.489 . . . . 0.68 112.01 -174.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -60.37 -30.22 69.42 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.125 0.417 . . . . 3.33 112.125 -174.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.1 m -73.54 -22.46 60.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 0.54 111.004 -177.608 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -103.29 -44.98 5.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 0.61 110.935 178.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 88.3 m-85 -116.82 122.74 31.12 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.983 -0.553 . . . . 0.8 110.217 -176.354 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.5 176.59 5.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 2.12 111.853 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.69 -10.79 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.65 . . . . 3.3 112.047 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.95 -26.08 74.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.872 -0.68 . . . . 1.46 111.713 174.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 41.7 m -101.73 135.45 43.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.226 -0.287 . . . . 1.03 110.226 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -89.17 154.53 20.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.767 0.318 . . . . 1.6 110.332 -178.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -88.36 112.23 48.48 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 2.68 110.757 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.62 142.78 44.99 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.838 2.358 . . . . 1.14 111.909 177.466 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.13 -32.4 23.33 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.463 -0.655 . . . . 1.9 111.463 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.0 p -125.64 150.91 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.93 -0.396 . . . . 2.75 109.93 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.43 39.6 80.11 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.65 -0.786 . . . . 0.82 111.971 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.79 124.77 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.557 -0.534 . . . . 0.87 109.557 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -117.31 148.17 41.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.156 -0.475 . . . . 2.65 110.81 -177.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -83.25 -176.68 6.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 0.49 109.458 173.381 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -63.04 -39.47 94.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.104 0.478 . . . . 4.09 110.286 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 36.3 t -66.23 -53.98 30.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.889 -0.596 . . . . 1.54 111.142 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.92 -17.1 62.12 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.453 0.538 . . . . 0.72 112.453 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -108.21 19.62 19.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.053 0.454 . . . . 1.25 110.345 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.69 -126.37 2.75 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.185 -1.007 . . . . 2.19 112.587 -178.011 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -88.95 -6.7 57.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 5.15 111.111 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.04 137.73 24.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.745 -0.662 . . . . 6.76 110.827 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 25.6 m -107.43 105.63 56.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.501 -0.555 . . . . 8.83 109.501 174.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.09 138.94 37.89 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 11.04 112.99 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 127.86 50.13 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.815 -0.63 . . . . 13.86 109.72 175.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.43 58.6 4.52 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.603 2.202 . . . . 16.55 111.848 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.09 132.15 34.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.255 0.55 . . . . 18.07 110.994 -176.458 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.395 -0.812 . . . . 20.26 109.169 176.786 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 112.197 -0.361 . . . . 20.38 112.197 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.67 -14.08 26.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.85 0.357 . . . . 18.81 111.268 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -157.53 -175.15 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.351 -0.386 . . . . 18.06 110.079 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 67.37 55.12 0.67 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.7 0.625 . . . . 16.83 110.282 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.87 156.73 33.2 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.792 -0.718 . . . . 14.66 112.019 178.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 6' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' C' ' 6' ' ' GLN . 5.7 tp60 55.06 55.15 7.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.496 0.665 . . . . 15.8 110.752 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.71 103.34 13.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.51 -0.768 . . . . 13.13 109.912 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -76.12 72.14 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.441 0.638 . . . . 11.74 110.893 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 58.3 tp -152.84 135.0 14.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 8.72 109.063 175.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' C' ' 13' ' ' ALA . . . -84.24 122.95 75.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.911 -0.403 . . . . 5.93 109.911 176.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 30.8 Cg_exo -62.69 106.78 0.54 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.827 2.352 . . . . 5.25 112.206 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.38 24.67 18.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.049 -0.596 . . . . 2.28 112.626 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' C' ' 10' ' ' ALA . . . -83.63 73.18 10.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.376 0.608 . . . . 2.07 110.986 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -171.36 153.18 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.992 -1.114 . . . . 3.18 107.992 175.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.7 t -58.04 106.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.51 0.195 . . . . 0.53 110.688 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.42 -28.54 73.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.244 -0.503 . . . . 0.65 112.619 -178.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.49 -39.47 85.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.453 . . . . 1.04 110.744 178.663 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.46 -21.44 17.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.197 -0.456 . . . . 0.84 111.619 -177.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.87 74.91 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.946 -0.862 . . . . 0.77 110.946 -174.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.34 144.92 30.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.342 . . . . 2.1 110.189 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.13 24.92 9.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.55 112.853 -178.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 m -80.25 129.56 34.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.736 -0.468 . . . . 1.06 109.736 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 55.24 56.01 6.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.718 0.771 . . . . 2.23 109.728 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.86 148.73 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.35 -0.841 . . . . 1.16 110.809 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 96.1 mt -94.64 150.79 19.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 0.48 110.544 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.2 mmt180 -117.3 152.14 35.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.793 -0.64 . . . . 3.18 110.191 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.564 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 17.9 t -81.72 138.75 35.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.654 -0.499 . . . . 0.37 109.654 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.5 p -81.7 -23.23 36.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.585 -0.28 . . . . 0.75 111.726 -177.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -103.52 -18.7 14.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.939 0.348 . . . . 1.43 111.939 -176.358 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.564 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.4 p -150.71 -173.89 4.61 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.626 -0.509 . . . . 0.79 109.626 177.739 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.32 125.36 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.566 0.222 . . . . 0.47 110.455 -178.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.83 151.46 7.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.4 110.22 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -137.63 112.6 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.461 0.476 . . . . 0.45 110.19 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.59 165.6 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.61 110.094 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.5 m170 -98.27 132.77 43.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 0.42 108.328 171.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -47.49 -53.49 14.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.306 0.484 . . . . 0.68 112.306 -173.142 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -70.47 -20.85 62.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.854 0.359 . . . . 3.33 111.783 -173.33 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.7 m -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.173 0.511 . . . . 0.54 110.102 177.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 39' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 1.2 m170 -93.26 -51.3 5.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.61 110.535 176.416 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -111.71 91.37 14.65 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.793 -0.639 . . . . 0.8 110.404 -177.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 83.1 Cg_endo -97.32 3.48 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.957 2.438 . . . . 2.12 112.358 176.208 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.71 55.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 3.3 112.286 -172.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.76 41.51 2.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.408 -0.901 . . . . 1.46 112.367 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.923 -0.399 . . . . 1.03 109.923 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -88.01 122.45 31.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.669 0.271 . . . . 1.6 110.567 -177.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -69.68 112.86 13.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 2.68 111.117 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 47' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 55.2 Cg_endo -72.18 143.22 39.38 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.361 2.041 . . . . 1.14 112.141 177.674 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.55 -11.94 54.64 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.859 -0.686 . . . . 1.9 112.173 178.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 14.4 p -95.28 -70.63 0.7 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.374 0.607 . . . . 2.75 111.461 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.56 77.07 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.82 112.445 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 1.4 tm? -70.94 123.08 21.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.11 -0.7 . . . . 0.87 109.11 177.104 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -112.91 146.92 38.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 2.65 110.91 -176.442 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 21.1 p -83.57 -174.27 5.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.649 -0.871 . . . . 0.49 108.649 170.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 54' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' C' ' 54' ' ' ARG . 43.7 ttp180 -67.89 -43.89 78.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.495 -0.482 . . . . 4.09 110.101 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -59.32 -49.5 77.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.813 -0.63 . . . . 1.54 111.183 -178.091 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.2 m -70.41 -16.33 62.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.803 0.335 . . . . 0.72 111.557 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -90.2 -8.75 50.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 1.25 110.445 176.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.34 -64.98 0.45 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.981 -0.628 . . . . 2.19 112.211 -178.732 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -93.84 123.75 37.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.314 0.578 . . . . 5.15 110.386 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 8.7 p -150.33 137.07 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.698 -0.683 . . . . 6.76 110.118 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 46.3 m -78.99 118.04 70.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.219 -0.446 . . . . 8.83 110.575 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.72 154.41 59.24 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.405 2.07 . . . . 11.04 112.196 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.21 42.5 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.909 -0.587 . . . . 13.86 110.302 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.71 112.03 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.634 2.223 . . . . 16.55 111.81 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.93 148.64 29.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.185 -0.462 . . . . 18.07 110.299 -176.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.534 -0.746 . . . . 20.26 110.571 -178.764 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 CA-C-O 120.134 -0.259 . . . . 20.38 112.702 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.67 43.65 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.978 0.418 . . . . 18.81 111.473 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 21.5 ptm -148.57 113.28 5.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.34 0.59 . . . . 18.06 110.933 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -85.57 -60.56 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.739 -0.664 . . . . 16.83 109.898 176.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.51 60.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.589 -0.732 . . . . 14.66 111.369 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -105.46 62.65 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.236 0.541 . . . . 15.8 109.907 -176.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -127.85 51.34 1.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.626 . . . . 13.13 110.675 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.32 107.74 5.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.999 -0.546 . . . . 11.74 109.969 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -80.58 79.51 7.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.187 0.518 . . . . 8.72 110.784 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.83 123.22 88.84 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.558 -0.747 . . . . 5.93 110.127 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 24.4 Cg_exo -63.38 -44.71 13.75 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.601 2.201 . . . . 5.25 111.8 177.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.57 -56.62 3.38 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.376 -0.829 . . . . 2.28 113.195 175.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.92 121.9 26.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.122 0.487 . . . . 2.07 111.56 -175.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -157.53 145.54 18.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.864 -0.791 . . . . 3.18 108.864 177.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.3 t -71.45 103.47 2.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.553 -0.536 . . . . 0.53 109.553 178.624 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.38 -4.1 77.57 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-N 115.927 -0.579 . . . . 0.65 112.28 -175.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 36.8 t -67.78 -29.11 43.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.247 0.546 . . . . 1.04 109.704 177.244 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.42 -38.42 3.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.84 110.163 176.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.54 -5.94 26.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.993 -0.623 . . . . 0.77 111.823 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 21.1 t70 -108.29 146.64 32.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.886 0.374 . . . . 2.1 110.704 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.15 16.57 9.99 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.17 -0.538 . . . . 0.55 112.083 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -80.26 133.39 35.98 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 122.828 -0.219 . . . . 1.06 110.512 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.41 56.12 8.43 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.448 0.642 . . . . 2.23 109.813 -175.359 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' C' ' 33' ' ' ALA . 5.5 p -96.29 146.83 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 1.16 110.798 -172.218 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -86.85 144.05 27.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.102 0.477 . . . . 0.48 109.864 177.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -107.99 143.79 36.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.559 -0.746 . . . . 3.18 109.945 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 t -74.89 137.81 42.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.407 -0.59 . . . . 0.37 109.407 177.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 47.9 p -91.16 -19.62 22.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.116 0.484 . . . . 0.75 110.914 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -91.7 -24.11 19.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 1.43 110.792 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.58 -165.94 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.131 -0.692 . . . . 0.79 109.131 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 114.56 28.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.75 0.31 . . . . 0.47 110.35 177.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.79 142.88 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.4 110.607 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.62 117.15 32.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.854 -0.612 . . . . 0.45 109.514 176.577 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.409 ' HB2' ' NE2' ' C' ' 39' ' ' HIS . 37.7 p90 -147.43 156.28 42.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.61 110.943 -175.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -103.25 132.21 49.69 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.999 -0.741 . . . . 0.42 108.999 173.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -57.85 -40.23 79.65 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.68 110.881 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' C' ' 37' ' ' ARG . 43.8 mtm105 -72.62 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.475 -0.33 . . . . 3.33 111.463 -177.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 86.3 m -72.76 -23.36 60.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.54 111.001 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 39' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' C' ' 34' ' ' PHE . 10.7 m170 -96.47 -53.71 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.61 110.747 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 87.5 m-85 -113.07 142.8 27.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.944 -0.571 . . . . 0.8 110.649 -174.286 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 32.0 Cg_exo -60.08 155.06 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.78 2.32 . . . . 2.12 111.348 174.302 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -14.67 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 3.3 112.618 -172.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.73 3.26 87.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.089 -0.577 . . . . 1.46 112.392 177.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -92.62 136.43 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.572 -0.529 . . . . 1.03 109.572 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 25.9 m -88.97 130.3 35.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.969 0.414 . . . . 1.6 111.218 -175.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -81.0 117.43 68.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.788 -0.642 . . . . 2.68 110.595 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.06 146.13 51.41 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.91 2.407 . . . . 1.14 112.595 -177.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.1 -9.85 56.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.83 -0.7 . . . . 1.9 111.503 176.205 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -93.24 47.84 1.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 2.75 111.781 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.91 123.25 4.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.912 -0.661 . . . . 0.82 112.928 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 127.89 34.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.87 110.65 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -108.66 133.31 52.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 2.65 110.953 -178.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.7 p -73.19 178.5 4.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.187 -0.671 . . . . 0.49 109.187 172.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -56.16 -43.51 78.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.677 0.275 . . . . 4.09 111.605 -175.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -68.18 -50.19 55.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.586 -0.279 . . . . 1.54 111.621 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.3 m -68.37 -17.07 64.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.831 0.308 . . . . 0.72 111.831 -177.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -98.98 9.5 43.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.388 . . . . 1.25 110.833 177.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.1 -27.06 26.94 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.585 -0.817 . . . . 2.19 111.923 178.366 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.69 29.27 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.792 0.33 . . . . 5.15 111.08 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 m -89.59 159.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.403 -0.362 . . . . 6.76 110.166 178.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 41.1 p -110.36 104.19 55.35 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.56 0.219 . . . . 8.83 110.84 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.81 135.26 21.23 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.623 2.215 . . . . 11.04 110.991 173.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.8 116.53 57.7 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.39 -0.368 . . . . 13.86 110.618 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 126.47 11.89 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.488 2.125 . . . . 16.55 112.59 -177.604 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -89.69 82.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.338 0.589 . . . . 18.07 109.714 177.712 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.547 -0.74 . . . . 20.26 110.02 -179.323 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.227 -0.349 . . . . 20.38 112.227 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.91 119.13 33.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.943 0.402 . . . . 18.81 110.745 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.5 mmt -90.91 27.25 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 18.06 110.757 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.04 -44.63 8.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.061 -0.518 . . . . 16.83 110.451 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.98 49.15 0.25 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.959 -0.639 . . . . 14.66 112.096 177.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -141.21 -67.47 0.41 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.848 0.356 . . . . 15.8 110.889 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 7' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' C' ' 7' ' ' GLN . 59.2 tp60 -90.42 22.24 3.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.762 0.791 . . . . 13.13 110.41 -176.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.33 78.08 8.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 11.74 110.01 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.52 143.67 42.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 8.72 110.627 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.43 124.92 70.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.116 -0.493 . . . . 5.93 110.948 -177.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.06 114.17 2.9 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.712 2.274 . . . . 5.25 111.872 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.04 -172.8 31.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.888 -0.672 . . . . 2.28 112.245 178.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.1 76.65 4.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.338 0.59 . . . . 2.07 110.472 178.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -135.9 139.41 43.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.425 -0.807 . . . . 3.18 109.851 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 t -76.62 104.31 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.157 -0.683 . . . . 0.53 109.157 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.62 89.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.739 -0.664 . . . . 0.65 112.756 -173.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 22.3 t -76.73 -29.0 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 1.04 110.287 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.06 -51.69 2.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.232 -0.44 . . . . 0.84 110.278 178.147 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -13.13 4.0 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.734 -0.746 . . . . 0.77 112.596 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.09 151.17 23.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.117 0.484 . . . . 2.1 111.752 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.52 21.25 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.55 111.866 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -77.15 116.18 17.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.431 0.158 . . . . 1.06 110.881 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 56.12 65.26 1.48 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.478 0.656 . . . . 2.23 110.762 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.4 134.88 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.16 111.075 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -77.9 146.49 35.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.339 -0.846 . . . . 0.48 109.672 176.118 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -113.32 140.45 48.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 3.18 110.337 -174.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' C' ' 51' ' ' LEU . 7.7 t -69.38 125.03 25.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.054 -0.721 . . . . 0.37 109.054 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 13.2 t -79.42 -5.55 54.92 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.141 0.496 . . . . 0.75 111.163 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -111.69 -22.67 11.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.43 111.758 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.7 p -150.17 -171.77 4.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.79 109.766 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.36 115.45 28.49 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.871 0.367 . . . . 0.47 110.454 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.01 143.48 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.952 -0.567 . . . . 0.4 110.523 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.77 116.16 23.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.616 -0.513 . . . . 0.45 109.616 177.231 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.96 163.85 39.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.386 -0.37 . . . . 0.61 110.498 -174.395 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.0 m170 -100.79 145.98 27.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.878 -0.416 . . . . 0.42 109.878 174.11 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -52.81 -53.83 42.84 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.504 0.503 . . . . 0.68 110.827 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 66.8 mtt180 -70.07 -19.54 63.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 3.33 112.09 -174.082 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 89.3 m -77.09 -21.04 54.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.162 0.506 . . . . 0.54 110.484 177.142 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -103.23 -52.37 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.285 0.564 . . . . 0.61 110.647 176.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 53.7 m-85 -113.26 125.56 29.52 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.456 -0.793 . . . . 0.8 109.356 -178.092 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -52.28 148.73 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.619 2.213 . . . . 2.12 111.753 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -18.06 14.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.804 . . . . 3.3 112.934 -172.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.22 -2.12 61.89 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.071 -0.585 . . . . 1.46 112.488 176.168 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -99.3 142.28 30.99 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.024 -0.362 . . . . 1.03 110.024 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 43.3 m -88.22 124.11 33.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 1.6 111.219 -176.531 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -79.88 129.37 70.87 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 2.68 110.533 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.06 154.08 75.68 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.495 2.13 . . . . 1.14 111.3 176.159 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 -10.24 73.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 1.9 112.619 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 49' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' C' ' 50' ' ' GLY . 17.1 p -93.76 -160.81 0.79 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.782 -0.081 . . . . 2.75 110.782 178.392 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' C' ' 49' ' ' THR . . . -62.73 143.67 48.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.128 -0.558 . . . . 0.82 112.867 -179.021 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 27' ' ' CYS . 0.1 OUTLIER -90.83 144.51 25.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.951 0.405 . . . . 0.87 110.562 -178.503 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -105.68 133.24 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.216 -0.447 . . . . 2.65 109.997 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -72.46 165.16 25.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.772 -0.825 . . . . 0.49 108.772 175.311 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -55.27 -35.89 65.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.246 0.476 . . . . 4.09 111.61 -171.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -65.6 -51.03 62.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.433 -0.348 . . . . 1.54 111.061 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.25 -17.92 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.72 111.117 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -78.86 -14.03 59.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.989 0.423 . . . . 1.25 110.868 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.39 99.8 0.19 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.52 -0.847 . . . . 2.19 112.005 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.3 114.52 25.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.96 0.41 . . . . 5.15 110.954 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.97 62.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.925 -0.768 . . . . 6.76 108.925 175.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 24.5 m -87.56 115.21 62.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.133 -0.94 . . . . 8.83 110.551 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.43 158.26 32.77 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.887 2.392 . . . . 11.04 111.975 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.56 121.05 84.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.3 -0.409 . . . . 13.86 110.146 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.8 76.87 2.37 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.75 2.3 . . . . 16.55 112.058 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.19 13.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 18.07 110.816 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.809 -0.615 . . . . 20.26 110.544 -177.272 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.05 -0.42 . . . . 20.38 112.05 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.42 121.15 21.85 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.306 -0.257 . . . . 18.81 110.306 179.466 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 68.1 mtt -64.4 119.49 10.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 18.06 110.715 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -110.67 101.16 9.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.68 -0.691 . . . . 16.83 110.389 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.14 37.99 95.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.973 -0.632 . . . . 14.66 111.92 -177.74 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -121.17 -16.84 7.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.031 0.443 . . . . 15.8 110.589 -178.268 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -132.93 140.22 47.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 13.13 109.907 179.78 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 63.74 60.37 1.07 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.721 0.638 . . . . 11.74 110.438 179.815 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.94 142.93 45.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 8.72 110.728 -177.695 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.5 129.01 87.78 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.069 -0.514 . . . . 5.93 110.865 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.91 62.33 3.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.038 2.492 . . . . 5.25 112.442 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.48 -146.77 19.19 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.961 -0.637 . . . . 2.28 112.221 -179.558 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.551 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -81.4 75.36 8.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 2.07 110.663 -179.59 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.49 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 28.9 ttm-85 -158.23 130.32 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.924 -0.58 . . . . 3.18 110.803 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -77.84 114.34 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.877 -0.416 . . . . 0.53 109.877 177.609 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.66 64.8 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.085 -0.578 . . . . 0.65 112.926 -177.622 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -81.85 -32.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.978 0.418 . . . . 1.04 110.723 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.01 -40.26 6.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.148 0.425 . . . . 0.84 112.148 -176.386 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.59 51.36 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.343 -0.703 . . . . 0.77 111.343 -173.757 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.78 151.97 19.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.703 0.287 . . . . 2.1 110.374 177.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.87 21.83 12.08 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.676 -0.773 . . . . 0.55 112.159 178.746 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.03 127.4 32.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.183 . . . . 1.06 111.263 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 t70 55.17 66.47 1.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.587 0.708 . . . . 2.23 110.872 176.895 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 m -108.03 145.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.29 -0.868 . . . . 1.16 111.411 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' C' ' 36' ' ' TRP . 83.4 mt -98.09 144.02 28.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 0.48 110.306 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.4 mpt_? -109.96 153.84 23.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.137 -0.483 . . . . 3.18 110.355 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 34.2 t -71.3 142.69 50.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.228 -0.656 . . . . 0.37 109.228 173.484 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -84.75 -5.61 59.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 0.75 110.704 178.186 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -118.4 -9.36 10.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.43 110.939 178.491 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.72 173.19 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.93 0.395 . . . . 0.79 110.072 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.55 112.82 26.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.361 -0.607 . . . . 0.47 109.361 174.204 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.62 131.14 1.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.624 -0.716 . . . . 0.4 109.485 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.551 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -108.88 122.83 48.02 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.025 0.44 . . . . 0.45 110.655 -178.318 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.3 160.85 41.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.769 -0.65 . . . . 0.61 110.141 -178.635 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.69 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.4 m170 -88.85 133.22 34.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.264 -1.013 . . . . 0.42 108.264 172.724 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.463 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.6 t-105 -61.16 -33.27 73.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.68 111.017 -176.189 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -76.55 -13.75 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.054 0.454 . . . . 3.33 111.184 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 59.5 m -93.05 -22.52 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.082 0.468 . . . . 0.54 110.744 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -95.27 -30.9 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.987 -0.552 . . . . 0.61 110.671 175.505 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.31 158.74 74.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.8 110.274 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.37 156.66 62.12 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.495 2.13 . . . . 2.12 111.091 173.821 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -10.56 55.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.926 -0.579 . . . . 3.3 112.071 -174.169 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.92 -11.74 78.5 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.653 -0.784 . . . . 1.46 111.946 175.478 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -88.69 120.64 30.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.037 0.446 . . . . 1.03 110.644 -179.378 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.0 p -89.32 138.19 31.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.048 -0.524 . . . . 1.6 110.652 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.21 126.44 91.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.486 . . . . 2.68 110.365 -179.501 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 141.09 44.67 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.987 2.458 . . . . 1.14 113.248 -173.348 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.98 0.55 89.41 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.405 -0.816 . . . . 1.9 111.675 177.545 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -88.95 1.53 55.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.116 0.484 . . . . 2.75 110.304 177.077 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.68 131.47 3.25 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.537 -0.756 . . . . 0.82 111.955 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.78 123.06 19.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.019 -0.734 . . . . 0.87 109.019 178.424 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -110.46 130.97 55.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.322 0.582 . . . . 2.65 111.82 -173.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 26.0 p -74.89 -176.78 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.125 -0.943 . . . . 0.49 110.032 175.06 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -64.87 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.77 -0.372 . . . . 4.09 111.287 -175.492 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -68.75 -41.02 79.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.823 0.344 . . . . 1.54 110.429 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 65.1 m -69.01 -23.72 64.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.508 -0.314 . . . . 0.72 111.164 177.659 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -93.43 1.15 56.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 1.25 110.665 177.268 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.07 60.22 4.47 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.89 -0.595 . . . . 2.19 111.771 179.49 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.91 132.67 35.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.789 0.328 . . . . 5.15 110.26 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 m -94.56 68.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.382 0.61 . . . . 6.76 110.388 178.896 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.1 m -56.3 119.39 27.46 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.315 -0.857 . . . . 8.83 111.025 -178.465 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 145.37 43.74 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.86 2.373 . . . . 11.04 112.351 -178.651 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.25 69.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 13.86 110.224 178.174 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.94 79.83 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.664 2.243 . . . . 16.55 112.394 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -91.5 107.69 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.175 -0.466 . . . . 18.07 109.964 178.869 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.994 -0.527 . . . . 20.26 110.209 -177.356 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.132 -0.387 . . . . 20.38 112.132 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.07 -18.68 36.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.756 0.312 . . . . 18.81 110.974 -178.506 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 70.1 mtm -69.99 -18.07 63.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.282 -0.417 . . . . 18.06 110.994 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.96 -21.48 65.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.146 0.498 . . . . 16.83 110.047 175.346 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.34 110.11 2.35 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.677 -0.692 . . . . 14.66 111.761 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -132.91 -36.99 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.702 0.251 . . . . 15.8 111.167 -178.429 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.72 -24.86 64.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 13.13 111.543 -175.477 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.37 3.33 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.908 -0.587 . . . . 11.74 110.351 178.384 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -105.86 35.39 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.704 0.764 . . . . 8.72 109.529 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.4 123.39 85.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 5.93 110.219 179.294 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.29 51.12 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.479 2.786 . . . . 5.25 113.629 -176.482 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.38 -63.33 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.155 -0.545 . . . . 2.28 112.408 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 33' ' ' ALA . . . -115.26 169.91 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.763 0.316 . . . . 2.07 110.195 179.681 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -136.96 158.44 44.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.439 -0.578 . . . . 3.18 109.439 178.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -68.82 105.51 2.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.276 -0.638 . . . . 0.53 109.276 175.561 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 -21.02 67.07 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 121.017 -0.611 . . . . 0.65 112.285 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.48 -34.56 58.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.948 0.404 . . . . 1.04 110.627 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -102.23 -33.78 9.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.84 111.639 -177.6 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.93 20.07 51.42 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.579 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -140.06 154.72 47.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 2.1 110.687 -174.228 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.59 21.81 5.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.007 -0.616 . . . . 0.55 112.09 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -80.91 127.15 32.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.028 -0.36 . . . . 1.06 110.028 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 54.36 61.14 3.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.372 0.606 . . . . 2.23 109.737 -177.122 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.28 150.62 5.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.268 -0.878 . . . . 1.16 110.393 -172.719 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.403 HD12 ' H ' ' C' ' 36' ' ' TRP . 81.2 mt -91.79 143.99 25.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.895 -0.409 . . . . 0.48 109.895 179.185 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -108.55 152.45 24.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.635 -0.711 . . . . 3.18 110.173 -177.132 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -84.75 127.27 34.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.28 -0.637 . . . . 0.37 109.28 176.447 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -80.67 -5.89 57.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.206 0.527 . . . . 0.75 110.905 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -106.31 -27.34 11.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 1.43 111.488 -178.74 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.97 -161.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.885 -0.413 . . . . 0.79 109.885 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.1 115.77 31.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.66 0.267 . . . . 0.47 110.616 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.96 151.88 10.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.216 -0.447 . . . . 0.4 110.301 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 13' ' ' ALA . . . -136.69 112.36 9.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.334 -0.394 . . . . 0.45 110.107 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.8 p90 -156.87 177.22 11.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.18 -0.464 . . . . 0.61 109.862 -177.167 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.695 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 14.7 m170 -109.8 132.82 53.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.763 -0.829 . . . . 0.42 108.763 172.765 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.403 ' H ' HD12 ' C' ' 25' ' ' LEU . 75.9 t-105 -53.6 -53.23 54.68 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.106 0.41 . . . . 0.68 112.106 -171.737 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -60.81 -26.22 67.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.089 0.471 . . . . 3.33 111.359 -176.042 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.695 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.3 m -77.91 -23.66 48.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.069 -0.514 . . . . 0.54 110.809 -178.993 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 -34.37 11.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.61 110.779 179.316 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -126.56 75.9 74.24 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.847 -0.615 . . . . 0.8 110.365 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.43 13.11 2.85 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.985 2.457 . . . . 2.12 112.408 -177.121 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.18 4.31 31.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.931 -0.577 . . . . 3.3 111.413 -178.174 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.73 9.79 60.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.671 -0.776 . . . . 1.46 111.426 -177.113 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 25.7 m -67.64 131.79 46.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.281 . . . . 1.03 110.629 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -88.44 135.29 33.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.342 -0.39 . . . . 1.6 110.026 -178.884 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -72.42 134.41 82.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.298 -0.41 . . . . 2.68 111.018 -176.523 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.49 132.93 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.578 2.185 . . . . 1.14 112.195 178.992 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.86 -13.42 75.08 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.01 -0.836 . . . . 1.9 111.01 175.245 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.5 p -93.06 46.98 1.24 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.122 0.487 . . . . 2.75 111.113 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.48 106.31 3.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.72 . . . . 0.82 112.408 178.736 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.01 124.63 23.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.203 0.525 . . . . 0.87 109.942 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -110.56 135.33 51.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 2.65 110.749 -177.326 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.504 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -77.52 -179.04 5.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.49 109.663 174.289 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -62.19 -46.76 87.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.807 0.337 . . . . 4.09 110.575 -177.955 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -61.63 -45.74 92.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 1.54 111.28 -177.615 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.07 -23.14 61.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.617 0.228 . . . . 0.72 111.617 -179.612 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -80.81 -14.36 58.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 1.25 110.637 177.858 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.59 25.53 9.03 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.346 -0.701 . . . . 2.19 111.346 177.066 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.8 106.92 18.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.038 0.446 . . . . 5.15 110.455 -178.659 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.08 103.46 14.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.856 -0.794 . . . . 6.76 108.856 173.908 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.3 m -77.74 113.92 36.68 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.977 -0.556 . . . . 8.83 110.825 -176.791 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 142.87 17.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.198 1.932 . . . . 11.04 111.228 176.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -95.89 115.79 65.78 Favored Pre-proline 0 C--N 1.318 -0.763 0 C-N-CA 120.9 -0.32 . . . . 13.86 110.264 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 4.6 Cg_exo -73.9 120.52 6.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.539 2.159 . . . . 16.55 111.133 177.522 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -95.92 177.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.365 -0.379 . . . . 18.07 110.581 -179.962 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.637 -0.697 . . . . 20.26 109.908 -178.065 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 111.462 -0.655 . . . . 20.38 111.462 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.21 89.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.883 0.342 . . . . 18.81 111.018 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 87.4 mtp -122.66 113.92 19.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.955 -0.387 . . . . 18.06 109.955 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.07 108.24 18.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.061 0.458 . . . . 16.83 110.414 -178.239 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -50.8 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.039 -0.6 . . . . 14.66 111.608 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -62.2 -52.67 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.04 0.447 . . . . 15.8 110.094 178.858 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -89.9 52.56 2.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.871 -0.604 . . . . 13.13 110.4 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.81 -27.43 63.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.456 . . . . 11.74 109.965 178.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.4 104.47 13.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 8.72 110.065 173.087 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 150.51 84.63 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.437 -0.802 . . . . 5.93 110.951 -179.188 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.46 44.27 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.121 2.547 . . . . 5.25 113.359 -179.449 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.79 -52.12 5.16 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.601 -1.0 . . . . 2.28 110.601 174.656 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.53 73.39 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 2.07 109.305 171.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.1 ttt180 -156.0 123.43 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 3.18 110.249 -175.085 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -69.14 109.06 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.857 -0.423 . . . . 0.53 109.857 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.71 -18.24 61.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.377 -0.439 . . . . 0.65 112.771 -177.692 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -79.43 -37.12 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.729 0.3 . . . . 1.04 111.108 178.628 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -97.69 -33.95 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.046 0.387 . . . . 0.84 112.046 -176.421 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.86 -1.33 65.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.603 -0.808 . . . . 0.77 111.639 -175.122 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -119.16 150.43 40.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 2.1 110.345 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.25 24.84 10.28 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.557 -0.83 . . . . 0.55 113.424 -175.004 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -79.0 116.4 19.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.856 0.328 . . . . 1.06 110.657 178.124 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 66.95 1.1 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.744 0.652 . . . . 2.23 111.923 177.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.77 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.205 -0.452 . . . . 1.16 110.542 177.218 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.95 159.46 17.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.48 109.855 174.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -123.89 143.51 50.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 3.18 110.554 -176.066 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -82.14 134.77 35.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.321 -0.622 . . . . 0.37 109.321 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 49.6 p -85.32 -13.5 49.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.75 111.43 -178.64 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -103.52 -21.74 13.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 1.43 111.444 -178.651 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.21 -166.14 2.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 0.79 109.426 178.602 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.97 115.3 30.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.06 -0.348 . . . . 0.47 110.06 178.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.23 134.85 12.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.431 . . . . 0.4 110.205 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.06 115.86 23.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.258 -0.428 . . . . 0.45 110.388 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -160.5 151.73 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.048 -0.524 . . . . 0.61 110.307 -176.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.853 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.7 m80 -82.44 136.59 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.985 -1.117 . . . . 0.42 107.985 171.176 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -44.3 -52.17 7.79 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.466 0.479 . . . . 0.68 111.979 -175.699 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -56.44 -34.9 67.26 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.678 0.621 . . . . 3.33 112.678 -175.16 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.853 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 3.4 m -71.71 -21.93 61.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.897 -0.592 . . . . 0.54 111.149 -173.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -103.94 -49.66 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.82 -0.627 . . . . 0.61 110.546 176.232 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.9 m-85 -121.43 113.61 32.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.8 110.156 -175.932 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 7.2 Cg_exo -72.54 -172.73 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.922 2.415 . . . . 2.12 113.308 -177.469 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.35 -28.17 62.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 111.935 0.346 . . . . 3.3 111.935 -177.347 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.53 -9.49 55.46 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.244 -0.503 . . . . 1.46 112.743 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 44' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 36.5 m -124.63 116.98 23.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 1.03 110.369 176.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -88.37 155.15 19.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.264 -0.426 . . . . 1.6 110.224 -178.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -70.25 130.95 88.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 2.68 110.679 -175.262 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.66 147.27 50.77 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.814 2.343 . . . . 1.14 111.988 178.355 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.01 -1.89 88.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.808 -0.711 . . . . 1.9 111.577 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.1 p -94.67 -168.29 1.8 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.534 -0.333 . . . . 2.75 110.86 179.252 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.53 127.13 43.99 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.644 -0.788 . . . . 0.82 111.439 175.568 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.8 122.42 17.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.221 0.534 . . . . 0.87 109.99 -176.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.6 135.52 48.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.835 -0.62 . . . . 2.65 110.433 178.902 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.7 p -75.7 172.54 12.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.1 -0.704 . . . . 0.49 109.1 171.777 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -53.56 -41.48 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.026 0.441 . . . . 4.09 111.4 -175.957 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 55' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' C' ' 60' ' ' VAL . 35.1 t -68.22 -45.92 71.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.072 -0.513 . . . . 1.54 111.269 -177.236 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.0 m -72.58 -17.46 61.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.812 0.301 . . . . 0.72 111.812 -177.398 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -87.45 -8.45 56.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 1.25 110.608 174.858 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.84 -100.13 0.85 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.11 -0.567 . . . . 2.19 111.823 179.261 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -124.92 142.79 51.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.794 -0.447 . . . . 5.15 109.794 177.795 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.481 ' HA ' ' OG ' ' C' ' 55' ' ' SER . 58.3 t -108.49 135.54 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 6.76 110.643 -178.15 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.09 122.04 32.9 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 8.83 110.466 176.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.2 142.73 81.35 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.812 2.341 . . . . 11.04 112.14 -178.538 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.28 132.89 93.3 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.153 -0.476 . . . . 13.86 110.027 177.321 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.44 57.4 4.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.857 2.372 . . . . 16.55 112.775 -176.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -89.19 79.75 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.32 0.581 . . . . 18.07 109.72 -179.032 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.49 -0.777 . . . . 20.26 109.948 179.385 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.859 -0.496 . . . . 20.38 111.859 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.46 95.1 3.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 18.81 110.967 -178.916 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 63.6 mtt -82.09 -64.84 1.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.606 . . . . 18.06 109.472 177.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -164.86 -63.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 16.83 110.436 178.683 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.41 -151.14 23.31 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.754 -0.736 . . . . 14.66 111.981 179.576 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -88.12 -10.93 48.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 15.8 110.599 179.849 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.11 97.93 2.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.59 . . . . 13.13 110.22 177.473 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -83.4 -2.08 54.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.901 0.382 . . . . 11.74 111.24 -178.466 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.17 131.7 35.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.08 -0.509 . . . . 8.72 109.731 177.271 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 123.12 87.63 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.504 -0.316 . . . . 5.93 110.511 -179.848 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.44 48.87 1.63 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.503 2.802 . . . . 5.25 113.404 -178.545 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.21 -84.67 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.204 -0.522 . . . . 2.28 112.694 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.84 74.53 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.465 . . . . 2.07 111.065 -178.24 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -168.33 135.44 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 3.18 110.159 179.035 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 41.9 t -76.48 104.39 6.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.53 109.884 179.114 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.72 -6.59 88.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.011 -0.614 . . . . 0.65 112.271 -176.648 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 24.1 t -70.34 -31.65 47.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 1.04 110.664 -179.575 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -112.65 -39.33 4.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.999 0.428 . . . . 0.84 110.196 176.191 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.6 -9.63 9.92 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.612 -0.804 . . . . 0.77 112.08 179.479 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 2.0 m-20 -107.64 139.54 42.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.006 0.431 . . . . 2.1 111.035 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' C' ' 24' ' ' VAL . . . -107.39 2.81 34.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.03 -0.828 . . . . 0.55 111.03 174.927 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 132.35 45.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.426 -0.387 . . . . 1.06 110.409 179.316 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 56.13 49.71 14.99 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.398 0.618 . . . . 2.23 109.87 -176.612 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' C' ' 21' ' ' GLY . 4.4 p -89.38 151.28 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.343 -0.844 . . . . 1.16 110.602 -175.29 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.7 mt -100.96 160.44 14.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.435 -0.348 . . . . 0.48 110.189 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -126.82 136.03 51.81 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.594 -0.521 . . . . 3.18 109.594 -178.396 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 42.2 t -67.12 143.15 56.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.494 -0.482 . . . . 0.37 110.099 176.389 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.91 -23.35 23.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.049 178.6 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -95.03 -30.24 14.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 1.43 111.05 -178.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.0 OUTLIER -137.25 -177.59 4.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.669 -0.493 . . . . 0.79 109.669 -178.397 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.23 114.87 29.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.48 -0.327 . . . . 0.47 110.286 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -168.49 129.87 1.31 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.4 110.538 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -102.9 112.15 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.435 -0.58 . . . . 0.45 109.435 174.117 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -155.0 173.42 16.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.799 -0.637 . . . . 0.61 109.998 -175.392 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.431 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -110.13 135.96 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.169 -0.678 . . . . 0.42 109.169 173.384 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -61.59 -36.27 80.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.551 -0.75 . . . . 0.68 110.45 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -70.39 -26.46 63.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 3.33 111.276 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.8 m -84.23 -26.0 29.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.937 0.399 . . . . 0.54 110.914 178.884 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 39' ' ' HIS . . . . . 0.402 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 1.5 m-70 -89.81 -40.03 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.213 -0.448 . . . . 0.61 111.26 -178.965 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -124.32 71.38 55.64 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.315 -0.402 . . . . 0.8 110.173 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 3.0 Cg_exo -75.43 6.44 3.58 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.134 2.556 . . . . 2.12 113.004 -174.918 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.95 3.77 28.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 3.3 111.165 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.05 32.65 20.15 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.63 -0.795 . . . . 1.46 112.036 -179.708 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 8.6 m -68.3 148.08 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.947 -0.39 . . . . 1.03 109.947 177.658 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -86.57 121.67 29.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.94 0.4 . . . . 1.6 110.504 -175.367 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -66.32 120.09 67.42 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 2.68 110.855 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.62 143.8 38.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.435 2.09 . . . . 1.14 111.859 176.277 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.98 -10.37 42.91 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.73 -0.748 . . . . 1.9 112.526 -179.209 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -96.04 9.76 39.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.803 0.335 . . . . 2.75 111.685 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 117.92 0.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.634 -0.793 . . . . 0.82 112.287 -178.669 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -90.29 123.24 33.9 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.44 -0.578 . . . . 0.87 109.44 179.924 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' C' ' 57' ' ' SER . 28.6 mtm180 -110.46 149.07 30.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.394 0.616 . . . . 2.65 111.62 -178.851 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 30.3 p -102.3 -178.8 3.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.171 -0.922 . . . . 0.49 110.029 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -57.84 -39.1 76.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.507 0.558 . . . . 4.09 112.507 -172.106 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -63.7 -57.3 10.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.88 0.371 . . . . 1.54 111.443 -176.541 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 6.9 p -72.17 -24.58 61.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.233 -0.439 . . . . 0.72 111.699 -174.786 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 57' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' C' ' 52' ' ' ARG . 25.3 t -102.15 19.76 17.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.897 0.379 . . . . 1.25 110.728 -177.119 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.22 58.41 0.33 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.366 -0.921 . . . . 2.19 112.645 -179.46 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.96 78.23 6.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.082 0.468 . . . . 5.15 110.117 175.858 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.67 117.63 35.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 6.76 109.988 179.624 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -75.48 131.95 76.54 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.077 -0.342 . . . . 8.83 110.077 179.079 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.64 135.69 54.16 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.541 2.161 . . . . 11.04 111.805 179.805 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.98 129.36 93.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.046 -0.525 . . . . 13.86 110.939 -177.695 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.76 104.78 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.749 2.299 . . . . 16.55 111.938 -179.151 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.24 132.92 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.889 -0.596 . . . . 18.07 110.675 -178.56 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.672 -0.68 . . . . 20.26 110.103 178.419 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.694 -0.563 . . . . 20.38 111.694 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.2 -29.96 64.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.105 0.479 . . . . 18.81 110.992 -178.133 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 22.9 mmt -104.64 74.31 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.265 0.555 . . . . 18.06 109.948 176.349 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.22 -24.7 37.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.532 -0.758 . . . . 16.83 110.503 -177.096 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.67 134.09 35.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.982 -0.628 . . . . 14.66 112.061 179.025 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -73.21 -51.49 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.57 -0.159 . . . . 15.8 110.57 -178.273 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 57.02 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.867 0.729 . . . . 13.13 112.68 176.291 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.41 130.76 37.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.657 -0.701 . . . . 11.74 110.209 177.72 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.93 76.36 8.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.202 0.525 . . . . 8.72 110.885 -176.649 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -86.57 146.8 42.46 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.717 -0.674 . . . . 5.93 110.553 -179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 27.4 Cg_exo -62.81 -15.6 48.05 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.033 2.488 . . . . 5.25 112.311 177.51 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 171.87 23.91 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.501 -0.772 . . . . 2.28 112.69 175.519 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.438 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -110.55 74.88 0.9 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.274 0.559 . . . . 2.07 109.654 176.746 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -137.48 130.33 30.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.662 -0.699 . . . . 3.18 110.748 -174.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.45 111.22 5.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.53 109.994 178.264 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.03 -19.03 60.88 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.291 -0.48 . . . . 0.65 112.856 -178.026 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.27 -31.08 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.105 0.478 . . . . 1.04 110.682 178.522 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.6 m -109.04 -20.8 12.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.32 0.489 . . . . 0.84 112.32 -175.204 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.4 79.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.174 -0.77 . . . . 0.77 111.174 -174.398 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.17 147.09 37.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.281 -0.459 . . . . 2.1 109.932 -176.538 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.26 30.79 5.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.574 -0.822 . . . . 0.55 113.508 -176.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -75.28 121.08 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.237 0.519 . . . . 1.06 110.135 176.276 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 54.41 52.76 11.87 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.65 0.594 . . . . 2.23 110.508 -176.859 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' C' ' 33' ' ' ALA . 8.7 p -88.97 139.45 17.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.091 -0.504 . . . . 1.16 110.635 -173.902 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.09 147.8 25.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.096 -0.502 . . . . 0.48 110.688 -179.073 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.529 HH11 ' HB2' ' C' ' 33' ' ' ALA . 30.7 mmm180 -113.74 149.75 34.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.534 -0.757 . . . . 3.18 109.739 179.71 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 17.6 t -85.2 135.55 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.448 -0.575 . . . . 0.37 109.448 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.9 p -81.94 -18.68 42.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.75 111.171 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -100.5 -22.52 14.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 1.43 111.923 -176.44 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.4 p -150.55 -165.08 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.542 . . . . 0.79 109.535 178.438 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.65 115.58 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.958 -0.386 . . . . 0.47 109.958 179.477 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.36 146.78 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.4 111.273 -177.955 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.529 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -131.71 112.54 12.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.678 -0.692 . . . . 0.45 109.779 177.535 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.17 165.35 36.22 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.121 -0.49 . . . . 0.61 109.74 -177.212 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.786 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.9 m170 -96.71 138.37 34.38 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.297 -1.001 . . . . 0.42 108.297 171.2 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -46.09 -52.53 11.91 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.3 0.375 . . . . 0.68 111.712 -177.903 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.8 mtm180 -70.37 -5.93 31.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.33 112.124 -174.424 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.786 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -91.92 -20.86 20.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.096 0.474 . . . . 0.54 110.66 179.31 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -103.86 -36.17 7.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.61 110.68 174.891 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 92.4 m-85 -121.87 147.28 48.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.8 110.107 -179.405 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.51 159.62 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.519 2.146 . . . . 2.12 111.633 176.463 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -8.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 3.3 111.978 -175.093 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.69 -7.4 87.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.824 -0.703 . . . . 1.46 111.768 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.0 m -98.11 132.6 43.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.838 0.351 . . . . 1.03 110.212 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -88.87 142.21 27.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.386 -0.37 . . . . 1.6 110.2 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -80.63 127.32 75.85 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 2.68 110.796 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.03 135.65 70.01 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.752 2.301 . . . . 1.14 111.743 175.204 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -24.47 61.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.928 -0.653 . . . . 1.9 111.68 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -138.91 135.59 34.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.908 -0.404 . . . . 2.75 109.908 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.8 53.61 4.89 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.68 -0.771 . . . . 0.82 112.225 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.51 122.82 19.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.408 -0.59 . . . . 0.87 109.408 178.061 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -118.91 136.43 54.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.12 -0.491 . . . . 2.65 110.475 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -73.54 170.4 15.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.142 -0.481 . . . . 0.49 109.944 177.058 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -49.4 -48.7 46.92 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.645 0.59 . . . . 4.09 111.911 -174.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -63.69 -45.87 88.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.57 -0.286 . . . . 1.54 111.466 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 89.1 m -72.0 -32.36 67.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.741 0.274 . . . . 0.72 111.741 -177.47 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p -80.88 -14.13 58.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 1.25 111.418 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 -170.33 29.44 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.792 -0.718 . . . . 2.19 112.008 -179.306 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -118.82 126.03 50.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.661 0.267 . . . . 5.15 110.425 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.7 122.64 51.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.23 0.538 . . . . 6.76 109.888 176.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -110.12 105.07 56.83 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.893 -0.594 . . . . 8.83 110.281 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.44 145.75 34.23 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.471 2.114 . . . . 11.04 111.902 178.105 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.11 120.05 72.17 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.194 -0.457 . . . . 13.86 110.924 -177.915 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.28 74.11 3.71 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.826 2.351 . . . . 16.55 112.512 -178.589 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.51 63.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.642 0.734 . . . . 18.07 111.067 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.382 -0.818 . . . . 20.26 110.093 179.623 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.048 -0.421 . . . . 20.38 112.048 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.07 0.59 43.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.942 0.401 . . . . 18.81 110.951 -177.95 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.7 ttt -77.54 78.85 4.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.269 0.557 . . . . 18.06 109.563 177.429 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.77 -174.24 3.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 16.83 110.314 -178.082 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.65 -145.92 13.97 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.749 -0.739 . . . . 14.66 112.07 177.937 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -162.64 -69.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 15.8 109.774 179.616 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -110.13 67.55 0.65 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.485 -0.561 . . . . 13.13 109.485 175.159 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.98 64.72 8.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 11.74 110.985 -175.107 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.99 121.02 25.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.403 -0.592 . . . . 8.72 109.403 175.617 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -60.24 129.74 88.94 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.449 . . . . 5.93 110.971 -179.587 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 21.8 Cg_exo -66.14 75.14 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.921 2.414 . . . . 5.25 112.096 175.244 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.45 126.42 1.69 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.326 -0.71 . . . . 2.28 111.326 177.666 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.0 92.74 7.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.911 0.386 . . . . 2.07 110.495 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 3.18 110.09 -179.578 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.81 105.44 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.53 109.172 175.469 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.66 62.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.43 -0.414 . . . . 0.65 113.063 -176.23 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.32 -30.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.04 110.964 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -111.17 -18.1 13.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.509 0.559 . . . . 0.84 112.509 -172.934 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.46 26.8 71.98 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.616 -0.993 . . . . 0.77 110.616 -173.209 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -142.78 148.47 37.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.282 -0.459 . . . . 2.1 110.589 -170.897 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.58 25.15 5.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.069 -0.586 . . . . 0.55 111.975 177.805 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -80.6 129.17 34.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.233 -0.284 . . . . 1.06 110.233 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.71 52.06 11.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.177 0.989 . . . . 2.23 108.953 -179.245 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -100.69 149.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.716 -1.129 . . . . 1.16 111.235 -171.507 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.2 mt -91.23 144.04 26.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.073 -0.512 . . . . 0.48 109.896 176.61 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' C' ' 32' ' ' ALA . 4.3 tpp180 -110.9 130.86 55.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.084 -0.507 . . . . 3.18 109.998 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 1.8 t -68.07 134.56 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.7 -0.482 . . . . 0.37 109.7 177.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 67.6 p -92.32 -14.85 28.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.75 110.84 -179.543 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -98.16 -18.9 18.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.915 -0.584 . . . . 1.43 111.076 -179.344 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -151.64 -170.61 3.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.07 -0.715 . . . . 0.79 109.07 176.782 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.94 113.9 27.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.538 -0.542 . . . . 0.47 109.538 178.331 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' C' ' 26' ' ' ARG . . . -171.22 137.43 1.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.55 . . . . 0.4 110.298 -178.631 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -119.03 112.89 20.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.081 -0.711 . . . . 0.45 109.081 175.99 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.68 156.7 43.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.053 -0.351 . . . . 0.61 110.053 -178.371 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.29 128.82 35.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.279 -1.008 . . . . 0.42 108.279 172.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -47.83 -53.2 16.3 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.502 0.501 . . . . 0.68 111.962 -172.309 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 71.5 mtm180 -68.07 -14.16 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 3.33 112.357 -172.546 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -80.31 -21.79 42.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.54 110.631 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -105.62 -43.72 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.61 110.521 176.46 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 93.6 m-85 -110.53 139.99 22.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.8 110.384 -176.664 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.27 158.62 47.73 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.719 2.279 . . . . 2.12 111.197 177.201 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.4 43.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 3.3 112.293 -173.788 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.73 -31.65 60.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.676 -0.773 . . . . 1.46 111.545 175.298 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 38.0 m -74.59 131.12 40.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.29 -0.263 . . . . 1.03 110.29 179.361 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 9.8 p -88.73 134.83 33.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 1.6 111.189 -175.089 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.81 111.76 14.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.698 . . . . 2.68 110.088 178.257 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.17 136.3 28.98 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.66 2.24 . . . . 1.14 112.863 -174.065 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.29 0.16 71.34 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.904 -0.665 . . . . 1.9 111.652 176.772 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -122.57 83.01 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.812 0.339 . . . . 2.75 111.14 177.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.97 88.75 1.38 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.842 -0.694 . . . . 0.82 112.387 178.932 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -78.14 122.75 26.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.975 -0.75 . . . . 0.87 108.975 178.739 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.541 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 36.4 ptt180 -133.67 135.45 44.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.213 0.53 . . . . 2.65 110.734 -176.204 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.5 p -73.29 173.81 8.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.49 110.367 178.419 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 54' ' ' ARG . . . . . 0.562 ' HA ' ' OG ' ' C' ' 57' ' ' SER . 2.7 ptp180 -63.15 -32.5 73.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.295 0.498 . . . . 4.09 111.426 -174.68 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 1.54 109.838 175.91 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 69.4 m -74.27 -30.23 62.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.694 -0.685 . . . . 0.72 112.829 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 57' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' C' ' 54' ' ' ARG . 19.9 p -75.19 -14.22 60.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 1.25 111.184 -174.815 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.43 -158.21 9.44 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.399 -1.08 . . . . 2.19 110.399 174.158 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -120.06 131.18 55.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.181 0.49 . . . . 5.15 109.999 177.084 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 m -99.12 42.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 6.76 110.434 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m -72.64 116.06 46.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 8.83 111.086 -176.755 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -83.21 140.2 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.538 2.158 . . . . 11.04 111.487 175.056 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.42 122.43 86.68 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.456 -0.338 . . . . 13.86 110.146 179.448 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.41 89.91 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.64 2.227 . . . . 16.55 112.449 -177.736 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.77 147.41 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.84 -0.618 . . . . 18.07 110.719 178.459 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.527 -0.749 . . . . 20.26 110.366 -178.472 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.392 -0.283 . . . . 20.38 112.392 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.43 66.92 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.769 0.319 . . . . 18.81 111.271 -176.885 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -127.19 21.24 6.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.905 0.383 . . . . 18.06 110.767 178.647 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.56 68.07 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 16.83 110.591 -179.583 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.02 -27.9 65.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.872 -0.68 . . . . 14.66 112.04 178.38 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -92.76 -47.49 7.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.769 -0.456 . . . . 15.8 109.769 177.631 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 51.25 74.85 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.847 0.717 . . . . 13.13 111.043 177.102 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -95.29 145.62 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 11.74 110.861 -176.807 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 tp -124.34 117.26 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 8.72 110.744 -177.948 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.78 145.2 83.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.044 -0.525 . . . . 5.93 110.171 175.931 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.69 98.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.604 2.869 . . . . 5.25 113.849 -176.399 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.02 78.58 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.571 -0.74 . . . . 2.28 113.036 174.603 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.38 71.75 8.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.303 0.573 . . . . 2.07 110.646 -179.802 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -163.22 155.61 18.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.892 -1.151 . . . . 3.18 107.892 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.09 108.65 1.59 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.631 -0.507 . . . . 0.53 109.631 177.149 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.05 -14.21 55.38 Favored Glycine 0 C--N 1.329 0.145 0 O-C-N 123.372 0.42 . . . . 0.65 113.102 -175.936 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.13 -31.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.082 0.468 . . . . 1.04 110.583 178.186 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.4 m -108.02 -26.35 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.471 . . . . 0.84 112.197 -174.883 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.33 25.25 59.56 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.075 -0.81 . . . . 0.77 111.075 -174.401 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.97 142.36 32.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.663 -0.268 . . . . 2.1 110.96 -173.56 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.15 16.98 24.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.003 -0.618 . . . . 0.55 112.275 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -80.22 128.93 34.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.934 -0.395 . . . . 1.06 109.934 178.305 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 58.56 40.43 23.71 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.471 0.653 . . . . 2.23 110.36 -178.107 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' C' ' 33' ' ' ALA . 1.5 p -90.37 150.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.272 -0.877 . . . . 1.16 110.422 -175.376 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 92.8 mt -102.25 151.26 22.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.787 -0.449 . . . . 0.48 109.787 177.05 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.2 tpp180 -119.49 140.32 50.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 3.18 110.119 -175.347 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.6 t -73.47 142.88 46.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.923 -0.769 . . . . 0.37 108.923 174.319 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.6 p -96.92 -21.38 17.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 0.75 110.743 178.678 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -89.66 -21.05 22.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.43 110.567 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.4 p -151.18 -175.5 5.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.5 -0.926 . . . . 0.79 108.5 174.806 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 114.61 28.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.651 0.262 . . . . 0.47 110.347 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.44 135.8 6.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.4 110.442 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.18 118.83 36.42 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.707 0.629 . . . . 0.45 110.121 178.377 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.93 151.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.349 -0.387 . . . . 0.61 110.647 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.702 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -82.65 136.13 34.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.628 -0.878 . . . . 0.42 108.628 172.006 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 62.0 t-105 -49.04 -53.65 19.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.255 0.347 . . . . 0.68 111.618 -175.906 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.23 -15.94 64.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.361 0.504 . . . . 3.33 112.361 -173.921 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.4 m -85.35 -21.15 29.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.105 0.478 . . . . 0.54 110.717 -178.822 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -107.56 -45.12 4.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.016 -0.538 . . . . 0.61 111.052 178.048 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.39 146.17 36.8 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.8 110.355 -176.855 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' C' ' 44' ' ' THR . 10.8 Cg_endo -55.82 144.11 78.39 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.01 2.473 . . . . 2.12 111.797 175.594 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -16.24 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.461 -0.791 . . . . 3.3 112.085 -175.144 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.14 -18.82 75.88 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.17 177.373 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' C' ' 41' ' ' PRO . 42.8 m -74.8 147.9 40.8 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.086 -0.339 . . . . 1.03 110.086 178.722 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -88.09 122.01 31.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.849 0.357 . . . . 1.6 110.738 -174.89 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -70.97 120.58 80.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.853 -0.612 . . . . 2.68 110.368 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.67 132.32 32.51 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.611 2.207 . . . . 1.14 111.933 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -43.3 6.71 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.146 -0.782 . . . . 1.9 111.146 176.596 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 t -115.12 135.21 54.44 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.041 -0.355 . . . . 2.75 110.041 175.293 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.2 64.14 3.55 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.773 -0.727 . . . . 0.82 112.201 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.49 131.38 37.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.088 0.47 . . . . 0.87 110.394 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -114.93 133.58 55.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.22 -0.446 . . . . 2.65 110.773 -176.669 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.5 p -77.12 178.45 7.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.205 -0.665 . . . . 0.49 109.205 173.074 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -56.99 -40.39 76.49 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.93 0.344 . . . . 4.09 111.93 -173.88 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -68.92 -49.18 60.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 1.54 110.919 -178.364 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.57 -17.9 62.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.72 111.348 -178.557 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -90.84 7.99 37.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.986 0.422 . . . . 1.25 110.429 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.53 -142.01 12.87 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.851 -0.69 . . . . 2.19 111.897 178.701 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -122.65 143.62 49.66 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.014 -0.365 . . . . 5.15 110.014 179.655 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.49 130.18 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 6.76 110.57 179.768 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -101.06 135.66 19.89 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 8.83 110.585 -177.753 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.2 134.13 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.582 2.188 . . . . 11.04 111.423 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.93 123.79 87.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 13.86 110.768 -178.785 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.0 80.25 1.86 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.813 2.342 . . . . 16.55 111.857 179.723 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.24 -2.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.803 -0.635 . . . . 18.07 111.865 -175.555 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.483 -0.77 . . . . 20.26 110.425 -179.916 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 112.003 -0.439 . . . . 20.38 112.003 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 155.58 30.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.782 0.325 . . . . 18.81 111.099 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.5 ttt -147.35 121.87 9.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.082 -0.508 . . . . 18.06 110.06 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.32 53.37 1.77 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 16.83 111.232 -179.697 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.22 123.44 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.832 -0.699 . . . . 14.66 112.176 -179.015 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -100.48 -1.97 34.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.302 0.573 . . . . 15.8 109.741 176.102 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -89.77 -174.64 4.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.164 -0.925 . . . . 13.13 110.293 178.263 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 67.08 22.53 9.9 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.584 0.552 . . . . 11.74 110.779 178.741 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.69 92.12 3.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 8.72 110.2 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -74.01 126.89 88.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.901 -0.59 . . . . 5.93 110.105 178.548 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 23.4 Cg_exo -65.73 -6.05 13.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.105 2.537 . . . . 5.25 113.048 -179.167 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.84 -127.88 8.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.393 -0.683 . . . . 2.28 111.393 -178.639 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.11 73.85 7.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.879 0.371 . . . . 2.07 110.221 177.134 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 57.4 mtt180 -145.94 130.94 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 3.18 110.587 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' C' ' 34' ' ' PHE . 13.2 t -64.02 114.53 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.53 109.527 175.349 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.07 -22.91 50.67 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.331 0.394 . . . . 0.65 113.353 -174.546 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.52 -30.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.085 0.469 . . . . 1.04 110.889 179.003 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -107.26 -31.11 8.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 0.84 112.912 -173.476 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 85.04 -9.26 66.88 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.089 -0.804 . . . . 0.77 111.089 -172.704 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -106.88 147.69 29.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.171 -0.514 . . . . 2.1 110.674 -177.512 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.07 27.49 6.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.96 -0.638 . . . . 0.55 112.62 179.535 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.9 m -77.19 117.6 18.89 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.862 -0.421 . . . . 1.06 109.862 177.822 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 54.57 64.42 1.82 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.901 0.858 . . . . 2.23 109.511 -174.171 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.483 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.7 p -97.32 150.96 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.243 -0.89 . . . . 1.16 110.201 -176.339 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 96.5 mt -103.93 144.14 31.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.76 -0.459 . . . . 0.48 109.76 176.995 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -115.18 138.4 50.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.12 -0.491 . . . . 3.18 110.259 -179.674 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -60.14 139.92 57.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.37 109.549 174.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -90.61 -17.56 26.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.078 0.466 . . . . 0.75 111.015 179.528 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -94.83 -23.73 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 1.43 110.697 -178.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.43 -168.9 3.22 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.115 -0.698 . . . . 0.79 109.115 178.532 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.68 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.716 0.293 . . . . 0.47 110.741 -178.541 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.96 121.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.4 110.617 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.483 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.79 117.91 35.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.372 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 15' ' ' CYS . 46.8 p90 -158.16 165.78 34.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.634 -0.257 . . . . 0.61 110.585 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.709 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.9 m170 -95.65 140.89 29.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.534 -0.914 . . . . 0.42 108.534 173.779 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.4 t-105 -59.39 -45.42 91.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.635 0.255 . . . . 0.68 111.0 -177.537 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 37' ' ' ARG . 48.9 mtm180 -65.39 -14.48 60.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.286 -0.415 . . . . 3.33 111.968 -177.439 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.4 m -89.9 -20.49 23.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.957 0.408 . . . . 0.54 110.655 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -103.09 -39.75 6.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.091 -0.504 . . . . 0.61 111.403 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.68 161.02 59.9 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.257 -0.429 . . . . 0.8 110.17 -177.592 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.97 146.2 98.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.619 2.213 . . . . 2.12 112.13 178.983 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.96 66.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.5 -0.773 . . . . 3.3 111.333 -178.065 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.08 88.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.782 -0.723 . . . . 1.46 111.978 176.258 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 36.4 m -95.19 134.82 37.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.802 0.334 . . . . 1.03 110.114 179.403 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.7 p -88.95 150.08 23.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.346 -0.388 . . . . 1.6 110.571 -178.12 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -81.15 143.19 52.26 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.934 -0.575 . . . . 2.68 110.209 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 132.17 35.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.642 2.228 . . . . 1.14 112.244 178.876 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.85 -0.7 89.1 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.994 -0.548 . . . . 1.9 112.444 -178.016 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 28.7 p -90.06 -9.98 46.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.135 0.493 . . . . 2.75 110.639 176.687 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.96 137.12 3.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.775 -0.726 . . . . 0.82 111.922 -178.782 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 124.01 21.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.87 110.16 179.904 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -107.92 136.03 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 2.65 110.965 -177.146 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.42 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.1 p -87.0 -178.22 6.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.49 109.769 175.924 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -64.69 -39.96 94.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.839 -0.344 . . . . 4.09 111.296 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -68.98 -48.7 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.54 0.209 . . . . 1.54 111.058 -178.163 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 90.7 m -67.31 -39.85 85.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.578 0.228 . . . . 0.72 111.114 -178.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -76.43 -13.48 60.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.989 0.423 . . . . 1.25 110.372 -179.365 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.6 -8.96 61.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.079 -0.582 . . . . 2.19 112.308 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -88.27 -9.99 51.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.57 0.7 . . . . 5.15 109.488 179.558 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -92.9 70.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.141 -0.936 . . . . 6.76 109.562 178.609 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 5.7 t -122.4 132.45 24.26 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 8.83 109.995 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.23 134.31 54.99 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.95 2.433 . . . . 11.04 112.493 -178.558 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.28 124.71 91.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 13.86 111.418 -176.624 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.21 106.47 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.621 2.214 . . . . 16.55 112.209 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.56 12.81 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 18.07 110.418 178.138 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.452 -0.794 . . . . 20.26 110.366 -176.939 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.935 -0.466 . . . . 20.38 111.935 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.15 36.18 27.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.095 0.474 . . . . 18.81 111.322 179.671 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 24.3 ttt -89.07 127.29 35.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.018 -0.537 . . . . 18.06 110.329 -177.91 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.87 160.43 19.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.746 -0.464 . . . . 16.83 109.746 176.812 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.8 121.1 4.81 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.803 -0.713 . . . . 14.66 112.213 -179.151 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -115.47 23.03 12.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.039 0.447 . . . . 15.8 110.395 -179.559 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 61.53 65.98 0.9 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.146 -0.934 . . . . 13.13 110.435 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -73.08 -26.47 61.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 11.74 110.872 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.42 93.91 7.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.806 -0.442 . . . . 8.72 109.806 177.001 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -64.24 137.46 97.13 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.929 -0.578 . . . . 5.93 111.075 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 11.9 Cg_exo -70.7 74.03 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.938 2.426 . . . . 5.25 112.171 176.888 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.29 81.31 1.59 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.82 -0.705 . . . . 2.28 112.32 178.559 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.27 73.41 8.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.317 0.58 . . . . 2.07 109.541 175.258 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -149.0 163.67 36.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.262 -0.881 . . . . 3.18 110.181 -177.721 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 t -69.28 108.21 3.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.53 109.584 175.298 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.82 -16.2 56.18 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.398 -0.429 . . . . 0.65 112.746 -177.109 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.09 -30.13 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.974 0.416 . . . . 1.04 110.495 177.882 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.1 m -109.64 -29.63 8.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.84 112.42 -175.235 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.82 3.94 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.904 -0.878 . . . . 0.77 110.904 -173.425 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' C' ' 22' ' ' THR . 10.6 t70 -124.43 153.76 41.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.897 -0.652 . . . . 2.1 109.419 -176.062 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 27.69 3.61 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.299 -0.953 . . . . 0.55 113.355 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 22' ' ' THR . . . . . 0.469 HG22 ' OD1' ' C' ' 20' ' ' ASP . 6.0 t -77.68 135.28 38.05 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.282 0.541 . . . . 1.06 109.711 177.003 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.76 43.35 31.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.878 -0.601 . . . . 2.23 110.183 179.375 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.93 149.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.471 -0.786 . . . . 1.16 110.504 -172.307 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.18 143.05 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 0.48 109.98 179.238 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 19.2 mmm180 -109.48 143.16 39.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 3.18 110.441 -178.251 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.4 t -73.47 145.43 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.473 -0.565 . . . . 0.37 109.473 177.389 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -90.92 -34.54 15.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.101 -0.499 . . . . 0.75 111.612 -178.954 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -89.2 -13.86 37.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 1.43 111.24 -176.85 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.27 -171.27 3.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.523 -0.547 . . . . 0.79 109.523 175.262 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.74 115.33 30.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.232 -0.285 . . . . 0.47 110.232 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.11 143.73 10.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.331 -0.395 . . . . 0.4 110.696 -179.334 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.17 113.51 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.45 109.659 177.263 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.43 154.79 39.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.416 . . . . 0.61 110.696 -178.038 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.6 m170 -92.95 134.15 35.4 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.768 -0.827 . . . . 0.42 108.768 172.845 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -49.39 -53.15 24.04 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.267 0.354 . . . . 0.68 111.217 -176.125 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.18 -30.08 69.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.933 -0.576 . . . . 3.33 111.829 -176.106 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.8 m -80.66 -22.08 40.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.54 111.487 -175.022 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -31.67 8.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.454 -0.339 . . . . 0.61 111.443 -178.568 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.12 141.78 41.77 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.405 . . . . 0.8 110.732 -176.333 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.62 153.99 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.799 2.333 . . . . 2.12 111.417 174.844 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -18.56 61.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.35 -0.841 . . . . 3.3 112.362 -172.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.9 -13.23 80.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.955 -0.64 . . . . 1.46 112.447 177.597 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -87.37 130.91 34.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.739 -0.467 . . . . 1.03 109.739 177.589 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 138.48 31.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.326 -0.397 . . . . 1.6 109.957 -175.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -68.9 115.23 29.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 2.68 110.103 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.1 138.0 46.06 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.038 2.492 . . . . 1.14 112.805 -176.431 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.47 -5.4 65.2 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.766 -0.652 . . . . 1.9 111.819 177.702 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -88.75 -9.71 50.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 2.75 111.023 -179.794 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.01 137.23 3.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.602 -0.808 . . . . 0.82 112.276 179.145 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.01 123.85 22.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.872 0.368 . . . . 0.87 110.676 176.893 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.373 -0.376 . . . . 2.65 110.337 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.0 p -72.79 -177.43 2.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.49 110.453 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -53.35 -49.29 67.44 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.781 0.432 . . . . 4.09 111.959 -172.774 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -68.88 -42.06 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.808 0.337 . . . . 1.54 111.392 -177.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.3 m -72.08 -28.15 63.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.202 0.445 . . . . 0.72 112.202 -175.077 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.6 p -107.94 11.21 28.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.974 0.416 . . . . 1.25 111.034 179.047 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.26 -172.15 16.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.485 -0.864 . . . . 2.19 112.746 -175.217 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -100.73 97.86 8.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.927 -0.398 . . . . 5.15 109.927 179.65 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.87 140.96 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.105 0.478 . . . . 6.76 110.873 -177.639 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 9.1 p -108.16 103.48 50.46 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.053 -0.521 . . . . 8.83 109.881 173.82 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 144.87 24.29 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.871 2.38 . . . . 11.04 111.992 -179.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.22 128.02 26.07 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.218 -0.446 . . . . 13.86 110.017 176.644 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.81 35.14 0.43 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.909 2.406 . . . . 16.55 112.883 -178.184 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 t -93.38 88.41 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.142 0.496 . . . . 18.07 109.914 -179.146 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.222 -0.894 . . . . 20.26 110.273 -176.869 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 111.717 -0.553 . . . . 20.38 111.717 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.96 65.78 1.37 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.107 0.479 . . . . 18.81 110.908 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 91.5 mtp -61.21 118.56 7.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.821 -0.627 . . . . 18.06 110.677 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 70.54 -3.43 1.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.497 0.719 . . . . 16.83 111.392 -179.354 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.07 -12.34 63.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.083 -0.58 . . . . 14.66 111.749 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -88.65 -4.87 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.049 0.452 . . . . 15.8 110.232 177.835 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -82.48 68.64 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 13.13 110.89 -178.257 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.36 -42.38 99.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 11.74 109.759 176.692 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.06 109.43 17.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 8.72 109.505 175.738 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -79.98 123.28 83.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.396 -0.365 . . . . 5.93 110.521 -178.985 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 14.9 Cg_exo -69.96 77.82 1.12 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.781 2.32 . . . . 5.25 111.908 177.262 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.06 135.49 20.14 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.917 -0.658 . . . . 2.28 112.393 179.594 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.29 88.49 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.972 0.415 . . . . 2.07 110.16 177.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -131.94 143.29 50.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 3.18 111.273 -176.774 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 t -68.3 115.47 7.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.53 109.346 174.191 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.75 60.86 Favored Glycine 0 C--O 1.228 -0.267 0 O-C-N 123.358 0.411 . . . . 0.65 113.509 -174.852 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.9 -33.39 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.061 0.457 . . . . 1.04 110.953 179.223 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.87 -37.16 7.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.81 0.67 . . . . 0.84 112.81 -171.283 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.93 -7.39 76.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.856 -0.688 . . . . 0.77 111.598 -175.489 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -104.52 149.16 25.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.93 0.395 . . . . 2.1 110.523 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.14 6.89 32.54 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.295 -0.722 . . . . 0.55 111.295 175.66 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.9 m -66.89 133.7 50.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.56 -0.32 . . . . 1.06 110.289 178.53 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.31 41.18 4.23 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.15 0.906 . . . . 2.23 111.896 -177.458 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.16 142.6 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.564 -0.744 . . . . 1.16 110.452 -177.715 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' C' ' 36' ' ' TRP . 49.6 mt -87.66 148.88 24.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.027 0.442 . . . . 0.48 110.177 177.665 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 26.3 mmm180 -119.54 138.57 53.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.544 -0.753 . . . . 3.18 110.054 -177.069 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.91 137.51 53.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.014 -0.736 . . . . 0.37 109.014 178.05 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -92.42 -14.53 28.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.75 111.153 -178.891 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -98.86 -20.75 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.187 -0.46 . . . . 1.43 111.014 -179.659 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.3 p -150.82 -166.25 2.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.917 -0.771 . . . . 0.79 108.917 176.994 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.06 114.95 29.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.687 0.279 . . . . 0.47 110.848 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.54 139.46 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.372 -0.376 . . . . 0.4 110.92 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.38 112.86 19.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.105 -0.498 . . . . 0.45 110.195 178.191 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -149.91 148.61 29.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 0.61 110.197 -179.201 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.5 m170 -80.42 138.74 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.618 -0.882 . . . . 0.42 108.618 172.606 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.0 t-105 -52.8 -50.59 63.31 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.173 0.296 . . . . 0.68 110.76 -177.651 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -67.0 -14.35 62.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.789 -0.641 . . . . 3.33 112.288 -175.688 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 85.1 m -88.56 -20.78 24.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.078 0.466 . . . . 0.54 110.876 -179.425 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -107.49 -43.86 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.61 111.212 177.03 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.0 m-85 -120.72 112.27 33.95 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.8 110.149 -176.669 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.52 -174.46 0.45 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.888 2.392 . . . . 2.12 113.106 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.06 51.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 3.3 112.535 -175.768 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.52 -25.04 62.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.002 -0.618 . . . . 1.46 113.086 -179.683 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 44' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 4.5 m -107.83 126.2 52.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.942 0.401 . . . . 1.03 110.778 -179.792 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -89.43 138.6 31.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.255 -0.646 . . . . 1.6 109.255 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -74.86 126.24 88.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 2.68 111.07 -177.209 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 153.52 56.5 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.771 2.314 . . . . 1.14 111.881 177.909 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.76 -24.41 55.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.955 -0.641 . . . . 1.9 111.624 178.713 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -141.27 159.6 41.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.822 -0.436 . . . . 2.75 109.822 177.09 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.79 56.83 6.26 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.818 -0.706 . . . . 0.82 112.024 -178.853 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.93 121.71 23.09 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.229 -0.656 . . . . 0.87 109.229 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -123.33 132.31 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.168 -0.469 . . . . 2.65 110.969 -175.602 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 p -74.71 -172.21 1.49 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.49 109.802 175.58 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -59.94 -47.45 85.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.627 0.251 . . . . 4.09 111.422 -176.229 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -68.5 -46.58 69.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.443 -0.344 . . . . 1.54 111.564 -177.211 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.8 m -71.24 -21.57 62.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.852 -0.339 . . . . 0.72 111.344 -177.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.4 t -99.75 13.32 34.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 1.25 110.498 179.188 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.98 -41.51 10.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.703 -0.76 . . . . 2.19 111.461 177.555 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.47 152.97 17.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.073 0.463 . . . . 5.15 110.174 178.276 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.92 115.59 36.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.952 -0.567 . . . . 6.76 110.135 179.191 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.4 114.24 20.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.33 -0.395 . . . . 8.83 111.014 177.835 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.78 147.1 19.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.511 2.141 . . . . 11.04 112.319 -178.387 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.67 140.41 22.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.048 -0.523 . . . . 13.86 110.306 178.795 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.39 32.96 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.122 2.548 . . . . 16.55 113.018 -179.266 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.19 98.23 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 18.07 109.478 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.563 -0.732 . . . . 20.26 109.954 -177.307 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.599 -0.6 . . . . 20.38 111.599 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.09 -71.71 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.818 0.309 . . . . 18.81 110.997 179.416 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.5 ptm -106.46 -33.33 7.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.895 0.379 . . . . 18.06 110.795 179.67 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.88 83.03 6.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 16.83 110.588 -179.712 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.14 -178.3 46.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.816 -0.707 . . . . 14.66 112.039 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -124.48 14.19 8.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 15.8 110.393 -179.497 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 59.1 47.4 11.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.679 -0.691 . . . . 13.13 110.97 -176.513 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -152.32 -57.28 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 11.74 110.422 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 66.4 tp -104.67 123.9 48.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.968 -0.56 . . . . 8.72 110.66 -178.789 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -73.13 123.77 89.9 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 5.93 109.815 175.144 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 37.3 Cg_exo -60.85 -19.1 60.39 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.921 2.414 . . . . 5.25 113.01 -177.447 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.58 -46.38 3.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.038 -0.601 . . . . 2.28 112.298 178.337 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.95 73.42 10.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.34 0.591 . . . . 2.07 110.839 179.704 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.411 ' N ' ' HB3' ' C' ' 33' ' ' ALA . 50.8 ttt85 -169.95 132.75 1.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.214 -0.903 . . . . 3.18 109.011 175.024 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 41.4 t -72.08 103.93 3.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.186 -0.461 . . . . 0.53 110.231 -178.621 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.48 -8.66 84.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.65 111.74 179.446 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.427 HG11 ' O ' ' C' ' 38' ' ' CYS . 25.5 t -61.68 -49.07 85.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 1.04 110.139 178.765 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.1 p -98.87 -28.12 13.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.482 -0.562 . . . . 0.84 109.482 175.12 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 3.61 55.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.895 -0.669 . . . . 0.77 111.945 178.281 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.57 145.05 48.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.767 0.318 . . . . 2.1 110.843 -176.722 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.68 17.04 13.77 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.55 111.891 179.201 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -78.31 122.77 26.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.533 0.166 . . . . 1.06 110.935 -177.947 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.35 51.65 15.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.62 0.724 . . . . 2.23 110.299 -178.0 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.557 HG11 ' HB1' ' C' ' 33' ' ' ALA . 6.6 p -92.39 155.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.634 -1.166 . . . . 1.16 110.416 -175.262 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 97.4 mt -86.31 146.59 26.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.678 -0.49 . . . . 0.48 109.678 176.589 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -109.45 138.45 45.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.305 -0.407 . . . . 3.18 110.272 -176.198 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.65 138.84 53.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.702 -0.481 . . . . 0.37 109.702 177.383 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -94.89 -24.51 16.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 0.75 111.339 179.744 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.48 -20.11 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.998 0.427 . . . . 1.43 110.575 -177.744 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.47 -171.09 3.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.158 -1.052 . . . . 0.79 108.158 174.491 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.76 112.92 26.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.961 -0.385 . . . . 0.47 109.961 178.148 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.66 146.17 8.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.123 -0.49 . . . . 0.4 110.001 -178.502 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.557 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -109.66 121.41 45.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.125 -0.489 . . . . 0.45 109.694 177.403 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 31.0 p90 -149.8 143.21 25.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.226 -0.443 . . . . 0.61 110.476 -178.492 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 68.9 m80 -90.33 138.81 31.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.691 -0.855 . . . . 0.42 108.691 171.618 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -59.28 -43.78 92.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.354 0.409 . . . . 0.68 110.02 178.355 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.62 -26.16 66.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.027 -0.533 . . . . 3.33 111.534 -177.37 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.1 m -81.98 -23.9 35.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.041 0.448 . . . . 0.54 110.653 179.679 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -101.19 -41.46 6.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.319 -0.4 . . . . 0.61 111.701 -175.812 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.95 132.48 24.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.691 0.281 . . . . 0.8 110.706 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.6 164.7 22.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.723 2.282 . . . . 2.12 111.34 172.185 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.77 -3.48 5.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 3.3 112.12 -175.712 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.67 73.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.965 -0.636 . . . . 1.46 111.67 173.705 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -101.4 136.1 41.81 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.079 -0.341 . . . . 1.03 110.079 178.705 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -89.03 140.22 29.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 1.6 110.862 -175.604 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -81.91 118.15 71.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.68 110.641 179.854 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 158.35 49.32 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.64 2.227 . . . . 1.14 111.836 176.241 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.9 -16.45 61.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.03 -0.605 . . . . 1.9 111.677 177.351 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -142.84 146.37 34.07 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.203 -0.295 . . . . 2.75 110.203 178.602 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.19 48.47 4.58 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.719 -0.753 . . . . 0.82 112.518 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.2 122.12 27.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.159 0.504 . . . . 0.87 110.307 176.973 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.448 ' CZ ' ' HA ' ' C' ' 57' ' ' SER . 24.2 ptt180 -127.1 135.71 51.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.362 0.601 . . . . 2.65 110.051 -179.744 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.8 p -72.28 177.9 4.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.49 110.207 -178.424 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -58.43 -41.69 85.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.977 0.362 . . . . 4.09 111.977 -174.258 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -64.3 -42.64 96.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.109 0.481 . . . . 1.54 110.522 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 56' ' ' CYS . . . . . 0.424 ' CB ' ' HB2' ' C' ' 52' ' ' ARG . 85.1 m -72.97 -19.9 61.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.72 111.472 176.839 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 57' ' ' SER . . . . . 0.448 ' HA ' ' CZ ' ' C' ' 52' ' ' ARG . 19.6 t -80.86 -14.28 58.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.104 -0.498 . . . . 1.25 110.477 -175.468 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.15 143.23 16.5 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.648 -0.787 . . . . 2.19 111.414 176.765 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.27 152.87 21.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.809 -0.441 . . . . 5.15 109.809 -179.847 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.49 124.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.26 0.553 . . . . 6.76 110.841 -179.66 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 5.4 p -82.18 115.14 55.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.669 -0.696 . . . . 8.83 110.321 175.279 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.26 134.05 59.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.84 2.36 . . . . 11.04 112.069 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -97.32 141.81 23.59 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 13.86 110.284 -178.206 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 4.5 Cg_exo -75.38 63.19 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.6 2.2 . . . . 16.55 111.881 178.886 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.96 129.12 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 18.07 110.538 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.538 -0.744 . . . . 20.26 110.402 177.809 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 111.887 -0.485 . . . . 20.38 111.887 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.45 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.478 0.18 . . . . 18.81 111.324 -177.763 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.74 37.43 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 18.06 110.818 -178.048 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.72 131.55 46.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.955 -0.566 . . . . 16.83 110.954 178.371 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.66 -28.61 15.1 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.974 -0.85 . . . . 14.66 110.974 -175.213 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -98.82 -61.01 1.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.381 -0.6 . . . . 15.8 109.381 175.635 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 52.66 58.78 5.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.397 -0.819 . . . . 13.13 110.181 -179.301 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -75.71 119.19 19.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.615 -0.72 . . . . 11.74 110.696 -178.023 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.35 107.38 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 8.72 110.702 179.915 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.34 141.9 29.35 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.591 . . . . 5.93 110.453 -179.591 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.95 -1.23 6.59 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.903 2.402 . . . . 5.25 112.582 -178.912 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.94 -31.6 81.46 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.792 -0.523 . . . . 2.28 111.792 176.532 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.19 73.11 10.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.068 0.461 . . . . 2.07 109.957 175.785 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -169.47 128.35 0.98 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.538 -0.755 . . . . 3.18 109.532 -177.95 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 42.8 t -73.65 103.9 4.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.581 -0.526 . . . . 0.53 109.581 -179.289 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.64 -21.37 77.11 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.65 113.485 -171.974 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 89.9 t -60.55 -38.09 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.887 0.375 . . . . 1.04 111.052 -179.101 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.3 p -109.24 -48.12 3.31 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.947 -0.301 . . . . 0.84 110.491 179.771 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.03 -16.54 5.25 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.914 -0.66 . . . . 0.77 112.536 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 33.7 m-20 -86.88 140.09 29.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.091 0.472 . . . . 2.1 111.799 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.15 -3.62 33.56 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.737 -0.665 . . . . 0.55 111.47 173.864 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m -80.88 136.46 36.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.329 . . . . 1.06 111.052 177.899 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 64.65 44.79 3.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.793 0.806 . . . . 2.23 110.771 174.248 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' C' ' 33' ' ' ALA . 11.7 m -93.4 155.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.381 -0.827 . . . . 1.16 111.751 -178.036 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' C' ' 36' ' ' TRP . 96.4 mt -97.17 145.51 25.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.355 -0.839 . . . . 0.48 108.963 172.796 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 24.7 tpt180 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.192 -0.458 . . . . 3.18 110.361 -174.278 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.33 136.85 57.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.673 -0.491 . . . . 0.37 109.673 177.676 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.58 -26.91 22.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.75 111.049 -179.633 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -90.02 -20.32 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.582 . . . . 1.43 111.502 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.12 -166.07 2.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.338 -0.616 . . . . 0.79 109.338 176.728 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.5 114.28 28.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.198 -0.297 . . . . 0.47 110.198 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -164.38 130.5 2.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.289 -0.414 . . . . 0.4 110.187 -179.786 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.5 112.76 24.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.09 -0.505 . . . . 0.45 109.845 176.943 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -152.11 163.79 38.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.229 -0.441 . . . . 0.61 110.565 -173.359 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -97.43 137.92 35.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.241 -0.652 . . . . 0.42 109.241 173.283 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.424 ' HB2' HD12 ' C' ' 25' ' ' LEU . 71.4 t-105 -60.91 -42.68 98.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.438 0.461 . . . . 0.68 110.122 178.617 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -62.52 -34.74 77.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.907 0.384 . . . . 3.33 111.293 -179.712 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.435 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 93.5 m -73.83 -22.44 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 0.54 111.143 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -98.05 -40.86 8.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.407 . . . . 0.61 111.798 -177.935 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 83.6 m-85 -137.6 140.85 31.33 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.296 -0.411 . . . . 0.8 109.971 -176.535 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.85 177.09 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.597 2.198 . . . . 2.12 112.193 178.326 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.571 -0.286 . . . . 3.3 111.682 -178.154 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.66 -35.58 89.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.019 -0.61 . . . . 1.46 112.145 176.073 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 44' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 22.6 m -86.03 131.25 34.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.867 -0.419 . . . . 1.03 109.867 178.918 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.6 m -88.86 150.73 22.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 1.6 111.028 -176.576 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -99.18 130.61 26.87 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.845 -0.616 . . . . 2.68 110.79 -174.012 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.13 140.41 37.54 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.325 2.016 . . . . 1.14 111.72 175.856 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.87 -20.29 63.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.911 -0.662 . . . . 1.9 112.023 -179.051 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -142.67 137.81 30.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.799 -0.445 . . . . 2.75 109.799 177.795 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.18 53.71 3.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.735 -0.745 . . . . 0.82 112.082 -179.555 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 123.32 17.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.817 -0.438 . . . . 0.87 109.817 179.065 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -112.13 141.55 45.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.39 -0.368 . . . . 2.65 110.934 -178.494 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 p -78.3 -179.58 6.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.003 -0.74 . . . . 0.49 109.003 171.872 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -60.87 -44.23 97.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 4.09 110.735 -175.764 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -63.28 -48.62 77.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.067 -0.515 . . . . 1.54 111.408 -178.355 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -71.68 -17.1 62.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.779 0.323 . . . . 0.72 111.372 -179.363 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 1.25 110.309 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.61 -171.37 12.63 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.729 -0.748 . . . . 2.19 112.189 -179.686 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -147.29 142.09 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.022 -0.362 . . . . 5.15 110.022 178.414 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.64 87.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.175 -0.466 . . . . 6.76 109.79 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -79.45 121.65 83.0 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.158 -0.474 . . . . 8.83 110.754 -179.533 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.4 133.65 19.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.421 2.081 . . . . 11.04 112.244 -177.829 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.35 129.96 23.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 13.86 110.266 179.796 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.6 91.45 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.569 2.179 . . . . 16.55 111.616 174.907 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.24 78.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.294 0.568 . . . . 18.07 109.481 179.458 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.276 -0.869 . . . . 20.26 109.634 -179.313 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.784 -0.526 . . . . 20.38 111.784 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.0 -28.03 61.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.693 0.282 . . . . 18.81 111.095 -179.084 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.6 tpp -79.57 80.77 5.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 18.06 109.763 178.256 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -138.14 139.62 39.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.813 -0.631 . . . . 16.83 109.83 -179.302 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.48 106.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.636 -0.792 . . . . 14.66 112.233 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 6' ' ' GLN . . . . . 0.432 ' HG2' ' HG3' ' C' ' 7' ' ' GLN . 5.6 pm0 -70.26 -17.44 63.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 15.8 110.804 -179.801 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 7' ' ' GLN . . . . . 0.432 ' HG3' ' HG2' ' C' ' 6' ' ' GLN . 45.7 mt-30 -117.09 22.48 12.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.207 0.527 . . . . 13.13 110.28 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.02 -41.61 97.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.042 -0.725 . . . . 11.74 109.042 175.338 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -111.04 80.48 1.31 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.427 -0.806 . . . . 8.72 109.162 172.206 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -64.64 134.86 96.15 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 5.93 110.727 -178.091 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 13.5 Cg_exo -70.51 54.57 1.48 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.148 2.565 . . . . 5.25 113.207 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.24 -25.28 75.83 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.178 -0.769 . . . . 2.28 111.178 174.515 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.08 116.79 32.2 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 2.07 109.631 173.481 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -150.57 143.52 24.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.2 -0.667 . . . . 3.18 109.2 -176.867 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' C' ' 17' ' ' VAL . 43.9 t -64.39 105.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.53 110.349 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.85 -12.14 67.34 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 121.296 -0.478 . . . . 0.65 112.347 -179.856 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.454 ' HB ' ' SG ' ' C' ' 15' ' ' CYS . 61.0 t -76.77 -28.71 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 1.04 110.213 176.59 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.1 m -110.38 -36.17 5.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.004 -0.544 . . . . 0.84 112.036 -177.976 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.65 7.89 74.5 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.045 -0.822 . . . . 0.77 111.045 -173.651 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -126.51 154.58 43.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.547 -0.326 . . . . 2.1 111.022 -176.871 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.91 16.36 12.18 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.402 -0.679 . . . . 0.55 111.402 175.332 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -80.05 125.57 29.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.667 -0.266 . . . . 1.06 111.166 -179.682 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.18 45.83 26.58 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 122.207 1.003 . . . . 2.23 110.028 -178.579 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.7 p -96.04 151.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.078 -0.964 . . . . 1.16 109.399 -177.159 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.34 146.75 23.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.107 0.479 . . . . 0.48 110.749 -178.108 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.6 mmm180 -107.31 149.79 27.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.18 109.876 -178.865 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -84.31 139.11 32.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 176.8 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.6 p -87.4 -13.12 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.504 0.557 . . . . 0.75 112.504 -174.857 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -111.92 -20.8 11.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.823 0.344 . . . . 1.43 110.396 -179.478 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.408 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 2.0 p -140.32 -177.12 4.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.532 -0.544 . . . . 0.79 109.532 176.379 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.32 28.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.345 -0.389 . . . . 0.47 110.224 -177.974 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.56 146.61 13.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.4 110.742 -176.645 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -125.59 111.84 15.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.45 109.617 176.143 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -157.8 144.03 17.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.61 109.67 -178.777 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.906 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 57.7 m80 -75.18 140.38 43.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.207 -1.035 . . . . 0.42 108.207 171.021 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -54.41 -50.76 66.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.783 0.265 . . . . 0.68 110.804 -175.922 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.6 mtp180 -64.02 -15.28 59.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 3.33 112.344 -176.295 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.3 m -83.92 -20.99 32.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.027 0.441 . . . . 0.54 110.697 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -108.59 -25.88 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.61 111.106 176.325 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 61.9 m-85 -132.86 139.03 33.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.364 . . . . 0.8 110.277 -178.565 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 148.25 90.63 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.605 2.203 . . . . 2.12 111.475 175.451 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.26 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.308 -0.86 . . . . 3.3 112.718 -172.525 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 -23.12 77.9 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.68 -0.771 . . . . 1.46 111.988 177.707 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -81.11 143.29 32.53 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.0 -0.37 . . . . 1.03 110.0 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -88.8 131.62 34.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 1.6 111.057 -174.818 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 22.8 ptt180 -75.9 128.81 82.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.874 -0.603 . . . . 2.68 109.932 175.976 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 24.0 Cg_exo -63.21 132.23 35.49 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.383 2.055 . . . . 1.14 112.249 -178.668 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -22.07 31.14 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.144 -0.782 . . . . 1.9 111.144 176.451 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -89.84 52.4 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.176 0.512 . . . . 2.75 110.577 177.972 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 108.77 3.14 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.673 -0.775 . . . . 0.82 112.225 -178.501 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.59 123.2 19.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.87 109.247 177.179 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -122.76 135.14 54.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.342 -0.39 . . . . 2.65 110.732 -175.63 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.81 158.69 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.173 -0.676 . . . . 0.49 109.173 175.736 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -56.21 -31.16 63.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.737 0.699 . . . . 4.09 111.714 -170.415 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -65.91 -46.43 78.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.568 0.223 . . . . 1.54 110.741 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.6 m -72.08 -23.87 61.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.726 0.298 . . . . 0.72 111.219 -179.978 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -78.39 0.53 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.398 -0.365 . . . . 1.25 111.045 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.88 -126.59 9.76 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.725 -0.55 . . . . 2.19 111.725 179.574 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.94 135.72 33.47 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.66 -0.496 . . . . 5.15 109.66 175.675 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 52.8 t -93.11 131.26 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.171 -0.468 . . . . 6.76 110.288 -179.652 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 39.9 p -90.22 117.79 68.32 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.432 -0.349 . . . . 8.83 110.123 178.217 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 134.87 64.0 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.804 2.336 . . . . 11.04 112.271 179.594 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.21 130.68 85.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.072 -0.513 . . . . 13.86 110.557 179.678 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.01 88.24 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.546 2.164 . . . . 16.55 112.548 -179.564 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -98.66 12.07 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 18.07 111.001 178.229 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.649 -0.691 . . . . 20.26 109.668 179.863 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.931 -0.468 . . . . 20.38 111.931 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.75 54.28 10.8 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.831 0.452 . . . . 18.81 111.822 177.652 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ptp -119.94 157.58 28.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.175 -0.466 . . . . 18.06 110.197 179.06 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -159.35 -39.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.037 0.446 . . . . 16.83 110.31 -177.633 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.18 178.43 38.39 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.973 -0.632 . . . . 14.66 111.568 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 57.94 46.28 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.402 0.62 . . . . 15.8 110.71 -179.987 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.33 19.82 11.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.537 -0.756 . . . . 13.13 110.271 -177.882 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -61.03 -52.78 63.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.58 -0.736 . . . . 11.74 110.336 -178.185 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 tp -70.58 104.72 2.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.119 -0.491 . . . . 8.72 110.023 176.891 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -69.81 123.02 87.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.397 -0.365 . . . . 5.93 110.434 179.514 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 16.8 Cg_exo -66.77 105.44 0.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.605 2.204 . . . . 5.25 111.748 177.536 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.72 -58.73 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.677 -0.773 . . . . 2.28 112.024 -179.689 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.15 158.19 38.59 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.242 -0.281 . . . . 2.07 110.242 179.695 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.68 167.0 31.81 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.294 -0.632 . . . . 3.18 109.294 -179.755 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.85 105.7 1.67 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.003 -0.369 . . . . 0.53 110.003 179.458 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.66 -30.05 75.61 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.347 -0.454 . . . . 0.65 112.597 -176.957 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 -30.6 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 1.04 110.779 -179.37 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -101.26 -36.73 8.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.173 -0.467 . . . . 0.84 111.764 -178.302 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.59 -1.66 66.51 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.258 -0.737 . . . . 0.77 111.258 -174.746 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -120.91 145.29 47.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 2.1 110.875 -177.039 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.23 14.7 56.84 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.711 -0.677 . . . . 0.55 111.481 172.977 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.3 m -63.95 119.63 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.397 0.279 . . . . 1.06 110.532 178.014 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 52.88 50.82 17.18 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.709 0.631 . . . . 2.23 110.753 -178.878 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.414 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.2 p -89.59 146.05 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 1.16 110.39 -176.076 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.89 144.2 25.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.48 110.232 179.194 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -106.77 146.54 30.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 3.18 109.767 -178.386 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 5.3 t -80.49 138.72 36.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.985 -0.746 . . . . 0.37 108.985 176.256 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -92.91 -13.54 28.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 0.75 111.873 -177.299 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.93 -18.56 14.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.435 -0.348 . . . . 1.43 111.198 178.795 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -149.72 -167.71 2.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.451 -0.574 . . . . 0.79 109.451 177.059 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 114.7 29.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.719 0.295 . . . . 0.47 110.402 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -160.37 153.79 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.309 -0.405 . . . . 0.4 110.858 -179.518 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -134.72 113.45 11.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.852 -0.613 . . . . 0.45 109.67 176.095 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.38 163.26 40.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.899 -0.591 . . . . 0.61 109.752 -178.438 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.714 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.8 m170 -94.01 139.21 31.22 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.787 -0.82 . . . . 0.42 108.787 172.208 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 60.5 t-105 -49.29 -53.24 22.84 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.412 0.445 . . . . 0.68 111.643 -176.559 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -71.07 -9.1 57.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 3.33 112.19 -174.462 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 63.3 m -91.55 -21.34 20.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.984 0.421 . . . . 0.54 110.76 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -107.63 -40.84 5.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.183 -0.462 . . . . 0.61 110.958 177.865 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.81 148.56 40.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.992 -0.549 . . . . 0.8 110.631 -175.428 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 154.17 73.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.852 2.368 . . . . 2.12 112.144 177.84 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.04 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.197 -0.911 . . . . 3.3 111.95 -175.114 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -7.22 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 1.46 111.906 176.145 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -101.29 129.81 47.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.014 -0.365 . . . . 1.03 110.014 177.709 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -87.73 130.77 34.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.796 -0.446 . . . . 1.6 109.796 -179.34 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 16.3 ptm180 -71.56 118.6 67.78 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 2.68 111.11 -175.71 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.57 132.92 22.97 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.682 2.255 . . . . 1.14 112.549 -177.884 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.86 51.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.905 -0.664 . . . . 1.9 111.785 178.469 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 60.73 0.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 2.75 110.934 -176.983 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.6 82.53 0.77 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.401 -0.904 . . . . 0.82 112.458 179.356 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -76.25 128.28 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.074 -0.713 . . . . 0.87 109.074 177.056 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -124.41 145.87 49.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.162 0.506 . . . . 2.65 111.877 -174.774 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -83.58 -178.8 7.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 0.49 108.909 171.914 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' C' ' 55' ' ' SER . 11.5 ptp180 -63.13 -41.2 99.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.289 0.495 . . . . 4.09 111.476 -173.925 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 55' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 19.6 t -68.74 -40.68 79.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.787 0.327 . . . . 1.54 111.234 -175.153 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.43 -15.74 61.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.72 111.31 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -96.4 -13.61 23.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.078 0.466 . . . . 1.25 110.619 177.134 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.62 88.91 1.78 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.564 -0.614 . . . . 2.19 111.564 -175.974 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' C' ' 55' ' ' SER . 5.6 p-10 -88.96 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.19 0.519 . . . . 5.15 110.744 -177.883 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.86 78.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.088 -0.708 . . . . 6.76 109.088 175.934 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -59.98 117.44 23.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.335 -0.848 . . . . 8.83 110.895 -177.371 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 136.33 38.0 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.509 2.139 . . . . 11.04 111.985 -178.827 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -78.71 131.04 68.81 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 13.86 110.153 177.789 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 52.1 Cg_exo -54.83 106.57 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.717 2.278 . . . . 16.55 111.889 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.89 151.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.146 -0.479 . . . . 18.07 110.055 -178.859 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.398 -0.81 . . . . 20.26 109.531 178.844 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.841 -0.504 . . . . 20.38 111.841 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.74 48.92 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.479 . . . . 18.81 111.315 178.555 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 51.3 ttp -89.61 64.12 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.504 0.668 . . . . 18.06 109.972 179.545 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -88.86 138.1 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 16.83 110.893 -177.462 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.71 -66.24 0.24 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.961 -0.638 . . . . 14.66 112.743 177.195 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 57.93 38.61 26.99 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.096 0.474 . . . . 15.8 110.873 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -81.25 -1.26 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 13.13 111.101 -177.618 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -102.54 3.07 37.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.316 0.579 . . . . 11.74 109.857 175.178 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.1 tp -90.08 133.75 34.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.726 -0.67 . . . . 8.72 110.119 -179.644 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -80.4 144.52 57.66 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 5.93 110.348 179.577 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 11.3 Cg_exo -71.48 53.32 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.03 2.487 . . . . 5.25 112.429 177.648 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.11 -86.05 1.29 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.74 -0.544 . . . . 2.28 111.74 -177.843 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.21 108.13 3.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.717 0.294 . . . . 2.07 110.217 179.136 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -162.12 142.68 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 3.18 110.202 -176.409 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.3 t -65.92 118.96 10.48 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.086 -0.339 . . . . 0.53 110.086 177.975 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.33 -17.07 77.35 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.884 -0.674 . . . . 0.65 112.265 -179.548 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -82.74 -31.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.568 0.223 . . . . 1.04 111.117 179.734 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 71.1 m -106.52 -29.13 9.85 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.571 0.582 . . . . 0.84 112.571 -177.175 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.06 81.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.894 -0.882 . . . . 0.77 110.894 -172.48 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.49 154.0 48.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.181 -0.51 . . . . 2.1 110.141 -172.877 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.09 23.97 6.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.02 -0.609 . . . . 0.55 112.63 179.209 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -81.5 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.209 -0.293 . . . . 1.06 110.209 178.474 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.23 37.47 28.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.365 0.602 . . . . 2.23 109.959 -177.5 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.8 p -90.21 158.0 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 1.16 110.565 -174.428 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 79.7 mt -95.63 146.38 24.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.74 0.305 . . . . 0.48 110.348 176.577 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -109.89 131.51 55.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 3.18 110.015 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.97 132.37 47.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.111 -0.7 . . . . 0.37 109.111 176.386 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.02 -17.52 32.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.256 0.551 . . . . 0.75 111.121 -178.926 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -97.77 -20.12 17.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.541 . . . . 1.43 111.339 -177.346 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -151.48 -164.72 2.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.104 -0.702 . . . . 0.79 109.104 176.096 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.2 114.15 28.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.203 -0.295 . . . . 0.47 110.203 178.54 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.22 131.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.4 110.868 -179.143 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -111.87 113.44 25.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.73 -0.668 . . . . 0.45 109.739 177.121 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 25.3 p90 -151.99 146.53 25.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.254 -0.43 . . . . 0.61 109.986 -179.832 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.892 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 53.7 m80 -79.55 135.2 36.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.419 -0.956 . . . . 0.42 108.419 171.338 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 73.9 t-105 -51.28 -52.04 48.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.671 0.272 . . . . 0.68 111.482 -174.042 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -68.17 -16.78 64.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 3.33 112.124 -173.456 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.93 -22.85 48.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.186 0.517 . . . . 0.54 110.52 178.804 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -104.54 -50.29 3.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.972 -0.558 . . . . 0.61 110.67 179.131 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 78.2 m-85 -108.16 122.04 41.84 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.511 -0.768 . . . . 0.8 109.702 -177.089 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 50.8 Cg_exo -55.21 162.73 5.31 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.972 2.448 . . . . 2.12 112.38 -179.338 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -18.27 41.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.865 -1.062 . . . . 3.3 112.669 -170.75 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.66 4.73 77.64 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.603 178.503 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 91.1 m -112.59 133.32 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.749 0.309 . . . . 1.03 110.512 177.725 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -88.8 144.4 26.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 1.6 110.597 -175.971 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 46' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 45.9 ttp180 -87.2 122.23 71.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 2.68 110.84 -179.551 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 47' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.3 Cg_exo -69.0 132.26 24.15 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.503 2.135 . . . . 1.14 111.736 176.957 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.88 -14.73 48.33 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.971 -0.633 . . . . 1.9 112.18 -179.741 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.9 t -88.83 -10.7 47.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 2.75 111.206 -178.218 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 122.79 0.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.847 -0.692 . . . . 0.82 111.654 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.41 123.23 33.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.005 0.431 . . . . 0.87 110.155 -177.602 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -116.65 128.94 55.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.458 . . . . 2.65 110.736 -178.85 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -75.3 -169.74 1.04 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.612 . . . . 0.49 110.072 175.313 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.69 -52.83 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.373 -0.376 . . . . 4.09 111.403 -176.663 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -68.72 -42.78 77.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.539 -0.301 . . . . 1.54 111.808 -175.49 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.7 m -71.93 -17.36 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.72 111.88 -176.627 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -88.15 8.31 27.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.094 0.473 . . . . 1.25 110.532 -179.117 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.22 174.47 29.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.685 -0.769 . . . . 2.19 112.159 179.532 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.43 92.86 3.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.644 -0.502 . . . . 5.15 109.644 176.794 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -89.36 102.59 13.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.869 -0.605 . . . . 6.76 110.774 -176.528 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 87.4 m -67.98 130.17 92.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 8.83 110.392 177.014 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.34 135.21 52.64 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.636 2.224 . . . . 11.04 112.145 179.123 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.8 120.88 83.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.894 -0.594 . . . . 13.86 111.046 -178.883 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.49 131.49 15.0 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.305 2.004 . . . . 16.55 111.354 176.572 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.9 -9.24 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.955 0.407 . . . . 18.07 111.168 -179.4 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.704 -0.665 . . . . 20.26 110.324 177.93 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.015 -0.434 . . . . 20.38 112.015 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.17 111.82 17.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.756 0.312 . . . . 18.81 110.292 178.675 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.3 ttp -83.53 121.61 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 18.06 110.577 -178.864 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -125.34 150.33 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.837 -0.619 . . . . 16.83 109.746 179.83 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.41 -59.99 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.212 -0.755 . . . . 14.66 111.212 -177.662 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -69.24 -30.89 69.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.518 . . . . 15.8 109.662 174.485 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -110.26 148.5 31.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.499 -0.773 . . . . 13.13 109.375 175.827 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -128.84 117.91 21.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.828 0.347 . . . . 11.74 110.393 -179.742 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.13 113.58 22.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.19 -0.459 . . . . 8.72 110.245 -179.696 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.3 145.42 93.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.107 -0.497 . . . . 5.93 110.568 178.516 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 23.6 Cg_exo -63.66 -11.48 26.59 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.977 2.452 . . . . 5.25 113.325 -177.454 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.37 77.72 1.11 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.967 -0.635 . . . . 2.28 112.854 176.774 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -105.21 74.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.877 0.37 . . . . 2.07 110.269 177.575 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -160.64 129.62 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.509 . . . . 3.18 110.81 -177.929 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.3 110.59 6.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.24 -0.652 . . . . 0.53 109.24 174.509 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.19 -24.71 65.6 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 121.304 -0.474 . . . . 0.65 112.841 -176.449 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.99 -30.75 33.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 1.04 110.781 179.168 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 95.3 m -104.63 -46.48 4.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.84 112.299 -175.039 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.92 -8.34 45.86 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.436 -0.666 . . . . 0.77 111.436 -174.041 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.51 154.14 22.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 2.1 110.722 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 11.15 30.38 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.112 -0.795 . . . . 0.55 111.112 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.28 134.97 53.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.35 . . . . 1.06 110.343 177.75 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 41.65 48.57 3.61 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.137 0.898 . . . . 2.23 111.757 -178.732 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.404 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.0 p -89.06 146.67 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.165 -0.925 . . . . 1.16 110.421 -176.319 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 84.3 mt -96.99 157.64 15.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.474 -0.33 . . . . 0.48 110.205 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 9.3 mmm180 -120.71 141.45 50.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.921 -0.581 . . . . 3.18 111.064 -174.225 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.81 139.77 47.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.823 -0.806 . . . . 0.37 108.823 173.203 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p -92.4 -21.23 20.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 0.75 111.217 179.43 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -89.54 -23.12 22.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 1.43 110.623 -178.448 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.91 -164.91 2.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.207 -0.664 . . . . 0.79 109.207 177.113 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 115.07 29.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.77 0.319 . . . . 0.47 110.48 179.449 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.14 139.1 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.96 -0.563 . . . . 0.4 110.331 178.866 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -121.24 118.93 30.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.001 -0.545 . . . . 0.45 110.171 178.765 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 34' ' ' PHE . . . . . 0.404 ' N ' HG22 ' C' ' 24' ' ' VAL . 52.3 p90 -160.22 162.72 33.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.61 109.901 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.7 m170 -91.34 133.35 35.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.099 -1.074 . . . . 0.42 108.099 171.616 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.401 ' HB2' HD12 ' C' ' 25' ' ' LEU . 74.3 t-105 -59.3 -36.96 76.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.68 110.915 -177.215 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -68.82 -19.88 64.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 3.33 110.883 -179.697 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -90.57 -23.14 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.279 -0.419 . . . . 0.54 111.071 -178.123 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -92.46 -38.59 11.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.394 -0.366 . . . . 0.61 110.643 176.838 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 94.3 m-85 -126.66 73.47 74.76 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.488 . . . . 0.8 110.815 -178.753 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 0.06 10.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.018 2.479 . . . . 2.12 112.057 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.7 3.41 29.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 3.3 111.24 -177.828 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.43 24.8 30.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.625 -0.797 . . . . 1.46 112.35 179.747 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 7.2 m -66.18 141.93 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.869 -0.419 . . . . 1.03 109.869 176.849 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.8 t -88.13 133.04 34.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.004 0.431 . . . . 1.6 110.228 -175.437 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -70.72 119.0 70.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.551 -0.749 . . . . 2.68 110.548 -179.65 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.67 132.45 20.32 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.591 2.194 . . . . 1.14 112.316 -179.42 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.18 -8.62 74.81 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 1.9 111.566 177.355 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.9 p -91.96 28.52 1.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.945 0.403 . . . . 2.75 111.541 -179.963 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.72 121.76 3.06 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.941 -0.647 . . . . 0.82 112.296 179.857 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 52' ' ' ARG . 0.5 OUTLIER -75.91 128.33 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.668 -0.493 . . . . 0.87 109.668 -178.821 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.413 ' N ' HD13 ' C' ' 51' ' ' LEU . 86.3 mtt180 -113.15 138.69 49.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.408 . . . . 2.65 111.395 -176.845 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 p -88.89 -176.45 5.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 0.49 109.213 173.779 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -67.29 -39.52 85.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.41 -0.516 . . . . 4.09 111.332 -175.87 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 42.3 t -67.17 -45.4 77.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.598 0.237 . . . . 1.54 110.729 -178.381 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.7 m -71.9 -17.26 62.11 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.661 0.245 . . . . 0.72 111.661 -179.512 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -96.28 -14.19 22.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.93 0.395 . . . . 1.25 110.985 178.699 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.53 85.71 0.5 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 2.19 111.899 -177.944 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.58 146.09 24.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.947 0.403 . . . . 5.15 110.316 -178.874 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.04 131.39 50.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.094 -0.503 . . . . 6.76 110.134 179.737 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 p -80.25 123.52 83.15 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.559 -0.291 . . . . 8.83 110.392 176.223 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.25 133.94 37.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.398 2.065 . . . . 11.04 111.676 -178.097 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.25 135.56 47.33 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 13.86 110.173 -179.673 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.56 42.88 1.38 Allowed 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.674 2.249 . . . . 16.55 112.308 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.84 108.88 19.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.117 -0.492 . . . . 18.07 110.629 -177.077 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.612 -0.709 . . . . 20.26 110.077 -179.855 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.851 -0.499 . . . . 20.38 111.851 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.48 -24.29 25.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 18.81 110.825 179.748 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 123.48 23.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 18.06 110.54 -179.072 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -103.92 -52.38 2.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.752 -0.658 . . . . 16.83 110.0 -179.801 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.87 76.63 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.612 -0.722 . . . . 14.66 111.786 -179.164 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -71.0 -27.13 63.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.015 0.436 . . . . 15.8 109.929 -179.809 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -82.45 13.67 3.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.592 . . . . 13.13 111.277 178.517 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -93.91 14.81 18.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 11.74 110.24 176.72 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.49 101.63 0.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.787 . . . . 8.72 109.44 179.352 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.53 128.21 91.33 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.967 -0.56 . . . . 5.93 110.864 -178.01 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 13.7 Cg_exo -71.18 52.51 1.48 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.134 2.556 . . . . 5.25 112.916 176.565 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.21 -29.83 65.95 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.331 -0.708 . . . . 2.28 111.331 177.008 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' C' ' 21' ' ' GLY . . . -126.24 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 2.07 109.353 174.898 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.445 ' H ' ' HB1' ' C' ' 33' ' ' ALA . 29.5 ttm180 -166.34 112.81 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.954 -0.566 . . . . 3.18 111.198 -176.513 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -68.22 122.91 19.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.646 -0.502 . . . . 0.53 109.646 174.872 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -24.85 64.77 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.65 113.401 -175.023 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.04 -32.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 1.04 111.177 -179.502 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.3 -40.36 7.96 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.315 0.487 . . . . 0.84 112.315 -174.439 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.63 -17.62 58.96 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.191 -0.764 . . . . 0.77 111.191 -173.076 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.5 148.8 21.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.365 . . . . 2.1 110.616 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' C' ' 13' ' ' ALA . . . -107.27 15.05 39.58 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.043 -0.599 . . . . 0.55 111.623 176.261 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.8 m -74.76 124.38 26.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.253 . . . . 1.06 110.401 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.77 42.9 28.63 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.915 -0.584 . . . . 2.23 110.823 -177.348 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 9.9 p -88.06 136.27 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.535 . . . . 1.16 110.301 -175.538 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -94.44 157.1 16.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.0 -0.546 . . . . 0.48 109.913 -178.292 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 28.6 mmm180 -121.68 149.6 42.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.901 -0.591 . . . . 3.18 110.189 -177.197 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -81.56 143.64 31.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.805 -0.443 . . . . 0.37 109.805 -179.818 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.99 -21.91 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.273 -0.421 . . . . 0.75 111.576 -179.003 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m80 -100.94 -17.61 16.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.541 -0.299 . . . . 1.43 111.358 -177.219 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 p -151.13 -169.94 3.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.79 109.51 177.512 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.87 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.489 -0.323 . . . . 0.47 110.359 178.841 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.19 132.39 8.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.535 -0.302 . . . . 0.4 110.77 -178.66 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -106.93 112.85 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.515 . . . . 0.45 109.852 176.263 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -158.78 164.74 35.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.298 -0.41 . . . . 0.61 110.187 -177.63 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.66 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 28.6 m170 -98.81 138.83 35.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.439 -0.948 . . . . 0.42 108.439 171.639 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -54.99 -46.3 75.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.644 0.259 . . . . 0.68 110.54 -178.182 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 73.4 mtp180 -65.96 -18.3 65.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 3.33 112.101 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.7 m -85.35 -20.34 30.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.044 0.449 . . . . 0.54 110.809 -179.19 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -99.93 -39.27 8.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.61 110.777 174.974 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 94.9 m-85 -127.04 144.97 52.29 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.8 109.903 -179.432 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.51 154.8 34.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.593 2.196 . . . . 2.12 111.856 177.594 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -10.97 28.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 3.3 112.06 -174.68 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.54 -2.07 76.82 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.839 -0.696 . . . . 1.46 112.144 176.761 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.9 m -90.31 139.82 30.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.023 -0.362 . . . . 1.03 110.023 178.601 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.8 p -88.39 132.81 34.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.433 -0.349 . . . . 1.6 110.873 -175.631 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -88.42 134.31 34.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 2.68 110.911 -177.915 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.63 132.59 38.47 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.653 2.235 . . . . 1.14 111.328 173.745 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.08 -51.2 5.46 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.869 -0.605 . . . . 1.9 113.404 -174.023 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -95.73 -18.25 20.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 2.75 111.214 -175.451 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -131.78 67.89 0.56 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.537 -0.84 . . . . 0.82 112.521 -178.428 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.77 122.63 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.25 -0.648 . . . . 0.87 109.25 176.89 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 52' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 53.2 mtm180 -121.38 140.23 52.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.972 0.415 . . . . 2.65 111.122 -173.125 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.4 p -80.39 -174.72 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.49 109.784 175.703 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -61.71 -49.56 75.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.614 0.245 . . . . 4.09 111.19 -176.036 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.6 t -64.24 -43.92 93.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.432 -0.349 . . . . 1.54 111.28 -176.151 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.5 m -71.62 -19.7 62.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.157 -0.217 . . . . 0.72 111.557 -178.064 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.0 m -83.41 -13.93 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.886 0.374 . . . . 1.25 110.732 178.811 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.8 170.6 13.37 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.241 -0.744 . . . . 2.19 111.241 178.122 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.54 114.97 29.55 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.446 0.641 . . . . 5.15 110.497 179.399 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 60' ' ' VAL . . . . . 0.502 ' O ' ' HD3' ' C' ' 62' ' ' PRO . 25.1 t -90.4 75.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.854 -0.795 . . . . 6.76 108.854 176.583 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.5 p -99.52 105.57 34.36 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.525 -0.761 . . . . 8.83 111.669 -175.09 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 62' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' C' ' 60' ' ' VAL . 13.1 Cg_exo -70.25 135.75 30.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.58 2.187 . . . . 11.04 111.453 176.319 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -62.23 120.69 60.63 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 13.86 110.346 179.4 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 33.2 Cg_exo -62.49 92.82 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.026 2.484 . . . . 16.55 112.803 -178.223 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -105.29 156.74 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 18.07 110.585 178.622 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.701 -0.666 . . . . 20.26 109.329 177.755 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.764 -0.534 . . . . 20.38 111.764 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.5 44.3 18.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.232 0.539 . . . . 18.81 110.808 -179.207 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.59 -30.69 41.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.805 -0.634 . . . . 18.06 110.917 -177.087 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 47.46 66.87 0.91 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.164 0.506 . . . . 16.83 111.168 -179.282 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.84 65.08 4.18 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.782 -0.645 . . . . 14.66 111.7 179.61 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -148.31 52.56 1.01 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.618 . . . . 15.8 109.973 -179.594 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -80.37 92.83 5.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.977 -0.556 . . . . 13.13 109.541 177.619 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 65.6 t30 57.43 43.45 23.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.641 0.734 . . . . 11.74 110.14 -176.316 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 tp -102.21 134.0 46.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 8.72 110.59 -176.044 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.73 146.07 34.74 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.132 -0.486 . . . . 5.93 109.888 176.561 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.74 46.04 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.014 2.476 . . . . 5.25 112.476 178.295 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.78 169.68 36.32 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.305 -0.718 . . . . 2.28 111.305 -177.445 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.464 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -80.82 80.93 7.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.423 . . . . 2.07 111.144 -177.625 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' C' C ' 14' ' ' ARG . . . . . 0.426 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.9 mtm-85 -124.39 141.55 51.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.219 0.533 . . . . 3.18 111.095 178.875 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 t -87.7 104.88 16.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.831 . . . . 0.53 109.698 178.873 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -16.8 69.31 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.859 -0.609 . . . . 0.65 113.846 -172.733 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.58 -29.91 48.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.04 110.86 -179.258 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.94 -42.56 2.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.347 -0.388 . . . . 0.84 110.388 178.137 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.88 -11.44 10.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.057 -0.592 . . . . 0.77 111.812 -178.508 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.96 141.94 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.116 0.484 . . . . 2.1 111.405 -177.634 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -110.98 16.86 27.64 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.577 -0.738 . . . . 0.55 111.273 175.826 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.9 m -76.09 115.56 15.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.461 -0.37 . . . . 1.06 110.323 179.344 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 45.77 70.99 0.31 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.921 0.763 . . . . 2.23 112.062 178.776 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.464 HG21 ' HB1' ' C' ' 13' ' ' ALA . 15.2 m -88.4 146.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 1.16 110.413 178.665 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.37 148.53 22.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.973 -0.558 . . . . 0.48 109.836 -179.436 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -108.58 145.51 34.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.059 -0.519 . . . . 3.18 110.054 -179.649 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 8.0 t -75.52 135.4 40.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.004 -0.739 . . . . 0.37 109.004 177.026 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 37.1 p -86.24 -7.26 58.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.939 0.4 . . . . 0.75 111.344 -179.522 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -110.75 -19.64 12.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.416 -0.356 . . . . 1.43 111.157 -179.16 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.8 p -151.56 -172.13 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.714 -0.476 . . . . 0.79 109.714 177.289 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.68 30.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.856 -0.156 . . . . 0.47 111.397 -176.153 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.74 141.87 4.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.811 -0.177 . . . . 0.4 111.127 179.241 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.25 118.11 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.791 -0.448 . . . . 0.45 109.791 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -161.87 163.36 29.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.61 111.19 -175.222 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -96.6 140.59 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.365 -0.606 . . . . 0.42 109.365 172.103 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -62.14 -42.31 99.12 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.537 -0.542 . . . . 0.68 109.537 174.678 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -63.43 -22.75 67.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.917 -0.583 . . . . 3.33 111.819 -179.442 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 63.7 m -87.17 -21.82 25.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.54 111.303 -179.055 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.42 -38.81 8.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.874 0.369 . . . . 0.61 110.813 179.924 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.95 149.88 74.09 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.5 -0.556 . . . . 0.8 109.5 -179.001 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.68 140.25 61.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.252 1.968 . . . . 2.12 111.502 178.05 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.96 -8.83 17.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 3.3 111.944 -175.611 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.81 71.81 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.778 -0.929 . . . . 1.46 110.778 172.455 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -87.45 131.57 34.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.266 -0.642 . . . . 1.03 109.266 174.603 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -87.73 115.37 25.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.141 0.496 . . . . 1.6 110.642 -176.083 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -57.96 136.3 83.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 2.68 111.179 -178.599 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.74 135.24 32.4 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.951 2.434 . . . . 1.14 112.89 -175.991 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.92 -10.66 71.75 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.042 -0.599 . . . . 1.9 111.75 179.05 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -89.31 12.08 17.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 2.75 111.057 -179.739 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.03 116.35 1.56 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.763 -0.732 . . . . 0.82 112.504 178.405 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.3 OUTLIER -71.28 125.99 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.374 -0.602 . . . . 0.87 109.374 179.239 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -115.17 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 2.65 111.062 -175.507 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 p -73.31 174.77 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.695 -0.854 . . . . 0.49 108.695 172.056 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -58.29 -41.55 84.66 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.432 0.53 . . . . 4.09 112.432 -169.245 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -69.41 -47.84 62.9 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.22 -0.3 . . . . 1.54 111.339 -178.385 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.36 -18.74 61.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.688 0.28 . . . . 0.72 111.211 -178.781 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -84.59 -13.88 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.35 . . . . 1.25 110.429 -179.54 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.94 119.67 4.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.683 -0.77 . . . . 2.19 112.04 -179.721 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -89.62 179.19 6.09 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.279 -0.637 . . . . 5.15 109.279 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -110.99 102.68 14.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.436 0.636 . . . . 6.76 111.033 -178.985 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -93.06 120.56 66.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.684 -0.689 . . . . 8.83 110.163 178.448 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.56 142.64 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.456 2.104 . . . . 11.04 111.895 -178.938 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.67 69.39 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.155 -0.475 . . . . 13.86 110.099 179.034 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.61 57.79 3.72 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.878 2.385 . . . . 16.55 112.459 -179.404 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.44 139.59 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 18.07 110.026 178.073 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.381 -0.819 . . . . 20.26 110.084 179.412 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.96 -0.456 . . . . 20.38 111.96 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.0 107.07 4.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.922 0.391 . . . . 18.81 110.433 -179.503 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 62.8 mtt -95.76 -60.95 1.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.08 -0.509 . . . . 18.06 110.09 -179.721 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -103.87 -20.15 14.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.533 . . . . 16.83 110.958 178.758 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.11 72.29 2.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.125 -0.559 . . . . 14.66 112.977 -176.812 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -103.7 2.0 32.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 15.8 110.238 177.666 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 64.62 24.29 12.97 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.293 -0.867 . . . . 13.13 111.416 177.934 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.16 119.74 36.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.93 -0.577 . . . . 11.74 109.558 176.935 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -79.77 73.37 6.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.064 0.459 . . . . 8.72 110.598 -179.211 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.1 122.82 87.61 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.552 -0.536 . . . . 5.93 109.552 175.846 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.57 -11.84 28.59 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.282 . . . . 5.25 113.169 -175.657 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.85 -46.61 3.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.849 -0.691 . . . . 2.28 111.626 -176.419 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.83 76.86 2.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 2.07 110.609 176.953 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -144.39 145.13 31.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.478 -0.783 . . . . 3.18 109.435 179.87 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.7 t -67.1 103.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.53 109.231 177.567 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.24 -11.54 78.09 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.834 -0.621 . . . . 0.65 112.97 -171.472 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 58.6 t -65.73 -42.45 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.833 0.349 . . . . 1.04 110.38 178.932 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -104.25 -37.2 7.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.401 -0.363 . . . . 0.84 110.684 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.01 -5.72 27.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.77 112.184 -178.883 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 5.6 m-20 -102.19 135.34 43.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.963 0.411 . . . . 2.1 111.212 -179.211 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.63 1.64 34.29 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.239 -0.744 . . . . 0.55 111.239 174.137 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 40.4 m -69.08 132.4 46.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.465 -0.368 . . . . 1.06 110.636 177.359 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 55.62 47.39 20.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.726 0.774 . . . . 2.23 109.885 178.25 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.81 149.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.274 -0.876 . . . . 1.16 110.713 -173.971 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -99.36 153.32 19.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.234 -0.439 . . . . 0.48 110.45 -179.671 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 16.7 tpp180 -115.57 143.01 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.624 . . . . 3.18 109.842 -177.983 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.4 t -75.62 147.02 39.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.37 110.077 177.326 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.7 p -86.35 -38.46 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.514 . . . . 0.75 112.0 -179.482 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -90.43 -12.09 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.299 . . . . 1.43 111.7 -176.571 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 30' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.8 p -150.97 -179.64 7.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.223 -0.658 . . . . 0.79 109.223 174.768 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 115.54 30.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.866 -0.42 . . . . 0.47 109.866 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -159.91 136.34 8.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.913 -0.585 . . . . 0.4 110.229 -179.023 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.88 112.18 25.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.45 109.807 175.986 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.32 158.92 40.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.61 109.98 -177.38 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -94.32 146.91 23.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.696 -0.483 . . . . 0.42 109.696 173.342 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -56.81 -53.52 56.87 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.584 0.553 . . . . 0.68 110.364 -179.632 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -63.9 -37.06 86.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.364 0.505 . . . . 3.33 112.364 -175.549 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.422 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 70.7 m -65.46 -24.32 67.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.957 0.408 . . . . 0.54 111.159 -177.989 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -100.89 -54.85 2.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.175 0.512 . . . . 0.61 110.698 178.366 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -107.18 129.26 24.58 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.73 -0.668 . . . . 0.8 109.66 -176.829 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.84 162.03 9.43 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.829 2.352 . . . . 2.12 112.224 178.693 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.19 38.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 3.3 111.903 -173.782 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.34 -15.2 81.73 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.795 -0.717 . . . . 1.46 111.73 175.019 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -90.47 125.7 35.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.07 -0.345 . . . . 1.03 110.07 179.389 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -89.27 134.58 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.803 0.335 . . . . 1.6 110.832 -177.895 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -71.46 124.35 90.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 2.68 111.097 -177.631 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.05 143.4 36.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.852 2.368 . . . . 1.14 112.81 -178.558 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.32 -10.3 48.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.915 -0.66 . . . . 1.9 112.33 178.801 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -89.14 0.09 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.347 0.594 . . . . 2.75 110.655 -179.887 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.71 119.15 1.28 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.985 -0.626 . . . . 0.82 111.986 -178.529 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.19 123.93 33.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.107 0.479 . . . . 0.87 110.318 -179.109 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -122.58 142.8 50.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.001 -0.545 . . . . 2.65 111.34 -173.998 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -73.39 165.76 24.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.49 109.489 175.176 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -53.93 -34.63 60.14 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.157 0.435 . . . . 4.09 111.899 -173.145 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 28.0 t -66.09 -50.05 65.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.924 0.392 . . . . 1.54 110.455 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.5 m -72.92 -26.54 61.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.117 0.414 . . . . 0.72 112.117 -178.571 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -89.53 0.28 57.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 1.25 111.044 -178.954 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.13 46.68 2.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.776 -0.726 . . . . 2.19 111.986 -179.312 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -110.24 20.75 17.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.16 0.505 . . . . 5.15 110.31 -179.148 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 t -88.72 70.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.574 0.702 . . . . 6.76 109.84 -177.836 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 p -106.35 125.33 33.19 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.405 -0.816 . . . . 8.83 110.633 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.8 133.99 22.96 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.305 2.003 . . . . 11.04 111.804 179.182 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.91 127.04 90.09 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.988 -0.551 . . . . 13.86 110.995 179.888 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.8 86.36 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.54 2.16 . . . . 16.55 111.593 178.157 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.55 113.27 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 18.07 110.414 -177.932 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.681 -0.676 . . . . 20.26 109.921 -178.668 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.477 -0.249 . . . . 20.38 112.477 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.68 89.48 5.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.963 0.411 . . . . 18.81 111.383 -176.114 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -88.34 -55.69 3.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.089 -0.708 . . . . 18.06 109.089 174.774 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 57.06 58.71 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 16.83 111.409 177.68 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.81 12.48 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.181 -0.918 . . . . 14.66 111.077 173.92 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -125.46 20.29 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 15.8 110.829 179.998 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.35 78.54 0.23 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.223 -0.898 . . . . 13.13 111.273 -179.365 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -94.47 -51.02 4.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.818 -0.438 . . . . 11.74 109.818 179.47 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.57 113.8 7.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 8.72 109.552 176.77 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.48 133.31 56.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 5.93 110.745 -177.151 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.52 57.86 2.41 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.032 2.488 . . . . 5.25 111.878 176.939 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.67 19.09 56.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.755 -0.657 . . . . 2.28 112.551 -177.385 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.08 71.9 1.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.297 0.57 . . . . 2.07 109.928 177.756 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -150.65 129.71 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.327 -0.852 . . . . 3.18 109.356 -179.596 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 15' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 32.0 t -62.0 112.65 2.42 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.723 -0.473 . . . . 0.53 109.723 178.22 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.59 -23.77 55.5 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 121.38 -0.438 . . . . 0.65 112.993 -175.911 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.03 -32.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.04 111.142 179.701 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.3 m -105.92 -47.42 3.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.194 0.442 . . . . 0.84 112.194 -174.689 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.0 -23.25 19.59 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.444 -0.663 . . . . 0.77 111.444 -173.902 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.78 152.21 21.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.732 0.301 . . . . 2.1 111.069 -178.165 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.83 6.79 33.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.043 -0.599 . . . . 0.55 111.804 177.307 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -70.58 127.9 34.29 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.645 -0.132 . . . . 1.06 110.645 178.563 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 58.11 39.44 26.11 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.51 0.506 . . . . 2.23 110.906 179.55 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -89.23 148.15 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.232 -0.44 . . . . 1.16 110.53 -175.093 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -114.62 148.64 37.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.48 110.217 -179.069 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 26' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.2 mpt_? -119.31 148.63 42.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.647 -0.501 . . . . 3.18 109.647 179.967 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 27' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 40.3 t -68.95 139.28 55.05 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.112 -0.635 . . . . 0.37 109.486 174.307 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 28' ' ' THR . . . . . 0.408 HG21 ' HA3' ' C' ' 50' ' ' GLY . 12.4 t -85.07 4.43 34.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.424 0.631 . . . . 0.75 110.596 178.932 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -127.62 -8.6 5.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 1.43 110.68 176.7 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 9.0 m -145.02 177.44 8.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.79 110.13 -177.948 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 112.96 26.2 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.802 -0.814 . . . . 0.47 108.802 173.072 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 32' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.0 111.8 0.98 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.088 -0.505 . . . . 0.4 110.531 -179.544 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -93.21 112.58 24.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.007 0.432 . . . . 0.45 109.903 176.057 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.68 158.1 40.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.878 -0.601 . . . . 0.61 109.828 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 35' ' ' HIS . . . . . 0.76 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.4 m170 -87.24 138.45 31.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.166 -1.05 . . . . 0.42 108.166 172.192 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -48.94 -50.99 32.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.107 0.254 . . . . 0.68 111.443 -175.849 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 37' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 90.8 mtt180 -67.71 -10.46 52.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.016 -0.538 . . . . 3.33 112.099 -175.325 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 38' ' ' CYS . . . . . 0.76 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.6 m -89.96 -21.63 22.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.906 0.384 . . . . 0.54 110.947 -179.083 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -101.94 -36.87 8.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.429 . . . . 0.61 110.486 174.92 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 40' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 57.3 m-85 -124.5 150.0 63.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.989 -0.55 . . . . 0.8 110.219 -176.061 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.83 144.18 94.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.565 2.176 . . . . 2.12 111.089 172.786 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.85 -15.6 55.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.542 -0.754 . . . . 3.3 111.982 -175.733 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.75 -24.34 76.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.87 -0.681 . . . . 1.46 112.157 175.723 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.8 m -75.94 136.5 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.988 -0.375 . . . . 1.03 109.988 179.328 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -87.94 128.96 35.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.105 0.479 . . . . 1.6 111.266 -172.959 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -69.24 119.16 68.42 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 2.68 110.194 179.366 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.62 132.8 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.537 2.158 . . . . 1.14 112.405 -176.317 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.05 -11.53 67.32 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.438 -0.665 . . . . 1.9 111.438 177.126 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 21.5 p -89.7 37.44 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.368 0.604 . . . . 2.75 110.634 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 50' ' ' GLY . . . . . 0.408 ' HA3' HG21 ' C' ' 28' ' ' THR . . . 105.72 123.85 5.24 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.571 -0.74 . . . . 0.82 111.869 -178.12 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 123.73 22.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.105 -0.702 . . . . 0.87 109.105 178.406 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -115.52 128.48 56.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.945 0.403 . . . . 2.65 110.993 -174.876 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 53' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 15.6 p -73.24 174.13 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.724 -0.671 . . . . 0.49 109.672 177.507 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -57.66 -37.87 74.13 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.862 0.301 . . . . 4.09 111.655 -170.309 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 32.9 t -69.31 -38.84 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.977 0.418 . . . . 1.54 110.343 179.992 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.7 m -73.18 -33.24 65.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.19 -0.459 . . . . 0.72 111.984 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.1 p -83.84 -14.94 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 1.25 110.873 179.438 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.79 -58.89 1.66 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.956 -0.857 . . . . 2.19 110.956 175.468 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.01 89.74 7.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.402 -0.592 . . . . 5.15 109.402 174.753 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -88.87 104.28 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.951 -0.568 . . . . 6.76 110.479 -175.899 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.6 p -105.73 108.39 61.45 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.773 -0.649 . . . . 8.83 110.608 179.533 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.79 140.61 95.79 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.645 2.23 . . . . 11.04 111.807 178.715 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.39 136.43 91.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.991 -0.55 . . . . 13.86 110.861 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.71 69.71 5.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 16.55 112.128 -178.999 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.46 121.17 39.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.808 -0.633 . . . . 18.07 110.063 179.052 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.541 -0.742 . . . . 20.26 109.2 179.968 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 109.549 -0.537 . . . . 3.1800000000000002 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.6 t -67.1 106.29 1.93 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.497 -0.557 . . . . 0.53000000000000003 109.497 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.41 -21.76 57.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 121.344 -0.455 . . . . 0.65000000000000002 112.937 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.22 -33.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.834 0.35 . . . . 1.04 111.027 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.35 -38.96 6.64 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.085 0.402 . . . . 0.83999999999999997 112.085 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.11 58.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.862 -0.685 . . . . 0.77000000000000002 111.421 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.01 155.05 17.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.984 0.421 . . . . 2.1000000000000001 110.9 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.08 17.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.024 -0.83 . . . . 0.55000000000000004 111.024 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -64.08 118.1 8.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.294 -0.453 . . . . 1.0600000000000001 110.823 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.12 47.53 21.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.616 -0.72 . . . . 2.23 110.744 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.451 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.9 p -89.16 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.662 -0.699 . . . . 1.1599999999999999 109.735 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.43 143.7 29.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.77 0.319 . . . . 0.47999999999999998 110.521 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 40.3 mmt-85 -104.74 147.04 28.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 3.1800000000000002 109.948 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.36 146.55 29.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.408 -0.59 . . . . 0.37 109.408 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -92.55 -29.69 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.461 -0.336 . . . . 0.75 111.705 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -89.71 -17.23 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.32 . . . . 1.4299999999999999 111.105 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 p -150.9 -173.27 4.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.973 -0.751 . . . . 0.79000000000000004 108.973 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.98 115.64 30.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.008 -0.367 . . . . 0.46999999999999997 110.008 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -157.29 156.9 33.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.409 -0.36 . . . . 0.40000000000000002 110.459 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 111.84 9.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.841 -0.618 . . . . 0.45000000000000001 109.807 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.451 ' N ' HG22 ' C' ' 24' ' ' VAL . 37.8 p90 -156.24 158.96 38.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.99 -0.55 . . . . 0.60999999999999999 109.836 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.6 m170 -92.3 133.13 36.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.267 -1.012 . . . . 0.41999999999999998 108.267 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.45 -52.49 28.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.375 0.422 . . . . 0.68000000000000005 111.585 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -62.57 -25.8 68.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 3.3300000000000001 111.86 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.14 -22.45 52.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.939 0.399 . . . . 0.54000000000000004 110.852 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 0.9 OUTLIER -101.09 -40.69 7.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.324 -0.398 . . . . 0.60999999999999999 111.068 178.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -117.76 79.02 12.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.402 -0.363 . . . . 0.80000000000000004 110.458 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 3.8 Cg_endo -86.74 7.09 5.06 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.242 2.628 . . . . 2.1200000000000001 112.411 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.58 4.54 27.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 3.2999999999999998 111.789 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.7 26.64 24.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.477 -0.868 . . . . 1.46 111.76 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -75.73 140.64 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.895 -0.409 . . . . 1.03 109.895 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 11.5 p -88.7 135.35 33.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.669 0.271 . . . . 1.6000000000000001 110.627 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -73.85 112.68 17.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 2.6800000000000002 110.755 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.66 133.34 20.22 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.503 2.135 . . . . 1.1399999999999999 112.069 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.28 -17.49 69.02 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.611 -0.804 . . . . 1.8999999999999999 111.249 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 2.3 p -98.06 74.71 2.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.377 -0.412 . . . . 2.75 111.28 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.03 85.46 1.73 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.452 -0.88 . . . . 0.81999999999999995 112.851 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.38 124.15 20.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.243 -0.651 . . . . 0.87 109.243 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -125.69 130.72 52.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 2.6499999999999999 111.327 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -76.36 -178.37 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.48999999999999999 110.067 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -60.24 -46.28 90.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 4.0899999999999999 111.051 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -65.65 -48.42 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 1.54 111.056 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.76 -22.28 65.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.531 0.205 . . . . 0.71999999999999997 111.514 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -86.25 -2.6 58.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.496 0.189 . . . . 1.25 111.017 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.517 0 C-N-CA 120.812 -0.709 . . . . 2.1899999999999999 111.855 178.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.757 -0.46 . . . . 3.1800000000000002 109.757 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 4.4 t -81.83 104.8 12.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.973 -0.558 . . . . 0.53000000000000003 109.753 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -2.28 60.51 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 115.759 -0.655 . . . . 0.65000000000000002 113.306 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.75 -29.2 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.992 0.425 . . . . 1.04 110.384 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.99 -35.1 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.448 -0.342 . . . . 0.83999999999999997 111.056 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.22 -11.86 21.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.892 -0.671 . . . . 0.77000000000000002 111.992 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 24.4 t70 -97.73 147.15 24.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.733 0.302 . . . . 2.1000000000000001 110.632 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.21 16.34 8.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.965 -0.636 . . . . 0.55000000000000004 112.121 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.16 132.63 35.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 1.0600000000000001 110.121 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t0 52.59 56.16 8.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.791 0.805 . . . . 2.23 109.488 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' C' ' 33' ' ' ALA . 6.2 p -91.44 137.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.168 -0.924 . . . . 1.1599999999999999 110.63 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.97 147.9 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 0.47999999999999998 110.225 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 10.4 mmm180 -114.47 136.05 53.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.963 -0.562 . . . . 3.1800000000000002 110.16 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.8 t -67.56 136.78 55.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.349 -0.387 . . . . 0.37 110.102 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -88.26 -12.76 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.75 111.108 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -100.96 -23.25 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 1.4299999999999999 110.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.3 p -151.28 -172.4 4.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.79000000000000004 109.656 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.34 113.96 27.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.684 -0.234 . . . . 0.46999999999999997 110.417 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.28 140.15 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.427 . . . . 0.40000000000000002 110.653 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.71 112.17 23.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.45000000000000001 109.354 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' C' ' 15' ' ' CYS . 34.8 p90 -150.89 166.85 29.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.293 -0.412 . . . . 0.60999999999999999 110.806 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -104.4 138.17 41.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.277 -0.638 . . . . 0.41999999999999998 109.277 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 69.2 t-105 -63.44 -34.44 77.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.835 -0.62 . . . . 0.68000000000000005 110.387 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' C' ' 37' ' ' ARG . 19.4 mtm180 -68.69 -36.6 78.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 3.3300000000000001 110.798 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -73.61 -23.15 59.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.54000000000000004 110.919 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -92.32 -54.71 3.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.136 -0.484 . . . . 0.60999999999999999 110.935 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.16 144.07 30.44 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.80000000000000004 110.227 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.27 165.09 25.66 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.795 2.33 . . . . 2.1200000000000001 112.068 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -13.96 47.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.192 -0.913 . . . . 3.2999999999999998 112.961 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.44 -6.5 77.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.49 -0.862 . . . . 1.46 112.519 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.9 m -91.48 130.46 37.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 1.03 111.123 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.3 t -89.9 150.37 22.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.816 -0.629 . . . . 1.6000000000000001 109.459 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 93.5 mtt180 -79.41 131.69 64.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.543 -0.54 . . . . 2.6800000000000002 109.543 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.6 132.15 21.43 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.176 1.917 . . . . 1.1399999999999999 111.925 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.33 -2.32 67.19 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.861 -0.685 . . . . 1.8999999999999999 112.323 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.2 p -89.3 -2.77 58.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.817 0.342 . . . . 2.75 111.22 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.86 5.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.519 -0.848 . . . . 0.81999999999999995 112.444 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.5 123.35 25.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.047 0.451 . . . . 0.87 109.844 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.74 133.32 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 2.6499999999999999 111.295 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -77.38 -174.24 3.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.176 -0.676 . . . . 0.48999999999999999 109.176 172.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.23 -53.17 59.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 4.0899999999999999 111.374 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -63.46 -42.47 98.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.54 111.646 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 -17.27 62.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.679 0.276 . . . . 0.71999999999999997 111.297 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 70.6 m -85.39 -3.04 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 1.25 110.989 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.433 0 C-N-CA 120.606 -0.807 . . . . 2.1899999999999999 112.381 178.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 108.648 -0.871 . . . . 3.1800000000000002 108.648 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 49.3 t -72.17 103.78 3.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 0.53000000000000003 110.497 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.73 -7.65 83.92 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.856 -0.611 . . . . 0.65000000000000002 111.644 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.94 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 1.04 110.255 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.2 p -102.73 -28.08 12.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.914 0.388 . . . . 0.83999999999999997 110.038 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.11 24.75 10.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.77000000000000002 111.693 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 27.9 t70 -142.59 147.83 36.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 2.1000000000000001 110.706 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.23 16.94 8.04 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.631 -0.587 . . . . 0.55000000000000004 111.631 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.5 m -80.44 120.02 23.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.155 -0.313 . . . . 1.0600000000000001 110.155 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.72 50.03 17.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.56 0.695 . . . . 2.23 110.167 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.43 144.53 8.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.936 -1.029 . . . . 1.1599999999999999 109.903 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.47 155.42 19.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.961 0.41 . . . . 0.47999999999999998 110.376 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.0 mmm180 -123.64 151.96 42.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.014 -0.735 . . . . 3.1800000000000002 109.014 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 37.9 t -69.63 138.78 53.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.618 -0.833 . . . . 0.37 109.176 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p -80.98 -10.86 59.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.101 0.477 . . . . 0.75 110.98 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -117.25 -7.81 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 1.4299999999999999 111.031 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 14.3 m -140.92 179.32 6.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.79000000000000004 110.406 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.6 113.29 26.76 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.011 -0.737 . . . . 0.46999999999999997 109.011 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.91 145.34 6.22 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.058 0.224 . . . . 0.40000000000000002 110.53 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.53 112.41 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.477 0.486 . . . . 0.45000000000000001 110.268 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -157.06 145.15 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.913 -0.585 . . . . 0.60999999999999999 110.146 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.821 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 77.2 m80 -86.75 151.35 23.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.516 -0.55 . . . . 0.41999999999999998 109.516 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 67.9 t-105 -61.98 -50.5 71.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.763 0.316 . . . . 0.68000000000000005 110.489 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 79.9 mtp180 -69.43 -14.53 62.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 3.3300000000000001 111.731 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.821 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.8 m -80.79 -20.96 41.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.251 0.548 . . . . 0.54000000000000004 110.029 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.06 -39.41 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.60999999999999999 111.392 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 99.0 m-85 -125.68 158.61 64.45 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.80000000000000004 110.496 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.42 159.82 51.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.595 2.197 . . . . 2.1200000000000001 110.935 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.3 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 3.2999999999999998 111.458 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.21 -12.8 79.75 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.231 -0.509 . . . . 1.46 112.413 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 23.7 m -88.81 138.9 30.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 1.03 109.914 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.11 137.74 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 1.6000000000000001 110.319 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 14.4 ptm180 -93.12 121.74 64.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.352 -0.385 . . . . 2.6800000000000002 111.221 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.02 136.57 29.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.769 2.312 . . . . 1.1399999999999999 111.639 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.74 -46.99 10.32 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.075 -0.583 . . . . 1.8999999999999999 112.721 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -17.65 16.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.163 0.506 . . . . 2.75 111.307 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -115.95 50.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.686 -0.769 . . . . 0.81999999999999995 112.63 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -70.09 123.54 21.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.934 -0.765 . . . . 0.87 108.934 178.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 76.0 mtt180 -117.82 140.97 48.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.933 0.397 . . . . 2.6499999999999999 111.832 -170.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 17.6 p -77.29 171.51 14.75 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.424 -0.954 . . . . 0.48999999999999999 108.424 169.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -56.55 -38.79 72.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.194 0.452 . . . . 4.0899999999999999 111.752 -171.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -68.62 -40.45 80.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 1.54 110.843 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -71.47 -26.19 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.732 0.301 . . . . 0.71999999999999997 111.021 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 41.9 p -93.46 19.76 8.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.983 0.421 . . . . 1.25 110.689 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 C-N-CA 121.13 -0.557 . . . . 2.1899999999999999 112.126 179.674 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.662 0.267 . . . . 3.1800000000000002 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.2 t -65.4 113.56 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.53000000000000003 109.699 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.61 -19.2 62.38 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.075 -0.583 . . . . 0.65000000000000002 113.496 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.93 -30.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.059 0.457 . . . . 1.04 110.686 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.6 m -108.57 -24.56 11.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.56 0.578 . . . . 0.83999999999999997 112.56 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.46 16.9 79.81 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.304 -0.718 . . . . 0.77000000000000002 111.304 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -134.85 156.2 49.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.451 . . . . 2.1000000000000001 110.137 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.89 22.09 5.19 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.816 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.0 m -75.66 125.83 29.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.0600000000000001 110.059 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 54.36 45.73 26.57 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.334 0.588 . . . . 2.23 110.234 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -91.75 151.77 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.1599999999999999 110.531 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' C' ' 36' ' ' TRP . 74.2 mt -96.02 149.49 21.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.142 -0.481 . . . . 0.47999999999999998 109.898 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -107.38 155.46 19.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.114 -0.494 . . . . 3.1800000000000002 110.505 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.1 t -88.92 140.43 29.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.613 -0.514 . . . . 0.37 109.613 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -90.37 -26.83 19.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.032 0.444 . . . . 0.75 111.275 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -89.96 -20.5 23.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 1.4299999999999999 111.05 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.0 p -151.0 -172.32 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.961 -0.755 . . . . 0.79000000000000004 108.961 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.27 114.27 28.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.949 -0.389 . . . . 0.46999999999999997 109.949 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.32 151.96 10.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.40000000000000002 110.776 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -119.35 120.58 37.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.805 -0.634 . . . . 0.45000000000000001 109.679 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.84 148.17 31.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.193 -0.458 . . . . 0.60999999999999999 110.873 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.6 m170 -88.82 126.61 35.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.79 -1.189 . . . . 0.41999999999999998 107.79 168.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.409 ' HB2' HD12 ' C' ' 25' ' ' LEU . 56.4 t-105 -56.57 -38.59 72.17 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.69 0.619 . . . . 0.68000000000000005 111.192 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -71.71 -23.7 61.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.904 0.383 . . . . 3.3300000000000001 111.222 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 84.4 m -85.14 -22.99 28.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.421 -0.354 . . . . 0.54000000000000004 110.93 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . 0.426 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 7.6 m-70 -102.15 -24.72 13.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.60999999999999999 111.539 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -130.87 65.1 75.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.913 0.387 . . . . 0.80000000000000004 110.522 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 6.2 Cg_exo -78.97 5.42 5.72 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.159 2.572 . . . . 2.1200000000000001 112.436 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.14 3.58 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.302 -0.408 . . . . 3.2999999999999998 111.326 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.8 8.24 45.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 1.46 112.7 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.3 m -67.72 129.35 39.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.121 -0.325 . . . . 1.03 110.121 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 p -90.03 149.17 22.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.631 0.253 . . . . 1.6000000000000001 110.575 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -78.13 121.97 84.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 2.6800000000000002 111.257 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.71 155.65 58.35 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.771 2.314 . . . . 1.1399999999999999 111.466 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.44 -19.43 79.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.98 -0.629 . . . . 1.8999999999999999 111.814 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -147.11 142.29 27.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.917 0.389 . . . . 2.75 110.212 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 51.71 1.47 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.784 -0.722 . . . . 0.81999999999999995 112.36 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.54 122.13 25.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.172 0.51 . . . . 0.87 110.372 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -127.89 137.29 52.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.171 -0.468 . . . . 2.6499999999999999 110.505 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -72.89 -177.0 2.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.476 -0.564 . . . . 0.48999999999999999 109.476 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -67.01 -40.43 87.31 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.631 -0.428 . . . . 4.0899999999999999 110.631 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -67.68 -43.58 79.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 1.54 111.459 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.78 -17.22 62.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.71999999999999997 110.791 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -87.41 19.66 3.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 1.25 110.574 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 110.498 -1.041 . . . . 2.1899999999999999 110.498 172.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 110.118 -0.327 . . . . 3.1800000000000002 110.118 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -64.19 103.42 0.62 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.53000000000000003 109.516 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.08 -17.41 69.7 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.867 -0.682 . . . . 0.65000000000000002 112.764 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 42.0 t -61.78 -38.56 80.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.824 0.345 . . . . 1.04 110.981 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.6 p -109.52 -28.96 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.979 0.419 . . . . 0.83999999999999997 110.576 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.51 -14.38 56.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.044 -0.598 . . . . 0.77000000000000002 111.829 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -94.94 140.27 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 2.1000000000000001 110.987 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.09 20.23 16.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.925 -0.655 . . . . 0.55000000000000004 112.476 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -78.36 116.37 18.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.461 0.172 . . . . 1.0600000000000001 110.581 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.71 66.19 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 2.23 111.386 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.49 140.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 1.1599999999999999 110.987 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -88.06 143.8 26.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 0.47999999999999998 109.405 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.6 OUTLIER -108.07 135.54 49.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.069 0.462 . . . . 3.1800000000000002 110.612 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 6.7 t -63.57 141.27 58.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.299 -0.864 . . . . 0.37 110.261 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.3 p -89.51 -26.23 21.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.324 -0.398 . . . . 0.75 111.35 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -89.64 -21.51 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.4299999999999999 110.904 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.9 p -150.49 -172.29 4.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.478 -0.934 . . . . 0.79000000000000004 108.478 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.03 114.4 28.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.788 0.328 . . . . 0.46999999999999997 110.187 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.45 123.23 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.40000000000000002 109.847 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.34 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.583 -0.525 . . . . 0.45000000000000001 109.583 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -147.77 162.92 38.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.004 -0.544 . . . . 0.60999999999999999 110.122 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.427 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -93.03 133.72 35.89 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.873 -0.788 . . . . 0.41999999999999998 108.873 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -51.14 -48.05 61.91 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.632 0.582 . . . . 0.68000000000000005 111.092 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 33.7 mmt180 -74.41 -5.46 42.59 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.388 0.514 . . . . 3.3300000000000001 112.388 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.5 m -91.23 -22.2 20.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 0.54000000000000004 110.561 175.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -102.35 -43.31 5.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.01 0.433 . . . . 0.60999999999999999 110.722 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 88.3 m-85 -118.58 137.72 25.1 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.595 . . . . 0.80000000000000004 109.928 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.41 177.65 6.46 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.7 2.267 . . . . 2.1200000000000001 112.633 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.11 -37.89 78.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.68 0.276 . . . . 3.2999999999999998 111.699 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.64 -20.93 64.43 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.105 -0.498 . . . . 1.46 113.787 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.12 132.35 34.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.125 0.463 . . . . 1.03 110.111 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.74 137.99 31.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.29 -0.414 . . . . 1.6000000000000001 110.956 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -74.84 117.29 61.4 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.763 -0.653 . . . . 2.6800000000000002 110.632 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.41 132.63 22.66 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.587 2.191 . . . . 1.1399999999999999 111.638 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.23 -39.3 12.94 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.769 -0.729 . . . . 1.8999999999999999 111.459 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.1 m -98.14 112.49 24.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.447 -0.377 . . . . 2.75 110.597 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.58 59.99 3.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.885 -0.674 . . . . 0.81999999999999995 112.801 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.76 122.51 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.847 -0.797 . . . . 0.87 108.847 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 33.6 ptt180 -133.69 146.04 50.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.103 0.478 . . . . 2.6499999999999999 111.032 -174.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.46 177.14 5.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.329 -0.85 . . . . 0.48999999999999999 110.649 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -55.78 -49.37 73.36 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.151 0.282 . . . . 4.0899999999999999 111.204 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -59.19 -43.25 92.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.999 0.428 . . . . 1.54 110.513 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.82 -27.76 62.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.404 0.52 . . . . 0.71999999999999997 112.404 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -75.85 -7.14 53.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.874 0.369 . . . . 1.25 111.31 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.682 0 C-N-CA 120.937 -0.649 . . . . 2.1899999999999999 111.794 -179.381 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.233 0 N-CA-C 109.721 -0.474 . . . . 3.1800000000000002 109.721 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 27.9 t -61.48 106.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 0.53000000000000003 110.123 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.05 -25.7 64.67 Favored Glycine 0 C--O 1.229 -0.182 0 O-C-N 123.454 0.471 . . . . 0.65000000000000002 112.516 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.17 -29.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.494 . . . . 1.04 110.885 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 88.5 m -108.1 -33.46 7.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.83999999999999997 112.116 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.05 6.03 72.38 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.86 -0.896 . . . . 0.77000000000000002 110.86 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.36 147.08 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.588 . . . . 2.1000000000000001 109.912 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.45 30.99 4.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.864 -0.684 . . . . 0.55000000000000004 112.752 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -74.72 125.73 29.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 1.0600000000000001 109.723 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.13 51.91 14.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.438 0.637 . . . . 2.23 110.325 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.33 151.1 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.599 -0.728 . . . . 1.1599999999999999 110.565 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' C' ' 36' ' ' TRP . 80.6 mt -102.27 148.38 25.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.47999999999999998 110.023 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.3 tpt180 -115.57 138.73 50.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.844 -0.617 . . . . 3.1800000000000002 110.447 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -75.49 143.69 42.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.743 -0.466 . . . . 0.37 109.743 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -91.04 -30.79 16.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.545 . . . . 0.75 111.855 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -91.58 -14.38 30.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.351 . . . . 1.4299999999999999 111.507 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 p -150.47 -174.22 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.437 -0.579 . . . . 0.79000000000000004 109.437 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.63 114.06 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.673 -0.492 . . . . 0.46999999999999997 109.673 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.14 125.13 1.87 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.40000000000000002 110.835 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.76 25.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.45000000000000001 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -151.83 160.63 43.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.374 -0.375 . . . . 0.60999999999999999 110.598 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.1 m170 -90.8 134.83 34.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.941 -0.763 . . . . 0.41999999999999998 108.941 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.445 ' HB2' HD12 ' C' ' 25' ' ' LEU . 28.0 t-105 -50.54 -51.58 46.55 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.336 0.397 . . . . 0.68000000000000005 111.476 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -62.19 -27.8 69.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 3.3300000000000001 112.193 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -78.49 -22.91 46.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 0.54000000000000004 111.346 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -100.22 -37.08 9.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.264 -0.425 . . . . 0.60999999999999999 110.865 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.3 85.65 25.63 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 0.80000000000000004 110.289 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.45 -5.19 12.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.117 2.544 . . . . 2.1200000000000001 113.386 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.21 4.23 31.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.896 0.379 . . . . 3.2999999999999998 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.41 33.78 27.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.713 -0.756 . . . . 1.46 112.024 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -61.66 142.21 57.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 1.03 110.733 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -88.48 135.45 33.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.422 -0.354 . . . . 1.6000000000000001 110.157 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -67.4 125.78 91.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 2.6800000000000002 110.342 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 137.64 38.17 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.575 2.184 . . . . 1.1399999999999999 112.377 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.1 1.51 70.43 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.952 -0.642 . . . . 1.8999999999999999 111.988 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -104.86 26.61 8.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.36 0.6 . . . . 2.75 110.746 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 118.08 122.38 3.19 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.546 -0.752 . . . . 0.81999999999999995 111.805 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.7 123.57 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 54.1 mtt85 -125.68 134.29 51.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.359 -0.382 . . . . 2.6499999999999999 111.119 -174.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.9 p -76.29 177.19 7.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.977 -0.749 . . . . 0.48999999999999999 108.977 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -59.96 -40.33 88.66 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.318 0.508 . . . . 4.0899999999999999 111.487 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m -65.09 -46.54 80.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.868 0.366 . . . . 1.54 110.965 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.91 -17.85 62.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.71999999999999997 111.418 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 36.3 m -88.84 -14.33 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.38 . . . . 1.25 110.56 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.816 0 C-N-CA 120.907 -0.663 . . . . 2.1899999999999999 112.623 -177.034 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 110.108 -0.33 . . . . 3.1800000000000002 110.108 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -81.9 102.76 11.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.53000000000000003 108.608 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.66 80.34 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.828 -0.624 . . . . 0.65000000000000002 112.806 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.4 HG11 ' O ' ' C' ' 38' ' ' CYS . 33.4 t -66.14 -28.83 44.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.085 0.469 . . . . 1.04 110.725 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.56 -41.9 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.314 -0.403 . . . . 0.83999999999999997 110.326 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.49 -10.82 8.07 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.911 -0.661 . . . . 0.77000000000000002 112.256 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -100.23 148.19 24.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 2.1000000000000001 111.843 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.75 16.43 21.15 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.488 -0.778 . . . . 0.55000000000000004 111.491 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.4 m -74.0 115.59 13.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.826 -0.187 . . . . 1.0600000000000001 110.739 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.19 66.34 1.26 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.801 0.688 . . . . 2.23 111.014 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -89.97 136.53 23.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.63 -0.714 . . . . 1.1599999999999999 111.008 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.03 144.09 28.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.667 -0.697 . . . . 0.47999999999999998 110.014 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.1 mpt_? -103.78 146.65 28.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.953 -0.567 . . . . 3.1800000000000002 110.19 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 27.0 t -72.62 141.39 48.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.515 -0.55 . . . . 0.37 109.515 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.44 -26.05 33.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.581 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -94.91 -28.12 15.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 1.4299999999999999 111.521 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.9 p -143.93 -174.02 4.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.57 . . . . 0.79000000000000004 109.46 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.58 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.781 0.324 . . . . 0.46999999999999997 110.719 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -160.8 138.46 9.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.046 -0.525 . . . . 0.40000000000000002 109.973 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.56 112.12 22.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.858 -0.423 . . . . 0.45000000000000001 109.858 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -156.53 166.0 34.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.834 0.35 . . . . 0.60999999999999999 110.976 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -97.29 135.22 39.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.41999999999999998 108.795 171.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -59.62 -39.28 83.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.924 -0.58 . . . . 0.68000000000000005 110.593 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.61 -15.83 60.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 3.3300000000000001 111.73 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.4 ' O ' HG11 ' C' ' 17' ' ' VAL . 68.7 m -84.32 -22.45 30.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.168 0.509 . . . . 0.54000000000000004 110.12 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.24 -56.07 2.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 0.60999999999999999 111.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 75.6 m-85 -106.99 135.24 19.6 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.833 -0.621 . . . . 0.80000000000000004 110.14 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 9.1 Cg_exo -70.78 176.3 7.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.272 . . . . 2.1200000000000001 112.667 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.94 65.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.437 -0.347 . . . . 3.2999999999999998 111.654 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.52 -23.08 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.46 112.88 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 13.1 m -99.0 128.88 45.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.883 -0.414 . . . . 1.03 109.883 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 63.0 p -89.21 138.0 31.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.465 -0.334 . . . . 1.6000000000000001 111.216 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -75.61 116.17 52.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 2.6800000000000002 110.348 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.96 133.42 21.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.237 1.958 . . . . 1.1399999999999999 111.449 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.15 79.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.938 -0.649 . . . . 1.8999999999999999 111.733 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.4 p -131.53 141.46 49.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.012 -0.366 . . . . 2.75 110.012 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.74 53.15 3.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.81999999999999995 112.275 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 123.25 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.81 -0.441 . . . . 0.87 109.81 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -117.25 145.7 43.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.915 0.388 . . . . 2.6499999999999999 110.779 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 13.9 p -84.65 -176.21 6.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.308 -0.627 . . . . 0.48999999999999999 109.308 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -62.5 -48.31 80.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 4.0899999999999999 111.348 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 19.3 t -67.1 -44.77 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.324 -0.398 . . . . 1.54 111.244 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -72.14 -29.33 63.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.816 0.302 . . . . 0.71999999999999997 111.816 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 2.6 t -90.65 -12.23 37.46 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.793 -0.363 . . . . 1.25 111.679 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 C-N-CA 120.023 -1.084 . . . . 2.1899999999999999 113.092 179.354 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 73.1 mtt180 . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 109.636 -0.505 . . . . 3.1800000000000002 109.636 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.87 106.62 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.227 -0.657 . . . . 0.53000000000000003 109.227 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 -22.3 55.0 Favored Glycine 0 C--N 1.33 0.224 0 O-C-N 123.349 0.405 . . . . 0.65000000000000002 113.109 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.4 -30.2 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.04 110.891 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 86.5 m -108.57 -46.02 3.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.774 0.657 . . . . 0.83999999999999997 112.774 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . 0.658 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 102.67 -17.17 53.74 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.77000000000000002 111.536 -173.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.42 150.37 20.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.864 0.364 . . . . 2.1000000000000001 110.758 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.13 9.04 29.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.186 -0.766 . . . . 0.55000000000000004 111.186 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 m -72.48 136.7 46.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.389 . . . . 1.0600000000000001 110.539 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.92 47.09 7.0 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.967 0.889 . . . . 2.23 111.075 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.65 140.45 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.1599999999999999 109.854 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.35 144.56 25.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.932 0.396 . . . . 0.47999999999999998 110.381 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -109.32 149.69 29.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.588 -0.733 . . . . 3.1800000000000002 109.551 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.64 137.36 33.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.022 0.439 . . . . 0.37 110.521 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 33.8 p -85.51 -3.5 58.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.591 . . . . 0.75 111.957 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -122.18 -15.44 7.71 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.002 -0.279 . . . . 1.4299999999999999 111.631 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -151.9 -167.42 2.77 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.79000000000000004 109.548 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.01 29.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.548 -0.296 . . . . 0.46999999999999997 110.249 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.96 145.68 15.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.326 -0.397 . . . . 0.40000000000000002 110.528 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.58 112.53 16.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.008 -0.542 . . . . 0.45000000000000001 110.052 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.76 162.72 38.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.924 -0.398 . . . . 0.60999999999999999 109.924 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.757 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -95.28 138.08 33.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.713 -0.847 . . . . 0.41999999999999998 108.713 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -50.29 -53.03 31.56 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.239 0.337 . . . . 0.68000000000000005 111.399 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -66.34 -18.07 65.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 3.3300000000000001 111.97 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.0 m -84.17 -22.2 31.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.162 0.506 . . . . 0.54000000000000004 110.852 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.94 -34.63 8.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.60999999999999999 110.672 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -124.12 132.42 24.3 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.80000000000000004 109.785 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.14 154.65 27.3 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.892 2.395 . . . . 2.1200000000000001 111.695 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.39 -19.84 57.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.388 -0.823 . . . . 3.2999999999999998 112.449 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.74 -18.8 78.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.067 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -85.49 125.36 32.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 1.03 110.013 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m -88.51 136.42 33.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 1.6000000000000001 110.567 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -69.92 123.94 89.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 2.6800000000000002 110.299 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.79 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.664 2.243 . . . . 1.1399999999999999 112.581 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.84 5.42 82.08 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.827 -0.701 . . . . 1.8999999999999999 111.583 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -92.7 18.46 8.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.14 0.495 . . . . 2.75 110.881 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.86 135.17 8.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.977 -0.63 . . . . 0.81999999999999995 111.69 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 123.82 22.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.962 0.41 . . . . 0.87 110.008 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -117.41 138.05 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 2.6499999999999999 110.69 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -81.12 -176.67 6.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.668 -0.493 . . . . 0.48999999999999999 109.668 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -57.4 -52.48 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 4.0899999999999999 111.1 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.9 t -63.11 -46.29 88.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.497 -0.32 . . . . 1.54 111.359 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 80.6 m -72.18 -17.77 61.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.072 0.397 . . . . 0.71999999999999997 112.072 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -81.65 -13.75 57.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.423 -0.511 . . . . 1.25 110.147 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.68 0 CA-C-N 115.707 -0.679 . . . . 2.1899999999999999 111.495 178.031 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.417 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.7 ttp180 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.602 0.239 . . . . 3.1800000000000002 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -69.08 111.32 4.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.768 -0.456 . . . . 0.53000000000000003 109.768 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.69 81.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.27 -0.49 . . . . 0.65000000000000002 112.846 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.45 -37.65 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.763 0.316 . . . . 1.04 110.931 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.0 m -96.14 -43.55 7.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 0.83999999999999997 111.621 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.37 1.01 55.65 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.144 -0.783 . . . . 0.77000000000000002 111.144 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -117.22 143.48 45.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.338 . . . . 2.1000000000000001 110.407 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -110.37 9.32 30.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.958 -0.639 . . . . 0.55000000000000004 112.078 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -72.78 134.02 44.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.168 -0.308 . . . . 1.0600000000000001 110.168 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.34 48.6 21.6 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.628 0.58 . . . . 2.23 110.848 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.9 p -91.18 145.05 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 1.1599999999999999 110.518 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.26 147.43 23.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.274 -0.421 . . . . 0.47999999999999998 110.407 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -112.7 150.28 31.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 3.1800000000000002 110.876 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 11.7 t -82.79 134.28 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.37 108.883 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.459 HG22 ' O ' ' C' ' 51' ' ' LEU . 5.9 t -85.57 -11.72 53.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.732 -0.387 . . . . 0.75 111.491 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.75 -17.95 13.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.795 0.294 . . . . 1.4299999999999999 111.795 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.57 -167.55 2.85 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.475 -0.565 . . . . 0.79000000000000004 109.475 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 114.09 28.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.755 0.312 . . . . 0.46999999999999997 110.36 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -157.8 146.34 19.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.40000000000000002 110.374 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -133.26 112.18 11.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.136 -0.484 . . . . 0.45000000000000001 110.256 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.6 164.82 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.104 -0.498 . . . . 0.60999999999999999 109.847 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.3 m170 -96.54 137.76 35.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.104 -1.073 . . . . 0.41999999999999998 108.104 171.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -47.65 -51.65 20.82 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.533 0.521 . . . . 0.68000000000000005 112.006 -173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -61.65 -32.88 73.07 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.152 0.427 . . . . 3.3300000000000001 112.152 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 9.1 m -71.35 -21.4 62.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.54000000000000004 111.043 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.89 -42.93 5.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.60999999999999999 111.174 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.99 142.94 29.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.41 -0.359 . . . . 0.80000000000000004 110.714 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.16 149.02 6.49 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.602 2.868 . . . . 2.1200000000000001 112.75 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -16.15 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.328 -0.851 . . . . 3.2999999999999998 112.566 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.64 18.27 56.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 1.46 112.285 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.4 m -106.63 131.27 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.498 0.19 . . . . 1.03 110.542 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -88.54 133.59 34.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.975 -0.379 . . . . 1.6000000000000001 109.975 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 46' ' ' ARG . 4.1 ptm180 -80.82 130.09 65.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.714 0.292 . . . . 2.6800000000000002 110.682 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.16 146.88 47.14 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.83 2.354 . . . . 1.1399999999999999 112.203 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.02 -40.71 4.52 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.29 -0.724 . . . . 1.8999999999999999 111.29 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.8 p -100.09 83.36 2.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.923 0.392 . . . . 2.75 110.663 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 116.94 64.05 0.33 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.458 -0.877 . . . . 0.81999999999999995 112.906 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.459 ' O ' HG22 ' C' ' 28' ' ' THR . 0.8 OUTLIER -77.0 121.79 24.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.782 -0.822 . . . . 0.87 108.782 176.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -126.29 132.1 51.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.436 -0.347 . . . . 2.6499999999999999 110.731 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.09 179.62 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.48999999999999999 109.561 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -60.17 -42.35 94.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 4.0899999999999999 111.282 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -66.49 -46.26 76.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 1.54 111.057 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -71.41 -33.4 69.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.803 0.297 . . . . 0.71999999999999997 111.803 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 46.1 p -83.32 -11.31 57.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 1.25 110.725 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.861 0 C-N-CA 120.971 -0.633 . . . . 2.1899999999999999 111.784 179.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.604 -0.517 . . . . 3.1800000000000002 109.604 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.75 103.87 1.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.52 -0.548 . . . . 0.53000000000000003 109.52 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.26 86.14 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.65000000000000002 113.458 -171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.94 -40.38 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.809 0.338 . . . . 1.04 110.988 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -111.67 -20.59 12.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.359 . . . . 0.83999999999999997 111.147 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.95 77.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.929 -0.653 . . . . 0.77000000000000002 112.036 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -109.84 146.78 34.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.259 -0.275 . . . . 2.1000000000000001 110.259 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.1 17.18 9.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.55000000000000004 112.753 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.76 119.43 23.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.505 -0.183 . . . . 1.0600000000000001 110.505 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.72 63.1 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.413 0.445 . . . . 2.23 111.258 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -89.1 140.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 1.1599999999999999 110.793 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.15 145.99 24.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.676 -0.693 . . . . 0.47999999999999998 109.538 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.87 141.46 42.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 3.1800000000000002 110.945 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -69.79 128.24 35.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.158 -0.682 . . . . 0.37 109.158 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 46.8 p -84.49 -8.26 59.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.495 0.664 . . . . 0.75 110.292 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -99.91 -27.97 13.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.387 -0.824 . . . . 1.4299999999999999 111.056 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.1 p -151.74 -161.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.028 -0.269 . . . . 0.79000000000000004 110.408 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.71 119.74 39.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.676 -0.238 . . . . 0.46999999999999997 110.788 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -173.12 141.09 0.93 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.175 -0.466 . . . . 0.40000000000000002 110.8 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.86 112.82 19.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.597 -0.52 . . . . 0.45000000000000001 109.597 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -155.56 169.57 24.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 0.60999999999999999 110.943 -173.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -102.55 134.92 45.1 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.37 -0.604 . . . . 0.41999999999999998 109.37 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -63.61 -35.19 79.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.613 -0.721 . . . . 0.68000000000000005 110.532 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -76.97 -17.39 58.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 3.3300000000000001 111.745 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.06 -22.49 27.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.069 0.462 . . . . 0.54000000000000004 110.411 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -93.3 -51.35 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.088 -0.506 . . . . 0.60999999999999999 110.362 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.76 152.81 47.79 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.695 . . . . 0.80000000000000004 109.963 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.29 148.48 70.59 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.244 1.963 . . . . 2.1200000000000001 110.705 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.27 -11.38 31.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.022 -0.535 . . . . 3.2999999999999998 111.69 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.21 7.49 80.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.11 -0.567 . . . . 1.46 112.216 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -93.02 140.54 29.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.763 -0.257 . . . . 1.03 110.308 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.3 p -87.91 143.73 26.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.973 0.416 . . . . 1.6000000000000001 110.149 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -89.48 129.69 46.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.538 -0.542 . . . . 2.6800000000000002 109.538 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 132.73 44.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.939 2.426 . . . . 1.1399999999999999 112.761 -173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.82 -10.41 83.13 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.342 -0.703 . . . . 1.8999999999999999 111.342 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -89.59 26.38 1.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.388 0.613 . . . . 2.75 110.387 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 131.99 7.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.506 -0.77 . . . . 0.81999999999999995 111.758 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.76 123.13 18.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.422 -0.584 . . . . 0.87 109.422 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -110.24 147.32 34.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.32 0.581 . . . . 2.6499999999999999 110.726 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.4 p -91.49 -170.05 2.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.354 -0.839 . . . . 0.48999999999999999 109.526 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -61.05 -49.64 76.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.655 -0.248 . . . . 4.0899999999999999 111.283 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' C' ' 58' ' ' GLY . 15.7 m -68.64 -36.97 79.31 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.196 0.522 . . . . 1.54 111.867 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -73.64 -15.73 61.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.806 0.336 . . . . 0.71999999999999997 111.422 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -97.83 7.31 46.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.353 0.597 . . . . 1.25 109.772 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' C' ' 55' ' ' SER . . . . . . . . 0 C--O 1.224 -0.473 0 N-CA-C 110.256 -1.138 . . . . 2.1899999999999999 110.256 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.462 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.6 ttt180 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.946 0.403 . . . . 3.1800000000000002 110.604 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 29.5 t -90.47 103.67 16.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 0.53000000000000003 109.183 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 -4.54 89.81 Favored Glycine 0 N--CA 1.453 -0.183 0 CA-C-N 115.967 -0.561 . . . . 0.65000000000000002 113.253 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.11 -32.13 46.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.106 0.479 . . . . 1.04 110.21 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 p -115.89 -41.34 3.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.006 -0.543 . . . . 0.83999999999999997 110.285 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.55 -15.78 7.1 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.874 -0.679 . . . . 0.77000000000000002 112.381 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -91.12 140.81 29.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 2.1000000000000001 111.343 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -111.28 3.48 28.22 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.989 -0.624 . . . . 0.55000000000000004 112.138 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 57.6 m -80.47 134.65 36.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.52 0.2 . . . . 1.0600000000000001 110.739 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 59.46 50.02 8.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.629 0.728 . . . . 2.23 110.94 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 m -89.88 144.61 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.669 -0.696 . . . . 1.1599999999999999 110.869 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.6 153.26 18.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.47999999999999998 110.023 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 25.1 mmt180 -106.86 154.44 21.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.151 -0.477 . . . . 3.1800000000000002 110.411 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.4 t -89.19 144.0 26.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -23.85 22.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.766 0.317 . . . . 0.75 111.331 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -95.22 -17.58 21.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 1.4299999999999999 111.232 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 9.5 p -150.84 -177.2 5.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.138 -0.69 . . . . 0.79000000000000004 109.138 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.17 119.33 38.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.577 -0.283 . . . . 0.46999999999999997 110.525 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.92 149.36 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.086 -0.506 . . . . 0.40000000000000002 110.226 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.32 112.21 18.31 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.54 -0.541 . . . . 0.45000000000000001 109.54 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -152.69 162.07 41.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.284 -0.416 . . . . 0.60999999999999999 110.779 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -91.41 136.6 32.99 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.42 -0.585 . . . . 0.41999999999999998 109.42 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -59.83 -36.04 76.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.68000000000000005 109.975 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -72.2 -22.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 3.3300000000000001 111.777 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 87.6 m -90.38 -23.44 21.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.54000000000000004 111.284 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -102.07 -21.07 14.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.942 -0.303 . . . . 0.60999999999999999 111.526 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -131.08 149.06 72.67 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.766 -0.457 . . . . 0.80000000000000004 109.766 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.56 147.17 60.24 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.692 2.261 . . . . 2.1200000000000001 111.447 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.64 61.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.203 -0.908 . . . . 3.2999999999999998 112.664 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.27 -10.82 86.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.672 . . . . 1.46 112.771 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -73.44 130.04 39.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.694 0.283 . . . . 1.03 110.5 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.7 t -88.86 136.64 32.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.584 -0.525 . . . . 1.6000000000000001 109.584 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -79.48 126.82 80.23 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.047 -0.524 . . . . 2.6800000000000002 110.391 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.86 135.77 31.05 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.363 2.042 . . . . 1.1399999999999999 111.513 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -29.36 73.85 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.737 -0.665 . . . . 1.8999999999999999 112.186 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -139.38 133.24 30.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.144 -0.317 . . . . 2.75 110.144 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.07 57.19 1.61 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.524 -0.846 . . . . 0.81999999999999995 112.342 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.53 123.91 22.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.498 -0.556 . . . . 0.87 109.498 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.77 140.36 49.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.482 -0.326 . . . . 2.6499999999999999 110.801 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.34 169.48 12.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.409 -0.96 . . . . 0.48999999999999999 108.409 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.08 -34.63 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.851 0.751 . . . . 4.0899999999999999 111.158 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -64.22 -44.9 90.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 1.54 110.978 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.4 m -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.71999999999999997 111.136 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.3 m -88.73 15.26 8.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 1.25 110.695 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.687 0 C-N-CA 121.051 -0.595 . . . . 2.1899999999999999 111.715 179.811 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 110.303 -0.258 . . . . 3.1800000000000002 110.303 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 9.4 t -82.07 104.78 12.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.705 -0.48 . . . . 0.53000000000000003 109.705 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.17 -11.09 79.17 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.969 -0.559 . . . . 0.65000000000000002 113.008 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 t -67.54 -28.0 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.056 0.455 . . . . 1.04 110.67 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.39 -34.7 2.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.83999999999999997 110.866 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.27 -6.91 24.97 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.818 -0.706 . . . . 0.77000000000000002 112.132 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 9.1 m-20 -102.16 145.71 29.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 2.1000000000000001 111.086 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.89 3.87 30.41 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.382 -0.687 . . . . 0.55000000000000004 111.382 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -63.4 121.05 12.84 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.397 0.279 . . . . 1.0600000000000001 110.871 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 56.89 52.3 9.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.774 0.797 . . . . 2.23 109.806 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.447 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.0 p -89.91 146.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 1.1599999999999999 110.566 -176.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.84 161.89 13.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.239 -0.437 . . . . 0.47999999999999998 110.324 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 11.3 tpt180 -135.01 134.51 40.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.241 -0.651 . . . . 3.1800000000000002 109.241 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 29.4 t -66.43 141.13 58.03 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 119.761 -0.776 . . . . 0.37 109.919 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -81.95 -15.62 53.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 0.75 111.093 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -111.18 -9.4 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 1.4299999999999999 110.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.46 173.82 11.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.123 0.487 . . . . 0.79000000000000004 110.305 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.29 111.49 24.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.898 -0.779 . . . . 0.46999999999999997 108.898 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -167.19 125.22 1.28 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.013 -0.539 . . . . 0.40000000000000002 110.117 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.447 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.15 112.24 24.43 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.152 -0.684 . . . . 0.45000000000000001 109.152 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 41.9 p90 -150.01 160.9 43.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.213 -0.448 . . . . 0.60999999999999999 110.435 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -98.44 134.41 41.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.29 -0.633 . . . . 0.41999999999999998 109.29 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -64.35 -31.93 73.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.575 -0.739 . . . . 0.68000000000000005 109.856 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -72.26 -28.25 63.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.71 . . . . 3.3300000000000001 110.915 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 58.8 m -80.46 -23.03 40.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.54000000000000004 110.88 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -88.97 -44.42 10.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.18 -0.463 . . . . 0.60999999999999999 110.578 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -122.59 78.65 47.22 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.928 -0.578 . . . . 0.80000000000000004 110.653 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.01 -5.37 17.09 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.045 2.496 . . . . 2.1200000000000001 111.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.65 -8.41 56.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 3.2999999999999998 111.587 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.42 24.08 11.68 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.501 -0.857 . . . . 1.46 112.482 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -65.59 141.29 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.787 0.327 . . . . 1.03 110.624 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.0 m -89.16 131.65 35.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 1.6000000000000001 110.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 142.03 85.16 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 2.6800000000000002 111.183 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 149.62 55.13 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.706 2.271 . . . . 1.1399999999999999 112.556 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.57 -6.04 41.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.736 -0.665 . . . . 1.8999999999999999 111.651 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.6 p -89.12 46.6 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.558 0.694 . . . . 2.75 110.127 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 90.38 121.63 2.34 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.142 -0.935 . . . . 0.81999999999999995 110.907 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' C' ' 51' ' ' LEU . 2.0 tm? -64.24 125.3 24.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.443 -0.577 . . . . 0.87 109.443 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 94.9 mtt180 -112.96 142.99 45.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 2.6499999999999999 110.377 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 22.0 p -78.45 -178.26 5.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.48999999999999999 109.789 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -60.87 -45.51 94.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.672 0.272 . . . . 4.0899999999999999 110.581 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.6 t -63.13 -41.63 99.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 1.54 110.788 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 62.4 m -69.75 -33.48 72.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.636 0.255 . . . . 0.71999999999999997 111.278 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -76.78 -14.03 59.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.155 0.503 . . . . 1.25 109.839 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 CA-C-N 115.688 -0.687 . . . . 2.1899999999999999 112.585 175.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.68 -0.489 . . . . 3.1800000000000002 109.68 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 33.7 t -74.73 103.49 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.852 -0.796 . . . . 0.53000000000000003 108.852 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.24 -14.03 80.94 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 115.877 -0.602 . . . . 0.65000000000000002 113.536 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 59.6 t -68.37 -37.03 77.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.943 0.401 . . . . 1.04 110.661 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.08 -28.28 7.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.39 . . . . 0.83999999999999997 110.678 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.21 56.52 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.158 -0.544 . . . . 0.77000000000000002 112.098 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 17.7 t70 -110.29 155.21 22.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 2.1000000000000001 111.019 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.08 21.03 4.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.937 -0.649 . . . . 0.55000000000000004 112.148 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -80.79 124.4 29.03 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.722 -0.473 . . . . 1.0600000000000001 109.722 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.59 53.8 9.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 122.025 0.917 . . . . 2.23 109.352 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.438 HG22 ' N ' ' C' ' 34' ' ' PHE . 3.9 p -93.61 141.26 15.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.033 -0.985 . . . . 1.1599999999999999 110.606 -172.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' C' ' 36' ' ' TRP . 78.2 mt -84.9 153.81 22.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.822 0.344 . . . . 0.47999999999999998 110.403 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -116.47 140.17 49.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.919 -0.582 . . . . 3.1800000000000002 110.957 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 13.8 t -74.41 139.24 43.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.635 -0.506 . . . . 0.37 109.635 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 26.0 p -89.54 -23.68 21.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.875 0.369 . . . . 0.75 111.328 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -94.08 -20.77 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 1.4299999999999999 111.18 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.17 -172.74 4.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.942 -0.762 . . . . 0.79000000000000004 108.942 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.81 114.56 28.47 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.176 -0.305 . . . . 0.46999999999999997 110.176 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.12 135.34 6.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.378 . . . . 0.40000000000000002 110.687 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.68 123.54 48.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.45000000000000001 109.545 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 23.8 p90 -159.75 153.26 22.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.365 -0.38 . . . . 0.60999999999999999 110.68 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -93.62 130.4 39.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.598 -0.889 . . . . 0.41999999999999998 108.598 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 67.0 t-105 -60.95 -34.29 74.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.68000000000000005 110.623 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.02 -38.58 82.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 3.3300000000000001 111.269 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 85.4 m -70.02 -26.83 64.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.54000000000000004 110.688 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' C' ' 54' ' ' ARG . 4.3 m-70 -89.8 -53.5 4.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.60999999999999999 111.957 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.77 143.65 30.44 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.305 -0.407 . . . . 0.80000000000000004 111.003 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.1 169.67 14.65 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.056 2.504 . . . . 2.1200000000000001 112.011 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.77 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.343 -0.844 . . . . 3.2999999999999998 111.835 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.8 -30.07 72.61 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.804 -0.712 . . . . 1.46 111.833 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.0 m -79.02 135.86 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.672 0.272 . . . . 1.03 110.479 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.2 t -89.64 151.89 21.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.514 -0.312 . . . . 1.6000000000000001 110.262 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.589 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 22.2 mtp180 -88.76 115.73 64.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.675 -0.491 . . . . 2.6800000000000002 109.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.37 132.02 34.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.499 2.132 . . . . 1.1399999999999999 112.116 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.33 -26.28 59.82 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.408 -0.677 . . . . 1.8999999999999999 111.408 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 13.9 p -133.24 139.85 47.18 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.308 0.243 . . . . 2.75 110.754 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.05 51.3 19.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.698 -0.763 . . . . 0.81999999999999995 112.377 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 122.85 15.99 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.685 -0.487 . . . . 0.87 109.685 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -116.05 142.26 47.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.916 0.389 . . . . 2.6499999999999999 110.997 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.511 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -79.6 -172.04 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.48999999999999999 110.205 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' C' ' 39' ' ' HIS . 42.9 ttp180 -60.67 -52.06 66.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.689 0.28 . . . . 4.0899999999999999 111.276 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -65.16 -43.17 92.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.357 -0.383 . . . . 1.54 111.512 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.7 m -71.37 -26.77 62.94 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.169 -0.212 . . . . 0.71999999999999997 111.471 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -87.44 -13.92 41.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.113 0.482 . . . . 1.25 110.451 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 C-N-CA 120.88 -0.676 . . . . 2.1899999999999999 112.063 -178.799 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 120.586 0.232 . . . . 3.1800000000000002 110.529 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 35.9 t -70.28 118.59 13.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.53000000000000003 109.975 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.84 76.39 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.65000000000000002 113.154 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.22 -46.69 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 1.04 111.329 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.66 -34.96 16.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 0.83999999999999997 111.71 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.3 -20.97 44.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.872 -0.68 . . . . 0.77000000000000002 111.914 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.67 150.26 21.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.609 0.242 . . . . 2.1000000000000001 110.531 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.08 11.58 11.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.878 -0.677 . . . . 0.55000000000000004 112.323 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.9 m -80.26 133.22 35.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.795 -0.446 . . . . 1.0600000000000001 109.795 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.27 48.94 14.14 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 122.141 0.972 . . . . 2.23 109.33 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -90.42 139.66 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.312 -0.858 . . . . 1.1599999999999999 110.833 -174.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.32 144.37 25.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.394 -0.821 . . . . 0.47999999999999998 109.421 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -117.92 142.74 47.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.373 -0.376 . . . . 3.1800000000000002 110.792 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.92 133.08 44.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.525 -0.546 . . . . 0.37 109.525 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 31.6 p -84.58 -15.58 45.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 0.75 111.318 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -101.2 -20.75 15.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 1.4299999999999999 111.486 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.06 -166.58 2.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.51 -0.552 . . . . 0.79000000000000004 109.51 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.67 114.92 29.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.755 0.312 . . . . 0.46999999999999997 110.373 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.89 128.32 3.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.40000000000000002 110.627 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -101.38 111.94 24.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.26 -0.644 . . . . 0.45000000000000001 109.26 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -152.57 -175.05 5.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.42 -0.355 . . . . 0.60999999999999999 110.083 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m80 -129.83 161.27 31.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.511 -0.922 . . . . 0.41999999999999998 108.511 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -58.01 -53.31 59.71 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 121.187 -0.205 . . . . 0.68000000000000005 111.287 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -56.43 -45.2 80.85 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.048 0.759 . . . . 3.3300000000000001 113.048 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 0.1 OUTLIER -66.46 -21.6 66.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.164 0.431 . . . . 0.54000000000000004 112.164 -173.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -109.17 -36.49 6.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.012 -0.275 . . . . 0.60999999999999999 111.73 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.26 139.02 33.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.774 0.321 . . . . 0.80000000000000004 110.923 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.03 156.58 63.83 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.621 2.214 . . . . 2.1200000000000001 111.637 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -15.32 53.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.108 -0.951 . . . . 3.2999999999999998 112.596 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.86 79.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.946 -0.645 . . . . 1.46 111.971 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -85.02 136.17 33.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.8 -0.444 . . . . 1.03 109.8 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -88.47 126.28 35.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 1.6000000000000001 110.557 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -78.85 122.33 84.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 2.6800000000000002 111.082 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.15 141.6 57.98 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.446 2.097 . . . . 1.1399999999999999 111.547 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.4 -28.3 52.88 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.839 -0.696 . . . . 1.8999999999999999 112.672 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -141.1 61.31 1.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.091 0.472 . . . . 2.75 110.851 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.23 46.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.517 -0.849 . . . . 0.81999999999999995 112.352 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.81 123.84 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.295 0.569 . . . . 0.87 110.541 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -125.54 133.22 52.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.777 -0.647 . . . . 2.6499999999999999 110.299 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -73.37 179.1 4.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.509 -0.552 . . . . 0.48999999999999999 109.509 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -37.98 76.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.21 0.448 . . . . 4.0899999999999999 112.21 -172.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -70.38 -51.62 28.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.845 0.355 . . . . 1.54 111.459 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 55.9 m -73.5 -18.01 61.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.778 0.658 . . . . 0.71999999999999997 112.778 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -76.36 -14.34 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 1.25 111.438 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.106 0 C-N-CA 120.246 -0.978 . . . . 2.1899999999999999 112.499 -178.557 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.958 0.408 . . . . 3.1800000000000002 110.713 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -70.39 114.39 8.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.478 -0.783 . . . . 0.53000000000000003 109.802 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.64 62.57 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.504 -0.379 . . . . 0.65000000000000002 113.265 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.43 -30.13 29.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 1.04 110.796 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 79.6 m -108.6 -28.41 9.31 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.51 0.559 . . . . 0.83999999999999997 112.51 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.06 9.91 86.13 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.202 -0.759 . . . . 0.77000000000000002 111.202 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.85 145.83 50.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.226 -0.487 . . . . 2.1000000000000001 110.275 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.59 24.63 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.831 -0.699 . . . . 0.55000000000000004 112.749 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -77.65 122.85 25.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.874 -0.417 . . . . 1.0600000000000001 109.874 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 54.86 49.14 18.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.311 0.577 . . . . 2.23 110.094 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.56 145.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.739 -0.664 . . . . 1.1599999999999999 110.18 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.91 146.71 23.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.025 0.44 . . . . 0.47999999999999998 110.095 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 26' ' ' ARG . 12.2 mmt180 -110.79 148.01 33.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 3.1800000000000002 110.069 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.4 t -79.12 139.82 37.96 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 0.37 108.681 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 60.1 p -89.92 -24.5 21.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.29 0.567 . . . . 0.75 110.724 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -89.88 -20.79 22.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 1.4299999999999999 111.19 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.6 p -150.9 -171.77 4.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.796 -0.816 . . . . 0.79000000000000004 108.796 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.7 115.43 30.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.376 -0.231 . . . . 0.46999999999999997 110.376 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.84 153.69 14.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.40000000000000002 110.514 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 118.86 23.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.525 0.516 . . . . 0.45000000000000001 110.114 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -158.02 154.9 28.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.16 -0.473 . . . . 0.60999999999999999 110.529 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m170 -86.65 133.12 33.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.347 -0.983 . . . . 0.41999999999999998 108.347 172.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' C' ' 46' ' ' ARG . 70.0 t-105 -49.67 -53.08 26.49 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.244 0.34 . . . . 0.68000000000000005 111.338 -174.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 64.9 mtp180 -62.3 -23.48 66.76 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.316 0.488 . . . . 3.3300000000000001 112.316 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -79.97 -22.08 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.918 0.39 . . . . 0.54000000000000004 111.185 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -103.95 -44.19 5.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.60999999999999999 110.665 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 71.1 m-85 -119.07 136.35 24.32 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.583 -0.735 . . . . 0.80000000000000004 109.821 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 21.6 Cg_exo -65.65 157.5 58.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.442 2.094 . . . . 2.1200000000000001 111.291 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -12.22 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 3.2999999999999998 112.174 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.11 -25.28 74.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.751 -0.737 . . . . 1.46 111.384 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -85.29 125.84 33.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.03 110.131 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -87.57 131.84 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.474 -0.33 . . . . 1.6000000000000001 110.158 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' CZ2' ' C' ' 36' ' ' TRP . 19.3 ptp180 -70.75 132.75 86.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 2.6800000000000002 110.775 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.98 132.61 30.68 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.942 2.428 . . . . 1.1399999999999999 112.421 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.35 -12.22 60.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.829 -0.7 . . . . 1.8999999999999999 111.718 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 9.5 p -90.07 10.72 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 2.75 111.147 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 139.08 117.29 1.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 0.81999999999999995 111.94 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -63.36 123.28 18.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.522 -0.547 . . . . 0.87 109.522 178.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 81.6 mtm180 -120.9 133.59 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 2.6499999999999999 111.248 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -78.48 162.8 26.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.989 -0.745 . . . . 0.48999999999999999 108.989 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.23 -38.48 18.6 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.459 0.54 . . . . 4.0899999999999999 112.459 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -64.64 -50.13 68.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.994 0.426 . . . . 1.54 110.758 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 82.5 m -72.67 -29.41 63.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.961 -0.563 . . . . 0.71999999999999997 111.722 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.1 p -82.79 1.1 40.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 1.25 110.718 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.543 0 C-N-CA 120.848 -0.692 . . . . 2.1899999999999999 111.674 176.778 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.633 0.254 . . . . 3.1800000000000002 111.024 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -69.59 107.95 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.53000000000000003 110.08 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.33 66.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.448 -0.406 . . . . 0.65000000000000002 113.017 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.91 -31.93 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.09 0.472 . . . . 1.04 110.576 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.0 -32.54 7.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.268 0.47 . . . . 0.83999999999999997 112.268 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.29 16.46 58.98 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.156 -0.778 . . . . 0.77000000000000002 111.156 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.86 144.47 41.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.412 -0.394 . . . . 2.1000000000000001 110.355 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.86 9.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.55000000000000004 112.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.9 m -80.72 128.46 33.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.953 -0.388 . . . . 1.0600000000000001 109.953 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 56.28 47.15 19.81 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.607 0.567 . . . . 2.23 109.743 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.459 HG21 ' HB1' ' C' ' 33' ' ' ALA . 7.7 p -89.35 142.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.1599999999999999 110.561 -175.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.24 144.33 25.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.009 0.433 . . . . 0.47999999999999998 109.951 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 25.6 tpt180 -114.16 138.06 50.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.681 -0.691 . . . . 3.1800000000000002 109.559 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -70.82 139.85 51.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.325 -0.62 . . . . 0.37 109.325 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.6 p -91.57 -17.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.199 -0.455 . . . . 0.75 111.46 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -103.03 -16.82 15.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.297 -0.411 . . . . 1.4299999999999999 111.052 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.3 -172.51 4.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.934 -0.765 . . . . 0.79000000000000004 108.934 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.48 114.42 28.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.737 0.303 . . . . 0.46999999999999997 110.271 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.573 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -158.4 146.34 18.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.40000000000000002 110.053 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -125.85 112.98 16.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.458 . . . . 0.45000000000000001 109.959 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.05 159.84 39.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.85 -0.614 . . . . 0.60999999999999999 110.008 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.85 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.4 m80 -92.84 143.69 26.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.108 -1.071 . . . . 0.41999999999999998 108.108 171.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -48.17 -53.11 17.96 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.379 0.424 . . . . 0.68000000000000005 111.593 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -61.27 -20.45 62.89 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.121 -0.491 . . . . 3.3300000000000001 112.259 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.85 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 13.8 m -84.2 -20.54 32.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.204 -0.453 . . . . 0.54000000000000004 111.119 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -114.29 -33.23 5.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.326 -0.397 . . . . 0.60999999999999999 111.655 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.46 148.3 65.93 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.31 -0.405 . . . . 0.80000000000000004 110.19 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.0 146.73 72.11 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.504 2.136 . . . . 2.1200000000000001 111.57 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.9 -11.76 57.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 3.2999999999999998 111.653 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.32 -29.79 74.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.706 -0.759 . . . . 1.46 111.379 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -82.27 138.79 34.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.383 -0.599 . . . . 1.03 109.383 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.2 t -88.29 140.59 29.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.154 0.502 . . . . 1.6000000000000001 110.397 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -72.81 110.95 9.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.326 -0.852 . . . . 2.6800000000000002 110.088 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.93 145.2 44.75 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.674 2.249 . . . . 1.1399999999999999 112.621 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.58 8.6 30.27 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.223 -0.751 . . . . 1.8999999999999999 111.223 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -117.56 33.58 5.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.154 0.502 . . . . 2.75 110.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.53 78.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.636 -0.792 . . . . 0.81999999999999995 112.355 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.25 122.29 17.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.262 -0.644 . . . . 0.87 109.262 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -120.27 140.66 50.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.529 -0.305 . . . . 2.6499999999999999 110.538 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.2 p -74.61 176.63 6.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.29 -0.633 . . . . 0.48999999999999999 109.29 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.55 -41.98 95.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.491 0.186 . . . . 4.0899999999999999 111.029 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.1 m -64.75 -46.12 83.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.54 111.358 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.53 -17.35 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.41 . . . . 0.71999999999999997 111.035 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -88.94 -5.21 58.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.391 -0.368 . . . . 1.25 110.318 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 C-N-CA 120.986 -0.626 . . . . 2.1899999999999999 112.363 -178.547 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 108.454 -0.943 . . . . 3.1800000000000002 108.454 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.7 t -56.96 107.74 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.146 0.279 . . . . 0.53000000000000003 110.654 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.37 -16.6 62.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.271 -0.49 . . . . 0.65000000000000002 112.661 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.29 -30.38 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.008 0.433 . . . . 1.04 110.679 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.6 m -108.35 -24.71 11.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.159 0.429 . . . . 0.83999999999999997 112.159 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.2 15.15 80.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.788 -0.72 . . . . 0.77000000000000002 111.431 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.72 136.15 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.598 -0.301 . . . . 2.1000000000000001 110.422 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.09 16.55 38.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.55000000000000004 112.719 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -77.61 131.84 37.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.901 -0.407 . . . . 1.0600000000000001 109.901 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 39.1 t70 55.99 46.22 22.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.94 0.876 . . . . 2.23 109.577 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.81 149.25 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.194 -0.912 . . . . 1.1599999999999999 110.09 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.0 157.08 17.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.306 -0.406 . . . . 0.47999999999999998 110.18 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -117.2 143.78 45.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.782 -0.644 . . . . 3.1800000000000002 110.109 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.88 141.18 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.712 -0.477 . . . . 0.37 109.712 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.5 p -82.29 -28.76 31.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.253 -0.431 . . . . 0.75 111.764 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -95.75 -17.11 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.883 0.327 . . . . 1.4299999999999999 111.883 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.64 -172.28 4.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.79000000000000004 110.053 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.36 114.01 27.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.025 -0.534 . . . . 0.46999999999999997 109.678 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.96 119.86 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.40000000000000002 110.321 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.58 112.32 24.4 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.538 -0.541 . . . . 0.45000000000000001 109.538 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.65 168.43 26.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.60999999999999999 110.404 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.6 m170 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.316 -0.994 . . . . 0.41999999999999998 108.316 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -56.51 -38.62 72.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.68000000000000005 111.438 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -66.72 -27.27 67.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 3.3300000000000001 111.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 32.7 m -86.92 -22.38 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.977 -0.556 . . . . 0.54000000000000004 111.48 -172.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -95.96 -31.03 13.29 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.875 -0.33 . . . . 0.60999999999999999 111.162 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -128.8 78.63 75.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.268 . . . . 0.80000000000000004 110.339 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.84 -41.63 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.983 2.455 . . . . 2.1200000000000001 112.846 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.21 -54.74 4.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.441 -0.345 . . . . 3.2999999999999998 111.28 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.71 59.59 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.64 -0.791 . . . . 1.46 111.68 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -81.36 96.79 7.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.168 0.509 . . . . 1.03 111.473 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -141.28 92.74 2.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.905 -0.776 . . . . 1.6000000000000001 108.905 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -57.79 118.65 27.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 2.6800000000000002 111.216 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.32 133.32 22.5 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.628 2.218 . . . . 1.1399999999999999 112.596 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.48 -10.37 79.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.059 -0.591 . . . . 1.8999999999999999 111.88 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.9 p -94.83 35.52 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.0 0.429 . . . . 2.75 111.191 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.8 136.03 9.17 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.907 -0.663 . . . . 0.81999999999999995 112.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -72.33 122.61 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.485 -0.561 . . . . 0.87 109.485 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.8 131.57 54.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 2.6499999999999999 110.503 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -74.96 -179.79 4.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.46 . . . . 0.48999999999999999 110.039 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -59.97 -49.42 77.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.505 0.187 . . . . 4.0899999999999999 111.505 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.8 t -64.1 -41.55 97.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.577 -0.283 . . . . 1.54 111.049 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 79.2 m -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.71999999999999997 110.896 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.6 m -89.19 2.4 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.48 -0.327 . . . . 1.25 110.663 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.305 0 C-N-CA 120.83 -0.7 . . . . 2.1899999999999999 111.638 175.713 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.967 -0.383 . . . . 3.1800000000000002 109.967 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 7.1 t -82.86 104.81 13.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.53000000000000003 109.939 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.4 -8.31 75.21 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.007 -0.542 . . . . 0.65000000000000002 113.405 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.466 HG11 ' O ' ' C' ' 38' ' ' CYS . 43.5 t -71.46 -29.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.051 0.453 . . . . 1.04 110.523 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.4 p -120.43 -34.03 3.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.297 -0.41 . . . . 0.83999999999999997 110.529 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 -13.01 23.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.126 -0.559 . . . . 0.77000000000000002 111.825 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' C' ' 22' ' ' THR . 15.7 t70 -95.97 152.71 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.269 . . . . 2.1000000000000001 110.796 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.93 14.08 5.22 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.55000000000000004 113.12 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . 0.546 HG22 ' OD2' ' C' ' 20' ' ' ASP . 9.5 t -81.7 136.34 35.48 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.178 0.489 . . . . 1.0600000000000001 109.904 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.71 49.84 17.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.912 0.863 . . . . 2.23 109.496 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 p -89.08 136.96 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.272 -0.876 . . . . 1.1599999999999999 110.028 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.54 149.73 25.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 0.47999999999999998 110.668 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.468 HH11 ' HB2' ' C' ' 33' ' ' ALA . 23.8 mmm180 -116.95 129.83 56.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.944 -0.571 . . . . 3.1800000000000002 110.464 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.0 140.48 58.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.37 109.77 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 42.8 p -89.17 -20.13 24.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.999 0.428 . . . . 0.75 111.292 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -94.06 -22.32 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 1.4299999999999999 111.134 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.59 -168.44 3.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.069 -0.715 . . . . 0.79000000000000004 109.069 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.81 114.65 29.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.833 0.349 . . . . 0.46999999999999997 110.103 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -156.64 131.11 8.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.40000000000000002 110.465 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.468 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -109.73 111.83 23.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.78 -0.645 . . . . 0.45000000000000001 109.623 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.9 p90 -155.63 166.51 33.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.60999999999999999 110.047 -178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.451 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -102.33 133.3 47.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.775 -0.824 . . . . 0.41999999999999998 108.775 171.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.68 -41.4 81.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.68000000000000005 110.924 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.21 -29.06 68.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 3.3300000000000001 111.352 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.466 ' O ' HG11 ' C' ' 17' ' ' VAL . 93.8 m -74.71 -22.0 59.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.086 0.47 . . . . 0.54000000000000004 110.474 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -96.66 -56.03 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.12 -0.491 . . . . 0.60999999999999999 111.12 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.18 147.94 38.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.928 -0.578 . . . . 0.80000000000000004 110.22 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.88 163.91 29.1 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.656 2.237 . . . . 2.1200000000000001 111.976 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -14.83 59.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.268 -0.878 . . . . 3.2999999999999998 112.468 -171.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.88 -16.54 80.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.789 -0.72 . . . . 1.46 111.802 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.99 127.85 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.552 -0.536 . . . . 1.03 109.552 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.6 p -88.2 138.09 31.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 1.6000000000000001 111.254 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 55.8 ttp180 -76.72 120.43 81.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.437 -0.801 . . . . 2.6800000000000002 110.305 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.2 Cg_exo -68.72 131.66 23.24 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.242 1.961 . . . . 1.1399999999999999 111.476 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.6 -40.88 6.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.846 -0.692 . . . . 1.8999999999999999 111.614 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -115.46 70.57 0.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.42 0.628 . . . . 2.75 110.702 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.05 51.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.66 -0.7 . . . . 0.81999999999999995 111.714 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.43 122.89 19.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.665 -0.494 . . . . 0.87 109.665 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.06 137.16 53.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 2.6499999999999999 110.918 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.522 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.4 p -77.22 -179.65 5.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.172 -0.677 . . . . 0.48999999999999999 109.172 173.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.7 -45.13 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 4.0899999999999999 110.952 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -65.24 -53.06 50.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.055 -0.521 . . . . 1.54 111.572 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.31 -16.41 62.45 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.71999999999999997 111.399 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 31.8 t -83.57 6.53 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 1.25 110.448 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 120.677 -0.773 . . . . 2.1899999999999999 113.045 176.372 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 . . . . . 0 CA--C 1.518 -0.282 0 N-CA-C 109.319 -0.622 . . . . 3.1800000000000002 109.319 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.65 109.87 1.83 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.255 -0.429 . . . . 0.53000000000000003 109.858 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.84 -29.61 58.89 Favored Glycine 0 CA--C 1.52 0.365 0 O-C-N 123.512 0.507 . . . . 0.65000000000000002 113.63 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.5 -34.18 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 1.04 111.135 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -100.79 -31.77 11.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.482 0.549 . . . . 0.83999999999999997 112.482 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.32 31.4 59.27 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.364 -1.095 . . . . 0.77000000000000002 110.364 -170.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.65 154.08 40.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.228 -0.486 . . . . 2.1000000000000001 110.676 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.98 28.84 5.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.975 -0.631 . . . . 0.55000000000000004 112.68 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -79.53 128.12 32.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.786 -0.449 . . . . 1.0600000000000001 109.786 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 53.71 47.73 23.1 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.53 0.681 . . . . 2.23 109.823 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.416 HG22 ' N ' ' C' ' 34' ' ' PHE . 1.1 p -89.66 149.82 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.258 -0.883 . . . . 1.1599999999999999 110.506 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.0 mt -100.89 151.93 21.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.321 -0.4 . . . . 0.47999999999999998 110.101 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -111.54 135.15 52.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.899 -0.592 . . . . 3.1800000000000002 110.24 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.6 t -66.52 142.99 57.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.586 -0.524 . . . . 0.37 109.586 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.7 p -93.42 -24.62 17.99 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.322 0.49 . . . . 0.75 112.322 -176.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . 0.652 ' HD2' ' SG ' ' C' ' 56' ' ' CYS . 18.9 t60 -97.56 -15.67 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.206 0.527 . . . . 1.4299999999999999 110.336 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.8 OUTLIER -150.31 -175.25 5.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.615 -0.883 . . . . 0.79000000000000004 108.615 175.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.83 114.29 28.43 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.891 0.376 . . . . 0.46999999999999997 110.666 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.36 142.88 14.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.40000000000000002 109.807 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.33 117.23 28.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.528 0.517 . . . . 0.45000000000000001 109.962 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.416 ' N ' HG22 ' C' ' 24' ' ' VAL . 33.0 p90 -156.61 167.77 29.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.827 0.346 . . . . 0.60999999999999999 110.772 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.493 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.8 m170 -97.77 123.86 41.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.493 -0.929 . . . . 0.41999999999999998 108.493 172.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -58.01 -32.53 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.723 -0.671 . . . . 0.68000000000000005 110.74 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -76.64 -19.47 57.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 3.3300000000000001 111.873 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 74.9 m -87.36 -21.94 25.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.26 0.552 . . . . 0.54000000000000004 110.018 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -90.01 -53.35 4.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.60999999999999999 110.353 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -115.98 143.99 31.92 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.647 -0.706 . . . . 0.80000000000000004 109.993 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -173.59 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.685 2.256 . . . . 2.1200000000000001 113.064 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.86 67.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 3.2999999999999998 111.167 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.49 -17.73 62.5 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.164 -0.541 . . . . 1.46 112.514 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.77 130.51 45.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.859 0.361 . . . . 1.03 110.592 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 t -89.53 150.25 22.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.385 -0.371 . . . . 1.6000000000000001 110.235 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -87.79 120.34 70.86 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.89 -0.595 . . . . 2.6800000000000002 110.595 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.08 134.18 26.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 1.1399999999999999 111.379 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 -43.41 20.0 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.771 -0.65 . . . . 1.8999999999999999 113.018 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.8 p -111.42 -14.41 13.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.904 0.352 . . . . 2.75 111.865 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.41 57.03 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.577 -0.82 . . . . 0.81999999999999995 112.448 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.9 OUTLIER -76.1 121.82 23.38 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -123.47 131.82 53.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.114 0.483 . . . . 2.6499999999999999 111.56 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.401 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -73.76 179.83 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.647 -0.706 . . . . 0.48999999999999999 109.551 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -57.89 -40.1 79.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.762 0.282 . . . . 4.0899999999999999 111.762 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.7 t -69.31 -47.92 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.986 0.422 . . . . 1.54 111.04 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' C' ' 29' ' ' HIS . 81.7 m -72.21 -21.63 61.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.71999999999999997 111.812 -177.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -102.47 16.07 27.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.489 -0.56 . . . . 1.25 109.489 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.795 0 CA-C-N 115.667 -0.697 . . . . 2.1899999999999999 112.122 -179.781 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.314 -0.624 . . . . 3.1800000000000002 109.314 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 46.8 t -67.69 104.62 1.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.916 -0.402 . . . . 0.53000000000000003 109.916 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.19 -19.99 79.72 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.65000000000000002 113.218 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.75 -43.11 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.756 0.312 . . . . 1.04 111.23 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p -108.76 -29.78 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.387 . . . . 0.83999999999999997 110.896 -177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.5 56.24 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.871 -0.681 . . . . 0.77000000000000002 111.998 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 10.2 m-20 -97.17 145.35 26.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 2.1000000000000001 110.615 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.27 17.25 10.54 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.049 -0.596 . . . . 0.55000000000000004 112.091 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -80.1 135.49 36.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.926 -0.398 . . . . 1.0600000000000001 109.926 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 48.3 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.974 0.892 . . . . 2.23 109.344 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.69 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.194 -0.912 . . . . 1.1599999999999999 110.315 -174.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 85.5 mt -91.87 154.27 18.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.902 0.382 . . . . 0.47999999999999998 110.551 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -122.27 130.62 53.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.584 -0.735 . . . . 3.1800000000000002 109.749 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -68.69 136.31 52.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.37 109.746 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.0 p -87.96 -19.49 27.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.103 0.478 . . . . 0.75 110.998 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -93.21 -24.97 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 1.4299999999999999 111.116 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.9 p -151.13 -163.99 1.9 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.465 -0.569 . . . . 0.79000000000000004 109.465 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 114.78 29.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.46999999999999997 110.227 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 138.74 10.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.40000000000000002 110.498 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -122.06 112.85 18.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.777 -0.647 . . . . 0.45000000000000001 109.343 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 44.6 p90 -155.7 170.25 22.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.151 -0.477 . . . . 0.60999999999999999 110.183 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -105.75 133.82 49.87 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.507 -0.553 . . . . 0.41999999999999998 109.507 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.7 t-105 -60.25 -36.8 78.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.652 -0.703 . . . . 0.68000000000000005 110.073 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -68.44 -34.17 75.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.625 -0.716 . . . . 3.3300000000000001 110.93 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.74 -22.71 56.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.54000000000000004 110.874 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 2.8 m170 -90.47 -42.26 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 0.60999999999999999 111.582 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.8 77.3 29.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.484 -0.325 . . . . 0.80000000000000004 111.284 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 7.1 Cg_exo -74.54 4.17 4.73 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.146 2.564 . . . . 2.1200000000000001 112.284 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.57 -7.27 59.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 3.2999999999999998 110.873 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 28.04 11.17 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.598 -0.811 . . . . 1.46 112.109 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 15.3 m -69.42 144.05 53.45 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.979 -0.378 . . . . 1.03 109.979 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.4 t -88.24 143.93 26.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 1.6000000000000001 110.536 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -92.72 117.62 67.64 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.436 -0.802 . . . . 2.6800000000000002 111.453 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.99 132.89 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.714 2.276 . . . . 1.1399999999999999 111.56 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.92 5.04 68.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.756 -0.735 . . . . 1.8999999999999999 112.548 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -89.63 -75.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.338 0.59 . . . . 2.75 111.106 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.37 101.37 0.57 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.485 -0.78 . . . . 0.81999999999999995 111.658 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.18 128.25 34.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.978 0.418 . . . . 0.87 110.354 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -114.08 135.17 54.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.198 -0.455 . . . . 2.6499999999999999 110.364 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.523 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 14.3 p -74.39 176.57 6.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.432 -0.581 . . . . 0.48999999999999999 109.432 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' C' ' 55' ' ' SER . 8.1 ptm85 -58.5 -43.91 89.25 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 4.0899999999999999 111.527 -175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . 0.457 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 20.2 m -65.86 -46.53 78.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.655 -0.248 . . . . 1.54 111.148 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.9 m -72.37 -22.58 61.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.71999999999999997 111.569 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -81.41 -13.95 57.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.015 0.436 . . . . 1.25 110.02 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 111.295 -0.722 . . . . 2.1899999999999999 111.295 178.063 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.701 0.286 . . . . 3.1800000000000002 110.353 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 43.0 t -75.2 104.93 5.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.396 -0.594 . . . . 0.53000000000000003 109.396 177.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.8 -12.42 84.2 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.65000000000000002 113.631 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 87.2 t -67.19 -41.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 1.04 110.736 178.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 p -106.67 -28.44 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 0.83999999999999997 110.919 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.77 1.47 55.2 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.859 -0.686 . . . . 0.77000000000000002 112.092 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 19.5 m-20 -107.2 147.38 30.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.493 . . . . 2.1000000000000001 111.812 -178.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 2.4 22.78 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.862 -0.895 . . . . 0.55000000000000004 110.862 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . 0.416 HG22 ' HB3' ' C' ' 20' ' ' ASP . 13.4 t -72.91 134.64 44.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.659 -0.271 . . . . 1.0600000000000001 110.438 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.62 47.17 21.29 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.53 0.681 . . . . 2.23 109.922 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.6 p -89.59 148.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.148 -0.933 . . . . 1.1599999999999999 110.668 -173.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.438 HD12 ' H ' ' C' ' 36' ' ' TRP . 90.4 mt -100.01 155.8 17.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.227 -0.442 . . . . 0.47999999999999998 110.21 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.0 mmm180 -114.6 153.82 29.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.74 -0.664 . . . . 3.1800000000000002 109.424 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -89.39 141.77 28.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.262 0.553 . . . . 0.37 110.433 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -81.17 -26.62 35.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 0.75 112.168 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' C' ' 56' ' ' CYS . 11.8 m170 -102.61 -14.93 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.982 -0.287 . . . . 1.4299999999999999 111.614 -176.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.1 p -150.95 -174.6 4.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.964 -0.384 . . . . 0.79000000000000004 109.964 178.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 115.03 29.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.405 -0.362 . . . . 0.46999999999999997 110.227 -178.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.56 135.1 4.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.384 -0.371 . . . . 0.40000000000000002 111.043 -177.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 111.87 24.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.329 -0.619 . . . . 0.45000000000000001 109.329 172.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -156.45 169.95 23.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.003 -0.544 . . . . 0.60999999999999999 110.076 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 28.5 m170 -106.95 130.75 54.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.114 -0.698 . . . . 0.41999999999999998 109.114 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.438 ' H ' HD12 ' C' ' 25' ' ' LEU . 42.3 t-105 -59.15 -36.75 75.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.68 -0.691 . . . . 0.68000000000000005 110.092 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -70.67 -25.39 62.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.993 -0.549 . . . . 3.3300000000000001 111.432 -178.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 84.2 m -83.83 -27.36 28.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 0.54000000000000004 110.83 178.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -89.59 -29.06 19.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.806 0.336 . . . . 0.60999999999999999 110.911 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.46 71.27 76.98 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.058 -0.519 . . . . 0.80000000000000004 110.251 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.86 13.68 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.185 2.59 . . . . 2.1200000000000001 112.64 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.36 4.46 35.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 3.2999999999999998 111.397 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.18 17.98 38.21 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.589 -0.815 . . . . 1.46 111.518 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.7 m -74.24 130.04 38.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 1.03 110.853 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -88.95 137.91 31.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.716 -0.476 . . . . 1.6000000000000001 109.716 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -72.69 136.5 80.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 2.6800000000000002 111.069 -175.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.63 149.34 61.16 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.176 2.584 . . . . 1.1399999999999999 112.653 -175.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.8 18.91 56.3 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.855 -0.688 . . . . 1.8999999999999999 112.443 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -116.33 37.28 3.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.329 0.585 . . . . 2.75 110.471 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.62 129.77 6.45 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.786 -0.721 . . . . 0.81999999999999995 111.769 -177.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -71.18 124.01 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.723 -0.473 . . . . 0.87 109.723 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.35 136.81 52.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 2.6499999999999999 110.729 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.61 162.64 28.99 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.072 -1.084 . . . . 0.48999999999999999 108.072 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -59.87 -31.96 70.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.838 0.745 . . . . 4.0899999999999999 111.405 -170.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -64.88 -44.88 88.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.745 0.307 . . . . 1.54 110.588 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' C' ' 29' ' ' HIS . 86.7 m -72.75 -17.86 61.56 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.798 0.295 . . . . 0.71999999999999997 111.798 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -89.08 -13.0 39.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.482 -0.487 . . . . 1.25 110.192 176.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.732 0 C-N-CA 120.985 -0.626 . . . . 2.1899999999999999 112.025 179.131 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.116 -0.698 . . . . 3.1800000000000002 109.116 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.93 104.07 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.829 -0.434 . . . . 0.53000000000000003 109.829 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -3.62 90.6 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.65000000000000002 112.548 -175.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.73 -41.68 54.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.044 0.45 . . . . 1.04 110.543 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.34 -29.23 8.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.83999999999999997 110.243 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.47 45.04 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.886 -0.673 . . . . 0.77000000000000002 112.252 179.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -96.13 147.85 23.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.914 0.387 . . . . 2.1000000000000001 111.142 -177.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.28 15.82 13.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.107 -0.568 . . . . 0.55000000000000004 112.531 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -80.79 127.9 33.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.449 -0.204 . . . . 1.0600000000000001 110.449 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.3 t70 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.638 0.732 . . . . 2.23 110.492 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -89.39 135.19 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.849 -0.614 . . . . 1.1599999999999999 111.124 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.15 158.96 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.361 -0.836 . . . . 0.47999999999999998 109.545 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -117.24 134.77 54.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 3.1800000000000002 110.713 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.57 138.87 55.46 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.16 -0.682 . . . . 0.37 109.16 177.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.1 p -91.24 -20.88 21.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.204 0.526 . . . . 0.75 110.781 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.75 -24.14 21.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.4299999999999999 110.844 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.7 -169.07 3.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.434 -0.58 . . . . 0.79000000000000004 109.434 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.11 114.86 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.314 -0.254 . . . . 0.46999999999999997 110.314 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.54 3.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.25 -0.432 . . . . 0.40000000000000002 110.479 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.64 121.75 45.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.534 0.521 . . . . 0.45000000000000001 109.633 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.17 173.24 16.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.386 . . . . 0.60999999999999999 111.24 -174.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -105.1 125.31 50.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.368 -0.604 . . . . 0.41999999999999998 109.368 173.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -62.04 -31.69 72.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.878 -0.601 . . . . 0.68000000000000005 109.746 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.92 -24.22 61.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.796 -0.638 . . . . 3.3300000000000001 111.458 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -88.02 -22.79 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.54000000000000004 110.617 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.85 -42.65 11.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.158 -0.474 . . . . 0.60999999999999999 111.107 -178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -122.65 147.33 50.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.80000000000000004 110.794 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.12 170.07 13.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.025 2.483 . . . . 2.1200000000000001 112.074 177.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -18.12 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.643 . . . . 3.2999999999999998 111.338 -177.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.26 -13.9 82.38 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 1.46 112.161 176.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -92.74 132.55 36.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.796 0.331 . . . . 1.03 110.548 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 m -88.66 136.24 33.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.283 -0.417 . . . . 1.6000000000000001 110.674 -177.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -81.92 121.81 79.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.646 . . . . 2.6800000000000002 110.369 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 42.3 Cg_endo -69.81 149.16 66.22 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.419 2.079 . . . . 1.1399999999999999 111.572 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -33.48 5.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.45 -0.881 . . . . 1.8999999999999999 113.238 -175.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -105.75 -38.05 6.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 2.75 111.501 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.94 72.07 0.21 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.768 -0.729 . . . . 0.81999999999999995 112.336 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 0.4 OUTLIER -75.41 121.97 23.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -122.56 134.39 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 2.6499999999999999 111.09 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -74.36 176.92 6.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.584 -0.734 . . . . 0.48999999999999999 109.38 173.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -61.13 -37.32 82.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.048 0.386 . . . . 4.0899999999999999 110.292 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -65.06 -51.89 58.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 1.54 110.972 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 77.5 m -71.98 -19.54 61.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.552 0.215 . . . . 0.71999999999999997 111.369 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -78.74 -14.09 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.114 0.483 . . . . 1.25 109.754 178.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 110.534 -1.026 . . . . 2.1899999999999999 110.534 173.035 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.843 -0.429 . . . . 3.1800000000000002 109.843 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 11.2 t -79.68 103.77 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.258 -0.645 . . . . 0.53000000000000003 109.258 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.66 -18.4 75.71 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.65000000000000002 113.367 -171.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 48.3 t -64.39 -32.78 59.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.735 0.303 . . . . 1.04 111.104 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -118.09 -33.84 4.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.907 0.384 . . . . 0.83999999999999997 110.819 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.62 -13.98 24.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.775 -0.726 . . . . 0.77000000000000002 112.24 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 11.5 m-20 -87.61 131.6 34.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 2.1000000000000001 110.911 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.41 -1.9 33.09 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.314 -0.714 . . . . 0.55000000000000004 111.314 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -76.94 135.43 38.76 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 110.081 -0.34 . . . . 1.0600000000000001 110.081 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.88 45.96 20.53 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.435 0.636 . . . . 2.23 109.784 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.61 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.151 -0.931 . . . . 1.1599999999999999 110.048 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.39 146.2 25.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.897 0.379 . . . . 0.47999999999999998 110.242 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -113.92 132.47 55.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.925 -0.579 . . . . 3.1800000000000002 110.165 -175.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -63.52 130.72 45.56 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.658 -0.497 . . . . 0.37 109.658 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 48.4 p -85.92 -5.81 59.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.75 110.983 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -108.42 -21.46 12.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 1.4299999999999999 111.209 -178.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.8 p -152.28 -163.51 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.726 -0.472 . . . . 0.79000000000000004 109.726 176.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.56 114.93 29.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.161 -0.311 . . . . 0.46999999999999997 110.161 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.48 128.47 1.81 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.429 -0.351 . . . . 0.40000000000000002 110.473 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.69 112.56 25.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.744 0.653 . . . . 0.45000000000000001 109.771 176.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -154.72 167.58 29.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.395 -0.366 . . . . 0.60999999999999999 110.339 -176.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.8 m170 -106.06 138.56 42.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.964 -0.754 . . . . 0.41999999999999998 108.964 172.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -61.79 -33.73 74.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 0.68000000000000005 110.385 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -74.64 -25.29 59.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 3.3300000000000001 111.452 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.7 m -83.67 -22.77 32.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.124 0.488 . . . . 0.54000000000000004 110.597 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -96.88 -49.62 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.075 -0.512 . . . . 0.60999999999999999 111.517 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 96.3 m-85 -110.95 149.62 40.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.757 0.313 . . . . 0.80000000000000004 111.003 -173.197 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 16.6 Cg_exo -67.86 158.21 58.33 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.617 2.211 . . . . 2.1200000000000001 110.881 174.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.19 -7.96 34.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.954 -0.566 . . . . 3.2999999999999998 111.521 -177.351 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.18 -12.22 84.57 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.536 -0.626 . . . . 1.46 111.536 174.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 37.5 m -95.15 135.08 37.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.26 -0.274 . . . . 1.03 110.26 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 p -89.05 136.13 33.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.987 0.422 . . . . 1.6000000000000001 111.257 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -80.96 127.93 72.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 2.6800000000000002 110.604 -177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.03 140.47 37.99 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.874 2.383 . . . . 1.1399999999999999 112.046 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.43 25.56 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.011 -0.614 . . . . 1.8999999999999999 111.984 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 74.1 1.48 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.886 0.374 . . . . 2.75 110.545 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 61.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.739 -0.743 . . . . 0.81999999999999995 112.212 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 122.7 18.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.938 0.399 . . . . 0.87 110.074 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -117.4 134.33 54.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.231 -0.44 . . . . 2.6499999999999999 110.884 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -81.08 169.67 17.16 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.66 -0.867 . . . . 0.48999999999999999 108.66 171.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -51.94 -47.17 64.86 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.415 0.447 . . . . 4.0899999999999999 111.419 -174.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -63.72 -45.05 91.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.917 -0.583 . . . . 1.54 111.762 -176.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 95.6 m -71.77 -31.11 66.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.71999999999999997 111.433 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 44.5 p -85.41 7.23 23.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.718 -0.219 . . . . 1.25 111.026 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 121.22 -0.514 . . . . 2.1899999999999999 113.115 -176.763 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.4 ttp180 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.862 0.363 . . . . 3.1800000000000002 110.746 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.37 111.79 5.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.592 . . . . 0.53000000000000003 109.938 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.42 -31.94 71.51 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.477 0.486 . . . . 0.65000000000000002 113.128 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.34 -37.54 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.366 . . . . 1.04 110.923 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.43 -39.95 9.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.256 0.465 . . . . 0.83999999999999997 112.256 -175.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.86 6.41 65.44 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.73 -0.748 . . . . 0.77000000000000002 111.423 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.82 149.1 42.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.793 0.33 . . . . 2.1000000000000001 110.434 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -107.62 12.25 38.99 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.55000000000000004 112.943 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 m -80.13 128.06 33.05 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.665 -0.315 . . . . 1.0600000000000001 111.085 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.06 51.11 7.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.493 -0.776 . . . . 2.23 111.161 177.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -90.15 145.31 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.721 . . . . 1.1599999999999999 111.227 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 78.0 mt -101.11 143.98 30.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.275 -0.875 . . . . 0.47999999999999998 109.175 175.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 137.2 49.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.637 0.256 . . . . 3.1800000000000002 110.465 -178.571 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -64.57 135.21 55.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.16 -19.02 29.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.181 0.515 . . . . 0.75 110.88 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -97.47 -18.08 19.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.4299999999999999 111.332 -177.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.53 -168.6 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.288 -0.634 . . . . 0.79000000000000004 109.288 176.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.25 114.89 29.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.663 0.268 . . . . 0.46999999999999997 110.603 -178.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -172.13 136.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.40000000000000002 109.936 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -122.05 122.83 40.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.296 0.372 . . . . 0.45000000000000001 110.004 177.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -160.07 169.51 23.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.033 -0.53 . . . . 0.60999999999999999 110.294 -176.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.3 m170 -95.91 130.68 42.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.002 -1.111 . . . . 0.41999999999999998 108.002 171.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -56.12 -37.28 69.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.68000000000000005 111.684 -177.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -72.17 -15.15 61.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 3.3300000000000001 111.614 -177.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.6 m -90.89 -22.52 20.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.197 -0.456 . . . . 0.54000000000000004 110.676 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -94.19 -40.78 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 0.60999999999999999 110.494 175.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.72 79.55 31.29 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.80000000000000004 110.178 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -83.55 11.34 3.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.814 2.342 . . . . 2.1200000000000001 112.862 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.92 0.76 52.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 3.2999999999999998 111.187 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.05 23.77 37.03 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 1.46 111.661 -176.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -61.88 149.52 40.15 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.606 0.362 . . . . 1.03 110.67 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -87.74 121.7 30.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.74 0.305 . . . . 1.6000000000000001 110.524 -176.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 11.5 ttp180 -64.48 120.39 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 2.6800000000000002 110.967 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 17.4 Cg_exo -65.14 132.26 31.28 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.431 2.088 . . . . 1.1399999999999999 111.703 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.53 -15.95 38.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.787 -0.721 . . . . 1.8999999999999999 111.835 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.3 p -97.07 37.3 1.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 2.75 111.003 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.55 113.5 2.17 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.81999999999999995 111.829 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.85 123.52 29.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.735 -0.468 . . . . 0.87 109.735 -177.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -112.19 148.04 34.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.046 0.45 . . . . 2.6499999999999999 110.724 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 22.0 p -93.9 178.01 5.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.105 -0.702 . . . . 0.48999999999999999 109.105 175.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -58.73 -33.47 70.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.886 0.312 . . . . 4.0899999999999999 111.142 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -69.77 -51.56 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 1.54 111.24 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -71.98 -17.72 62.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.319 -0.4 . . . . 0.71999999999999997 111.341 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -92.23 -1.23 57.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.48 . . . . 1.25 110.283 173.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.652 0 CA-C-N 115.921 -0.581 . . . . 2.1899999999999999 112.04 -179.949 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 . . . . . 0 N--CA 1.451 -0.381 0 N-CA-C 110.145 -0.317 . . . . 3.1800000000000002 110.145 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 t -63.15 106.12 0.81 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.53000000000000003 109.515 175.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.37 -31.61 57.02 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.41 0.444 . . . . 0.65000000000000002 113.492 -175.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.03 -34.44 70.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.074 0.464 . . . . 1.04 111.043 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.81 -38.14 7.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.052 0.39 . . . . 0.83999999999999997 112.052 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.96 -9.2 59.81 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.585 -0.606 . . . . 0.77000000000000002 111.585 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.41 146.18 37.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.954 0.407 . . . . 2.1000000000000001 111.191 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.13 12.96 40.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.067 -0.813 . . . . 0.55000000000000004 111.067 174.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -73.94 128.55 35.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.444 . . . . 1.0600000000000001 110.375 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 55.57 47.13 21.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.669 0.747 . . . . 2.23 109.651 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.04 153.78 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.25 -0.887 . . . . 1.1599999999999999 110.744 -174.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -107.48 144.26 34.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.47999999999999998 109.834 176.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 144.64 40.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.124 -0.489 . . . . 3.1800000000000002 110.166 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.1 t -68.51 140.11 55.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.393 -0.595 . . . . 0.37 109.393 177.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.5 p -90.43 -18.65 25.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.897 0.379 . . . . 0.75 110.895 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -92.83 -24.2 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 1.4299999999999999 111.077 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.3 p -150.38 -173.1 4.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.036 -0.727 . . . . 0.79000000000000004 109.036 178.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.93 118.76 37.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.582 0.229 . . . . 0.46999999999999997 110.437 -178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.24 135.99 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.40000000000000002 110.233 -177.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.33 112.76 22.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 0.45000000000000001 110.11 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -153.99 166.61 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.062 -0.517 . . . . 0.60999999999999999 109.873 -177.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.763 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.3 m170 -97.71 140.32 32.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.41999999999999998 108.638 173.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -49.18 -53.5 20.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.413 0.446 . . . . 0.68000000000000005 111.615 -175.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -72.34 -5.55 37.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 3.3300000000000001 112.136 -173.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -91.45 -21.26 21.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.896 0.379 . . . . 0.54000000000000004 110.63 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -108.4 -29.5 8.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.60999999999999999 110.941 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.62 138.55 29.54 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.80000000000000004 110.511 -177.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.5 148.6 93.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.544 2.162 . . . . 2.1200000000000001 111.068 173.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -18.76 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 3.2999999999999998 112.079 -174.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 -16.51 71.14 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.087 -0.578 . . . . 1.46 111.853 175.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.1 m -90.59 130.77 36.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.498 -0.556 . . . . 1.03 109.498 176.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.43 143.54 26.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 1.6000000000000001 110.993 -174.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.34 125.2 86.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 2.6800000000000002 110.789 -177.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.08 163.5 39.02 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.044 2.496 . . . . 1.1399999999999999 112.413 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.27 7.1 8.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.853 -0.689 . . . . 1.8999999999999999 111.92 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -108.92 -1.82 18.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 2.75 110.856 -178.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.74 120.87 0.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.025 -0.607 . . . . 0.81999999999999995 111.673 -177.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 122.68 25.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 0.87 109.771 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -111.17 134.9 52.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.436 -0.347 . . . . 2.6499999999999999 110.937 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -75.69 166.56 23.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.614 -0.884 . . . . 0.48999999999999999 108.614 170.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -63.42 -30.54 71.65 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.744 . . . . 4.0899999999999999 110.871 -172.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.4 m -65.12 -45.23 85.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.927 178.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.1 m -72.76 -31.2 64.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.71999999999999997 111.9 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -83.53 -1.62 54.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 1.25 111.542 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.747 0 C-N-CA 120.875 -0.678 . . . . 2.1899999999999999 111.608 -178.566 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' C' ' 19' ' ' GLY . 49.1 ttp180 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.88 -0.415 . . . . 3.1800000000000002 109.88 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 31.3 t -70.91 103.0 2.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.084 -0.71 . . . . 0.53000000000000003 109.084 176.021 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.12 1.8 83.6 Favored Glycine 0 CA--C 1.509 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.65000000000000002 112.748 -174.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 32.0 t -77.17 -28.72 16.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.096 0.474 . . . . 1.04 110.091 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.9 p -123.6 -35.46 2.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.83999999999999997 111.019 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' C' ' 14' ' ' ARG . . . 109.91 2.51 30.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.962 -0.637 . . . . 0.77000000000000002 112.266 -178.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 8.7 m-20 -107.39 140.44 40.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 2.1000000000000001 111.232 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.59 -1.99 30.8 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.55000000000000004 111.522 175.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -74.86 135.19 41.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.0600000000000001 110.059 178.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.34 41.05 16.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.927 0.394 . . . . 2.23 110.277 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.483 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.9 p -88.29 146.05 6.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 1.1599999999999999 110.636 -174.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 77.1 mt -105.96 159.29 16.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.029 -0.532 . . . . 0.47999999999999998 110.379 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 14.0 mmt180 -126.39 143.18 51.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 3.1800000000000002 109.717 -178.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 35.3 t -70.63 146.53 49.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.864 -0.734 . . . . 0.37 109.066 173.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.464 HG21 ' HA2' ' C' ' 50' ' ' GLY . 28.7 p -84.79 -27.0 27.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.101 0.477 . . . . 0.75 110.812 177.276 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.4 -12.4 21.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 1.4299999999999999 111.091 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 m -139.55 172.76 12.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.033 0.444 . . . . 0.79000000000000004 110.279 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 113.69 27.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.659 -0.7 . . . . 0.46999999999999997 109.388 174.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.12 134.74 3.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.485 -0.325 . . . . 0.40000000000000002 110.601 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -100.72 111.98 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.759 -0.655 . . . . 0.45000000000000001 109.57 175.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.06 164.71 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.0 -0.545 . . . . 0.60999999999999999 110.23 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 32.5 m170 -104.63 138.57 40.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.598 -0.519 . . . . 0.41999999999999998 109.598 174.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -63.93 -34.46 78.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.76 -0.655 . . . . 0.68000000000000005 109.74 178.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -76.64 -15.51 59.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.586 . . . . 3.3300000000000001 111.072 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 97.8 m -92.29 -22.45 19.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.54000000000000004 110.507 176.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -93.96 -41.82 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.843 -0.617 . . . . 0.60999999999999999 111.632 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -119.95 147.32 44.1 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.985 -0.552 . . . . 0.80000000000000004 111.242 -171.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.76 164.33 27.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.003 2.468 . . . . 2.1200000000000001 111.503 174.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.05 -15.54 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 3.2999999999999998 112.184 -174.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -10.23 85.46 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.809 -0.71 . . . . 1.46 112.459 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.4 m -87.19 137.5 32.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.856 0.36 . . . . 1.03 110.72 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -89.65 131.82 35.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.328 -0.396 . . . . 1.6000000000000001 110.841 -177.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -89.94 123.15 66.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 2.6800000000000002 110.915 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.78 133.63 22.29 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.325 2.017 . . . . 1.1399999999999999 111.266 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.42 -47.06 10.98 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.1 -0.571 . . . . 1.8999999999999999 112.961 -174.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -118.96 60.08 0.82 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.133 0.492 . . . . 2.75 110.779 -177.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 164.07 57.17 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.356 -0.698 . . . . 0.81999999999999995 111.356 -177.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.52 124.98 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.374 0.607 . . . . 0.87 110.587 -176.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.37 145.56 31.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.625 -0.716 . . . . 2.6499999999999999 110.602 -177.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 21.4 p -89.66 -169.37 2.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.064 -0.516 . . . . 0.48999999999999999 109.998 178.001 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.7 -53.0 63.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.574 0.226 . . . . 4.0899999999999999 110.84 -179.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 41.4 t -61.22 -42.92 99.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.54 110.971 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.19 -16.93 62.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.105 0.409 . . . . 0.71999999999999997 112.105 -176.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 43.5 m -101.1 4.73 42.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.072 0.463 . . . . 1.25 110.627 177.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.762 0 C-N-CA 120.847 -0.692 . . . . 2.1899999999999999 112.115 -179.613 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.825 -0.435 . . . . 3.1800000000000002 109.825 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 39.6 t -65.37 105.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.713 -0.477 . . . . 0.53000000000000003 109.713 177.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.89 66.17 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.268 -0.492 . . . . 0.65000000000000002 112.901 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -32.19 56.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.04 110.97 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -106.71 -37.83 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.83999999999999997 111.91 -176.072 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.58 -23.63 35.4 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.317 -0.713 . . . . 0.77000000000000002 111.317 -174.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -86.79 148.93 25.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 2.1000000000000001 111.027 -178.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.82 12.71 35.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.55000000000000004 111.888 177.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 47.8 m -73.9 124.25 25.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.373 0.13 . . . . 1.0600000000000001 111.174 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 55.69 66.76 1.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.072 0.857 . . . . 2.23 111.118 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -108.48 142.3 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 1.1599999999999999 111.362 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' C' ' 36' ' ' TRP . 34.4 mt -82.27 144.35 30.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.662 . . . . 0.47999999999999998 110.51 178.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.43 145.81 29.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.576 -0.738 . . . . 3.1800000000000002 110.307 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.14 136.75 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.666 -0.494 . . . . 0.37 109.666 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -88.56 -5.19 58.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.75 111.648 -178.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -113.72 -20.21 11.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 1.4299999999999999 110.812 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.82 -171.95 4.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.157 -0.682 . . . . 0.79000000000000004 109.157 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.04 29.8 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.691 -0.485 . . . . 0.46999999999999997 109.691 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 155.39 24.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.311 -0.404 . . . . 0.40000000000000002 110.619 -178.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.13 124.59 17.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.872 -0.604 . . . . 0.45000000000000001 109.979 178.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -163.84 161.08 22.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.471 -0.331 . . . . 0.60999999999999999 110.354 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.71 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.91 127.54 36.03 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.373 -0.973 . . . . 0.41999999999999998 108.373 172.606 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.475 ' HB2' HD12 ' C' ' 25' ' ' LEU . 68.1 t-105 -45.58 -53.51 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.483 0.489 . . . . 0.68000000000000005 112.01 -174.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -60.37 -30.22 69.42 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.125 0.417 . . . . 3.3300000000000001 112.125 -174.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.1 m -73.54 -22.46 60.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 0.54000000000000004 111.004 -177.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -103.29 -44.98 5.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 0.60999999999999999 110.935 178.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 88.3 m-85 -116.82 122.74 31.12 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.983 -0.553 . . . . 0.80000000000000004 110.217 -176.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.5 176.59 5.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 2.1200000000000001 111.853 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.69 -10.79 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.65 . . . . 3.2999999999999998 112.047 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.95 -26.08 74.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.872 -0.68 . . . . 1.46 111.713 174.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 41.7 m -101.73 135.45 43.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.226 -0.287 . . . . 1.03 110.226 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -89.17 154.53 20.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.767 0.318 . . . . 1.6000000000000001 110.332 -178.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -88.36 112.23 48.48 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 2.6800000000000002 110.757 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.62 142.78 44.99 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.838 2.358 . . . . 1.1399999999999999 111.909 177.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.13 -32.4 23.33 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.463 -0.655 . . . . 1.8999999999999999 111.463 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.0 p -125.64 150.91 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.93 -0.396 . . . . 2.75 109.93 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.43 39.6 80.11 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.65 -0.786 . . . . 0.81999999999999995 111.971 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.79 124.77 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.557 -0.534 . . . . 0.87 109.557 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -117.31 148.17 41.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.156 -0.475 . . . . 2.6499999999999999 110.81 -177.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -83.25 -176.68 6.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 0.48999999999999999 109.458 173.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -63.04 -39.47 94.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.104 0.478 . . . . 4.0899999999999999 110.286 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 36.3 t -66.23 -53.98 30.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.889 -0.596 . . . . 1.54 111.142 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.92 -17.1 62.12 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.453 0.538 . . . . 0.71999999999999997 112.453 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -108.21 19.62 19.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.053 0.454 . . . . 1.25 110.345 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.865 0 C-N-CA 120.185 -1.007 . . . . 2.1899999999999999 112.587 -178.011 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 107.992 -1.114 . . . . 3.1800000000000002 107.992 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.7 t -58.04 106.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.51 0.195 . . . . 0.53000000000000003 110.688 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.42 -28.54 73.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.244 -0.503 . . . . 0.65000000000000002 112.619 -178.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.49 -39.47 85.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.453 . . . . 1.04 110.744 178.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.46 -21.44 17.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.197 -0.456 . . . . 0.83999999999999997 111.619 -177.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.87 74.91 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.946 -0.862 . . . . 0.77000000000000002 110.946 -174.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.34 144.92 30.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.342 . . . . 2.1000000000000001 110.189 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.13 24.92 9.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.55000000000000004 112.853 -178.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 m -80.25 129.56 34.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.736 -0.468 . . . . 1.0600000000000001 109.736 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 55.24 56.01 6.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.718 0.771 . . . . 2.23 109.728 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.86 148.73 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.35 -0.841 . . . . 1.1599999999999999 110.809 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 96.1 mt -94.64 150.79 19.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 0.47999999999999998 110.544 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.2 mmt180 -117.3 152.14 35.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.793 -0.64 . . . . 3.1800000000000002 110.191 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.564 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 17.9 t -81.72 138.75 35.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.654 -0.499 . . . . 0.37 109.654 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.5 p -81.7 -23.23 36.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.585 -0.28 . . . . 0.75 111.726 -177.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -103.52 -18.7 14.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.939 0.348 . . . . 1.4299999999999999 111.939 -176.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.564 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.4 p -150.71 -173.89 4.61 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.626 -0.509 . . . . 0.79000000000000004 109.626 177.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.32 125.36 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.566 0.222 . . . . 0.46999999999999997 110.455 -178.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.83 151.46 7.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.40000000000000002 110.22 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -137.63 112.6 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.461 0.476 . . . . 0.45000000000000001 110.19 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.59 165.6 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.60999999999999999 110.094 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.5 m170 -98.27 132.77 43.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 0.41999999999999998 108.328 171.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -47.49 -53.49 14.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.306 0.484 . . . . 0.68000000000000005 112.306 -173.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -70.47 -20.85 62.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.854 0.359 . . . . 3.3300000000000001 111.783 -173.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.7 m -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.173 0.511 . . . . 0.54000000000000004 110.102 177.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 1.2 m170 -93.26 -51.3 5.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.60999999999999999 110.535 176.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -111.71 91.37 14.65 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.793 -0.639 . . . . 0.80000000000000004 110.404 -177.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 83.1 Cg_endo -97.32 3.48 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.957 2.438 . . . . 2.1200000000000001 112.358 176.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.71 55.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 3.2999999999999998 112.286 -172.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.76 41.51 2.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.408 -0.901 . . . . 1.46 112.367 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.923 -0.399 . . . . 1.03 109.923 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -88.01 122.45 31.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.669 0.271 . . . . 1.6000000000000001 110.567 -177.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -69.68 112.86 13.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 2.6800000000000002 111.117 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 55.2 Cg_endo -72.18 143.22 39.38 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.361 2.041 . . . . 1.1399999999999999 112.141 177.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.55 -11.94 54.64 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.859 -0.686 . . . . 1.8999999999999999 112.173 178.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 14.4 p -95.28 -70.63 0.7 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.374 0.607 . . . . 2.75 111.461 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.56 77.07 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.81999999999999995 112.445 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 1.4 tm? -70.94 123.08 21.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.11 -0.7 . . . . 0.87 109.11 177.104 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -112.91 146.92 38.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 2.6499999999999999 110.91 -176.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 21.1 p -83.57 -174.27 5.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.649 -0.871 . . . . 0.48999999999999999 108.649 170.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' C' ' 54' ' ' ARG . 43.7 ttp180 -67.89 -43.89 78.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.495 -0.482 . . . . 4.0899999999999999 110.101 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -59.32 -49.5 77.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.813 -0.63 . . . . 1.54 111.183 -178.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.2 m -70.41 -16.33 62.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.803 0.335 . . . . 0.71999999999999997 111.557 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -90.2 -8.75 50.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 1.25 110.445 176.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.606 0 C-N-CA 120.981 -0.628 . . . . 2.1899999999999999 112.211 -178.732 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 108.864 -0.791 . . . . 3.1800000000000002 108.864 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.3 t -71.45 103.47 2.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.553 -0.536 . . . . 0.53000000000000003 109.553 178.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.38 -4.1 77.57 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-N 115.927 -0.579 . . . . 0.65000000000000002 112.28 -175.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 36.8 t -67.78 -29.11 43.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.247 0.546 . . . . 1.04 109.704 177.244 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.42 -38.42 3.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.83999999999999997 110.163 176.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.54 -5.94 26.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.993 -0.623 . . . . 0.77000000000000002 111.823 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 21.1 t70 -108.29 146.64 32.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.886 0.374 . . . . 2.1000000000000001 110.704 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.15 16.57 9.99 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.17 -0.538 . . . . 0.55000000000000004 112.083 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -80.26 133.39 35.98 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 122.828 -0.219 . . . . 1.0600000000000001 110.512 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.41 56.12 8.43 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.448 0.642 . . . . 2.23 109.813 -175.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' C' ' 33' ' ' ALA . 5.5 p -96.29 146.83 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 110.798 -172.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -86.85 144.05 27.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.102 0.477 . . . . 0.47999999999999998 109.864 177.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -107.99 143.79 36.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.559 -0.746 . . . . 3.1800000000000002 109.945 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 t -74.89 137.81 42.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.407 -0.59 . . . . 0.37 109.407 177.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 47.9 p -91.16 -19.62 22.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.116 0.484 . . . . 0.75 110.914 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -91.7 -24.11 19.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 1.4299999999999999 110.792 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.58 -165.94 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.131 -0.692 . . . . 0.79000000000000004 109.131 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 114.56 28.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 110.35 177.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.79 142.88 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.40000000000000002 110.607 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.62 117.15 32.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.854 -0.612 . . . . 0.45000000000000001 109.514 176.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.409 ' HB2' ' NE2' ' C' ' 39' ' ' HIS . 37.7 p90 -147.43 156.28 42.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.60999999999999999 110.943 -175.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -103.25 132.21 49.69 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.999 -0.741 . . . . 0.41999999999999998 108.999 173.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -57.85 -40.23 79.65 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.68000000000000005 110.881 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' C' ' 37' ' ' ARG . 43.8 mtm105 -72.62 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.475 -0.33 . . . . 3.3300000000000001 111.463 -177.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 86.3 m -72.76 -23.36 60.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.54000000000000004 111.001 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' C' ' 34' ' ' PHE . 10.7 m170 -96.47 -53.71 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.60999999999999999 110.747 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 87.5 m-85 -113.07 142.8 27.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.944 -0.571 . . . . 0.80000000000000004 110.649 -174.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 32.0 Cg_exo -60.08 155.06 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.78 2.32 . . . . 2.1200000000000001 111.348 174.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -14.67 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 3.2999999999999998 112.618 -172.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.73 3.26 87.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.089 -0.577 . . . . 1.46 112.392 177.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -92.62 136.43 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.572 -0.529 . . . . 1.03 109.572 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 25.9 m -88.97 130.3 35.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.969 0.414 . . . . 1.6000000000000001 111.218 -175.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -81.0 117.43 68.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.788 -0.642 . . . . 2.6800000000000002 110.595 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.06 146.13 51.41 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.91 2.407 . . . . 1.1399999999999999 112.595 -177.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.1 -9.85 56.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.83 -0.7 . . . . 1.8999999999999999 111.503 176.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -93.24 47.84 1.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 2.75 111.781 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.91 123.25 4.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.912 -0.661 . . . . 0.81999999999999995 112.928 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 127.89 34.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.87 110.65 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -108.66 133.31 52.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 2.6499999999999999 110.953 -178.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.7 p -73.19 178.5 4.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.187 -0.671 . . . . 0.48999999999999999 109.187 172.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -56.16 -43.51 78.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.677 0.275 . . . . 4.0899999999999999 111.605 -175.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -68.18 -50.19 55.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.586 -0.279 . . . . 1.54 111.621 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.3 m -68.37 -17.07 64.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.831 0.308 . . . . 0.71999999999999997 111.831 -177.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -98.98 9.5 43.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.388 . . . . 1.25 110.833 177.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.511 0 C-N-CA 120.585 -0.817 . . . . 2.1899999999999999 111.923 178.366 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 109.851 -0.426 . . . . 3.1800000000000002 109.851 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 t -76.62 104.31 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.157 -0.683 . . . . 0.53000000000000003 109.157 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.62 89.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.739 -0.664 . . . . 0.65000000000000002 112.756 -173.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 22.3 t -76.73 -29.0 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 1.04 110.287 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.06 -51.69 2.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.232 -0.44 . . . . 0.83999999999999997 110.278 178.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -13.13 4.0 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.734 -0.746 . . . . 0.77000000000000002 112.596 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.09 151.17 23.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.117 0.484 . . . . 2.1000000000000001 111.752 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.52 21.25 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.55000000000000004 111.866 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -77.15 116.18 17.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.431 0.158 . . . . 1.0600000000000001 110.881 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 56.12 65.26 1.48 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.478 0.656 . . . . 2.23 110.762 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.4 134.88 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.1599999999999999 111.075 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -77.9 146.49 35.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.339 -0.846 . . . . 0.47999999999999998 109.672 176.118 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -113.32 140.45 48.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 3.1800000000000002 110.337 -174.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' C' ' 51' ' ' LEU . 7.7 t -69.38 125.03 25.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.054 -0.721 . . . . 0.37 109.054 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 13.2 t -79.42 -5.55 54.92 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.141 0.496 . . . . 0.75 111.163 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -111.69 -22.67 11.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.4299999999999999 111.758 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.7 p -150.17 -171.77 4.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.79000000000000004 109.766 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.36 115.45 28.49 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.871 0.367 . . . . 0.46999999999999997 110.454 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.01 143.48 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.952 -0.567 . . . . 0.40000000000000002 110.523 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.77 116.16 23.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.616 -0.513 . . . . 0.45000000000000001 109.616 177.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.96 163.85 39.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.386 -0.37 . . . . 0.60999999999999999 110.498 -174.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.0 m170 -100.79 145.98 27.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.878 -0.416 . . . . 0.41999999999999998 109.878 174.11 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -52.81 -53.83 42.84 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.504 0.503 . . . . 0.68000000000000005 110.827 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 66.8 mtt180 -70.07 -19.54 63.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 112.09 -174.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 89.3 m -77.09 -21.04 54.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.162 0.506 . . . . 0.54000000000000004 110.484 177.142 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -103.23 -52.37 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.285 0.564 . . . . 0.60999999999999999 110.647 176.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 53.7 m-85 -113.26 125.56 29.52 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.456 -0.793 . . . . 0.80000000000000004 109.356 -178.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -52.28 148.73 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.619 2.213 . . . . 2.1200000000000001 111.753 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -18.06 14.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.804 . . . . 3.2999999999999998 112.934 -172.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.22 -2.12 61.89 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.071 -0.585 . . . . 1.46 112.488 176.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -99.3 142.28 30.99 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.024 -0.362 . . . . 1.03 110.024 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 43.3 m -88.22 124.11 33.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 1.6000000000000001 111.219 -176.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -79.88 129.37 70.87 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 2.6800000000000002 110.533 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.06 154.08 75.68 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.495 2.13 . . . . 1.1399999999999999 111.3 176.159 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 -10.24 73.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 1.8999999999999999 112.619 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' C' ' 50' ' ' GLY . 17.1 p -93.76 -160.81 0.79 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.782 -0.081 . . . . 2.75 110.782 178.392 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' C' ' 49' ' ' THR . . . -62.73 143.67 48.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.128 -0.558 . . . . 0.81999999999999995 112.867 -179.021 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 27' ' ' CYS . 0.1 OUTLIER -90.83 144.51 25.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.951 0.405 . . . . 0.87 110.562 -178.503 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -105.68 133.24 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.216 -0.447 . . . . 2.6499999999999999 109.997 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -72.46 165.16 25.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.772 -0.825 . . . . 0.48999999999999999 108.772 175.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -55.27 -35.89 65.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.246 0.476 . . . . 4.0899999999999999 111.61 -171.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -65.6 -51.03 62.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.433 -0.348 . . . . 1.54 111.061 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.25 -17.92 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.71999999999999997 111.117 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -78.86 -14.03 59.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.989 0.423 . . . . 1.25 110.868 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 C-N-CA 120.52 -0.847 . . . . 2.1899999999999999 112.005 -179.313 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.49 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 28.9 ttm-85 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 120.695 0.283 . . . . 3.1800000000000002 110.803 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -77.84 114.34 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.877 -0.416 . . . . 0.53000000000000003 109.877 177.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.66 64.8 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.085 -0.578 . . . . 0.65000000000000002 112.926 -177.622 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -81.85 -32.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.978 0.418 . . . . 1.04 110.723 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.01 -40.26 6.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.148 0.425 . . . . 0.83999999999999997 112.148 -176.386 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.59 51.36 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.343 -0.703 . . . . 0.77000000000000002 111.343 -173.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.78 151.97 19.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.703 0.287 . . . . 2.1000000000000001 110.374 177.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.87 21.83 12.08 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.676 -0.773 . . . . 0.55000000000000004 112.159 178.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.03 127.4 32.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.183 . . . . 1.0600000000000001 111.263 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 t70 55.17 66.47 1.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.587 0.708 . . . . 2.23 110.872 176.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 m -108.03 145.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.29 -0.868 . . . . 1.1599999999999999 111.411 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' C' ' 36' ' ' TRP . 83.4 mt -98.09 144.02 28.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 0.47999999999999998 110.306 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.4 mpt_? -109.96 153.84 23.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.137 -0.483 . . . . 3.1800000000000002 110.355 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 34.2 t -71.3 142.69 50.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.228 -0.656 . . . . 0.37 109.228 173.484 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -84.75 -5.61 59.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 0.75 110.704 178.186 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -118.4 -9.36 10.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.4299999999999999 110.939 178.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.72 173.19 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.93 0.395 . . . . 0.79000000000000004 110.072 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.55 112.82 26.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.361 -0.607 . . . . 0.46999999999999997 109.361 174.204 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.62 131.14 1.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.624 -0.716 . . . . 0.40000000000000002 109.485 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.88 122.83 48.02 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.025 0.44 . . . . 0.45000000000000001 110.655 -178.318 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.3 160.85 41.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.769 -0.65 . . . . 0.60999999999999999 110.141 -178.635 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.69 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.4 m170 -88.85 133.22 34.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.264 -1.013 . . . . 0.41999999999999998 108.264 172.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.463 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.6 t-105 -61.16 -33.27 73.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.68000000000000005 111.017 -176.189 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -76.55 -13.75 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.054 0.454 . . . . 3.3300000000000001 111.184 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 59.5 m -93.05 -22.52 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.082 0.468 . . . . 0.54000000000000004 110.744 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -95.27 -30.9 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.987 -0.552 . . . . 0.60999999999999999 110.671 175.505 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.31 158.74 74.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.80000000000000004 110.274 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.37 156.66 62.12 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.495 2.13 . . . . 2.1200000000000001 111.091 173.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -10.56 55.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.926 -0.579 . . . . 3.2999999999999998 112.071 -174.169 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.92 -11.74 78.5 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.653 -0.784 . . . . 1.46 111.946 175.478 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -88.69 120.64 30.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.037 0.446 . . . . 1.03 110.644 -179.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.0 p -89.32 138.19 31.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.048 -0.524 . . . . 1.6000000000000001 110.652 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.21 126.44 91.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.486 . . . . 2.6800000000000002 110.365 -179.501 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 141.09 44.67 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.987 2.458 . . . . 1.1399999999999999 113.248 -173.348 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.98 0.55 89.41 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.405 -0.816 . . . . 1.8999999999999999 111.675 177.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -88.95 1.53 55.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.116 0.484 . . . . 2.75 110.304 177.077 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.68 131.47 3.25 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.537 -0.756 . . . . 0.81999999999999995 111.955 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.78 123.06 19.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.019 -0.734 . . . . 0.87 109.019 178.424 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -110.46 130.97 55.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.322 0.582 . . . . 2.6499999999999999 111.82 -173.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 26.0 p -74.89 -176.78 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.125 -0.943 . . . . 0.48999999999999999 110.032 175.06 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -64.87 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.77 -0.372 . . . . 4.0899999999999999 111.287 -175.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -68.75 -41.02 79.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.823 0.344 . . . . 1.54 110.429 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 65.1 m -69.01 -23.72 64.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.508 -0.314 . . . . 0.71999999999999997 111.164 177.659 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -93.43 1.15 56.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 1.25 110.665 177.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.465 0 CA-C-N 115.89 -0.595 . . . . 2.1899999999999999 111.771 179.49 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 . . . . . 0 CA--C 1.516 -0.35 0 N-CA-C 109.439 -0.578 . . . . 3.1800000000000002 109.439 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -68.82 105.51 2.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.276 -0.638 . . . . 0.53000000000000003 109.276 175.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 -21.02 67.07 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 121.017 -0.611 . . . . 0.65000000000000002 112.285 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.48 -34.56 58.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.948 0.404 . . . . 1.04 110.627 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -102.23 -33.78 9.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.83999999999999997 111.639 -177.6 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.93 20.07 51.42 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 -174.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -140.06 154.72 47.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 2.1000000000000001 110.687 -174.228 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.59 21.81 5.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.007 -0.616 . . . . 0.55000000000000004 112.09 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -80.91 127.15 32.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.028 -0.36 . . . . 1.0600000000000001 110.028 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 54.36 61.14 3.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.372 0.606 . . . . 2.23 109.737 -177.122 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.28 150.62 5.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.268 -0.878 . . . . 1.1599999999999999 110.393 -172.719 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.403 HD12 ' H ' ' C' ' 36' ' ' TRP . 81.2 mt -91.79 143.99 25.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.895 -0.409 . . . . 0.47999999999999998 109.895 179.185 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -108.55 152.45 24.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.635 -0.711 . . . . 3.1800000000000002 110.173 -177.132 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -84.75 127.27 34.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.28 -0.637 . . . . 0.37 109.28 176.447 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -80.67 -5.89 57.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.206 0.527 . . . . 0.75 110.905 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -106.31 -27.34 11.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 1.4299999999999999 111.488 -178.74 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.97 -161.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.885 -0.413 . . . . 0.79000000000000004 109.885 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.1 115.77 31.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.66 0.267 . . . . 0.46999999999999997 110.616 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.96 151.88 10.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.216 -0.447 . . . . 0.40000000000000002 110.301 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -136.69 112.36 9.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.334 -0.394 . . . . 0.45000000000000001 110.107 179.244 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.8 p90 -156.87 177.22 11.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.18 -0.464 . . . . 0.60999999999999999 109.862 -177.167 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.695 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 14.7 m170 -109.8 132.82 53.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.763 -0.829 . . . . 0.41999999999999998 108.763 172.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.403 ' H ' HD12 ' C' ' 25' ' ' LEU . 75.9 t-105 -53.6 -53.23 54.68 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.106 0.41 . . . . 0.68000000000000005 112.106 -171.737 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -60.81 -26.22 67.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.089 0.471 . . . . 3.3300000000000001 111.359 -176.042 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.695 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.3 m -77.91 -23.66 48.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.069 -0.514 . . . . 0.54000000000000004 110.809 -178.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 -34.37 11.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.60999999999999999 110.779 179.316 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -126.56 75.9 74.24 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.847 -0.615 . . . . 0.80000000000000004 110.365 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.43 13.11 2.85 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.985 2.457 . . . . 2.1200000000000001 112.408 -177.121 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.18 4.31 31.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.931 -0.577 . . . . 3.2999999999999998 111.413 -178.174 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.73 9.79 60.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.671 -0.776 . . . . 1.46 111.426 -177.113 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 25.7 m -67.64 131.79 46.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.281 . . . . 1.03 110.629 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -88.44 135.29 33.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.342 -0.39 . . . . 1.6000000000000001 110.026 -178.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -72.42 134.41 82.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.298 -0.41 . . . . 2.6800000000000002 111.018 -176.523 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.49 132.93 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.578 2.185 . . . . 1.1399999999999999 112.195 178.992 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.86 -13.42 75.08 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.01 -0.836 . . . . 1.8999999999999999 111.01 175.245 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.5 p -93.06 46.98 1.24 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.122 0.487 . . . . 2.75 111.113 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.48 106.31 3.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.72 . . . . 0.81999999999999995 112.408 178.736 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.01 124.63 23.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.203 0.525 . . . . 0.87 109.942 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -110.56 135.33 51.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 2.6499999999999999 110.749 -177.326 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.504 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -77.52 -179.04 5.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.48999999999999999 109.663 174.289 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -62.19 -46.76 87.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.807 0.337 . . . . 4.0899999999999999 110.575 -177.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -61.63 -45.74 92.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 1.54 111.28 -177.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.07 -23.14 61.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.617 0.228 . . . . 0.71999999999999997 111.617 -179.612 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -80.81 -14.36 58.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 1.25 110.637 177.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.846 0 N-CA-C 111.346 -0.701 . . . . 2.1899999999999999 111.346 177.066 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.1 ttt180 . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.249 -0.278 . . . . 3.1800000000000002 110.249 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -69.14 109.06 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.857 -0.423 . . . . 0.53000000000000003 109.857 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.71 -18.24 61.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.377 -0.439 . . . . 0.65000000000000002 112.771 -177.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -79.43 -37.12 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.729 0.3 . . . . 1.04 111.108 178.628 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -97.69 -33.95 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.046 0.387 . . . . 0.83999999999999997 112.046 -176.421 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.86 -1.33 65.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.603 -0.808 . . . . 0.77000000000000002 111.639 -175.122 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -119.16 150.43 40.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 2.1000000000000001 110.345 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.25 24.84 10.28 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.557 -0.83 . . . . 0.55000000000000004 113.424 -175.004 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -79.0 116.4 19.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.856 0.328 . . . . 1.0600000000000001 110.657 178.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 66.95 1.1 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.744 0.652 . . . . 2.23 111.923 177.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.77 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.205 -0.452 . . . . 1.1599999999999999 110.542 177.218 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.95 159.46 17.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.47999999999999998 109.855 174.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -123.89 143.51 50.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 3.1800000000000002 110.554 -176.066 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -82.14 134.77 35.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.321 -0.622 . . . . 0.37 109.321 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 49.6 p -85.32 -13.5 49.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.75 111.43 -178.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -103.52 -21.74 13.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 1.4299999999999999 111.444 -178.651 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.21 -166.14 2.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 0.79000000000000004 109.426 178.602 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.97 115.3 30.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.06 -0.348 . . . . 0.46999999999999997 110.06 178.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.23 134.85 12.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.431 . . . . 0.40000000000000002 110.205 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.06 115.86 23.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.258 -0.428 . . . . 0.45000000000000001 110.388 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -160.5 151.73 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.048 -0.524 . . . . 0.60999999999999999 110.307 -176.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.853 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.7 m80 -82.44 136.59 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.985 -1.117 . . . . 0.41999999999999998 107.985 171.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -44.3 -52.17 7.79 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.466 0.479 . . . . 0.68000000000000005 111.979 -175.699 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -56.44 -34.9 67.26 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.678 0.621 . . . . 3.3300000000000001 112.678 -175.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.853 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 3.4 m -71.71 -21.93 61.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.897 -0.592 . . . . 0.54000000000000004 111.149 -173.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -103.94 -49.66 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.82 -0.627 . . . . 0.60999999999999999 110.546 176.232 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.9 m-85 -121.43 113.61 32.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.156 -175.932 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 7.2 Cg_exo -72.54 -172.73 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.922 2.415 . . . . 2.1200000000000001 113.308 -177.469 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.35 -28.17 62.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 111.935 0.346 . . . . 3.2999999999999998 111.935 -177.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.53 -9.49 55.46 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.244 -0.503 . . . . 1.46 112.743 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 36.5 m -124.63 116.98 23.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 1.03 110.369 176.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -88.37 155.15 19.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.264 -0.426 . . . . 1.6000000000000001 110.224 -178.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -70.25 130.95 88.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 2.6800000000000002 110.679 -175.262 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.66 147.27 50.77 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.814 2.343 . . . . 1.1399999999999999 111.988 178.355 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.01 -1.89 88.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.808 -0.711 . . . . 1.8999999999999999 111.577 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.1 p -94.67 -168.29 1.8 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.534 -0.333 . . . . 2.75 110.86 179.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.53 127.13 43.99 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.644 -0.788 . . . . 0.81999999999999995 111.439 175.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.8 122.42 17.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.221 0.534 . . . . 0.87 109.99 -176.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.6 135.52 48.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.835 -0.62 . . . . 2.6499999999999999 110.433 178.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.7 p -75.7 172.54 12.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.1 -0.704 . . . . 0.48999999999999999 109.1 171.777 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -53.56 -41.48 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.026 0.441 . . . . 4.0899999999999999 111.4 -175.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -68.22 -45.92 71.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.072 -0.513 . . . . 1.54 111.269 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.0 m -72.58 -17.46 61.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.812 0.301 . . . . 0.71999999999999997 111.812 -177.398 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -87.45 -8.45 56.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 1.25 110.608 174.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 C-N-CA 121.11 -0.567 . . . . 2.1899999999999999 111.823 179.261 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.159 -0.311 . . . . 3.1800000000000002 110.159 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 41.9 t -76.48 104.39 6.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.53000000000000003 109.884 179.114 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.72 -6.59 88.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.011 -0.614 . . . . 0.65000000000000002 112.271 -176.648 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 24.1 t -70.34 -31.65 47.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 1.04 110.664 -179.575 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -112.65 -39.33 4.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.999 0.428 . . . . 0.83999999999999997 110.196 176.191 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.6 -9.63 9.92 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.612 -0.804 . . . . 0.77000000000000002 112.08 179.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 2.0 m-20 -107.64 139.54 42.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.006 0.431 . . . . 2.1000000000000001 111.035 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' C' ' 24' ' ' VAL . . . -107.39 2.81 34.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.03 -0.828 . . . . 0.55000000000000004 111.03 174.927 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 132.35 45.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.426 -0.387 . . . . 1.0600000000000001 110.409 179.316 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 56.13 49.71 14.99 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.398 0.618 . . . . 2.23 109.87 -176.612 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' C' ' 21' ' ' GLY . 4.4 p -89.38 151.28 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.343 -0.844 . . . . 1.1599999999999999 110.602 -175.29 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.7 mt -100.96 160.44 14.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.435 -0.348 . . . . 0.47999999999999998 110.189 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -126.82 136.03 51.81 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.594 -0.521 . . . . 3.1800000000000002 109.594 -178.396 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 42.2 t -67.12 143.15 56.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.494 -0.482 . . . . 0.37 110.099 176.389 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.91 -23.35 23.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.049 178.6 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -95.03 -30.24 14.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 1.4299999999999999 111.05 -178.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.0 OUTLIER -137.25 -177.59 4.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.669 -0.493 . . . . 0.79000000000000004 109.669 -178.397 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.23 114.87 29.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.48 -0.327 . . . . 0.46999999999999997 110.286 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -168.49 129.87 1.31 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.40000000000000002 110.538 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -102.9 112.15 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.435 -0.58 . . . . 0.45000000000000001 109.435 174.117 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -155.0 173.42 16.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.799 -0.637 . . . . 0.60999999999999999 109.998 -175.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.431 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -110.13 135.96 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.169 -0.678 . . . . 0.41999999999999998 109.169 173.384 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -61.59 -36.27 80.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.551 -0.75 . . . . 0.68000000000000005 110.45 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -70.39 -26.46 63.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 3.3300000000000001 111.276 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.8 m -84.23 -26.0 29.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.937 0.399 . . . . 0.54000000000000004 110.914 178.884 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . 0.402 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 1.5 m-70 -89.81 -40.03 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.213 -0.448 . . . . 0.60999999999999999 111.26 -178.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -124.32 71.38 55.64 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.315 -0.402 . . . . 0.80000000000000004 110.173 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 3.0 Cg_exo -75.43 6.44 3.58 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.134 2.556 . . . . 2.1200000000000001 113.004 -174.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.95 3.77 28.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 3.2999999999999998 111.165 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.05 32.65 20.15 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.63 -0.795 . . . . 1.46 112.036 -179.708 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 8.6 m -68.3 148.08 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.947 -0.39 . . . . 1.03 109.947 177.658 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -86.57 121.67 29.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.94 0.4 . . . . 1.6000000000000001 110.504 -175.367 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -66.32 120.09 67.42 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 2.6800000000000002 110.855 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.62 143.8 38.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.435 2.09 . . . . 1.1399999999999999 111.859 176.277 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.98 -10.37 42.91 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.73 -0.748 . . . . 1.8999999999999999 112.526 -179.209 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -96.04 9.76 39.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.803 0.335 . . . . 2.75 111.685 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 117.92 0.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.634 -0.793 . . . . 0.81999999999999995 112.287 -178.669 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -90.29 123.24 33.9 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.44 -0.578 . . . . 0.87 109.44 179.924 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' C' ' 57' ' ' SER . 28.6 mtm180 -110.46 149.07 30.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.394 0.616 . . . . 2.6499999999999999 111.62 -178.851 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 30.3 p -102.3 -178.8 3.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.171 -0.922 . . . . 0.48999999999999999 110.029 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -57.84 -39.1 76.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.507 0.558 . . . . 4.0899999999999999 112.507 -172.106 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -63.7 -57.3 10.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.88 0.371 . . . . 1.54 111.443 -176.541 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 6.9 p -72.17 -24.58 61.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.233 -0.439 . . . . 0.71999999999999997 111.699 -174.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' C' ' 52' ' ' ARG . 25.3 t -102.15 19.76 17.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.897 0.379 . . . . 1.25 110.728 -177.119 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.715 0 C-N-CA 120.366 -0.921 . . . . 2.1899999999999999 112.645 -179.46 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 . . . . . 0 N--CA 1.45 -0.425 0 CA-C-O 120.528 0.204 . . . . 3.1800000000000002 110.748 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.45 111.22 5.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.53000000000000003 109.994 178.264 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.03 -19.03 60.88 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.291 -0.48 . . . . 0.65000000000000002 112.856 -178.026 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.27 -31.08 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.105 0.478 . . . . 1.04 110.682 178.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.6 m -109.04 -20.8 12.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.32 0.489 . . . . 0.83999999999999997 112.32 -175.204 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.4 79.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.174 -0.77 . . . . 0.77000000000000002 111.174 -174.398 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.17 147.09 37.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.281 -0.459 . . . . 2.1000000000000001 109.932 -176.538 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.26 30.79 5.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.574 -0.822 . . . . 0.55000000000000004 113.508 -176.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -75.28 121.08 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.237 0.519 . . . . 1.0600000000000001 110.135 176.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 54.41 52.76 11.87 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.65 0.594 . . . . 2.23 110.508 -176.859 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' C' ' 33' ' ' ALA . 8.7 p -88.97 139.45 17.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.091 -0.504 . . . . 1.1599999999999999 110.635 -173.902 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.09 147.8 25.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.096 -0.502 . . . . 0.47999999999999998 110.688 -179.073 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.529 HH11 ' HB2' ' C' ' 33' ' ' ALA . 30.7 mmm180 -113.74 149.75 34.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.534 -0.757 . . . . 3.1800000000000002 109.739 179.71 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 17.6 t -85.2 135.55 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.448 -0.575 . . . . 0.37 109.448 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.9 p -81.94 -18.68 42.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.75 111.171 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -100.5 -22.52 14.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 1.4299999999999999 111.923 -176.44 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.4 p -150.55 -165.08 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.542 . . . . 0.79000000000000004 109.535 178.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.65 115.58 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.958 -0.386 . . . . 0.46999999999999997 109.958 179.477 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.36 146.78 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.40000000000000002 111.273 -177.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.529 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -131.71 112.54 12.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.678 -0.692 . . . . 0.45000000000000001 109.779 177.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.17 165.35 36.22 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.121 -0.49 . . . . 0.60999999999999999 109.74 -177.212 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.786 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.9 m170 -96.71 138.37 34.38 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.297 -1.001 . . . . 0.41999999999999998 108.297 171.2 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -46.09 -52.53 11.91 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.3 0.375 . . . . 0.68000000000000005 111.712 -177.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.8 mtm180 -70.37 -5.93 31.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.3300000000000001 112.124 -174.424 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.786 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -91.92 -20.86 20.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.096 0.474 . . . . 0.54000000000000004 110.66 179.31 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -103.86 -36.17 7.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.60999999999999999 110.68 174.891 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 92.4 m-85 -121.87 147.28 48.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.80000000000000004 110.107 -179.405 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.51 159.62 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.519 2.146 . . . . 2.1200000000000001 111.633 176.463 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -8.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 3.2999999999999998 111.978 -175.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.69 -7.4 87.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.824 -0.703 . . . . 1.46 111.768 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.0 m -98.11 132.6 43.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.838 0.351 . . . . 1.03 110.212 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -88.87 142.21 27.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.386 -0.37 . . . . 1.6000000000000001 110.2 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -80.63 127.32 75.85 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 2.6800000000000002 110.796 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.03 135.65 70.01 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.752 2.301 . . . . 1.1399999999999999 111.743 175.204 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -24.47 61.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.928 -0.653 . . . . 1.8999999999999999 111.68 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -138.91 135.59 34.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.908 -0.404 . . . . 2.75 109.908 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.8 53.61 4.89 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.68 -0.771 . . . . 0.81999999999999995 112.225 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.51 122.82 19.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.408 -0.59 . . . . 0.87 109.408 178.061 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -118.91 136.43 54.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.12 -0.491 . . . . 2.6499999999999999 110.475 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -73.54 170.4 15.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.142 -0.481 . . . . 0.48999999999999999 109.944 177.058 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -49.4 -48.7 46.92 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.645 0.59 . . . . 4.0899999999999999 111.911 -174.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -63.69 -45.87 88.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.57 -0.286 . . . . 1.54 111.466 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 89.1 m -72.0 -32.36 67.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.741 0.274 . . . . 0.71999999999999997 111.741 -177.47 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p -80.88 -14.13 58.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 1.25 111.418 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.677 0 C-N-CA 120.792 -0.718 . . . . 2.1899999999999999 112.008 -179.306 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 C--O 1.233 0.229 0 N-CA-C 110.09 -0.337 . . . . 3.1800000000000002 110.09 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.81 105.44 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.53000000000000003 109.172 175.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.66 62.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.43 -0.414 . . . . 0.65000000000000002 113.063 -176.23 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.32 -30.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.04 110.964 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -111.17 -18.1 13.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.509 0.559 . . . . 0.83999999999999997 112.509 -172.934 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.46 26.8 71.98 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.616 -0.993 . . . . 0.77000000000000002 110.616 -173.209 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -142.78 148.47 37.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.282 -0.459 . . . . 2.1000000000000001 110.589 -170.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.58 25.15 5.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.069 -0.586 . . . . 0.55000000000000004 111.975 177.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -80.6 129.17 34.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.233 -0.284 . . . . 1.0600000000000001 110.233 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.71 52.06 11.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.177 0.989 . . . . 2.23 108.953 -179.245 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -100.69 149.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.716 -1.129 . . . . 1.1599999999999999 111.235 -171.507 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.2 mt -91.23 144.04 26.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.073 -0.512 . . . . 0.47999999999999998 109.896 176.61 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' C' ' 32' ' ' ALA . 4.3 tpp180 -110.9 130.86 55.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.084 -0.507 . . . . 3.1800000000000002 109.998 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 1.8 t -68.07 134.56 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.7 -0.482 . . . . 0.37 109.7 177.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 67.6 p -92.32 -14.85 28.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.75 110.84 -179.543 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -98.16 -18.9 18.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.915 -0.584 . . . . 1.4299999999999999 111.076 -179.344 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -151.64 -170.61 3.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.07 -0.715 . . . . 0.79000000000000004 109.07 176.782 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.94 113.9 27.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.538 -0.542 . . . . 0.46999999999999997 109.538 178.331 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' C' ' 26' ' ' ARG . . . -171.22 137.43 1.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.55 . . . . 0.40000000000000002 110.298 -178.631 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -119.03 112.89 20.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.081 -0.711 . . . . 0.45000000000000001 109.081 175.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.68 156.7 43.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.053 -0.351 . . . . 0.60999999999999999 110.053 -178.371 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.29 128.82 35.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.279 -1.008 . . . . 0.41999999999999998 108.279 172.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -47.83 -53.2 16.3 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.502 0.501 . . . . 0.68000000000000005 111.962 -172.309 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 71.5 mtm180 -68.07 -14.16 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 3.3300000000000001 112.357 -172.546 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -80.31 -21.79 42.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.54000000000000004 110.631 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -105.62 -43.72 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.60999999999999999 110.521 176.46 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 93.6 m-85 -110.53 139.99 22.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.80000000000000004 110.384 -176.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.27 158.62 47.73 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.719 2.279 . . . . 2.1200000000000001 111.197 177.201 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.4 43.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 3.2999999999999998 112.293 -173.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.73 -31.65 60.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.676 -0.773 . . . . 1.46 111.545 175.298 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 38.0 m -74.59 131.12 40.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.29 -0.263 . . . . 1.03 110.29 179.361 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 9.8 p -88.73 134.83 33.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 1.6000000000000001 111.189 -175.089 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.81 111.76 14.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.698 . . . . 2.6800000000000002 110.088 178.257 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.17 136.3 28.98 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.66 2.24 . . . . 1.1399999999999999 112.863 -174.065 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.29 0.16 71.34 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.904 -0.665 . . . . 1.8999999999999999 111.652 176.772 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -122.57 83.01 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.812 0.339 . . . . 2.75 111.14 177.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.97 88.75 1.38 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.842 -0.694 . . . . 0.81999999999999995 112.387 178.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -78.14 122.75 26.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.975 -0.75 . . . . 0.87 108.975 178.739 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.541 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 36.4 ptt180 -133.67 135.45 44.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.213 0.53 . . . . 2.6499999999999999 110.734 -176.204 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.5 p -73.29 173.81 8.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.48999999999999999 110.367 178.419 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . 0.562 ' HA ' ' OG ' ' C' ' 57' ' ' SER . 2.7 ptp180 -63.15 -32.5 73.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.295 0.498 . . . . 4.0899999999999999 111.426 -174.68 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 1.54 109.838 175.91 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 69.4 m -74.27 -30.23 62.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.694 -0.685 . . . . 0.71999999999999997 112.829 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' C' ' 54' ' ' ARG . 19.9 p -75.19 -14.22 60.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 1.25 111.184 -174.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.797 0 N-CA-C 110.399 -1.08 . . . . 2.1899999999999999 110.399 174.158 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 . . . . . 0 CA--C 1.52 -0.2 0 N-CA-C 107.892 -1.151 . . . . 3.1800000000000002 107.892 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.09 108.65 1.59 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.631 -0.507 . . . . 0.53000000000000003 109.631 177.149 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.05 -14.21 55.38 Favored Glycine 0 C--N 1.329 0.145 0 O-C-N 123.372 0.42 . . . . 0.65000000000000002 113.102 -175.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.13 -31.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.082 0.468 . . . . 1.04 110.583 178.186 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.4 m -108.02 -26.35 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.471 . . . . 0.83999999999999997 112.197 -174.883 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.33 25.25 59.56 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 -174.401 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.97 142.36 32.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.663 -0.268 . . . . 2.1000000000000001 110.96 -173.56 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.15 16.98 24.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.003 -0.618 . . . . 0.55000000000000004 112.275 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -80.22 128.93 34.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.934 -0.395 . . . . 1.0600000000000001 109.934 178.305 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 58.56 40.43 23.71 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.471 0.653 . . . . 2.23 110.36 -178.107 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' C' ' 33' ' ' ALA . 1.5 p -90.37 150.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.272 -0.877 . . . . 1.1599999999999999 110.422 -175.376 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 92.8 mt -102.25 151.26 22.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.787 -0.449 . . . . 0.47999999999999998 109.787 177.05 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.2 tpp180 -119.49 140.32 50.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 3.1800000000000002 110.119 -175.347 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.6 t -73.47 142.88 46.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.923 -0.769 . . . . 0.37 108.923 174.319 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.6 p -96.92 -21.38 17.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 0.75 110.743 178.678 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -89.66 -21.05 22.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.4299999999999999 110.567 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.4 p -151.18 -175.5 5.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.5 -0.926 . . . . 0.79000000000000004 108.5 174.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 114.61 28.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.651 0.262 . . . . 0.46999999999999997 110.347 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.44 135.8 6.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.40000000000000002 110.442 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.18 118.83 36.42 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.707 0.629 . . . . 0.45000000000000001 110.121 178.377 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.93 151.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.349 -0.387 . . . . 0.60999999999999999 110.647 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.702 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -82.65 136.13 34.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.628 -0.878 . . . . 0.41999999999999998 108.628 172.006 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 62.0 t-105 -49.04 -53.65 19.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.255 0.347 . . . . 0.68000000000000005 111.618 -175.906 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.23 -15.94 64.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.361 0.504 . . . . 3.3300000000000001 112.361 -173.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.4 m -85.35 -21.15 29.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.105 0.478 . . . . 0.54000000000000004 110.717 -178.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -107.56 -45.12 4.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.016 -0.538 . . . . 0.60999999999999999 111.052 178.048 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.39 146.17 36.8 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.80000000000000004 110.355 -176.855 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' C' ' 44' ' ' THR . 10.8 Cg_endo -55.82 144.11 78.39 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.01 2.473 . . . . 2.1200000000000001 111.797 175.594 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -16.24 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.461 -0.791 . . . . 3.2999999999999998 112.085 -175.144 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.14 -18.82 75.88 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.17 177.373 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' C' ' 41' ' ' PRO . 42.8 m -74.8 147.9 40.8 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.086 -0.339 . . . . 1.03 110.086 178.722 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -88.09 122.01 31.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.849 0.357 . . . . 1.6000000000000001 110.738 -174.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -70.97 120.58 80.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.853 -0.612 . . . . 2.6800000000000002 110.368 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.67 132.32 32.51 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.611 2.207 . . . . 1.1399999999999999 111.933 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -43.3 6.71 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.146 -0.782 . . . . 1.8999999999999999 111.146 176.596 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 t -115.12 135.21 54.44 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.041 -0.355 . . . . 2.75 110.041 175.293 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.2 64.14 3.55 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.773 -0.727 . . . . 0.81999999999999995 112.201 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.49 131.38 37.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.088 0.47 . . . . 0.87 110.394 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -114.93 133.58 55.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.22 -0.446 . . . . 2.6499999999999999 110.773 -176.669 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.5 p -77.12 178.45 7.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.205 -0.665 . . . . 0.48999999999999999 109.205 173.074 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -56.99 -40.39 76.49 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.93 0.344 . . . . 4.0899999999999999 111.93 -173.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -68.92 -49.18 60.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 1.54 110.919 -178.364 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.57 -17.9 62.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.71999999999999997 111.348 -178.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -90.84 7.99 37.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.986 0.422 . . . . 1.25 110.429 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 C-N-CA 120.851 -0.69 . . . . 2.1899999999999999 111.897 178.701 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 57.4 mtt180 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 120.74 0.305 . . . . 3.1800000000000002 110.587 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' C' ' 34' ' ' PHE . 13.2 t -64.02 114.53 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.53000000000000003 109.527 175.349 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.07 -22.91 50.67 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.331 0.394 . . . . 0.65000000000000002 113.353 -174.546 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.52 -30.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.085 0.469 . . . . 1.04 110.889 179.003 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -107.26 -31.11 8.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 0.83999999999999997 112.912 -173.476 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 85.04 -9.26 66.88 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.089 -0.804 . . . . 0.77000000000000002 111.089 -172.704 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -106.88 147.69 29.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.171 -0.514 . . . . 2.1000000000000001 110.674 -177.512 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.07 27.49 6.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.96 -0.638 . . . . 0.55000000000000004 112.62 179.535 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.9 m -77.19 117.6 18.89 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.862 -0.421 . . . . 1.0600000000000001 109.862 177.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 54.57 64.42 1.82 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.901 0.858 . . . . 2.23 109.511 -174.171 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.483 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.7 p -97.32 150.96 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.243 -0.89 . . . . 1.1599999999999999 110.201 -176.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 96.5 mt -103.93 144.14 31.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.76 -0.459 . . . . 0.47999999999999998 109.76 176.995 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -115.18 138.4 50.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.12 -0.491 . . . . 3.1800000000000002 110.259 -179.674 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -60.14 139.92 57.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.37 109.549 174.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -90.61 -17.56 26.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.078 0.466 . . . . 0.75 111.015 179.528 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -94.83 -23.73 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 1.4299999999999999 110.697 -178.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.43 -168.9 3.22 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.115 -0.698 . . . . 0.79000000000000004 109.115 178.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.68 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.716 0.293 . . . . 0.46999999999999997 110.741 -178.541 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.96 121.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.40000000000000002 110.617 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.483 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.79 117.91 35.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 0.45000000000000001 110.372 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 15' ' ' CYS . 46.8 p90 -158.16 165.78 34.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.634 -0.257 . . . . 0.60999999999999999 110.585 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.709 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.9 m170 -95.65 140.89 29.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.534 -0.914 . . . . 0.41999999999999998 108.534 173.779 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.4 t-105 -59.39 -45.42 91.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.635 0.255 . . . . 0.68000000000000005 111.0 -177.537 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 37' ' ' ARG . 48.9 mtm180 -65.39 -14.48 60.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.286 -0.415 . . . . 3.3300000000000001 111.968 -177.439 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.4 m -89.9 -20.49 23.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.957 0.408 . . . . 0.54000000000000004 110.655 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -103.09 -39.75 6.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.091 -0.504 . . . . 0.60999999999999999 111.403 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.68 161.02 59.9 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.257 -0.429 . . . . 0.80000000000000004 110.17 -177.592 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.97 146.2 98.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.619 2.213 . . . . 2.1200000000000001 112.13 178.983 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.96 66.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.5 -0.773 . . . . 3.2999999999999998 111.333 -178.065 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.08 88.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.782 -0.723 . . . . 1.46 111.978 176.258 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 36.4 m -95.19 134.82 37.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.802 0.334 . . . . 1.03 110.114 179.403 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.7 p -88.95 150.08 23.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.346 -0.388 . . . . 1.6000000000000001 110.571 -178.12 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -81.15 143.19 52.26 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.934 -0.575 . . . . 2.6800000000000002 110.209 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 132.17 35.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.642 2.228 . . . . 1.1399999999999999 112.244 178.876 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.85 -0.7 89.1 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.994 -0.548 . . . . 1.8999999999999999 112.444 -178.016 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 28.7 p -90.06 -9.98 46.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.135 0.493 . . . . 2.75 110.639 176.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.96 137.12 3.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.775 -0.726 . . . . 0.81999999999999995 111.922 -178.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 124.01 21.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.87 110.16 179.904 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -107.92 136.03 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 2.6499999999999999 110.965 -177.146 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.42 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.1 p -87.0 -178.22 6.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.48999999999999999 109.769 175.924 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -64.69 -39.96 94.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.839 -0.344 . . . . 4.0899999999999999 111.296 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -68.98 -48.7 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.54 0.209 . . . . 1.54 111.058 -178.163 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 90.7 m -67.31 -39.85 85.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.578 0.228 . . . . 0.71999999999999997 111.114 -178.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -76.43 -13.48 60.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.989 0.423 . . . . 1.25 110.372 -179.365 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 121.079 -0.582 . . . . 2.1899999999999999 112.308 178.831 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-O 120.741 0.305 . . . . 3.1800000000000002 110.181 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 t -69.28 108.21 3.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.53000000000000003 109.584 175.298 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.82 -16.2 56.18 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.398 -0.429 . . . . 0.65000000000000002 112.746 -177.109 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.09 -30.13 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.974 0.416 . . . . 1.04 110.495 177.882 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.1 m -109.64 -29.63 8.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.83999999999999997 112.42 -175.235 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.82 3.94 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.904 -0.878 . . . . 0.77000000000000002 110.904 -173.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' C' ' 22' ' ' THR . 10.6 t70 -124.43 153.76 41.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.897 -0.652 . . . . 2.1000000000000001 109.419 -176.062 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 27.69 3.61 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.299 -0.953 . . . . 0.55000000000000004 113.355 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . 0.469 HG22 ' OD1' ' C' ' 20' ' ' ASP . 6.0 t -77.68 135.28 38.05 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.282 0.541 . . . . 1.0600000000000001 109.711 177.003 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.76 43.35 31.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.878 -0.601 . . . . 2.23 110.183 179.375 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.93 149.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.471 -0.786 . . . . 1.1599999999999999 110.504 -172.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.18 143.05 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 0.47999999999999998 109.98 179.238 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 19.2 mmm180 -109.48 143.16 39.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 3.1800000000000002 110.441 -178.251 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.4 t -73.47 145.43 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.473 -0.565 . . . . 0.37 109.473 177.389 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -90.92 -34.54 15.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.101 -0.499 . . . . 0.75 111.612 -178.954 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -89.2 -13.86 37.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 1.4299999999999999 111.24 -176.85 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.27 -171.27 3.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.523 -0.547 . . . . 0.79000000000000004 109.523 175.262 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.74 115.33 30.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.232 -0.285 . . . . 0.46999999999999997 110.232 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.11 143.73 10.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.331 -0.395 . . . . 0.40000000000000002 110.696 -179.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.17 113.51 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.45000000000000001 109.659 177.263 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.43 154.79 39.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.416 . . . . 0.60999999999999999 110.696 -178.038 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.6 m170 -92.95 134.15 35.4 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.768 -0.827 . . . . 0.41999999999999998 108.768 172.845 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -49.39 -53.15 24.04 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.267 0.354 . . . . 0.68000000000000005 111.217 -176.125 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.18 -30.08 69.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.933 -0.576 . . . . 3.3300000000000001 111.829 -176.106 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.8 m -80.66 -22.08 40.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.54000000000000004 111.487 -175.022 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -31.67 8.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.454 -0.339 . . . . 0.60999999999999999 111.443 -178.568 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.12 141.78 41.77 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.405 . . . . 0.80000000000000004 110.732 -176.333 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.62 153.99 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.799 2.333 . . . . 2.1200000000000001 111.417 174.844 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -18.56 61.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.35 -0.841 . . . . 3.2999999999999998 112.362 -172.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.9 -13.23 80.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.955 -0.64 . . . . 1.46 112.447 177.597 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -87.37 130.91 34.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.739 -0.467 . . . . 1.03 109.739 177.589 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 138.48 31.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.326 -0.397 . . . . 1.6000000000000001 109.957 -175.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -68.9 115.23 29.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 2.6800000000000002 110.103 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.1 138.0 46.06 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.038 2.492 . . . . 1.1399999999999999 112.805 -176.431 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.47 -5.4 65.2 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.766 -0.652 . . . . 1.8999999999999999 111.819 177.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -88.75 -9.71 50.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 2.75 111.023 -179.794 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.01 137.23 3.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.602 -0.808 . . . . 0.81999999999999995 112.276 179.145 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.01 123.85 22.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.872 0.368 . . . . 0.87 110.676 176.893 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.373 -0.376 . . . . 2.6499999999999999 110.337 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.0 p -72.79 -177.43 2.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.48999999999999999 110.453 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -53.35 -49.29 67.44 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.781 0.432 . . . . 4.0899999999999999 111.959 -172.774 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -68.88 -42.06 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.808 0.337 . . . . 1.54 111.392 -177.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.3 m -72.08 -28.15 63.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.202 0.445 . . . . 0.71999999999999997 112.202 -175.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.6 p -107.94 11.21 28.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.974 0.416 . . . . 1.25 111.034 179.047 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 C-N-CA 120.485 -0.864 . . . . 2.1899999999999999 112.746 -175.217 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.826 0.346 . . . . 3.1800000000000002 111.273 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 t -68.3 115.47 7.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.53000000000000003 109.346 174.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.75 60.86 Favored Glycine 0 C--O 1.228 -0.267 0 O-C-N 123.358 0.411 . . . . 0.65000000000000002 113.509 -174.852 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.9 -33.39 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.061 0.457 . . . . 1.04 110.953 179.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.87 -37.16 7.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.81 0.67 . . . . 0.83999999999999997 112.81 -171.283 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.93 -7.39 76.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.856 -0.688 . . . . 0.77000000000000002 111.598 -175.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -104.52 149.16 25.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.93 0.395 . . . . 2.1000000000000001 110.523 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.14 6.89 32.54 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.295 -0.722 . . . . 0.55000000000000004 111.295 175.66 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.9 m -66.89 133.7 50.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.56 -0.32 . . . . 1.0600000000000001 110.289 178.53 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.31 41.18 4.23 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.15 0.906 . . . . 2.23 111.896 -177.458 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.16 142.6 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.564 -0.744 . . . . 1.1599999999999999 110.452 -177.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' C' ' 36' ' ' TRP . 49.6 mt -87.66 148.88 24.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.027 0.442 . . . . 0.47999999999999998 110.177 177.665 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 26.3 mmm180 -119.54 138.57 53.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.544 -0.753 . . . . 3.1800000000000002 110.054 -177.069 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.91 137.51 53.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.014 -0.736 . . . . 0.37 109.014 178.05 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -92.42 -14.53 28.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.75 111.153 -178.891 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -98.86 -20.75 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.187 -0.46 . . . . 1.4299999999999999 111.014 -179.659 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.3 p -150.82 -166.25 2.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.917 -0.771 . . . . 0.79000000000000004 108.917 176.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.06 114.95 29.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.687 0.279 . . . . 0.46999999999999997 110.848 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.54 139.46 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.372 -0.376 . . . . 0.40000000000000002 110.92 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.38 112.86 19.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.105 -0.498 . . . . 0.45000000000000001 110.195 178.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -149.91 148.61 29.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 0.60999999999999999 110.197 -179.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.5 m170 -80.42 138.74 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.618 -0.882 . . . . 0.41999999999999998 108.618 172.606 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.0 t-105 -52.8 -50.59 63.31 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.173 0.296 . . . . 0.68000000000000005 110.76 -177.651 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -67.0 -14.35 62.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.789 -0.641 . . . . 3.3300000000000001 112.288 -175.688 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 85.1 m -88.56 -20.78 24.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.078 0.466 . . . . 0.54000000000000004 110.876 -179.425 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -107.49 -43.86 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.60999999999999999 111.212 177.03 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.0 m-85 -120.72 112.27 33.95 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.80000000000000004 110.149 -176.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.52 -174.46 0.45 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.888 2.392 . . . . 2.1200000000000001 113.106 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.06 51.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 3.2999999999999998 112.535 -175.768 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.52 -25.04 62.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.002 -0.618 . . . . 1.46 113.086 -179.683 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 4.5 m -107.83 126.2 52.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.942 0.401 . . . . 1.03 110.778 -179.792 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -89.43 138.6 31.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.255 -0.646 . . . . 1.6000000000000001 109.255 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -74.86 126.24 88.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 2.6800000000000002 111.07 -177.209 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 153.52 56.5 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.771 2.314 . . . . 1.1399999999999999 111.881 177.909 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.76 -24.41 55.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.955 -0.641 . . . . 1.8999999999999999 111.624 178.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -141.27 159.6 41.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.822 -0.436 . . . . 2.75 109.822 177.09 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.79 56.83 6.26 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.818 -0.706 . . . . 0.81999999999999995 112.024 -178.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.93 121.71 23.09 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.229 -0.656 . . . . 0.87 109.229 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -123.33 132.31 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.168 -0.469 . . . . 2.6499999999999999 110.969 -175.602 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 p -74.71 -172.21 1.49 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.48999999999999999 109.802 175.58 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -59.94 -47.45 85.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.627 0.251 . . . . 4.0899999999999999 111.422 -176.229 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -68.5 -46.58 69.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.443 -0.344 . . . . 1.54 111.564 -177.211 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.8 m -71.24 -21.57 62.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.852 -0.339 . . . . 0.71999999999999997 111.344 -177.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.4 t -99.75 13.32 34.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 1.25 110.498 179.188 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 C-N-CA 120.703 -0.76 . . . . 2.1899999999999999 111.461 177.555 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.411 ' N ' ' HB3' ' C' ' 33' ' ' ALA . 50.8 ttt85 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 109.011 -0.737 . . . . 3.1800000000000002 109.011 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 41.4 t -72.08 103.93 3.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.186 -0.461 . . . . 0.53000000000000003 110.231 -178.621 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.48 -8.66 84.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.65000000000000002 111.74 179.446 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.427 HG11 ' O ' ' C' ' 38' ' ' CYS . 25.5 t -61.68 -49.07 85.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 1.04 110.139 178.765 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.1 p -98.87 -28.12 13.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.482 -0.562 . . . . 0.83999999999999997 109.482 175.12 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 3.61 55.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.895 -0.669 . . . . 0.77000000000000002 111.945 178.281 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.57 145.05 48.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.767 0.318 . . . . 2.1000000000000001 110.843 -176.722 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.68 17.04 13.77 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.55000000000000004 111.891 179.201 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -78.31 122.77 26.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.533 0.166 . . . . 1.0600000000000001 110.935 -177.947 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.35 51.65 15.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.62 0.724 . . . . 2.23 110.299 -178.0 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.557 HG11 ' HB1' ' C' ' 33' ' ' ALA . 6.6 p -92.39 155.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.634 -1.166 . . . . 1.1599999999999999 110.416 -175.262 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 97.4 mt -86.31 146.59 26.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.678 -0.49 . . . . 0.47999999999999998 109.678 176.589 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -109.45 138.45 45.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.305 -0.407 . . . . 3.1800000000000002 110.272 -176.198 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.65 138.84 53.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.702 -0.481 . . . . 0.37 109.702 177.383 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -94.89 -24.51 16.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 0.75 111.339 179.744 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.48 -20.11 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.998 0.427 . . . . 1.4299999999999999 110.575 -177.744 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.47 -171.09 3.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.158 -1.052 . . . . 0.79000000000000004 108.158 174.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.76 112.92 26.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.961 -0.385 . . . . 0.46999999999999997 109.961 178.148 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.66 146.17 8.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.123 -0.49 . . . . 0.40000000000000002 110.001 -178.502 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.557 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -109.66 121.41 45.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.125 -0.489 . . . . 0.45000000000000001 109.694 177.403 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 31.0 p90 -149.8 143.21 25.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.226 -0.443 . . . . 0.60999999999999999 110.476 -178.492 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 68.9 m80 -90.33 138.81 31.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.691 -0.855 . . . . 0.41999999999999998 108.691 171.618 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -59.28 -43.78 92.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.354 0.409 . . . . 0.68000000000000005 110.02 178.355 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.62 -26.16 66.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.027 -0.533 . . . . 3.3300000000000001 111.534 -177.37 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.1 m -81.98 -23.9 35.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.041 0.448 . . . . 0.54000000000000004 110.653 179.679 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -101.19 -41.46 6.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.319 -0.4 . . . . 0.60999999999999999 111.701 -175.812 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.95 132.48 24.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.691 0.281 . . . . 0.80000000000000004 110.706 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.6 164.7 22.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.723 2.282 . . . . 2.1200000000000001 111.34 172.185 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.77 -3.48 5.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 3.2999999999999998 112.12 -175.712 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.67 73.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.965 -0.636 . . . . 1.46 111.67 173.705 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -101.4 136.1 41.81 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.079 -0.341 . . . . 1.03 110.079 178.705 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -89.03 140.22 29.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 1.6000000000000001 110.862 -175.604 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -81.91 118.15 71.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.6800000000000002 110.641 179.854 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 158.35 49.32 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.64 2.227 . . . . 1.1399999999999999 111.836 176.241 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.9 -16.45 61.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.03 -0.605 . . . . 1.8999999999999999 111.677 177.351 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -142.84 146.37 34.07 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.203 -0.295 . . . . 2.75 110.203 178.602 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.19 48.47 4.58 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.719 -0.753 . . . . 0.81999999999999995 112.518 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.2 122.12 27.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.159 0.504 . . . . 0.87 110.307 176.973 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.448 ' CZ ' ' HA ' ' C' ' 57' ' ' SER . 24.2 ptt180 -127.1 135.71 51.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.362 0.601 . . . . 2.6499999999999999 110.051 -179.744 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.8 p -72.28 177.9 4.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.48999999999999999 110.207 -178.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -58.43 -41.69 85.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.977 0.362 . . . . 4.0899999999999999 111.977 -174.258 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -64.3 -42.64 96.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.109 0.481 . . . . 1.54 110.522 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . 0.424 ' CB ' ' HB2' ' C' ' 52' ' ' ARG . 85.1 m -72.97 -19.9 61.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.71999999999999997 111.472 176.839 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . 0.448 ' HA ' ' CZ ' ' C' ' 52' ' ' ARG . 19.6 t -80.86 -14.28 58.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.104 -0.498 . . . . 1.25 110.477 -175.468 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.812 0 C-N-CA 120.648 -0.787 . . . . 2.1899999999999999 111.414 176.765 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.532 -0.544 . . . . 3.1800000000000002 109.532 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 42.8 t -73.65 103.9 4.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.581 -0.526 . . . . 0.53000000000000003 109.581 -179.289 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.64 -21.37 77.11 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.65000000000000002 113.485 -171.974 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 89.9 t -60.55 -38.09 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.887 0.375 . . . . 1.04 111.052 -179.101 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.3 p -109.24 -48.12 3.31 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.947 -0.301 . . . . 0.83999999999999997 110.491 179.771 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.03 -16.54 5.25 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.914 -0.66 . . . . 0.77000000000000002 112.536 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 33.7 m-20 -86.88 140.09 29.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.091 0.472 . . . . 2.1000000000000001 111.799 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.15 -3.62 33.56 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.737 -0.665 . . . . 0.55000000000000004 111.47 173.864 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m -80.88 136.46 36.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.329 . . . . 1.0600000000000001 111.052 177.899 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 64.65 44.79 3.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.793 0.806 . . . . 2.23 110.771 174.248 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' C' ' 33' ' ' ALA . 11.7 m -93.4 155.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.381 -0.827 . . . . 1.1599999999999999 111.751 -178.036 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' C' ' 36' ' ' TRP . 96.4 mt -97.17 145.51 25.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.355 -0.839 . . . . 0.47999999999999998 108.963 172.796 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 24.7 tpt180 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.192 -0.458 . . . . 3.1800000000000002 110.361 -174.278 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.33 136.85 57.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.673 -0.491 . . . . 0.37 109.673 177.676 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.58 -26.91 22.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.75 111.049 -179.633 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -90.02 -20.32 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.582 . . . . 1.4299999999999999 111.502 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.12 -166.07 2.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.338 -0.616 . . . . 0.79000000000000004 109.338 176.728 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.5 114.28 28.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.198 -0.297 . . . . 0.46999999999999997 110.198 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -164.38 130.5 2.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.289 -0.414 . . . . 0.40000000000000002 110.187 -179.786 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.5 112.76 24.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.09 -0.505 . . . . 0.45000000000000001 109.845 176.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -152.11 163.79 38.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.229 -0.441 . . . . 0.60999999999999999 110.565 -173.359 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -97.43 137.92 35.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.241 -0.652 . . . . 0.41999999999999998 109.241 173.283 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.424 ' HB2' HD12 ' C' ' 25' ' ' LEU . 71.4 t-105 -60.91 -42.68 98.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.438 0.461 . . . . 0.68000000000000005 110.122 178.617 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -62.52 -34.74 77.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.907 0.384 . . . . 3.3300000000000001 111.293 -179.712 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.435 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 93.5 m -73.83 -22.44 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 0.54000000000000004 111.143 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -98.05 -40.86 8.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.407 . . . . 0.60999999999999999 111.798 -177.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 83.6 m-85 -137.6 140.85 31.33 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.296 -0.411 . . . . 0.80000000000000004 109.971 -176.535 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.85 177.09 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.597 2.198 . . . . 2.1200000000000001 112.193 178.326 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.571 -0.286 . . . . 3.2999999999999998 111.682 -178.154 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.66 -35.58 89.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.019 -0.61 . . . . 1.46 112.145 176.073 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 22.6 m -86.03 131.25 34.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.867 -0.419 . . . . 1.03 109.867 178.918 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.6 m -88.86 150.73 22.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 1.6000000000000001 111.028 -176.576 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -99.18 130.61 26.87 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.845 -0.616 . . . . 2.6800000000000002 110.79 -174.012 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.13 140.41 37.54 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.325 2.016 . . . . 1.1399999999999999 111.72 175.856 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.87 -20.29 63.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.911 -0.662 . . . . 1.8999999999999999 112.023 -179.051 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -142.67 137.81 30.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.799 -0.445 . . . . 2.75 109.799 177.795 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.18 53.71 3.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.735 -0.745 . . . . 0.81999999999999995 112.082 -179.555 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 123.32 17.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.817 -0.438 . . . . 0.87 109.817 179.065 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -112.13 141.55 45.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.39 -0.368 . . . . 2.6499999999999999 110.934 -178.494 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 p -78.3 -179.58 6.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.003 -0.74 . . . . 0.48999999999999999 109.003 171.872 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -60.87 -44.23 97.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 4.0899999999999999 110.735 -175.764 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -63.28 -48.62 77.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.067 -0.515 . . . . 1.54 111.408 -178.355 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -71.68 -17.1 62.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.779 0.323 . . . . 0.71999999999999997 111.372 -179.363 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 1.25 110.309 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 C-N-CA 120.729 -0.748 . . . . 2.1899999999999999 112.189 -179.686 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.2 -0.667 . . . . 3.1800000000000002 109.2 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' C' ' 17' ' ' VAL . 43.9 t -64.39 105.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.53000000000000003 110.349 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.85 -12.14 67.34 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 121.296 -0.478 . . . . 0.65000000000000002 112.347 -179.856 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.454 ' HB ' ' SG ' ' C' ' 15' ' ' CYS . 61.0 t -76.77 -28.71 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 1.04 110.213 176.59 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.1 m -110.38 -36.17 5.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.004 -0.544 . . . . 0.83999999999999997 112.036 -177.976 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.65 7.89 74.5 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.045 -0.822 . . . . 0.77000000000000002 111.045 -173.651 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -126.51 154.58 43.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.547 -0.326 . . . . 2.1000000000000001 111.022 -176.871 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.91 16.36 12.18 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.402 -0.679 . . . . 0.55000000000000004 111.402 175.332 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -80.05 125.57 29.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.667 -0.266 . . . . 1.0600000000000001 111.166 -179.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.18 45.83 26.58 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 122.207 1.003 . . . . 2.23 110.028 -178.579 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.7 p -96.04 151.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.078 -0.964 . . . . 1.1599999999999999 109.399 -177.159 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.34 146.75 23.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.107 0.479 . . . . 0.47999999999999998 110.749 -178.108 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.6 mmm180 -107.31 149.79 27.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.1800000000000002 109.876 -178.865 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -84.31 139.11 32.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 176.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.6 p -87.4 -13.12 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.504 0.557 . . . . 0.75 112.504 -174.857 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -111.92 -20.8 11.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.823 0.344 . . . . 1.4299999999999999 110.396 -179.478 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.408 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 2.0 p -140.32 -177.12 4.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.532 -0.544 . . . . 0.79000000000000004 109.532 176.379 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.32 28.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.345 -0.389 . . . . 0.46999999999999997 110.224 -177.974 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.56 146.61 13.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 110.742 -176.645 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -125.59 111.84 15.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.45000000000000001 109.617 176.143 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -157.8 144.03 17.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.60999999999999999 109.67 -178.777 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.906 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 57.7 m80 -75.18 140.38 43.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.207 -1.035 . . . . 0.41999999999999998 108.207 171.021 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -54.41 -50.76 66.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.783 0.265 . . . . 0.68000000000000005 110.804 -175.922 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.6 mtp180 -64.02 -15.28 59.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 3.3300000000000001 112.344 -176.295 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.3 m -83.92 -20.99 32.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.027 0.441 . . . . 0.54000000000000004 110.697 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -108.59 -25.88 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.60999999999999999 111.106 176.325 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 61.9 m-85 -132.86 139.03 33.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.364 . . . . 0.80000000000000004 110.277 -178.565 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 148.25 90.63 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.605 2.203 . . . . 2.1200000000000001 111.475 175.451 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.26 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.308 -0.86 . . . . 3.2999999999999998 112.718 -172.525 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 -23.12 77.9 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.68 -0.771 . . . . 1.46 111.988 177.707 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -81.11 143.29 32.53 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.0 -0.37 . . . . 1.03 110.0 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -88.8 131.62 34.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 1.6000000000000001 111.057 -174.818 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 22.8 ptt180 -75.9 128.81 82.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.874 -0.603 . . . . 2.6800000000000002 109.932 175.976 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 24.0 Cg_exo -63.21 132.23 35.49 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.383 2.055 . . . . 1.1399999999999999 112.249 -178.668 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -22.07 31.14 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.144 -0.782 . . . . 1.8999999999999999 111.144 176.451 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -89.84 52.4 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.176 0.512 . . . . 2.75 110.577 177.972 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 108.77 3.14 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.673 -0.775 . . . . 0.81999999999999995 112.225 -178.501 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.59 123.2 19.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.87 109.247 177.179 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -122.76 135.14 54.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.342 -0.39 . . . . 2.6499999999999999 110.732 -175.63 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.81 158.69 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.173 -0.676 . . . . 0.48999999999999999 109.173 175.736 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -56.21 -31.16 63.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.737 0.699 . . . . 4.0899999999999999 111.714 -170.415 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -65.91 -46.43 78.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.568 0.223 . . . . 1.54 110.741 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.6 m -72.08 -23.87 61.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.726 0.298 . . . . 0.71999999999999997 111.219 -179.978 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -78.39 0.53 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.398 -0.365 . . . . 1.25 111.045 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 111.725 -0.55 . . . . 2.1899999999999999 111.725 179.574 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 109.294 -0.632 . . . . 3.1800000000000002 109.294 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.85 105.7 1.67 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.003 -0.369 . . . . 0.53000000000000003 110.003 179.458 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.66 -30.05 75.61 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.347 -0.454 . . . . 0.65000000000000002 112.597 -176.957 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 -30.6 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 1.04 110.779 -179.37 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -101.26 -36.73 8.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.173 -0.467 . . . . 0.83999999999999997 111.764 -178.302 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.59 -1.66 66.51 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.258 -0.737 . . . . 0.77000000000000002 111.258 -174.746 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -120.91 145.29 47.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 2.1000000000000001 110.875 -177.039 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.23 14.7 56.84 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.711 -0.677 . . . . 0.55000000000000004 111.481 172.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.3 m -63.95 119.63 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.397 0.279 . . . . 1.0600000000000001 110.532 178.014 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 52.88 50.82 17.18 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.709 0.631 . . . . 2.23 110.753 -178.878 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.414 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.2 p -89.59 146.05 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 1.1599999999999999 110.39 -176.076 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.89 144.2 25.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.47999999999999998 110.232 179.194 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -106.77 146.54 30.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 3.1800000000000002 109.767 -178.386 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 5.3 t -80.49 138.72 36.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.985 -0.746 . . . . 0.37 108.985 176.256 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -92.91 -13.54 28.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 0.75 111.873 -177.299 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.93 -18.56 14.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.435 -0.348 . . . . 1.4299999999999999 111.198 178.795 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -149.72 -167.71 2.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.451 -0.574 . . . . 0.79000000000000004 109.451 177.059 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 114.7 29.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.719 0.295 . . . . 0.46999999999999997 110.402 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -160.37 153.79 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.309 -0.405 . . . . 0.40000000000000002 110.858 -179.518 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -134.72 113.45 11.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.852 -0.613 . . . . 0.45000000000000001 109.67 176.095 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.38 163.26 40.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.899 -0.591 . . . . 0.60999999999999999 109.752 -178.438 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.714 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.8 m170 -94.01 139.21 31.22 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.787 -0.82 . . . . 0.41999999999999998 108.787 172.208 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 60.5 t-105 -49.29 -53.24 22.84 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.412 0.445 . . . . 0.68000000000000005 111.643 -176.559 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -71.07 -9.1 57.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 3.3300000000000001 112.19 -174.462 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 63.3 m -91.55 -21.34 20.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.984 0.421 . . . . 0.54000000000000004 110.76 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -107.63 -40.84 5.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.183 -0.462 . . . . 0.60999999999999999 110.958 177.865 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.81 148.56 40.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.992 -0.549 . . . . 0.80000000000000004 110.631 -175.428 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 154.17 73.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.852 2.368 . . . . 2.1200000000000001 112.144 177.84 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.04 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.197 -0.911 . . . . 3.2999999999999998 111.95 -175.114 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -7.22 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 1.46 111.906 176.145 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -101.29 129.81 47.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.014 -0.365 . . . . 1.03 110.014 177.709 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -87.73 130.77 34.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.796 -0.446 . . . . 1.6000000000000001 109.796 -179.34 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 16.3 ptm180 -71.56 118.6 67.78 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 2.6800000000000002 111.11 -175.71 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.57 132.92 22.97 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.682 2.255 . . . . 1.1399999999999999 112.549 -177.884 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.86 51.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.905 -0.664 . . . . 1.8999999999999999 111.785 178.469 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 60.73 0.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 2.75 110.934 -176.983 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.6 82.53 0.77 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.401 -0.904 . . . . 0.81999999999999995 112.458 179.356 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -76.25 128.28 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.074 -0.713 . . . . 0.87 109.074 177.056 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -124.41 145.87 49.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.162 0.506 . . . . 2.6499999999999999 111.877 -174.774 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -83.58 -178.8 7.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 0.48999999999999999 108.909 171.914 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' C' ' 55' ' ' SER . 11.5 ptp180 -63.13 -41.2 99.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.289 0.495 . . . . 4.0899999999999999 111.476 -173.925 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 19.6 t -68.74 -40.68 79.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.787 0.327 . . . . 1.54 111.234 -175.153 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.43 -15.74 61.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.71999999999999997 111.31 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -96.4 -13.61 23.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.078 0.466 . . . . 1.25 110.619 177.134 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.689 0 N-CA-C 111.564 -0.614 . . . . 2.1899999999999999 111.564 -175.974 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 110.202 -0.296 . . . . 3.1800000000000002 110.202 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.3 t -65.92 118.96 10.48 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.086 -0.339 . . . . 0.53000000000000003 110.086 177.975 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.33 -17.07 77.35 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.884 -0.674 . . . . 0.65000000000000002 112.265 -179.548 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -82.74 -31.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.568 0.223 . . . . 1.04 111.117 179.734 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 71.1 m -106.52 -29.13 9.85 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.571 0.582 . . . . 0.83999999999999997 112.571 -177.175 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.06 81.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.894 -0.882 . . . . 0.77000000000000002 110.894 -172.48 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.49 154.0 48.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.181 -0.51 . . . . 2.1000000000000001 110.141 -172.877 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.09 23.97 6.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.02 -0.609 . . . . 0.55000000000000004 112.63 179.209 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -81.5 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.209 -0.293 . . . . 1.0600000000000001 110.209 178.474 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.23 37.47 28.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.365 0.602 . . . . 2.23 109.959 -177.5 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.8 p -90.21 158.0 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 1.1599999999999999 110.565 -174.428 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 79.7 mt -95.63 146.38 24.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.74 0.305 . . . . 0.47999999999999998 110.348 176.577 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -109.89 131.51 55.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 3.1800000000000002 110.015 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.97 132.37 47.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.111 -0.7 . . . . 0.37 109.111 176.386 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.02 -17.52 32.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.256 0.551 . . . . 0.75 111.121 -178.926 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -97.77 -20.12 17.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.541 . . . . 1.4299999999999999 111.339 -177.346 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -151.48 -164.72 2.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.104 -0.702 . . . . 0.79000000000000004 109.104 176.096 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.2 114.15 28.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.203 -0.295 . . . . 0.46999999999999997 110.203 178.54 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.22 131.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.40000000000000002 110.868 -179.143 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -111.87 113.44 25.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.73 -0.668 . . . . 0.45000000000000001 109.739 177.121 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 25.3 p90 -151.99 146.53 25.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.254 -0.43 . . . . 0.60999999999999999 109.986 -179.832 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.892 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 53.7 m80 -79.55 135.2 36.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.419 -0.956 . . . . 0.41999999999999998 108.419 171.338 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 73.9 t-105 -51.28 -52.04 48.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.671 0.272 . . . . 0.68000000000000005 111.482 -174.042 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -68.17 -16.78 64.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 3.3300000000000001 112.124 -173.456 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.93 -22.85 48.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.186 0.517 . . . . 0.54000000000000004 110.52 178.804 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -104.54 -50.29 3.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.972 -0.558 . . . . 0.60999999999999999 110.67 179.131 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 78.2 m-85 -108.16 122.04 41.84 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.511 -0.768 . . . . 0.80000000000000004 109.702 -177.089 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 50.8 Cg_exo -55.21 162.73 5.31 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.972 2.448 . . . . 2.1200000000000001 112.38 -179.338 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -18.27 41.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.865 -1.062 . . . . 3.2999999999999998 112.669 -170.75 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.66 4.73 77.64 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.603 178.503 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 91.1 m -112.59 133.32 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.749 0.309 . . . . 1.03 110.512 177.725 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -88.8 144.4 26.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 1.6000000000000001 110.597 -175.971 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 45.9 ttp180 -87.2 122.23 71.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 2.6800000000000002 110.84 -179.551 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.3 Cg_exo -69.0 132.26 24.15 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.503 2.135 . . . . 1.1399999999999999 111.736 176.957 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.88 -14.73 48.33 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.971 -0.633 . . . . 1.8999999999999999 112.18 -179.741 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.9 t -88.83 -10.7 47.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 2.75 111.206 -178.218 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 122.79 0.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.847 -0.692 . . . . 0.81999999999999995 111.654 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.41 123.23 33.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.005 0.431 . . . . 0.87 110.155 -177.602 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -116.65 128.94 55.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.458 . . . . 2.6499999999999999 110.736 -178.85 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -75.3 -169.74 1.04 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.612 . . . . 0.48999999999999999 110.072 175.313 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.69 -52.83 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.373 -0.376 . . . . 4.0899999999999999 111.403 -176.663 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -68.72 -42.78 77.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.539 -0.301 . . . . 1.54 111.808 -175.49 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.7 m -71.93 -17.36 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.71999999999999997 111.88 -176.627 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -88.15 8.31 27.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.094 0.473 . . . . 1.25 110.532 -179.117 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.731 0 C-N-CA 120.685 -0.769 . . . . 2.1899999999999999 112.159 179.532 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.452 0.168 . . . . 3.1800000000000002 110.81 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.3 110.59 6.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.24 -0.652 . . . . 0.53000000000000003 109.24 174.509 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.19 -24.71 65.6 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 121.304 -0.474 . . . . 0.65000000000000002 112.841 -176.449 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.99 -30.75 33.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 1.04 110.781 179.168 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 95.3 m -104.63 -46.48 4.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.83999999999999997 112.299 -175.039 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.92 -8.34 45.86 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.436 -0.666 . . . . 0.77000000000000002 111.436 -174.041 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.51 154.14 22.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 2.1000000000000001 110.722 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 11.15 30.38 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.112 -0.795 . . . . 0.55000000000000004 111.112 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.28 134.97 53.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.35 . . . . 1.0600000000000001 110.343 177.75 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 41.65 48.57 3.61 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.137 0.898 . . . . 2.23 111.757 -178.732 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.404 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.0 p -89.06 146.67 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.165 -0.925 . . . . 1.1599999999999999 110.421 -176.319 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 84.3 mt -96.99 157.64 15.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.474 -0.33 . . . . 0.47999999999999998 110.205 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 9.3 mmm180 -120.71 141.45 50.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.921 -0.581 . . . . 3.1800000000000002 111.064 -174.225 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.81 139.77 47.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.823 -0.806 . . . . 0.37 108.823 173.203 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p -92.4 -21.23 20.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 0.75 111.217 179.43 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -89.54 -23.12 22.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 1.4299999999999999 110.623 -178.448 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.91 -164.91 2.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.207 -0.664 . . . . 0.79000000000000004 109.207 177.113 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 115.07 29.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.77 0.319 . . . . 0.46999999999999997 110.48 179.449 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.14 139.1 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.96 -0.563 . . . . 0.40000000000000002 110.331 178.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -121.24 118.93 30.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.001 -0.545 . . . . 0.45000000000000001 110.171 178.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . 0.404 ' N ' HG22 ' C' ' 24' ' ' VAL . 52.3 p90 -160.22 162.72 33.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.60999999999999999 109.901 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.7 m170 -91.34 133.35 35.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.099 -1.074 . . . . 0.41999999999999998 108.099 171.616 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.401 ' HB2' HD12 ' C' ' 25' ' ' LEU . 74.3 t-105 -59.3 -36.96 76.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.68000000000000005 110.915 -177.215 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -68.82 -19.88 64.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 3.3300000000000001 110.883 -179.697 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -90.57 -23.14 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.279 -0.419 . . . . 0.54000000000000004 111.071 -178.123 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -92.46 -38.59 11.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.394 -0.366 . . . . 0.60999999999999999 110.643 176.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 94.3 m-85 -126.66 73.47 74.76 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.488 . . . . 0.80000000000000004 110.815 -178.753 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 0.06 10.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.018 2.479 . . . . 2.1200000000000001 112.057 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.7 3.41 29.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 3.2999999999999998 111.24 -177.828 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.43 24.8 30.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.625 -0.797 . . . . 1.46 112.35 179.747 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 7.2 m -66.18 141.93 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.869 -0.419 . . . . 1.03 109.869 176.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.8 t -88.13 133.04 34.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.004 0.431 . . . . 1.6000000000000001 110.228 -175.437 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -70.72 119.0 70.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.551 -0.749 . . . . 2.6800000000000002 110.548 -179.65 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.67 132.45 20.32 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.591 2.194 . . . . 1.1399999999999999 112.316 -179.42 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.18 -8.62 74.81 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 1.8999999999999999 111.566 177.355 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.9 p -91.96 28.52 1.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.945 0.403 . . . . 2.75 111.541 -179.963 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.72 121.76 3.06 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.941 -0.647 . . . . 0.81999999999999995 112.296 179.857 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 52' ' ' ARG . 0.5 OUTLIER -75.91 128.33 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.668 -0.493 . . . . 0.87 109.668 -178.821 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.413 ' N ' HD13 ' C' ' 51' ' ' LEU . 86.3 mtt180 -113.15 138.69 49.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.408 . . . . 2.6499999999999999 111.395 -176.845 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 p -88.89 -176.45 5.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 0.48999999999999999 109.213 173.779 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -67.29 -39.52 85.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.41 -0.516 . . . . 4.0899999999999999 111.332 -175.87 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 42.3 t -67.17 -45.4 77.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.598 0.237 . . . . 1.54 110.729 -178.381 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.7 m -71.9 -17.26 62.11 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.661 0.245 . . . . 0.71999999999999997 111.661 -179.512 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -96.28 -14.19 22.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.93 0.395 . . . . 1.25 110.985 178.699 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 2.1899999999999999 111.899 -177.944 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.529 0.204 . . . . 3.1800000000000002 111.198 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -68.22 122.91 19.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.646 -0.502 . . . . 0.53000000000000003 109.646 174.872 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -24.85 64.77 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.65000000000000002 113.401 -175.023 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.04 -32.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 1.04 111.177 -179.502 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.3 -40.36 7.96 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.315 0.487 . . . . 0.83999999999999997 112.315 -174.439 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.63 -17.62 58.96 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.191 -0.764 . . . . 0.77000000000000002 111.191 -173.076 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.5 148.8 21.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.365 . . . . 2.1000000000000001 110.616 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.27 15.05 39.58 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.043 -0.599 . . . . 0.55000000000000004 111.623 176.261 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.8 m -74.76 124.38 26.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.253 . . . . 1.0600000000000001 110.401 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.77 42.9 28.63 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.915 -0.584 . . . . 2.23 110.823 -177.348 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 9.9 p -88.06 136.27 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.535 . . . . 1.1599999999999999 110.301 -175.538 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -94.44 157.1 16.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.0 -0.546 . . . . 0.47999999999999998 109.913 -178.292 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 28.6 mmm180 -121.68 149.6 42.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.901 -0.591 . . . . 3.1800000000000002 110.189 -177.197 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -81.56 143.64 31.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.805 -0.443 . . . . 0.37 109.805 -179.818 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.99 -21.91 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.273 -0.421 . . . . 0.75 111.576 -179.003 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -100.94 -17.61 16.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.541 -0.299 . . . . 1.4299999999999999 111.358 -177.219 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 p -151.13 -169.94 3.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.79000000000000004 109.51 177.512 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.87 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.489 -0.323 . . . . 0.46999999999999997 110.359 178.841 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.19 132.39 8.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.535 -0.302 . . . . 0.40000000000000002 110.77 -178.66 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -106.93 112.85 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.515 . . . . 0.45000000000000001 109.852 176.263 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -158.78 164.74 35.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.298 -0.41 . . . . 0.60999999999999999 110.187 -177.63 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.66 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 28.6 m170 -98.81 138.83 35.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.439 -0.948 . . . . 0.41999999999999998 108.439 171.639 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -54.99 -46.3 75.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.644 0.259 . . . . 0.68000000000000005 110.54 -178.182 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 73.4 mtp180 -65.96 -18.3 65.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 3.3300000000000001 112.101 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.7 m -85.35 -20.34 30.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.044 0.449 . . . . 0.54000000000000004 110.809 -179.19 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -99.93 -39.27 8.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.60999999999999999 110.777 174.974 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 94.9 m-85 -127.04 144.97 52.29 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.80000000000000004 109.903 -179.432 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.51 154.8 34.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.593 2.196 . . . . 2.1200000000000001 111.856 177.594 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -10.97 28.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 3.2999999999999998 112.06 -174.68 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.54 -2.07 76.82 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.839 -0.696 . . . . 1.46 112.144 176.761 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.9 m -90.31 139.82 30.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.023 -0.362 . . . . 1.03 110.023 178.601 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.8 p -88.39 132.81 34.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.433 -0.349 . . . . 1.6000000000000001 110.873 -175.631 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -88.42 134.31 34.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 2.6800000000000002 110.911 -177.915 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.63 132.59 38.47 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.653 2.235 . . . . 1.1399999999999999 111.328 173.745 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.08 -51.2 5.46 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.869 -0.605 . . . . 1.8999999999999999 113.404 -174.023 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -95.73 -18.25 20.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 2.75 111.214 -175.451 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -131.78 67.89 0.56 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.537 -0.84 . . . . 0.81999999999999995 112.521 -178.428 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.77 122.63 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.25 -0.648 . . . . 0.87 109.25 176.89 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 53.2 mtm180 -121.38 140.23 52.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.972 0.415 . . . . 2.6499999999999999 111.122 -173.125 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.4 p -80.39 -174.72 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.48999999999999999 109.784 175.703 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -61.71 -49.56 75.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.614 0.245 . . . . 4.0899999999999999 111.19 -176.036 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.6 t -64.24 -43.92 93.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.432 -0.349 . . . . 1.54 111.28 -176.151 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.5 m -71.62 -19.7 62.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.157 -0.217 . . . . 0.71999999999999997 111.557 -178.064 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.0 m -83.41 -13.93 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.886 0.374 . . . . 1.25 110.732 178.811 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 111.241 -0.744 . . . . 2.1899999999999999 111.241 178.122 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . 0.426 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.9 mtm-85 . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.219 0.533 . . . . 3.1800000000000002 111.095 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 t -87.7 104.88 16.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.831 . . . . 0.53000000000000003 109.698 178.873 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -16.8 69.31 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.859 -0.609 . . . . 0.65000000000000002 113.846 -172.733 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.58 -29.91 48.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.04 110.86 -179.258 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.94 -42.56 2.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.347 -0.388 . . . . 0.83999999999999997 110.388 178.137 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.88 -11.44 10.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.057 -0.592 . . . . 0.77000000000000002 111.812 -178.508 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.96 141.94 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.116 0.484 . . . . 2.1000000000000001 111.405 -177.634 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -110.98 16.86 27.64 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.577 -0.738 . . . . 0.55000000000000004 111.273 175.826 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.9 m -76.09 115.56 15.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.461 -0.37 . . . . 1.0600000000000001 110.323 179.344 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 45.77 70.99 0.31 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.921 0.763 . . . . 2.23 112.062 178.776 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 m -88.4 146.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 1.1599999999999999 110.413 178.665 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.37 148.53 22.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.973 -0.558 . . . . 0.47999999999999998 109.836 -179.436 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -108.58 145.51 34.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.059 -0.519 . . . . 3.1800000000000002 110.054 -179.649 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 8.0 t -75.52 135.4 40.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.004 -0.739 . . . . 0.37 109.004 177.026 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 37.1 p -86.24 -7.26 58.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.939 0.4 . . . . 0.75 111.344 -179.522 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -110.75 -19.64 12.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.416 -0.356 . . . . 1.4299999999999999 111.157 -179.16 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.8 p -151.56 -172.13 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.714 -0.476 . . . . 0.79000000000000004 109.714 177.289 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.68 30.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.856 -0.156 . . . . 0.46999999999999997 111.397 -176.153 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.74 141.87 4.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.811 -0.177 . . . . 0.40000000000000002 111.127 179.241 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.25 118.11 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.791 -0.448 . . . . 0.45000000000000001 109.791 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -161.87 163.36 29.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.60999999999999999 111.19 -175.222 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -96.6 140.59 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.365 -0.606 . . . . 0.41999999999999998 109.365 172.103 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -62.14 -42.31 99.12 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.537 -0.542 . . . . 0.68000000000000005 109.537 174.678 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -63.43 -22.75 67.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.917 -0.583 . . . . 3.3300000000000001 111.819 -179.442 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 63.7 m -87.17 -21.82 25.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.54000000000000004 111.303 -179.055 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.42 -38.81 8.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.874 0.369 . . . . 0.60999999999999999 110.813 179.924 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.95 149.88 74.09 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.5 -0.556 . . . . 0.80000000000000004 109.5 -179.001 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.68 140.25 61.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.252 1.968 . . . . 2.1200000000000001 111.502 178.05 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.96 -8.83 17.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 3.2999999999999998 111.944 -175.611 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.81 71.81 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.778 -0.929 . . . . 1.46 110.778 172.455 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -87.45 131.57 34.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.266 -0.642 . . . . 1.03 109.266 174.603 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -87.73 115.37 25.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.141 0.496 . . . . 1.6000000000000001 110.642 -176.083 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -57.96 136.3 83.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 2.6800000000000002 111.179 -178.599 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.74 135.24 32.4 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.951 2.434 . . . . 1.1399999999999999 112.89 -175.991 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.92 -10.66 71.75 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.042 -0.599 . . . . 1.8999999999999999 111.75 179.05 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -89.31 12.08 17.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 2.75 111.057 -179.739 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.03 116.35 1.56 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.763 -0.732 . . . . 0.81999999999999995 112.504 178.405 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.3 OUTLIER -71.28 125.99 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.374 -0.602 . . . . 0.87 109.374 179.239 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -115.17 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 2.6499999999999999 111.062 -175.507 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 p -73.31 174.77 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.695 -0.854 . . . . 0.48999999999999999 108.695 172.056 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -58.29 -41.55 84.66 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.432 0.53 . . . . 4.0899999999999999 112.432 -169.245 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -69.41 -47.84 62.9 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.22 -0.3 . . . . 1.54 111.339 -178.385 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.36 -18.74 61.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.688 0.28 . . . . 0.71999999999999997 111.211 -178.781 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -84.59 -13.88 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.35 . . . . 1.25 110.429 -179.54 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.667 0 C-N-CA 120.683 -0.77 . . . . 2.1899999999999999 112.04 -179.721 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.435 -0.58 . . . . 3.1800000000000002 109.435 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.7 t -67.1 103.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.53000000000000003 109.231 177.567 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.24 -11.54 78.09 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.834 -0.621 . . . . 0.65000000000000002 112.97 -171.472 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 58.6 t -65.73 -42.45 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.833 0.349 . . . . 1.04 110.38 178.932 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -104.25 -37.2 7.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.401 -0.363 . . . . 0.83999999999999997 110.684 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.01 -5.72 27.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.77000000000000002 112.184 -178.883 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 5.6 m-20 -102.19 135.34 43.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.963 0.411 . . . . 2.1000000000000001 111.212 -179.211 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.63 1.64 34.29 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.239 -0.744 . . . . 0.55000000000000004 111.239 174.137 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 40.4 m -69.08 132.4 46.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.465 -0.368 . . . . 1.0600000000000001 110.636 177.359 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 55.62 47.39 20.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.726 0.774 . . . . 2.23 109.885 178.25 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.81 149.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.274 -0.876 . . . . 1.1599999999999999 110.713 -173.971 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -99.36 153.32 19.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.234 -0.439 . . . . 0.47999999999999998 110.45 -179.671 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 16.7 tpp180 -115.57 143.01 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.624 . . . . 3.1800000000000002 109.842 -177.983 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.4 t -75.62 147.02 39.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.37 110.077 177.326 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.7 p -86.35 -38.46 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.514 . . . . 0.75 112.0 -179.482 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -90.43 -12.09 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.299 . . . . 1.4299999999999999 111.7 -176.571 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.8 p -150.97 -179.64 7.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.223 -0.658 . . . . 0.79000000000000004 109.223 174.768 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 115.54 30.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.866 -0.42 . . . . 0.46999999999999997 109.866 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -159.91 136.34 8.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.913 -0.585 . . . . 0.40000000000000002 110.229 -179.023 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.88 112.18 25.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.45000000000000001 109.807 175.986 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.32 158.92 40.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.60999999999999999 109.98 -177.38 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -94.32 146.91 23.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.696 -0.483 . . . . 0.41999999999999998 109.696 173.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -56.81 -53.52 56.87 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.584 0.553 . . . . 0.68000000000000005 110.364 -179.632 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -63.9 -37.06 86.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.364 0.505 . . . . 3.3300000000000001 112.364 -175.549 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.422 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 70.7 m -65.46 -24.32 67.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.957 0.408 . . . . 0.54000000000000004 111.159 -177.989 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -100.89 -54.85 2.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.175 0.512 . . . . 0.60999999999999999 110.698 178.366 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -107.18 129.26 24.58 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.73 -0.668 . . . . 0.80000000000000004 109.66 -176.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.84 162.03 9.43 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.829 2.352 . . . . 2.1200000000000001 112.224 178.693 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.19 38.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 3.2999999999999998 111.903 -173.782 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.34 -15.2 81.73 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.795 -0.717 . . . . 1.46 111.73 175.019 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -90.47 125.7 35.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.07 -0.345 . . . . 1.03 110.07 179.389 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -89.27 134.58 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.803 0.335 . . . . 1.6000000000000001 110.832 -177.895 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -71.46 124.35 90.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 2.6800000000000002 111.097 -177.631 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.05 143.4 36.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.852 2.368 . . . . 1.1399999999999999 112.81 -178.558 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.32 -10.3 48.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.915 -0.66 . . . . 1.8999999999999999 112.33 178.801 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -89.14 0.09 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.347 0.594 . . . . 2.75 110.655 -179.887 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.71 119.15 1.28 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.985 -0.626 . . . . 0.81999999999999995 111.986 -178.529 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.19 123.93 33.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.107 0.479 . . . . 0.87 110.318 -179.109 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -122.58 142.8 50.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.001 -0.545 . . . . 2.6499999999999999 111.34 -173.998 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -73.39 165.76 24.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.48999999999999999 109.489 175.176 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -53.93 -34.63 60.14 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.157 0.435 . . . . 4.0899999999999999 111.899 -173.145 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 28.0 t -66.09 -50.05 65.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.924 0.392 . . . . 1.54 110.455 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.5 m -72.92 -26.54 61.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.117 0.414 . . . . 0.71999999999999997 112.117 -178.571 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -89.53 0.28 57.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 1.25 111.044 -178.954 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 120.776 -0.726 . . . . 2.1899999999999999 111.986 -179.312 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 109.356 -0.609 . . . . 3.1800000000000002 109.356 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' C' C ' 15' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 32.0 t -62.0 112.65 2.42 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.723 -0.473 . . . . 0.53000000000000003 109.723 178.22 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.59 -23.77 55.5 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 121.38 -0.438 . . . . 0.65000000000000002 112.993 -175.911 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.03 -32.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.04 111.142 179.701 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.3 m -105.92 -47.42 3.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.194 0.442 . . . . 0.83999999999999997 112.194 -174.689 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.0 -23.25 19.59 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.444 -0.663 . . . . 0.77000000000000002 111.444 -173.902 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.78 152.21 21.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.732 0.301 . . . . 2.1000000000000001 111.069 -178.165 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.83 6.79 33.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.043 -0.599 . . . . 0.55000000000000004 111.804 177.307 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -70.58 127.9 34.29 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.645 -0.132 . . . . 1.0600000000000001 110.645 178.563 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 58.11 39.44 26.11 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.51 0.506 . . . . 2.23 110.906 179.55 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -89.23 148.15 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.232 -0.44 . . . . 1.1599999999999999 110.53 -175.093 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -114.62 148.64 37.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.47999999999999998 110.217 -179.069 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 26' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.2 mpt_? -119.31 148.63 42.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.647 -0.501 . . . . 3.1800000000000002 109.647 179.967 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 27' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 40.3 t -68.95 139.28 55.05 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.112 -0.635 . . . . 0.37 109.486 174.307 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 28' ' ' THR . . . . . 0.408 HG21 ' HA3' ' C' ' 50' ' ' GLY . 12.4 t -85.07 4.43 34.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.424 0.631 . . . . 0.75 110.596 178.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -127.62 -8.6 5.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 1.4299999999999999 110.68 176.7 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 9.0 m -145.02 177.44 8.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.79000000000000004 110.13 -177.948 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 112.96 26.2 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.802 -0.814 . . . . 0.46999999999999997 108.802 173.072 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 32' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.0 111.8 0.98 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.088 -0.505 . . . . 0.40000000000000002 110.531 -179.544 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -93.21 112.58 24.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.007 0.432 . . . . 0.45000000000000001 109.903 176.057 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.68 158.1 40.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.878 -0.601 . . . . 0.60999999999999999 109.828 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 35' ' ' HIS . . . . . 0.76 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.4 m170 -87.24 138.45 31.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.166 -1.05 . . . . 0.41999999999999998 108.166 172.192 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -48.94 -50.99 32.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.107 0.254 . . . . 0.68000000000000005 111.443 -175.849 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 37' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 90.8 mtt180 -67.71 -10.46 52.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.016 -0.538 . . . . 3.3300000000000001 112.099 -175.325 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 38' ' ' CYS . . . . . 0.76 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.6 m -89.96 -21.63 22.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.906 0.384 . . . . 0.54000000000000004 110.947 -179.083 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -101.94 -36.87 8.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.429 . . . . 0.60999999999999999 110.486 174.92 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 40' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 57.3 m-85 -124.5 150.0 63.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.989 -0.55 . . . . 0.80000000000000004 110.219 -176.061 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.83 144.18 94.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.565 2.176 . . . . 2.1200000000000001 111.089 172.786 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.85 -15.6 55.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.542 -0.754 . . . . 3.2999999999999998 111.982 -175.733 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.75 -24.34 76.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.87 -0.681 . . . . 1.46 112.157 175.723 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.8 m -75.94 136.5 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.988 -0.375 . . . . 1.03 109.988 179.328 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -87.94 128.96 35.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.105 0.479 . . . . 1.6000000000000001 111.266 -172.959 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -69.24 119.16 68.42 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 2.6800000000000002 110.194 179.366 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.62 132.8 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.537 2.158 . . . . 1.1399999999999999 112.405 -176.317 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.05 -11.53 67.32 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.438 -0.665 . . . . 1.8999999999999999 111.438 177.126 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 21.5 p -89.7 37.44 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.368 0.604 . . . . 2.75 110.634 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 50' ' ' GLY . . . . . 0.408 ' HA3' HG21 ' C' ' 28' ' ' THR . . . 105.72 123.85 5.24 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 111.869 -178.12 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 123.73 22.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.105 -0.702 . . . . 0.87 109.105 178.406 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -115.52 128.48 56.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.945 0.403 . . . . 2.6499999999999999 110.993 -174.876 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 53' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 15.6 p -73.24 174.13 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.724 -0.671 . . . . 0.48999999999999999 109.672 177.507 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -57.66 -37.87 74.13 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.862 0.301 . . . . 4.0899999999999999 111.655 -170.309 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 32.9 t -69.31 -38.84 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.977 0.418 . . . . 1.54 110.343 179.992 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.7 m -73.18 -33.24 65.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.19 -0.459 . . . . 0.71999999999999997 111.984 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.1 p -83.84 -14.94 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 1.25 110.873 179.438 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 110.956 -0.857 . . . . 2.1899999999999999 110.956 175.468 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.599 -0.6 . . . . 20.379999999999999 111.599 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.42 34.53 0.87 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 18.809999999999999 110.507 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 48.9 ttm -148.43 33.98 0.79 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.675 0.75 . . . . 18.059999999999999 110.232 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -85.91 -15.47 41.58 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.776 -0.647 . . . . 16.829999999999998 109.965 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.88 22.87 32.5 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.965 -0.636 . . . . 14.66 112.249 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.54 -44.02 95.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.033 0.444 . . . . 15.800000000000001 110.302 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' C' ' 7' ' ' GLN . 15.3 mm-40 -94.79 66.52 3.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.476 0.655 . . . . 13.130000000000001 109.855 176.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -87.97 10.58 18.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.259 -0.882 . . . . 11.74 109.933 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.66 96.17 10.33 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.312 -0.858 . . . . 8.7200000000000006 109.073 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -59.97 132.52 89.61 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.049 -0.523 . . . . 5.9299999999999997 111.483 -175.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 27.8 Cg_exo -61.14 107.39 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.859 2.373 . . . . 5.25 112.387 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.06 16.45 80.57 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.13 -0.557 . . . . 2.2799999999999998 112.377 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.47 99.3 4.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 2.0699999999999998 110.611 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -139.24 164.03 30.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.643 -0.708 . . . . 3.1800000000000002 109.549 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.6 t -67.1 106.29 1.93 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.497 -0.557 . . . . 0.53000000000000003 109.497 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.41 -21.76 57.73 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 121.344 -0.455 . . . . 0.65000000000000002 112.937 -176.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -75.22 -33.09 27.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.834 0.35 . . . . 1.04 111.027 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.35 -38.96 6.64 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.085 0.402 . . . . 0.83999999999999997 112.085 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.45 -17.11 58.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.862 -0.685 . . . . 0.77000000000000002 111.421 -175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -98.01 155.05 17.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.984 0.421 . . . . 2.1000000000000001 110.9 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.54 9.08 17.11 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.024 -0.83 . . . . 0.55000000000000004 111.024 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -64.08 118.1 8.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.294 -0.453 . . . . 1.0600000000000001 110.823 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 55.12 47.53 21.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.616 -0.72 . . . . 2.23 110.744 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.451 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.9 p -89.16 141.41 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.662 -0.699 . . . . 1.1599999999999999 109.735 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.43 143.7 29.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.77 0.319 . . . . 0.47999999999999998 110.521 -175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 40.3 mmt-85 -104.74 147.04 28.13 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 3.1800000000000002 109.948 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.36 146.55 29.31 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.408 -0.59 . . . . 0.37 109.408 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.4 p -92.55 -29.69 16.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.461 -0.336 . . . . 0.75 111.705 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -89.71 -17.23 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.773 0.32 . . . . 1.4299999999999999 111.105 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 p -150.9 -173.27 4.43 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.973 -0.751 . . . . 0.79000000000000004 108.973 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.98 115.64 30.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.008 -0.367 . . . . 0.46999999999999997 110.008 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -157.29 156.9 33.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.409 -0.36 . . . . 0.40000000000000002 110.459 -177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -135.37 111.84 9.89 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.841 -0.618 . . . . 0.45000000000000001 109.807 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.451 ' N ' HG22 ' C' ' 24' ' ' VAL . 37.8 p90 -156.24 158.96 38.45 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.99 -0.55 . . . . 0.60999999999999999 109.836 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.719 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.6 m170 -92.3 133.13 36.13 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.267 -1.012 . . . . 0.41999999999999998 108.267 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -49.45 -52.49 28.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.375 0.422 . . . . 0.68000000000000005 111.585 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -62.57 -25.8 68.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 3.3300000000000001 111.86 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.14 -22.45 52.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.939 0.399 . . . . 0.54000000000000004 110.852 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . 0.462 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 0.9 OUTLIER -101.09 -40.69 7.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.324 -0.398 . . . . 0.60999999999999999 111.068 178.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -117.76 79.02 12.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.402 -0.363 . . . . 0.80000000000000004 110.458 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 3.8 Cg_endo -86.74 7.09 5.06 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.242 2.628 . . . . 2.1200000000000001 112.411 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.58 4.54 27.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 3.2999999999999998 111.789 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.7 26.64 24.3 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.477 -0.868 . . . . 1.46 111.76 -178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -75.73 140.64 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.895 -0.409 . . . . 1.03 109.895 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 11.5 p -88.7 135.35 33.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.669 0.271 . . . . 1.6000000000000001 110.627 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -73.85 112.68 17.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 2.6800000000000002 110.755 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.66 133.34 20.22 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.503 2.135 . . . . 1.1399999999999999 112.069 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.28 -17.49 69.02 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.611 -0.804 . . . . 1.8999999999999999 111.249 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 2.3 p -98.06 74.71 2.29 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.377 -0.412 . . . . 2.75 111.28 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.03 85.46 1.73 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.452 -0.88 . . . . 0.81999999999999995 112.851 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.38 124.15 20.54 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.243 -0.651 . . . . 0.87 109.243 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -125.69 130.72 52.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.965 0.412 . . . . 2.6499999999999999 111.327 -174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -76.36 -178.37 4.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.973 -0.558 . . . . 0.48999999999999999 110.067 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -60.24 -46.28 90.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.655 0.264 . . . . 4.0899999999999999 111.051 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 t -65.65 -48.42 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.204 -0.453 . . . . 1.54 111.056 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.76 -22.28 65.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.531 0.205 . . . . 0.71999999999999997 111.514 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -86.25 -2.6 58.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.496 0.189 . . . . 1.25 111.017 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.8 -69.44 1.3 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.812 -0.709 . . . . 2.1899999999999999 111.855 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -110.92 112.6 24.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.742 0.306 . . . . 5.1500000000000004 110.308 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.83 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.081 -0.509 . . . . 6.7599999999999998 109.705 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 28.8 m -116.89 105.92 48.68 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.171 -0.468 . . . . 8.8300000000000001 110.507 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.35 161.66 44.97 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.737 2.291 . . . . 11.039999999999999 112.235 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.58 116.62 66.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.203 -0.453 . . . . 13.859999999999999 110.11 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.94 99.69 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.174 2.583 . . . . 16.550000000000001 112.764 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.95 129.14 41.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.109 -0.496 . . . . 18.07 109.953 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.61 -0.709 . . . . 20.260000000000002 110.501 -176.272 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.712 -0.555 . . . . 20.379999999999999 111.712 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.77 26.73 16.28 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.95 0.405 . . . . 18.809999999999999 111.63 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 50.2 ttm -116.14 -39.32 3.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.431 . . . . 18.059999999999999 110.703 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -75.89 -34.49 59.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.958 -0.565 . . . . 16.829999999999998 110.988 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.4 148.26 48.37 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.576 -0.821 . . . . 14.66 111.965 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -78.46 -30.37 47.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.219 0.533 . . . . 15.800000000000001 109.959 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' C' ' 7' ' ' GLN . 2.7 pt20 -91.48 165.25 13.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.056 -0.52 . . . . 13.130000000000001 109.968 176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -129.34 136.74 50.4 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.495 -0.558 . . . . 11.74 109.495 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.1 64.92 2.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.48 . . . . 8.7200000000000006 110.657 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.75 137.54 23.15 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.953 -0.567 . . . . 5.9299999999999997 110.018 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.91 41.91 0.49 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.978 2.452 . . . . 5.25 113.106 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.61 -134.33 44.48 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.173 -0.537 . . . . 2.2799999999999998 112.036 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.83 73.48 9.96 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.127 0.489 . . . . 2.0699999999999998 110.189 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.7 ttp180 -157.08 134.91 10.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.829 -0.623 . . . . 3.1800000000000002 109.757 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 4.4 t -81.83 104.8 12.47 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.973 -0.558 . . . . 0.53000000000000003 109.753 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -2.28 60.51 Favored Glycine 0 N--CA 1.454 -0.159 0 CA-C-N 115.759 -0.655 . . . . 0.65000000000000002 113.306 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.75 -29.2 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.992 0.425 . . . . 1.04 110.384 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.5 p -122.99 -35.1 3.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.448 -0.342 . . . . 0.83999999999999997 111.056 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.22 -11.86 21.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.892 -0.671 . . . . 0.77000000000000002 111.992 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 24.4 t70 -97.73 147.15 24.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.733 0.302 . . . . 2.1000000000000001 110.632 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.21 16.34 8.12 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.965 -0.636 . . . . 0.55000000000000004 112.121 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.16 132.63 35.94 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.121 -0.326 . . . . 1.0600000000000001 110.121 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t0 52.59 56.16 8.04 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.791 0.805 . . . . 2.23 109.488 -174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' C' ' 33' ' ' ALA . 6.2 p -91.44 137.37 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.168 -0.924 . . . . 1.1599999999999999 110.63 -173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.3 mt -91.97 147.9 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 0.47999999999999998 110.225 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 10.4 mmm180 -114.47 136.05 53.43 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.963 -0.562 . . . . 3.1800000000000002 110.16 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.8 t -67.56 136.78 55.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.349 -0.387 . . . . 0.37 110.102 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 66.2 p -88.26 -12.76 42.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.072 0.463 . . . . 0.75 111.108 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -100.96 -23.25 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 1.4299999999999999 110.827 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.3 p -151.28 -172.4 4.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.656 -0.498 . . . . 0.79000000000000004 109.656 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.34 113.96 27.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.684 -0.234 . . . . 0.46999999999999997 110.417 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.28 140.15 6.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.262 -0.427 . . . . 0.40000000000000002 110.653 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.71 112.17 23.68 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.45000000000000001 109.354 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' C' ' 15' ' ' CYS . 34.8 p90 -150.89 166.85 29.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.293 -0.412 . . . . 0.60999999999999999 110.806 -174.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -104.4 138.17 41.21 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.277 -0.638 . . . . 0.41999999999999998 109.277 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.413 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 69.2 t-105 -63.44 -34.44 77.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.835 -0.62 . . . . 0.68000000000000005 110.387 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' C' ' 37' ' ' ARG . 19.4 mtm180 -68.69 -36.6 78.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 3.3300000000000001 110.798 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 77.2 m -73.61 -23.15 59.86 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.049 -0.523 . . . . 0.54000000000000004 110.919 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -92.32 -54.71 3.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.136 -0.484 . . . . 0.60999999999999999 110.935 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -113.16 144.07 30.44 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.953 -0.567 . . . . 0.80000000000000004 110.227 -175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.27 165.09 25.66 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.795 2.33 . . . . 2.1200000000000001 112.068 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -13.96 47.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.192 -0.913 . . . . 3.2999999999999998 112.961 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.44 -6.5 77.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.49 -0.862 . . . . 1.46 112.519 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.9 m -91.48 130.46 37.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.156 0.503 . . . . 1.03 111.123 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.3 t -89.9 150.37 22.22 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.816 -0.629 . . . . 1.6000000000000001 109.459 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.413 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 93.5 mtt180 -79.41 131.69 64.57 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.543 -0.54 . . . . 2.6800000000000002 109.543 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.6 132.15 21.43 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.176 1.917 . . . . 1.1399999999999999 111.925 -177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -75.33 -2.32 67.19 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.861 -0.685 . . . . 1.8999999999999999 112.323 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.2 p -89.3 -2.77 58.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.817 0.342 . . . . 2.75 111.22 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.45 147.86 5.66 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.519 -0.848 . . . . 0.81999999999999995 112.444 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.5 123.35 25.31 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.047 0.451 . . . . 0.87 109.844 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.74 133.32 55.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.312 -0.404 . . . . 2.6499999999999999 111.295 -175.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -77.38 -174.24 3.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.176 -0.676 . . . . 0.48999999999999999 109.176 172.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -62.23 -53.17 59.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 4.0899999999999999 111.374 -173.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.0 m -63.46 -42.47 98.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 1.54 111.646 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.1 m -71.38 -17.27 62.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.679 0.276 . . . . 0.71999999999999997 111.297 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 70.6 m -85.39 -3.04 58.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 1.25 110.989 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.27 38.62 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.606 -0.807 . . . . 2.1899999999999999 112.381 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -92.6 69.37 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.278 0.561 . . . . 5.1500000000000004 110.491 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 31.6 t -89.51 109.45 20.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.564 -0.744 . . . . 6.7599999999999998 109.742 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -67.82 115.01 23.45 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.385 -0.37 . . . . 8.8300000000000001 111.014 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.92 146.88 16.54 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.628 2.219 . . . . 11.039999999999999 112.481 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.49 137.65 20.75 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 13.859999999999999 110.584 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.05 71.34 2.86 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.623 2.215 . . . . 16.550000000000001 111.188 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.84 138.89 52.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.913 -0.585 . . . . 18.07 110.81 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.685 -0.674 . . . . 20.260000000000002 110.091 -178.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.689 0 N-CA-C 112.078 -0.409 . . . . 20.379999999999999 112.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.17 -71.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.607 0.763 . . . . 18.809999999999999 111.378 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.3 ptm -141.14 120.32 12.93 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.606 -0.516 . . . . 18.059999999999999 109.606 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' C' ' 4' ' ' GLU . 0.0 OUTLIER -81.3 -33.98 32.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.296 -0.411 . . . . 16.829999999999998 110.527 -177.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.25 112.1 0.85 Allowed Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.433 -0.889 . . . . 14.66 112.563 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.12 0.57 14.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.922 0.391 . . . . 15.800000000000001 110.513 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -79.22 66.97 4.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.289 0.566 . . . . 13.130000000000001 110.031 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -69.8 -43.45 72.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.659 -0.701 . . . . 11.74 109.566 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.3 tp -101.2 120.22 39.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 8.7200000000000006 109.587 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.2 123.42 85.25 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.603 -0.518 . . . . 5.9299999999999997 109.603 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.31 89.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.888 2.392 . . . . 5.25 112.429 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.62 -17.04 37.36 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.71 -0.677 . . . . 2.2799999999999998 111.506 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.94 74.8 4.49 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.357 0.599 . . . . 2.0699999999999998 109.45 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -161.53 141.93 10.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.019 -0.991 . . . . 3.1800000000000002 108.648 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 49.3 t -72.17 103.78 3.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.022 0.439 . . . . 0.53000000000000003 110.497 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.73 -7.65 83.92 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.856 -0.611 . . . . 0.65000000000000002 111.644 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -61.94 -45.85 97.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 1.04 110.255 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.2 p -102.73 -28.08 12.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.914 0.388 . . . . 0.83999999999999997 110.038 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.11 24.75 10.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.911 -0.661 . . . . 0.77000000000000002 111.693 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 27.9 t70 -142.59 147.83 36.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 2.1000000000000001 110.706 -175.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.23 16.94 8.04 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 111.631 -0.587 . . . . 0.55000000000000004 111.631 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 8.5 m -80.44 120.02 23.9 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.155 -0.313 . . . . 1.0600000000000001 110.155 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 53.72 50.03 17.94 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.56 0.695 . . . . 2.23 110.167 -176.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.7 p -89.43 144.53 8.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.936 -1.029 . . . . 1.1599999999999999 109.903 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.9 mt -88.47 155.42 19.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.961 0.41 . . . . 0.47999999999999998 110.376 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.0 mmm180 -123.64 151.96 42.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.014 -0.735 . . . . 3.1800000000000002 109.014 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 37.9 t -69.63 138.78 53.37 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.618 -0.833 . . . . 0.37 109.176 174.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 21.9 p -80.98 -10.86 59.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.101 0.477 . . . . 0.75 110.98 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -117.25 -7.81 11.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.964 -0.562 . . . . 1.4299999999999999 111.031 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 14.3 m -140.92 179.32 6.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.053 0.454 . . . . 0.79000000000000004 110.406 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.6 113.29 26.76 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.011 -0.737 . . . . 0.46999999999999997 109.011 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.91 145.34 6.22 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 123.058 0.224 . . . . 0.40000000000000002 110.53 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.53 112.41 24.12 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.477 0.486 . . . . 0.45000000000000001 110.268 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -157.06 145.15 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.913 -0.585 . . . . 0.60999999999999999 110.146 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.821 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 77.2 m80 -86.75 151.35 23.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.516 -0.55 . . . . 0.41999999999999998 109.516 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 67.9 t-105 -61.98 -50.5 71.82 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.763 0.316 . . . . 0.68000000000000005 110.489 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 79.9 mtp180 -69.43 -14.53 62.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 3.3300000000000001 111.731 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.821 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.8 m -80.79 -20.96 41.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.251 0.548 . . . . 0.54000000000000004 110.029 175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -103.06 -39.41 6.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.847 -0.615 . . . . 0.60999999999999999 111.392 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 99.0 m-85 -125.68 158.61 64.45 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.80000000000000004 110.496 -175.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -70.42 159.82 51.6 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.595 2.197 . . . . 2.1200000000000001 110.935 174.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.02 -18.3 64.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.073 -0.512 . . . . 3.2999999999999998 111.458 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.21 -12.8 79.75 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.231 -0.509 . . . . 1.46 112.413 177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 23.7 m -88.81 138.9 30.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.914 -0.402 . . . . 1.03 109.914 177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.11 137.74 32.06 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.759 0.314 . . . . 1.6000000000000001 110.319 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 14.4 ptm180 -93.12 121.74 64.91 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.352 -0.385 . . . . 2.6800000000000002 111.221 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.02 136.57 29.96 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.769 2.312 . . . . 1.1399999999999999 111.639 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.74 -46.99 10.32 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.075 -0.583 . . . . 1.8999999999999999 112.721 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -17.65 16.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.163 0.506 . . . . 2.75 111.307 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -115.95 50.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.686 -0.769 . . . . 0.81999999999999995 112.63 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -70.09 123.54 21.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.934 -0.765 . . . . 0.87 108.934 178.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 76.0 mtt180 -117.82 140.97 48.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.933 0.397 . . . . 2.6499999999999999 111.832 -170.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 17.6 p -77.29 171.51 14.75 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.424 -0.954 . . . . 0.48999999999999999 108.424 169.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -56.55 -38.79 72.39 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.194 0.452 . . . . 4.0899999999999999 111.752 -171.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 38.4 t -68.62 -40.45 80.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.932 0.396 . . . . 1.54 110.843 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.5 m -71.47 -26.19 62.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.732 0.301 . . . . 0.71999999999999997 111.021 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 41.9 p -93.46 19.76 8.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.983 0.421 . . . . 1.25 110.689 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.67 10.97 60.57 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.13 -0.557 . . . . 2.1899999999999999 112.126 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -91.12 156.8 17.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.837 0.351 . . . . 5.1500000000000004 110.156 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.63 114.58 42.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.301 -0.408 . . . . 6.7599999999999998 110.448 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 69.4 m -93.5 117.56 67.37 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.737 -0.468 . . . . 8.8300000000000001 109.737 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.05 134.27 39.01 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.257 1.971 . . . . 11.039999999999999 112.219 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.56 122.72 68.0 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.951 -0.568 . . . . 13.859999999999999 110.038 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.88 86.24 0.11 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.842 2.362 . . . . 16.550000000000001 112.221 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 m -92.01 170.64 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.88 -0.6 . . . . 18.07 110.994 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.515 -0.755 . . . . 20.260000000000002 110.328 -178.455 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.853 -0.499 . . . . 20.379999999999999 111.853 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.56 60.15 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.405 0.622 . . . . 18.809999999999999 111.206 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 71.8 mtm -80.81 145.37 31.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.532 -0.758 . . . . 18.059999999999999 109.621 176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -74.38 78.25 1.88 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.956 0.408 . . . . 16.829999999999998 110.908 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.4 83.96 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.583 -0.607 . . . . 14.66 111.583 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -110.69 8.65 22.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.893 0.378 . . . . 15.800000000000001 110.731 -176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -97.05 104.78 16.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.138 -0.483 . . . . 13.130000000000001 110.268 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -81.24 79.73 7.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 11.74 110.416 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 56.6 tp -143.21 133.02 23.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.968 -0.56 . . . . 8.7200000000000006 110.34 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.16 139.19 52.61 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.063 -0.517 . . . . 5.9299999999999997 110.57 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.79 57.89 2.58 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.099 2.532 . . . . 5.25 113.107 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 148.03 -150.38 22.58 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.791 -0.718 . . . . 2.2799999999999998 112.48 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.23 83.55 3.61 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.805 0.336 . . . . 2.0699999999999998 111.435 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -146.74 152.24 38.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.348 -0.387 . . . . 3.1800000000000002 110.72 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.2 t -65.4 113.56 4.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.53000000000000003 109.699 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.61 -19.2 62.38 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.075 -0.583 . . . . 0.65000000000000002 113.496 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.0 t -79.93 -30.47 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.059 0.457 . . . . 1.04 110.686 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.6 m -108.57 -24.56 11.33 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.56 0.578 . . . . 0.83999999999999997 112.56 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.46 16.9 79.81 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 111.304 -0.718 . . . . 0.77000000000000002 111.304 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -134.85 156.2 49.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.297 -0.451 . . . . 2.1000000000000001 110.137 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.89 22.09 5.19 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.721 -0.752 . . . . 0.55000000000000004 112.816 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 12.0 m -75.66 125.83 29.82 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.0600000000000001 110.059 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 54.36 45.73 26.57 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.334 0.588 . . . . 2.23 110.234 -176.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -91.75 151.77 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.567 -0.742 . . . . 1.1599999999999999 110.531 -175.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.409 HD12 ' HB2' ' C' ' 36' ' ' TRP . 74.2 mt -96.02 149.49 21.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.142 -0.481 . . . . 0.47999999999999998 109.898 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -107.38 155.46 19.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.114 -0.494 . . . . 3.1800000000000002 110.505 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.1 t -88.92 140.43 29.44 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.613 -0.514 . . . . 0.37 109.613 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.5 p -90.37 -26.83 19.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.032 0.444 . . . . 0.75 111.275 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -89.96 -20.5 23.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 1.4299999999999999 111.05 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.0 p -151.0 -172.32 4.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.961 -0.755 . . . . 0.79000000000000004 108.961 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.27 114.27 28.42 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.949 -0.389 . . . . 0.46999999999999997 109.949 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.32 151.96 10.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.261 -0.427 . . . . 0.40000000000000002 110.776 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.423 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -119.35 120.58 37.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.805 -0.634 . . . . 0.45000000000000001 109.679 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.84 148.17 31.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.193 -0.458 . . . . 0.60999999999999999 110.873 -176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.6 m170 -88.82 126.61 35.43 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.79 -1.189 . . . . 0.41999999999999998 107.79 168.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.409 ' HB2' HD12 ' C' ' 25' ' ' LEU . 56.4 t-105 -56.57 -38.59 72.17 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.69 0.619 . . . . 0.68000000000000005 111.192 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -71.71 -23.7 61.68 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.904 0.383 . . . . 3.3300000000000001 111.222 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 84.4 m -85.14 -22.99 28.6 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.421 -0.354 . . . . 0.54000000000000004 110.93 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . 0.426 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 7.6 m-70 -102.15 -24.72 13.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.60999999999999999 111.539 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -130.87 65.1 75.83 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.913 0.387 . . . . 0.80000000000000004 110.522 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 6.2 Cg_exo -78.97 5.42 5.72 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.159 2.572 . . . . 2.1200000000000001 112.436 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.14 3.58 26.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.302 -0.408 . . . . 3.2999999999999998 111.326 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.8 8.24 45.94 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 1.46 112.7 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.3 m -67.72 129.35 39.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.121 -0.325 . . . . 1.03 110.121 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 p -90.03 149.17 22.64 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.631 0.253 . . . . 1.6000000000000001 110.575 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -78.13 121.97 84.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.392 -0.367 . . . . 2.6800000000000002 111.257 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.71 155.65 58.35 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.771 2.314 . . . . 1.1399999999999999 111.466 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.44 -19.43 79.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.98 -0.629 . . . . 1.8999999999999999 111.814 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -147.11 142.29 27.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 120.917 0.389 . . . . 2.75 110.212 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.97 51.71 1.47 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.784 -0.722 . . . . 0.81999999999999995 112.36 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.54 122.13 25.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.172 0.51 . . . . 0.87 110.372 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -127.89 137.29 52.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.171 -0.468 . . . . 2.6499999999999999 110.505 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -72.89 -177.0 2.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.476 -0.564 . . . . 0.48999999999999999 109.476 176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -67.01 -40.43 87.31 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.631 -0.428 . . . . 4.0899999999999999 110.631 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.7 m -67.68 -43.58 79.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.456 . . . . 1.54 111.459 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.78 -17.22 62.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.714 0.292 . . . . 0.71999999999999997 110.791 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 68.8 m -87.41 19.66 3.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.876 0.37 . . . . 1.25 110.574 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.58 94.28 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.498 -1.041 . . . . 2.1899999999999999 110.498 172.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -91.94 74.63 5.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.612 0.72 . . . . 5.1500000000000004 109.485 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.53 123.22 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.722 -0.672 . . . . 6.7599999999999998 110.721 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 33.6 m -97.57 115.18 65.72 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.002 -0.544 . . . . 8.8300000000000001 109.827 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.72 132.91 54.4 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.519 2.146 . . . . 11.039999999999999 111.91 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.13 141.93 33.33 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.838 -0.619 . . . . 13.859999999999999 110.812 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.87 57.63 4.55 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.804 2.336 . . . . 16.550000000000001 112.515 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.4 153.21 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.006 -0.543 . . . . 18.07 110.358 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.469 -0.777 . . . . 20.260000000000002 110.786 -179.423 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 112.042 -0.423 . . . . 20.379999999999999 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.58 122.54 27.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.834 0.349 . . . . 18.809999999999999 110.523 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 42.0 tpp -85.27 59.73 5.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.513 0.673 . . . . 18.059999999999999 110.094 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -93.92 69.73 3.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.512 0.672 . . . . 16.829999999999998 110.177 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.6 48.22 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.205 -0.907 . . . . 14.66 111.106 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -80.87 -12.89 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.725 0.298 . . . . 15.800000000000001 111.296 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 58.59 56.4 4.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.484 -0.78 . . . . 13.130000000000001 110.465 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -113.9 92.26 3.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.079 -0.51 . . . . 11.74 110.322 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -102.03 146.67 27.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.839 -0.619 . . . . 8.7200000000000006 109.917 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.84 130.88 33.36 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.149 -0.478 . . . . 5.9299999999999997 110.134 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.12 64.52 3.43 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.947 2.431 . . . . 5.25 112.684 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.41 41.36 58.68 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.708 -0.758 . . . . 2.2799999999999998 111.221 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.39 75.22 1.49 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 2.0699999999999998 110.077 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -129.07 141.84 51.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.878 -0.601 . . . . 3.1800000000000002 110.118 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -64.19 103.42 0.62 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.847 -0.615 . . . . 0.53000000000000003 109.516 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.08 -17.41 69.7 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.867 -0.682 . . . . 0.65000000000000002 112.764 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 42.0 t -61.78 -38.56 80.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.824 0.345 . . . . 1.04 110.981 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.6 p -109.52 -28.96 8.63 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.979 0.419 . . . . 0.83999999999999997 110.576 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.51 -14.38 56.53 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.044 -0.598 . . . . 0.77000000000000002 111.829 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -94.94 140.27 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.83 0.348 . . . . 2.1000000000000001 110.987 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.09 20.23 16.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.925 -0.655 . . . . 0.55000000000000004 112.476 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -78.36 116.37 18.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.461 0.172 . . . . 1.0600000000000001 110.581 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 54.71 66.19 1.3 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 2.23 111.386 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.49 140.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.689 -0.687 . . . . 1.1599999999999999 110.987 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 74.9 mt -88.06 143.8 26.87 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 0.47999999999999998 109.405 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.6 OUTLIER -108.07 135.54 49.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.069 0.462 . . . . 3.1800000000000002 110.612 -179.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 6.7 t -63.57 141.27 58.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.299 -0.864 . . . . 0.37 110.261 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.3 p -89.51 -26.23 21.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.324 -0.398 . . . . 0.75 111.35 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -89.64 -21.51 22.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.4299999999999999 110.904 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.9 p -150.49 -172.29 4.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.478 -0.934 . . . . 0.79000000000000004 108.478 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.03 114.4 28.66 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.788 0.328 . . . . 0.46999999999999997 110.187 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.45 123.23 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.952 -0.567 . . . . 0.40000000000000002 109.847 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.01 112.34 24.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.583 -0.525 . . . . 0.45000000000000001 109.583 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -147.77 162.92 38.23 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.004 -0.544 . . . . 0.60999999999999999 110.122 -174.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.427 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -93.03 133.72 35.89 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.873 -0.788 . . . . 0.41999999999999998 108.873 172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 t-105 -51.14 -48.05 61.91 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.632 0.582 . . . . 0.68000000000000005 111.092 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 33.7 mmt180 -74.41 -5.46 42.59 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.388 0.514 . . . . 3.3300000000000001 112.388 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.5 m -91.23 -22.2 20.72 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 0.54000000000000004 110.561 175.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.7 m-70 -102.35 -43.31 5.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.01 0.433 . . . . 0.60999999999999999 110.722 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 88.3 m-85 -118.58 137.72 25.1 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.595 . . . . 0.80000000000000004 109.928 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.41 177.65 6.46 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.7 2.267 . . . . 2.1200000000000001 112.633 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.11 -37.89 78.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.68 0.276 . . . . 3.2999999999999998 111.699 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.64 -20.93 64.43 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.105 -0.498 . . . . 1.46 113.787 -176.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.12 132.35 34.35 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 117.125 0.463 . . . . 1.03 110.111 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.74 137.99 31.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.29 -0.414 . . . . 1.6000000000000001 110.956 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -74.84 117.29 61.4 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.763 -0.653 . . . . 2.6800000000000002 110.632 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.41 132.63 22.66 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.587 2.191 . . . . 1.1399999999999999 111.638 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.23 -39.3 12.94 Favored Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.769 -0.729 . . . . 1.8999999999999999 111.459 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.1 m -98.14 112.49 24.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.447 -0.377 . . . . 2.75 110.597 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.58 59.99 3.12 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.885 -0.674 . . . . 0.81999999999999995 112.801 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -63.76 122.51 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.847 -0.797 . . . . 0.87 108.847 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.455 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 33.6 ptt180 -133.69 146.04 50.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.103 0.478 . . . . 2.6499999999999999 111.032 -174.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.7 p -73.46 177.14 5.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.329 -0.85 . . . . 0.48999999999999999 110.649 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -55.78 -49.37 73.36 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 123.151 0.282 . . . . 4.0899999999999999 111.204 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.6 t -59.19 -43.25 92.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.999 0.428 . . . . 1.54 110.513 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.3 m -72.82 -27.76 62.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.404 0.52 . . . . 0.71999999999999997 112.404 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 81.4 p -75.85 -7.14 53.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.874 0.369 . . . . 1.25 111.31 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.84 -149.6 5.11 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.937 -0.649 . . . . 2.1899999999999999 111.794 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -92.4 167.07 12.23 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.929 0.395 . . . . 5.1500000000000004 110.23 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 m -125.48 40.75 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-O 121.271 0.558 . . . . 6.7599999999999998 110.681 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 75.9 p -78.67 130.83 69.59 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.696 -0.683 . . . . 8.8300000000000001 110.197 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.15 133.24 51.73 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.341 2.027 . . . . 11.039999999999999 111.671 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.83 126.91 29.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.338 -0.392 . . . . 13.859999999999999 110.445 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.53 98.84 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.593 2.195 . . . . 16.550000000000001 111.831 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.5 t -89.57 -39.84 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.318 0.58 . . . . 18.07 110.416 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 C--N 1.314 -0.976 0 CA-C-N 115.316 -0.856 . . . . 20.260000000000002 109.976 179.817 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.886 0 N-CA-C 111.965 -0.454 . . . . 20.379999999999999 111.965 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.61 -20.01 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.714 0.292 . . . . 18.809999999999999 111.648 -177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -73.41 -12.41 60.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.26 -0.427 . . . . 18.059999999999999 111.238 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.25 84.1 7.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.919 -0.4 . . . . 16.829999999999998 109.919 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . 0.616 ' HA2' ' OD1' ' C' ' 8' ' ' ASN . . . -132.61 33.69 2.6 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.695 -0.764 . . . . 14.66 112.633 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -74.95 -28.42 60.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 15.800000000000001 111.026 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -120.22 35.3 4.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.969 0.414 . . . . 13.130000000000001 110.634 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . 0.616 ' OD1' ' HA2' ' C' ' 5' ' ' GLY . 16.7 m120 -115.08 24.59 11.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.167 0.508 . . . . 11.74 110.513 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -101.25 76.93 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.926 -0.579 . . . . 8.7200000000000006 110.285 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.62 125.91 90.61 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 5.9299999999999997 109.944 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.2 95.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.952 2.435 . . . . 5.25 113.071 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -126.0 41.52 1.64 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.514 -0.634 . . . . 2.2799999999999998 111.514 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.66 81.68 8.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.064 0.459 . . . . 2.0699999999999998 111.287 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.03 154.99 28.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 3.1800000000000002 109.721 176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 27.9 t -61.48 106.52 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 0.53000000000000003 110.123 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.05 -25.7 64.67 Favored Glycine 0 C--O 1.229 -0.182 0 O-C-N 123.454 0.471 . . . . 0.65000000000000002 112.516 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -67.17 -29.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.136 0.494 . . . . 1.04 110.885 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 88.5 m -108.1 -33.46 7.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 0.83999999999999997 112.116 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.05 6.03 72.38 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.86 -0.896 . . . . 0.77000000000000002 110.86 -172.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -132.36 147.08 52.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.024 -0.588 . . . . 2.1000000000000001 109.912 -175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.45 30.99 4.78 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.864 -0.684 . . . . 0.55000000000000004 112.752 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.9 m -74.72 125.73 29.35 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.723 -0.473 . . . . 1.0600000000000001 109.723 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.13 51.91 14.74 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.438 0.637 . . . . 2.23 110.325 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -89.33 151.1 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.599 -0.728 . . . . 1.1599999999999999 110.565 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' C' ' 36' ' ' TRP . 80.6 mt -102.27 148.38 25.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.331 -0.395 . . . . 0.47999999999999998 110.023 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.3 tpt180 -115.57 138.73 50.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.844 -0.617 . . . . 3.1800000000000002 110.447 -175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.7 t -75.49 143.69 42.42 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.743 -0.466 . . . . 0.37 109.743 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -91.04 -30.79 16.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.0 -0.545 . . . . 0.75 111.855 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -91.58 -14.38 30.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.351 . . . . 1.4299999999999999 111.507 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 p -150.47 -174.22 4.69 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.437 -0.579 . . . . 0.79000000000000004 109.437 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.63 114.06 28.04 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.673 -0.492 . . . . 0.46999999999999997 109.673 -177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.14 125.13 1.87 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.182 -0.463 . . . . 0.40000000000000002 110.835 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.55 112.76 25.91 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.024 -0.732 . . . . 0.45000000000000001 109.024 173.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -151.83 160.63 43.49 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.374 -0.375 . . . . 0.60999999999999999 110.598 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.1 m170 -90.8 134.83 34.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.941 -0.763 . . . . 0.41999999999999998 108.941 173.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.445 ' HB2' HD12 ' C' ' 25' ' ' LEU . 28.0 t-105 -50.54 -51.58 46.55 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.336 0.397 . . . . 0.68000000000000005 111.476 -174.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -62.19 -27.8 69.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.855 -0.611 . . . . 3.3300000000000001 112.193 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -78.49 -22.91 46.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 0.54000000000000004 111.346 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -100.22 -37.08 9.07 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.264 -0.425 . . . . 0.60999999999999999 110.865 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -118.3 85.65 25.63 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 0.80000000000000004 110.289 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.45 -5.19 12.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.117 2.544 . . . . 2.1200000000000001 113.386 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.21 4.23 31.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.896 0.379 . . . . 3.2999999999999998 111.067 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.41 33.78 27.5 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.713 -0.756 . . . . 1.46 112.024 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -61.66 142.21 57.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.801 0.334 . . . . 1.03 110.733 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 45.3 m -88.48 135.45 33.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.422 -0.354 . . . . 1.6000000000000001 110.157 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -67.4 125.78 91.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.888 -0.596 . . . . 2.6800000000000002 110.342 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.0 137.64 38.17 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.575 2.184 . . . . 1.1399999999999999 112.377 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.1 1.51 70.43 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.952 -0.642 . . . . 1.8999999999999999 111.988 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 32.2 p -104.86 26.61 8.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.36 0.6 . . . . 2.75 110.746 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 118.08 122.38 3.19 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.546 -0.752 . . . . 0.81999999999999995 111.805 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -66.7 123.57 20.47 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.548 -0.538 . . . . 0.87 109.548 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 54.1 mtt85 -125.68 134.29 51.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.359 -0.382 . . . . 2.6499999999999999 111.119 -174.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.9 p -76.29 177.19 7.45 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.977 -0.749 . . . . 0.48999999999999999 108.977 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -59.96 -40.33 88.66 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.318 0.508 . . . . 4.0899999999999999 111.487 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m -65.09 -46.54 80.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.868 0.366 . . . . 1.54 110.965 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.91 -17.85 62.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.418 -0.355 . . . . 0.71999999999999997 111.418 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 36.3 m -88.84 -14.33 37.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.38 . . . . 1.25 110.56 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.59 100.15 1.66 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.907 -0.663 . . . . 2.1899999999999999 112.623 -177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -89.54 42.26 1.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.59 0.71 . . . . 5.1500000000000004 109.745 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.13 146.82 24.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.542 -0.754 . . . . 6.7599999999999998 110.559 -172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.1 t -65.57 135.24 95.67 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.958 -0.565 . . . . 8.8300000000000001 109.805 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.07 133.51 47.55 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.838 2.359 . . . . 11.039999999999999 112.425 -176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.59 130.5 33.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.853 -0.612 . . . . 13.859999999999999 110.896 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.09 92.78 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.567 2.178 . . . . 16.550000000000001 111.423 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -91.24 124.82 43.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.178 -0.465 . . . . 18.07 110.654 -178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.924 -0.56 . . . . 20.260000000000002 109.754 177.36 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.877 -0.489 . . . . 20.379999999999999 111.877 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.44 133.08 53.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.437 -0.208 . . . . 18.809999999999999 110.437 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 24.1 ptp -124.94 10.4 8.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.079 0.466 . . . . 18.059999999999999 110.748 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -89.0 72.51 8.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.509 . . . . 16.829999999999998 110.718 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.45 -44.7 97.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.024 -0.608 . . . . 14.66 111.749 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 57.97 49.29 11.99 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.14 0.495 . . . . 15.800000000000001 110.977 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -104.48 88.93 3.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.881 -0.6 . . . . 13.130000000000001 110.261 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -81.09 90.78 6.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.604 -0.725 . . . . 11.74 110.727 -177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 tp -81.01 104.8 11.76 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.263 -0.426 . . . . 8.7200000000000006 110.349 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.81 128.64 45.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 5.9299999999999997 110.383 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.0 109.03 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.782 2.322 . . . . 5.25 112.203 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.37 96.43 0.72 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.782 -0.723 . . . . 2.2799999999999998 111.922 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.39 74.92 4.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.205 0.526 . . . . 2.0699999999999998 110.809 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -147.79 130.51 16.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.702 -0.681 . . . . 3.1800000000000002 110.108 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 t -81.9 102.76 11.09 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.608 -0.886 . . . . 0.53000000000000003 108.608 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.73 -13.66 80.34 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.828 -0.624 . . . . 0.65000000000000002 112.806 -172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.4 HG11 ' O ' ' C' ' 38' ' ' CYS . 33.4 t -66.14 -28.83 44.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.085 0.469 . . . . 1.04 110.725 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.56 -41.9 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.314 -0.403 . . . . 0.83999999999999997 110.326 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.49 -10.82 8.07 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.911 -0.661 . . . . 0.77000000000000002 112.256 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -100.23 148.19 24.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.234 0.54 . . . . 2.1000000000000001 111.843 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.75 16.43 21.15 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.488 -0.778 . . . . 0.55000000000000004 111.491 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.4 m -74.0 115.59 13.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.826 -0.187 . . . . 1.0600000000000001 110.739 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.9 t70 53.19 66.34 1.26 Allowed 'General case' 0 C--O 1.234 0.257 0 O-C-N 123.801 0.688 . . . . 2.23 111.014 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 m -89.97 136.53 23.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.63 -0.714 . . . . 1.1599999999999999 111.008 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.03 144.09 28.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.667 -0.697 . . . . 0.47999999999999998 110.014 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.1 mpt_? -103.78 146.65 28.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.953 -0.567 . . . . 3.1800000000000002 110.19 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 27.0 t -72.62 141.39 48.34 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.515 -0.55 . . . . 0.37 109.515 176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 17.0 p -82.44 -26.05 33.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.158 -0.474 . . . . 0.75 111.581 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -94.91 -28.12 15.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.306 -0.407 . . . . 1.4299999999999999 111.521 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.9 p -143.93 -174.02 4.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.57 . . . . 0.79000000000000004 109.46 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.58 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.781 0.324 . . . . 0.46999999999999997 110.719 -176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -160.8 138.46 9.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.046 -0.525 . . . . 0.40000000000000002 109.973 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -114.56 112.12 22.43 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.858 -0.423 . . . . 0.45000000000000001 109.858 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -156.53 166.0 34.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.834 0.35 . . . . 0.60999999999999999 110.976 -174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -97.29 135.22 39.51 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.41999999999999998 108.795 171.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -59.62 -39.28 83.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.924 -0.58 . . . . 0.68000000000000005 110.593 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -74.61 -15.83 60.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.85 0.357 . . . . 3.3300000000000001 111.73 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.4 ' O ' HG11 ' C' ' 17' ' ' VAL . 68.7 m -84.32 -22.45 30.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.168 0.509 . . . . 0.54000000000000004 110.12 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.24 -56.07 2.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 0.60999999999999999 111.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.469 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 75.6 m-85 -106.99 135.24 19.6 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.833 -0.621 . . . . 0.80000000000000004 110.14 -174.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 9.1 Cg_exo -70.78 176.3 7.74 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.707 2.272 . . . . 2.1200000000000001 112.667 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.4 -30.94 65.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.437 -0.347 . . . . 3.2999999999999998 111.654 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.52 -23.08 66.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.46 112.88 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 13.1 m -99.0 128.88 45.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.883 -0.414 . . . . 1.03 109.883 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 63.0 p -89.21 138.0 31.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.465 -0.334 . . . . 1.6000000000000001 111.216 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -75.61 116.17 52.6 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.189 -0.46 . . . . 2.6800000000000002 110.348 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.96 133.42 21.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.237 1.958 . . . . 1.1399999999999999 111.449 177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.15 79.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.938 -0.649 . . . . 1.8999999999999999 111.733 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.4 p -131.53 141.46 49.73 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.012 -0.366 . . . . 2.75 110.012 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.74 53.15 3.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.614 -0.803 . . . . 0.81999999999999995 112.275 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 123.25 21.49 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.81 -0.441 . . . . 0.87 109.81 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 61.1 mtm-85 -117.25 145.7 43.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.915 0.388 . . . . 2.6499999999999999 110.779 -176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 13.9 p -84.65 -176.21 6.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.308 -0.627 . . . . 0.48999999999999999 109.308 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -62.5 -48.31 80.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 4.0899999999999999 111.348 -174.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 19.3 t -67.1 -44.77 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.324 -0.398 . . . . 1.54 111.244 -175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -72.14 -29.33 63.94 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.816 0.302 . . . . 0.71999999999999997 111.816 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 2.6 t -90.65 -12.23 37.46 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.793 -0.363 . . . . 1.25 111.679 -174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 179.75 -111.26 0.31 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.023 -1.084 . . . . 2.1899999999999999 113.092 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -115.54 146.98 41.22 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.062 -0.347 . . . . 5.1500000000000004 110.062 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -128.89 122.92 57.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.06 0.457 . . . . 6.7599999999999998 111.11 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 24.4 m -109.46 105.22 56.91 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.695 -0.483 . . . . 8.8300000000000001 109.695 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.01 137.1 51.21 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.531 2.154 . . . . 11.039999999999999 112.397 -176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' C' ' 65' ' ' VAL . . . -80.29 155.72 74.24 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.753 -0.658 . . . . 13.859999999999999 110.256 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.46 23.88 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.89 2.393 . . . . 16.550000000000001 113.184 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' C' ' 63' ' ' ALA . 27.3 m -122.95 7.78 5.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.636 -0.711 . . . . 18.07 109.445 175.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.22 -0.9 . . . . 20.260000000000002 109.985 -179.049 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.768 -0.533 . . . . 20.379999999999999 111.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.522 ' O ' ' HG2' ' C' ' 6' ' ' GLN . . . -81.44 -61.12 2.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.739 0.304 . . . . 18.809999999999999 111.389 -176.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 20.3 mmt -78.85 40.6 0.4 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.665 0.617 . . . . 18.059999999999999 112.665 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.87 -6.43 9.58 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.509 -0.552 . . . . 16.829999999999998 109.509 172.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.05 -79.61 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.601 -0.727 . . . . 14.66 112.372 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' C' ' 2' ' ' ALA . 30.4 mm-40 57.79 37.22 27.04 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.954 0.407 . . . . 15.800000000000001 110.08 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 58.3 69.85 0.7 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.254 -0.884 . . . . 13.130000000000001 109.691 -174.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -81.06 68.93 7.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.651 0.739 . . . . 11.74 110.202 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 62.9 tp -149.12 100.53 3.06 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.152 -0.931 . . . . 8.7200000000000006 109.454 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' C' ' 13' ' ' ALA . . . -87.42 123.43 69.7 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.026 -0.534 . . . . 5.9299999999999997 110.016 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.87 -25.43 60.13 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.788 2.325 . . . . 5.25 112.704 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.66 22.99 32.53 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.829 -0.623 . . . . 2.2799999999999998 112.343 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' C' ' 10' ' ' ALA . . . -135.83 107.11 6.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.015 0.436 . . . . 2.0699999999999998 111.196 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.658 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 73.1 mtt180 -136.47 164.42 28.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 3.1800000000000002 109.636 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -68.87 106.62 2.77 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.227 -0.657 . . . . 0.53000000000000003 109.227 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.06 -22.3 55.0 Favored Glycine 0 C--N 1.33 0.224 0 O-C-N 123.349 0.405 . . . . 0.65000000000000002 113.109 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.9 t -75.4 -30.2 22.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.04 110.891 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 86.5 m -108.57 -46.02 3.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.774 0.657 . . . . 0.83999999999999997 112.774 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . 0.658 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 102.67 -17.17 53.74 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.786 -0.721 . . . . 0.77000000000000002 111.536 -173.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -92.42 150.37 20.84 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.864 0.364 . . . . 2.1000000000000001 110.758 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.13 9.04 29.15 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 111.186 -0.766 . . . . 0.55000000000000004 111.186 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 13.2 m -72.48 136.7 46.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.421 -0.389 . . . . 1.0600000000000001 110.539 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 43.92 47.09 7.0 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.967 0.889 . . . . 2.23 111.075 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.65 140.45 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 114.756 -1.111 . . . . 1.1599999999999999 109.854 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.35 144.56 25.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.932 0.396 . . . . 0.47999999999999998 110.381 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -109.32 149.69 29.1 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.588 -0.733 . . . . 3.1800000000000002 109.551 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.6 t -83.64 137.36 33.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.022 0.439 . . . . 0.37 110.521 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 33.8 p -85.51 -3.5 58.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.901 -0.591 . . . . 0.75 111.957 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -122.18 -15.44 7.71 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.002 -0.279 . . . . 1.4299999999999999 111.631 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 8.2 p -151.9 -167.42 2.77 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.79000000000000004 109.548 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.44 115.01 29.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.548 -0.296 . . . . 0.46999999999999997 110.249 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.96 145.68 15.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.326 -0.397 . . . . 0.40000000000000002 110.528 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -125.58 112.53 16.28 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.008 -0.542 . . . . 0.45000000000000001 110.052 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -157.76 162.72 38.52 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.924 -0.398 . . . . 0.60999999999999999 109.924 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.757 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -95.28 138.08 33.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.713 -0.847 . . . . 0.41999999999999998 108.713 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -50.29 -53.03 31.56 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.239 0.337 . . . . 0.68000000000000005 111.399 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -66.34 -18.07 65.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 3.3300000000000001 111.97 -174.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.757 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.0 m -84.17 -22.2 31.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.162 0.506 . . . . 0.54000000000000004 110.852 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.94 -34.63 8.87 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.098 -0.501 . . . . 0.60999999999999999 110.672 178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -124.12 132.42 24.3 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.965 -0.561 . . . . 0.80000000000000004 109.785 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -56.14 154.65 27.3 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.892 2.395 . . . . 2.1200000000000001 111.695 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.39 -19.84 57.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.388 -0.823 . . . . 3.2999999999999998 112.449 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.74 -18.8 78.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.067 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.6 m -85.49 125.36 32.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.897 0.38 . . . . 1.03 110.013 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m -88.51 136.42 33.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.078 -0.51 . . . . 1.6000000000000001 110.567 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -69.92 123.94 89.68 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 2.6800000000000002 110.299 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.79 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.664 2.243 . . . . 1.1399999999999999 112.581 -177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.84 5.42 82.08 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.827 -0.701 . . . . 1.8999999999999999 111.583 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -92.7 18.46 8.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.14 0.495 . . . . 2.75 110.881 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.86 135.17 8.06 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.977 -0.63 . . . . 0.81999999999999995 111.69 -176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.89 123.82 22.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.962 0.41 . . . . 0.87 110.008 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -117.41 138.05 52.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 2.6499999999999999 110.69 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -81.12 -176.67 6.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.668 -0.493 . . . . 0.48999999999999999 109.668 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -57.4 -52.48 65.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.746 0.308 . . . . 4.0899999999999999 111.1 -177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 35.9 t -63.11 -46.29 88.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.497 -0.32 . . . . 1.54 111.359 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 80.6 m -72.18 -17.77 61.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.072 0.397 . . . . 0.71999999999999997 112.072 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -81.65 -13.75 57.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.423 -0.511 . . . . 1.25 110.147 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.06 -117.7 3.32 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.707 -0.679 . . . . 2.1899999999999999 111.495 178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -148.92 144.2 26.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.686 0.279 . . . . 5.1500000000000004 110.635 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.454 ' O ' ' HD3' ' C' ' 62' ' ' PRO . 43.9 t -89.18 100.5 10.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.005 0.431 . . . . 6.7599999999999998 110.101 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 19.0 p -100.48 106.16 41.15 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.772 -0.649 . . . . 8.8300000000000001 111.559 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' C' ' 60' ' ' VAL . 17.2 Cg_exo -67.86 142.59 57.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.623 2.215 . . . . 11.039999999999999 111.431 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.21 120.12 77.7 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.296 -0.411 . . . . 13.859999999999999 110.802 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.41 41.65 1.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.699 2.266 . . . . 16.550000000000001 112.349 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.85 98.6 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.943 -0.571 . . . . 18.07 109.989 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.576 -0.726 . . . . 20.260000000000002 110.265 -177.103 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.134 -0.387 . . . . 20.379999999999999 112.134 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.81 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.386 0.674 . . . . 18.809999999999999 111.815 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 56.2 ttm -157.68 83.02 0.89 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.185 0.517 . . . . 18.059999999999999 110.363 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -101.42 65.39 1.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.977 -0.556 . . . . 16.829999999999998 110.174 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -132.38 38.67 1.85 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.513 -0.767 . . . . 14.66 111.695 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.81 -26.16 37.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.23 0.538 . . . . 15.800000000000001 110.09 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -81.96 108.97 15.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.607 -0.724 . . . . 13.130000000000001 109.746 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -111.35 89.19 2.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.143 -0.48 . . . . 11.74 110.576 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.57 118.15 23.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.105 -0.498 . . . . 8.7200000000000006 110.163 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.45 139.58 78.38 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.964 -0.562 . . . . 5.9299999999999997 110.301 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.16 69.64 2.43 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.028 2.485 . . . . 5.25 112.759 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.27 34.28 89.07 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 116.042 -0.526 . . . . 2.2799999999999998 111.838 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.499 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -142.9 75.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.901 0.381 . . . . 2.0699999999999998 111.002 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.417 ' HA ' ' CA ' ' C' ' 21' ' ' GLY . 61.7 ttp180 -147.56 128.29 14.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.334 -0.394 . . . . 3.1800000000000002 110.696 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 t -69.08 111.32 4.99 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.768 -0.456 . . . . 0.53000000000000003 109.768 177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.59 -31.69 81.64 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.27 -0.49 . . . . 0.65000000000000002 112.846 -176.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.45 -37.65 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.763 0.316 . . . . 1.04 110.931 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.0 m -96.14 -43.55 7.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 0.83999999999999997 111.621 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.37 1.01 55.65 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.144 -0.783 . . . . 0.77000000000000002 111.144 -172.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -117.22 143.48 45.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.809 0.338 . . . . 2.1000000000000001 110.407 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' C' ' 14' ' ' ARG . . . -110.37 9.32 30.83 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.958 -0.639 . . . . 0.55000000000000004 112.078 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.4 m -72.78 134.02 44.76 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.168 -0.308 . . . . 1.0600000000000001 110.168 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 53.34 48.6 21.6 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.628 0.58 . . . . 2.23 110.848 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.9 p -91.18 145.05 7.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.772 -0.649 . . . . 1.1599999999999999 110.518 -176.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.26 147.43 23.78 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.274 -0.421 . . . . 0.47999999999999998 110.407 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -112.7 150.28 31.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.75 -0.659 . . . . 3.1800000000000002 110.876 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 11.7 t -82.79 134.28 35.12 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.883 -0.784 . . . . 0.37 108.883 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.459 HG22 ' O ' ' C' ' 51' ' ' LEU . 5.9 t -85.57 -11.72 53.33 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.732 -0.387 . . . . 0.75 111.491 -175.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m170 -107.75 -17.95 13.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.795 0.294 . . . . 1.4299999999999999 111.795 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 p -150.57 -167.55 2.85 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.475 -0.565 . . . . 0.79000000000000004 109.475 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 114.09 28.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.755 0.312 . . . . 0.46999999999999997 110.36 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -157.8 146.34 19.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.40000000000000002 110.374 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.499 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -133.26 112.18 11.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.136 -0.484 . . . . 0.45000000000000001 110.256 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -156.6 164.82 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.104 -0.498 . . . . 0.60999999999999999 109.847 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.3 m170 -96.54 137.76 35.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.104 -1.073 . . . . 0.41999999999999998 108.104 171.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -47.65 -51.65 20.82 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.533 0.521 . . . . 0.68000000000000005 112.006 -173.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -61.65 -32.88 73.07 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.152 0.427 . . . . 3.3300000000000001 112.152 -176.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 9.1 m -71.35 -21.4 62.04 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.54000000000000004 111.043 -175.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -104.89 -42.93 5.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.858 -0.61 . . . . 0.60999999999999999 111.174 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -114.99 142.94 29.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.41 -0.359 . . . . 0.80000000000000004 110.714 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.16 149.02 6.49 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.602 2.868 . . . . 2.1200000000000001 112.75 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -16.15 61.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.328 -0.851 . . . . 3.2999999999999998 112.566 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.64 18.27 56.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.704 -0.76 . . . . 1.46 112.285 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.4 m -106.63 131.27 53.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.498 0.19 . . . . 1.03 110.542 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -88.54 133.59 34.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.975 -0.379 . . . . 1.6000000000000001 109.975 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 46' ' ' ARG . 4.1 ptm180 -80.82 130.09 65.32 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.714 0.292 . . . . 2.6800000000000002 110.682 -179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.16 146.88 47.14 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.83 2.354 . . . . 1.1399999999999999 112.203 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.02 -40.71 4.52 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.29 -0.724 . . . . 1.8999999999999999 111.29 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.8 p -100.09 83.36 2.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.923 0.392 . . . . 2.75 110.663 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.438 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 116.94 64.05 0.33 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.458 -0.877 . . . . 0.81999999999999995 112.906 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.459 ' O ' HG22 ' C' ' 28' ' ' THR . 0.8 OUTLIER -77.0 121.79 24.0 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.782 -0.822 . . . . 0.87 108.782 176.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -126.29 132.1 51.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.436 -0.347 . . . . 2.6499999999999999 110.731 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.2 p -73.09 179.62 3.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 0.48999999999999999 109.561 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -60.17 -42.35 94.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.748 0.309 . . . . 4.0899999999999999 111.282 -174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 33.7 t -66.49 -46.26 76.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.4 -0.364 . . . . 1.54 111.057 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.8 m -71.41 -33.4 69.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.803 0.297 . . . . 0.71999999999999997 111.803 -177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 46.1 p -83.32 -11.31 57.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.047 0.451 . . . . 1.25 110.725 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.41 75.08 0.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.971 -0.633 . . . . 2.1899999999999999 111.784 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -88.85 135.61 33.44 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.727 -0.472 . . . . 5.1500000000000004 109.727 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.6 144.23 23.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.815 -0.63 . . . . 6.7599999999999998 109.837 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.2 m -93.41 104.86 13.57 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.4 -0.364 . . . . 8.8300000000000001 110.039 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.43 141.77 32.18 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.538 2.159 . . . . 11.039999999999999 112.263 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.14 134.89 76.98 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.85 -0.613 . . . . 13.859999999999999 110.392 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.36 66.58 2.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.986 2.457 . . . . 16.550000000000001 112.131 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.25 149.56 31.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.645 -0.707 . . . . 18.07 109.794 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' C' ' 66' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 119.26 -0.4 . . . . 20.260000000000002 110.747 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.058 -0.417 . . . . 20.379999999999999 112.058 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.11 84.79 0.09 Allowed 'General case' 0 C--O 1.234 0.24 0 C-N-CA 122.926 0.49 . . . . 18.809999999999999 111.349 -178.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.4 ttt -67.96 -27.09 66.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.966 -0.561 . . . . 18.059999999999999 109.833 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 59.75 -99.61 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.006 -0.997 . . . . 16.829999999999998 111.939 174.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.58 -157.88 53.37 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.724 -0.75 . . . . 14.66 112.829 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -66.57 -26.93 67.35 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.19 0.596 . . . . 15.800000000000001 112.016 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -79.01 -7.84 58.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.718 0.294 . . . . 13.130000000000001 111.541 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -79.22 90.76 4.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.189 0.518 . . . . 11.74 110.521 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 48.7 tp -86.21 124.37 32.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.66 -0.7 . . . . 8.7200000000000006 110.263 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.14 160.39 40.07 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.726 -0.67 . . . . 5.9299999999999997 111.306 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.98 58.97 1.22 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.439 2.759 . . . . 5.25 112.521 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 60.26 0.22 Allowed Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 110.983 -0.847 . . . . 2.2799999999999998 110.983 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.31 88.24 0.63 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.159 0.504 . . . . 2.0699999999999998 110.487 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -150.2 150.5 31.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.735 -0.666 . . . . 3.1800000000000002 109.604 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.75 103.87 1.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.52 -0.548 . . . . 0.53000000000000003 109.52 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.26 86.14 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.884 -0.598 . . . . 0.65000000000000002 113.458 -171.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 99.1 t -71.94 -40.38 68.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.809 0.338 . . . . 1.04 110.988 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -111.67 -20.59 12.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.359 . . . . 0.83999999999999997 111.147 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.85 10.95 77.94 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.929 -0.653 . . . . 0.77000000000000002 112.036 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -109.84 146.78 34.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.259 -0.275 . . . . 2.1000000000000001 110.259 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.1 17.18 9.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.775 -0.726 . . . . 0.55000000000000004 112.753 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.76 119.43 23.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.505 -0.183 . . . . 1.0600000000000001 110.505 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 58.72 63.1 1.75 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.413 0.445 . . . . 2.23 111.258 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -89.1 140.27 16.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 1.1599999999999999 110.793 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 91.9 mt -91.15 145.99 24.21 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.676 -0.693 . . . . 0.47999999999999998 109.538 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.87 141.46 42.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.043 0.449 . . . . 3.1800000000000002 110.945 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 12.2 t -69.79 128.24 35.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.158 -0.682 . . . . 0.37 109.158 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 46.8 p -84.49 -8.26 59.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.495 0.664 . . . . 0.75 110.292 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -99.91 -27.97 13.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.387 -0.824 . . . . 1.4299999999999999 111.056 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.1 p -151.74 -161.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 121.028 -0.269 . . . . 0.79000000000000004 110.408 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.71 119.74 39.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.676 -0.238 . . . . 0.46999999999999997 110.788 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -173.12 141.09 0.93 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.175 -0.466 . . . . 0.40000000000000002 110.8 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.86 112.82 19.28 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.597 -0.52 . . . . 0.45000000000000001 109.597 175.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -155.56 169.57 24.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.942 0.401 . . . . 0.60999999999999999 110.943 -173.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -102.55 134.92 45.1 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.37 -0.604 . . . . 0.41999999999999998 109.37 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -63.61 -35.19 79.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.613 -0.721 . . . . 0.68000000000000005 110.532 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -76.97 -17.39 58.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 3.3300000000000001 111.745 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 95.8 m -86.06 -22.49 27.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.069 0.462 . . . . 0.54000000000000004 110.411 176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -93.3 -51.35 5.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.088 -0.506 . . . . 0.60999999999999999 110.362 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.76 152.81 47.79 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.672 -0.695 . . . . 0.80000000000000004 109.963 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -57.29 148.48 70.59 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.244 1.963 . . . . 2.1200000000000001 110.705 172.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.27 -11.38 31.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.022 -0.535 . . . . 3.2999999999999998 111.69 -176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -87.21 7.49 80.42 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.11 -0.567 . . . . 1.46 112.216 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -93.02 140.54 29.38 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.763 -0.257 . . . . 1.03 110.308 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.3 p -87.91 143.73 26.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.973 0.416 . . . . 1.6000000000000001 110.149 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -89.48 129.69 46.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.538 -0.542 . . . . 2.6800000000000002 109.538 -178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -60.6 132.73 44.57 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.939 2.426 . . . . 1.1399999999999999 112.761 -173.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -82.82 -10.41 83.13 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.342 -0.703 . . . . 1.8999999999999999 111.342 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -89.59 26.38 1.75 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.388 0.613 . . . . 2.75 110.387 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 131.99 7.4 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 115.506 -0.77 . . . . 0.81999999999999995 111.758 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.76 123.13 18.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.422 -0.584 . . . . 0.87 109.422 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -110.24 147.32 34.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.32 0.581 . . . . 2.6499999999999999 110.726 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.4 p -91.49 -170.05 2.49 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.354 -0.839 . . . . 0.48999999999999999 109.526 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -61.05 -49.64 76.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.655 -0.248 . . . . 4.0899999999999999 111.283 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' C' ' 58' ' ' GLY . 15.7 m -68.64 -36.97 79.31 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.196 0.522 . . . . 1.54 111.867 -174.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 99.4 m -73.64 -15.73 61.25 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.806 0.336 . . . . 0.71999999999999997 111.422 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -97.83 7.31 46.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.353 0.597 . . . . 1.25 109.772 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' C' ' 55' ' ' SER . . . 144.19 147.23 4.64 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 110.256 -1.138 . . . . 2.1899999999999999 110.256 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.92 131.59 34.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 118.194 0.997 . . . . 5.1500000000000004 110.727 -169.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -89.54 78.34 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.112 -0.949 . . . . 6.7599999999999998 109.643 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -77.19 117.02 62.45 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.497 -0.774 . . . . 8.8300000000000001 110.107 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.18 133.81 57.76 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.463 2.109 . . . . 11.039999999999999 111.814 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.27 137.6 56.2 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 13.859999999999999 110.041 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.49 72.57 1.79 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 122.931 2.42 . . . . 16.550000000000001 112.701 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.59 33.57 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 122.016 0.913 . . . . 18.07 109.066 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.037 0 CA-C-N 115.085 -0.961 . . . . 20.260000000000002 109.844 179.749 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.471 -0.651 . . . . 20.379999999999999 111.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.96 155.7 26.32 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.185 -0.302 . . . . 18.809999999999999 110.185 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 17.4 ptm -106.35 80.04 1.45 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.626 0.726 . . . . 18.059999999999999 110.718 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -75.83 141.87 42.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 16.829999999999998 110.289 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.52 176.13 14.33 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.794 -0.922 . . . . 14.66 110.794 -175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -89.87 44.46 1.21 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.523 0.678 . . . . 15.800000000000001 110.172 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -94.84 94.21 7.92 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.278 -0.874 . . . . 13.130000000000001 110.925 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -82.57 -8.52 59.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.255 -0.429 . . . . 11.74 110.114 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.06 60.64 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.322 0.582 . . . . 8.7200000000000006 110.463 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -94.39 135.16 24.51 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.594 -0.73 . . . . 5.9299999999999997 110.647 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 16.8 Cg_exo -67.95 -11.67 32.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.649 2.233 . . . . 5.25 111.933 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.73 -146.4 20.63 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.64 -0.709 . . . . 2.2799999999999998 112.087 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.429 ' HB2' HH22 ' C' ' 26' ' ' ARG . . . -153.87 73.53 0.95 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.934 0.397 . . . . 2.0699999999999998 110.306 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.462 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.6 ttt180 -152.46 133.55 14.23 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 3.1800000000000002 110.604 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 29.5 t -90.47 103.67 16.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.183 -0.673 . . . . 0.53000000000000003 109.183 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 -4.54 89.81 Favored Glycine 0 N--CA 1.453 -0.183 0 CA-C-N 115.967 -0.561 . . . . 0.65000000000000002 113.253 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 39.6 t -71.11 -32.13 46.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.106 0.479 . . . . 1.04 110.21 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.2 p -115.89 -41.34 3.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.006 -0.543 . . . . 0.83999999999999997 110.285 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.55 -15.78 7.1 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.874 -0.679 . . . . 0.77000000000000002 112.381 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -91.12 140.81 29.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 2.1000000000000001 111.343 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -111.28 3.48 28.22 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.989 -0.624 . . . . 0.55000000000000004 112.138 177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 57.6 m -80.47 134.65 36.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.52 0.2 . . . . 1.0600000000000001 110.739 178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 59.46 50.02 8.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.629 0.728 . . . . 2.23 110.94 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 m -89.88 144.61 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.669 -0.696 . . . . 1.1599999999999999 110.869 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.1 mt -98.6 153.26 18.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.47999999999999998 110.023 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 25.1 mmt180 -106.86 154.44 21.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.151 -0.477 . . . . 3.1800000000000002 110.411 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.4 t -89.19 144.0 26.43 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.155 -0.683 . . . . 0.37 109.155 175.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.3 p -89.45 -23.85 22.01 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.766 0.317 . . . . 0.75 111.331 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -95.22 -17.58 21.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 1.4299999999999999 111.232 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 9.5 p -150.84 -177.2 5.86 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.138 -0.69 . . . . 0.79000000000000004 109.138 176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.17 119.33 38.71 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.577 -0.283 . . . . 0.46999999999999997 110.525 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.92 149.36 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.086 -0.506 . . . . 0.40000000000000002 110.226 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -121.32 112.21 18.31 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.54 -0.541 . . . . 0.45000000000000001 109.54 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -152.69 162.07 41.73 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.284 -0.416 . . . . 0.60999999999999999 110.779 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -91.41 136.6 32.99 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.42 -0.585 . . . . 0.41999999999999998 109.42 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -59.83 -36.04 76.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.519 -0.764 . . . . 0.68000000000000005 109.975 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -72.2 -22.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.924 -0.58 . . . . 3.3300000000000001 111.777 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 87.6 m -90.38 -23.44 21.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.632 0.253 . . . . 0.54000000000000004 111.284 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -102.07 -21.07 14.52 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.942 -0.303 . . . . 0.60999999999999999 111.526 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -131.08 149.06 72.67 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.766 -0.457 . . . . 0.80000000000000004 109.766 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -55.56 147.17 60.24 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.692 2.261 . . . . 2.1200000000000001 111.447 174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -24.64 61.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.203 -0.908 . . . . 3.2999999999999998 112.664 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.27 -10.82 86.04 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.888 -0.672 . . . . 1.46 112.771 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -73.44 130.04 39.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.694 0.283 . . . . 1.03 110.5 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.7 t -88.86 136.64 32.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.584 -0.525 . . . . 1.6000000000000001 109.584 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -79.48 126.82 80.23 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.047 -0.524 . . . . 2.6800000000000002 110.391 -176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.86 135.77 31.05 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.363 2.042 . . . . 1.1399999999999999 111.513 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -29.36 73.85 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.737 -0.665 . . . . 1.8999999999999999 112.186 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.7 p -139.38 133.24 30.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.144 -0.317 . . . . 2.75 110.144 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 91.07 57.19 1.61 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.524 -0.846 . . . . 0.81999999999999995 112.342 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.53 123.91 22.12 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.498 -0.556 . . . . 0.87 109.498 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -117.77 140.36 49.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.482 -0.326 . . . . 2.6499999999999999 110.801 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.4 p -86.34 169.48 12.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.409 -0.96 . . . . 0.48999999999999999 108.409 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.08 -34.63 78.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 118.851 0.751 . . . . 4.0899999999999999 111.158 -174.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 5.4 m -64.22 -44.9 90.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 1.54 110.978 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.4 m -71.85 -16.94 62.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.334 -0.394 . . . . 0.71999999999999997 111.136 178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.3 m -88.73 15.26 8.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.123 0.487 . . . . 1.25 110.695 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.68 -136.41 13.51 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 121.051 -0.595 . . . . 2.1899999999999999 111.715 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -124.12 78.62 1.66 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.227 0.537 . . . . 5.1500000000000004 110.238 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.06 87.83 2.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.814 -0.63 . . . . 6.7599999999999998 110.442 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.3 p -106.71 121.05 46.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.925 -0.58 . . . . 8.8300000000000001 110.848 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.81 134.68 64.23 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.702 2.268 . . . . 11.039999999999999 111.257 175.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.27 120.1 51.96 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.202 -0.454 . . . . 13.859999999999999 110.94 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.45 91.11 0.68 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.646 2.231 . . . . 16.550000000000001 111.945 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.8 m -125.84 148.55 30.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.011 -0.541 . . . . 18.07 110.538 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.375 -0.821 . . . . 20.260000000000002 110.281 177.363 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.192 -0.363 . . . . 20.379999999999999 112.192 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.08 -35.75 49.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.866 0.365 . . . . 18.809999999999999 111.149 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.6 mmt -74.85 -36.3 62.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.103 -0.499 . . . . 18.059999999999999 111.01 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.73 -20.01 47.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.476 -0.329 . . . . 16.829999999999998 111.438 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.4 142.78 6.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.714 -0.755 . . . . 14.66 111.982 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -80.34 -63.22 1.46 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.587 0.232 . . . . 15.800000000000001 110.443 -178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -171.67 89.99 0.12 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.175 -0.466 . . . . 13.130000000000001 110.967 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -96.68 -38.91 9.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.769 -0.826 . . . . 11.74 108.769 171.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 55.9 tp -103.73 106.63 17.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.232 -0.895 . . . . 8.7200000000000006 109.223 174.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.98 134.77 90.17 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 5.9299999999999997 110.508 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.7 69.78 2.13 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 123.049 2.499 . . . . 5.25 112.707 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.7 51.24 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.789 -0.641 . . . . 2.2799999999999998 112.635 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.13 73.37 8.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.016 0.436 . . . . 2.0699999999999998 110.859 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 45.0 ttm180 -168.99 136.84 1.94 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.803 -0.635 . . . . 3.1800000000000002 110.303 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.459 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 9.4 t -82.07 104.78 12.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.705 -0.48 . . . . 0.53000000000000003 109.705 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.17 -11.09 79.17 Favored Glycine 0 N--CA 1.453 -0.192 0 CA-C-N 115.969 -0.559 . . . . 0.65000000000000002 113.008 -174.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 t -67.54 -28.0 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.056 0.455 . . . . 1.04 110.67 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.3 p -124.39 -34.7 2.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.087 -0.506 . . . . 0.83999999999999997 110.866 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.27 -6.91 24.97 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.818 -0.706 . . . . 0.77000000000000002 112.132 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 9.1 m-20 -102.16 145.71 29.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.993 0.425 . . . . 2.1000000000000001 111.086 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.89 3.87 30.41 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.382 -0.687 . . . . 0.55000000000000004 111.382 173.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.4 m -63.4 121.05 12.84 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.397 0.279 . . . . 1.0600000000000001 110.871 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 56.89 52.3 9.55 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.774 0.797 . . . . 2.23 109.806 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.447 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.0 p -89.91 146.48 6.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.408 -0.815 . . . . 1.1599999999999999 110.566 -176.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.8 mt -100.84 161.89 13.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.239 -0.437 . . . . 0.47999999999999998 110.324 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.566 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 11.3 tpt180 -135.01 134.51 40.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.241 -0.651 . . . . 3.1800000000000002 109.241 -175.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 29.4 t -66.43 141.13 58.03 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 119.761 -0.776 . . . . 0.37 109.919 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.9 p -81.95 -15.62 53.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.045 -0.525 . . . . 0.75 111.093 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -111.18 -9.4 14.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.196 -0.456 . . . . 1.4299999999999999 110.995 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 13.6 m -140.46 173.82 11.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.123 0.487 . . . . 0.79000000000000004 110.305 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.29 111.49 24.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.898 -0.779 . . . . 0.46999999999999997 108.898 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -167.19 125.22 1.28 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.013 -0.539 . . . . 0.40000000000000002 110.117 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.447 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.15 112.24 24.43 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.152 -0.684 . . . . 0.45000000000000001 109.152 175.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 41.9 p90 -150.01 160.9 43.27 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.213 -0.448 . . . . 0.60999999999999999 110.435 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -98.44 134.41 41.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.29 -0.633 . . . . 0.41999999999999998 109.29 172.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -64.35 -31.93 73.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.575 -0.739 . . . . 0.68000000000000005 109.856 178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -72.26 -28.25 63.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.71 . . . . 3.3300000000000001 110.915 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 58.8 m -80.46 -23.03 40.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.832 0.349 . . . . 0.54000000000000004 110.88 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -88.97 -44.42 10.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.18 -0.463 . . . . 0.60999999999999999 110.578 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -122.59 78.65 47.22 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.928 -0.578 . . . . 0.80000000000000004 110.653 -177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.01 -5.37 17.09 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.045 2.496 . . . . 2.1200000000000001 111.934 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.65 -8.41 56.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 3.2999999999999998 111.587 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.42 24.08 11.68 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.501 -0.857 . . . . 1.46 112.482 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.6 m -65.59 141.29 58.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.787 0.327 . . . . 1.03 110.624 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.0 m -89.16 131.65 35.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 1.6000000000000001 110.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 142.03 85.16 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 2.6800000000000002 111.183 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.69 149.62 55.13 Favored 'Trans proline' 0 C--O 1.237 0.43 0 C-N-CA 122.706 2.271 . . . . 1.1399999999999999 112.556 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -104.57 -6.04 41.57 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.736 -0.665 . . . . 1.8999999999999999 111.651 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.6 p -89.12 46.6 1.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.558 0.694 . . . . 2.75 110.127 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 90.38 121.63 2.34 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.142 -0.935 . . . . 0.81999999999999995 110.907 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' C' ' 51' ' ' LEU . 2.0 tm? -64.24 125.3 24.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.443 -0.577 . . . . 0.87 109.443 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 94.9 mtt180 -112.96 142.99 45.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.784 -0.644 . . . . 2.6499999999999999 110.377 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 22.0 p -78.45 -178.26 5.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.48999999999999999 109.789 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -60.87 -45.51 94.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.672 0.272 . . . . 4.0899999999999999 110.581 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.6 t -63.13 -41.63 99.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.09 -0.505 . . . . 1.54 110.788 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 62.4 m -69.75 -33.48 72.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.636 0.255 . . . . 0.71999999999999997 111.278 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 5.6 t -76.78 -14.03 59.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.155 0.503 . . . . 1.25 109.839 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 -118.95 6.37 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.688 -0.687 . . . . 2.1899999999999999 112.585 175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -147.48 106.51 3.85 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.509 -0.552 . . . . 5.1500000000000004 109.509 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 11.1 t -108.89 65.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.621 0.724 . . . . 6.7599999999999998 109.896 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -81.42 128.01 71.44 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.304 -0.862 . . . . 8.8300000000000001 109.996 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.25 142.23 72.37 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.456 2.104 . . . . 11.039999999999999 111.592 177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.19 129.27 75.86 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.46 -0.336 . . . . 13.859999999999999 110.256 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.23 50.59 1.92 Allowed 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.912 2.408 . . . . 16.550000000000001 112.466 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.49 125.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.679 -0.692 . . . . 18.07 109.645 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.584 -0.722 . . . . 20.260000000000002 110.443 -177.539 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 111.731 -0.547 . . . . 20.379999999999999 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.47 56.17 3.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.828 0.347 . . . . 18.809999999999999 111.137 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ptp -148.34 35.12 0.8 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.231 0.539 . . . . 18.059999999999999 110.886 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -87.61 54.21 3.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.929 -0.578 . . . . 16.829999999999998 110.944 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.58 -150.37 17.75 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.835 -0.621 . . . . 14.66 111.993 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -135.47 63.02 1.62 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.112 -0.699 . . . . 15.800000000000001 109.112 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' C' ' 10' ' ' ALA . 15.5 mm100 60.49 42.52 14.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.987 -1.006 . . . . 13.130000000000001 110.965 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 t30 57.32 63.88 1.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.674 -0.694 . . . . 11.74 110.459 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 32.2 tp 51.33 65.38 1.5 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.311 -0.859 . . . . 8.7200000000000006 111.593 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.412 ' HB2' ' HB2' ' C' ' 7' ' ' GLN . . . -60.36 141.95 90.84 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.852 -0.613 . . . . 5.9299999999999997 110.312 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.81 76.8 1.52 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.597 2.198 . . . . 5.25 112.438 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.35 -31.24 71.34 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.551 -0.619 . . . . 2.2799999999999998 111.551 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.74 74.15 10.2 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.201 0.524 . . . . 2.0699999999999998 110.137 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -159.57 130.6 5.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.884 -0.598 . . . . 3.1800000000000002 109.68 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 33.7 t -74.73 103.49 5.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.852 -0.796 . . . . 0.53000000000000003 108.852 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.24 -14.03 80.94 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 115.877 -0.602 . . . . 0.65000000000000002 113.536 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 59.6 t -68.37 -37.03 77.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.943 0.401 . . . . 1.04 110.661 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.08 -28.28 7.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.918 0.39 . . . . 0.83999999999999997 110.678 -178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.21 56.52 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.158 -0.544 . . . . 0.77000000000000002 112.098 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.534 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 17.7 t70 -110.29 155.21 22.38 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 2.1000000000000001 111.019 -176.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.08 21.03 4.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.937 -0.649 . . . . 0.55000000000000004 112.148 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.1 m -80.79 124.4 29.03 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.722 -0.473 . . . . 1.0600000000000001 109.722 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 30.5 t70 55.59 53.8 9.19 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 122.025 0.917 . . . . 2.23 109.352 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.438 HG22 ' N ' ' C' ' 34' ' ' PHE . 3.9 p -93.61 141.26 15.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.033 -0.985 . . . . 1.1599999999999999 110.606 -172.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' C' ' 36' ' ' TRP . 78.2 mt -84.9 153.81 22.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.822 0.344 . . . . 0.47999999999999998 110.403 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -116.47 140.17 49.65 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.919 -0.582 . . . . 3.1800000000000002 110.957 -177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 13.8 t -74.41 139.24 43.88 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.635 -0.506 . . . . 0.37 109.635 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 26.0 p -89.54 -23.68 21.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.875 0.369 . . . . 0.75 111.328 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -94.08 -20.77 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.191 -0.459 . . . . 1.4299999999999999 111.18 -177.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.17 -172.74 4.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.942 -0.762 . . . . 0.79000000000000004 108.942 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.81 114.56 28.47 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.176 -0.305 . . . . 0.46999999999999997 110.176 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.12 135.34 6.14 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.367 -0.378 . . . . 0.40000000000000002 110.687 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.68 123.54 48.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.45000000000000001 109.545 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 23.8 p90 -159.75 153.26 22.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.365 -0.38 . . . . 0.60999999999999999 110.68 -177.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -93.62 130.4 39.54 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.598 -0.889 . . . . 0.41999999999999998 108.598 171.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' C' ' 46' ' ' ARG . 67.0 t-105 -60.95 -34.29 74.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.006 -0.543 . . . . 0.68000000000000005 110.623 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -68.02 -38.58 82.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 3.3300000000000001 111.269 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.502 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 85.4 m -70.02 -26.83 64.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.54000000000000004 110.688 178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' C' ' 54' ' ' ARG . 4.3 m-70 -89.8 -53.5 4.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.064 -0.516 . . . . 0.60999999999999999 111.957 -175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.77 143.65 30.44 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.305 -0.407 . . . . 0.80000000000000004 111.003 -172.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.1 169.67 14.65 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.056 2.504 . . . . 2.1200000000000001 112.011 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.77 -18.68 65.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.343 -0.844 . . . . 3.2999999999999998 111.835 -175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.8 -30.07 72.61 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.804 -0.712 . . . . 1.46 111.833 175.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 22.0 m -79.02 135.86 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.672 0.272 . . . . 1.03 110.479 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 21.2 t -89.64 151.89 21.66 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.514 -0.312 . . . . 1.6000000000000001 110.262 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.589 ' HG2' ' CD1' ' C' ' 36' ' ' TRP . 22.2 mtp180 -88.76 115.73 64.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.675 -0.491 . . . . 2.6800000000000002 109.675 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.37 132.02 34.3 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.499 2.132 . . . . 1.1399999999999999 112.116 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.33 -26.28 59.82 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.408 -0.677 . . . . 1.8999999999999999 111.408 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 13.9 p -133.24 139.85 47.18 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 122.308 0.243 . . . . 2.75 110.754 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.05 51.3 19.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.698 -0.763 . . . . 0.81999999999999995 112.377 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 122.85 15.99 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.685 -0.487 . . . . 0.87 109.685 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -116.05 142.26 47.04 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.916 0.389 . . . . 2.6499999999999999 110.997 -176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.511 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -79.6 -172.04 3.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.48999999999999999 110.205 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . 0.411 ' HB2' ' CE1' ' C' ' 39' ' ' HIS . 42.9 ttp180 -60.67 -52.06 66.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.689 0.28 . . . . 4.0899999999999999 111.276 -177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 11.2 m -65.16 -43.17 92.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.357 -0.383 . . . . 1.54 111.512 -175.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.7 m -71.37 -26.77 62.94 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 121.169 -0.212 . . . . 0.71999999999999997 111.471 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -87.44 -13.92 41.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.113 0.482 . . . . 1.25 110.451 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.57 48.75 0.9 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.88 -0.676 . . . . 2.1899999999999999 112.063 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -89.33 104.22 16.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.11 0.481 . . . . 5.1500000000000004 109.805 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 39.3 t -89.24 97.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.666 -0.697 . . . . 6.7599999999999998 109.151 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' C' ' 62' ' ' PRO . 29.3 m -66.11 113.53 12.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.8 -0.636 . . . . 8.8300000000000001 110.469 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' C' ' 61' ' ' THR . 6.3 Cg_exo -76.32 142.4 23.98 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.474 2.116 . . . . 11.039999999999999 111.842 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.54 122.5 80.7 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.98 -0.555 . . . . 13.859999999999999 109.73 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.79 106.96 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.42 2.08 . . . . 16.550000000000001 112.214 -175.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -91.2 -8.32 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.35 0.595 . . . . 18.07 109.985 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.3 -0.864 . . . . 20.260000000000002 109.715 177.029 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 111.682 -0.567 . . . . 20.379999999999999 111.682 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.09 56.92 1.24 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.379 . . . . 18.809999999999999 110.996 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tpt -68.34 -30.25 69.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.251 0.548 . . . . 18.059999999999999 110.284 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -133.07 148.15 52.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 16.829999999999998 110.028 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.71 176.36 35.61 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.94 -0.864 . . . . 14.66 110.94 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -102.97 -60.32 1.57 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.94 0.37 . . . . 15.800000000000001 110.128 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.54 56.53 1.13 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.938 0.399 . . . . 13.130000000000001 110.458 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -87.57 107.34 18.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.173 -0.467 . . . . 11.74 110.233 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.9 tp -105.05 126.02 51.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.919 -0.582 . . . . 8.7200000000000006 110.119 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.43 123.37 82.96 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.426 -0.352 . . . . 5.9299999999999997 110.311 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.52 34.04 0.3 Allowed 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 123.169 2.58 . . . . 5.25 113.535 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.17 -71.31 1.29 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 111.147 -0.781 . . . . 2.2799999999999998 111.147 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' C' ' 21' ' ' GLY . . . -80.43 79.52 7.02 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.19 0.519 . . . . 2.0699999999999998 109.9 175.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -140.73 126.7 19.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.794 -0.639 . . . . 3.1800000000000002 110.529 -177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 35.9 t -70.28 118.59 13.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.21 -0.45 . . . . 0.53000000000000003 109.975 177.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.9 -29.84 76.39 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.977 -0.556 . . . . 0.65000000000000002 113.154 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.4 t -75.22 -46.69 38.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 1.04 111.329 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.66 -34.96 16.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.782 0.325 . . . . 0.83999999999999997 111.71 -173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.3 -20.97 44.9 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.872 -0.68 . . . . 0.77000000000000002 111.914 -177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.67 150.26 21.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.609 0.242 . . . . 2.1000000000000001 110.531 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' C' ' 13' ' ' ALA . . . -119.08 11.58 11.62 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.878 -0.677 . . . . 0.55000000000000004 112.323 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.9 m -80.26 133.22 35.96 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.795 -0.446 . . . . 1.0600000000000001 109.795 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.4 t70 57.27 48.94 14.14 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 122.141 0.972 . . . . 2.23 109.33 -177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.509 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.1 p -90.42 139.66 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.312 -0.858 . . . . 1.1599999999999999 110.833 -174.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -93.32 144.37 25.38 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.394 -0.821 . . . . 0.47999999999999998 109.421 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -117.92 142.74 47.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.373 -0.376 . . . . 3.1800000000000002 110.792 -174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 4.6 t -72.92 133.08 44.22 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.525 -0.546 . . . . 0.37 109.525 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 31.6 p -84.58 -15.58 45.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 0.75 111.318 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -101.2 -20.75 15.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 1.4299999999999999 111.486 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 p -151.06 -166.58 2.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.51 -0.552 . . . . 0.79000000000000004 109.51 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.67 114.92 29.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.755 0.312 . . . . 0.46999999999999997 110.373 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -162.89 128.32 3.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.40000000000000002 110.627 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' C' ' 15' ' ' CYS . . . -101.38 111.94 24.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.26 -0.644 . . . . 0.45000000000000001 109.26 174.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -152.57 -175.05 5.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.42 -0.355 . . . . 0.60999999999999999 110.083 -175.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.771 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m80 -129.83 161.27 31.15 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.511 -0.922 . . . . 0.41999999999999998 108.511 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -58.01 -53.31 59.71 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 121.187 -0.205 . . . . 0.68000000000000005 111.287 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -56.43 -45.2 80.85 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.048 0.759 . . . . 3.3300000000000001 113.048 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 0.1 OUTLIER -66.46 -21.6 66.2 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.164 0.431 . . . . 0.54000000000000004 112.164 -173.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -109.17 -36.49 6.03 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.012 -0.275 . . . . 0.60999999999999999 111.73 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -126.26 139.02 33.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.774 0.321 . . . . 0.80000000000000004 110.923 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.03 156.58 63.83 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.621 2.214 . . . . 2.1200000000000001 111.637 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -15.32 53.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.108 -0.951 . . . . 3.2999999999999998 112.596 -173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.95 -15.86 79.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.946 -0.645 . . . . 1.46 111.971 176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 1.1 m -85.02 136.17 33.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.8 -0.444 . . . . 1.03 109.8 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -88.47 126.28 35.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.768 0.318 . . . . 1.6000000000000001 110.557 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -78.85 122.33 84.52 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.08 -0.509 . . . . 2.6800000000000002 111.082 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.15 141.6 57.98 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.446 2.097 . . . . 1.1399999999999999 111.547 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.4 -28.3 52.88 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.839 -0.696 . . . . 1.8999999999999999 112.672 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 16.5 p -141.1 61.31 1.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.091 0.472 . . . . 2.75 110.851 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.23 46.34 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.517 -0.849 . . . . 0.81999999999999995 112.352 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.81 123.84 20.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.295 0.569 . . . . 0.87 110.541 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -125.54 133.22 52.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.777 -0.647 . . . . 2.6499999999999999 110.299 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.1 p -73.37 179.1 4.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.509 -0.552 . . . . 0.48999999999999999 109.509 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -37.98 76.76 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.21 0.448 . . . . 4.0899999999999999 112.21 -172.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 22.4 m -70.38 -51.62 28.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.845 0.355 . . . . 1.54 111.459 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 55.9 m -73.5 -18.01 61.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.778 0.658 . . . . 0.71999999999999997 112.778 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -76.36 -14.34 60.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.987 0.422 . . . . 1.25 111.438 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.36 -170.32 15.48 Favored Glycine 0 N--CA 1.439 -1.106 0 C-N-CA 120.246 -0.978 . . . . 2.1899999999999999 112.499 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.11 43.54 1.15 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.323 0.583 . . . . 5.1500000000000004 109.864 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.0 t -88.95 93.29 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.795 -0.639 . . . . 6.7599999999999998 110.702 -175.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.9 p -120.43 107.38 39.03 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.9 -0.591 . . . . 8.8300000000000001 110.273 176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.64 147.84 93.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.786 2.324 . . . . 11.039999999999999 112.632 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.33 127.53 34.29 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 13.859999999999999 110.576 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.4 135.64 22.68 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.457 2.105 . . . . 16.550000000000001 111.841 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.6 t -89.55 89.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.336 -0.616 . . . . 18.07 109.336 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.421 -0.8 . . . . 20.260000000000002 110.29 -176.729 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.777 0 N-CA-C 112.141 -0.384 . . . . 20.379999999999999 112.141 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.98 51.55 13.36 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.825 0.45 . . . . 18.809999999999999 111.149 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -102.05 -18.44 15.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 18.059999999999999 110.992 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 172.76 12.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.047 -0.524 . . . . 16.829999999999998 110.325 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.7 -119.07 2.92 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.923 -0.656 . . . . 14.66 112.254 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -86.13 -6.43 59.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.161 0.505 . . . . 15.800000000000001 110.708 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -85.79 54.11 3.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 13.130000000000001 111.08 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -88.48 66.84 8.4 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.658 0.742 . . . . 11.74 110.202 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt -75.22 124.42 27.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.623 -0.717 . . . . 8.7200000000000006 110.712 -177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 125.08 91.46 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.007 -0.542 . . . . 5.9299999999999997 110.508 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -72.13 47.28 1.02 Allowed 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 123.186 2.591 . . . . 5.25 112.968 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.61 136.27 4.41 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 121.015 -0.612 . . . . 2.2799999999999998 111.725 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.36 74.33 9.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 2.0699999999999998 110.184 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -136.44 151.43 49.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.529 -0.759 . . . . 3.1800000000000002 110.713 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -70.39 114.39 8.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.478 -0.783 . . . . 0.53000000000000003 109.802 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.64 62.57 Favored Glycine 0 C--N 1.33 0.208 0 C-N-CA 121.504 -0.379 . . . . 0.65000000000000002 113.265 -175.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 44.3 t -73.43 -30.13 29.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.092 0.472 . . . . 1.04 110.796 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 79.6 m -108.6 -28.41 9.31 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.51 0.559 . . . . 0.83999999999999997 112.51 -174.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.06 9.91 86.13 Favored Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 111.202 -0.759 . . . . 0.77000000000000002 111.202 -174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -127.85 145.83 50.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.226 -0.487 . . . . 2.1000000000000001 110.275 -175.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.59 24.63 9.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.831 -0.699 . . . . 0.55000000000000004 112.749 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -77.65 122.85 25.88 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.874 -0.417 . . . . 1.0600000000000001 109.874 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 54.86 49.14 18.48 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.311 0.577 . . . . 2.23 110.094 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.56 145.68 7.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.739 -0.664 . . . . 1.1599999999999999 110.18 -176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 68.0 mt -92.91 146.71 23.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.025 0.44 . . . . 0.47999999999999998 110.095 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 26' ' ' ARG . 12.2 mmt180 -110.79 148.01 33.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 3.1800000000000002 110.069 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.4 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.4 t -79.12 139.82 37.96 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.681 -0.859 . . . . 0.37 108.681 174.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 60.1 p -89.92 -24.5 21.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.29 0.567 . . . . 0.75 110.724 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -89.88 -20.79 22.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.034 -0.53 . . . . 1.4299999999999999 111.19 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 7.6 p -150.9 -171.77 4.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.796 -0.816 . . . . 0.79000000000000004 108.796 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.7 115.43 30.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.376 -0.231 . . . . 0.46999999999999997 110.376 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.84 153.69 14.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.154 -0.476 . . . . 0.40000000000000002 110.514 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.09 118.86 23.19 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.525 0.516 . . . . 0.45000000000000001 110.114 178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -158.02 154.9 28.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.16 -0.473 . . . . 0.60999999999999999 110.529 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.679 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.6 m170 -86.65 133.12 33.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.347 -0.983 . . . . 0.41999999999999998 108.347 172.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.417 ' CZ2' ' HA ' ' C' ' 46' ' ' ARG . 70.0 t-105 -49.67 -53.08 26.49 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.244 0.34 . . . . 0.68000000000000005 111.338 -174.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 64.9 mtp180 -62.3 -23.48 66.76 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.316 0.488 . . . . 3.3300000000000001 112.316 -175.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -79.97 -22.08 42.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.918 0.39 . . . . 0.54000000000000004 111.185 -177.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -103.95 -44.19 5.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.197 0.522 . . . . 0.60999999999999999 110.665 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.426 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 71.1 m-85 -119.07 136.35 24.32 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.583 -0.735 . . . . 0.80000000000000004 109.821 -177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 21.6 Cg_exo -65.65 157.5 58.26 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.442 2.094 . . . . 2.1200000000000001 111.291 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.93 -12.22 53.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.841 -0.618 . . . . 3.2999999999999998 112.174 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.11 -25.28 74.99 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.751 -0.737 . . . . 1.46 111.384 173.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 93.1 m -85.29 125.84 33.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.789 0.328 . . . . 1.03 110.131 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.4 m -87.57 131.84 34.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.474 -0.33 . . . . 1.6000000000000001 110.158 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' CZ2' ' C' ' 36' ' ' TRP . 19.3 ptp180 -70.75 132.75 86.85 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 2.6800000000000002 110.775 -177.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.98 132.61 30.68 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.942 2.428 . . . . 1.1399999999999999 112.421 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.35 -12.22 60.09 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.829 -0.7 . . . . 1.8999999999999999 111.718 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 9.5 p -90.07 10.72 23.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.079 0.466 . . . . 2.75 111.147 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . 139.08 117.29 1.47 Allowed Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.784 -0.722 . . . . 0.81999999999999995 111.94 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -63.36 123.28 18.32 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.522 -0.547 . . . . 0.87 109.522 178.211 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 81.6 mtm180 -120.9 133.59 55.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.268 -0.424 . . . . 2.6499999999999999 111.248 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -78.48 162.8 26.1 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.989 -0.745 . . . . 0.48999999999999999 108.989 171.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -48.23 -38.48 18.6 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.459 0.54 . . . . 4.0899999999999999 112.459 -173.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -64.64 -50.13 68.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.994 0.426 . . . . 1.54 110.758 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 82.5 m -72.67 -29.41 63.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.961 -0.563 . . . . 0.71999999999999997 111.722 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.1 p -82.79 1.1 40.66 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.939 0.399 . . . . 1.25 110.718 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.36 -18.91 79.83 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.848 -0.692 . . . . 2.1899999999999999 111.674 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.45 81.09 4.37 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.571 -0.529 . . . . 5.1500000000000004 109.571 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 58.9 t -89.49 116.04 30.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.77 -0.65 . . . . 6.7599999999999998 109.906 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.2 m -72.69 115.57 41.13 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.292 -0.413 . . . . 8.8300000000000001 110.119 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.47 152.07 33.72 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.572 2.181 . . . . 11.039999999999999 112.613 -176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -110.47 116.89 52.11 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.883 -0.599 . . . . 13.859999999999999 109.813 176.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 15.8 Cg_exo -69.32 61.11 1.48 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.049 2.499 . . . . 16.550000000000001 112.6 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -94.9 158.06 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.218 -0.446 . . . . 18.07 110.087 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.579 -0.724 . . . . 20.260000000000002 110.093 -178.196 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.946 -0.462 . . . . 20.379999999999999 111.946 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.77 74.67 8.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.316 0.579 . . . . 18.809999999999999 110.517 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . 0.583 ' SD ' ' HG3' ' C' ' 4' ' ' GLU . 0.0 OUTLIER -105.32 -1.1 25.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.788 -0.642 . . . . 18.059999999999999 111.068 -178.209 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.583 ' HG3' ' SD ' ' C' ' 3' ' ' MET . 44.3 mt-10 -104.84 122.18 45.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.913 0.387 . . . . 16.829999999999998 110.274 176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.3 6.46 55.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.86 -0.686 . . . . 14.66 111.938 -177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -71.89 -31.81 66.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.361 . . . . 15.800000000000001 110.645 -178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -82.87 2.68 33.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.354 0.597 . . . . 13.130000000000001 110.057 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -114.54 32.69 5.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.403 -0.817 . . . . 11.74 109.686 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 tt 57.0 94.98 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.082 -0.963 . . . . 8.7200000000000006 111.082 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.78 123.24 89.16 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 116.074 -0.512 . . . . 5.9299999999999997 109.892 176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.08 -17.42 31.67 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.735 2.29 . . . . 5.25 113.405 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.88 16.35 79.17 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.99 -0.624 . . . . 2.2799999999999998 111.898 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.28 110.05 17.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.795 0.331 . . . . 2.0699999999999998 110.883 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -146.89 129.48 15.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.223 -0.444 . . . . 3.1800000000000002 111.024 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 26.8 t -69.59 107.95 3.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.53000000000000003 110.08 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.76 -24.33 66.32 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.448 -0.406 . . . . 0.65000000000000002 113.017 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.91 -31.93 55.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.09 0.472 . . . . 1.04 110.576 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 73.6 m -108.0 -32.54 7.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.268 0.47 . . . . 0.83999999999999997 112.268 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.29 16.46 58.98 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.156 -0.778 . . . . 0.77000000000000002 111.156 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -137.86 144.47 41.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.412 -0.394 . . . . 2.1000000000000001 110.355 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.78 23.86 9.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.946 -0.645 . . . . 0.55000000000000004 112.54 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.9 m -80.72 128.46 33.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.953 -0.388 . . . . 1.0600000000000001 109.953 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 56.28 47.15 19.81 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.607 0.567 . . . . 2.23 109.743 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.459 HG21 ' HB1' ' C' ' 33' ' ' ALA . 7.7 p -89.35 142.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.525 -0.761 . . . . 1.1599999999999999 110.561 -175.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 63.1 mt -92.24 144.33 25.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.009 0.433 . . . . 0.47999999999999998 109.951 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 25.6 tpt180 -114.16 138.06 50.94 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.681 -0.691 . . . . 3.1800000000000002 109.559 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.446 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.7 t -70.82 139.85 51.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.325 -0.62 . . . . 0.37 109.325 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.6 p -91.57 -17.89 24.92 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.199 -0.455 . . . . 0.75 111.46 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -103.03 -16.82 15.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.297 -0.411 . . . . 1.4299999999999999 111.052 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.446 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.8 p -151.3 -172.51 4.23 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.934 -0.765 . . . . 0.79000000000000004 108.934 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.48 114.42 28.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.737 0.303 . . . . 0.46999999999999997 110.271 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.573 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -158.4 146.34 18.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.40000000000000002 110.053 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.459 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -125.85 112.98 16.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.191 -0.458 . . . . 0.45000000000000001 109.959 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -156.05 159.84 39.48 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.85 -0.614 . . . . 0.60999999999999999 110.008 -177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.85 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.4 m80 -92.84 143.69 26.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.108 -1.071 . . . . 0.41999999999999998 108.108 171.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -48.17 -53.11 17.96 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.379 0.424 . . . . 0.68000000000000005 111.593 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -61.27 -20.45 62.89 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.121 -0.491 . . . . 3.3300000000000001 112.259 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.85 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 13.8 m -84.2 -20.54 32.15 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.204 -0.453 . . . . 0.54000000000000004 111.119 -174.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -114.29 -33.23 5.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.326 -0.397 . . . . 0.60999999999999999 111.655 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.46 148.3 65.93 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.31 -0.405 . . . . 0.80000000000000004 110.19 -176.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.0 146.73 72.11 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.504 2.136 . . . . 2.1200000000000001 111.57 177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.9 -11.76 57.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.544 -0.753 . . . . 3.2999999999999998 111.653 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.32 -29.79 74.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.706 -0.759 . . . . 1.46 111.379 172.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 19.7 m -82.27 138.79 34.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.383 -0.599 . . . . 1.03 109.383 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.2 t -88.29 140.59 29.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.154 0.502 . . . . 1.6000000000000001 110.397 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -72.81 110.95 9.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.326 -0.852 . . . . 2.6800000000000002 110.088 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.93 145.2 44.75 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.674 2.249 . . . . 1.1399999999999999 112.621 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.58 8.6 30.27 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.223 -0.751 . . . . 1.8999999999999999 111.223 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -117.56 33.58 5.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.154 0.502 . . . . 2.75 110.981 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.53 78.08 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.636 -0.792 . . . . 0.81999999999999995 112.355 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.25 122.29 17.55 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.262 -0.644 . . . . 0.87 109.262 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -120.27 140.66 50.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.529 -0.305 . . . . 2.6499999999999999 110.538 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.2 p -74.61 176.63 6.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.29 -0.633 . . . . 0.48999999999999999 109.29 173.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.55 -41.98 95.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.491 0.186 . . . . 4.0899999999999999 111.029 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 17.1 m -64.75 -46.12 83.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.54 111.358 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 74.3 m -71.53 -17.35 62.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.962 0.41 . . . . 0.71999999999999997 111.035 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -88.94 -5.21 58.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.391 -0.368 . . . . 1.25 110.318 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.83 128.62 9.63 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.986 -0.626 . . . . 2.1899999999999999 112.363 -178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -99.27 102.32 13.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.995 0.426 . . . . 5.1500000000000004 110.506 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.59 129.92 56.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 6.7599999999999998 109.948 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 2.9 m -91.25 113.01 56.96 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.345 -0.388 . . . . 8.8300000000000001 110.348 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -66.2 134.02 35.01 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.17 1.913 . . . . 11.039999999999999 111.436 178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.91 118.65 71.09 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.094 -0.503 . . . . 13.859999999999999 110.768 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.78 125.72 20.05 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.927 2.418 . . . . 16.550000000000001 111.94 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 p -89.54 -21.39 6.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.44 0.638 . . . . 18.07 110.465 -177.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.29 -0.862 . . . . 20.260000000000002 109.736 179.909 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 112.159 -0.376 . . . . 20.379999999999999 112.159 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.02 39.26 3.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 18.809999999999999 110.18 178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.9 ptm -68.34 -20.93 64.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 18.059999999999999 111.2 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -76.7 -16.96 59.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.672 0.272 . . . . 16.829999999999998 110.995 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.11 29.02 8.71 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.9 -0.666 . . . . 14.66 112.152 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -86.09 -39.36 16.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.467 0.651 . . . . 15.800000000000001 109.54 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.45 78.97 1.43 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.071 -0.968 . . . . 13.130000000000001 108.752 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -142.64 140.57 31.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.954 -0.566 . . . . 11.74 110.471 -175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.41 84.46 1.47 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 8.7200000000000006 110.018 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -61.98 146.22 91.88 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 5.9299999999999997 110.778 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 12.0 Cg_exo -71.51 45.4 0.67 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.224 2.616 . . . . 5.25 112.434 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -144.38 44.34 0.92 Allowed Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.6 -0.6 . . . . 2.2799999999999998 111.6 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.27 75.19 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.476 0.655 . . . . 2.0699999999999998 110.226 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -162.14 157.94 23.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.111 -0.95 . . . . 3.1800000000000002 108.454 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.7 t -56.96 107.74 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.146 0.279 . . . . 0.53000000000000003 110.654 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.37 -16.6 62.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.271 -0.49 . . . . 0.65000000000000002 112.661 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.29 -30.38 15.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.008 0.433 . . . . 1.04 110.679 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.6 m -108.35 -24.71 11.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.159 0.429 . . . . 0.83999999999999997 112.159 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.2 15.15 80.8 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.788 -0.72 . . . . 0.77000000000000002 111.431 -175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.72 136.15 44.46 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.598 -0.301 . . . . 2.1000000000000001 110.422 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.09 16.55 38.84 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.834 -0.698 . . . . 0.55000000000000004 112.719 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -77.61 131.84 37.98 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.901 -0.407 . . . . 1.0600000000000001 109.901 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 39.1 t70 55.99 46.22 22.3 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.94 0.876 . . . . 2.23 109.577 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 1.1 p -91.81 149.25 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.194 -0.912 . . . . 1.1599999999999999 110.09 -176.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.2 mt -102.0 157.08 17.12 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.306 -0.406 . . . . 0.47999999999999998 110.18 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -117.2 143.78 45.49 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.782 -0.644 . . . . 3.1800000000000002 110.109 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.88 141.18 34.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.712 -0.477 . . . . 0.37 109.712 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 30.5 p -82.29 -28.76 31.54 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.253 -0.431 . . . . 0.75 111.764 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -95.75 -17.11 21.48 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.883 0.327 . . . . 1.4299999999999999 111.883 -176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.64 -172.28 4.15 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.818 -0.353 . . . . 0.79000000000000004 110.053 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.36 114.01 27.95 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.025 -0.534 . . . . 0.46999999999999997 109.678 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.96 119.86 1.62 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.182 -0.463 . . . . 0.40000000000000002 110.321 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.58 112.32 24.4 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.538 -0.541 . . . . 0.45000000000000001 109.538 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -154.65 168.43 26.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.247 -0.433 . . . . 0.60999999999999999 110.404 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.706 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.6 m170 -97.31 136.17 38.17 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.316 -0.994 . . . . 0.41999999999999998 108.316 172.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 55.4 t-105 -56.51 -38.62 72.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.68000000000000005 111.438 -177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -66.72 -27.27 67.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.93 -0.577 . . . . 3.3300000000000001 111.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 32.7 m -86.92 -22.38 25.69 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.977 -0.556 . . . . 0.54000000000000004 111.48 -172.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -95.96 -31.03 13.29 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.875 -0.33 . . . . 0.60999999999999999 111.162 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -128.8 78.63 75.82 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.664 0.268 . . . . 0.80000000000000004 110.339 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -78.84 -41.63 0.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.983 2.455 . . . . 2.1200000000000001 112.846 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.21 -54.74 4.28 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.441 -0.345 . . . . 3.2999999999999998 111.28 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -91.71 59.59 2.88 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.64 -0.791 . . . . 1.46 111.68 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -81.36 96.79 7.44 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.168 0.509 . . . . 1.03 111.473 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -141.28 92.74 2.5 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.905 -0.776 . . . . 1.6000000000000001 108.905 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -57.79 118.65 27.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 2.6800000000000002 111.216 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.32 133.32 22.5 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.628 2.218 . . . . 1.1399999999999999 112.596 -178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.48 -10.37 79.87 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.059 -0.591 . . . . 1.8999999999999999 111.88 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 3.9 p -94.83 35.52 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.0 0.429 . . . . 2.75 111.191 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.8 136.03 9.17 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.907 -0.663 . . . . 0.81999999999999995 112.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -72.33 122.61 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.485 -0.561 . . . . 0.87 109.485 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -121.8 131.57 54.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.841 -0.618 . . . . 2.6499999999999999 110.503 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -74.96 -179.79 4.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.189 -0.46 . . . . 0.48999999999999999 110.039 177.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -59.97 -49.42 77.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.505 0.187 . . . . 4.0899999999999999 111.505 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 13.8 t -64.1 -41.55 97.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.577 -0.283 . . . . 1.54 111.049 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 79.2 m -71.78 -18.94 62.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 0.71999999999999997 110.896 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.6 m -89.19 2.4 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.48 -0.327 . . . . 1.25 110.663 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.95 -21.44 71.5 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.83 -0.7 . . . . 2.1899999999999999 111.638 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.51 -1.82 56.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.939 0.876 . . . . 5.1500000000000004 109.788 177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 57.6 t -101.24 105.28 17.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.27 -0.877 . . . . 6.7599999999999998 110.049 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . 0.422 ' HA ' ' HD2' ' C' ' 62' ' ' PRO . 27.0 m -90.92 112.12 51.84 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.59 -0.522 . . . . 8.8300000000000001 109.59 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' C' ' 61' ' ' THR . 11.4 Cg_endo -56.79 134.16 62.68 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.525 2.15 . . . . 11.039999999999999 111.877 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.87 139.46 82.93 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.011 -0.54 . . . . 13.859999999999999 110.452 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.3 52.35 2.74 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.71 2.274 . . . . 16.550000000000001 112.271 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.01 124.05 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.082 -0.508 . . . . 18.07 110.518 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.247 0.959 0 CA-C-N 116.105 -0.498 . . . . 20.260000000000002 110.571 179.447 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.754 -0.538 . . . . 20.379999999999999 111.754 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.35 -159.22 0.32 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.625 0.37 . . . . 18.809999999999999 110.964 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 61.5 mtm 63.88 26.61 14.31 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.169 0.509 . . . . 18.059999999999999 110.762 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.08 -27.3 60.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.784 -0.644 . . . . 16.829999999999998 110.019 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.05 49.86 0.93 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.035 -0.826 . . . . 14.66 111.035 175.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -58.72 -45.05 90.48 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.409 0.623 . . . . 15.800000000000001 109.952 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.34 95.05 3.56 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.25 -0.886 . . . . 13.130000000000001 109.435 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -75.37 83.0 2.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.264 0.554 . . . . 11.74 110.792 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 51.1 tp -78.13 132.52 37.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 8.7200000000000006 110.101 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.27 122.9 79.58 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.448 -0.575 . . . . 5.9299999999999997 109.448 175.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.82 -19.64 62.67 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.939 2.426 . . . . 5.25 112.806 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.13 -51.28 0.85 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.6 . . . . 2.2799999999999998 111.844 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.72 74.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.379 0.609 . . . . 2.0699999999999998 110.462 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -153.76 127.18 8.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.637 -0.71 . . . . 3.1800000000000002 109.967 176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 7.1 t -82.86 104.81 13.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.887 -0.597 . . . . 0.53000000000000003 109.939 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.4 -8.31 75.21 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 116.007 -0.542 . . . . 0.65000000000000002 113.405 -173.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.466 HG11 ' O ' ' C' ' 38' ' ' CYS . 43.5 t -71.46 -29.66 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.051 0.453 . . . . 1.04 110.523 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.4 p -120.43 -34.03 3.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.297 -0.41 . . . . 0.83999999999999997 110.529 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.18 -13.01 23.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.126 -0.559 . . . . 0.77000000000000002 111.825 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.546 ' OD2' HG22 ' C' ' 22' ' ' THR . 15.7 t70 -95.97 152.71 18.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.269 . . . . 2.1000000000000001 110.796 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.93 14.08 5.22 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.55000000000000004 113.12 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . 0.546 HG22 ' OD2' ' C' ' 20' ' ' ASP . 9.5 t -81.7 136.34 35.48 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.178 0.489 . . . . 1.0600000000000001 109.904 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.0 t70 54.71 49.84 17.14 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.912 0.863 . . . . 2.23 109.496 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 p -89.08 136.96 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.272 -0.876 . . . . 1.1599999999999999 110.028 -174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 98.2 mt -84.54 149.73 25.71 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.217 -0.447 . . . . 0.47999999999999998 110.668 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.468 HH11 ' HB2' ' C' ' 33' ' ' ALA . 23.8 mmm180 -116.95 129.83 56.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.944 -0.571 . . . . 3.1800000000000002 110.464 -178.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.0 t -65.0 140.48 58.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.079 -0.51 . . . . 0.37 109.77 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 42.8 p -89.17 -20.13 24.61 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.999 0.428 . . . . 0.75 111.292 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -94.06 -22.32 18.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 1.4299999999999999 111.134 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 p -151.59 -168.44 3.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.069 -0.715 . . . . 0.79000000000000004 109.069 178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.81 114.65 29.06 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.833 0.349 . . . . 0.46999999999999997 110.103 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -156.64 131.11 8.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.246 -0.434 . . . . 0.40000000000000002 110.465 -178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.468 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -109.73 111.83 23.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.78 -0.645 . . . . 0.45000000000000001 109.623 174.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.522 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.9 p90 -155.63 166.51 33.3 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.054 -0.521 . . . . 0.60999999999999999 110.047 -178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.451 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -102.33 133.3 47.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.775 -0.824 . . . . 0.41999999999999998 108.775 171.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -57.68 -41.4 81.53 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.666 -0.697 . . . . 0.68000000000000005 110.924 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -67.21 -29.06 68.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 3.3300000000000001 111.352 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.466 ' O ' HG11 ' C' ' 17' ' ' VAL . 93.8 m -74.71 -22.0 59.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.086 0.47 . . . . 0.54000000000000004 110.474 178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -96.66 -56.03 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.12 -0.491 . . . . 0.60999999999999999 111.12 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -114.18 147.94 38.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.928 -0.578 . . . . 0.80000000000000004 110.22 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.88 163.91 29.1 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.656 2.237 . . . . 2.1200000000000001 111.976 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.64 -14.83 59.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.268 -0.878 . . . . 3.2999999999999998 112.468 -171.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.88 -16.54 80.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.789 -0.72 . . . . 1.46 111.802 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.8 m -88.99 127.85 35.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.552 -0.536 . . . . 1.03 109.552 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.6 p -88.2 138.09 31.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.13 0.491 . . . . 1.6000000000000001 111.254 -173.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 55.8 ttp180 -76.72 120.43 81.65 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.437 -0.801 . . . . 2.6800000000000002 110.305 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.2 Cg_exo -68.72 131.66 23.24 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.242 1.961 . . . . 1.1399999999999999 111.476 178.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.6 -40.88 6.63 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.846 -0.692 . . . . 1.8999999999999999 111.614 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.8 p -115.46 70.57 0.75 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.42 0.628 . . . . 2.75 110.702 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 141.05 51.04 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.66 -0.7 . . . . 0.81999999999999995 111.714 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.43 122.89 19.38 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.665 -0.494 . . . . 0.87 109.665 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.06 137.16 53.1 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 2.6499999999999999 110.918 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.522 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.4 p -77.22 -179.65 5.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.172 -0.677 . . . . 0.48999999999999999 109.172 173.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -56.7 -45.13 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 4.0899999999999999 110.952 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . 0.61 ' HA ' ' HB3' ' C' ' 59' ' ' ASP . 3.6 m -65.24 -53.06 50.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.055 -0.521 . . . . 1.54 111.572 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.31 -16.41 62.45 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.295 -0.411 . . . . 0.71999999999999997 111.399 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 31.8 t -83.57 6.53 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.057 0.456 . . . . 1.25 110.448 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.03 48.65 1.33 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.677 -0.773 . . . . 2.1899999999999999 113.045 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.61 ' HB3' ' HA ' ' C' ' 55' ' ' SER . 37.5 t70 -89.29 -19.12 25.72 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.986 0.898 . . . . 5.1500000000000004 109.149 173.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 m -89.71 48.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.442 -1.254 . . . . 6.7599999999999998 109.893 176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 56.9 m -107.48 123.43 38.09 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.096 -0.956 . . . . 8.8300000000000001 110.472 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -55.85 133.79 60.2 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.503 2.135 . . . . 11.039999999999999 111.445 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.18 131.52 92.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.221 -0.445 . . . . 13.859999999999999 111.172 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.93 111.55 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.562 2.175 . . . . 16.550000000000001 111.308 174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.1 p -133.32 140.52 46.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.266 -0.424 . . . . 18.07 110.33 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.707 -0.663 . . . . 20.260000000000002 109.981 -179.768 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 112.076 -0.41 . . . . 20.379999999999999 112.076 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.73 4.34 33.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 18.809999999999999 111.452 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.4 ttt -118.02 28.11 8.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.774 0.797 . . . . 18.059999999999999 108.921 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -107.77 107.52 18.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.48 -0.782 . . . . 16.829999999999998 110.788 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -134.06 7.29 4.76 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.472 -0.786 . . . . 14.66 111.49 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -99.04 -49.99 4.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 15.800000000000001 109.926 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.5 -19.96 30.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.765 -0.652 . . . . 13.130000000000001 110.131 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -85.41 126.82 34.09 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.538 -0.755 . . . . 11.74 110.348 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 75.5 mt -79.8 109.73 14.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.965 -0.562 . . . . 8.7200000000000006 110.452 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -67.9 123.81 87.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.875 -0.602 . . . . 5.9299999999999997 110.268 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 33.7 Cg_exo -58.2 107.75 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.819 2.346 . . . . 5.25 112.519 -178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.27 70.01 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.779 -0.725 . . . . 2.2799999999999998 112.246 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.01 72.5 10.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.346 0.593 . . . . 2.0699999999999998 110.241 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 61.2 mtm180 -152.01 154.71 36.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.216 -0.902 . . . . 3.1800000000000002 109.319 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.65 109.87 1.83 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.255 -0.429 . . . . 0.53000000000000003 109.858 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.84 -29.61 58.89 Favored Glycine 0 CA--C 1.52 0.365 0 O-C-N 123.512 0.507 . . . . 0.65000000000000002 113.63 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 79.0 t -71.5 -34.18 52.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 1.04 111.135 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.9 m -100.79 -31.77 11.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.482 0.549 . . . . 0.83999999999999997 112.482 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.32 31.4 59.27 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.364 -1.095 . . . . 0.77000000000000002 110.364 -170.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -147.65 154.08 40.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.228 -0.486 . . . . 2.1000000000000001 110.676 -172.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.98 28.84 5.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.975 -0.631 . . . . 0.55000000000000004 112.68 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.5 m -79.53 128.12 32.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.786 -0.449 . . . . 1.0600000000000001 109.786 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 53.71 47.73 23.1 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.53 0.681 . . . . 2.23 109.823 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.416 HG22 ' N ' ' C' ' 34' ' ' PHE . 1.1 p -89.66 149.82 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.258 -0.883 . . . . 1.1599999999999999 110.506 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.0 mt -100.89 151.93 21.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.321 -0.4 . . . . 0.47999999999999998 110.101 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -111.54 135.15 52.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.899 -0.592 . . . . 3.1800000000000002 110.24 -177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.6 t -66.52 142.99 57.33 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.586 -0.524 . . . . 0.37 109.586 176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 32.7 p -93.42 -24.62 17.99 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.322 0.49 . . . . 0.75 112.322 -176.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . 0.652 ' HD2' ' SG ' ' C' ' 56' ' ' CYS . 18.9 t60 -97.56 -15.67 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.206 0.527 . . . . 1.4299999999999999 110.336 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.8 OUTLIER -150.31 -175.25 5.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.615 -0.883 . . . . 0.79000000000000004 108.615 175.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.83 114.29 28.43 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.891 0.376 . . . . 0.46999999999999997 110.666 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.36 142.88 14.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.765 -0.652 . . . . 0.40000000000000002 109.807 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.33 117.23 28.94 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.528 0.517 . . . . 0.45000000000000001 109.962 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.416 ' N ' HG22 ' C' ' 24' ' ' VAL . 33.0 p90 -156.61 167.77 29.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.827 0.346 . . . . 0.60999999999999999 110.772 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.493 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 21.8 m170 -97.77 123.86 41.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.493 -0.929 . . . . 0.41999999999999998 108.493 172.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -58.01 -32.53 68.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.723 -0.671 . . . . 0.68000000000000005 110.74 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -76.64 -19.47 57.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.794 -0.639 . . . . 3.3300000000000001 111.873 -177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 74.9 m -87.36 -21.94 25.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.26 0.552 . . . . 0.54000000000000004 110.018 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -90.01 -53.35 4.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.60999999999999999 110.353 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -115.98 143.99 31.92 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.647 -0.706 . . . . 0.80000000000000004 109.993 -178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -173.59 1.54 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.685 2.256 . . . . 2.1200000000000001 113.064 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.85 -26.86 67.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 3.2999999999999998 111.167 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.49 -17.73 62.5 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.164 -0.541 . . . . 1.46 112.514 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 14.6 m -98.77 130.51 45.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.859 0.361 . . . . 1.03 110.592 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 t -89.53 150.25 22.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.385 -0.371 . . . . 1.6000000000000001 110.235 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -87.79 120.34 70.86 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.89 -0.595 . . . . 2.6800000000000002 110.595 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.08 134.18 26.71 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.69 2.26 . . . . 1.1399999999999999 111.379 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.41 -43.41 20.0 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.771 -0.65 . . . . 1.8999999999999999 113.018 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.8 p -111.42 -14.41 13.74 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.904 0.352 . . . . 2.75 111.865 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.41 57.03 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.577 -0.82 . . . . 0.81999999999999995 112.448 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.9 OUTLIER -76.1 121.82 23.38 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -123.47 131.82 53.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.114 0.483 . . . . 2.6499999999999999 111.56 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.401 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -73.76 179.83 4.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.647 -0.706 . . . . 0.48999999999999999 109.551 173.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -57.89 -40.1 79.5 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.762 0.282 . . . . 4.0899999999999999 111.762 -175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 39.7 t -69.31 -47.92 63.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.986 0.422 . . . . 1.54 111.04 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' C' ' 29' ' ' HIS . 81.7 m -72.21 -21.63 61.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.49 -0.323 . . . . 0.71999999999999997 111.812 -177.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -102.47 16.07 27.39 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.489 -0.56 . . . . 1.25 109.489 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.48 113.55 3.97 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.667 -0.697 . . . . 2.1899999999999999 112.122 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -89.06 125.71 35.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.791 0.329 . . . . 5.1500000000000004 110.179 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.29 145.02 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.022 -0.535 . . . . 6.7599999999999998 110.41 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 27.2 m -83.17 113.09 43.69 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.189 -0.46 . . . . 8.8300000000000001 110.601 178.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.41 153.15 61.08 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.716 2.277 . . . . 11.039999999999999 111.742 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.11 122.41 50.52 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.614 -0.266 . . . . 13.859999999999999 110.43 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.31 120.59 7.95 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.897 2.398 . . . . 16.550000000000001 112.251 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -100.3 22.21 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.078 0.466 . . . . 18.07 111.259 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.661 -0.685 . . . . 20.260000000000002 110.363 -179.791 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.771 -0.532 . . . . 20.379999999999999 111.771 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.83 49.85 9.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.026 0.441 . . . . 18.809999999999999 111.238 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 46.8 ttp -62.64 -53.61 51.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 18.059999999999999 110.705 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -99.19 1.05 44.54 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.567 -0.742 . . . . 16.829999999999998 110.117 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.71 -125.58 1.9 Allowed Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.773 -0.648 . . . . 14.66 112.13 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 64.27 22.61 12.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 122.568 0.347 . . . . 15.800000000000001 110.84 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 63.05 21.29 12.81 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.729 -0.669 . . . . 13.130000000000001 110.705 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -87.56 101.08 13.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.982 -0.554 . . . . 11.74 110.123 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.53 115.84 14.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.96 -0.564 . . . . 8.7200000000000006 110.496 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.85 122.56 70.14 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.124 -0.489 . . . . 5.9299999999999997 110.814 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.24 60.75 4.0 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 123.25 2.633 . . . . 5.25 113.001 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.96 22.52 74.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.803 -0.713 . . . . 2.2799999999999998 112.167 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.35 75.55 3.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.995 0.426 . . . . 2.0699999999999998 110.429 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -161.58 143.47 11.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.314 -0.624 . . . . 3.1800000000000002 109.314 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 46.8 t -67.69 104.62 1.68 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.916 -0.402 . . . . 0.53000000000000003 109.916 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.19 -19.99 79.72 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.839 -0.619 . . . . 0.65000000000000002 113.218 -174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 58.9 t -61.75 -43.11 96.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.756 0.312 . . . . 1.04 111.23 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.8 p -108.76 -29.78 8.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.912 0.387 . . . . 0.83999999999999997 110.896 -177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.76 -11.5 56.24 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.871 -0.681 . . . . 0.77000000000000002 111.998 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 10.2 m-20 -97.17 145.35 26.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.918 0.39 . . . . 2.1000000000000001 110.615 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.27 17.25 10.54 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.049 -0.596 . . . . 0.55000000000000004 112.091 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 14.7 t -80.1 135.49 36.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.926 -0.398 . . . . 1.0600000000000001 109.926 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 48.3 20.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.974 0.892 . . . . 2.23 109.344 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -88.69 146.55 6.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.194 -0.912 . . . . 1.1599999999999999 110.315 -174.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 85.5 mt -91.87 154.27 18.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.902 0.382 . . . . 0.47999999999999998 110.551 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 tpp180 -122.27 130.62 53.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.584 -0.735 . . . . 3.1800000000000002 109.749 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 13.2 t -68.69 136.31 52.7 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.746 -0.465 . . . . 0.37 109.746 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.0 p -87.96 -19.49 27.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.103 0.478 . . . . 0.75 110.998 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -93.21 -24.97 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.059 -0.519 . . . . 1.4299999999999999 111.116 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.9 p -151.13 -163.99 1.9 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.465 -0.569 . . . . 0.79000000000000004 109.465 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 114.78 29.31 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.46999999999999997 110.227 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 138.74 10.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.289 -0.414 . . . . 0.40000000000000002 110.498 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -122.06 112.85 18.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.777 -0.647 . . . . 0.45000000000000001 109.343 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 44.6 p90 -155.7 170.25 22.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.151 -0.477 . . . . 0.60999999999999999 110.183 -176.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -105.75 133.82 49.87 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.507 -0.553 . . . . 0.41999999999999998 109.507 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.48 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.7 t-105 -60.25 -36.8 78.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.652 -0.703 . . . . 0.68000000000000005 110.073 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -68.44 -34.17 75.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.625 -0.716 . . . . 3.3300000000000001 110.93 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 90.8 m -75.74 -22.71 56.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.54000000000000004 110.874 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . 0.401 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 2.8 m170 -90.47 -42.26 10.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.405 -0.361 . . . . 0.60999999999999999 111.582 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -120.8 77.3 29.54 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.484 -0.325 . . . . 0.80000000000000004 111.284 -176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 7.1 Cg_exo -74.54 4.17 4.73 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.146 2.564 . . . . 2.1200000000000001 112.284 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.57 -7.27 59.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 3.2999999999999998 110.873 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.31 28.04 11.17 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.598 -0.811 . . . . 1.46 112.109 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 15.3 m -69.42 144.05 53.45 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.979 -0.378 . . . . 1.03 109.979 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.4 t -88.24 143.93 26.74 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.072 0.463 . . . . 1.6000000000000001 110.536 -175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -92.72 117.62 67.64 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.436 -0.802 . . . . 2.6800000000000002 111.453 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -69.99 132.89 23.9 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.714 2.276 . . . . 1.1399999999999999 111.56 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.92 5.04 68.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.756 -0.735 . . . . 1.8999999999999999 112.548 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -89.63 -75.44 0.45 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.338 0.59 . . . . 2.75 111.106 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -127.37 101.37 0.57 Allowed Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.485 -0.78 . . . . 0.81999999999999995 111.658 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.18 128.25 34.93 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.978 0.418 . . . . 0.87 110.354 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -114.08 135.17 54.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.198 -0.455 . . . . 2.6499999999999999 110.364 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.523 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 14.3 p -74.39 176.57 6.63 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.432 -0.581 . . . . 0.48999999999999999 109.432 174.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' C' ' 55' ' ' SER . 8.1 ptm85 -58.5 -43.91 89.25 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 4.0899999999999999 111.527 -175.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . 0.457 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 20.2 m -65.86 -46.53 78.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.655 -0.248 . . . . 1.54 111.148 -176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.9 m -72.37 -22.58 61.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.743 0.306 . . . . 0.71999999999999997 111.569 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 28.9 t -81.41 -13.95 57.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.015 0.436 . . . . 1.25 110.02 178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.4 49.0 0.85 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.295 -0.722 . . . . 2.1899999999999999 111.295 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -105.85 120.06 40.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.803 0.335 . . . . 5.1500000000000004 110.762 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -119.61 130.04 74.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.075 -0.511 . . . . 6.7599999999999998 110.236 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.0 t -83.46 134.69 44.83 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.81 -0.632 . . . . 8.8300000000000001 109.737 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 134.46 59.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.842 2.361 . . . . 11.039999999999999 112.153 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.57 125.77 54.59 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 13.859999999999999 110.597 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.25 64.98 5.35 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.664 2.243 . . . . 16.550000000000001 111.828 177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.58 126.39 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.059 -0.519 . . . . 18.07 110.311 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.568 -0.73 . . . . 20.260000000000002 109.583 -179.184 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.65 0 N-CA-C 111.732 -0.547 . . . . 20.379999999999999 111.732 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.22 21.74 12.63 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.993 0.425 . . . . 18.809999999999999 111.463 178.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.3 ttm -128.52 85.01 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.197 -0.456 . . . . 18.059999999999999 109.839 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -69.36 124.27 23.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.766 -0.652 . . . . 16.829999999999998 110.169 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.49 -65.31 0.55 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.795 -0.717 . . . . 14.66 112.06 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -86.32 -52.08 5.84 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 15.800000000000001 110.076 178.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -93.28 81.94 4.48 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.098 -0.501 . . . . 13.130000000000001 109.932 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -83.97 41.49 0.81 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.967 -0.561 . . . . 11.74 111.051 -178.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -73.55 112.5 9.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 8.7200000000000006 110.149 179.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.22 125.35 86.65 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.844 -0.617 . . . . 5.9299999999999997 110.608 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.9 -13.72 41.12 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.966 2.444 . . . . 5.25 112.405 -179.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.69 -26.69 70.85 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.954 -0.641 . . . . 2.2799999999999998 111.598 175.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.32 74.31 3.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.268 0.556 . . . . 2.0699999999999998 109.964 177.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -144.23 144.11 31.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.839 -0.619 . . . . 3.1800000000000002 110.353 -178.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 43.0 t -75.2 104.93 5.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.396 -0.594 . . . . 0.53000000000000003 109.396 177.069 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.8 -12.42 84.2 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.014 -0.539 . . . . 0.65000000000000002 113.631 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 87.2 t -67.19 -41.97 87.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 1.04 110.736 178.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 p -106.67 -28.44 10.21 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 0.83999999999999997 110.919 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.77 1.47 55.2 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.859 -0.686 . . . . 0.77000000000000002 112.092 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 19.5 m-20 -107.2 147.38 30.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.493 . . . . 2.1000000000000001 111.812 -178.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.98 2.4 22.78 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.862 -0.895 . . . . 0.55000000000000004 110.862 175.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . 0.416 HG22 ' HB3' ' C' ' 20' ' ' ASP . 13.4 t -72.91 134.64 44.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.659 -0.271 . . . . 1.0600000000000001 110.438 178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 55.62 47.17 21.29 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.53 0.681 . . . . 2.23 109.922 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.427 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.6 p -89.59 148.85 4.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.148 -0.933 . . . . 1.1599999999999999 110.668 -173.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.438 HD12 ' H ' ' C' ' 36' ' ' TRP . 90.4 mt -100.01 155.8 17.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.227 -0.442 . . . . 0.47999999999999998 110.21 -179.747 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.0 mmm180 -114.6 153.82 29.45 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.74 -0.664 . . . . 3.1800000000000002 109.424 178.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -89.39 141.77 28.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.262 0.553 . . . . 0.37 110.433 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.6 p -81.17 -26.62 35.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.801 -0.636 . . . . 0.75 112.168 -177.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' C' ' 56' ' ' CYS . 11.8 m170 -102.61 -14.93 16.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.982 -0.287 . . . . 1.4299999999999999 111.614 -176.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.42 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.1 p -150.95 -174.6 4.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.964 -0.384 . . . . 0.79000000000000004 109.964 178.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.59 115.03 29.75 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.405 -0.362 . . . . 0.46999999999999997 110.227 -178.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -164.56 135.1 4.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.384 -0.371 . . . . 0.40000000000000002 111.043 -177.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.3 111.87 24.44 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.329 -0.619 . . . . 0.45000000000000001 109.329 172.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -156.45 169.95 23.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.003 -0.544 . . . . 0.60999999999999999 110.076 -176.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.427 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 28.5 m170 -106.95 130.75 54.56 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.114 -0.698 . . . . 0.41999999999999998 109.114 173.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.438 ' H ' HD12 ' C' ' 25' ' ' LEU . 42.3 t-105 -59.15 -36.75 75.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.68 -0.691 . . . . 0.68000000000000005 110.092 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -70.67 -25.39 62.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.993 -0.549 . . . . 3.3300000000000001 111.432 -178.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 84.2 m -83.83 -27.36 28.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.801 0.334 . . . . 0.54000000000000004 110.83 178.247 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -89.59 -29.06 19.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.806 0.336 . . . . 0.60999999999999999 110.911 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.46 71.27 76.98 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.058 -0.519 . . . . 0.80000000000000004 110.251 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.86 13.68 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.185 2.59 . . . . 2.1200000000000001 112.64 -176.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.36 4.46 35.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.94 0.4 . . . . 3.2999999999999998 111.397 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.18 17.98 38.21 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.589 -0.815 . . . . 1.46 111.518 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.7 m -74.24 130.04 38.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.832 0.348 . . . . 1.03 110.853 -179.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 6.0 m -88.95 137.91 31.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.716 -0.476 . . . . 1.6000000000000001 109.716 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -72.69 136.5 80.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.877 0.37 . . . . 2.6800000000000002 111.069 -175.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.63 149.34 61.16 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.176 2.584 . . . . 1.1399999999999999 112.653 -175.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.8 18.91 56.3 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.855 -0.688 . . . . 1.8999999999999999 112.443 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 19.4 p -116.33 37.28 3.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.329 0.585 . . . . 2.75 110.471 178.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.62 129.77 6.45 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.786 -0.721 . . . . 0.81999999999999995 111.769 -177.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -71.18 124.01 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.723 -0.473 . . . . 0.87 109.723 -179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -116.35 136.81 52.67 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.172 -0.467 . . . . 2.6499999999999999 110.729 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -73.61 162.64 28.99 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.072 -1.084 . . . . 0.48999999999999999 108.072 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -59.87 -31.96 70.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.838 0.745 . . . . 4.0899999999999999 111.405 -170.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 30.2 t -64.88 -44.88 88.2 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.745 0.307 . . . . 1.54 110.588 179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' C' ' 29' ' ' HIS . 86.7 m -72.75 -17.86 61.56 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.798 0.295 . . . . 0.71999999999999997 111.798 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -89.08 -13.0 39.61 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.482 -0.487 . . . . 1.25 110.192 176.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.11 -125.07 5.69 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.985 -0.626 . . . . 2.1899999999999999 112.025 179.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -131.29 157.81 42.32 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.999 -0.371 . . . . 5.1500000000000004 109.999 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 38.8 t -109.4 130.99 61.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.245 -0.434 . . . . 6.7599999999999998 110.081 -179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' C' ' 62' ' ' PRO . 12.9 p -93.48 131.37 32.68 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.425 -0.352 . . . . 8.8300000000000001 111.525 -179.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 61' ' ' THR . 19.7 Cg_exo -65.5 142.89 73.55 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.648 2.232 . . . . 11.039999999999999 111.237 175.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -66.25 119.03 58.8 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.427 -0.351 . . . . 13.859999999999999 110.613 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 40.5 Cg_exo -56.89 135.35 70.18 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.134 2.556 . . . . 16.550000000000001 112.71 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.84 -0.5 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.096 0.474 . . . . 18.07 110.94 178.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.446 -0.787 . . . . 20.260000000000002 110.128 179.603 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.898 -0.481 . . . . 20.379999999999999 111.898 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.73 28.32 17.76 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.295 0.569 . . . . 18.809999999999999 111.319 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtt -134.06 -64.32 0.7 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.059 -0.519 . . . . 18.059999999999999 110.301 -178.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -86.51 62.71 7.58 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.951 0.405 . . . . 16.829999999999998 110.203 178.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.89 -39.33 97.24 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.837 -0.62 . . . . 14.66 112.227 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -82.06 -55.57 4.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.864 -0.421 . . . . 15.800000000000001 109.864 177.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 51.42 52.18 15.28 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.814 0.816 . . . . 13.130000000000001 109.698 -178.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -137.84 -21.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.897 -1.047 . . . . 11.74 110.572 -175.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . 0.404 HD22 ' N ' ' C' ' 9' ' ' LEU . 2.8 mm? -96.22 54.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.037 -0.529 . . . . 8.7200000000000006 110.416 -176.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.46 136.28 93.18 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.713 -0.676 . . . . 5.9299999999999997 110.282 178.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.44 -17.05 30.72 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.709 2.273 . . . . 5.25 112.582 -177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.99 67.32 0.84 Allowed Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.676 -0.693 . . . . 2.2799999999999998 112.208 179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.64 74.48 2.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.282 0.563 . . . . 2.0699999999999998 110.388 178.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -169.9 146.73 3.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.284 -0.871 . . . . 3.1800000000000002 109.116 -177.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -67.93 104.07 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.829 -0.434 . . . . 0.53000000000000003 109.829 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.45 -3.62 90.6 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.65000000000000002 112.548 -175.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.73 -41.68 54.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.044 0.45 . . . . 1.04 110.543 179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 31.2 p -109.34 -29.23 8.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.948 0.404 . . . . 0.83999999999999997 110.243 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.47 45.04 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.886 -0.673 . . . . 0.77000000000000002 112.252 179.529 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -96.13 147.85 23.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.914 0.387 . . . . 2.1000000000000001 111.142 -177.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.28 15.82 13.08 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.107 -0.568 . . . . 0.55000000000000004 112.531 179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -80.79 127.9 33.04 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.449 -0.204 . . . . 1.0600000000000001 110.449 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.3 t70 58.28 55.62 4.95 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.638 0.732 . . . . 2.23 110.492 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 m -89.39 135.19 26.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.849 -0.614 . . . . 1.1599999999999999 111.124 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -85.15 158.96 20.24 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.361 -0.836 . . . . 0.47999999999999998 109.545 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -117.24 134.77 54.39 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.125 -0.489 . . . . 3.1800000000000002 110.713 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 6.7 t -68.57 138.87 55.46 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.16 -0.682 . . . . 0.37 109.16 177.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.1 p -91.24 -20.88 21.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.204 0.526 . . . . 0.75 110.781 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.75 -24.14 21.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.4299999999999999 110.844 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -150.7 -169.07 3.29 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.434 -0.58 . . . . 0.79000000000000004 109.434 177.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.11 114.86 29.41 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.314 -0.254 . . . . 0.46999999999999997 110.314 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.76 137.54 3.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.25 -0.432 . . . . 0.40000000000000002 110.479 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.64 121.75 45.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.534 0.521 . . . . 0.45000000000000001 109.633 176.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -160.17 173.24 16.06 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.912 0.386 . . . . 0.60999999999999999 111.24 -174.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -105.1 125.31 50.84 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.368 -0.604 . . . . 0.41999999999999998 109.368 173.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -62.04 -31.69 72.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.878 -0.601 . . . . 0.68000000000000005 109.746 177.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.92 -24.22 61.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.796 -0.638 . . . . 3.3300000000000001 111.458 -179.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 96.6 m -88.02 -22.79 24.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.026 0.441 . . . . 0.54000000000000004 110.617 176.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -89.85 -42.65 11.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.158 -0.474 . . . . 0.60999999999999999 111.107 -178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -122.65 147.33 50.26 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.365 -0.38 . . . . 0.80000000000000004 110.794 -175.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.12 170.07 13.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.025 2.483 . . . . 2.1200000000000001 112.074 177.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.07 -18.12 65.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.784 -0.643 . . . . 3.2999999999999998 111.338 -177.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.26 -13.9 82.38 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.838 -0.696 . . . . 1.46 112.161 176.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -92.74 132.55 36.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.796 0.331 . . . . 1.03 110.548 -179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.3 m -88.66 136.24 33.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.283 -0.417 . . . . 1.6000000000000001 110.674 -177.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -81.92 121.81 79.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.78 -0.646 . . . . 2.6800000000000002 110.369 -179.37 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 42.3 Cg_endo -69.81 149.16 66.22 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.419 2.079 . . . . 1.1399999999999999 111.572 177.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.47 -33.48 5.36 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.45 -0.881 . . . . 1.8999999999999999 113.238 -175.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.5 p -105.75 -38.05 6.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.101 0.477 . . . . 2.75 111.501 -178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.94 72.07 0.21 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.768 -0.729 . . . . 0.81999999999999995 112.336 -178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 0.4 OUTLIER -75.41 121.97 23.1 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.288 -0.634 . . . . 0.87 109.288 -179.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -122.56 134.39 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 2.6499999999999999 111.09 -176.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -74.36 176.92 6.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.584 -0.734 . . . . 0.48999999999999999 109.38 173.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 tpm_? -61.13 -37.32 82.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.048 0.386 . . . . 4.0899999999999999 110.292 -177.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 48.4 t -65.06 -51.89 58.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.019 -0.537 . . . . 1.54 110.972 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 77.5 m -71.98 -19.54 61.87 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.552 0.215 . . . . 0.71999999999999997 111.369 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -78.74 -14.09 59.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.114 0.483 . . . . 1.25 109.754 178.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -92.06 69.43 1.87 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.534 -1.026 . . . . 2.1899999999999999 110.534 173.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.43 133.92 33.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.068 0.461 . . . . 5.1500000000000004 111.176 -173.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.11 128.58 67.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.422 -0.808 . . . . 6.7599999999999998 110.198 -178.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 6.8 p -102.16 141.95 23.59 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 116.305 -0.407 . . . . 8.8300000000000001 110.256 176.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.58 145.67 42.42 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.398 2.065 . . . . 11.039999999999999 111.627 176.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.46 138.24 44.74 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.325 -0.398 . . . . 13.859999999999999 110.422 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.98 50.37 2.79 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.83 2.353 . . . . 16.550000000000001 112.333 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.04 85.97 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.842 -0.617 . . . . 18.07 109.609 179.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.702 -0.666 . . . . 20.260000000000002 110.152 -176.775 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 N-CA-C 111.888 -0.485 . . . . 20.379999999999999 111.888 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.2 102.21 6.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.652 0.263 . . . . 18.809999999999999 110.968 -178.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 68.2 mtm 61.05 28.52 18.26 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.595 -0.729 . . . . 18.059999999999999 111.454 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -86.54 154.52 21.02 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.96 -0.385 . . . . 16.829999999999998 109.96 -178.577 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.48 35.0 8.87 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.879 -0.676 . . . . 14.66 111.562 -177.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 59.31 34.27 22.84 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.29 0.567 . . . . 15.800000000000001 110.53 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -86.3 -10.29 54.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.771 -0.649 . . . . 13.130000000000001 110.734 -174.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.6 135.59 37.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.053 -0.521 . . . . 11.74 110.267 178.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.9 tp -91.28 87.17 6.38 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.091 0.472 . . . . 8.7200000000000006 109.965 177.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -79.93 142.65 56.42 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 5.9299999999999997 110.393 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 12.8 Cg_exo -70.96 45.94 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.259 2.64 . . . . 5.25 112.617 177.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.81 6.31 40.76 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.457 -0.657 . . . . 2.2799999999999998 111.457 178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.54 73.48 7.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.268 0.556 . . . . 2.0699999999999998 110.31 179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -158.44 127.88 5.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.515 -0.766 . . . . 3.1800000000000002 109.843 179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 11.2 t -79.68 103.77 9.82 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.258 -0.645 . . . . 0.53000000000000003 109.258 176.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -70.66 -18.4 75.71 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.799 -0.637 . . . . 0.65000000000000002 113.367 -171.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 48.3 t -64.39 -32.78 59.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.735 0.303 . . . . 1.04 111.104 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 32.1 p -118.09 -33.84 4.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.907 0.384 . . . . 0.83999999999999997 110.819 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.62 -13.98 24.94 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.775 -0.726 . . . . 0.77000000000000002 112.24 -179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 11.5 m-20 -87.61 131.6 34.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.921 0.391 . . . . 2.1000000000000001 110.911 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.41 -1.9 33.09 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.314 -0.714 . . . . 0.55000000000000004 111.314 175.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -76.94 135.43 38.76 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 110.081 -0.34 . . . . 1.0600000000000001 110.081 177.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 56.88 45.96 20.53 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.435 0.636 . . . . 2.23 109.784 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.61 150.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.151 -0.931 . . . . 1.1599999999999999 110.048 -175.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.39 146.2 25.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.897 0.379 . . . . 0.47999999999999998 110.242 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -113.92 132.47 55.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.925 -0.579 . . . . 3.1800000000000002 110.165 -175.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -63.52 130.72 45.56 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.658 -0.497 . . . . 0.37 109.658 177.052 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 48.4 p -85.92 -5.81 59.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.153 0.502 . . . . 0.75 110.983 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -108.42 -21.46 12.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.026 -0.534 . . . . 1.4299999999999999 111.209 -178.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.8 p -152.28 -163.51 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.726 -0.472 . . . . 0.79000000000000004 109.726 176.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.56 114.93 29.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 110.161 -0.311 . . . . 0.46999999999999997 110.161 178.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.48 128.47 1.81 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.429 -0.351 . . . . 0.40000000000000002 110.473 -179.625 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.69 112.56 25.6 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.744 0.653 . . . . 0.45000000000000001 109.771 176.34 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -154.72 167.58 29.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.395 -0.366 . . . . 0.60999999999999999 110.339 -176.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.8 m170 -106.06 138.56 42.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.964 -0.754 . . . . 0.41999999999999998 108.964 172.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -61.79 -33.73 74.63 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.755 -0.657 . . . . 0.68000000000000005 110.385 -179.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -74.64 -25.29 59.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 3.3300000000000001 111.452 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.7 m -83.67 -22.77 32.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.124 0.488 . . . . 0.54000000000000004 110.597 179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -96.88 -49.62 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.075 -0.512 . . . . 0.60999999999999999 111.517 -179.034 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.413 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 96.3 m-85 -110.95 149.62 40.7 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-O 120.757 0.313 . . . . 0.80000000000000004 111.003 -173.197 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 16.6 Cg_exo -67.86 158.21 58.33 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.617 2.211 . . . . 2.1200000000000001 110.881 174.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.19 -7.96 34.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.954 -0.566 . . . . 3.2999999999999998 111.521 -177.351 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.18 -12.22 84.57 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.536 -0.626 . . . . 1.46 111.536 174.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 37.5 m -95.15 135.08 37.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.26 -0.274 . . . . 1.03 110.26 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 2.9 p -89.05 136.13 33.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.987 0.422 . . . . 1.6000000000000001 111.257 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -80.96 127.93 72.96 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 2.6800000000000002 110.604 -177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.03 140.47 37.99 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.874 2.383 . . . . 1.1399999999999999 112.046 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -30.43 25.56 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.011 -0.614 . . . . 1.8999999999999999 111.984 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 74.1 1.48 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 120.886 0.374 . . . . 2.75 110.545 -178.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.52 61.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.739 -0.743 . . . . 0.81999999999999995 112.212 179.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 122.7 18.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.938 0.399 . . . . 0.87 110.074 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -117.4 134.33 54.96 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.231 -0.44 . . . . 2.6499999999999999 110.884 -177.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.1 p -81.08 169.67 17.16 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.66 -0.867 . . . . 0.48999999999999999 108.66 171.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -51.94 -47.17 64.86 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 123.415 0.447 . . . . 4.0899999999999999 111.419 -174.19 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 21.7 m -63.72 -45.05 91.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.917 -0.583 . . . . 1.54 111.762 -176.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 95.6 m -71.77 -31.11 66.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.71999999999999997 111.433 -178.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 44.5 p -85.41 7.23 23.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.718 -0.219 . . . . 1.25 111.026 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.69 91.38 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.22 -0.514 . . . . 2.1899999999999999 113.115 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -105.59 121.34 43.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.33 -0.618 . . . . 5.1500000000000004 109.33 176.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.57 126.4 42.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.086 0.469 . . . . 6.7599999999999998 110.414 -178.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.1 p -91.42 119.12 68.72 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.059 -0.519 . . . . 8.8300000000000001 110.838 179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -75.72 144.14 27.64 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.575 2.183 . . . . 11.039999999999999 111.963 178.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.37 132.83 51.59 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.189 -0.459 . . . . 13.859999999999999 110.446 -179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.85 108.13 1.03 Allowed 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.65 2.233 . . . . 16.550000000000001 111.977 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -92.81 99.53 9.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.942 -0.572 . . . . 18.07 110.207 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.616 -0.707 . . . . 20.260000000000002 109.724 179.674 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.798 -0.521 . . . . 20.379999999999999 111.798 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.42 126.02 34.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.798 0.332 . . . . 18.809999999999999 110.86 -178.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 88.9 mtp -116.84 114.02 23.32 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.226 -0.443 . . . . 18.059999999999999 110.128 -179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.85 -20.68 57.93 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.951 0.405 . . . . 16.829999999999998 110.781 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.43 172.29 30.22 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.508 -0.637 . . . . 14.66 111.508 177.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 64.15 17.07 10.46 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.704 0.402 . . . . 15.800000000000001 111.175 179.084 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -80.81 -21.52 40.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.169 0.509 . . . . 13.130000000000001 110.7 -177.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.23 -1.22 48.63 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.472 -0.785 . . . . 11.74 109.611 177.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 94.3 mt -128.02 45.36 2.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.117 -0.947 . . . . 8.7200000000000006 109.305 179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.42 142.48 92.16 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.365 -0.834 . . . . 5.9299999999999997 110.77 -177.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.46 25.11 0.23 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.296 2.664 . . . . 5.25 113.566 -178.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 70.11 23.8 76.95 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 2.2799999999999998 111.969 -178.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.522 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -103.09 74.18 1.28 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.999 0.428 . . . . 2.0699999999999998 110.496 -177.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.413 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 56.4 ttp180 -157.87 129.04 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.935 -0.575 . . . . 3.1800000000000002 110.746 -178.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -69.37 111.79 5.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.899 -0.592 . . . . 0.53000000000000003 109.938 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -59.42 -31.94 71.51 Favored Glycine 0 N--CA 1.451 -0.301 0 O-C-N 123.477 0.486 . . . . 0.65000000000000002 113.128 -177.157 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.34 -37.54 79.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.87 0.366 . . . . 1.04 110.923 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.5 m -95.43 -39.95 9.74 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.256 0.465 . . . . 0.83999999999999997 112.256 -175.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.86 6.41 65.44 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.73 -0.748 . . . . 0.77000000000000002 111.423 -174.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -119.82 149.1 42.61 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.793 0.33 . . . . 2.1000000000000001 110.434 -178.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -107.62 12.25 38.99 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.55000000000000004 112.943 -177.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 72.1 m -80.13 128.06 33.05 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 122.665 -0.315 . . . . 1.0600000000000001 111.085 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t0 59.06 51.11 7.4 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.493 -0.776 . . . . 2.23 111.161 177.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -90.15 145.31 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.613 -0.721 . . . . 1.1599999999999999 111.227 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 78.0 mt -101.11 143.98 30.56 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.275 -0.875 . . . . 0.47999999999999998 109.175 175.046 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 137.2 49.56 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.637 0.256 . . . . 3.1800000000000002 110.465 -178.571 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.2 t -64.57 135.21 55.74 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.9 -0.778 . . . . 0.37 108.9 176.053 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.16 -19.02 29.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.181 0.515 . . . . 0.75 110.88 -178.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -97.47 -18.08 19.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.4299999999999999 111.332 -177.111 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.6 p -151.53 -168.6 3.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.288 -0.634 . . . . 0.79000000000000004 109.288 176.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.25 114.89 29.44 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.663 0.268 . . . . 0.46999999999999997 110.603 -178.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -172.13 136.61 0.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.001 -0.545 . . . . 0.40000000000000002 109.936 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -122.05 122.83 40.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.296 0.372 . . . . 0.45000000000000001 110.004 177.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -160.07 169.51 23.23 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.033 -0.53 . . . . 0.60999999999999999 110.294 -176.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.762 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.3 m170 -95.91 130.68 42.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.002 -1.111 . . . . 0.41999999999999998 108.002 171.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -56.12 -37.28 69.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.684 -0.689 . . . . 0.68000000000000005 111.684 -177.33 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -72.17 -15.15 61.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.291 -0.413 . . . . 3.3300000000000001 111.614 -177.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.6 m -90.89 -22.52 20.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.197 -0.456 . . . . 0.54000000000000004 110.676 -178.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -94.19 -40.78 9.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 0.60999999999999999 110.494 175.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -120.72 79.55 31.29 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.054 -0.521 . . . . 0.80000000000000004 110.178 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -83.55 11.34 3.33 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.814 2.342 . . . . 2.1200000000000001 112.862 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.92 0.76 52.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.275 -0.42 . . . . 3.2999999999999998 111.187 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.05 23.77 37.03 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.731 -0.747 . . . . 1.46 111.661 -176.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -61.88 149.52 40.15 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 122.606 0.362 . . . . 1.03 110.67 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -87.74 121.7 30.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.74 0.305 . . . . 1.6000000000000001 110.524 -176.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 11.5 ttp180 -64.48 120.39 64.98 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.828 -0.624 . . . . 2.6800000000000002 110.967 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 17.4 Cg_exo -65.14 132.26 31.28 Favored 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.431 2.088 . . . . 1.1399999999999999 111.703 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.53 -15.95 38.69 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.787 -0.721 . . . . 1.8999999999999999 111.835 179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 22.3 p -97.07 37.3 1.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 2.75 111.003 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.55 113.5 2.17 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.903 -0.665 . . . . 0.81999999999999995 111.829 -179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -82.85 123.52 29.45 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.735 -0.468 . . . . 0.87 109.735 -177.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -112.19 148.04 34.9 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.046 0.45 . . . . 2.6499999999999999 110.724 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 22.0 p -93.9 178.01 5.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.105 -0.702 . . . . 0.48999999999999999 109.105 175.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -58.73 -33.47 70.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.886 0.312 . . . . 4.0899999999999999 111.142 -177.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 7.8 m -69.77 -51.56 32.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.885 0.374 . . . . 1.54 111.24 179.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -71.98 -17.72 62.04 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.319 -0.4 . . . . 0.71999999999999997 111.341 -177.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -92.23 -1.23 57.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.48 . . . . 1.25 110.283 173.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.12 89.97 1.1 Allowed Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.921 -0.581 . . . . 2.1899999999999999 112.04 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -88.93 -5.91 57.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.216 0.531 . . . . 5.1500000000000004 110.395 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.8 m -88.74 72.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.532 -0.758 . . . . 6.7599999999999998 110.916 -177.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 29.8 m -67.67 122.16 82.28 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.314 -0.857 . . . . 8.8300000000000001 110.155 179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.99 139.87 89.93 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.766 2.311 . . . . 11.039999999999999 112.173 -177.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.16 138.99 78.86 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.708 -0.678 . . . . 13.859999999999999 110.478 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.1 38.02 0.66 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.873 2.382 . . . . 16.550000000000001 112.136 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.9 116.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.773 -0.649 . . . . 18.07 109.695 -179.114 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.366 -0.826 . . . . 20.260000000000002 109.736 -179.993 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 112.102 -0.399 . . . . 20.379999999999999 112.102 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.35 87.54 4.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.014 0.435 . . . . 18.809999999999999 110.433 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 26.3 mmt -93.96 -37.04 11.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.927 -0.579 . . . . 18.059999999999999 110.027 179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -71.21 137.67 48.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.537 -0.756 . . . . 16.829999999999998 109.941 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.61 -43.03 3.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.984 -0.626 . . . . 14.66 112.056 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -66.19 -36.26 82.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.095 0.474 . . . . 15.800000000000001 110.345 178.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -103.8 162.33 13.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.849 -0.614 . . . . 13.130000000000001 110.355 178.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -123.26 103.82 8.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.731 -0.47 . . . . 11.74 109.731 176.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.0 107.38 8.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.245 -0.434 . . . . 8.7200000000000006 111.093 -177.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -86.11 128.17 58.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.757 -0.656 . . . . 5.9299999999999997 109.822 176.143 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 12.7 Cg_exo -70.2 80.95 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.733 2.288 . . . . 5.25 112.558 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.56 128.94 33.23 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.57 -0.824 . . . . 2.2799999999999998 111.261 174.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 75.93 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.235 0.541 . . . . 2.0699999999999998 111.104 -177.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -130.31 145.24 51.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.886 -0.597 . . . . 3.1800000000000002 110.145 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 t -63.15 106.12 0.81 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.53000000000000003 109.515 175.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.37 -31.61 57.02 Favored Glycine 0 CA--C 1.517 0.207 0 O-C-N 123.41 0.444 . . . . 0.65000000000000002 113.492 -175.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.03 -34.44 70.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.074 0.464 . . . . 1.04 111.043 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.7 m -101.81 -38.14 7.97 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.052 0.39 . . . . 0.83999999999999997 112.052 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.96 -9.2 59.81 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.585 -0.606 . . . . 0.77000000000000002 111.585 -175.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.41 146.18 37.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.954 0.407 . . . . 2.1000000000000001 111.191 -177.348 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.13 12.96 40.75 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.067 -0.813 . . . . 0.55000000000000004 111.067 174.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -73.94 128.55 35.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.312 -0.444 . . . . 1.0600000000000001 110.375 178.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 55.57 47.13 21.47 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.669 0.747 . . . . 2.23 109.651 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -95.04 153.78 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.25 -0.887 . . . . 1.1599999999999999 110.744 -174.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -107.48 144.26 34.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.188 -0.46 . . . . 0.47999999999999998 109.834 176.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -111.45 144.64 40.33 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.124 -0.489 . . . . 3.1800000000000002 110.166 -179.789 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 9.1 t -68.51 140.11 55.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.393 -0.595 . . . . 0.37 109.393 177.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 43.5 p -90.43 -18.65 25.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.897 0.379 . . . . 0.75 110.895 179.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 -92.83 -24.2 18.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 1.4299999999999999 111.077 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.462 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 8.3 p -150.38 -173.1 4.35 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.036 -0.727 . . . . 0.79000000000000004 109.036 178.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -100.93 118.76 37.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.582 0.229 . . . . 0.46999999999999997 110.437 -178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.24 135.99 1.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.40000000000000002 110.233 -177.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.33 112.76 22.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.16 -0.473 . . . . 0.45000000000000001 110.11 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -153.99 166.61 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.062 -0.517 . . . . 0.60999999999999999 109.873 -177.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.763 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.3 m170 -97.71 140.32 32.27 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.638 -0.875 . . . . 0.41999999999999998 108.638 173.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -49.18 -53.5 20.85 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.413 0.446 . . . . 0.68000000000000005 111.615 -175.333 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -72.34 -5.55 37.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.472 . . . . 3.3300000000000001 112.136 -173.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.5 m -91.45 -21.26 21.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.896 0.379 . . . . 0.54000000000000004 110.63 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -108.4 -29.5 8.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.292 -0.413 . . . . 0.60999999999999999 110.941 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -122.62 138.55 29.54 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.083 -0.508 . . . . 0.80000000000000004 110.511 -177.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.5 148.6 93.07 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.544 2.162 . . . . 2.1200000000000001 111.068 173.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 -18.76 59.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.597 -0.729 . . . . 3.2999999999999998 112.079 -174.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 -16.51 71.14 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.087 -0.578 . . . . 1.46 111.853 175.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.1 m -90.59 130.77 36.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.498 -0.556 . . . . 1.03 109.498 176.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 18.2 m -88.43 143.54 26.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.937 0.398 . . . . 1.6000000000000001 110.993 -174.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.34 125.2 86.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.733 -0.667 . . . . 2.6800000000000002 110.789 -177.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.08 163.5 39.02 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 123.044 2.496 . . . . 1.1399999999999999 112.413 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -125.27 7.1 8.08 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.853 -0.689 . . . . 1.8999999999999999 111.92 177.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.0 t -108.92 -1.82 18.79 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.897 0.38 . . . . 2.75 110.856 -178.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.74 120.87 0.98 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 121.025 -0.607 . . . . 0.81999999999999995 111.673 -177.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.38 122.68 25.49 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.771 -0.455 . . . . 0.87 109.771 -178.162 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.6 mtm180 -111.17 134.9 52.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.436 -0.347 . . . . 2.6499999999999999 110.937 -178.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -75.69 166.56 23.36 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.614 -0.884 . . . . 0.48999999999999999 108.614 170.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -63.42 -30.54 71.65 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.744 . . . . 4.0899999999999999 110.871 -172.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' C' ' 59' ' ' ASP . 17.4 m -65.12 -45.23 85.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.461 -0.336 . . . . 1.54 110.927 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.1 m -72.76 -31.2 64.74 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.9 0.333 . . . . 0.71999999999999997 111.9 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 50.5 p -83.53 -1.62 54.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.894 0.378 . . . . 1.25 111.542 -177.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.4 98.74 2.46 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.875 -0.678 . . . . 2.1899999999999999 111.608 -178.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' C' ' 55' ' ' SER . 33.0 t70 -88.82 86.77 7.03 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.625 0.726 . . . . 5.1500000000000004 110.344 -177.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.53 136.26 11.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.651 -1.159 . . . . 6.7599999999999998 108.842 177.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.0 p -73.45 117.63 62.13 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.348 . . . . 8.8300000000000001 111.055 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.4 139.77 21.09 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.393 2.062 . . . . 11.039999999999999 111.56 177.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.89 124.51 85.29 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 13.859999999999999 110.744 -178.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.07 64.8 4.21 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.861 2.374 . . . . 16.550000000000001 112.105 178.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.64 16.9 7.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 18.07 110.907 -178.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.446 -0.788 . . . . 20.260000000000002 110.615 -177.439 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.745 0 N-CA-C 112.054 -0.418 . . . . 20.379999999999999 112.054 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.85 83.9 2.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 18.809999999999999 110.668 179.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' C' ' 7' ' ' GLN . 16.0 tpt -75.73 -58.49 3.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.069 -0.514 . . . . 18.059999999999999 110.342 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -66.49 -29.49 69.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.095 -0.502 . . . . 16.829999999999998 110.575 -178.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.99 -26.85 67.84 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.979 -0.555 . . . . 14.66 112.567 178.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -97.48 5.47 49.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 15.800000000000001 111.094 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' C' ' 3' ' ' MET . 28.4 mt-30 -92.5 33.37 1.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 13.130000000000001 110.825 -179.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -80.47 -8.49 59.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.332 0.587 . . . . 11.74 110.095 177.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -104.06 78.24 1.5 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.697 -0.683 . . . . 8.7200000000000006 109.595 176.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' C' ' 12' ' ' GLY . . . -64.95 124.9 87.93 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.235 -0.439 . . . . 5.9299999999999997 110.963 -177.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.05 26.35 0.26 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.92 2.414 . . . . 5.25 113.071 178.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' C' ' 10' ' ' ALA . . . -81.98 -40.88 10.0 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.68 -0.568 . . . . 2.2799999999999998 111.68 179.187 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.62 75.09 0.97 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.29 0.567 . . . . 2.0699999999999998 109.715 175.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' C' ' 19' ' ' GLY . 49.1 ttp180 -134.38 146.15 49.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.663 -0.699 . . . . 3.1800000000000002 109.88 -177.248 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 31.3 t -70.91 103.0 2.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.084 -0.71 . . . . 0.53000000000000003 109.084 176.021 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.12 1.8 83.6 Favored Glycine 0 CA--C 1.509 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.65000000000000002 112.748 -174.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 32.0 t -77.17 -28.72 16.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.096 0.474 . . . . 1.04 110.091 178.156 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 28.9 p -123.6 -35.46 2.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.995 -0.548 . . . . 0.83999999999999997 111.019 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' C' ' 14' ' ' ARG . . . 109.91 2.51 30.23 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.962 -0.637 . . . . 0.77000000000000002 112.266 -178.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 8.7 m-20 -107.39 140.44 40.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.931 0.396 . . . . 2.1000000000000001 111.232 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.59 -1.99 30.8 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.55000000000000004 111.522 175.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -74.86 135.19 41.56 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.059 -0.349 . . . . 1.0600000000000001 110.059 178.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.34 41.05 16.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.927 0.394 . . . . 2.23 110.277 -177.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.483 ' HA ' ' CD2' ' C' ' 35' ' ' HIS . 3.9 p -88.29 146.05 6.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.102 -0.499 . . . . 1.1599999999999999 110.636 -174.162 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 77.1 mt -105.96 159.29 16.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.029 -0.532 . . . . 0.47999999999999998 110.379 -177.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 14.0 mmt180 -126.39 143.18 51.26 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.726 -0.67 . . . . 3.1800000000000002 109.717 -178.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 35.3 t -70.63 146.53 49.97 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 119.864 -0.734 . . . . 0.37 109.066 173.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.464 HG21 ' HA2' ' C' ' 50' ' ' GLY . 28.7 p -84.79 -27.0 27.14 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.101 0.477 . . . . 0.75 110.812 177.276 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -98.4 -12.4 21.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.066 -0.515 . . . . 1.4299999999999999 111.091 -179.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 m -139.55 172.76 12.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.033 0.444 . . . . 0.79000000000000004 110.279 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.99 113.69 27.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.659 -0.7 . . . . 0.46999999999999997 109.388 174.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.12 134.74 3.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.485 -0.325 . . . . 0.40000000000000002 110.601 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -100.72 111.98 24.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.759 -0.655 . . . . 0.45000000000000001 109.57 175.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -155.06 164.71 38.5 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.0 -0.545 . . . . 0.60999999999999999 110.23 -176.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.483 ' CD2' ' HA ' ' C' ' 24' ' ' VAL . 32.5 m170 -104.63 138.57 40.76 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.598 -0.519 . . . . 0.41999999999999998 109.598 174.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 59.7 t-105 -63.93 -34.46 78.01 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.76 -0.655 . . . . 0.68000000000000005 109.74 178.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -76.64 -15.51 59.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.586 . . . . 3.3300000000000001 111.072 -179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 97.8 m -92.29 -22.45 19.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.113 0.482 . . . . 0.54000000000000004 110.507 176.35 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -93.96 -41.82 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.843 -0.617 . . . . 0.60999999999999999 111.632 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -119.95 147.32 44.1 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.985 -0.552 . . . . 0.80000000000000004 111.242 -171.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.76 164.33 27.22 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 123.003 2.468 . . . . 2.1200000000000001 111.503 174.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.05 -15.54 62.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.634 -0.712 . . . . 3.2999999999999998 112.184 -174.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -80.64 -10.23 85.46 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.809 -0.71 . . . . 1.46 112.459 178.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.4 m -87.19 137.5 32.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.856 0.36 . . . . 1.03 110.72 -178.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 17.0 m -89.65 131.82 35.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.328 -0.396 . . . . 1.6000000000000001 110.841 -177.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -89.94 123.15 66.85 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.994 -0.548 . . . . 2.6800000000000002 110.915 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.78 133.63 22.29 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.325 2.017 . . . . 1.1399999999999999 111.266 174.192 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.42 -47.06 10.98 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.1 -0.571 . . . . 1.8999999999999999 112.961 -174.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -118.96 60.08 0.82 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.133 0.492 . . . . 2.75 110.779 -177.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' C' ' 28' ' ' THR . . . 164.07 57.17 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.356 -0.698 . . . . 0.81999999999999995 111.356 -177.24 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.52 124.98 25.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.374 0.607 . . . . 0.87 110.587 -176.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -106.37 145.56 31.55 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.625 -0.716 . . . . 2.6499999999999999 110.602 -177.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 21.4 p -89.66 -169.37 2.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.064 -0.516 . . . . 0.48999999999999999 109.998 178.001 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -59.7 -53.0 63.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.574 0.226 . . . . 4.0899999999999999 110.84 -179.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 41.4 t -61.22 -42.92 99.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.54 110.971 -178.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.19 -16.93 62.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.105 0.409 . . . . 0.71999999999999997 112.105 -176.582 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 43.5 m -101.1 4.73 42.45 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.072 0.463 . . . . 1.25 110.627 177.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.7 -134.59 7.91 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.847 -0.692 . . . . 2.1899999999999999 112.115 -179.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -91.44 84.01 5.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.994 0.426 . . . . 5.1500000000000004 110.299 -178.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -89.38 110.29 21.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.917 -0.583 . . . . 6.7599999999999998 110.279 179.367 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' C' ' 62' ' ' PRO . 8.4 p -67.29 109.62 3.93 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 123.453 0.471 . . . . 8.8300000000000001 110.74 177.053 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' C' ' 61' ' ' THR . 6.4 Cg_exo -74.11 134.16 19.05 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.7 2.267 . . . . 11.039999999999999 112.509 -176.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.38 144.38 53.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.784 -0.644 . . . . 13.859999999999999 109.787 175.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.21 92.86 0.34 Allowed 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.62 2.214 . . . . 16.550000000000001 112.198 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.7 2.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 18.07 111.542 -177.534 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.666 -0.683 . . . . 20.260000000000002 110.409 -178.853 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.934 -0.466 . . . . 20.379999999999999 111.934 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.61 -167.77 1.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.051 -0.351 . . . . 18.809999999999999 110.051 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -57.87 -64.41 0.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.856 -0.424 . . . . 18.059999999999999 109.856 175.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 61.89 178.96 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.543 0.687 . . . . 16.829999999999998 112.119 173.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.31 131.72 1.42 Allowed Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.731 -0.668 . . . . 14.66 111.76 179.493 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -125.74 51.88 1.7 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.015 0.436 . . . . 15.800000000000001 110.499 179.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -147.56 160.78 42.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.195 0.522 . . . . 13.130000000000001 111.439 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -144.3 -54.05 0.34 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.488 -0.778 . . . . 11.74 109.048 177.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 83.4 mt -103.63 151.24 23.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.795 . . . . 8.7200000000000006 109.402 174.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.17 121.64 70.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 120.945 -0.302 . . . . 5.9299999999999997 110.206 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.77 -14.06 38.28 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.536 2.157 . . . . 5.25 112.259 -178.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.53 -17.38 73.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.925 -0.655 . . . . 2.2799999999999998 111.952 178.163 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.82 98.23 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.001 0.429 . . . . 2.0699999999999998 110.216 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.05 164.97 31.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.012 -0.54 . . . . 3.1800000000000002 109.825 -179.249 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 39.6 t -65.37 105.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.713 -0.477 . . . . 0.53000000000000003 109.713 177.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.31 -27.89 66.17 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.268 -0.492 . . . . 0.65000000000000002 112.901 -177.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -32.19 56.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.893 0.378 . . . . 1.04 110.97 179.467 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -106.71 -37.83 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.83999999999999997 111.91 -176.072 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.58 -23.63 35.4 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.317 -0.713 . . . . 0.77000000000000002 111.317 -174.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -86.79 148.93 25.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 2.1000000000000001 111.027 -178.753 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.82 12.71 35.04 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.55000000000000004 111.888 177.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 47.8 m -73.9 124.25 25.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.373 0.13 . . . . 1.0600000000000001 111.174 179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 55.69 66.76 1.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 124.072 0.857 . . . . 2.23 111.118 177.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 m -108.48 142.3 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.945 -0.57 . . . . 1.1599999999999999 111.362 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.475 HD12 ' HB2' ' C' ' 36' ' ' TRP . 34.4 mt -82.27 144.35 30.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.745 -0.662 . . . . 0.47999999999999998 110.51 178.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.43 145.81 29.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.576 -0.738 . . . . 3.1800000000000002 110.307 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.3 t -85.14 136.75 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.666 -0.494 . . . . 0.37 109.666 178.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -88.56 -5.19 58.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.92 0.39 . . . . 0.75 111.648 -178.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -113.72 -20.21 11.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 1.4299999999999999 110.812 -178.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.82 -171.95 4.07 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.157 -0.682 . . . . 0.79000000000000004 109.157 179.007 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.69 115.04 29.8 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.691 -0.485 . . . . 0.46999999999999997 109.691 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -160.45 155.39 24.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.311 -0.404 . . . . 0.40000000000000002 110.619 -178.041 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.13 124.59 17.98 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.872 -0.604 . . . . 0.45000000000000001 109.979 178.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -163.84 161.08 22.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.471 -0.331 . . . . 0.60999999999999999 110.354 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.71 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.91 127.54 36.03 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.373 -0.973 . . . . 0.41999999999999998 108.373 172.606 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.475 ' HB2' HD12 ' C' ' 25' ' ' LEU . 68.1 t-105 -45.58 -53.51 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.483 0.489 . . . . 0.68000000000000005 112.01 -174.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -60.37 -30.22 69.42 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.125 0.417 . . . . 3.3300000000000001 112.125 -174.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.1 m -73.54 -22.46 60.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.101 0.477 . . . . 0.54000000000000004 111.004 -177.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -103.29 -44.98 5.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.015 -0.539 . . . . 0.60999999999999999 110.935 178.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 88.3 m-85 -116.82 122.74 31.12 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 115.983 -0.553 . . . . 0.80000000000000004 110.217 -176.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.5 176.59 5.59 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 2.1200000000000001 111.853 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.69 -10.79 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.65 . . . . 3.2999999999999998 112.047 -174.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.95 -26.08 74.78 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.872 -0.68 . . . . 1.46 111.713 174.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 41.7 m -101.73 135.45 43.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.226 -0.287 . . . . 1.03 110.226 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.3 t -89.17 154.53 20.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.767 0.318 . . . . 1.6000000000000001 110.332 -178.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -88.36 112.23 48.48 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.964 -0.562 . . . . 2.6800000000000002 110.757 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.62 142.78 44.99 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.838 2.358 . . . . 1.1399999999999999 111.909 177.466 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.13 -32.4 23.33 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 111.463 -0.655 . . . . 1.8999999999999999 111.463 176.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 17.0 p -125.64 150.91 47.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.93 -0.396 . . . . 2.75 109.93 176.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.43 39.6 80.11 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.65 -0.786 . . . . 0.81999999999999995 111.971 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -62.79 124.77 21.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.557 -0.534 . . . . 0.87 109.557 179.37 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -117.31 148.17 41.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.156 -0.475 . . . . 2.6499999999999999 110.81 -177.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -83.25 -176.68 6.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.814 -0.63 . . . . 0.48999999999999999 109.458 173.381 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -63.04 -39.47 94.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.104 0.478 . . . . 4.0899999999999999 110.286 -178.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 36.3 t -66.23 -53.98 30.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.889 -0.596 . . . . 1.54 111.142 -178.212 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.92 -17.1 62.12 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.453 0.538 . . . . 0.71999999999999997 112.453 -175.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -108.21 19.62 19.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.053 0.454 . . . . 1.25 110.345 -179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.69 -126.37 2.75 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.185 -1.007 . . . . 2.1899999999999999 112.587 -178.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -88.95 -6.7 57.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.495 0.664 . . . . 5.1500000000000004 111.111 -172.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.3 t -98.04 137.73 24.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.745 -0.662 . . . . 6.7599999999999998 110.827 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 25.6 m -107.43 105.63 56.38 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.501 -0.555 . . . . 8.8300000000000001 109.501 174.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.09 138.94 37.89 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 11.039999999999999 112.99 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.97 127.86 50.13 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.815 -0.63 . . . . 13.859999999999999 109.72 175.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.43 58.6 4.52 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 122.603 2.202 . . . . 16.550000000000001 111.848 179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -89.09 132.15 34.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.255 0.55 . . . . 18.07 110.994 -176.458 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.395 -0.812 . . . . 20.260000000000002 109.169 176.786 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 112.197 -0.361 . . . . 20.379999999999999 112.197 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.67 -14.08 26.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.85 0.357 . . . . 18.809999999999999 111.268 -178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -157.53 -175.15 5.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.351 -0.386 . . . . 18.059999999999999 110.079 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 67.37 55.12 0.67 Allowed 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.7 0.625 . . . . 16.829999999999998 110.282 178.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.87 156.73 33.2 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.792 -0.718 . . . . 14.66 112.019 178.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . 0.479 ' HA ' ' OE1' ' C' ' 6' ' ' GLN . 5.7 tp60 55.06 55.15 7.99 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.496 0.665 . . . . 15.800000000000001 110.752 -179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -84.71 103.34 13.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.51 -0.768 . . . . 13.130000000000001 109.912 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -76.12 72.14 2.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.441 0.638 . . . . 11.74 110.893 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 58.3 tp -152.84 135.0 14.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.267 -0.879 . . . . 8.7200000000000006 109.063 175.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' C' ' 13' ' ' ALA . . . -84.24 122.95 75.65 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.911 -0.403 . . . . 5.9299999999999997 109.911 176.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 30.8 Cg_exo -62.69 106.78 0.54 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.827 2.352 . . . . 5.25 112.206 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.38 24.67 18.17 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.049 -0.596 . . . . 2.2799999999999998 112.626 178.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' C' ' 10' ' ' ALA . . . -83.63 73.18 10.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.376 0.608 . . . . 2.0699999999999998 110.986 -179.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -171.36 153.18 3.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.992 -1.114 . . . . 3.1800000000000002 107.992 175.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 40.7 t -58.04 106.72 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.51 0.195 . . . . 0.53000000000000003 110.688 -176.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.42 -28.54 73.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.244 -0.503 . . . . 0.65000000000000002 112.619 -178.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 90.6 t -64.49 -39.47 85.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.05 0.453 . . . . 1.04 110.744 178.663 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.46 -21.44 17.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.197 -0.456 . . . . 0.83999999999999997 111.619 -177.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.09 24.87 74.91 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.946 -0.862 . . . . 0.77000000000000002 110.946 -174.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.34 144.92 30.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.515 -0.342 . . . . 2.1000000000000001 110.189 -172.263 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.13 24.92 9.06 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.55000000000000004 112.853 -178.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.0 m -80.25 129.56 34.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.736 -0.468 . . . . 1.0600000000000001 109.736 176.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 31.7 t70 55.24 56.01 6.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.718 0.771 . . . . 2.23 109.728 -179.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 p -102.86 148.73 7.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.35 -0.841 . . . . 1.1599999999999999 110.809 -172.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 96.1 mt -94.64 150.79 19.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.248 -0.433 . . . . 0.47999999999999998 110.544 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.2 mmt180 -117.3 152.14 35.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.793 -0.64 . . . . 3.1800000000000002 110.191 -177.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.564 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 17.9 t -81.72 138.75 35.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.654 -0.499 . . . . 0.37 109.654 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.5 p -81.7 -23.23 36.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.585 -0.28 . . . . 0.75 111.726 -177.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -103.52 -18.7 14.66 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.939 0.348 . . . . 1.4299999999999999 111.939 -176.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.564 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.4 p -150.71 -173.89 4.61 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.626 -0.509 . . . . 0.79000000000000004 109.626 177.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.32 125.36 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.566 0.222 . . . . 0.46999999999999997 110.455 -178.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -166.83 151.46 7.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.40000000000000002 110.22 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -137.63 112.6 9.05 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.461 0.476 . . . . 0.45000000000000001 110.19 178.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.59 165.6 36.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.039 -0.528 . . . . 0.60999999999999999 110.094 -178.359 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.755 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.5 m170 -98.27 132.77 43.48 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.328 -0.99 . . . . 0.41999999999999998 108.328 171.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.3 t-105 -47.49 -53.49 14.15 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.306 0.484 . . . . 0.68000000000000005 112.306 -173.142 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -70.47 -20.85 62.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.854 0.359 . . . . 3.3300000000000001 111.783 -173.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.755 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.7 m -74.16 -27.17 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.173 0.511 . . . . 0.54000000000000004 110.102 177.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . 0.456 ' O ' ' HD3' ' C' ' 41' ' ' PRO . 1.2 m170 -93.26 -51.3 5.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.687 -0.688 . . . . 0.60999999999999999 110.535 176.416 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -111.71 91.37 14.65 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.793 -0.639 . . . . 0.80000000000000004 110.404 -177.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' C' ' 39' ' ' HIS . 83.1 Cg_endo -97.32 3.48 1.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.957 2.438 . . . . 2.1200000000000001 112.358 176.208 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.08 -0.71 55.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.898 -0.592 . . . . 3.2999999999999998 112.286 -172.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.76 41.51 2.88 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.408 -0.901 . . . . 1.46 112.367 179.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.923 -0.399 . . . . 1.03 109.923 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 20.1 m -88.01 122.45 31.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.669 0.271 . . . . 1.6000000000000001 110.567 -177.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -69.68 112.86 13.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 2.6800000000000002 111.117 -178.108 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . 0.426 ' HG2' ' HA ' ' C' ' 51' ' ' LEU . 55.2 Cg_endo -72.18 143.22 39.38 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.361 2.041 . . . . 1.1399999999999999 112.141 177.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.55 -11.94 54.64 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.859 -0.686 . . . . 1.8999999999999999 112.173 178.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 14.4 p -95.28 -70.63 0.7 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.374 0.607 . . . . 2.75 111.461 -179.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.56 77.07 0.24 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.683 -0.69 . . . . 0.81999999999999995 112.445 -179.41 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.426 ' HA ' ' HG2' ' C' ' 47' ' ' PRO . 1.4 tm? -70.94 123.08 21.2 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.11 -0.7 . . . . 0.87 109.11 177.104 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -112.91 146.92 38.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 2.6499999999999999 110.91 -176.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 21.1 p -83.57 -174.27 5.19 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.649 -0.871 . . . . 0.48999999999999999 108.649 170.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' C' ' 54' ' ' ARG . 43.7 ttp180 -67.89 -43.89 78.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.495 -0.482 . . . . 4.0899999999999999 110.101 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -59.32 -49.5 77.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.813 -0.63 . . . . 1.54 111.183 -178.091 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 87.2 m -70.41 -16.33 62.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.803 0.335 . . . . 0.71999999999999997 111.557 -177.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 35.5 m -90.2 -8.75 50.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 1.25 110.445 176.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.34 -64.98 0.45 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.981 -0.628 . . . . 2.1899999999999999 112.211 -178.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -93.84 123.75 37.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.314 0.578 . . . . 5.1500000000000004 110.386 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 8.7 p -150.33 137.07 12.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.698 -0.683 . . . . 6.7599999999999998 110.118 179.069 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 46.3 m -78.99 118.04 70.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.219 -0.446 . . . . 8.8300000000000001 110.575 179.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.72 154.41 59.24 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.405 2.07 . . . . 11.039999999999999 112.196 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.39 130.21 42.5 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.909 -0.587 . . . . 13.859999999999999 110.302 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.71 112.03 1.07 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.634 2.223 . . . . 16.550000000000001 111.81 179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.93 148.64 29.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.185 -0.462 . . . . 18.07 110.299 -176.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.534 -0.746 . . . . 20.260000000000002 110.571 -178.764 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 CA-C-O 120.134 -0.259 . . . . 20.379999999999999 112.702 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.67 43.65 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.978 0.418 . . . . 18.809999999999999 111.473 179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 21.5 ptm -148.57 113.28 5.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.34 0.59 . . . . 18.059999999999999 110.933 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -85.57 -60.56 1.99 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.739 -0.664 . . . . 16.829999999999998 109.898 176.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.51 60.74 0.6 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.589 -0.732 . . . . 14.66 111.369 178.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -105.46 62.65 0.68 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.236 0.541 . . . . 15.800000000000001 109.907 -176.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -127.85 51.34 1.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.822 -0.626 . . . . 13.130000000000001 110.675 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.32 107.74 5.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.999 -0.546 . . . . 11.74 109.969 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 79.7 mt -80.58 79.51 7.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.187 0.518 . . . . 8.7200000000000006 110.784 -178.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.83 123.22 88.84 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.558 -0.747 . . . . 5.9299999999999997 110.127 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 24.4 Cg_exo -63.38 -44.71 13.75 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.601 2.201 . . . . 5.25 111.8 177.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.57 -56.62 3.38 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.376 -0.829 . . . . 2.2799999999999998 113.195 175.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.92 121.9 26.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.122 0.487 . . . . 2.0699999999999998 111.56 -175.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -157.53 145.54 18.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.864 -0.791 . . . . 3.1800000000000002 108.864 177.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.3 t -71.45 103.47 2.94 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.553 -0.536 . . . . 0.53000000000000003 109.553 178.624 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.38 -4.1 77.57 Favored Glycine 0 CA--C 1.507 -0.409 0 CA-C-N 115.927 -0.579 . . . . 0.65000000000000002 112.28 -175.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 36.8 t -67.78 -29.11 43.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.247 0.546 . . . . 1.04 109.704 177.244 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.0 p -118.42 -38.42 3.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.607 -0.724 . . . . 0.83999999999999997 110.163 176.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.54 -5.94 26.34 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.993 -0.623 . . . . 0.77000000000000002 111.823 -179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 21.1 t70 -108.29 146.64 32.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.886 0.374 . . . . 2.1000000000000001 110.704 -177.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -120.15 16.57 9.99 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.17 -0.538 . . . . 0.55000000000000004 112.083 179.242 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.2 m -80.26 133.39 35.98 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 122.828 -0.219 . . . . 1.0600000000000001 110.512 -176.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.41 56.12 8.43 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.448 0.642 . . . . 2.23 109.813 -175.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' C' ' 33' ' ' ALA . 5.5 p -96.29 146.83 6.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.282 -0.872 . . . . 1.1599999999999999 110.798 -172.218 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 81.1 mt -86.85 144.05 27.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.102 0.477 . . . . 0.47999999999999998 109.864 177.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -107.99 143.79 36.18 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.559 -0.746 . . . . 3.1800000000000002 109.945 -179.569 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.7 t -74.89 137.81 42.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.407 -0.59 . . . . 0.37 109.407 177.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 47.9 p -91.16 -19.62 22.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.116 0.484 . . . . 0.75 110.914 178.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -91.7 -24.11 19.58 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 1.4299999999999999 110.792 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 5.4 p -151.58 -165.94 2.38 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.131 -0.692 . . . . 0.79000000000000004 109.131 176.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 114.56 28.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.75 0.31 . . . . 0.46999999999999997 110.35 177.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.79 142.88 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.317 -0.401 . . . . 0.40000000000000002 110.607 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -111.62 117.15 32.16 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.854 -0.612 . . . . 0.45000000000000001 109.514 176.577 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.409 ' HB2' ' NE2' ' C' ' 39' ' ' HIS . 37.7 p90 -147.43 156.28 42.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.60999999999999999 110.943 -175.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -103.25 132.21 49.69 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.999 -0.741 . . . . 0.41999999999999998 108.999 173.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -57.85 -40.23 79.65 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.68000000000000005 110.881 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' C' ' 37' ' ' ARG . 43.8 mtm105 -72.62 -31.68 65.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.475 -0.33 . . . . 3.3300000000000001 111.463 -177.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 86.3 m -72.76 -23.36 60.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.974 0.416 . . . . 0.54000000000000004 111.001 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' C' ' 34' ' ' PHE . 10.7 m170 -96.47 -53.71 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 0.60999999999999999 110.747 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.424 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 87.5 m-85 -113.07 142.8 27.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.944 -0.571 . . . . 0.80000000000000004 110.649 -174.286 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 32.0 Cg_exo -60.08 155.06 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.78 2.32 . . . . 2.1200000000000001 111.348 174.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.62 -14.67 45.82 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.546 -0.752 . . . . 3.2999999999999998 112.618 -172.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.73 3.26 87.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.089 -0.577 . . . . 1.46 112.392 177.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 5.1 m -92.62 136.43 33.24 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.572 -0.529 . . . . 1.03 109.572 177.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 25.9 m -88.97 130.3 35.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.969 0.414 . . . . 1.6000000000000001 111.218 -175.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -81.0 117.43 68.06 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.788 -0.642 . . . . 2.6800000000000002 110.595 -178.201 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.06 146.13 51.41 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.91 2.407 . . . . 1.1399999999999999 112.595 -177.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -96.1 -9.85 56.68 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.83 -0.7 . . . . 1.8999999999999999 111.503 176.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -93.24 47.84 1.28 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 2.75 111.781 -178.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.91 123.25 4.87 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.912 -0.661 . . . . 0.81999999999999995 112.928 177.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.86 127.89 34.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.997 0.427 . . . . 0.87 110.65 177.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -108.66 133.31 52.94 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.124 -0.489 . . . . 2.6499999999999999 110.953 -178.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.7 p -73.19 178.5 4.4 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.187 -0.671 . . . . 0.48999999999999999 109.187 172.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -56.16 -43.51 78.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.677 0.275 . . . . 4.0899999999999999 111.605 -175.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 49.4 m -68.18 -50.19 55.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.586 -0.279 . . . . 1.54 111.621 -177.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.3 m -68.37 -17.07 64.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.831 0.308 . . . . 0.71999999999999997 111.831 -177.161 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -98.98 9.5 43.42 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.388 . . . . 1.25 110.833 177.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.1 -27.06 26.94 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.585 -0.817 . . . . 2.1899999999999999 111.923 178.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -99.69 29.27 4.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.792 0.33 . . . . 5.1500000000000004 111.08 -177.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 m -89.59 159.94 2.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.403 -0.362 . . . . 6.7599999999999998 110.166 178.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 41.1 p -110.36 104.19 55.35 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 120.56 0.219 . . . . 8.8300000000000001 110.84 179.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.81 135.26 21.23 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.623 2.215 . . . . 11.039999999999999 110.991 173.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.8 116.53 57.7 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.39 -0.368 . . . . 13.859999999999999 110.618 -179.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.01 126.47 11.89 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.488 2.125 . . . . 16.550000000000001 112.59 -177.604 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.7 t -89.69 82.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.338 0.589 . . . . 18.07 109.714 177.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.547 -0.74 . . . . 20.260000000000002 110.02 -179.323 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 112.227 -0.349 . . . . 20.379999999999999 112.227 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.91 119.13 33.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.943 0.402 . . . . 18.809999999999999 110.745 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 23.5 mmt -90.91 27.25 1.86 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.027 -0.533 . . . . 18.059999999999999 110.757 178.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -92.04 -44.63 8.75 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.061 -0.518 . . . . 16.829999999999998 110.451 -178.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.98 49.15 0.25 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.959 -0.639 . . . . 14.66 112.096 177.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -141.21 -67.47 0.41 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.848 0.356 . . . . 15.800000000000001 110.889 -178.407 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' C' ' 7' ' ' GLN . 9.0 tp-100 -90.42 22.24 3.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.762 0.791 . . . . 13.130000000000001 110.41 -176.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -87.33 78.08 8.81 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.743 -0.662 . . . . 11.74 110.01 -179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 87.0 mt -75.52 143.67 42.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.54 -0.755 . . . . 8.7200000000000006 110.627 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.43 124.92 70.98 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.116 -0.493 . . . . 5.9299999999999997 110.948 -177.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.06 114.17 2.9 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 122.712 2.274 . . . . 5.25 111.872 176.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.04 -172.8 31.14 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.888 -0.672 . . . . 2.2799999999999998 112.245 178.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.1 76.65 4.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.338 0.59 . . . . 2.0699999999999998 110.472 178.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -135.9 139.41 43.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.425 -0.807 . . . . 3.1800000000000002 109.851 -179.306 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 t -76.62 104.31 7.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.157 -0.683 . . . . 0.53000000000000003 109.157 176.212 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.27 -0.62 89.26 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.739 -0.664 . . . . 0.65000000000000002 112.756 -173.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 22.3 t -76.73 -29.0 17.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.109 0.48 . . . . 1.04 110.287 178.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.0 p -117.06 -51.69 2.54 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.232 -0.44 . . . . 0.83999999999999997 110.278 178.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -13.13 4.0 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.734 -0.746 . . . . 0.77000000000000002 112.596 179.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.09 151.17 23.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.117 0.484 . . . . 2.1000000000000001 111.752 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.41 17.52 21.25 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.55000000000000004 111.866 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -77.15 116.18 17.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.431 0.158 . . . . 1.0600000000000001 110.881 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 56.12 65.26 1.48 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.478 0.656 . . . . 2.23 110.762 179.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -94.4 134.88 30.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.323 0.583 . . . . 1.1599999999999999 111.075 179.574 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 83.0 mt -77.9 146.49 35.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.339 -0.846 . . . . 0.47999999999999998 109.672 176.118 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -113.32 140.45 48.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.796 -0.638 . . . . 3.1800000000000002 110.337 -174.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' C' ' 51' ' ' LEU . 7.7 t -69.38 125.03 25.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.054 -0.721 . . . . 0.37 109.054 177.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 13.2 t -79.42 -5.55 54.92 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.141 0.496 . . . . 0.75 111.163 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -111.69 -22.67 11.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.4299999999999999 111.758 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.417 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 1.7 p -150.17 -171.77 4.0 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.766 -0.457 . . . . 0.79000000000000004 109.766 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.36 115.45 28.49 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.871 0.367 . . . . 0.46999999999999997 110.454 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.01 143.48 6.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.952 -0.567 . . . . 0.40000000000000002 110.523 -179.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.77 116.16 23.24 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.616 -0.513 . . . . 0.45000000000000001 109.616 177.231 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -153.96 163.85 39.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.386 -0.37 . . . . 0.60999999999999999 110.498 -174.395 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.408 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 33.0 m170 -100.79 145.98 27.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.878 -0.416 . . . . 0.41999999999999998 109.878 174.11 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -52.81 -53.83 42.84 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.504 0.503 . . . . 0.68000000000000005 110.827 177.023 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 66.8 mtt180 -70.07 -19.54 63.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 3.3300000000000001 112.09 -174.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 89.3 m -77.09 -21.04 54.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.162 0.506 . . . . 0.54000000000000004 110.484 177.142 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -103.23 -52.37 3.04 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.285 0.564 . . . . 0.60999999999999999 110.647 176.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 53.7 m-85 -113.26 125.56 29.52 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.456 -0.793 . . . . 0.80000000000000004 109.356 -178.092 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -52.28 148.73 24.48 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.619 2.213 . . . . 2.1200000000000001 111.753 178.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -18.06 14.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.43 -0.804 . . . . 3.2999999999999998 112.934 -172.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.22 -2.12 61.89 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.071 -0.585 . . . . 1.46 112.488 176.168 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -99.3 142.28 30.99 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.024 -0.362 . . . . 1.03 110.024 178.099 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 43.3 m -88.22 124.11 33.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.059 0.457 . . . . 1.6000000000000001 111.219 -176.531 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -79.88 129.37 70.87 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.669 -0.696 . . . . 2.6800000000000002 110.533 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.06 154.08 75.68 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.495 2.13 . . . . 1.1399999999999999 111.3 176.159 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 -10.24 73.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.856 -0.688 . . . . 1.8999999999999999 112.619 -177.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' C' ' 50' ' ' GLY . 17.1 p -93.76 -160.81 0.79 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.782 -0.081 . . . . 2.75 110.782 178.392 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' C' ' 49' ' ' THR . . . -62.73 143.67 48.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.128 -0.558 . . . . 0.81999999999999995 112.867 -179.021 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' C' ' 27' ' ' CYS . 0.1 OUTLIER -90.83 144.51 25.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.951 0.405 . . . . 0.87 110.562 -178.503 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -105.68 133.24 50.74 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.216 -0.447 . . . . 2.6499999999999999 109.997 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p -72.46 165.16 25.14 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.772 -0.825 . . . . 0.48999999999999999 108.772 175.311 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ptt180 -55.27 -35.89 65.5 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.246 0.476 . . . . 4.0899999999999999 111.61 -171.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -65.6 -51.03 62.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.433 -0.348 . . . . 1.54 111.061 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.25 -17.92 61.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.71999999999999997 111.117 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 47.9 t -78.86 -14.03 59.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.989 0.423 . . . . 1.25 110.868 -179.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.39 99.8 0.19 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.52 -0.847 . . . . 2.1899999999999999 112.005 -179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -89.3 114.52 25.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.96 0.41 . . . . 5.1500000000000004 110.954 -179.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.97 62.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.925 -0.768 . . . . 6.7599999999999998 108.925 175.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 24.5 m -87.56 115.21 62.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.133 -0.94 . . . . 8.8300000000000001 110.551 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.43 158.26 32.77 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.887 2.392 . . . . 11.039999999999999 111.975 -179.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.56 121.05 84.17 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.3 -0.409 . . . . 13.859999999999999 110.146 177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.8 76.87 2.37 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.75 2.3 . . . . 16.550000000000001 112.058 -179.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 35.6 m -108.19 13.21 8.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 18.07 110.816 -179.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.809 -0.615 . . . . 20.260000000000002 110.544 -177.272 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.05 -0.42 . . . . 20.379999999999999 112.05 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.42 121.15 21.85 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.306 -0.257 . . . . 18.809999999999999 110.306 179.466 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 68.1 mtt -64.4 119.49 10.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.133 -0.485 . . . . 18.059999999999999 110.715 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -110.67 101.16 9.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.68 -0.691 . . . . 16.829999999999998 110.389 -178.848 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.14 37.99 95.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.973 -0.632 . . . . 14.66 111.92 -177.74 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -121.17 -16.84 7.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.031 0.443 . . . . 15.800000000000001 110.589 -178.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -132.93 140.22 47.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.952 -0.567 . . . . 13.130000000000001 109.907 179.78 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 63.74 60.37 1.07 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.721 0.638 . . . . 11.74 110.438 179.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -73.94 142.93 45.89 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.391 -0.822 . . . . 8.7200000000000006 110.728 -177.695 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.5 129.01 87.78 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.069 -0.514 . . . . 5.9299999999999997 110.865 -179.011 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.91 62.33 3.16 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.038 2.492 . . . . 5.25 112.442 178.665 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.48 -146.77 19.19 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.961 -0.637 . . . . 2.2799999999999998 112.221 -179.558 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.551 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -81.4 75.36 8.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.035 0.445 . . . . 2.0699999999999998 110.663 -179.59 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.49 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 28.9 ttm-85 -158.23 130.32 6.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.924 -0.58 . . . . 3.1800000000000002 110.803 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -77.84 114.34 16.6 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.877 -0.416 . . . . 0.53000000000000003 109.877 177.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -66.14 -16.66 64.8 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 121.085 -0.578 . . . . 0.65000000000000002 112.926 -177.622 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -81.85 -32.48 11.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.978 0.418 . . . . 1.04 110.723 178.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.01 -40.26 6.94 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.148 0.425 . . . . 0.83999999999999997 112.148 -176.386 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.0 -19.59 51.36 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.343 -0.703 . . . . 0.77000000000000002 111.343 -173.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -93.78 151.97 19.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.703 0.287 . . . . 2.1000000000000001 110.374 177.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.87 21.83 12.08 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.676 -0.773 . . . . 0.55000000000000004 112.159 178.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 4.8 m -81.03 127.4 32.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.183 . . . . 1.0600000000000001 111.263 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 37.2 t70 55.17 66.47 1.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.587 0.708 . . . . 2.23 110.872 176.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 m -108.03 145.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.29 -0.868 . . . . 1.1599999999999999 111.411 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' C' ' 36' ' ' TRP . 83.4 mt -98.09 144.02 28.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.852 -0.613 . . . . 0.47999999999999998 110.306 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.689 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 8.4 mpt_? -109.96 153.84 23.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.137 -0.483 . . . . 3.1800000000000002 110.355 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 34.2 t -71.3 142.69 50.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.228 -0.656 . . . . 0.37 109.228 173.484 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -84.75 -5.61 59.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 0.75 110.704 178.186 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -118.4 -9.36 10.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.902 -0.59 . . . . 1.4299999999999999 110.939 178.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.0 m -145.72 173.19 12.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.93 0.395 . . . . 0.79000000000000004 110.072 -179.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.55 112.82 26.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.361 -0.607 . . . . 0.46999999999999997 109.361 174.204 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.689 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -169.62 131.14 1.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.624 -0.716 . . . . 0.40000000000000002 109.485 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.551 ' CB ' ' HA ' ' C' ' 13' ' ' ALA . . . -108.88 122.83 48.02 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.025 0.44 . . . . 0.45000000000000001 110.655 -178.318 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -155.3 160.85 41.09 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.769 -0.65 . . . . 0.60999999999999999 110.141 -178.635 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.69 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 23.4 m170 -88.85 133.22 34.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.264 -1.013 . . . . 0.41999999999999998 108.264 172.724 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.463 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.6 t-105 -61.16 -33.27 73.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.833 -0.621 . . . . 0.68000000000000005 111.017 -176.189 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 63.0 mtt85 -76.55 -13.75 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.054 0.454 . . . . 3.3300000000000001 111.184 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 59.5 m -93.05 -22.52 19.09 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.082 0.468 . . . . 0.54000000000000004 110.744 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -95.27 -30.9 13.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.987 -0.552 . . . . 0.60999999999999999 110.671 175.505 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -131.31 158.74 74.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.13 -0.486 . . . . 0.80000000000000004 110.274 -179.249 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.37 156.66 62.12 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.495 2.13 . . . . 2.1200000000000001 111.091 173.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.14 -10.56 55.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.926 -0.579 . . . . 3.2999999999999998 112.071 -174.169 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.92 -11.74 78.5 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.653 -0.784 . . . . 1.46 111.946 175.478 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 31.3 m -88.69 120.64 30.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.037 0.446 . . . . 1.03 110.644 -179.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.0 p -89.32 138.19 31.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.048 -0.524 . . . . 1.6000000000000001 110.652 -178.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -72.21 126.44 91.11 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.132 -0.486 . . . . 2.6800000000000002 110.365 -179.501 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.67 141.09 44.67 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.987 2.458 . . . . 1.1399999999999999 113.248 -173.348 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.98 0.55 89.41 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.405 -0.816 . . . . 1.8999999999999999 111.675 177.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 8.1 p -88.95 1.53 55.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.116 0.484 . . . . 2.75 110.304 177.077 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.68 131.47 3.25 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.537 -0.756 . . . . 0.81999999999999995 111.955 178.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.78 123.06 19.91 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.019 -0.734 . . . . 0.87 109.019 178.424 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -110.46 130.97 55.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.322 0.582 . . . . 2.6499999999999999 111.82 -173.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.513 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 26.0 p -74.89 -176.78 3.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.125 -0.943 . . . . 0.48999999999999999 110.032 175.06 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -64.87 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.77 -0.372 . . . . 4.0899999999999999 111.287 -175.492 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 34.9 t -68.75 -41.02 79.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.823 0.344 . . . . 1.54 110.429 179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 65.1 m -69.01 -23.72 64.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.508 -0.314 . . . . 0.71999999999999997 111.164 177.659 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -93.43 1.15 56.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.99 0.424 . . . . 1.25 110.665 177.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.07 60.22 4.47 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.89 -0.595 . . . . 2.1899999999999999 111.771 179.49 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -89.91 132.67 35.18 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.789 0.328 . . . . 5.1500000000000004 110.26 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 m -94.56 68.39 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.382 0.61 . . . . 6.7599999999999998 110.388 178.896 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 20.1 m -56.3 119.39 27.46 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.315 -0.857 . . . . 8.8300000000000001 111.025 -178.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.2 145.37 43.74 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.86 2.373 . . . . 11.039999999999999 112.351 -178.651 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.21 130.25 69.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.195 -0.457 . . . . 13.859999999999999 110.224 178.174 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.94 79.83 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.664 2.243 . . . . 16.550000000000001 112.394 179.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 48.5 t -91.5 107.69 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.175 -0.466 . . . . 18.07 109.964 178.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.994 -0.527 . . . . 20.260000000000002 110.209 -177.356 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.132 -0.387 . . . . 20.379999999999999 112.132 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.07 -18.68 36.14 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.756 0.312 . . . . 18.809999999999999 110.974 -178.506 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 70.1 mtm -69.99 -18.07 63.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.282 -0.417 . . . . 18.059999999999999 110.994 179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -67.96 -21.48 65.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.146 0.498 . . . . 16.829999999999998 110.047 175.346 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.34 110.11 2.35 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.677 -0.692 . . . . 14.66 111.761 -179.912 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -132.91 -36.99 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.702 0.251 . . . . 15.800000000000001 111.167 -178.429 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.72 -24.86 64.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.95 0.405 . . . . 13.130000000000001 111.543 -175.477 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.37 3.33 54.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.908 -0.587 . . . . 11.74 110.351 178.384 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 29.4 tp -105.86 35.39 2.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.704 0.764 . . . . 8.7200000000000006 109.529 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.4 123.39 85.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 5.9299999999999997 110.219 179.294 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.29 51.12 1.69 Allowed 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.479 2.786 . . . . 5.25 113.629 -176.482 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.38 -63.33 2.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.155 -0.545 . . . . 2.2799999999999998 112.408 179.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 33' ' ' ALA . . . -115.26 169.91 8.78 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.763 0.316 . . . . 2.0699999999999998 110.195 179.681 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -136.96 158.44 44.44 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.439 -0.578 . . . . 3.1800000000000002 109.439 178.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.8 t -68.82 105.51 2.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.276 -0.638 . . . . 0.53000000000000003 109.276 175.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.83 -21.02 67.07 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 121.017 -0.611 . . . . 0.65000000000000002 112.285 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.48 -34.56 58.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.948 0.404 . . . . 1.04 110.627 178.298 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 96.1 m -102.23 -33.78 9.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.83999999999999997 111.639 -177.6 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.93 20.07 51.42 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 -174.579 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -140.06 154.72 47.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.631 0.253 . . . . 2.1000000000000001 110.687 -174.228 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -127.59 21.81 5.61 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.007 -0.616 . . . . 0.55000000000000004 112.09 179.667 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -80.91 127.15 32.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.028 -0.36 . . . . 1.0600000000000001 110.028 179.209 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 54.36 61.14 3.16 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.372 0.606 . . . . 2.23 109.737 -177.122 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 p -100.28 150.62 5.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.268 -0.878 . . . . 1.1599999999999999 110.393 -172.719 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.403 HD12 ' H ' ' C' ' 36' ' ' TRP . 81.2 mt -91.79 143.99 25.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.895 -0.409 . . . . 0.47999999999999998 109.895 179.185 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -108.55 152.45 24.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.635 -0.711 . . . . 3.1800000000000002 110.173 -177.132 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 15.6 t -84.75 127.27 34.03 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.28 -0.637 . . . . 0.37 109.28 176.447 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 72.3 p -80.67 -5.89 57.62 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.206 0.527 . . . . 0.75 110.905 -178.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -106.31 -27.34 11.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 1.4299999999999999 111.488 -178.74 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 p -150.97 -161.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.885 -0.413 . . . . 0.79000000000000004 109.885 -178.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.1 115.77 31.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.66 0.267 . . . . 0.46999999999999997 110.616 -179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.96 151.88 10.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.216 -0.447 . . . . 0.40000000000000002 110.301 179.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 13' ' ' ALA . . . -136.69 112.36 9.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.334 -0.394 . . . . 0.45000000000000001 110.107 179.244 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' C' ' 53' ' ' CYS . 31.8 p90 -156.87 177.22 11.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.18 -0.464 . . . . 0.60999999999999999 109.862 -177.167 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.695 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 14.7 m170 -109.8 132.82 53.8 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.763 -0.829 . . . . 0.41999999999999998 108.763 172.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.403 ' H ' HD12 ' C' ' 25' ' ' LEU . 75.9 t-105 -53.6 -53.23 54.68 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.106 0.41 . . . . 0.68000000000000005 112.106 -171.737 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -60.81 -26.22 67.15 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.089 0.471 . . . . 3.3300000000000001 111.359 -176.042 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.695 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 34.3 m -77.91 -23.66 48.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.069 -0.514 . . . . 0.54000000000000004 110.809 -178.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.85 -34.37 11.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.124 -0.489 . . . . 0.60999999999999999 110.779 179.316 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -126.56 75.9 74.24 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.847 -0.615 . . . . 0.80000000000000004 110.365 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -85.43 13.11 2.85 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.985 2.457 . . . . 2.1200000000000001 112.408 -177.121 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.18 4.31 31.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.931 -0.577 . . . . 3.2999999999999998 111.413 -178.174 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.73 9.79 60.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.671 -0.776 . . . . 1.46 111.426 -177.113 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 25.7 m -67.64 131.79 46.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.639 -0.281 . . . . 1.03 110.629 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.5 m -88.44 135.29 33.54 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.342 -0.39 . . . . 1.6000000000000001 110.026 -178.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ptt180 -72.42 134.41 82.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.298 -0.41 . . . . 2.6800000000000002 111.018 -176.523 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -71.49 132.93 21.45 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.578 2.185 . . . . 1.1399999999999999 112.195 178.992 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -83.86 -13.42 75.08 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.01 -0.836 . . . . 1.8999999999999999 111.01 175.245 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 11.5 p -93.06 46.98 1.24 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.122 0.487 . . . . 2.75 111.113 178.803 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.48 106.31 3.11 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.787 -0.72 . . . . 0.81999999999999995 112.408 178.736 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.01 124.63 23.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.203 0.525 . . . . 0.87 109.942 178.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -110.56 135.33 51.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.101 -0.5 . . . . 2.6499999999999999 110.749 -177.326 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.504 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.9 p -77.52 -179.04 5.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.663 -0.495 . . . . 0.48999999999999999 109.663 174.289 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -62.19 -46.76 87.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.807 0.337 . . . . 4.0899999999999999 110.575 -177.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 43.7 t -61.63 -45.74 92.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 1.54 111.28 -177.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.07 -23.14 61.31 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.617 0.228 . . . . 0.71999999999999997 111.617 -179.612 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 59.6 m -80.81 -14.36 58.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.949 0.404 . . . . 1.25 110.637 177.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.59 25.53 9.03 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.346 -0.701 . . . . 2.1899999999999999 111.346 177.066 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -89.8 106.92 18.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.038 0.446 . . . . 5.1500000000000004 110.455 -178.659 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.08 103.46 14.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.856 -0.794 . . . . 6.7599999999999998 108.856 173.908 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.3 m -77.74 113.92 36.68 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.977 -0.556 . . . . 8.8300000000000001 110.825 -176.791 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.24 142.87 17.18 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.198 1.932 . . . . 11.039999999999999 111.228 176.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -95.89 115.79 65.78 Favored Pre-proline 0 C--N 1.318 -0.763 0 C-N-CA 120.9 -0.32 . . . . 13.859999999999999 110.264 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 4.6 Cg_exo -73.9 120.52 6.41 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.539 2.159 . . . . 16.550000000000001 111.133 177.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.3 m -95.92 177.08 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.365 -0.379 . . . . 18.07 110.581 -179.962 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.637 -0.697 . . . . 20.260000000000002 109.908 -178.065 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 111.462 -0.655 . . . . 20.379999999999999 111.462 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.39 -46.21 89.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.883 0.342 . . . . 18.809999999999999 111.018 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 87.4 mtp -122.66 113.92 19.89 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.955 -0.387 . . . . 18.059999999999999 109.955 176.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -86.07 108.24 18.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.061 0.458 . . . . 16.829999999999998 110.414 -178.239 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.68 -50.8 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.039 -0.6 . . . . 14.66 111.608 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -62.2 -52.67 62.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.04 0.447 . . . . 15.800000000000001 110.094 178.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.9 52.56 2.32 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.871 -0.604 . . . . 13.130000000000001 110.4 179.431 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -70.81 -27.43 63.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.059 0.456 . . . . 11.74 109.965 178.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.4 104.47 13.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 8.7200000000000006 110.065 173.087 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.3 150.51 84.63 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.437 -0.802 . . . . 5.9299999999999997 110.951 -179.188 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.46 44.27 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.121 2.547 . . . . 5.25 113.359 -179.449 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.79 -52.12 5.16 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 110.601 -1.0 . . . . 2.2799999999999998 110.601 174.656 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.53 73.39 1.51 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.305 -0.628 . . . . 2.0699999999999998 109.305 171.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.1 ttt180 -156.0 123.43 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.59 -0.732 . . . . 3.1800000000000002 110.249 -175.085 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -69.14 109.06 3.85 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.857 -0.423 . . . . 0.53000000000000003 109.857 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.71 -18.24 61.4 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.377 -0.439 . . . . 0.65000000000000002 112.771 -177.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.9 t -79.43 -37.12 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.729 0.3 . . . . 1.04 111.108 178.628 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 99.0 m -97.69 -33.95 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.046 0.387 . . . . 0.83999999999999997 112.046 -176.421 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.86 -1.33 65.46 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.603 -0.808 . . . . 0.77000000000000002 111.639 -175.122 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -119.16 150.43 40.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.652 0.263 . . . . 2.1000000000000001 110.345 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -115.25 24.84 10.28 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.557 -0.83 . . . . 0.55000000000000004 113.424 -175.004 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 38.3 m -79.0 116.4 19.27 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.856 0.328 . . . . 1.0600000000000001 110.657 178.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 66.95 1.1 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.744 0.652 . . . . 2.23 111.923 177.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.77 153.3 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.205 -0.452 . . . . 1.1599999999999999 110.542 177.218 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 31.1 mt -88.95 159.46 17.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.167 -0.47 . . . . 0.47999999999999998 109.855 174.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mmm180 -123.89 143.51 50.32 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.939 -0.573 . . . . 3.1800000000000002 110.554 -176.066 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 10.8 t -82.14 134.77 35.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.321 -0.622 . . . . 0.37 109.321 177.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 49.6 p -85.32 -13.5 49.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 0.75 111.43 -178.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -103.52 -21.74 13.72 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 1.4299999999999999 111.444 -178.651 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.21 -166.14 2.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.426 -0.583 . . . . 0.79000000000000004 109.426 178.602 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.97 115.3 30.19 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.06 -0.348 . . . . 0.46999999999999997 110.06 178.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -155.23 134.85 12.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.251 -0.431 . . . . 0.40000000000000002 110.205 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.06 115.86 23.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.258 -0.428 . . . . 0.45000000000000001 110.388 179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -160.5 151.73 19.2 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.048 -0.524 . . . . 0.60999999999999999 110.307 -176.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.853 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 18.7 m80 -82.44 136.59 34.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.985 -1.117 . . . . 0.41999999999999998 107.985 171.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.0 t-105 -44.3 -52.17 7.79 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 123.466 0.479 . . . . 0.68000000000000005 111.979 -175.699 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -56.44 -34.9 67.26 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.678 0.621 . . . . 3.3300000000000001 112.678 -175.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.853 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 3.4 m -71.71 -21.93 61.7 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.897 -0.592 . . . . 0.54000000000000004 111.149 -173.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -103.94 -49.66 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.82 -0.627 . . . . 0.60999999999999999 110.546 176.232 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.9 m-85 -121.43 113.61 32.12 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.156 -175.932 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 7.2 Cg_exo -72.54 -172.73 0.98 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.922 2.415 . . . . 2.1200000000000001 113.308 -177.469 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.35 -28.17 62.9 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 111.935 0.346 . . . . 3.2999999999999998 111.935 -177.347 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.53 -9.49 55.46 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.244 -0.503 . . . . 1.46 112.743 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 36.5 m -124.63 116.98 23.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.98 0.419 . . . . 1.03 110.369 176.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 42.7 m -88.37 155.15 19.86 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.264 -0.426 . . . . 1.6000000000000001 110.224 -178.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -70.25 130.95 88.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.0 -0.546 . . . . 2.6800000000000002 110.679 -175.262 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.66 147.27 50.77 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.814 2.343 . . . . 1.1399999999999999 111.988 178.355 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.01 -1.89 88.56 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.808 -0.711 . . . . 1.8999999999999999 111.577 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.1 p -94.67 -168.29 1.8 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.534 -0.333 . . . . 2.75 110.86 179.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.53 127.13 43.99 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.644 -0.788 . . . . 0.81999999999999995 111.439 175.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.8 122.42 17.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.221 0.534 . . . . 0.87 109.99 -176.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.6 135.52 48.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.835 -0.62 . . . . 2.6499999999999999 110.433 178.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.7 p -75.7 172.54 12.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.1 -0.704 . . . . 0.48999999999999999 109.1 171.777 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -53.56 -41.48 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.026 0.441 . . . . 4.0899999999999999 111.4 -175.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' C' ' 60' ' ' VAL . 35.1 t -68.22 -45.92 71.99 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.072 -0.513 . . . . 1.54 111.269 -177.236 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 83.0 m -72.58 -17.46 61.7 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.812 0.301 . . . . 0.71999999999999997 111.812 -177.398 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -87.45 -8.45 56.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.935 0.398 . . . . 1.25 110.608 174.858 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.84 -100.13 0.85 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.11 -0.567 . . . . 2.1899999999999999 111.823 179.261 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -124.92 142.79 51.23 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.794 -0.447 . . . . 5.1500000000000004 109.794 177.795 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.481 ' HA ' ' OG ' ' C' ' 55' ' ' SER . 58.3 t -108.49 135.54 46.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.421 -0.354 . . . . 6.7599999999999998 110.643 -178.15 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -116.09 122.04 32.9 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.279 -0.419 . . . . 8.8300000000000001 110.466 176.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.2 142.73 81.35 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.812 2.341 . . . . 11.039999999999999 112.14 -178.538 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.28 132.89 93.3 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.153 -0.476 . . . . 13.859999999999999 110.027 177.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.44 57.4 4.18 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.857 2.372 . . . . 16.550000000000001 112.775 -176.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 19.6 t -89.19 79.75 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.32 0.581 . . . . 18.07 109.72 -179.032 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.49 -0.777 . . . . 20.260000000000002 109.948 179.385 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.859 -0.496 . . . . 20.379999999999999 111.859 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.46 95.1 3.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.098 0.475 . . . . 18.809999999999999 110.967 -178.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 63.6 mtt -82.09 -64.84 1.1 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.868 -0.606 . . . . 18.059999999999999 109.472 177.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -164.86 -63.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.863 -0.608 . . . . 16.829999999999998 110.436 178.683 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.41 -151.14 23.31 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.754 -0.736 . . . . 14.66 111.981 179.576 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -88.12 -10.93 48.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.026 0.441 . . . . 15.800000000000001 110.599 179.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -72.11 97.93 2.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.901 -0.59 . . . . 13.130000000000001 110.22 177.473 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -83.4 -2.08 54.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.901 0.382 . . . . 11.74 111.24 -178.466 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 57.3 tp -83.17 131.7 35.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.08 -0.509 . . . . 8.7200000000000006 109.731 177.271 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 123.12 87.63 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.504 -0.316 . . . . 5.9299999999999997 110.511 -179.848 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.44 48.87 1.63 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.503 2.802 . . . . 5.25 113.404 -178.545 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.21 -84.67 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.204 -0.522 . . . . 2.2799999999999998 112.694 178.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.84 74.53 10.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.465 . . . . 2.0699999999999998 111.065 -178.24 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 33.2 ttt180 -168.33 135.44 2.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.831 -0.622 . . . . 3.1800000000000002 110.159 179.035 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 41.9 t -76.48 104.39 6.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.1 0.476 . . . . 0.53000000000000003 109.884 179.114 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.72 -6.59 88.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.011 -0.614 . . . . 0.65000000000000002 112.271 -176.648 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 24.1 t -70.34 -31.65 47.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.898 0.38 . . . . 1.04 110.664 -179.575 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 26.5 p -112.65 -39.33 4.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.999 0.428 . . . . 0.83999999999999997 110.196 176.191 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.6 -9.63 9.92 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.612 -0.804 . . . . 0.77000000000000002 112.08 179.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 2.0 m-20 -107.64 139.54 42.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.006 0.431 . . . . 2.1000000000000001 111.035 179.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.51 ' O ' ' HB ' ' C' ' 24' ' ' VAL . . . -107.39 2.81 34.71 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.03 -0.828 . . . . 0.55000000000000004 111.03 174.927 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 21.8 m -71.03 132.35 45.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.426 -0.387 . . . . 1.0600000000000001 110.409 179.316 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 56.13 49.71 14.99 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.398 0.618 . . . . 2.23 109.87 -176.612 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' C' ' 21' ' ' GLY . 4.4 p -89.38 151.28 3.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.343 -0.844 . . . . 1.1599999999999999 110.602 -175.29 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.7 mt -100.96 160.44 14.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.435 -0.348 . . . . 0.47999999999999998 110.189 179.411 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -126.82 136.03 51.81 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.594 -0.521 . . . . 3.1800000000000002 109.594 -178.396 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.416 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 42.2 t -67.12 143.15 56.81 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.494 -0.482 . . . . 0.37 110.099 176.389 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.3 p -87.91 -23.35 23.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.049 178.6 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -95.03 -30.24 14.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.187 -0.46 . . . . 1.4299999999999999 111.05 -178.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.416 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 0.0 OUTLIER -137.25 -177.59 4.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.669 -0.493 . . . . 0.79000000000000004 109.669 -178.397 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.23 114.87 29.4 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.48 -0.327 . . . . 0.46999999999999997 110.286 -179.364 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -168.49 129.87 1.31 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.071 -0.513 . . . . 0.40000000000000002 110.538 -178.249 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -102.9 112.15 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.435 -0.58 . . . . 0.45000000000000001 109.435 174.117 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -155.0 173.42 16.59 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.799 -0.637 . . . . 0.60999999999999999 109.998 -175.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.431 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 29.7 m170 -110.13 135.96 50.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.169 -0.678 . . . . 0.41999999999999998 109.169 173.384 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -61.59 -36.27 80.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.551 -0.75 . . . . 0.68000000000000005 110.45 179.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -70.39 -26.46 63.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 3.3300000000000001 111.276 178.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 73.8 m -84.23 -26.0 29.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.937 0.399 . . . . 0.54000000000000004 110.914 178.884 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . 0.402 ' C ' ' HD3' ' C' ' 41' ' ' PRO . 1.5 m-70 -89.81 -40.03 12.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.213 -0.448 . . . . 0.60999999999999999 111.26 -178.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -124.32 71.38 55.64 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.315 -0.402 . . . . 0.80000000000000004 110.173 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' C' ' 39' ' ' HIS . 3.0 Cg_exo -75.43 6.44 3.58 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.134 2.556 . . . . 2.1200000000000001 113.004 -174.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.95 3.77 28.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.847 0.356 . . . . 3.2999999999999998 111.165 179.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.05 32.65 20.15 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.63 -0.795 . . . . 1.46 112.036 -179.708 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 8.6 m -68.3 148.08 51.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.947 -0.39 . . . . 1.03 109.947 177.658 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m -86.57 121.67 29.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.94 0.4 . . . . 1.6000000000000001 110.504 -175.367 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -66.32 120.09 67.42 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.663 -0.699 . . . . 2.6800000000000002 110.855 179.528 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.62 143.8 38.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.435 2.09 . . . . 1.1399999999999999 111.859 176.277 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.98 -10.37 42.91 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.73 -0.748 . . . . 1.8999999999999999 112.526 -179.209 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -96.04 9.76 39.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.803 0.335 . . . . 2.75 111.685 -179.271 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 117.92 0.67 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.634 -0.793 . . . . 0.81999999999999995 112.287 -178.669 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.5 OUTLIER -90.29 123.24 33.9 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.44 -0.578 . . . . 0.87 109.44 179.924 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' C' ' 57' ' ' SER . 28.6 mtm180 -110.46 149.07 30.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.394 0.616 . . . . 2.6499999999999999 111.62 -178.851 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 30.3 p -102.3 -178.8 3.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.171 -0.922 . . . . 0.48999999999999999 110.029 179.795 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -57.84 -39.1 76.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.507 0.558 . . . . 4.0899999999999999 112.507 -172.106 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -63.7 -57.3 10.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.88 0.371 . . . . 1.54 111.443 -176.541 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 6.9 p -72.17 -24.58 61.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.233 -0.439 . . . . 0.71999999999999997 111.699 -174.786 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' C' ' 52' ' ' ARG . 25.3 t -102.15 19.76 17.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.897 0.379 . . . . 1.25 110.728 -177.119 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.22 58.41 0.33 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.366 -0.921 . . . . 2.1899999999999999 112.645 -179.46 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.96 78.23 6.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.082 0.468 . . . . 5.1500000000000004 110.117 175.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 43.4 t -91.67 117.63 35.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 6.7599999999999998 109.988 179.624 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 9.1 t -75.48 131.95 76.54 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 110.077 -0.342 . . . . 8.8300000000000001 110.077 179.079 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -62.64 135.69 54.16 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.541 2.161 . . . . 11.039999999999999 111.805 179.805 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.98 129.36 93.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.046 -0.525 . . . . 13.859999999999999 110.939 -177.695 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.76 104.78 0.39 Allowed 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.749 2.299 . . . . 16.550000000000001 111.938 -179.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 p -119.24 132.92 67.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.889 -0.596 . . . . 18.07 110.675 -178.56 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.672 -0.68 . . . . 20.260000000000002 110.103 178.419 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.546 0 N-CA-C 111.694 -0.563 . . . . 20.379999999999999 111.694 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.2 -29.96 64.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.105 0.479 . . . . 18.809999999999999 110.992 -178.133 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 22.9 mmt -104.64 74.31 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.265 0.555 . . . . 18.059999999999999 109.948 176.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.22 -24.7 37.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.532 -0.758 . . . . 16.829999999999998 110.503 -177.096 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.67 134.09 35.27 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.982 -0.628 . . . . 14.66 112.061 179.025 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -73.21 -51.49 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.57 -0.159 . . . . 15.800000000000001 110.57 -178.273 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 57.02 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.867 0.729 . . . . 13.130000000000001 112.68 176.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.41 130.76 37.49 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.657 -0.701 . . . . 11.74 110.209 177.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.93 76.36 8.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.202 0.525 . . . . 8.7200000000000006 110.885 -176.649 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -86.57 146.8 42.46 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.717 -0.674 . . . . 5.9299999999999997 110.553 -179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 27.4 Cg_exo -62.81 -15.6 48.05 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.033 2.488 . . . . 5.25 112.311 177.51 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.43 171.87 23.91 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.501 -0.772 . . . . 2.2799999999999998 112.69 175.519 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.438 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -110.55 74.88 0.9 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.274 0.559 . . . . 2.0699999999999998 109.654 176.746 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -137.48 130.33 30.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.662 -0.699 . . . . 3.1800000000000002 110.748 -174.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 33.7 t -69.45 111.22 5.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.53000000000000003 109.994 178.264 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -63.03 -19.03 60.88 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.291 -0.48 . . . . 0.65000000000000002 112.856 -178.026 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.7 t -76.27 -31.08 20.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.105 0.478 . . . . 1.04 110.682 178.522 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 90.6 m -109.04 -20.8 12.89 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.32 0.489 . . . . 0.83999999999999997 112.32 -175.204 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.35 19.4 79.65 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.174 -0.77 . . . . 0.77000000000000002 111.174 -174.398 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -141.17 147.09 37.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.281 -0.459 . . . . 2.1000000000000001 109.932 -176.538 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -119.26 30.79 5.68 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.574 -0.822 . . . . 0.55000000000000004 113.508 -176.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -75.28 121.08 21.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 117.237 0.519 . . . . 1.0600000000000001 110.135 176.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 54.41 52.76 11.87 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.65 0.594 . . . . 2.23 110.508 -176.859 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.445 HG21 ' HB1' ' C' ' 33' ' ' ALA . 8.7 p -88.97 139.45 17.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.091 -0.504 . . . . 1.1599999999999999 110.635 -173.902 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 62.1 mt -87.09 147.8 25.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.096 -0.502 . . . . 0.47999999999999998 110.688 -179.073 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.529 HH11 ' HB2' ' C' ' 33' ' ' ALA . 30.7 mmm180 -113.74 149.75 34.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.534 -0.757 . . . . 3.1800000000000002 109.739 179.71 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 17.6 t -85.2 135.55 33.9 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.448 -0.575 . . . . 0.37 109.448 177.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 35.9 p -81.94 -18.68 42.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.75 111.171 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -100.5 -22.52 14.98 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.905 -0.589 . . . . 1.4299999999999999 111.923 -176.44 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 7.4 p -150.55 -165.08 2.17 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.542 . . . . 0.79000000000000004 109.535 178.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.65 115.58 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.958 -0.386 . . . . 0.46999999999999997 109.958 179.477 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.36 146.78 18.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.40000000000000002 111.273 -177.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.529 ' HB2' HH11 ' C' ' 26' ' ' ARG . . . -131.71 112.54 12.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.678 -0.692 . . . . 0.45000000000000001 109.779 177.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -157.17 165.35 36.22 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.121 -0.49 . . . . 0.60999999999999999 109.74 -177.212 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.786 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.9 m170 -96.71 138.37 34.38 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.297 -1.001 . . . . 0.41999999999999998 108.297 171.2 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -46.09 -52.53 11.91 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 123.3 0.375 . . . . 0.68000000000000005 111.712 -177.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.498 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.8 mtm180 -70.37 -5.93 31.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 3.3300000000000001 112.124 -174.424 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.786 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -91.92 -20.86 20.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.096 0.474 . . . . 0.54000000000000004 110.66 179.31 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -103.86 -36.17 7.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.963 -0.562 . . . . 0.60999999999999999 110.68 174.891 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 92.4 m-85 -121.87 147.28 48.18 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.305 -0.407 . . . . 0.80000000000000004 110.107 -179.405 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.51 159.62 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.519 2.146 . . . . 2.1200000000000001 111.633 176.463 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.15 -8.14 28.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.7 -0.682 . . . . 3.2999999999999998 111.978 -175.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.69 -7.4 87.45 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.824 -0.703 . . . . 1.46 111.768 176.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.0 m -98.11 132.6 43.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.838 0.351 . . . . 1.03 110.212 178.339 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -88.87 142.21 27.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.386 -0.37 . . . . 1.6000000000000001 110.2 -179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -80.63 127.32 75.85 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.084 -0.507 . . . . 2.6800000000000002 110.796 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.03 135.65 70.01 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.752 2.301 . . . . 1.1399999999999999 111.743 175.204 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -24.47 61.94 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.928 -0.653 . . . . 1.8999999999999999 111.68 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 10.1 t -138.91 135.59 34.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.908 -0.404 . . . . 2.75 109.908 177.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.8 53.61 4.89 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.68 -0.771 . . . . 0.81999999999999995 112.225 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.51 122.82 19.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.408 -0.59 . . . . 0.87 109.408 178.061 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -118.91 136.43 54.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.12 -0.491 . . . . 2.6499999999999999 110.475 -176.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.2 p -73.54 170.4 15.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.142 -0.481 . . . . 0.48999999999999999 109.944 177.058 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.7 ttm180 -49.4 -48.7 46.92 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.645 0.59 . . . . 4.0899999999999999 111.911 -174.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m -63.69 -45.87 88.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.57 -0.286 . . . . 1.54 111.466 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 89.1 m -72.0 -32.36 67.13 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.741 0.274 . . . . 0.71999999999999997 111.741 -177.47 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.7 p -80.88 -14.13 58.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 1.25 111.418 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.26 -170.33 29.44 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.792 -0.718 . . . . 2.1899999999999999 112.008 -179.306 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -118.82 126.03 50.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.661 0.267 . . . . 5.1500000000000004 110.425 179.386 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 p -99.7 122.64 51.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.23 0.538 . . . . 6.7599999999999998 109.888 176.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 22.9 m -110.12 105.07 56.83 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 115.893 -0.594 . . . . 8.8300000000000001 110.281 179.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.44 145.75 34.23 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.471 2.114 . . . . 11.039999999999999 111.902 178.105 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.11 120.05 72.17 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.194 -0.457 . . . . 13.859999999999999 110.924 -177.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.28 74.11 3.71 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.826 2.351 . . . . 16.550000000000001 112.512 -178.589 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -90.51 63.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.642 0.734 . . . . 18.07 111.067 -179.557 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.382 -0.818 . . . . 20.260000000000002 110.093 179.623 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 N-CA-C 112.048 -0.421 . . . . 20.379999999999999 112.048 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.07 0.59 43.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.942 0.401 . . . . 18.809999999999999 110.951 -177.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.7 ttt -77.54 78.85 4.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.269 0.557 . . . . 18.059999999999999 109.563 177.429 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -129.77 -174.24 3.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.621 -0.718 . . . . 16.829999999999998 110.314 -178.082 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.65 -145.92 13.97 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.749 -0.739 . . . . 14.66 112.07 177.937 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -162.64 -69.63 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 15.800000000000001 109.774 179.616 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -110.13 67.55 0.65 Allowed 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.485 -0.561 . . . . 13.130000000000001 109.485 175.159 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -85.98 64.72 8.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.001 -0.545 . . . . 11.74 110.985 -175.107 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -81.99 121.02 25.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.403 -0.592 . . . . 8.7200000000000006 109.403 175.617 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -60.24 129.74 88.94 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.449 . . . . 5.9299999999999997 110.971 -179.587 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 21.8 Cg_exo -66.14 75.14 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.921 2.414 . . . . 5.25 112.096 175.244 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.45 126.42 1.69 Allowed Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.326 -0.71 . . . . 2.2799999999999998 111.326 177.666 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.0 92.74 7.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.911 0.386 . . . . 2.0699999999999998 110.495 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.152 -0.476 . . . . 3.1800000000000002 110.09 -179.578 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.81 105.44 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.172 -0.677 . . . . 0.53000000000000003 109.172 175.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.7 -24.66 62.48 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 121.43 -0.414 . . . . 0.65000000000000002 113.063 -176.23 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 45.9 t -71.32 -30.95 41.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.09 0.471 . . . . 1.04 110.964 179.303 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 74.2 m -111.17 -18.1 13.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.509 0.559 . . . . 0.83999999999999997 112.509 -172.934 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.46 26.8 71.98 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.616 -0.993 . . . . 0.77000000000000002 110.616 -173.209 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -142.78 148.47 37.22 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.282 -0.459 . . . . 2.1000000000000001 110.589 -170.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.58 25.15 5.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.069 -0.586 . . . . 0.55000000000000004 111.975 177.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -80.6 129.17 34.36 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.233 -0.284 . . . . 1.0600000000000001 110.233 178.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 26.7 t70 55.71 52.06 11.5 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 122.177 0.989 . . . . 2.23 108.953 -179.245 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -100.69 149.66 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.716 -1.129 . . . . 1.1599999999999999 111.235 -171.507 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 90.2 mt -91.23 144.04 26.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.073 -0.512 . . . . 0.47999999999999998 109.896 176.61 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.483 ' HD3' ' O ' ' C' ' 32' ' ' ALA . 4.3 tpp180 -110.9 130.86 55.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.084 -0.507 . . . . 3.1800000000000002 109.998 -179.072 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' C' ' 52' ' ' ARG . 1.8 t -68.07 134.56 50.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.7 -0.482 . . . . 0.37 109.7 177.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 67.6 p -92.32 -14.85 28.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.379 0.609 . . . . 0.75 110.84 -179.543 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -98.16 -18.9 18.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.915 -0.584 . . . . 1.4299999999999999 111.076 -179.344 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -151.64 -170.61 3.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.07 -0.715 . . . . 0.79000000000000004 109.07 176.782 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.94 113.9 27.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.538 -0.542 . . . . 0.46999999999999997 109.538 178.331 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.483 ' O ' ' HD3' ' C' ' 26' ' ' ARG . . . -171.22 137.43 1.13 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.55 . . . . 0.40000000000000002 110.298 -178.631 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -119.03 112.89 20.14 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.081 -0.711 . . . . 0.45000000000000001 109.081 175.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -145.68 156.7 43.8 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.053 -0.351 . . . . 0.60999999999999999 110.053 -178.371 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 17.6 m170 -89.29 128.82 35.9 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.279 -1.008 . . . . 0.41999999999999998 108.279 172.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -47.83 -53.2 16.3 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.502 0.501 . . . . 0.68000000000000005 111.962 -172.309 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 71.5 mtm180 -68.07 -14.16 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 3.3300000000000001 112.357 -172.546 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 56.5 m -80.31 -21.79 42.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.0 0.429 . . . . 0.54000000000000004 110.631 179.348 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -105.62 -43.72 4.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.062 -0.517 . . . . 0.60999999999999999 110.521 176.46 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 93.6 m-85 -110.53 139.99 22.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.80000000000000004 110.384 -176.664 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.27 158.62 47.73 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.719 2.279 . . . . 2.1200000000000001 111.197 177.201 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.74 -13.4 43.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 3.2999999999999998 112.293 -173.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.73 -31.65 60.16 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.676 -0.773 . . . . 1.46 111.545 175.298 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 38.0 m -74.59 131.12 40.69 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.29 -0.263 . . . . 1.03 110.29 179.361 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 9.8 p -88.73 134.83 33.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.054 0.454 . . . . 1.6000000000000001 111.189 -175.089 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -74.81 111.76 14.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.663 -0.698 . . . . 2.6800000000000002 110.088 178.257 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.17 136.3 28.98 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.66 2.24 . . . . 1.1399999999999999 112.863 -174.065 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.29 0.16 71.34 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.904 -0.665 . . . . 1.8999999999999999 111.652 176.772 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 1.6 p -122.57 83.01 2.05 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.812 0.339 . . . . 2.75 111.14 177.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.97 88.75 1.38 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.842 -0.694 . . . . 0.81999999999999995 112.387 178.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.7 OUTLIER -78.14 122.75 26.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.975 -0.75 . . . . 0.87 108.975 178.739 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.541 ' HA ' ' SG ' ' C' ' 27' ' ' CYS . 36.4 ptt180 -133.67 135.45 44.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.213 0.53 . . . . 2.6499999999999999 110.734 -176.204 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 20.5 p -73.29 173.81 8.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.306 -0.861 . . . . 0.48999999999999999 110.367 178.419 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . 0.562 ' HA ' ' OG ' ' C' ' 57' ' ' SER . 2.7 ptp180 -63.15 -32.5 73.91 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.295 0.498 . . . . 4.0899999999999999 111.426 -174.68 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.1 t -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 1.54 109.838 175.91 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 69.4 m -74.27 -30.23 62.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.694 -0.685 . . . . 0.71999999999999997 112.829 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' C' ' 54' ' ' ARG . 19.9 p -75.19 -14.22 60.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.068 0.461 . . . . 1.25 111.184 -174.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -129.43 -158.21 9.44 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.399 -1.08 . . . . 2.1899999999999999 110.399 174.158 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -120.06 131.18 55.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.181 0.49 . . . . 5.1500000000000004 109.999 177.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 9.0 m -99.12 42.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.326 0.584 . . . . 6.7599999999999998 110.434 -179.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 m -72.64 116.06 46.0 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 8.8300000000000001 111.086 -176.755 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -83.21 140.2 9.71 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.538 2.158 . . . . 11.039999999999999 111.487 175.056 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.42 122.43 86.68 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.456 -0.338 . . . . 13.859999999999999 110.146 179.448 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.41 89.91 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.64 2.227 . . . . 16.550000000000001 112.449 -177.736 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 18.8 m -89.77 147.41 5.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.84 -0.618 . . . . 18.07 110.719 178.459 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.527 -0.749 . . . . 20.260000000000002 110.366 -178.472 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 112.392 -0.283 . . . . 20.379999999999999 112.392 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.43 66.92 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.769 0.319 . . . . 18.809999999999999 111.271 -176.885 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 66.4 mtt -127.19 21.24 6.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.905 0.383 . . . . 18.059999999999999 110.767 178.647 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -88.56 68.07 8.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.967 0.413 . . . . 16.829999999999998 110.591 -179.583 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.02 -27.9 65.6 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.872 -0.68 . . . . 14.66 112.04 178.38 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -92.76 -47.49 7.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.769 -0.456 . . . . 15.800000000000001 109.769 177.631 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 51.25 74.85 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.847 0.717 . . . . 13.130000000000001 111.043 177.102 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -95.29 145.62 24.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.037 -0.529 . . . . 11.74 110.861 -176.807 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 60.8 tp -124.34 117.26 24.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.021 -0.536 . . . . 8.7200000000000006 110.744 -177.948 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.78 145.2 83.95 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.044 -0.525 . . . . 5.9299999999999997 110.171 175.931 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -49.69 98.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.604 2.869 . . . . 5.25 113.849 -176.399 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.86 23.02 78.58 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.571 -0.74 . . . . 2.2799999999999998 113.036 174.603 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.38 71.75 8.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.303 0.573 . . . . 2.0699999999999998 110.646 -179.802 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -163.22 155.61 18.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.892 -1.151 . . . . 3.1800000000000002 107.892 179.092 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.09 108.65 1.59 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.631 -0.507 . . . . 0.53000000000000003 109.631 177.149 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.05 -14.21 55.38 Favored Glycine 0 C--N 1.329 0.145 0 O-C-N 123.372 0.42 . . . . 0.65000000000000002 113.102 -175.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.13 -31.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.082 0.468 . . . . 1.04 110.583 178.186 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 72.4 m -108.02 -26.35 10.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.471 . . . . 0.83999999999999997 112.197 -174.883 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.33 25.25 59.56 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.075 -0.81 . . . . 0.77000000000000002 111.075 -174.401 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -141.97 142.36 32.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.663 -0.268 . . . . 2.1000000000000001 110.96 -173.56 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.15 16.98 24.72 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.003 -0.618 . . . . 0.55000000000000004 112.275 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -80.22 128.93 34.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.934 -0.395 . . . . 1.0600000000000001 109.934 178.305 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 58.56 40.43 23.71 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.471 0.653 . . . . 2.23 110.36 -178.107 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.43 HG21 ' HB1' ' C' ' 33' ' ' ALA . 1.5 p -90.37 150.91 3.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.272 -0.877 . . . . 1.1599999999999999 110.422 -175.376 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 92.8 mt -102.25 151.26 22.43 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.787 -0.449 . . . . 0.47999999999999998 109.787 177.05 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 12.2 tpp180 -119.49 140.32 50.67 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.99 -0.55 . . . . 3.1800000000000002 110.119 -175.347 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 6.6 t -73.47 142.88 46.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.923 -0.769 . . . . 0.37 108.923 174.319 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.6 p -96.92 -21.38 17.49 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.137 0.494 . . . . 0.75 110.743 178.678 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -89.66 -21.05 22.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 1.4299999999999999 110.567 -179.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.4 p -151.18 -175.5 5.19 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.5 -0.926 . . . . 0.79000000000000004 108.5 174.806 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.23 114.61 28.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.651 0.262 . . . . 0.46999999999999997 110.347 -179.519 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.44 135.8 6.08 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.952 -0.567 . . . . 0.40000000000000002 110.442 -179.794 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.43 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.18 118.83 36.42 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 123.707 0.629 . . . . 0.45000000000000001 110.121 178.377 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.93 151.36 26.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.349 -0.387 . . . . 0.60999999999999999 110.647 -179.265 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.702 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 25.8 m170 -82.65 136.13 34.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.628 -0.878 . . . . 0.41999999999999998 108.628 172.006 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.456 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 62.0 t-105 -49.04 -53.65 19.32 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.255 0.347 . . . . 0.68000000000000005 111.618 -175.906 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -67.23 -15.94 64.0 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.361 0.504 . . . . 3.3300000000000001 112.361 -173.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.4 m -85.35 -21.15 29.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.105 0.478 . . . . 0.54000000000000004 110.717 -178.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -107.56 -45.12 4.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.016 -0.538 . . . . 0.60999999999999999 111.052 178.048 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.39 146.17 36.8 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.928 -0.578 . . . . 0.80000000000000004 110.355 -176.855 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' C' ' 44' ' ' THR . 10.8 Cg_endo -55.82 144.11 78.39 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.01 2.473 . . . . 2.1200000000000001 111.797 175.594 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -16.24 59.62 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.461 -0.791 . . . . 3.2999999999999998 112.085 -175.144 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.14 -18.82 75.88 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.17 177.373 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . 0.418 ' OG1' ' HG2' ' C' ' 41' ' ' PRO . 42.8 m -74.8 147.9 40.8 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.086 -0.339 . . . . 1.03 110.086 178.722 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 10.3 m -88.09 122.01 31.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.849 0.357 . . . . 1.6000000000000001 110.738 -174.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -70.97 120.58 80.28 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.853 -0.612 . . . . 2.6800000000000002 110.368 -179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.67 132.32 32.51 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.611 2.207 . . . . 1.1399999999999999 111.933 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.13 -43.3 6.71 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.146 -0.782 . . . . 1.8999999999999999 111.146 176.596 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 t -115.12 135.21 54.44 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.041 -0.355 . . . . 2.75 110.041 175.293 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.2 64.14 3.55 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.773 -0.727 . . . . 0.81999999999999995 112.201 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt -77.49 131.38 37.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.088 0.47 . . . . 0.87 110.394 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -114.93 133.58 55.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.22 -0.446 . . . . 2.6499999999999999 110.773 -176.669 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.5 p -77.12 178.45 7.02 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.205 -0.665 . . . . 0.48999999999999999 109.205 173.074 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -56.99 -40.39 76.49 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.93 0.344 . . . . 4.0899999999999999 111.93 -173.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 12.3 m -68.92 -49.18 60.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.943 0.401 . . . . 1.54 110.919 -178.364 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.3 m -71.57 -17.9 62.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.71999999999999997 111.348 -178.557 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 18.5 t -90.84 7.99 37.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.986 0.422 . . . . 1.25 110.429 179.59 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.53 -142.01 12.87 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.851 -0.69 . . . . 2.1899999999999999 111.897 178.701 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -122.65 143.62 49.66 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.014 -0.365 . . . . 5.1500000000000004 110.014 179.655 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -96.49 130.18 45.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 6.7599999999999998 110.57 179.768 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -101.06 135.66 19.89 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 116.214 -0.448 . . . . 8.8300000000000001 110.585 -177.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -74.2 134.13 18.85 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.582 2.188 . . . . 11.039999999999999 111.423 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.93 123.79 87.03 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 13.859999999999999 110.768 -178.785 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.0 80.25 1.86 Allowed 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.813 2.342 . . . . 16.550000000000001 111.857 179.723 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -103.24 -2.38 9.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.803 -0.635 . . . . 18.07 111.865 -175.555 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.483 -0.77 . . . . 20.260000000000002 110.425 -179.916 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 112.003 -0.439 . . . . 20.379999999999999 112.003 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.93 155.58 30.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.782 0.325 . . . . 18.809999999999999 111.099 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 27.5 ttt -147.35 121.87 9.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.082 -0.508 . . . . 18.059999999999999 110.06 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.32 53.37 1.77 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.121 0.486 . . . . 16.829999999999998 111.232 -179.697 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -107.22 123.44 7.26 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.832 -0.699 . . . . 14.66 112.176 -179.015 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -100.48 -1.97 34.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.302 0.573 . . . . 15.800000000000001 109.741 176.102 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -89.77 -174.64 4.36 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.164 -0.925 . . . . 13.130000000000001 110.293 178.263 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 67.08 22.53 9.9 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.584 0.552 . . . . 11.74 110.779 178.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 90.1 mt -112.69 92.12 3.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 8.7200000000000006 110.2 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -74.01 126.89 88.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.901 -0.59 . . . . 5.9299999999999997 110.105 178.548 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 23.4 Cg_exo -65.73 -6.05 13.13 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.105 2.537 . . . . 5.25 113.048 -179.167 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.84 -127.88 8.29 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 111.393 -0.683 . . . . 2.2799999999999998 111.393 -178.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.11 73.85 7.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.879 0.371 . . . . 2.0699999999999998 110.221 177.134 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' C' ' 19' ' ' GLY . 57.4 mtt180 -145.94 130.94 18.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.017 -0.538 . . . . 3.1800000000000002 110.587 179.908 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' C' ' 34' ' ' PHE . 13.2 t -64.02 114.53 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.79 -0.641 . . . . 0.53000000000000003 109.527 175.349 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.07 -22.91 50.67 Favored Glycine 0 C--N 1.332 0.307 0 O-C-N 123.331 0.394 . . . . 0.65000000000000002 113.353 -174.546 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.52 -30.37 15.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.085 0.469 . . . . 1.04 110.889 179.003 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.8 m -107.26 -31.11 8.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.912 0.708 . . . . 0.83999999999999997 112.912 -173.476 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' C' ' 14' ' ' ARG . . . 85.04 -9.26 66.88 Favored Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.089 -0.804 . . . . 0.77000000000000002 111.089 -172.704 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -106.88 147.69 29.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.171 -0.514 . . . . 2.1000000000000001 110.674 -177.512 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -121.07 27.49 6.4 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.96 -0.638 . . . . 0.55000000000000004 112.62 179.535 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 31.9 m -77.19 117.6 18.89 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 109.862 -0.421 . . . . 1.0600000000000001 109.862 177.822 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 t70 54.57 64.42 1.82 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.901 0.858 . . . . 2.23 109.511 -174.171 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.483 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.7 p -97.32 150.96 4.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.243 -0.89 . . . . 1.1599999999999999 110.201 -176.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' C' ' 36' ' ' TRP . 96.5 mt -103.93 144.14 31.92 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.76 -0.459 . . . . 0.47999999999999998 109.76 176.995 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 0.0 OUTLIER -115.18 138.4 50.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.12 -0.491 . . . . 3.1800000000000002 110.259 -179.674 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 11.7 t -60.14 139.92 57.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.92 -0.582 . . . . 0.37 109.549 174.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 39.8 p -90.61 -17.56 26.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.078 0.466 . . . . 0.75 111.015 179.528 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -94.83 -23.73 17.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 1.4299999999999999 110.697 -178.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.9 p -151.43 -168.9 3.22 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.115 -0.698 . . . . 0.79000000000000004 109.115 178.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.68 115.81 31.34 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.716 0.293 . . . . 0.46999999999999997 110.741 -178.541 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.96 121.46 1.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.40000000000000002 110.617 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.483 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -99.79 117.91 35.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.051 -0.522 . . . . 0.45000000000000001 110.372 177.744 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 15' ' ' CYS . 46.8 p90 -158.16 165.78 34.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.634 -0.257 . . . . 0.60999999999999999 110.585 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.709 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.9 m170 -95.65 140.89 29.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.534 -0.914 . . . . 0.41999999999999998 108.534 173.779 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 59.4 t-105 -59.39 -45.42 91.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.635 0.255 . . . . 0.68000000000000005 111.0 -177.537 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' C' ' 37' ' ' ARG . 48.9 mtm180 -65.39 -14.48 60.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.286 -0.415 . . . . 3.3300000000000001 111.968 -177.439 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.4 m -89.9 -20.49 23.32 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.957 0.408 . . . . 0.54000000000000004 110.655 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -103.09 -39.75 6.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.091 -0.504 . . . . 0.60999999999999999 111.403 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.68 161.02 59.9 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.257 -0.429 . . . . 0.80000000000000004 110.17 -177.592 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.97 146.2 98.05 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.619 2.213 . . . . 2.1200000000000001 112.13 178.983 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.46 -20.96 66.18 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.5 -0.773 . . . . 3.2999999999999998 111.333 -178.065 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -81.49 -7.08 88.67 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.782 -0.723 . . . . 1.46 111.978 176.258 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 36.4 m -95.19 134.82 37.51 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.802 0.334 . . . . 1.03 110.114 179.403 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 15.7 p -88.95 150.08 23.0 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.346 -0.388 . . . . 1.6000000000000001 110.571 -178.12 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -81.15 143.19 52.26 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.934 -0.575 . . . . 2.6800000000000002 110.209 -179.403 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.05 132.17 35.62 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.642 2.228 . . . . 1.1399999999999999 112.244 178.876 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.85 -0.7 89.1 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.994 -0.548 . . . . 1.8999999999999999 112.444 -178.016 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 28.7 p -90.06 -9.98 46.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.135 0.493 . . . . 2.75 110.639 176.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.96 137.12 3.03 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.775 -0.726 . . . . 0.81999999999999995 111.922 -178.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.33 124.01 21.09 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.999 0.428 . . . . 0.87 110.16 179.904 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -107.92 136.03 48.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.274 -0.421 . . . . 2.6499999999999999 110.965 -177.146 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.42 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 16.1 p -87.0 -178.22 6.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.769 -0.456 . . . . 0.48999999999999999 109.769 175.924 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -64.69 -39.96 94.56 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.839 -0.344 . . . . 4.0899999999999999 111.296 -175.907 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 45.9 t -68.98 -48.7 62.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.54 0.209 . . . . 1.54 111.058 -178.163 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 90.7 m -67.31 -39.85 85.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.578 0.228 . . . . 0.71999999999999997 111.114 -178.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.1 t -76.43 -13.48 60.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.989 0.423 . . . . 1.25 110.372 -179.365 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.6 -8.96 61.01 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.079 -0.582 . . . . 2.1899999999999999 112.308 178.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -88.27 -9.99 51.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.57 0.7 . . . . 5.1500000000000004 109.488 179.558 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 14.8 t -92.9 70.37 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.141 -0.936 . . . . 6.7599999999999998 109.562 178.609 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 5.7 t -122.4 132.45 24.26 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.702 -0.681 . . . . 8.8300000000000001 109.995 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.23 134.31 54.99 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.95 2.433 . . . . 11.039999999999999 112.493 -178.558 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.28 124.71 91.18 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.846 -0.615 . . . . 13.859999999999999 111.418 -176.624 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.21 106.47 1.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.621 2.214 . . . . 16.550000000000001 112.209 179.533 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.56 12.81 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.329 0.585 . . . . 18.07 110.418 178.138 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.452 -0.794 . . . . 20.260000000000002 110.366 -176.939 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.935 -0.466 . . . . 20.379999999999999 111.935 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.15 36.18 27.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.095 0.474 . . . . 18.809999999999999 111.322 179.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 24.3 ttt -89.07 127.29 35.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.018 -0.537 . . . . 18.059999999999999 110.329 -177.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.87 160.43 19.43 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.746 -0.464 . . . . 16.829999999999998 109.746 176.812 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.8 121.1 4.81 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.803 -0.713 . . . . 14.66 112.213 -179.151 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -115.47 23.03 12.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.039 0.447 . . . . 15.800000000000001 110.395 -179.559 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 61.53 65.98 0.9 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.146 -0.934 . . . . 13.130000000000001 110.435 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -73.08 -26.47 61.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 11.74 110.872 179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 tp -95.42 93.91 7.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.806 -0.442 . . . . 8.7200000000000006 109.806 177.001 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -64.24 137.46 97.13 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.929 -0.578 . . . . 5.9299999999999997 111.075 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 11.9 Cg_exo -70.7 74.03 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.938 2.426 . . . . 5.25 112.171 176.888 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.29 81.31 1.59 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.82 -0.705 . . . . 2.2799999999999998 112.32 178.559 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.27 73.41 8.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.317 0.58 . . . . 2.0699999999999998 109.541 175.258 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -149.0 163.67 36.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.262 -0.881 . . . . 3.1800000000000002 110.181 -177.721 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 t -69.28 108.21 3.58 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.943 -0.571 . . . . 0.53000000000000003 109.584 175.298 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.82 -16.2 56.18 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.398 -0.429 . . . . 0.65000000000000002 112.746 -177.109 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.09 -30.13 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.974 0.416 . . . . 1.04 110.495 177.882 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 97.1 m -109.64 -29.63 8.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.83999999999999997 112.42 -175.235 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.82 3.94 90.27 Favored Glycine 0 N--CA 1.452 -0.256 0 N-CA-C 110.904 -0.878 . . . . 0.77000000000000002 110.904 -173.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.469 ' OD1' HG22 ' C' ' 22' ' ' THR . 10.6 t70 -124.43 153.76 41.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.897 -0.652 . . . . 2.1000000000000001 109.419 -176.062 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.03 27.69 3.61 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.299 -0.953 . . . . 0.55000000000000004 113.355 -177.474 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . 0.469 HG22 ' OD1' ' C' ' 20' ' ' ASP . 6.0 t -77.68 135.28 38.05 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 117.282 0.541 . . . . 1.0600000000000001 109.711 177.003 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 53.76 43.35 31.15 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.878 -0.601 . . . . 2.23 110.183 179.375 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 4.7 p -88.93 149.36 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.471 -0.786 . . . . 1.1599999999999999 110.504 -172.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -94.18 143.05 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.199 -0.455 . . . . 0.47999999999999998 109.98 179.238 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 19.2 mmm180 -109.48 143.16 39.48 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 3.1800000000000002 110.441 -178.251 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.4 t -73.47 145.43 45.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.473 -0.565 . . . . 0.37 109.473 177.389 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 18.4 p -90.92 -34.54 15.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.101 -0.499 . . . . 0.75 111.612 -178.954 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -89.2 -13.86 37.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.33 -0.395 . . . . 1.4299999999999999 111.24 -176.85 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.9 p -152.27 -171.27 3.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.523 -0.547 . . . . 0.79000000000000004 109.523 175.262 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.74 115.33 30.28 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.232 -0.285 . . . . 0.46999999999999997 110.232 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -162.11 143.73 10.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.331 -0.395 . . . . 0.40000000000000002 110.696 -179.334 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.17 113.51 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.794 -0.639 . . . . 0.45000000000000001 109.659 177.263 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -149.43 154.79 39.41 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.286 -0.416 . . . . 0.60999999999999999 110.696 -178.038 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.689 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 24.6 m170 -92.95 134.15 35.4 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.768 -0.827 . . . . 0.41999999999999998 108.768 172.845 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -49.39 -53.15 24.04 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.267 0.354 . . . . 0.68000000000000005 111.217 -176.125 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.9 mtt180 -60.18 -30.08 69.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.933 -0.576 . . . . 3.3300000000000001 111.829 -176.106 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 38.8 m -80.66 -22.08 40.81 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.056 -0.52 . . . . 0.54000000000000004 111.487 -175.022 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -106.32 -31.67 8.51 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.454 -0.339 . . . . 0.60999999999999999 111.443 -178.568 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.12 141.78 41.77 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.405 . . . . 0.80000000000000004 110.732 -176.333 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.62 153.99 76.01 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.799 2.333 . . . . 2.1200000000000001 111.417 174.844 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.25 -18.56 61.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.35 -0.841 . . . . 3.2999999999999998 112.362 -172.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.9 -13.23 80.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.955 -0.64 . . . . 1.46 112.447 177.597 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 18.3 m -87.37 130.91 34.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.739 -0.467 . . . . 1.03 109.739 177.589 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.5 t -88.01 138.48 31.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.326 -0.397 . . . . 1.6000000000000001 109.957 -175.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -68.9 115.23 29.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 2.6800000000000002 110.103 -179.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.1 138.0 46.06 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.038 2.492 . . . . 1.1399999999999999 112.805 -176.431 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.47 -5.4 65.2 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.766 -0.652 . . . . 1.8999999999999999 111.819 177.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.2 p -88.75 -9.71 50.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.062 0.458 . . . . 2.75 111.023 -179.794 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.01 137.23 3.45 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.602 -0.808 . . . . 0.81999999999999995 112.276 179.145 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -69.01 123.85 22.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.872 0.368 . . . . 0.87 110.676 176.893 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -120.5 124.07 44.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.373 -0.376 . . . . 2.6499999999999999 110.337 179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 15.0 p -72.79 -177.43 2.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.168 -0.469 . . . . 0.48999999999999999 110.453 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -53.35 -49.29 67.44 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.781 0.432 . . . . 4.0899999999999999 111.959 -172.774 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 16.7 m -68.88 -42.06 77.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.808 0.337 . . . . 1.54 111.392 -177.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 81.3 m -72.08 -28.15 63.12 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.202 0.445 . . . . 0.71999999999999997 112.202 -175.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.6 p -107.94 11.21 28.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.974 0.416 . . . . 1.25 111.034 179.047 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.26 -172.15 16.48 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.485 -0.864 . . . . 2.1899999999999999 112.746 -175.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -100.73 97.86 8.46 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.927 -0.398 . . . . 5.1500000000000004 109.927 179.65 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 12.0 p -146.87 140.96 20.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.105 0.478 . . . . 6.7599999999999998 110.873 -177.639 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 9.1 p -108.16 103.48 50.46 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.053 -0.521 . . . . 8.8300000000000001 109.881 173.82 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.01 144.87 24.29 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.871 2.38 . . . . 11.039999999999999 111.992 -179.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.22 128.02 26.07 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.218 -0.446 . . . . 13.859999999999999 110.017 176.644 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.81 35.14 0.43 Allowed 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.909 2.406 . . . . 16.550000000000001 112.883 -178.184 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 t -93.38 88.41 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.142 0.496 . . . . 18.07 109.914 -179.146 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.222 -0.894 . . . . 20.260000000000002 110.273 -176.869 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 111.717 -0.553 . . . . 20.379999999999999 111.717 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.96 65.78 1.37 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.107 0.479 . . . . 18.809999999999999 110.908 -178.274 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 91.5 mtp -61.21 118.56 7.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.821 -0.627 . . . . 18.059999999999999 110.677 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 70.54 -3.43 1.9 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.497 0.719 . . . . 16.829999999999998 111.392 -179.354 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.07 -12.34 63.71 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.083 -0.58 . . . . 14.66 111.749 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -88.65 -4.87 58.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.049 0.452 . . . . 15.800000000000001 110.232 177.835 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -82.48 68.64 9.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.992 -0.549 . . . . 13.130000000000001 110.89 -178.257 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -62.36 -42.38 99.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.616 -0.72 . . . . 11.74 109.759 176.692 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.06 109.43 17.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 8.7200000000000006 109.505 175.738 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -79.98 123.28 83.66 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.396 -0.365 . . . . 5.9299999999999997 110.521 -178.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 14.9 Cg_exo -69.96 77.82 1.12 Allowed 'Trans proline' 0 C--O 1.234 0.319 0 C-N-CA 122.781 2.32 . . . . 5.25 111.908 177.262 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.06 135.49 20.14 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.917 -0.658 . . . . 2.2799999999999998 112.393 179.594 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.29 88.49 2.54 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.972 0.415 . . . . 2.0699999999999998 110.16 177.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -131.94 143.29 50.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 3.1800000000000002 111.273 -176.774 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 16.7 t -68.3 115.47 7.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.644 -0.707 . . . . 0.53000000000000003 109.346 174.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.81 -26.75 60.86 Favored Glycine 0 C--O 1.228 -0.267 0 O-C-N 123.358 0.411 . . . . 0.65000000000000002 113.509 -174.852 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.9 -33.39 29.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.061 0.457 . . . . 1.04 110.953 179.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 81.3 m -104.87 -37.16 7.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.81 0.67 . . . . 0.83999999999999997 112.81 -171.283 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.93 -7.39 76.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.856 -0.688 . . . . 0.77000000000000002 111.598 -175.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -104.52 149.16 25.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.93 0.395 . . . . 2.1000000000000001 110.523 179.592 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -109.14 6.89 32.54 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.295 -0.722 . . . . 0.55000000000000004 111.295 175.66 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 5.9 m -66.89 133.7 50.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.56 -0.32 . . . . 1.0600000000000001 110.289 178.53 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 44.31 41.18 4.23 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.15 0.906 . . . . 2.23 111.896 -177.458 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.16 142.6 12.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.564 -0.744 . . . . 1.1599999999999999 110.452 -177.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.426 HD12 ' HB2' ' C' ' 36' ' ' TRP . 49.6 mt -87.66 148.88 24.59 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.027 0.442 . . . . 0.47999999999999998 110.177 177.665 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 26.3 mmm180 -119.54 138.57 53.1 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.544 -0.753 . . . . 3.1800000000000002 110.054 -177.069 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.2 t -68.91 137.51 53.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.014 -0.736 . . . . 0.37 109.014 178.05 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 41.5 p -92.42 -14.53 28.44 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.75 111.153 -178.891 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -98.86 -20.75 16.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.187 -0.46 . . . . 1.4299999999999999 111.014 -179.659 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 2.3 p -150.82 -166.25 2.49 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.917 -0.771 . . . . 0.79000000000000004 108.917 176.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.06 114.95 29.56 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.687 0.279 . . . . 0.46999999999999997 110.848 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -163.54 139.46 6.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.372 -0.376 . . . . 0.40000000000000002 110.92 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.38 112.86 19.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.105 -0.498 . . . . 0.45000000000000001 110.195 178.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -149.91 148.61 29.33 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.312 -0.404 . . . . 0.60999999999999999 110.197 -179.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 31.5 m170 -80.42 138.74 36.66 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.618 -0.882 . . . . 0.41999999999999998 108.618 172.606 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.426 ' HB2' HD12 ' C' ' 25' ' ' LEU . 72.0 t-105 -52.8 -50.59 63.31 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 123.173 0.296 . . . . 0.68000000000000005 110.76 -177.651 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -67.0 -14.35 62.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.789 -0.641 . . . . 3.3300000000000001 112.288 -175.688 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 85.1 m -88.56 -20.78 24.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.078 0.466 . . . . 0.54000000000000004 110.876 -179.425 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -107.49 -43.86 4.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.60999999999999999 111.212 177.03 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.559 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 93.0 m-85 -120.72 112.27 33.95 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.985 -0.552 . . . . 0.80000000000000004 110.149 -176.669 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.52 -174.46 0.45 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.888 2.392 . . . . 2.1200000000000001 113.106 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.99 -27.06 51.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 3.2999999999999998 112.535 -175.768 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.52 -25.04 62.56 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 121.002 -0.618 . . . . 1.46 113.086 -179.683 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 4.5 m -107.83 126.2 52.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.942 0.401 . . . . 1.03 110.778 -179.792 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 30.5 t -89.43 138.6 31.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.255 -0.646 . . . . 1.6000000000000001 109.255 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -74.86 126.24 88.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.89 0.376 . . . . 2.6800000000000002 111.07 -177.209 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 153.52 56.5 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.771 2.314 . . . . 1.1399999999999999 111.881 177.909 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.76 -24.41 55.84 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.955 -0.641 . . . . 1.8999999999999999 111.624 178.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -141.27 159.6 41.87 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.822 -0.436 . . . . 2.75 109.822 177.09 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.79 56.83 6.26 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.818 -0.706 . . . . 0.81999999999999995 112.024 -178.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.93 121.71 23.09 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.229 -0.656 . . . . 0.87 109.229 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -123.33 132.31 53.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.168 -0.469 . . . . 2.6499999999999999 110.969 -175.602 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.7 p -74.71 -172.21 1.49 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.427 -0.806 . . . . 0.48999999999999999 109.802 175.58 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -59.94 -47.45 85.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.627 0.251 . . . . 4.0899999999999999 111.422 -176.229 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -68.5 -46.58 69.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.443 -0.344 . . . . 1.54 111.564 -177.211 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.8 m -71.24 -21.57 62.1 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.852 -0.339 . . . . 0.71999999999999997 111.344 -177.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 19.4 t -99.75 13.32 34.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.098 0.475 . . . . 1.25 110.498 179.188 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.98 -41.51 10.4 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.703 -0.76 . . . . 2.1899999999999999 111.461 177.555 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.47 152.97 17.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.073 0.463 . . . . 5.1500000000000004 110.174 178.276 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.92 115.59 36.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.952 -0.567 . . . . 6.7599999999999998 110.135 179.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.4 114.24 20.48 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.33 -0.395 . . . . 8.8300000000000001 111.014 177.835 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -79.78 147.1 19.16 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.511 2.141 . . . . 11.039999999999999 112.319 -178.387 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.67 140.41 22.15 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.048 -0.523 . . . . 13.859999999999999 110.306 178.795 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.39 32.96 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 123.122 2.548 . . . . 16.550000000000001 113.018 -179.266 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.19 98.23 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 18.07 109.478 177.636 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.563 -0.732 . . . . 20.260000000000002 109.954 -177.307 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.599 -0.6 . . . . 20.379999999999999 111.599 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.09 -71.71 0.59 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.818 0.309 . . . . 18.809999999999999 110.997 179.416 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 25.5 ptm -106.46 -33.33 7.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.895 0.379 . . . . 18.059999999999999 110.795 179.67 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.88 83.03 6.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.298 -0.41 . . . . 16.829999999999998 110.588 -179.712 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.14 -178.3 46.89 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.816 -0.707 . . . . 14.66 112.039 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -124.48 14.19 8.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.767 0.318 . . . . 15.800000000000001 110.393 -179.497 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 59.1 47.4 11.95 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.679 -0.691 . . . . 13.130000000000001 110.97 -176.513 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -152.32 -57.28 0.14 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 11.74 110.422 179.43 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 66.4 tp -104.67 123.9 48.41 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.968 -0.56 . . . . 8.7200000000000006 110.66 -178.789 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -73.13 123.77 89.9 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.214 -0.448 . . . . 5.9299999999999997 109.815 175.144 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 37.3 Cg_exo -60.85 -19.1 60.39 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.921 2.414 . . . . 5.25 113.01 -177.447 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.58 -46.38 3.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.038 -0.601 . . . . 2.2799999999999998 112.298 178.337 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.95 73.42 10.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.34 0.591 . . . . 2.0699999999999998 110.839 179.704 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.411 ' N ' ' HB3' ' C' ' 33' ' ' ALA . 50.8 ttt85 -169.95 132.75 1.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.214 -0.903 . . . . 3.1800000000000002 109.011 175.024 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 41.4 t -72.08 103.93 3.43 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.186 -0.461 . . . . 0.53000000000000003 110.231 -178.621 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.48 -8.66 84.62 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.94 -0.648 . . . . 0.65000000000000002 111.74 179.446 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.427 HG11 ' O ' ' C' ' 38' ' ' CYS . 25.5 t -61.68 -49.07 85.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.799 0.333 . . . . 1.04 110.139 178.765 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.1 p -98.87 -28.12 13.6 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.482 -0.562 . . . . 0.83999999999999997 109.482 175.12 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.46 3.61 55.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.895 -0.669 . . . . 0.77000000000000002 111.945 178.281 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -121.57 145.05 48.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.767 0.318 . . . . 2.1000000000000001 110.843 -176.722 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.68 17.04 13.77 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 116.096 -0.502 . . . . 0.55000000000000004 111.891 179.201 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -78.31 122.77 26.18 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.533 0.166 . . . . 1.0600000000000001 110.935 -177.947 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.35 51.65 15.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.62 0.724 . . . . 2.23 110.299 -178.0 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.557 HG11 ' HB1' ' C' ' 33' ' ' ALA . 6.6 p -92.39 155.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.634 -1.166 . . . . 1.1599999999999999 110.416 -175.262 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 97.4 mt -86.31 146.59 26.43 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.678 -0.49 . . . . 0.47999999999999998 109.678 176.589 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -109.45 138.45 45.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.305 -0.407 . . . . 3.1800000000000002 110.272 -176.198 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 5.8 t -69.65 138.84 53.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.702 -0.481 . . . . 0.37 109.702 177.383 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -94.89 -24.51 16.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.376 -0.375 . . . . 0.75 111.339 179.744 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -89.48 -20.11 24.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.998 0.427 . . . . 1.4299999999999999 110.575 -177.744 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 1.8 p -151.47 -171.09 3.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.158 -1.052 . . . . 0.79000000000000004 108.158 174.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.76 112.92 26.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.961 -0.385 . . . . 0.46999999999999997 109.961 178.148 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.66 146.17 8.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.123 -0.49 . . . . 0.40000000000000002 110.001 -178.502 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.557 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -109.66 121.41 45.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.125 -0.489 . . . . 0.45000000000000001 109.694 177.403 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.533 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 31.0 p90 -149.8 143.21 25.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.226 -0.443 . . . . 0.60999999999999999 110.476 -178.492 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.685 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 68.9 m80 -90.33 138.81 31.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.691 -0.855 . . . . 0.41999999999999998 108.691 171.618 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 -59.28 -43.78 92.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.354 0.409 . . . . 0.68000000000000005 110.02 178.355 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -66.62 -26.16 66.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.027 -0.533 . . . . 3.3300000000000001 111.534 -177.37 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.1 m -81.98 -23.9 35.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.041 0.448 . . . . 0.54000000000000004 110.653 179.679 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -101.19 -41.46 6.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.319 -0.4 . . . . 0.60999999999999999 111.701 -175.812 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.95 132.48 24.32 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.691 0.281 . . . . 0.80000000000000004 110.706 -176.116 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.6 164.7 22.86 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.723 2.282 . . . . 2.1200000000000001 111.34 172.185 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.77 -3.48 5.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 3.2999999999999998 112.12 -175.712 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.78 -29.67 73.93 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.965 -0.636 . . . . 1.46 111.67 173.705 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -101.4 136.1 41.81 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.079 -0.341 . . . . 1.03 110.079 178.705 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -89.03 140.22 29.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 1.6000000000000001 110.862 -175.604 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -81.91 118.15 71.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.6800000000000002 110.641 179.854 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.12 158.35 49.32 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.64 2.227 . . . . 1.1399999999999999 111.836 176.241 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.9 -16.45 61.28 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.03 -0.605 . . . . 1.8999999999999999 111.677 177.351 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -142.84 146.37 34.07 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 110.203 -0.295 . . . . 2.75 110.203 178.602 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.19 48.47 4.58 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.719 -0.753 . . . . 0.81999999999999995 112.518 179.083 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -82.2 122.12 27.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.159 0.504 . . . . 0.87 110.307 176.973 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.448 ' CZ ' ' HA ' ' C' ' 57' ' ' SER . 24.2 ptt180 -127.1 135.71 51.12 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.362 0.601 . . . . 2.6499999999999999 110.051 -179.744 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 18.8 p -72.28 177.9 4.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.329 -0.85 . . . . 0.48999999999999999 110.207 -178.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -58.43 -41.69 85.61 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 111.977 0.362 . . . . 4.0899999999999999 111.977 -174.258 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 15.2 m -64.3 -42.64 96.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.109 0.481 . . . . 1.54 110.522 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . 0.424 ' CB ' ' HB2' ' C' ' 52' ' ' ARG . 85.1 m -72.97 -19.9 61.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.71999999999999997 111.472 176.839 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . 0.448 ' HA ' ' CZ ' ' C' ' 52' ' ' ARG . 19.6 t -80.86 -14.28 58.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.104 -0.498 . . . . 1.25 110.477 -175.468 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.15 143.23 16.5 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.648 -0.787 . . . . 2.1899999999999999 111.414 176.765 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.27 152.87 21.32 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.809 -0.441 . . . . 5.1500000000000004 109.809 -179.847 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.49 124.53 40.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.26 0.553 . . . . 6.7599999999999998 110.841 -179.66 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 5.4 p -82.18 115.14 55.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.669 -0.696 . . . . 8.8300000000000001 110.321 175.279 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.26 134.05 59.15 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.84 2.36 . . . . 11.039999999999999 112.069 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -97.32 141.81 23.59 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.928 -0.578 . . . . 13.859999999999999 110.284 -178.206 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 4.5 Cg_exo -75.38 63.19 6.29 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.6 2.2 . . . . 16.550000000000001 111.881 178.886 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.96 129.12 2.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.82 -0.627 . . . . 18.07 110.538 179.837 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.538 -0.744 . . . . 20.260000000000002 110.402 177.809 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 111.887 -0.485 . . . . 20.379999999999999 111.887 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.48 -65.45 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.478 0.18 . . . . 18.809999999999999 111.324 -177.763 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 19.2 ptp -147.74 37.43 0.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 18.059999999999999 110.818 -178.048 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -55.72 131.55 46.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.955 -0.566 . . . . 16.829999999999998 110.954 178.371 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.66 -28.61 15.1 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 110.974 -0.85 . . . . 14.66 110.974 -175.213 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -98.82 -61.01 1.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.381 -0.6 . . . . 15.800000000000001 109.381 175.635 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 52.66 58.78 5.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.397 -0.819 . . . . 13.130000000000001 110.181 -179.301 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -75.71 119.19 19.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.615 -0.72 . . . . 11.74 110.696 -178.023 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.35 107.38 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.892 -0.594 . . . . 8.7200000000000006 110.702 179.915 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.34 141.9 29.35 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.591 . . . . 5.9299999999999997 110.453 -179.591 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.95 -1.23 6.59 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.903 2.402 . . . . 5.25 112.582 -178.912 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.94 -31.6 81.46 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.792 -0.523 . . . . 2.2799999999999998 111.792 176.532 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.19 73.11 10.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.068 0.461 . . . . 2.0699999999999998 109.957 175.785 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -169.47 128.35 0.98 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.538 -0.755 . . . . 3.1800000000000002 109.532 -177.95 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 42.8 t -73.65 103.9 4.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.581 -0.526 . . . . 0.53000000000000003 109.581 -179.289 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.64 -21.37 77.11 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.835 -0.62 . . . . 0.65000000000000002 113.485 -171.974 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 89.9 t -60.55 -38.09 77.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.887 0.375 . . . . 1.04 111.052 -179.101 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 29.3 p -109.24 -48.12 3.31 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.947 -0.301 . . . . 0.83999999999999997 110.491 179.771 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.03 -16.54 5.25 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.914 -0.66 . . . . 0.77000000000000002 112.536 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 33.7 m-20 -86.88 140.09 29.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.091 0.472 . . . . 2.1000000000000001 111.799 -177.888 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.15 -3.62 33.56 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.737 -0.665 . . . . 0.55000000000000004 111.47 173.864 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 25.3 m -80.88 136.46 36.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.329 . . . . 1.0600000000000001 111.052 177.899 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 64.65 44.79 3.73 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.793 0.806 . . . . 2.23 110.771 174.248 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.412 HG21 ' HB1' ' C' ' 33' ' ' ALA . 11.7 m -93.4 155.57 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.381 -0.827 . . . . 1.1599999999999999 111.751 -178.036 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' C' ' 36' ' ' TRP . 96.4 mt -97.17 145.51 25.97 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.355 -0.839 . . . . 0.47999999999999998 108.963 172.796 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' C' ' 32' ' ' ALA . 24.7 tpt180 -112.35 132.04 55.21 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.192 -0.458 . . . . 3.1800000000000002 110.361 -174.278 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.33 136.85 57.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.673 -0.491 . . . . 0.37 109.673 177.676 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 24.1 p -87.58 -26.91 22.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.75 111.049 -179.633 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -90.02 -20.32 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.582 . . . . 1.4299999999999999 111.502 -176.863 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.12 -166.07 2.43 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.338 -0.616 . . . . 0.79000000000000004 109.338 176.728 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.5 114.28 28.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.198 -0.297 . . . . 0.46999999999999997 110.198 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.463 ' O ' ' HD2' ' C' ' 26' ' ' ARG . . . -164.38 130.5 2.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.289 -0.414 . . . . 0.40000000000000002 110.187 -179.786 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.412 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -112.5 112.76 24.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.09 -0.505 . . . . 0.45000000000000001 109.845 176.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -152.11 163.79 38.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.229 -0.441 . . . . 0.60999999999999999 110.565 -173.359 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -97.43 137.92 35.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.241 -0.652 . . . . 0.41999999999999998 109.241 173.283 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.424 ' HB2' HD12 ' C' ' 25' ' ' LEU . 71.4 t-105 -60.91 -42.68 98.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.438 0.461 . . . . 0.68000000000000005 110.122 178.617 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -62.52 -34.74 77.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.907 0.384 . . . . 3.3300000000000001 111.293 -179.712 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.435 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 93.5 m -73.83 -22.44 59.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 0.54000000000000004 111.143 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -98.05 -40.86 8.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.306 -0.407 . . . . 0.60999999999999999 111.798 -177.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.408 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 83.6 m-85 -137.6 140.85 31.33 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.296 -0.411 . . . . 0.80000000000000004 109.971 -176.535 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.85 177.09 9.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.597 2.198 . . . . 2.1200000000000001 112.193 178.326 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.2 -22.24 64.58 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.571 -0.286 . . . . 3.2999999999999998 111.682 -178.154 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.66 -35.58 89.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.019 -0.61 . . . . 1.46 112.145 176.073 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 22.6 m -86.03 131.25 34.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.867 -0.419 . . . . 1.03 109.867 178.918 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.6 m -88.86 150.73 22.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.932 0.396 . . . . 1.6000000000000001 111.028 -176.576 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -99.18 130.61 26.87 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.845 -0.616 . . . . 2.6800000000000002 110.79 -174.012 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -71.13 140.41 37.54 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.325 2.016 . . . . 1.1399999999999999 111.72 175.856 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.87 -20.29 63.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.911 -0.662 . . . . 1.8999999999999999 112.023 -179.051 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.6 t -142.67 137.81 30.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.799 -0.445 . . . . 2.75 109.799 177.795 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.18 53.71 3.81 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.735 -0.745 . . . . 0.81999999999999995 112.082 -179.555 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.86 123.32 17.2 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.817 -0.438 . . . . 0.87 109.817 179.065 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -112.13 141.55 45.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.39 -0.368 . . . . 2.6499999999999999 110.934 -178.494 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.5 p -78.3 -179.58 6.34 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.003 -0.74 . . . . 0.48999999999999999 109.003 171.872 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -60.87 -44.23 97.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.762 0.315 . . . . 4.0899999999999999 110.735 -175.764 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -63.28 -48.62 77.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.067 -0.515 . . . . 1.54 111.408 -178.355 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.9 m -71.68 -17.1 62.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.779 0.323 . . . . 0.71999999999999997 111.372 -179.363 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 27.1 t -78.23 -13.68 59.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 1.25 110.309 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -133.61 -171.37 12.63 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.729 -0.748 . . . . 2.1899999999999999 112.189 -179.686 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -147.29 142.09 26.8 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.022 -0.362 . . . . 5.1500000000000004 110.022 178.414 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.64 87.05 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.175 -0.466 . . . . 6.7599999999999998 109.79 179.464 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -79.45 121.65 83.0 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.158 -0.474 . . . . 8.8300000000000001 110.754 -179.533 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.4 133.65 19.49 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.421 2.081 . . . . 11.039999999999999 112.244 -177.829 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.35 129.96 23.31 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.952 -0.567 . . . . 13.859999999999999 110.266 179.796 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.6 91.45 0.16 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.569 2.179 . . . . 16.550000000000001 111.616 174.907 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -89.24 78.72 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.294 0.568 . . . . 18.07 109.481 179.458 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.276 -0.869 . . . . 20.260000000000002 109.634 -179.313 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.784 -0.526 . . . . 20.379999999999999 111.784 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.0 -28.03 61.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.693 0.282 . . . . 18.809999999999999 111.095 -179.084 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.6 tpp -79.57 80.77 5.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 18.059999999999999 109.763 178.256 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -138.14 139.62 39.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.813 -0.631 . . . . 16.829999999999998 109.83 -179.302 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.48 106.79 0.31 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.636 -0.792 . . . . 14.66 112.233 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . 0.432 ' HG2' ' HG3' ' C' ' 7' ' ' GLN . 5.6 pm0 -70.26 -17.44 63.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.926 0.393 . . . . 15.800000000000001 110.804 -179.801 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . 0.432 ' HG3' ' HG2' ' C' ' 6' ' ' GLN . 45.7 mt-30 -117.09 22.48 12.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.207 0.527 . . . . 13.130000000000001 110.28 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -64.02 -41.61 97.4 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.042 -0.725 . . . . 11.74 109.042 175.338 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -111.04 80.48 1.31 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.427 -0.806 . . . . 8.7200000000000006 109.162 172.206 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -64.64 134.86 96.15 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.577 -0.738 . . . . 5.9299999999999997 110.727 -178.091 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 13.5 Cg_exo -70.51 54.57 1.48 Allowed 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.148 2.565 . . . . 5.25 113.207 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.24 -25.28 75.83 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.178 -0.769 . . . . 2.2799999999999998 111.178 174.515 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.08 116.79 32.2 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.631 -0.507 . . . . 2.0699999999999998 109.631 173.481 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -150.57 143.52 24.71 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.2 -0.667 . . . . 3.1800000000000002 109.2 -176.867 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' C' ' 17' ' ' VAL . 43.9 t -64.39 105.99 1.04 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.349 -0.241 . . . . 0.53000000000000003 110.349 -179.948 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.85 -12.14 67.34 Favored Glycine 0 C--O 1.228 -0.271 0 C-N-CA 121.296 -0.478 . . . . 0.65000000000000002 112.347 -179.856 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.454 ' HB ' ' SG ' ' C' ' 15' ' ' CYS . 61.0 t -76.77 -28.71 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.306 0.574 . . . . 1.04 110.213 176.59 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.1 m -110.38 -36.17 5.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.004 -0.544 . . . . 0.83999999999999997 112.036 -177.976 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.65 7.89 74.5 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.045 -0.822 . . . . 0.77000000000000002 111.045 -173.651 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -126.51 154.58 43.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.547 -0.326 . . . . 2.1000000000000001 111.022 -176.871 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.91 16.36 12.18 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.402 -0.679 . . . . 0.55000000000000004 111.402 175.332 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 48.6 m -80.05 125.57 29.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.667 -0.266 . . . . 1.0600000000000001 111.166 -179.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 54.18 45.83 26.58 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 122.207 1.003 . . . . 2.23 110.028 -178.579 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.7 p -96.04 151.82 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.078 -0.964 . . . . 1.1599999999999999 109.399 -177.159 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 94.5 mt -94.34 146.75 23.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.107 0.479 . . . . 0.47999999999999998 110.749 -178.108 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 21.6 mmm180 -107.31 149.79 27.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.1800000000000002 109.876 -178.865 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.408 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.9 t -84.31 139.11 32.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.102 -0.703 . . . . 0.37 109.102 176.8 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 8.6 p -87.4 -13.12 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.504 0.557 . . . . 0.75 112.504 -174.857 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -111.92 -20.8 11.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.823 0.344 . . . . 1.4299999999999999 110.396 -179.478 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.408 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 2.0 p -140.32 -177.12 4.88 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.532 -0.544 . . . . 0.79000000000000004 109.532 176.379 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.32 28.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.345 -0.389 . . . . 0.46999999999999997 110.224 -177.974 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.56 146.61 13.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.226 -0.443 . . . . 0.40000000000000002 110.742 -176.645 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -125.59 111.84 15.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.876 -0.602 . . . . 0.45000000000000001 109.617 176.143 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -157.8 144.03 17.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.60999999999999999 109.67 -178.777 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.906 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 57.7 m80 -75.18 140.38 43.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.207 -1.035 . . . . 0.41999999999999998 108.207 171.021 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.8 t-105 -54.41 -50.76 66.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 117.783 0.265 . . . . 0.68000000000000005 110.804 -175.922 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 76.6 mtp180 -64.02 -15.28 59.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 3.3300000000000001 112.344 -176.295 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.906 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 57.3 m -83.92 -20.99 32.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.027 0.441 . . . . 0.54000000000000004 110.697 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -108.59 -25.88 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.60999999999999999 111.106 176.325 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.586 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 61.9 m-85 -132.86 139.03 33.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.398 -0.364 . . . . 0.80000000000000004 110.277 -178.565 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 148.25 90.63 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.605 2.203 . . . . 2.1200000000000001 111.475 175.451 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.05 -19.26 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.308 -0.86 . . . . 3.2999999999999998 112.718 -172.525 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.4 -23.12 77.9 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.68 -0.771 . . . . 1.46 111.988 177.707 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -81.11 143.29 32.53 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.0 -0.37 . . . . 1.03 110.0 179.423 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -88.8 131.62 34.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 1.6000000000000001 111.057 -174.818 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 22.8 ptt180 -75.9 128.81 82.56 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.874 -0.603 . . . . 2.6800000000000002 109.932 175.976 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 24.0 Cg_exo -63.21 132.23 35.49 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.383 2.055 . . . . 1.1399999999999999 112.249 -178.668 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.1 -22.07 31.14 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.144 -0.782 . . . . 1.8999999999999999 111.144 176.451 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 20.1 p -89.84 52.4 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.176 0.512 . . . . 2.75 110.577 177.972 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 108.77 3.14 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.673 -0.775 . . . . 0.81999999999999995 112.225 -178.501 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -67.59 123.2 19.8 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.247 -0.649 . . . . 0.87 109.247 177.179 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -122.76 135.14 54.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.342 -0.39 . . . . 2.6499999999999999 110.732 -175.63 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.0 p -76.81 158.69 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.173 -0.676 . . . . 0.48999999999999999 109.173 175.736 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -56.21 -31.16 63.24 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.737 0.699 . . . . 4.0899999999999999 111.714 -170.415 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 23.3 t -65.91 -46.43 78.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.568 0.223 . . . . 1.54 110.741 179.079 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 84.6 m -72.08 -23.87 61.41 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.726 0.298 . . . . 0.71999999999999997 111.219 -179.978 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -78.39 0.53 25.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.398 -0.365 . . . . 1.25 111.045 179.631 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.88 -126.59 9.76 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.725 -0.55 . . . . 2.1899999999999999 111.725 179.574 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -89.94 135.72 33.47 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.66 -0.496 . . . . 5.1500000000000004 109.66 175.675 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 52.8 t -93.11 131.26 40.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.171 -0.468 . . . . 6.7599999999999998 110.288 -179.652 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 39.9 p -90.22 117.79 68.32 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.432 -0.349 . . . . 8.8300000000000001 110.123 178.217 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.51 134.87 64.0 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.804 2.336 . . . . 11.039999999999999 112.271 179.594 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.21 130.68 85.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.072 -0.513 . . . . 13.859999999999999 110.557 179.678 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.01 88.24 0.45 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.546 2.164 . . . . 16.550000000000001 112.548 -179.564 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.6 m -98.66 12.07 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 18.07 111.001 178.229 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.649 -0.691 . . . . 20.260000000000002 109.668 179.863 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.931 -0.468 . . . . 20.379999999999999 111.931 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.75 54.28 10.8 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 122.831 0.452 . . . . 18.809999999999999 111.822 177.652 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ptp -119.94 157.58 28.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.175 -0.466 . . . . 18.059999999999999 110.197 179.06 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -159.35 -39.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.037 0.446 . . . . 16.829999999999998 110.31 -177.633 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.18 178.43 38.39 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.973 -0.632 . . . . 14.66 111.568 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 57.94 46.28 16.86 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.402 0.62 . . . . 15.800000000000001 110.71 -179.987 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.33 19.82 11.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.537 -0.756 . . . . 13.130000000000001 110.271 -177.882 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -61.03 -52.78 63.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.58 -0.736 . . . . 11.74 110.336 -178.185 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 50.6 tp -70.58 104.72 2.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.119 -0.491 . . . . 8.7200000000000006 110.023 176.891 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -69.81 123.02 87.79 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.397 -0.365 . . . . 5.9299999999999997 110.434 179.514 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 16.8 Cg_exo -66.77 105.44 0.94 Allowed 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.605 2.204 . . . . 5.25 111.748 177.536 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.72 -58.73 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.677 -0.773 . . . . 2.2799999999999998 112.024 -179.689 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.15 158.19 38.59 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.242 -0.281 . . . . 2.0699999999999998 110.242 179.695 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.68 167.0 31.81 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.294 -0.632 . . . . 3.1800000000000002 109.294 -179.755 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -66.85 105.7 1.67 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.003 -0.369 . . . . 0.53000000000000003 110.003 179.458 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.66 -30.05 75.61 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.347 -0.454 . . . . 0.65000000000000002 112.597 -176.957 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -67.02 -30.6 50.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.042 0.449 . . . . 1.04 110.779 -179.37 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 98.4 m -101.26 -36.73 8.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.173 -0.467 . . . . 0.83999999999999997 111.764 -178.302 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.59 -1.66 66.51 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.258 -0.737 . . . . 0.77000000000000002 111.258 -174.746 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -120.91 145.29 47.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.993 0.425 . . . . 2.1000000000000001 110.875 -177.039 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.23 14.7 56.84 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.711 -0.677 . . . . 0.55000000000000004 111.481 172.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 9.3 m -63.95 119.63 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.397 0.279 . . . . 1.0600000000000001 110.532 178.014 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 52.88 50.82 17.18 Favored 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.709 0.631 . . . . 2.23 110.753 -178.878 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.414 HG21 ' HB1' ' C' ' 33' ' ' ALA . 4.2 p -89.59 146.05 6.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.585 -0.734 . . . . 1.1599999999999999 110.39 -176.076 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.89 144.2 25.85 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.47999999999999998 110.232 179.194 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -106.77 146.54 30.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.803 -0.635 . . . . 3.1800000000000002 109.767 -178.386 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' C' ' 32' ' ' ALA . 5.3 t -80.49 138.72 36.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.985 -0.746 . . . . 0.37 108.985 176.256 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -92.91 -13.54 28.79 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 0.75 111.873 -177.299 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.93 -18.56 14.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.435 -0.348 . . . . 1.4299999999999999 111.198 178.795 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 6.0 p -149.72 -167.71 2.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.451 -0.574 . . . . 0.79000000000000004 109.451 177.059 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 114.7 29.11 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.719 0.295 . . . . 0.46999999999999997 110.402 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . . . -160.37 153.79 22.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.309 -0.405 . . . . 0.40000000000000002 110.858 -179.518 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.414 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -134.72 113.45 11.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.852 -0.613 . . . . 0.45000000000000001 109.67 176.095 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -155.38 163.26 40.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.899 -0.591 . . . . 0.60999999999999999 109.752 -178.438 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.714 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 27.8 m170 -94.01 139.21 31.22 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.787 -0.82 . . . . 0.41999999999999998 108.787 172.208 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' C' ' 46' ' ' ARG . 60.5 t-105 -49.29 -53.24 22.84 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 123.412 0.445 . . . . 0.68000000000000005 111.643 -176.559 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -71.07 -9.1 57.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 3.3300000000000001 112.19 -174.462 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 63.3 m -91.55 -21.34 20.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.984 0.421 . . . . 0.54000000000000004 110.76 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -107.63 -40.84 5.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.183 -0.462 . . . . 0.60999999999999999 110.958 177.865 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -113.81 148.56 40.12 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.992 -0.549 . . . . 0.80000000000000004 110.631 -175.428 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.02 154.17 73.31 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.852 2.368 . . . . 2.1200000000000001 112.144 177.84 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.19 -13.04 59.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.197 -0.911 . . . . 3.2999999999999998 111.95 -175.114 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.53 -7.22 85.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.944 -0.646 . . . . 1.46 111.906 176.145 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 7.6 m -101.29 129.81 47.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.014 -0.365 . . . . 1.03 110.014 177.709 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -87.73 130.77 34.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.796 -0.446 . . . . 1.6000000000000001 109.796 -179.34 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.409 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 16.3 ptm180 -71.56 118.6 67.78 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.905 -0.588 . . . . 2.6800000000000002 111.11 -175.71 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.57 132.92 22.97 Favored 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.682 2.255 . . . . 1.1399999999999999 112.549 -177.884 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.91 -22.86 51.7 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.905 -0.664 . . . . 1.8999999999999999 111.785 178.469 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.71 60.73 0.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.137 0.494 . . . . 2.75 110.934 -176.983 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.6 82.53 0.77 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.401 -0.904 . . . . 0.81999999999999995 112.458 179.356 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.8 OUTLIER -76.25 128.28 34.6 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.074 -0.713 . . . . 0.87 109.074 177.056 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -124.41 145.87 49.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.162 0.506 . . . . 2.6499999999999999 111.877 -174.774 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 17.0 p -83.58 -178.8 7.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.4 -0.818 . . . . 0.48999999999999999 108.909 171.914 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' C' ' 55' ' ' SER . 11.5 ptp180 -63.13 -41.2 99.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.289 0.495 . . . . 4.0899999999999999 111.476 -173.925 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' C' ' 54' ' ' ARG . 19.6 t -68.74 -40.68 79.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.787 0.327 . . . . 1.54 111.234 -175.153 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.43 -15.74 61.83 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.766 0.317 . . . . 0.71999999999999997 111.31 179.293 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -96.4 -13.61 23.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.078 0.466 . . . . 1.25 110.619 177.134 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.62 88.91 1.78 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.564 -0.614 . . . . 2.1899999999999999 111.564 -175.974 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' C' ' 55' ' ' SER . 5.6 p-10 -88.96 -6.16 57.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.19 0.519 . . . . 5.1500000000000004 110.744 -177.883 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.86 78.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.088 -0.708 . . . . 6.7599999999999998 109.088 175.934 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 8.7 m -59.98 117.44 23.52 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.335 -0.848 . . . . 8.8300000000000001 110.895 -177.371 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.91 136.33 38.0 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.509 2.139 . . . . 11.039999999999999 111.985 -178.827 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -78.71 131.04 68.81 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.221 -0.445 . . . . 13.859999999999999 110.153 177.789 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 52.1 Cg_exo -54.83 106.57 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.717 2.278 . . . . 16.550000000000001 111.889 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.89 151.57 3.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.146 -0.479 . . . . 18.07 110.055 -178.859 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.398 -0.81 . . . . 20.260000000000002 109.531 178.844 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.841 -0.504 . . . . 20.379999999999999 111.841 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.74 48.92 10.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.105 0.479 . . . . 18.809999999999999 111.315 178.555 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 51.3 ttp -89.61 64.12 6.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.504 0.668 . . . . 18.059999999999999 109.972 179.545 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -88.86 138.1 31.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.817 -0.629 . . . . 16.829999999999998 110.893 -177.462 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.71 -66.24 0.24 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.961 -0.638 . . . . 14.66 112.743 177.195 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 57.93 38.61 26.99 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.096 0.474 . . . . 15.800000000000001 110.873 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 25.2 pt20 -81.25 -1.26 44.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 13.130000000000001 111.101 -177.618 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -102.54 3.07 37.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.316 0.579 . . . . 11.74 109.857 175.178 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 53.1 tp -90.08 133.75 34.66 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.726 -0.67 . . . . 8.7200000000000006 110.119 -179.644 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -80.4 144.52 57.66 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 5.9299999999999997 110.348 179.577 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 11.3 Cg_exo -71.48 53.32 1.73 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.03 2.487 . . . . 5.25 112.429 177.648 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.11 -86.05 1.29 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.74 -0.544 . . . . 2.2799999999999998 111.74 -177.843 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.21 108.13 3.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.717 0.294 . . . . 2.0699999999999998 110.217 179.136 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -162.12 142.68 10.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 3.1800000000000002 110.202 -176.409 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 44.3 t -65.92 118.96 10.48 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.086 -0.339 . . . . 0.53000000000000003 110.086 177.975 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.33 -17.07 77.35 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.884 -0.674 . . . . 0.65000000000000002 112.265 -179.548 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 51.7 t -82.74 -31.62 9.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.568 0.223 . . . . 1.04 111.117 179.734 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 71.1 m -106.52 -29.13 9.85 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.571 0.582 . . . . 0.83999999999999997 112.571 -177.175 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.06 81.05 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.894 -0.882 . . . . 0.77000000000000002 110.894 -172.48 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -138.49 154.0 48.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.181 -0.51 . . . . 2.1000000000000001 110.141 -172.877 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -124.09 23.97 6.41 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.02 -0.609 . . . . 0.55000000000000004 112.63 179.209 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -81.5 130.87 35.21 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.209 -0.293 . . . . 1.0600000000000001 110.209 178.474 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 56.23 37.47 28.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.365 0.602 . . . . 2.23 109.959 -177.5 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.45 HG11 ' HB1' ' C' ' 33' ' ' ALA . 1.8 p -90.21 158.0 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 1.1599999999999999 110.565 -174.428 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' C' ' 34' ' ' PHE . 79.7 mt -95.63 146.38 24.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.74 0.305 . . . . 0.47999999999999998 110.348 176.577 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -109.89 131.51 55.0 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.924 -0.58 . . . . 3.1800000000000002 110.015 179.592 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 7.2 t -66.97 132.37 47.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.111 -0.7 . . . . 0.37 109.111 176.386 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.02 -17.52 32.78 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.256 0.551 . . . . 0.75 111.121 -178.926 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -97.77 -20.12 17.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.011 -0.541 . . . . 1.4299999999999999 111.339 -177.346 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -151.48 -164.72 2.06 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.104 -0.702 . . . . 0.79000000000000004 109.104 176.096 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.2 114.15 28.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.203 -0.295 . . . . 0.46999999999999997 110.203 178.54 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.22 131.85 1.96 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.294 -0.412 . . . . 0.40000000000000002 110.868 -179.143 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.45 ' HB1' HG11 ' C' ' 24' ' ' VAL . . . -111.87 113.44 25.78 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.73 -0.668 . . . . 0.45000000000000001 109.739 177.121 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.511 ' O ' ' HB2' ' C' ' 25' ' ' LEU . 25.3 p90 -151.99 146.53 25.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.254 -0.43 . . . . 0.60999999999999999 109.986 -179.832 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.892 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 53.7 m80 -79.55 135.2 36.55 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.419 -0.956 . . . . 0.41999999999999998 108.419 171.338 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.447 ' HB2' ' CD1' ' C' ' 25' ' ' LEU . 73.9 t-105 -51.28 -52.04 48.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.671 0.272 . . . . 0.68000000000000005 111.482 -174.042 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 -68.17 -16.78 64.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.9 -0.591 . . . . 3.3300000000000001 112.124 -173.456 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.892 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 58.2 m -77.93 -22.85 48.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.186 0.517 . . . . 0.54000000000000004 110.52 178.804 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -104.54 -50.29 3.34 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.972 -0.558 . . . . 0.60999999999999999 110.67 179.131 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' C' ' 41' ' ' PRO . 78.2 m-85 -108.16 122.04 41.84 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.511 -0.768 . . . . 0.80000000000000004 109.702 -177.089 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' C' ' 40' ' ' PHE . 50.8 Cg_exo -55.21 162.73 5.31 Favored 'Trans proline' 0 C--O 1.236 0.411 0 C-N-CA 122.972 2.448 . . . . 2.1200000000000001 112.38 -179.338 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.77 -18.27 41.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.865 -1.062 . . . . 3.2999999999999998 112.669 -170.75 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.66 4.73 77.64 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.987 -0.625 . . . . 1.46 112.603 178.503 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 91.1 m -112.59 133.32 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.749 0.309 . . . . 1.03 110.512 177.725 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -88.8 144.4 26.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.056 -0.52 . . . . 1.6000000000000001 110.597 -175.971 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . 0.443 ' HA ' ' HD3' ' C' ' 47' ' ' PRO . 45.9 ttp180 -87.2 122.23 71.04 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.794 -0.639 . . . . 2.6800000000000002 110.84 -179.551 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' C' ' 46' ' ' ARG . 12.3 Cg_exo -69.0 132.26 24.15 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.503 2.135 . . . . 1.1399999999999999 111.736 176.957 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.88 -14.73 48.33 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.971 -0.633 . . . . 1.8999999999999999 112.18 -179.741 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 12.9 t -88.83 -10.7 47.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.736 0.303 . . . . 2.75 111.206 -178.218 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.76 122.79 0.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.847 -0.692 . . . . 0.81999999999999995 111.654 -178.721 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.41 123.23 33.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.005 0.431 . . . . 0.87 110.155 -177.602 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -116.65 128.94 55.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.458 . . . . 2.6499999999999999 110.736 -178.85 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.503 ' HA ' ' CZ ' ' C' ' 34' ' ' PHE . 17.8 p -75.3 -169.74 1.04 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.855 -0.612 . . . . 0.48999999999999999 110.072 175.313 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -57.69 -52.83 63.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.373 -0.376 . . . . 4.0899999999999999 111.403 -176.663 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 27.9 t -68.72 -42.78 77.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.539 -0.301 . . . . 1.54 111.808 -175.49 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 75.7 m -71.93 -17.36 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.797 0.332 . . . . 0.71999999999999997 111.88 -176.627 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -88.15 8.31 27.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.094 0.473 . . . . 1.25 110.532 -179.117 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.22 174.47 29.62 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.685 -0.769 . . . . 2.1899999999999999 112.159 179.532 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -132.43 92.86 3.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.644 -0.502 . . . . 5.1500000000000004 109.644 176.794 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -89.36 102.59 13.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.869 -0.605 . . . . 6.7599999999999998 110.774 -176.528 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 87.4 m -67.98 130.17 92.83 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.842 -0.617 . . . . 8.8300000000000001 110.392 177.014 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.34 135.21 52.64 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.636 2.224 . . . . 11.039999999999999 112.145 179.123 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.8 120.88 83.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.894 -0.594 . . . . 13.859999999999999 111.046 -178.883 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.49 131.49 15.0 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.305 2.004 . . . . 16.550000000000001 111.354 176.572 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.9 -9.24 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.955 0.407 . . . . 18.07 111.168 -179.4 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.704 -0.665 . . . . 20.260000000000002 110.324 177.93 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.015 -0.434 . . . . 20.379999999999999 112.015 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.17 111.82 17.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.756 0.312 . . . . 18.809999999999999 110.292 178.675 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 49.3 ttp -83.53 121.61 27.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.043 0.449 . . . . 18.059999999999999 110.577 -178.864 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -125.34 150.33 47.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.837 -0.619 . . . . 16.829999999999998 109.746 179.83 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.41 -59.99 0.63 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.212 -0.755 . . . . 14.66 111.212 -177.662 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -69.24 -30.89 69.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.187 0.518 . . . . 15.800000000000001 109.662 174.485 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -110.26 148.5 31.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.499 -0.773 . . . . 13.130000000000001 109.375 175.827 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -128.84 117.91 21.85 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.828 0.347 . . . . 11.74 110.393 -179.742 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -86.13 113.58 22.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.19 -0.459 . . . . 8.7200000000000006 110.245 -179.696 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.3 145.42 93.29 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.107 -0.497 . . . . 5.9299999999999997 110.568 178.516 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 23.6 Cg_exo -63.66 -11.48 26.59 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.977 2.452 . . . . 5.25 113.325 -177.454 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.37 77.72 1.11 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.967 -0.635 . . . . 2.2799999999999998 112.854 176.774 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' C' ' 33' ' ' ALA . . . -105.21 74.64 1.11 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.877 0.37 . . . . 2.0699999999999998 110.269 177.575 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -160.64 129.62 4.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.509 . . . . 3.1800000000000002 110.81 -177.929 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -71.3 110.59 6.03 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.24 -0.652 . . . . 0.53000000000000003 109.24 174.509 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.19 -24.71 65.6 Favored Glycine 0 C--O 1.229 -0.171 0 C-N-CA 121.304 -0.474 . . . . 0.65000000000000002 112.841 -176.449 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -72.99 -30.75 33.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.133 0.492 . . . . 1.04 110.781 179.168 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 95.3 m -104.63 -46.48 4.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.003 -0.544 . . . . 0.83999999999999997 112.299 -175.039 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.92 -8.34 45.86 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.436 -0.666 . . . . 0.77000000000000002 111.436 -174.041 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -108.51 154.14 22.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 2.1000000000000001 110.722 -179.83 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 11.15 30.38 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.112 -0.795 . . . . 0.55000000000000004 111.112 175.267 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -66.28 134.97 53.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.35 . . . . 1.0600000000000001 110.343 177.75 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 41.65 48.57 3.61 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.137 0.898 . . . . 2.23 111.757 -178.732 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.404 HG22 ' N ' ' C' ' 34' ' ' PHE . 2.0 p -89.06 146.67 5.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.165 -0.925 . . . . 1.1599999999999999 110.421 -176.319 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 33' ' ' ALA . 84.3 mt -96.99 157.64 15.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.474 -0.33 . . . . 0.47999999999999998 110.205 -179.998 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 9.3 mmm180 -120.71 141.45 50.42 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.921 -0.581 . . . . 3.1800000000000002 111.064 -174.225 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -72.81 139.77 47.24 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.823 -0.806 . . . . 0.37 108.823 173.203 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 40.7 p -92.4 -21.23 20.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.126 0.488 . . . . 0.75 111.217 179.43 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -89.54 -23.12 22.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 1.4299999999999999 110.623 -178.448 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.6 p -151.91 -164.91 2.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.207 -0.664 . . . . 0.79000000000000004 109.207 177.113 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.64 115.07 29.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.77 0.319 . . . . 0.46999999999999997 110.48 179.449 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -161.14 139.1 9.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.96 -0.563 . . . . 0.40000000000000002 110.331 178.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' C' ' 25' ' ' LEU . . . -121.24 118.93 30.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.001 -0.545 . . . . 0.45000000000000001 110.171 178.765 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . 0.404 ' N ' HG22 ' C' ' 24' ' ' VAL . 52.3 p90 -160.22 162.72 33.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.076 -0.511 . . . . 0.60999999999999999 109.901 179.928 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.667 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 22.7 m170 -91.34 133.35 35.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.099 -1.074 . . . . 0.41999999999999998 108.099 171.616 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.401 ' HB2' HD12 ' C' ' 25' ' ' LEU . 74.3 t-105 -59.3 -36.96 76.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 0.68000000000000005 110.915 -177.215 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -68.82 -19.88 64.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.182 -0.463 . . . . 3.3300000000000001 110.883 -179.697 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 61.5 m -90.57 -23.14 20.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.279 -0.419 . . . . 0.54000000000000004 111.071 -178.123 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -92.46 -38.59 11.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.394 -0.366 . . . . 0.60999999999999999 110.643 176.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 44' ' ' THR . 94.3 m-85 -126.66 73.47 74.76 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.125 -0.488 . . . . 0.80000000000000004 110.815 -178.753 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.07 0.06 10.22 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.018 2.479 . . . . 2.1200000000000001 112.057 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.7 3.41 29.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.874 -0.603 . . . . 3.2999999999999998 111.24 -177.828 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.43 24.8 30.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.625 -0.797 . . . . 1.46 112.35 179.747 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' C' ' 40' ' ' PHE . 7.2 m -66.18 141.93 57.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.869 -0.419 . . . . 1.03 109.869 176.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.8 t -88.13 133.04 34.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.004 0.431 . . . . 1.6000000000000001 110.228 -175.437 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -70.72 119.0 70.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.551 -0.749 . . . . 2.6800000000000002 110.548 -179.65 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.67 132.45 20.32 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.591 2.194 . . . . 1.1399999999999999 112.316 -179.42 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.18 -8.62 74.81 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.932 -0.651 . . . . 1.8999999999999999 111.566 177.355 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.9 p -91.96 28.52 1.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.945 0.403 . . . . 2.75 111.541 -179.963 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.72 121.76 3.06 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.941 -0.647 . . . . 0.81999999999999995 112.296 179.857 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 52' ' ' ARG . 0.5 OUTLIER -75.91 128.33 34.86 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.668 -0.493 . . . . 0.87 109.668 -178.821 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.413 ' N ' HD13 ' C' ' 51' ' ' LEU . 86.3 mtt180 -113.15 138.69 49.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.956 0.408 . . . . 2.6499999999999999 111.395 -176.845 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.0 p -88.89 -176.45 5.2 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.213 -0.662 . . . . 0.48999999999999999 109.213 173.779 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -67.29 -39.52 85.98 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.41 -0.516 . . . . 4.0899999999999999 111.332 -175.87 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 42.3 t -67.17 -45.4 77.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.598 0.237 . . . . 1.54 110.729 -178.381 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 76.7 m -71.9 -17.26 62.11 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.661 0.245 . . . . 0.71999999999999997 111.661 -179.512 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 24.0 m -96.28 -14.19 22.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.93 0.395 . . . . 1.25 110.985 178.699 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.53 85.71 0.5 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.736 -0.745 . . . . 2.1899999999999999 111.899 -177.944 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.58 146.09 24.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.947 0.403 . . . . 5.1500000000000004 110.316 -178.874 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.04 131.39 50.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.094 -0.503 . . . . 6.7599999999999998 110.134 179.737 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 p -80.25 123.52 83.15 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.559 -0.291 . . . . 8.8300000000000001 110.392 176.223 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.25 133.94 37.15 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.398 2.065 . . . . 11.039999999999999 111.676 -178.097 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -82.25 135.56 47.33 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.346 -0.388 . . . . 13.859999999999999 110.173 -179.673 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -79.56 42.88 1.38 Allowed 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 122.674 2.249 . . . . 16.550000000000001 112.308 179.627 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.84 108.88 19.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.117 -0.492 . . . . 18.07 110.629 -177.077 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.612 -0.709 . . . . 20.260000000000002 110.077 -179.855 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.851 -0.499 . . . . 20.379999999999999 111.851 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.48 -24.29 25.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.967 0.413 . . . . 18.809999999999999 110.825 179.748 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.49 123.48 23.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.14 0.495 . . . . 18.059999999999999 110.54 -179.072 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -103.92 -52.38 2.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.752 -0.658 . . . . 16.829999999999998 110.0 -179.801 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.87 76.63 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.612 -0.722 . . . . 14.66 111.786 -179.164 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -71.0 -27.13 63.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.015 0.436 . . . . 15.800000000000001 109.929 -179.809 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -82.45 13.67 3.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.592 . . . . 13.130000000000001 111.277 178.517 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -93.91 14.81 18.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.948 0.404 . . . . 11.74 110.24 176.72 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.49 101.63 0.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.787 . . . . 8.7200000000000006 109.44 179.352 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' C' ' 11' ' ' PRO . . . -70.53 128.21 91.33 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.967 -0.56 . . . . 5.9299999999999997 110.864 -178.01 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' C' ' 10' ' ' ALA . 13.7 Cg_exo -71.18 52.51 1.48 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.134 2.556 . . . . 5.25 112.916 176.565 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.21 -29.83 65.95 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.331 -0.708 . . . . 2.2799999999999998 111.331 177.008 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.417 ' O ' ' HA3' ' C' ' 21' ' ' GLY . . . -126.24 74.78 1.47 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.353 -0.61 . . . . 2.0699999999999998 109.353 174.898 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.445 ' H ' ' HB1' ' C' ' 33' ' ' ALA . 29.5 ttm180 -166.34 112.81 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.954 -0.566 . . . . 3.1800000000000002 111.198 -176.513 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -68.22 122.91 19.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.646 -0.502 . . . . 0.53000000000000003 109.646 174.872 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.69 -24.85 64.77 Favored Glycine 0 C--O 1.229 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.65000000000000002 113.401 -175.023 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 59.6 t -84.04 -32.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.179 0.514 . . . . 1.04 111.177 -179.502 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 91.3 m -99.3 -40.36 7.96 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.315 0.487 . . . . 0.83999999999999997 112.315 -174.439 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.63 -17.62 58.96 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.191 -0.764 . . . . 0.77000000000000002 111.191 -173.076 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -94.5 148.8 21.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.868 0.365 . . . . 2.1000000000000001 110.616 -179.747 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' C' ' 13' ' ' ALA . . . -107.27 15.05 39.58 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.043 -0.599 . . . . 0.55000000000000004 111.623 176.261 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 20.8 m -74.76 124.38 26.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.253 . . . . 1.0600000000000001 110.401 178.805 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 55.77 42.9 28.63 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.915 -0.584 . . . . 2.23 110.823 -177.348 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 9.9 p -88.06 136.27 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.535 . . . . 1.1599999999999999 110.301 -175.538 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 mt -94.44 157.1 16.16 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.0 -0.546 . . . . 0.47999999999999998 109.913 -178.292 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 28.6 mmm180 -121.68 149.6 42.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.901 -0.591 . . . . 3.1800000000000002 110.189 -177.197 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . . . . . . . . . 9.1 t -81.56 143.64 31.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.805 -0.443 . . . . 0.37 109.805 -179.818 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 23.8 p -87.99 -21.91 24.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.273 -0.421 . . . . 0.75 111.576 -179.003 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -100.94 -17.61 16.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.541 -0.299 . . . . 1.4299999999999999 111.358 -177.219 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 p -151.13 -169.94 3.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.51 -0.552 . . . . 0.79000000000000004 109.51 177.512 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.02 114.87 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.489 -0.323 . . . . 0.46999999999999997 110.359 178.841 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -158.19 132.39 8.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.535 -0.302 . . . . 0.40000000000000002 110.77 -178.66 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -106.93 112.85 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.068 -0.515 . . . . 0.45000000000000001 109.852 176.263 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -158.78 164.74 35.55 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.298 -0.41 . . . . 0.60999999999999999 110.187 -177.63 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.66 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 28.6 m170 -98.81 138.83 35.39 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.439 -0.948 . . . . 0.41999999999999998 108.439 171.639 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -54.99 -46.3 75.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.644 0.259 . . . . 0.68000000000000005 110.54 -178.182 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 73.4 mtp180 -65.96 -18.3 65.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 3.3300000000000001 112.101 -177.855 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 79.7 m -85.35 -20.34 30.08 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.044 0.449 . . . . 0.54000000000000004 110.809 -179.19 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -99.93 -39.27 8.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.165 -0.471 . . . . 0.60999999999999999 110.777 174.974 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 94.9 m-85 -127.04 144.97 52.29 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.201 -0.454 . . . . 0.80000000000000004 109.903 -179.432 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -57.51 154.8 34.07 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.593 2.196 . . . . 2.1200000000000001 111.856 177.594 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.41 -10.97 28.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.707 -0.679 . . . . 3.2999999999999998 112.06 -174.68 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.54 -2.07 76.82 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.839 -0.696 . . . . 1.46 112.144 176.761 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.9 m -90.31 139.82 30.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.023 -0.362 . . . . 1.03 110.023 178.601 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 32.8 p -88.39 132.81 34.29 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.433 -0.349 . . . . 1.6000000000000001 110.873 -175.631 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -88.42 134.31 34.68 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.843 -0.617 . . . . 2.6800000000000002 110.911 -177.915 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.63 132.59 38.47 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 122.653 2.235 . . . . 1.1399999999999999 111.328 173.745 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.08 -51.2 5.46 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.869 -0.605 . . . . 1.8999999999999999 113.404 -174.023 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -95.73 -18.25 20.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.042 0.449 . . . . 2.75 111.214 -175.451 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.543 ' O ' ' HG3' ' C' ' 52' ' ' ARG . . . -131.78 67.89 0.56 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.537 -0.84 . . . . 0.81999999999999995 112.521 -178.428 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -61.77 122.63 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.25 -0.648 . . . . 0.87 109.25 176.89 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . 0.543 ' HG3' ' O ' ' C' ' 50' ' ' GLY . 53.2 mtm180 -121.38 140.23 52.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.972 0.415 . . . . 2.6499999999999999 111.122 -173.125 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 16.4 p -80.39 -174.72 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.48999999999999999 109.784 175.703 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -61.71 -49.56 75.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.614 0.245 . . . . 4.0899999999999999 111.19 -176.036 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.6 t -64.24 -43.92 93.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.432 -0.349 . . . . 1.54 111.28 -176.151 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 73.5 m -71.62 -19.7 62.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 121.157 -0.217 . . . . 0.71999999999999997 111.557 -178.064 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 56.0 m -83.41 -13.93 53.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.886 0.374 . . . . 1.25 110.732 178.811 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.8 170.6 13.37 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.241 -0.744 . . . . 2.1899999999999999 111.241 178.122 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.54 114.97 29.55 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.446 0.641 . . . . 5.1500000000000004 110.497 179.399 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . 0.502 ' O ' ' HD3' ' C' ' 62' ' ' PRO . 25.1 t -90.4 75.14 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 108.854 -0.795 . . . . 6.7599999999999998 108.854 176.583 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 10.5 p -99.52 105.57 34.36 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.525 -0.761 . . . . 8.8300000000000001 111.669 -175.09 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' C' ' 60' ' ' VAL . 13.1 Cg_exo -70.25 135.75 30.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.58 2.187 . . . . 11.039999999999999 111.453 176.319 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' C' ' 64' ' ' PRO . . . -62.23 120.69 60.63 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.19 -0.459 . . . . 13.859999999999999 110.346 179.4 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 63' ' ' ALA . 33.2 Cg_exo -62.49 92.82 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.026 2.484 . . . . 16.550000000000001 112.803 -178.223 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 31.9 m -105.29 156.74 6.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 18.07 110.585 178.622 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.701 -0.666 . . . . 20.260000000000002 109.329 177.755 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 N-CA-C 111.764 -0.534 . . . . 20.379999999999999 111.764 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.5 44.3 18.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.232 0.539 . . . . 18.809999999999999 110.808 -179.207 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -79.59 -30.69 41.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.805 -0.634 . . . . 18.059999999999999 110.917 -177.087 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 47.46 66.87 0.91 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.164 0.506 . . . . 16.829999999999998 111.168 -179.282 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.84 65.08 4.18 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.782 -0.645 . . . . 14.66 111.7 179.61 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -148.31 52.56 1.01 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.399 0.618 . . . . 15.800000000000001 109.973 -179.594 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -80.37 92.83 5.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.977 -0.556 . . . . 13.130000000000001 109.541 177.619 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 57.43 43.45 23.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.641 0.734 . . . . 11.74 110.14 -176.316 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 44.2 tp -102.21 134.0 46.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.632 -0.713 . . . . 8.7200000000000006 110.59 -176.044 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.73 146.07 34.74 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.132 -0.486 . . . . 5.9299999999999997 109.888 176.561 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.74 46.04 0.78 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.014 2.476 . . . . 5.25 112.476 178.295 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.78 169.68 36.32 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 111.305 -0.718 . . . . 2.2799999999999998 111.305 -177.445 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.464 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -80.82 80.93 7.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.989 0.423 . . . . 2.0699999999999998 111.144 -177.625 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . 0.426 ' HA ' ' HA2' ' C' ' 21' ' ' GLY . 61.9 mtm-85 -124.39 141.55 51.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.219 0.533 . . . . 3.1800000000000002 111.095 178.875 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . . . . . . . . . 4.2 t -87.7 104.88 16.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.831 . . . . 0.53000000000000003 109.698 178.873 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.16 -16.8 69.31 Favored Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.859 -0.609 . . . . 0.65000000000000002 113.846 -172.733 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 24.1 t -64.58 -29.91 48.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.108 0.48 . . . . 1.04 110.86 -179.258 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.94 -42.56 2.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.347 -0.388 . . . . 0.83999999999999997 110.388 178.137 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.88 -11.44 10.1 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.057 -0.592 . . . . 0.77000000000000002 111.812 -178.508 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.96 141.94 28.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.116 0.484 . . . . 2.1000000000000001 111.405 -177.634 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' C' ' 14' ' ' ARG . . . -110.98 16.86 27.64 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.577 -0.738 . . . . 0.55000000000000004 111.273 175.826 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 11.9 m -76.09 115.56 15.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.461 -0.37 . . . . 1.0600000000000001 110.323 179.344 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 45.77 70.99 0.31 Allowed 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.921 0.763 . . . . 2.23 112.062 178.776 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.464 HG21 ' HB1' ' C' ' 13' ' ' ALA . 15.2 m -88.4 146.39 6.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.254 -0.43 . . . . 1.1599999999999999 110.413 178.665 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.37 148.53 22.13 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.973 -0.558 . . . . 0.47999999999999998 109.836 -179.436 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -108.58 145.51 34.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.059 -0.519 . . . . 3.1800000000000002 110.054 -179.649 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.43 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 8.0 t -75.52 135.4 40.62 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.004 -0.739 . . . . 0.37 109.004 177.026 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 37.1 p -86.24 -7.26 58.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.939 0.4 . . . . 0.75 111.344 -179.522 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -110.75 -19.64 12.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.416 -0.356 . . . . 1.4299999999999999 111.157 -179.16 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 5.8 p -151.56 -172.13 4.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.714 -0.476 . . . . 0.79000000000000004 109.714 177.289 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -105.11 115.68 30.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.856 -0.156 . . . . 0.46999999999999997 111.397 -176.153 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.74 141.87 4.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.811 -0.177 . . . . 0.40000000000000002 111.127 179.241 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -108.25 118.11 35.91 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.791 -0.448 . . . . 0.45000000000000001 109.791 174.034 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -161.87 163.36 29.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.947 0.403 . . . . 0.60999999999999999 111.19 -175.222 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -96.6 140.59 30.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.365 -0.606 . . . . 0.41999999999999998 109.365 172.103 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -62.14 -42.31 99.12 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.537 -0.542 . . . . 0.68000000000000005 109.537 174.678 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 45.5 mtp180 -63.43 -22.75 67.07 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.917 -0.583 . . . . 3.3300000000000001 111.819 -179.442 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . . . . . . . . . 63.7 m -87.17 -21.82 25.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.416 -0.357 . . . . 0.54000000000000004 111.303 -179.055 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.42 -38.81 8.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.874 0.369 . . . . 0.60999999999999999 110.813 179.924 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -132.95 149.88 74.09 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.5 -0.556 . . . . 0.80000000000000004 109.5 -179.001 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.68 140.25 61.33 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.252 1.968 . . . . 2.1200000000000001 111.502 178.05 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.96 -8.83 17.41 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.718 . . . . 3.2999999999999998 111.944 -175.611 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.81 71.81 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.778 -0.929 . . . . 1.46 110.778 172.455 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -87.45 131.57 34.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.266 -0.642 . . . . 1.03 109.266 174.603 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 48.9 m -87.73 115.37 25.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.141 0.496 . . . . 1.6000000000000001 110.642 -176.083 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 40.6 ptt180 -57.96 136.3 83.77 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 2.6800000000000002 111.179 -178.599 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.74 135.24 32.4 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.951 2.434 . . . . 1.1399999999999999 112.89 -175.991 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.92 -10.66 71.75 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 121.042 -0.599 . . . . 1.8999999999999999 111.75 179.05 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 27.7 p -89.31 12.08 17.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.11 0.481 . . . . 2.75 111.057 -179.739 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.03 116.35 1.56 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.763 -0.732 . . . . 0.81999999999999995 112.504 178.405 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' C' ' 51' ' ' LEU . 0.3 OUTLIER -71.28 125.99 28.42 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.374 -0.602 . . . . 0.87 109.374 179.239 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -115.17 131.97 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.019 -0.537 . . . . 2.6499999999999999 111.062 -175.507 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 p -73.31 174.77 7.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.695 -0.854 . . . . 0.48999999999999999 108.695 172.056 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -58.29 -41.55 84.66 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.432 0.53 . . . . 4.0899999999999999 112.432 -169.245 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 25.2 t -69.41 -47.84 62.9 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 122.22 -0.3 . . . . 1.54 111.339 -178.385 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 56.0 m -72.36 -18.74 61.73 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.688 0.28 . . . . 0.71999999999999997 111.211 -178.781 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -84.59 -13.88 50.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.836 0.35 . . . . 1.25 110.429 -179.54 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.94 119.67 4.93 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.683 -0.77 . . . . 2.1899999999999999 112.04 -179.721 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -89.62 179.19 6.09 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.279 -0.637 . . . . 5.1500000000000004 109.279 179.738 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 m -110.99 102.68 14.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.436 0.636 . . . . 6.7599999999999998 111.033 -178.985 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 33.2 p -93.06 120.56 66.89 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.684 -0.689 . . . . 8.8300000000000001 110.163 178.448 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.56 142.64 95.48 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.456 2.104 . . . . 11.039999999999999 111.895 -178.938 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.9 138.67 69.39 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.155 -0.475 . . . . 13.859999999999999 110.099 179.034 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -73.61 57.79 3.72 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.878 2.385 . . . . 16.550000000000001 112.459 -179.404 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.44 139.59 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.935 -0.575 . . . . 18.07 110.026 178.073 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.381 -0.819 . . . . 20.260000000000002 110.084 179.412 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.96 -0.456 . . . . 20.379999999999999 111.96 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.0 107.07 4.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.922 0.391 . . . . 18.809999999999999 110.433 -179.503 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 62.8 mtt -95.76 -60.95 1.54 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.08 -0.509 . . . . 18.059999999999999 110.09 -179.721 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -103.87 -20.15 14.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.533 . . . . 16.829999999999998 110.958 178.758 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.11 72.29 2.77 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.125 -0.559 . . . . 14.66 112.977 -176.812 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -103.7 2.0 32.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.884 0.373 . . . . 15.800000000000001 110.238 177.666 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 64.62 24.29 12.97 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.293 -0.867 . . . . 13.130000000000001 111.416 177.934 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.16 119.74 36.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.93 -0.577 . . . . 11.74 109.558 176.935 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mp -79.77 73.37 6.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.064 0.459 . . . . 8.7200000000000006 110.598 -179.211 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.1 122.82 87.61 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.552 -0.536 . . . . 5.9299999999999997 109.552 175.846 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.57 -11.84 28.59 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.282 . . . . 5.25 113.169 -175.657 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.85 -46.61 3.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.849 -0.691 . . . . 2.2799999999999998 111.626 -176.419 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.83 76.86 2.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.245 0.545 . . . . 2.0699999999999998 110.609 176.953 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -144.39 145.13 31.76 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.478 -0.783 . . . . 3.1800000000000002 109.435 179.87 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' C' ' 20' ' ' ASP . 51.7 t -67.1 103.28 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.231 -0.655 . . . . 0.53000000000000003 109.231 177.567 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.24 -11.54 78.09 Favored Glycine 0 CA--C 1.509 -0.341 0 CA-C-N 115.834 -0.621 . . . . 0.65000000000000002 112.97 -171.472 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' C' ' 38' ' ' CYS . 58.6 t -65.73 -42.45 92.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.833 0.349 . . . . 1.04 110.38 178.932 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 30.8 p -104.25 -37.2 7.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.401 -0.363 . . . . 0.83999999999999997 110.684 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.01 -5.72 27.24 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.876 -0.678 . . . . 0.77000000000000002 112.184 -178.883 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.551 ' O ' ' HB3' ' C' ' 15' ' ' CYS . 5.6 m-20 -102.19 135.34 43.96 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.963 0.411 . . . . 2.1000000000000001 111.212 -179.211 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -107.63 1.64 34.29 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.239 -0.744 . . . . 0.55000000000000004 111.239 174.137 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 40.4 m -69.08 132.4 46.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.465 -0.368 . . . . 1.0600000000000001 110.636 177.359 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 16.0 t70 55.62 47.39 20.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.726 0.774 . . . . 2.23 109.885 178.25 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 p -89.81 149.3 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.274 -0.876 . . . . 1.1599999999999999 110.713 -173.971 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 88.1 mt -99.36 153.32 19.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.234 -0.439 . . . . 0.47999999999999998 110.45 -179.671 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 16.7 tpp180 -115.57 143.01 45.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.624 . . . . 3.1800000000000002 109.842 -177.983 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.519 ' HB3' ' O ' ' C' ' 30' ' ' CYS . 7.4 t -75.62 147.02 39.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.388 . . . . 0.37 110.077 177.326 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . . . . . . . . . 28.7 p -86.35 -38.46 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.514 . . . . 0.75 112.0 -179.482 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -90.43 -12.09 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.299 . . . . 1.4299999999999999 111.7 -176.571 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . 0.519 ' O ' ' HB3' ' C' ' 27' ' ' CYS . 4.8 p -150.97 -179.64 7.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.223 -0.658 . . . . 0.79000000000000004 109.223 174.768 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -103.6 115.54 30.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.866 -0.42 . . . . 0.46999999999999997 109.866 -179.752 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -159.91 136.34 8.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.913 -0.585 . . . . 0.40000000000000002 110.229 -179.023 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.88 112.18 25.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.103 -0.499 . . . . 0.45000000000000001 109.807 175.986 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -154.32 158.92 40.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.941 -0.572 . . . . 0.60999999999999999 109.98 -177.38 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -94.32 146.91 23.71 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.696 -0.483 . . . . 0.41999999999999998 109.696 173.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -56.81 -53.52 56.87 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 123.584 0.553 . . . . 0.68000000000000005 110.364 -179.632 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -63.9 -37.06 86.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.364 0.505 . . . . 3.3300000000000001 112.364 -175.549 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.422 ' HB3' ' HB ' ' C' ' 17' ' ' VAL . 70.7 m -65.46 -24.32 67.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.957 0.408 . . . . 0.54000000000000004 111.159 -177.989 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -100.89 -54.85 2.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.175 0.512 . . . . 0.60999999999999999 110.698 178.366 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -107.18 129.26 24.58 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.73 -0.668 . . . . 0.80000000000000004 109.66 -176.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.84 162.03 9.43 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.829 2.352 . . . . 2.1200000000000001 112.224 178.693 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.23 -11.19 38.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.322 -0.854 . . . . 3.2999999999999998 111.903 -173.782 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.34 -15.2 81.73 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.795 -0.717 . . . . 1.46 111.73 175.019 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 11.6 m -90.47 125.7 35.66 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.07 -0.345 . . . . 1.03 110.07 179.389 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 50.5 m -89.27 134.58 33.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.803 0.335 . . . . 1.6000000000000001 110.832 -177.895 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -71.46 124.35 90.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.893 -0.594 . . . . 2.6800000000000002 111.097 -177.631 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.05 143.4 36.09 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.852 2.368 . . . . 1.1399999999999999 112.81 -178.558 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.32 -10.3 48.52 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.915 -0.66 . . . . 1.8999999999999999 112.33 178.801 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -89.14 0.09 57.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.347 0.594 . . . . 2.75 110.655 -179.887 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 144.71 119.15 1.28 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.985 -0.626 . . . . 0.81999999999999995 111.986 -178.529 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -88.19 123.93 33.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.107 0.479 . . . . 0.87 110.318 -179.109 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 74.1 mtm180 -122.58 142.8 50.24 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.001 -0.545 . . . . 2.6499999999999999 111.34 -173.998 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . . . . . . . . . 14.5 p -73.39 165.76 24.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.48999999999999999 109.489 175.176 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -53.93 -34.63 60.14 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.157 0.435 . . . . 4.0899999999999999 111.899 -173.145 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 28.0 t -66.09 -50.05 65.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.924 0.392 . . . . 1.54 110.455 -179.738 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 78.5 m -72.92 -26.54 61.44 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.117 0.414 . . . . 0.71999999999999997 112.117 -178.571 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -89.53 0.28 57.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.99 0.424 . . . . 1.25 111.044 -178.954 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.13 46.68 2.22 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.776 -0.726 . . . . 2.1899999999999999 111.986 -179.312 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -110.24 20.75 17.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.16 0.505 . . . . 5.1500000000000004 110.31 -179.148 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 t -88.72 70.42 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.574 0.702 . . . . 6.7599999999999998 109.84 -177.836 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 4.2 p -106.35 125.33 33.19 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.405 -0.816 . . . . 8.8300000000000001 110.633 -179.854 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.8 133.99 22.96 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.305 2.003 . . . . 11.039999999999999 111.804 179.182 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.91 127.04 90.09 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.988 -0.551 . . . . 13.859999999999999 110.995 179.888 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.8 86.36 0.9 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.54 2.16 . . . . 16.550000000000001 111.593 178.157 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.55 113.27 26.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 18.07 110.414 -177.932 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.681 -0.676 . . . . 20.260000000000002 109.921 -178.668 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.477 -0.249 . . . . 20.379999999999999 112.477 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.68 89.48 5.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.963 0.411 . . . . 18.809999999999999 111.383 -176.114 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 3' ' ' MET . . . . . . . . . . . . . 65.4 mtt -88.34 -55.69 3.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.089 -0.708 . . . . 18.059999999999999 109.089 174.774 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 57.06 58.71 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 16.829999999999998 111.409 177.68 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.9 -17.81 12.48 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.181 -0.918 . . . . 14.66 111.077 173.92 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 6' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -125.46 20.29 8.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.873 0.368 . . . . 15.800000000000001 110.829 179.998 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 7' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 57.35 78.54 0.23 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.223 -0.898 . . . . 13.130000000000001 111.273 -179.365 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 8' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -94.47 -51.02 4.95 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.818 -0.438 . . . . 11.74 109.818 179.47 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 9' ' ' LEU . . . . . . . . . . . . . 49.7 tp -69.57 113.8 7.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 8.7200000000000006 109.552 176.77 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.48 133.31 56.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 5.9299999999999997 110.745 -177.151 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 11' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.52 57.86 2.41 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 123.032 2.488 . . . . 5.25 111.878 176.939 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.67 19.09 56.03 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.755 -0.657 . . . . 2.2799999999999998 112.551 -177.385 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.08 71.9 1.64 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.297 0.57 . . . . 2.0699999999999998 109.928 177.756 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 14' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -150.65 129.71 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.327 -0.852 . . . . 3.1800000000000002 109.356 -179.596 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 15' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' C' ' 33' ' ' ALA . 32.0 t -62.0 112.65 2.42 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.723 -0.473 . . . . 0.53000000000000003 109.723 178.22 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.59 -23.77 55.5 Favored Glycine 0 C--N 1.329 0.17 0 C-N-CA 121.38 -0.438 . . . . 0.65000000000000002 112.993 -175.911 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . . . . . . . . . 41.3 t -79.03 -32.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.845 0.355 . . . . 1.04 111.142 179.701 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 18' ' ' CYS . . . . . . . . . . . . . 80.3 m -105.92 -47.42 3.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.194 0.442 . . . . 0.83999999999999997 112.194 -174.689 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.0 -23.25 19.59 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.444 -0.663 . . . . 0.77000000000000002 111.444 -173.902 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -89.78 152.21 21.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.732 0.301 . . . . 2.1000000000000001 111.069 -178.165 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 21' ' ' GLY . . . . . . . . . . . . . . . -108.83 6.79 33.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.043 -0.599 . . . . 0.55000000000000004 111.804 177.307 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 33.3 m -70.58 127.9 34.29 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.645 -0.132 . . . . 1.0600000000000001 110.645 178.563 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 58.11 39.44 26.11 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.51 0.506 . . . . 2.23 110.906 179.55 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 24' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' C' ' 33' ' ' ALA . 3.6 p -89.23 148.15 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.232 -0.44 . . . . 1.1599999999999999 110.53 -175.093 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -114.62 148.64 37.83 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.023 -0.535 . . . . 0.47999999999999998 110.217 -179.069 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 26' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' C' ' 32' ' ' ALA . 7.2 mpt_? -119.31 148.63 42.95 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.647 -0.501 . . . . 3.1800000000000002 109.647 179.967 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 27' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' C' ' 53' ' ' CYS . 40.3 t -68.95 139.28 55.05 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.112 -0.635 . . . . 0.37 109.486 174.307 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 28' ' ' THR . . . . . 0.408 HG21 ' HA3' ' C' ' 50' ' ' GLY . 12.4 t -85.07 4.43 34.1 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.424 0.631 . . . . 0.75 110.596 178.932 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 29' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -127.62 -8.6 5.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 1.4299999999999999 110.68 176.7 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 30' ' ' CYS . . . . . . . . . . . . . 9.0 m -145.02 177.44 8.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.043 -0.526 . . . . 0.79000000000000004 110.13 -177.948 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.3 112.96 26.2 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.802 -0.814 . . . . 0.46999999999999997 108.802 173.072 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 32' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' C' ' 26' ' ' ARG . . . -165.0 111.8 0.98 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.088 -0.505 . . . . 0.40000000000000002 110.531 -179.544 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' C' ' 24' ' ' VAL . . . -93.21 112.58 24.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.007 0.432 . . . . 0.45000000000000001 109.903 176.057 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 34' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -153.68 158.1 40.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.878 -0.601 . . . . 0.60999999999999999 109.828 -179.81 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 35' ' ' HIS . . . . . 0.76 ' HB2' ' SG ' ' C' ' 38' ' ' CYS . 26.4 m170 -87.24 138.45 31.48 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.166 -1.05 . . . . 0.41999999999999998 108.166 172.192 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -48.94 -50.99 32.76 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 123.107 0.254 . . . . 0.68000000000000005 111.443 -175.849 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 37' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' C' ' 40' ' ' PHE . 90.8 mtt180 -67.71 -10.46 52.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.016 -0.538 . . . . 3.3300000000000001 112.099 -175.325 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 38' ' ' CYS . . . . . 0.76 ' SG ' ' HB2' ' C' ' 35' ' ' HIS . 60.6 m -89.96 -21.63 22.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.906 0.384 . . . . 0.54000000000000004 110.947 -179.083 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -101.94 -36.87 8.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.257 -0.429 . . . . 0.60999999999999999 110.486 174.92 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 40' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' C' ' 37' ' ' ARG . 57.3 m-85 -124.5 150.0 63.38 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.989 -0.55 . . . . 0.80000000000000004 110.219 -176.061 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 41' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.83 144.18 94.16 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.565 2.176 . . . . 2.1200000000000001 111.089 172.786 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.85 -15.6 55.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.542 -0.754 . . . . 3.2999999999999998 111.982 -175.733 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.75 -24.34 76.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.87 -0.681 . . . . 1.46 112.157 175.723 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 44' ' ' THR . . . . . . . . . . . . . 21.8 m -75.94 136.5 40.06 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.988 -0.375 . . . . 1.03 109.988 179.328 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 45' ' ' SER . . . . . . . . . . . . . 19.7 m -87.94 128.96 35.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.105 0.479 . . . . 1.6000000000000001 111.266 -172.959 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 46' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -69.24 119.16 68.42 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.437 -0.801 . . . . 2.6800000000000002 110.194 179.366 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 47' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.62 132.8 22.65 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.537 2.158 . . . . 1.1399999999999999 112.405 -176.317 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.05 -11.53 67.32 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.438 -0.665 . . . . 1.8999999999999999 111.438 177.126 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 21.5 p -89.7 37.44 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.368 0.604 . . . . 2.75 110.634 179.654 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . 0.408 ' HA3' HG21 ' C' ' 28' ' ' THR . . . 105.72 123.85 5.24 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 111.869 -178.12 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 123.73 22.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.105 -0.702 . . . . 0.87 109.105 178.406 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 52' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -115.52 128.48 56.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.945 0.403 . . . . 2.6499999999999999 110.993 -174.876 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 53' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' C' ' 27' ' ' CYS . 15.6 p -73.24 174.13 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.724 -0.671 . . . . 0.48999999999999999 109.672 177.507 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -57.66 -37.87 74.13 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.862 0.301 . . . . 4.0899999999999999 111.655 -170.309 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 55' ' ' SER . . . . . . . . . . . . . 32.9 t -69.31 -38.84 78.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.977 0.418 . . . . 1.54 110.343 179.992 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 56' ' ' CYS . . . . . . . . . . . . . 68.7 m -73.18 -33.24 65.3 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.19 -0.459 . . . . 0.71999999999999997 111.984 -179.371 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 57' ' ' SER . . . . . . . . . . . . . 25.1 p -83.84 -14.94 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.005 0.431 . . . . 1.25 110.873 179.438 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.79 -58.89 1.66 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.956 -0.857 . . . . 2.1899999999999999 110.956 175.468 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -92.01 89.74 7.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.402 -0.592 . . . . 5.1500000000000004 109.402 174.753 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 60' ' ' VAL . . . . . . . . . . . . . 50.0 t -88.87 104.28 14.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.951 -0.568 . . . . 6.7599999999999998 110.479 -175.899 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 61' ' ' THR . . . . . . . . . . . . . 11.6 p -105.73 108.39 61.45 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.773 -0.649 . . . . 8.8300000000000001 110.608 179.533 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.79 140.61 95.79 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.645 2.23 . . . . 11.039999999999999 111.807 178.715 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.39 136.43 91.84 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.991 -0.55 . . . . 13.859999999999999 110.861 -178.683 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 64' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.71 69.71 5.99 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.778 2.319 . . . . 16.550000000000001 112.128 -178.999 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.46 121.17 39.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.808 -0.633 . . . . 18.07 110.063 179.052 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.541 -0.742 . . . . 20.260000000000002 109.2 179.968 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' C' C ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' C' C ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_